{
  "url": "https://doi.org/10.1093/cid/ciy723",
  "cached_at": 1749607928.9096537,
  "cache_key": "url_1ef76ab91f671769",
  "content": {
    "success": true,
    "url": "https://doi.org/10.1093/cid/ciy723",
    "title": "Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients | Clinical Infectious Diseases | Oxford Academic",
    "description": "Of patients with pneumonia coming from the community, 18% are immunocompromised. Specific immunocompromised states are associated with specific microbiolog",
    "status_code": 200,
    "crawl_time": 7.528860092163086,
    "timestamp": "2025-06-11T05:12:08.900382",
    "cache_hit": false,
    "raw_html": "<!DOCTYPE html><html lang=\"en\" class=\"no-js\"><head><meta class=\"foundation-mq-small\"><meta class=\"foundation-mq-small-only\"><meta class=\"foundation-mq-medium\"><meta class=\"foundation-mq-medium-only\"><meta class=\"foundation-mq-large\"><meta class=\"foundation-mq-large-only\"><meta class=\"foundation-mq-xlarge\"><meta class=\"foundation-mq-xlarge-only\"><meta class=\"foundation-mq-xxlarge\"><meta class=\"foundation-data-attribute-namespace\">\n    <!-- charset must appear in the first 1024 bytes of the document -->\n    <meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\">\n        <title>Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients | Clinical Infectious Diseases | Oxford Academic</title>\n        \n                \n\n\n        <script async=\"\" src=\"https://buttons-config.sharethis.com/js/643701de45aa460012e1032e.js\"></script><script type=\"text/javascript\" async=\"\" src=\"https://www.googletagmanager.com/gtag/js?id=G-GLF90ZEMKF&amp;cx=c&amp;gtm=45He5690h1v79429524za200&amp;tag_exp=101509157~103116026~103200004~103233427~103351869~103351871~104617979~104617981~104661466~104661468~104684208~104684211\"></script><script type=\"text/javascript\" async=\"\" src=\"https://www.cdn.privado.ai/b230e0658a2d4f23bd9374dc1930f2c9.js\"></script><script async=\"\" src=\"https://www.googletagmanager.com/gtm.js?id=GTM-W6DD7HV\"></script><script type=\"text/javascript\" defer=\"\" src=\"//js.trendmd.com/trendmd.min.js\" data-trendmdconfig=\"{&quot;element&quot;:&quot;#trendmd-suggestions&quot;}\"></script>\n\n\n\n    <script src=\"https://ajax.googleapis.com/ajax/libs/jquery/3.7.1/jquery.min.js\" type=\"text/javascript\"></script>\n<script>window.jQuery || document.write('<script src=\"//oup.silverchair-cdn.com/Themes/Silver/app/js/jquery.3.7.1.min.js\" type=\"text/javascript\">\\x3C/script>')</script>\n<script src=\"//oup.silverchair-cdn.com/Themes/Silver/app/vendor/v-638830270403470925/jquery-migrate-1.4.1.min.js\" type=\"text/javascript\"></script>\n\n    <script type=\"text/javascript\" src=\"https://platform-api.sharethis.com/js/sharethis.js#property=643701de45aa460012e1032e&amp;product=sop\" async=\"async\"></script>\n\n\n    <meta name=\"viewport\" content=\"width=device-width, initial-scale=1, maximum-scale=10\">\n\n    \n    <meta http-equiv=\"X-UA-Compatible\" content=\"IE=Edge\">\n    <!-- Turn off telephone number detection. -->\n    <meta name=\"format-detection\" content=\"telephone=no\">\n\n<!-- Bookmark Icons -->\n  <link rel=\"apple-touch-icon\" sizes=\"180x180\" href=\"//oup.silverchair-cdn.com/UI/app/img/v-638830269404973882/apple-touch-icon.png\">\n  <link rel=\"icon\" type=\"image/png\" href=\"//oup.silverchair-cdn.com/UI/app/img/v-638830269405123889/favicon-32x32.png\" sizes=\"32x32\">\n  <link rel=\"icon\" type=\"image/png\" href=\"//oup.silverchair-cdn.com/UI/app/img/v-638830269405073884/favicon-16x16.png\" sizes=\"16x16\">\n  <link rel=\"mask-icon\" href=\"//oup.silverchair-cdn.com/UI/app/img/v-638830269422336701/safari-pinned-tab.svg\" color=\"#001C54\">\n  <link rel=\"icon\" href=\"//oup.silverchair-cdn.com/UI/app/img/v-638830269421737312/favicon.ico\">\n  <link rel=\"manifest\" href=\"//oup.silverchair-cdn.com/UI/app/img/v-638830269422036734/manifest.json\">\n  <meta name=\"msapplication-config\" content=\"//oup.silverchair-cdn.com/UI/app/img/v-638830269404973882/browserconfig.xml\">\n  <meta name=\"theme-color\" content=\"#002f65\">\n\n\n    \n\n\n\n\n<link rel=\"stylesheet\" type=\"text/css\" href=\"//oup.silverchair-cdn.com/UI/app/fonts/icons.css\">\n\n<link rel=\"stylesheet\" type=\"text/css\" href=\"//oup.silverchair-cdn.com/Themes/Client/app/css/v-638847457879323408/site.min.css\">\n\n\n    <link rel=\"stylesheet\" href=\"https://fonts.googleapis.com/css?family=Merriweather:300,400,400italic,700,700italic|Source+Sans+Pro:400,400italic,700,700italic\" as=\"style\" onload=\"this.onload=null;this.rel='stylesheet'\">\n\n\n        <link href=\"//oup.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/CSS/journals/v-638833379356521055/global.css\" rel=\"stylesheet\" type=\"text/css\">\n            <link href=\"//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/CSS/cid/v-638814360517039884/Site.css\" rel=\"stylesheet\" type=\"text/css\">\n\n\n\n<script> var dataLayer = [{\"full_title\":\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\",\"short_title\":\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\",\"authors\":\"Marta Francesca Di Pasquale,Giovanni Sotgiu,Andrea Gramegna,Dejan Radovanovic,Silvia Terraneo,Luis F Reyes,Jan Rupp,Juan González del Castillo,Francesco Blasi,Stefano Aliberti,Marcos I Restrepo\",\"issue_and_volume\":\"Volume 68 | Issue 9\",\"type\":\"research-article\",\"online_publication_date\":\"2018-08-23\",\"access_type\":\"Free\",\"license_type\":\"free\",\"event_type\":\"full-text\",\"supplier_tag\":\"SC_Journals\",\"object_type\":\"Article\",\"taxonomy\":\"taxId%3a39%7ctaxLabel%3aAcademicSubjects%7cnodeId%3aMED00290%7cnodeLabel%3aInfectious+Diseases%7cnodeLevel%3a3\",\"siteid\":\"cid\",\"authzrequired\":\"false\",\"doi\":\"10.1093/cid/ciy723\"}]; </script>\n            <script>\n                (function (w, d, s, l, i) {\n                    w[l] = w[l] || []; w[l].push({\n                        'gtm.start':\n                            new Date().getTime(), event: 'gtm.js'\n                    }); var f = d.getElementsByTagName(s)[0],\n                        j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : '';\n                        j.async = true; j.src =\n                        'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);\n                })(window, document, 'script', 'dataLayer', 'GTM-W6DD7HV');\n            </script>\n\n    \n\n        <script type=\"text/javascript\">\n            var App = App || {};\n            App.LoginUserInfo = {\n                isInstLoggedIn: 0,\n                isIndividualLoggedIn: 0\n            };\n\n            App.CurrentSubdomain = 'cid';\n            App.SiteURL = 'academic.oup.com/cid';\n        </script>\n    \n    \n    <link href=\"https://cdn.jsdelivr.net/chartist.js/latest/chartist.min.css\" onload=\"this.onload=null;this.removeAttribute('media');\" rel=\"stylesheet\" type=\"text/css\">\n    <script type=\"application/ld+json\">\n        {\"@context\":\"https://schema.org\",\"@type\":\"ScholarlyArticle\",\"@id\":\"https://academic.oup.com/cid/article/68/9/1482/5078600\",\"name\":\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\",\"about\":[\"acquired immunodeficiency syndrome\",\"chemotherapy regimen\",\"community acquired pneumonia\",\"hematologic neoplasms\",\"immunocompetence\",\"immunocompromised host\",\"pneumonia\",\"steroids\",\"bacteria\",\"microbiology\",\"viruses\",\"pathogenic organism\",\"community\",\"causality\"],\"datePublished\":\"2018-08-23\",\"isPartOf\":{\"@id\":\"https://academic.oup.com/cid/issue/68/9\",\"@type\":\"PublicationIssue\",\"issueNumber\":\"9\",\"datePublished\":\"2019-04-24\",\"isPartOf\":{\"@id\":\"https://academic.oup.com/cid/cid\",\"@type\":\"Periodical\",\"name\":\"Clinical Infectious Diseases\",\"issn\":[\"1537-6591\"]}},\"url\":\"https://dx.doi.org/10.1093/cid/ciy723\",\"keywords\":[\"acquired immunodeficiency syndrome\",\"chemotherapy regimen\",\"community acquired pneumonia\",\"hematologic neoplasms\",\"immunocompetence\",\"immunocompromised host\",\"pneumonia\",\"steroids\",\"bacteria\",\"microbiology\",\"viruses\",\"pathogenic organism\",\"community\",\"causality\",\"pneumonia\",\"multidrug-resistant pathogens\",\"microbiology\",\"MRSA\",\"immunocompromise\"],\"inLanguage\":\"en\",\"copyrightHolder\":\"Infectious Diseases Society of America\",\"copyrightYear\":\"2025\",\"publisher\":\"Oxford University Press\",\"author\":[{\"name\":\"Di Pasquale, Marta Francesca\",\"affiliation\":\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\",\"@type\":\"Person\",\"sameAs\":\"https://orcid.org/0000-0002-1450-5830\"},{\"name\":\"Sotgiu, Giovanni\",\"affiliation\":\"Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari\",\"@type\":\"Person\"},{\"name\":\"Gramegna, Andrea\",\"affiliation\":\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\",\"@type\":\"Person\"},{\"name\":\"Radovanovic, Dejan\",\"affiliation\":\"Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Pulmonary Unit, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco\",\"@type\":\"Person\"},{\"name\":\"Terraneo, Silvia\",\"affiliation\":\"Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Italy\",\"@type\":\"Person\"},{\"name\":\"Reyes, Luis F\",\"affiliation\":\"Microbiology Department, Universidad de La Sabana, Chia, Colombia\",\"@type\":\"Person\"},{\"name\":\"Rupp, Jan\",\"affiliation\":\"Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany\",\"@type\":\"Person\"},{\"name\":\"González del Castillo, Juan\",\"affiliation\":\"Emergency Department, Hospital Clínico San Carlos, Universidad Complutense  Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, IdISSC, Madrid, Spain\",\"@type\":\"Person\"},{\"name\":\"Blasi, Francesco\",\"affiliation\":\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\",\"@type\":\"Person\"},{\"name\":\"Aliberti, Stefano\",\"affiliation\":\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\",\"@type\":\"Person\"},{\"name\":\"Restrepo, Marcos I\",\"affiliation\":\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio\",\"@type\":\"Person\"}],\"description\":\"Of patients with pneumonia coming from the community, 18% are immunocompromised. Specific immunocompromised states are associated with specific microbiolog\",\"pageStart\":\"1482\",\"pageEnd\":\"1493\",\"siteName\":\"OUP Academic\",\"thumbnailURL\":\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\",\"headline\":\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\",\"image\":\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\",\"image:alt\":\"Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, &lt;5%, 5%–10%, 11%–20%, 21%–30%, or &gt;30% of total cases.\"}\n    </script>\n<meta property=\"og:site_name\" content=\"OUP Academic\">\n<meta property=\"og:title\" content=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\">\n<meta property=\"og:description\" content=\"Of patients with pneumonia coming from the community, 18% are immunocompromised. Specific immunocompromised states are associated with specific microbiolog\">\n<meta property=\"og:type\" content=\"article\">\n<meta property=\"og:url\" content=\"https://dx.doi.org/10.1093/cid/ciy723\">\n<meta property=\"og:updated_time\" content=\"\">\n<meta property=\"og:image\" content=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&amp;Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\">\n<meta property=\"og:image:url\" content=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&amp;Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\">\n<meta property=\"og:image:secure_url\" content=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&amp;Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\">\n<meta property=\"og:image:alt\" content=\"Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases.\">\n<meta name=\"twitter:card\" content=\"summary_large_image\">\n<meta name=\"citation_author\" content=\"Di Pasquale, Marta Francesca\"><meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\"><meta name=\"citation_author\" content=\"Sotgiu, Giovanni\"><meta name=\"citation_author_institution\" content=\"Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari\"><meta name=\"citation_author\" content=\"Gramegna, Andrea\"><meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\"><meta name=\"citation_author\" content=\"Radovanovic, Dejan\"><meta name=\"citation_author_institution\" content=\"Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Pulmonary Unit, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco\"><meta name=\"citation_author\" content=\"Terraneo, Silvia\"><meta name=\"citation_author_institution\" content=\"Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Italy\"><meta name=\"citation_author\" content=\"Reyes, Luis F\"><meta name=\"citation_author_institution\" content=\"Microbiology Department, Universidad de La Sabana, Chia, Colombia\"><meta name=\"citation_author\" content=\"Rupp, Jan\"><meta name=\"citation_author_institution\" content=\"Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany\"><meta name=\"citation_author\" content=\"González del Castillo, Juan\"><meta name=\"citation_author_institution\" content=\"Emergency Department, Hospital Clínico San Carlos, Universidad Complutense\"><meta name=\"citation_author_institution\" content=\"Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, IdISSC, Madrid, Spain\"><meta name=\"citation_author\" content=\"Blasi, Francesco\"><meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\"><meta name=\"citation_author\" content=\"Aliberti, Stefano\"><meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\"><meta name=\"citation_author\" content=\"Restrepo, Marcos I\"><meta name=\"citation_author_institution\" content=\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio\"><meta name=\"citation_title\" content=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\"><meta name=\"citation_firstpage\" content=\"1482\"><meta name=\"citation_lastpage\" content=\"1493\"><meta name=\"citation_doi\" content=\"10.1093/cid/ciy723\"><meta name=\"citation_keyword\" content=\"community acquired pneumonia\"><meta name=\"citation_keyword\" content=\"immunocompromised host\"><meta name=\"citation_keyword\" content=\"pneumonia\"><meta name=\"citation_keyword\" content=\"pathogenic organism\"><meta name=\"citation_keyword\" content=\"community\"><meta name=\"citation_keyword\" content=\"hematologic neoplasms\"><meta name=\"citation_keyword\" content=\"steroids\"><meta name=\"citation_keyword\" content=\"microbiology\"><meta name=\"citation_keyword\" content=\"acquired immunodeficiency syndrome\"><meta name=\"citation_keyword\" content=\"chemotherapy regimen\"><meta name=\"citation_keyword\" content=\"immunocompetence\"><meta name=\"citation_keyword\" content=\"viruses\"><meta name=\"citation_keyword\" content=\"causality\"><meta name=\"citation_keyword\" content=\"bacteria\"><meta name=\"citation_journal_title\" content=\"Clinical Infectious Diseases\"><meta name=\"citation_journal_abbrev\" content=\"Clin Infect Dis\"><meta name=\"citation_volume\" content=\"68\"><meta name=\"citation_issue\" content=\"9\"><meta name=\"citation_publication_date\" content=\"2019/04/24\"><meta name=\"citation_issn\" content=\"1058-4838\"><meta name=\"citation_publisher\" content=\"Oxford Academic\"><meta name=\"citation_reference\" content=\"citation_title=Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia; citation_author=Aliberti  S; citation_author=Di Pasquale  M; citation_author=Zanaboni  AM;  citation_journal_title=Clin Infect Dis;  citation_year=2012;  citation_volume=54;  citation_pages=470-8; \"><meta name=\"citation_reference\" content=\"citation_title=Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective; citation_author=Aliberti  S; citation_author=Cilloniz  C; citation_author=Chalmers  JD;  citation_journal_title=Thorax;  citation_year=2013;  citation_volume=68;  citation_pages=997-9; \"><meta name=\"citation_reference\" content=\"citation_title=Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia; citation_author=Shindo  Y; citation_author=Ito  R; citation_author=Kobayashi  D;  citation_journal_title=Am J Respir Crit Care Med;  citation_year=2013;  citation_volume=188;  citation_pages=985-95; \"><meta name=\"citation_reference\" content=\"citation_title=Community-acquired pneumonia; citation_author=Musher  DM; citation_author=Thorner  AR;  citation_journal_title=N Engl J Med;  citation_year=2014;  citation_volume=371;  citation_pages=1619-28; \"><meta name=\"citation_reference\" content=\"citation_title=Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults; citation_author=Infectious Diseases Society of America; American Thoracic Society; citation_author=Mandell  LA; citation_author=Wunderink  RG; citation_author=Anzueto  A;  citation_journal_title=Clin Infect Dis;  citation_year=2007;  citation_volume=44;  citation_pages=S27-72; \"><meta name=\"citation_reference\" content=\"citation_title=BTS guidelines for the management of community acquired pneumonia in adults; citation_author=Lim  WS; citation_author=Baudouin  SV; citation_author=George  RC;  citation_journal_title=Thorax;  citation_year=2009;  citation_volume=64;  citation_pages=iii1-55; \"><meta name=\"citation_reference\" content=\"citation_title=Guidelines for the management of adult lower respiratory tract infections—full version; citation_author=Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases; citation_author=Woodhead  M; citation_author=Blasi  F; citation_author=Ewig  S;  citation_journal_title=Clin Microbiol Infect;  citation_year=2011;  citation_volume=17(suppl 6);  citation_pages=E1-59; \"><meta name=\"citation_reference\" content=\"citation_title=Pneumonia in older residents of long-term care facilities; citation_author=Furman  CD; citation_author=Rayner  AV; citation_author=Tobin  EP;  citation_journal_title=Am Fam Physician;  citation_year=2004;  citation_volume=70;  citation_pages=1495-500; \"><meta name=\"citation_reference\" content=\"citation_title=Impact of age and comorbidity on cause and outcome in community-acquired pneumonia; citation_author=Cillóniz  C; citation_author=Polverino  E; citation_author=Ewig  S;  citation_journal_title=Chest;  citation_year=2013;  citation_volume=144;  citation_pages=999-1007; \"><meta name=\"citation_reference\" content=\"citation_title=Global Initiative for Meticillin-Resistant Staphylococcus aureus Pneumonia (GLIMP): an international, observational cohort study; citation_author=GLIMP investigators; citation_author=Aliberti  S; citation_author=Reyes  LF; citation_author=Faverio  P;  citation_journal_title=Lancet Infect Dis;  citation_year=2016;  citation_volume=16;  citation_pages=1364-76; \"><meta name=\"citation_reference\" content=\"citation_title=Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance; citation_author=Magiorakos  AP; citation_author=Srinivasan  A; citation_author=Carey  RB;  citation_journal_title=Clin Microbiol Infect;  citation_year=2012;  citation_volume=18;  citation_pages=268-81; \"><meta name=\"citation_reference\" content=\"citation_title=Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy; citation_author=Wan  QJ; citation_author=Hu  HF; citation_author=He  YC;  citation_journal_title=Kaohsiung J Med Sci;  citation_year=2015;  citation_volume=31;  citation_pages=42-6; \"><meta name=\"citation_reference\" content=\"citation_title=Pneumocystis pneumonia in patients with immunobullous dermatoses; citation_author=Li  F; citation_author=Jin  HZ; citation_author=Su  F; citation_author=Jia  L; citation_author=Sun  QN;  citation_journal_title=Int J Dermatol;  citation_year=2011;  citation_volume=50;  citation_pages=1144-9; \"><meta name=\"citation_reference\" content=\"citation_title=Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia; citation_author=Gruson  D; citation_author=Vargas  F; citation_author=Hilbert  G;  citation_journal_title=Intensive Care Med;  citation_year=2004;  citation_volume=30;  citation_pages=965-71; \"><meta name=\"citation_reference\" content=\"citation_title=Pneumonia during remission induction chemotherapy in patients with acute leukemia; citation_author=Garcia  JB; citation_author=Lei  X; citation_author=Wierda  W;  citation_journal_title=Ann Am Thorac Soc;  citation_year=2013;  citation_volume=10;  citation_pages=432-40; \"><meta name=\"citation_reference\" content=\"citation_title=Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients; citation_author=Lee  JO; citation_author=Kim  DY; citation_author=Lim  JH;  citation_journal_title=Lung Cancer;  citation_year=2008;  citation_volume=62;  citation_pages=381-4; \"><meta name=\"citation_reference\" content=\"citation_title=Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab; citation_author=Lim  KH; citation_author=Yoon  HI; citation_author=Kang  YA;  citation_journal_title=Korean J Intern Med;  citation_year=2010;  citation_volume=25;  citation_pages=86-92; \"><meta name=\"citation_reference\" content=\"citation_title=Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors; citation_author=Waks  AG; citation_author=Tolaney  SM; citation_author=Galar  A;  citation_journal_title=Breast Cancer Res Treat;  citation_year=2015;  citation_volume=154;  citation_pages=359-67; \"><meta name=\"citation_reference\" content=\"citation_title=Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy; citation_author=Kim  T; citation_author=Choi  SH; citation_author=Kim  SH;  citation_journal_title=Ann Hematol;  citation_year=2013;  citation_volume=92;  citation_pages=231-8; \"><meta name=\"citation_reference\" content=\"citation_title=The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia; citation_author=Aliberti  S; citation_author=Myers  JA; citation_author=Peyrani  P;  citation_journal_title=Eur Respir J;  citation_year=2009;  citation_volume=33;  citation_pages=142-7; \"><meta name=\"citation_reference\" content=\"citation_title=Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study; citation_author=Sogaard  OS; citation_author=Lohse  N; citation_author=Gerstoft  J;  citation_journal_title=Clin Infect Dis;  citation_year=2008;  citation_volume=47;  citation_pages=1345-53; \"><meta name=\"citation_reference\" content=\"citation_title=Therapeutic implication of BAL in patients with neutropenia; citation_author=Kuehnhardt  D; citation_author=Hannemann  M; citation_author=Schmidt  B; citation_author=Heider  U; citation_author=Possinger  K; citation_author=Eucker  J;  citation_journal_title=Ann Hematol;  citation_year=2009;  citation_volume=88;  citation_pages=1249-56; \"><meta name=\"citation_reference\" content=\"citation_title=Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the Infectious Diseases Working Party of the German Society of Haematology and Oncology; citation_author=Maschmeyer  G; citation_author=Beinert  T; citation_author=Buchheidt  D;  citation_journal_title=Eur J Cancer;  citation_year=2009;  citation_volume=45;  citation_pages=2462-72; \"><meta name=\"citation_reference\" content=\"citation_title=ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients; citation_author=5th European Conference on Infections in Leukemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN); citation_author=Alanio  A; citation_author=Hauser  PM; citation_author=Lagrou  K;  citation_journal_title=J Antimicrob Chemother;  citation_year=2016;  citation_volume=71;  citation_pages=2386-96; \"><meta name=\"citation_reference\" content=\"citation_title=Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America; citation_author=Infectious Diseases Society of America; citation_author=Freifeld  AG; citation_author=Bow  EJ; citation_author=Sepkowitz  KA;  citation_journal_title=Clin Infect Dis;  citation_year=2011;  citation_volume=52;  citation_pages=e56-93; \"><meta name=\"citation_reference\" content=\"citation_title=Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies; citation_author=Chemaly  RF; citation_author=Shah  DP; citation_author=Boeckh  MJ;  citation_journal_title=Clin Infect Dis;  citation_year=2014;  citation_volume=59;  citation_pages=S344-51; \"><meta name=\"citation_reference\" content=\"citation_title=Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010; citation_author=North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA; citation_author=Buchacz  K; citation_author=Lau  B; citation_author=Jing  Y;  citation_journal_title=J Infect Dis;  citation_year=2016;  citation_volume=214;  citation_pages=862-72; \"><meta name=\"citation_reference\" content=\"citation_title=Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era; citation_author=Madeddu  G; citation_author=Porqueddu  EM; citation_author=Cambosu  F;  citation_journal_title=Infection;  citation_year=2008;  citation_volume=36;  citation_pages=231-6; \"><meta name=\"citation_reference\" content=\"citation_title=The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness; citation_author=Harborview CAP Study Group; citation_author=Park  DR; citation_author=Sherbin  VL; citation_author=Goodman  MS;  citation_journal_title=J Infect Dis;  citation_year=2001;  citation_volume=184;  citation_pages=268-77; \"><meta name=\"citation_reference\" content=\"citation_title=Infections in patients with aplastic anemia: experience at a tertiary care cancer center; citation_author=Torres  HA; citation_author=Bodey  GP; citation_author=Rolston  KV; citation_author=Kantarjian  HM; citation_author=Raad  II; citation_author=Kontoyiannis  DP;  citation_journal_title=Cancer;  citation_year=2003;  citation_volume=98;  citation_pages=86-93; \"><meta name=\"citation_reference\" content=\"citation_title=Risk of hospitalization due to pneumococcal disease in adults in Spain: the CORIENNE study; citation_author=Gil-Prieto  R; citation_author=Pascual-Garcia  R; citation_author=Walter  S; citation_author=Álvaro-Meca  A; citation_author=Gil-De-Miguel  Á;  citation_journal_title=Hum Vaccin Immunother;  citation_year=2016;  citation_volume=12;  citation_pages=1900-5; \"><meta name=\"citation_reference\" content=\"citation_title=Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients; citation_author=Putot  A; citation_author=Tetu  J; citation_author=Perrin  S;  citation_journal_title=Eur J Clin Microbiol Infect Dis;  citation_year=2016;  citation_volume=35;  citation_pages=489-95; \"><meta name=\"citation_reference\" content=\"citation_title=Nursing home-acquired pneumonia: a 10 year single-centre experience; citation_author=Polverino  E; citation_author=Dambrava  P; citation_author=Cillóniz  C;  citation_journal_title=Thorax;  citation_year=2010;  citation_volume=65;  citation_pages=354-9; \"><meta name=\"citation_reference\" content=\"citation_title=Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study; citation_author=HER Study Group; citation_author=Kohli  R; citation_author=Lo  Y; citation_author=Homel  P;  citation_journal_title=Clin Infect Dis;  citation_year=2006;  citation_volume=43;  citation_pages=90-8; \"><meta name=\"citation_reference\" content=\"citation_title=Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain; citation_author=Benito  N; citation_author=Rañó  A; citation_author=Moreno  A;  citation_journal_title=J Acquir Immune Defic Syndr;  citation_year=2001;  citation_volume=27;  citation_pages=35-43; \"><meta name=\"citation_reference\" content=\"citation_title=Polymerase chain reaction positivity of Pneumocystis jirovecii during primary lung cancer treatment; citation_author=Mori  H; citation_author=Ohno  Y; citation_author=Ito  F;  citation_journal_title=Jpn J Clin Oncol;  citation_year=2010;  citation_volume=40;  citation_pages=658-62; \"><meta name=\"citation_reference\" content=\"citation_title=Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL; citation_author=Boersma  WG; citation_author=Erjavec  Z; citation_author=van der Werf  TS; citation_author=de Vries-Hosper  HG; citation_author=Gouw  AS; citation_author=Manson  WL;  citation_journal_title=Respir Med;  citation_year=2007;  citation_volume=101;  citation_pages=317-25; \"><meta name=\"citation_reference\" content=\"citation_title=Epidemiology of viral respiratory tract infections in an outpatient haematology facility; citation_author=Mikulska  M; citation_author=Del Bono  V; citation_author=Gandolfo  N;  citation_journal_title=Ann Hematol;  citation_year=2014;  citation_volume=93;  citation_pages=669-76; \"><meta name=\"citation_reference\" content=\"citation_title=Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative; citation_author=Beaird  OE; citation_author=Freifeld  A; citation_author=Ison  MG;  citation_journal_title=Transpl Infect Dis;  citation_year=2016;  citation_volume=18;  citation_pages=210-5; \"><meta name=\"citation_reference\" content=\"citation_title=Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients; citation_author=Poonyagariyagorn  HK; citation_author=Gershman  A; citation_author=Avery  R;  citation_journal_title=Transpl Infect Dis;  citation_year=2008;  citation_volume=10;  citation_pages=403-8; \"><meta name=\"citation_reference\" content=\"citation_title=Risk factors for vancomycin-resistant Enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation; citation_author=Tavadze  M; citation_author=Rybicki  L; citation_author=Mossad  S;  citation_journal_title=Bone Marrow Transplant;  citation_year=2014;  citation_volume=49;  citation_pages=1310-6; \"><meta name=\"citation_reference\" content=\"citation_title=Bacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance; citation_author=Bock  AM; citation_author=Cao  Q; citation_author=Ferrieri  P; citation_author=Young  JA; citation_author=Weisdorf  DJ;  citation_journal_title=Biol Blood Marrow Transplant;  citation_year=2013;  citation_volume=19;  citation_pages=102-8; \"><meta name=\"citation_reference\" content=\"citation_title=Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients; citation_author=Herbers  AH; citation_author=de Haan  AF; citation_author=van der Velden  WJ; citation_author=Donnelly  JP; citation_author=Blijlevens  NM;  citation_journal_title=Transpl Infect Dis;  citation_year=2014;  citation_volume=16;  citation_pages=279-85; \"><meta name=\"citation_reference\" content=\"citation_title=Community-acquired urinary tract infection in kidney transplantation: risk factors for bacteremia and recurrent infection; citation_author=Wu  SW; citation_author=Liu  KS; citation_author=Lin  CK;  citation_journal_title=J Formos Med Assoc;  citation_year=2013;  citation_volume=112;  citation_pages=138-43; \"><meta name=\"citation_reference\" content=\"citation_title=Blood stream infections in renal transplant recipients: a single-center study; citation_author=Daskalaki  E; citation_author=Koukoulaki  M; citation_author=Bakalis  A;  citation_journal_title=Transplant Proc;  citation_year=2014;  citation_volume=46;  citation_pages=3191-3; \"><meta name=\"citation_reference\" content=\"citation_title=Community-acquired bacterial bloodstream infections in HIV-infected patients: a systematic review; citation_author=Huson  MA; citation_author=Stolp  SM; citation_author=van der Poll  T; citation_author=Grobusch  MP;  citation_journal_title=Clin Infect Dis;  citation_year=2014;  citation_volume=58;  citation_pages=79-92; \"><meta name=\"citation_reference\" content=\"citation_title=Bloodstream infections in HIV-infected patients; citation_author=Taramasso  L; citation_author=Tatarelli  P; citation_author=Di Biagio  A;  citation_journal_title=Virulence;  citation_year=2016;  citation_volume=7;  citation_pages=320-8; \"><meta name=\"citation_fulltext_world_readable\" content=\"\"><meta name=\"citation_pdf_url\" content=\"https://academic.oup.com/cid/article-pdf/68/9/1482/28520951/ciy723.pdf\"><meta name=\"description\" content=\"Of patients with pneumonia coming from the community, 18% are immunocompromised. Specific immunocompromised states are associated with specific microbiolog\"><meta name=\"citation_xml_url\" content=\"https://academic.oup.com/cid/article-xml/68/9/1482/5078600\">\n\n\n    <link rel=\"canonical\" href=\"https://academic.oup.com/cid/article/68/9/1482/5078600\">\n\n\n\n\n\n\n\n\n    <meta name=\"product_code\" content=\"J_CID_2018_11_13\">\n    <meta name=\"product_code\" content=\"J_cid_2017_01_72\">\n    <meta name=\"product_code\" content=\"J_CID_2019_03_13\">\n    <meta name=\"product_code\" content=\"J_CID_2012_06_91\">\n    <meta name=\"product_code\" content=\"J_cid_2019_01_60\">\n    <meta name=\"product_code\" content=\"J_cid_1996_01_312\">\n    <meta name=\"product_code\" content=\"J_cid_1996_01_336\">\n    <meta name=\"product_code\" content=\"J_CID_2018_09_13\">\n    <meta name=\"product_code\" content=\"J_CID_2018_07_12\">\n    <meta name=\"product_code\" content=\"FBI_1to10YearRollingByJournal\">\n    <meta name=\"product_code\" content=\"J_CID_2018_07_13\">\n    <meta name=\"product_code\" content=\"J_CID_2012_01_96\">\n    <meta name=\"product_code\" content=\"Corona_Virus_Articles\">\n    <meta name=\"product_code\" content=\"J_cid_2019_01_24\">\n    <meta name=\"product_code\" content=\"J_CID_1996_01_9999\">\n    <meta name=\"product_code\" content=\"J_CID_2018_06_13\">\n    <meta name=\"product_code\" content=\"J_CID_2018_08_13\">\n    <meta name=\"product_code\" content=\"J_CID_2019_04_13\">\n    <meta name=\"product_code\" content=\"J_CID_2018_05_13\">\n    <meta name=\"product_code\" content=\"J_CID_2018_04_13\">\n    <meta name=\"product_code\" content=\"J_CID_2014_01_72\">\n    <meta name=\"product_code\" content=\"J_CID_2013_01_84\">\n    <meta name=\"product_code\" content=\"J_cid_2011_01_168\">\n    <meta name=\"product_code\" content=\"J_CID_2018_10_13\">\n    <meta name=\"product_code\" content=\"J_CID_2019_02_13\">\n    <meta name=\"product_code\" content=\"J_CID_2015_01_60\">\n    <meta name=\"product_code\" content=\"J_CID_2019_02_12\">\n    <meta name=\"product_code\" content=\"J_cid_2018_01_36\">\n    <meta name=\"product_code\" content=\"COMP_RetainedFBI\">\n    <meta name=\"product_code\" content=\"J_cid_2018_01_24\">\n    <meta name=\"product_code\" content=\"J_cid_1996_01_324\">\n    <meta name=\"product_code\" content=\"Funded_Free_Content\">\n    <meta name=\"product_code\" content=\"J_cid_1996_01_288\">\n    <meta name=\"product_code\" content=\"J_CID_1996_01_300\">\n    <meta name=\"product_code\" content=\"j_ALLJOURNALS\">\n    <meta name=\"product_code\" content=\"J_CID_2019_01_12\">\n    <meta name=\"product_code\" content=\"J_CID_2011_01_108\">\n    <meta name=\"product_code\" content=\"SOLR_FACET_FREE\">\n    <meta name=\"product_code\" content=\"J_5078600\">\n    <meta name=\"product_code\" content=\"I_115396\">\n\n\n\n\n\n    \n\n\n\n        <script>\n            var SCM = SCM || {};\n            SCM.pubGradeAdsEnabled = true;\n            SCM.pubGradeJSLibrary = 'https://cdn.pbgrd.com/core-oup-new.js';\n        </script>\n    <script async=\"async\" src=\"https://securepubads.g.doubleclick.net/tag/js/gpt.js\"></script>\n    <script>\n        var googletag = googletag || {};\n        googletag.cmd = googletag.cmd || [];\n    </script>\n        \n            <script type=\"text/javascript\">\n            var gptAdSlots = [];\n            googletag.cmd.push(function() {\n                    \n                    var mapping_ad1 = googletag.sizeMapping()\n                        .addSize([1024, 0], [[970, 90], [728, 90]])\n                        .addSize([768, 0], [728, 90])\n                        .addSize([0, 0], [320, 50])\n                        .build();\n                    gptAdSlots[\"ad1\"] = googletag.defineSlot('/116097782/cid_Supplement_Ad1',\n                            [[970, 90], [728, 90], [320, 50]], 'adBlockHeader')\n                        .defineSizeMapping(mapping_ad1)\n                        .addService(googletag.pubads());\n                    \n\n                    \n                    var mapping_ad2 = googletag.sizeMapping()\n                        .addSize([768, 0], [[300, 250], [300, 600], [160, 600]])\n                        .build();\n                    gptAdSlots[\"ad2\"] = googletag.defineSlot('/116097782/cid_Supplement_Ad2',\n                            [[300, 250], [160, 600], [300, 600]], 'adBlockMainBodyTop')\n                        .defineSizeMapping(mapping_ad2)\n                        .addService(googletag.pubads());\n                    \n\n                    \n                    var mapping_ad3 = googletag.sizeMapping()\n                        .addSize([768, 0], [[300, 250], [300, 600], [160, 600]])\n                        .build();\n                    gptAdSlots[\"ad3\"] = googletag.defineSlot('/116097782/cid_Supplement_Ad3',\n                        [[300, 250], [160, 600], [300, 600]], 'adBlockMainBodyBottom')\n                        .defineSizeMapping(mapping_ad3)\n                        .addService(googletag.pubads());\n                    \n\n                    \n                var mapping_ad4 = googletag.sizeMapping()\n                        .addSize([0,0], [320, 50])\n                        .addSize([768, 0], [728, 90])\n                        .build();\n                    gptAdSlots[\"ad4\"] = googletag.defineSlot('/116097782/cid_Supplement_Ad4',\n                        [728, 90], 'adBlockFooter')\n                        .defineSizeMapping(mapping_ad4)\n                        .addService(googletag.pubads());\n                    \n\n                    \n                var mapping_ad6 = googletag.sizeMapping()\n                        .addSize([1024, 0], [[970, 90], [728, 90]])\n                        .addSize([768, 0], [728, 90])\n                        .addSize([0, 0], [320, 50])\n                        .build();\n                    gptAdSlots[\"ad6\"] = googletag.defineSlot('/116097782/cid_Supplement_Ad6',\n                        [[728, 90], [970, 90]], 'adBlockStickyFooter')\n                        .defineSizeMapping(mapping_ad6)\n                        .addService(googletag.pubads());\n                    \n\n                    \n                    gptAdSlots[\"adInterstitial\"] = googletag.defineOutOfPageSlot('/116097782/cid_Interstitial_Ad',\n                        googletag.enums.OutOfPageFormat.INTERSTITIAL)\n                        .addService(googletag.pubads());\n                    \n\n                googletag.pubads().addEventListener('slotRenderEnded', function (event) {\n                    if (!event.isEmpty) {\n                        $('.js-' + event.slot.getSlotElementId()).each(function () {\n                            if ($(this).find('iframe').length) {\n                                $(this).removeClass('hide');\n                            }\n                        });\n                    }\n                });\n\n                googletag.pubads().addEventListener('impressionViewable', function (event) {\n                    if (!event.isEmpty) {\n                        $('.js-' + event.slot.getSlotElementId()).each(function () {\n                            var $adblockDiv = $(this).find('.js-adblock');\n                            var $adText = $(this).find('.js-adblock-advertisement-text');\n                            if ($adblockDiv && $adblockDiv.is(':visible') && $adblockDiv.find('*').length > 1) {\n                                $adText.removeClass('hide');\n                                App.CenterAdBlock.Init($adblockDiv, $adText);\n                            }\n                            else {\n                                $adText.addClass('hide');\n                            }\n\n                            //Initialize logic for Sticky Footer Ad\n                            var $stickyFooterDiv = $(this).parents('.js-sticky-footer-ad');\n                            if ($stickyFooterDiv && $stickyFooterDiv.is(':visible') && $stickyFooterDiv.find('*').length > 1) {\n                                App.StickyFooterAd.Init();\n                            }\n                        });\n                    }\n                });\n\n                googletag.pubads().setTargeting(\"jnlspage\", \"article\");\n                googletag.pubads().setTargeting(\"jnlsurl\", \"cid/article/68/9/1482/5078600\");\n                googletag.pubads().enableSingleRequest();\n                googletag.pubads().disableInitialLoad();\n                googletag.pubads().collapseEmptyDivs();\n            });\n            </script>\n        \n        <script id=\"altmetric-embed-js\" src=\"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-288192a491f0ad9cc434f05ea175659426f5ab0cfd6befb3f3592f96bb90b0d1.js\"></script><style></style><meta http-equiv=\"origin-trial\" content=\"AlK2UR5SkAlj8jjdEc9p3F3xuFYlF6LYjAML3EOqw1g26eCwWPjdmecULvBH5MVPoqKYrOfPhYVL71xAXI1IBQoAAAB8eyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ==\"><meta http-equiv=\"origin-trial\" content=\"Amm8/NmvvQfhwCib6I7ZsmUxiSCfOxWxHayJwyU1r3gRIItzr7bNQid6O8ZYaE1GSQTa69WwhPC9flq/oYkRBwsAAACCeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ==\"><meta http-equiv=\"origin-trial\" content=\"A9wSqI5i0iwGdf6L1CERNdmsTPgVu44ewj8QxTBYgsv1LCPUVF7YmWOvTappqB1139jAymxUW/RO8zmMqo4zlAAAAACNeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiRmxlZGdlQmlkZGluZ0FuZEF1Y3Rpb25TZXJ2ZXIiLCJleHBpcnkiOjE3MzY4MTI4MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9\"><meta http-equiv=\"origin-trial\" content=\"A+d7vJfYtay4OUbdtRPZA3y7bKQLsxaMEPmxgfhBGqKXNrdkCQeJlUwqa6EBbSfjwFtJWTrWIioXeMW+y8bWAgQAAACTeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiRmxlZGdlQmlkZGluZ0FuZEF1Y3Rpb25TZXJ2ZXIiLCJleHBpcnkiOjE3MzY4MTI4MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9\"><script src=\"https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202506050101/pubads_impl.js\" async=\"\"></script><link href=\"https://securepubads.g.doubleclick.net/pagead/managed/dict/m202506100101/gpt\" rel=\"compression-dictionary\"><style type=\"text/css\">.CtxtMenu_InfoClose {  top:.2em; right:.2em;}\n.CtxtMenu_InfoContent {  overflow:auto; text-align:left; font-size:80%;  padding:.4em .6em; border:1px inset; margin:1em 0px;  max-height:20em; max-width:30em; background-color:#EEEEEE;  white-space:normal;}\n.CtxtMenu_Info.CtxtMenu_MousePost {outline:none;}\n.CtxtMenu_Info {  position:fixed; left:50%; width:auto; text-align:center;  border:3px outset; padding:1em 2em; background-color:#DDDDDD;  color:black;  cursor:default; font-family:message-box; font-size:120%;  font-style:normal; text-indent:0; text-transform:none;  line-height:normal; letter-spacing:normal; word-spacing:normal;  word-wrap:normal; white-space:nowrap; float:none; z-index:201;  border-radius: 15px;                     /* Opera 10.5 and IE9 */  -webkit-border-radius:15px;               /* Safari and Chrome */  -moz-border-radius:15px;                  /* Firefox */  -khtml-border-radius:15px;                /* Konqueror */  box-shadow:0px 10px 20px #808080;         /* Opera 10.5 and IE9 */  -webkit-box-shadow:0px 10px 20px #808080; /* Safari 3 & Chrome */  -moz-box-shadow:0px 10px 20px #808080;    /* Forefox 3.5 */  -khtml-box-shadow:0px 10px 20px #808080;  /* Konqueror */  filter:progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color=\"gray\", Positive=\"true\"); /* IE */}\n</style><style type=\"text/css\">.CtxtMenu_MenuClose {  position:absolute;  cursor:pointer;  display:inline-block;  border:2px solid #AAA;  border-radius:18px;  -webkit-border-radius: 18px;             /* Safari and Chrome */  -moz-border-radius: 18px;                /* Firefox */  -khtml-border-radius: 18px;              /* Konqueror */  font-family: \"Courier New\", Courier;  font-size:24px;  color:#F0F0F0}\n.CtxtMenu_MenuClose span {  display:block; background-color:#AAA; border:1.5px solid;  border-radius:18px;  -webkit-border-radius: 18px;             /* Safari and Chrome */  -moz-border-radius: 18px;                /* Firefox */  -khtml-border-radius: 18px;              /* Konqueror */  line-height:0;  padding:8px 0 6px     /* may need to be browser-specific */}\n.CtxtMenu_MenuClose:hover {  color:white!important;  border:2px solid #CCC!important}\n.CtxtMenu_MenuClose:hover span {  background-color:#CCC!important}\n.CtxtMenu_MenuClose:hover:focus {  outline:none}\n</style><style type=\"text/css\">.CtxtMenu_Menu {  position:absolute;  background-color:white;  color:black;  width:auto; padding:5px 0px;  border:1px solid #CCCCCC; margin:0; cursor:default;  font: menu; text-align:left; text-indent:0; text-transform:none;  line-height:normal; letter-spacing:normal; word-spacing:normal;  word-wrap:normal; white-space:nowrap; float:none; z-index:201;  border-radius: 5px;                     /* Opera 10.5 and IE9 */  -webkit-border-radius: 5px;             /* Safari and Chrome */  -moz-border-radius: 5px;                /* Firefox */  -khtml-border-radius: 5px;              /* Konqueror */  box-shadow:0px 10px 20px #808080;         /* Opera 10.5 and IE9 */  -webkit-box-shadow:0px 10px 20px #808080; /* Safari 3 & Chrome */  -moz-box-shadow:0px 10px 20px #808080;    /* Forefox 3.5 */  -khtml-box-shadow:0px 10px 20px #808080;  /* Konqueror */}\n.CtxtMenu_MenuItem {  padding: 1px 2em;  background:transparent;}\n.CtxtMenu_MenuArrow {  position:absolute; right:.5em; padding-top:.25em; color:#666666;  font-family: null; font-size: .75em}\n.CtxtMenu_MenuActive .CtxtMenu_MenuArrow {color:white}\n.CtxtMenu_MenuArrow.CtxtMenu_RTL {left:.5em; right:auto}\n.CtxtMenu_MenuCheck {  position:absolute; left:.7em;  font-family: null}\n.CtxtMenu_MenuCheck.CtxtMenu_RTL { right:.7em; left:auto }\n.CtxtMenu_MenuRadioCheck {  position:absolute; left: .7em;}\n.CtxtMenu_MenuRadioCheck.CtxtMenu_RTL {  right: .7em; left:auto}\n.CtxtMenu_MenuInputBox {  padding-left: 1em; right:.5em; color:#666666;  font-family: null;}\n.CtxtMenu_MenuInputBox.CtxtMenu_RTL {  left: .1em;}\n.CtxtMenu_MenuComboBox {  left:.1em; padding-bottom:.5em;}\n.CtxtMenu_MenuSlider {  left: .1em;}\n.CtxtMenu_SliderValue {  position:absolute; right:.1em; padding-top:.25em; color:#333333;  font-size: .75em}\n.CtxtMenu_SliderBar {  outline: none; background: #d3d3d3}\n.CtxtMenu_MenuLabel {  padding: 1px 2em 3px 1.33em;  font-style:italic}\n.CtxtMenu_MenuRule {  border-top: 1px solid #DDDDDD;  margin: 4px 3px;}\n.CtxtMenu_MenuDisabled {  color:GrayText}\n.CtxtMenu_MenuActive {  background-color: #606872;  color: white;}\n.CtxtMenu_MenuDisabled:focus {  background-color: #E8E8E8}\n.CtxtMenu_MenuLabel:focus {  background-color: #E8E8E8}\n.CtxtMenu_ContextMenu:focus {  outline:none}\n.CtxtMenu_ContextMenu .CtxtMenu_MenuItem:focus {  outline:none}\n.CtxtMenu_SelectionMenu {  position:relative; float:left;  border-bottom: none; -webkit-box-shadow:none; -webkit-border-radius:0px; }\n.CtxtMenu_SelectionItem {  padding-right: 1em;}\n.CtxtMenu_Selection {  right: 40%; width:50%; }\n.CtxtMenu_SelectionBox {  padding: 0em; max-height:20em; max-width: none;  background-color:#FFFFFF;}\n.CtxtMenu_SelectionDivider {  clear: both; border-top: 2px solid #000000;}\n.CtxtMenu_Menu .CtxtMenu_MenuClose {  top:-10px; left:-10px}\n</style><style id=\"MJX-CHTML-styles\">\nmjx-container[jax=\"CHTML\"] {\n  line-height: 0;\n}\n\nmjx-container [space=\"1\"] {\n  margin-left: .111em;\n}\n\nmjx-container [space=\"2\"] {\n  margin-left: .167em;\n}\n\nmjx-container [space=\"3\"] {\n  margin-left: .222em;\n}\n\nmjx-container [space=\"4\"] {\n  margin-left: .278em;\n}\n\nmjx-container [space=\"5\"] {\n  margin-left: .333em;\n}\n\nmjx-container [rspace=\"1\"] {\n  margin-right: .111em;\n}\n\nmjx-container [rspace=\"2\"] {\n  margin-right: .167em;\n}\n\nmjx-container [rspace=\"3\"] {\n  margin-right: .222em;\n}\n\nmjx-container [rspace=\"4\"] {\n  margin-right: .278em;\n}\n\nmjx-container [rspace=\"5\"] {\n  margin-right: .333em;\n}\n\nmjx-container [size=\"s\"] {\n  font-size: 70.7%;\n}\n\nmjx-container [size=\"ss\"] {\n  font-size: 50%;\n}\n\nmjx-container [size=\"Tn\"] {\n  font-size: 60%;\n}\n\nmjx-container [size=\"sm\"] {\n  font-size: 85%;\n}\n\nmjx-container [size=\"lg\"] {\n  font-size: 120%;\n}\n\nmjx-container [size=\"Lg\"] {\n  font-size: 144%;\n}\n\nmjx-container [size=\"LG\"] {\n  font-size: 173%;\n}\n\nmjx-container [size=\"hg\"] {\n  font-size: 207%;\n}\n\nmjx-container [size=\"HG\"] {\n  font-size: 249%;\n}\n\nmjx-container [width=\"full\"] {\n  width: 100%;\n}\n\nmjx-box {\n  display: inline-block;\n}\n\nmjx-block {\n  display: block;\n}\n\nmjx-itable {\n  display: inline-table;\n}\n\nmjx-row {\n  display: table-row;\n}\n\nmjx-row > * {\n  display: table-cell;\n}\n\nmjx-mtext {\n  display: inline-block;\n}\n\nmjx-mstyle {\n  display: inline-block;\n}\n\nmjx-merror {\n  display: inline-block;\n  color: red;\n  background-color: yellow;\n}\n\nmjx-mphantom {\n  visibility: hidden;\n}\n\n_::-webkit-full-page-media, _:future, :root mjx-container {\n  will-change: opacity;\n}\n\nmjx-assistive-mml {\n  position: absolute !important;\n  top: 0px;\n  left: 0px;\n  clip: rect(1px, 1px, 1px, 1px);\n  padding: 1px 0px 0px 0px !important;\n  border: 0px !important;\n  display: block !important;\n  width: auto !important;\n  overflow: hidden !important;\n  -webkit-touch-callout: none;\n  -webkit-user-select: none;\n  -khtml-user-select: none;\n  -moz-user-select: none;\n  -ms-user-select: none;\n  user-select: none;\n}\n\nmjx-assistive-mml[display=\"block\"] {\n  width: 100% !important;\n}\n\nmjx-c::before {\n  display: block;\n  width: 0;\n}\n\n.MJX-TEX {\n  font-family: MJXZERO, MJXTEX;\n}\n\n.TEX-B {\n  font-family: MJXZERO, MJXTEX-B;\n}\n\n.TEX-I {\n  font-family: MJXZERO, MJXTEX-I;\n}\n\n.TEX-MI {\n  font-family: MJXZERO, MJXTEX-MI;\n}\n\n.TEX-BI {\n  font-family: MJXZERO, MJXTEX-BI;\n}\n\n.TEX-S1 {\n  font-family: MJXZERO, MJXTEX-S1;\n}\n\n.TEX-S2 {\n  font-family: MJXZERO, MJXTEX-S2;\n}\n\n.TEX-S3 {\n  font-family: MJXZERO, MJXTEX-S3;\n}\n\n.TEX-S4 {\n  font-family: MJXZERO, MJXTEX-S4;\n}\n\n.TEX-A {\n  font-family: MJXZERO, MJXTEX-A;\n}\n\n.TEX-C {\n  font-family: MJXZERO, MJXTEX-C;\n}\n\n.TEX-CB {\n  font-family: MJXZERO, MJXTEX-CB;\n}\n\n.TEX-FR {\n  font-family: MJXZERO, MJXTEX-FR;\n}\n\n.TEX-FRB {\n  font-family: MJXZERO, MJXTEX-FRB;\n}\n\n.TEX-SS {\n  font-family: MJXZERO, MJXTEX-SS;\n}\n\n.TEX-SSB {\n  font-family: MJXZERO, MJXTEX-SSB;\n}\n\n.TEX-SSI {\n  font-family: MJXZERO, MJXTEX-SSI;\n}\n\n.TEX-SC {\n  font-family: MJXZERO, MJXTEX-SC;\n}\n\n.TEX-T {\n  font-family: MJXZERO, MJXTEX-T;\n}\n\n.TEX-V {\n  font-family: MJXZERO, MJXTEX-V;\n}\n\n.TEX-VB {\n  font-family: MJXZERO, MJXTEX-VB;\n}\n\nmjx-stretchy-v mjx-c, mjx-stretchy-h mjx-c {\n  font-family: MJXZERO, MJXTEX-S1, MJXTEX-S4, MJXTEX, MJXTEX-A ! important;\n}\n\n@font-face /* 0 */ {\n  font-family: MJXZERO;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Zero.woff\") format(\"woff\");\n}\n\n@font-face /* 1 */ {\n  font-family: MJXTEX;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Main-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 2 */ {\n  font-family: MJXTEX-B;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Main-Bold.woff\") format(\"woff\");\n}\n\n@font-face /* 3 */ {\n  font-family: MJXTEX-I;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Math-Italic.woff\") format(\"woff\");\n}\n\n@font-face /* 4 */ {\n  font-family: MJXTEX-MI;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Main-Italic.woff\") format(\"woff\");\n}\n\n@font-face /* 5 */ {\n  font-family: MJXTEX-BI;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Math-BoldItalic.woff\") format(\"woff\");\n}\n\n@font-face /* 6 */ {\n  font-family: MJXTEX-S1;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Size1-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 7 */ {\n  font-family: MJXTEX-S2;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Size2-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 8 */ {\n  font-family: MJXTEX-S3;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Size3-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 9 */ {\n  font-family: MJXTEX-S4;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Size4-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 10 */ {\n  font-family: MJXTEX-A;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_AMS-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 11 */ {\n  font-family: MJXTEX-C;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Calligraphic-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 12 */ {\n  font-family: MJXTEX-CB;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Calligraphic-Bold.woff\") format(\"woff\");\n}\n\n@font-face /* 13 */ {\n  font-family: MJXTEX-FR;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Fraktur-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 14 */ {\n  font-family: MJXTEX-FRB;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Fraktur-Bold.woff\") format(\"woff\");\n}\n\n@font-face /* 15 */ {\n  font-family: MJXTEX-SS;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_SansSerif-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 16 */ {\n  font-family: MJXTEX-SSB;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_SansSerif-Bold.woff\") format(\"woff\");\n}\n\n@font-face /* 17 */ {\n  font-family: MJXTEX-SSI;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_SansSerif-Italic.woff\") format(\"woff\");\n}\n\n@font-face /* 18 */ {\n  font-family: MJXTEX-SC;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Script-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 19 */ {\n  font-family: MJXTEX-T;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Typewriter-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 20 */ {\n  font-family: MJXTEX-V;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Vector-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 21 */ {\n  font-family: MJXTEX-VB;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Vector-Bold.woff\") format(\"woff\");\n}\n</style><link id=\"altmetric-embed-css\" rel=\"stylesheet\" type=\"text/css\" href=\"https://d1bxh8uas1mnw7.cloudfront.net/assets/embed-59614f5c46b49b21eeef3bb28c4fb38d1e7069e8d014752fcb66e84942556802.css\"><link rel=\"stylesheet\" href=\"https://badge.dimensions.ai/badge.css\"><link rel=\"stylesheet\" href=\"data:text/css,@import%20url%28%27https%3A//cdn.privado.ai/version/indexV1.css%27%29%3B\"><script type=\"module\" src=\"https://js.trendmd.com/polyfills.js?0.549.0\"></script></head><body data-sitename=\"clinicalinfectiousdiseases\" class=\"off-canvas pg_Article pg_article\" theme-cid=\"\" data-sitestyletemplate=\"Journal\"><input type=\"hidden\" class=\"hfInterstitial\" data-interstitiallinks=\"cid/issue,cid/advance-articles,cid/advance-article,cid/supplements,cid/article,cid/article-abstract,cid/pages\" data-subdomain=\"cid\">\n    \n    \n    <script type=\"text/javascript\">\n                googletag.cmd.push(function () {\n                    \n                    googletag.pubads().setTargeting(\"jnlsdoi\", \"10.1093/cid/ciy723\");\n                    googletag.enableServices();\n                });\n    </script>\n\n\n\n\n    \n\n\n    <script type=\"text/javascript\">\n        var NTPT_PGEXTRA= 'event_type=full-text&supplier_tag=SC_Journals&object_type=Article&taxonomy=taxId%3a39%7ctaxLabel%3aAcademicSubjects%7cnodeId%3aMED00290%7cnodeLabel%3aInfectious+Diseases%7cnodeLevel%3a3&siteid=cid&authzrequired=false&doi=10.1093/cid/ciy723';\n    </script>\n\n\n\n\n    <script src=\"https://scholar.google.com/scholar_js/casa.js\" async=\"\" type=\"javascript/privado-block\"></script>\n\n\n\n            <noscript>\n                <iframe  src=\"https://www.googletagmanager.com/ns.html?id=GTM-W6DD7HV\"\n                        height=\"0\" width=\"0\" style=\"display:none;visibility:hidden\"></iframe>\n            </noscript>\n            <a href=\"#skipNav\" class=\"skipnav\">Skip to Main Content</a>\n<input id=\"hdnSiteID\" name=\"hdnSiteID\" type=\"hidden\" value=\"5269\"><input id=\"hdnAdDelaySeconds\" name=\"hdnAdDelaySeconds\" type=\"hidden\" value=\"8000\"><input id=\"hdnAdConfigurationTop\" name=\"hdnAdConfigurationTop\" type=\"hidden\" value=\"scrolldelay\"><input id=\"hdnAdConfigurationRightRail\" name=\"hdnAdConfigurationRightRail\" type=\"hidden\" value=\"sticky\">\n    \n\n\n\n\n\n\n<div class=\"master-container js-master-container\">\n<section class=\"master-header row js-master-header vt-site-page-header\">\n    <div class=\"widget widget-SitePageHeader widget-instance-SitePageHeader\">\n        \n\n    <div class=\"ad-banner js-ad-banner-header\">\n    <div class=\"widget widget-AdBlock widget-instance-HeaderAd\">\n        <div class=\"js-adBlock-parent-wrap adblock-parent-wrap\">\n    <div class=\"adBlockHeader-wrap js-adBlockHeader hide\">\n        <div id=\"adBlockHeader\" class=\"js-adblock at-adblock\" data-lazy-load-margin=\"150\">\n            <script>\n                googletag.cmd.push(function () {\n                    googletag.display('adBlockHeader');\n                });\n            </script>\n        </div>\n            <div class=\"advertisement-text at-adblock js-adblock-advertisement-text hide\">Advertisement</div>\n            </div>\n</div> \n    </div>\n\n    </div>\n\n    <div class=\"oup-header sigma \">\n        <div class=\"center-inner-row\">\n\n<div class=\"oup-header-logo\">\n\n        <a href=\"/\" data-google-interstitial=\"false\">\n            <img src=\"//oup.silverchair-cdn.com/UI/app/svg/umbrella/oxford-academic-logo.svg\" alt=\"Oxford Academic\" class=\"oup-header-image at-oup-header-image \" width=\"300\" height=\"74\">\n        </a>\n\n</div>                <div class=\"widget widget-CustomNavLinks widget-instance-CustomNavLinksDeskTop\">\n            <div class=\"custom-nav-links-box\">\n            <div class=\"custom-nav-link\">\n                <a href=\"/journals\" data-google-interstitial=\"false\">Journals</a>\n            </div>\n            <div class=\"custom-nav-link\">\n                <a href=\"/books\" data-google-interstitial=\"false\">Books</a>\n            </div>\n\n    </div>\n \n    </div>\n            <ul class=\"oup-header-menu account-menu sigma-account-menu \">\n\n                \n                <li class=\"oup-header-menu-item mobile\">\n                    <a href=\"javascript:;\" class=\"mobile-dropdown-toggle mobile-search-toggle\" data-google-interstitial=\"false\">\n                        <i class=\"icon-menu_search\"><span class=\"screenreader-text\">Search Menu</span></i>\n                    </a>\n                </li>\n                \n        <li class=\"oup-header-menu-item mobile\">\n            <a href=\"javascript:;\" class=\"mobile-dropdown-toggle navbar-ai-assistant-link js-navbar-ai-assistant-link\" data-google-interstitial=\"false\">\n                <i class=\"icon-spark\"><span class=\"screenreader-text\">AI Discovery Assistant</span></i>\n            </a>\n        </li>        \n\n\n                    <li class=\"oup-header-menu-item mobile info-icon-menu-item\">\n        <a href=\"/pages/information\" target=\"\" class=\"at-info-button sigma-info-wrapper\" role=\"button\" data-google-interstitial=\"false\">\n            <img class=\"sigma-info-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/i.svg\" alt=\"Information\">\n        </a>\n    </li>\n    <li class=\"oup-header-menu-item mobile account-icon-menu-item\">\n        <a href=\"javascript:;\" class=\"account-button js-account-button at-account-button \" role=\"button\" data-turnawayparams=\"journal%3dcid\" data-google-interstitial=\"false\">\n            <img class=\"sigma-account-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/account.svg\" alt=\"Account\">\n        </a>\n    </li>\n\n\n                \n                <li class=\"oup-header-menu-item mobile\">\n                    <a href=\"javascript:;\" class=\"mobile-dropdown-toggle mobile-nav-toggle\" data-google-interstitial=\"false\">\n                        <i class=\"icon-menu_hamburger\"><span class=\"screenreader-text\">Menu</span></i>\n                    </a>\n                </li>\n\n                \n\n                    <li class=\"oup-header-menu-item desktop info-icon-menu-item\">\n        <a href=\"/pages/information\" target=\"\" class=\"at-info-button sigma-info-wrapper\" role=\"button\" data-google-interstitial=\"false\">\n            <img class=\"sigma-info-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/i.svg\" alt=\"Information\">\n        </a>\n    </li>\n    <li class=\"oup-header-menu-item desktop account-icon-menu-item\">\n        <a href=\"javascript:;\" class=\"account-button js-account-button at-account-button sigma-logo-wrapper\" role=\"button\" data-turnawayparams=\"journal%3dcid\" data-google-interstitial=\"false\">\n            <img class=\"sigma-account-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/account.svg\" alt=\"Account\">\n        </a>\n    </li>\n        <li class=\"oup-header-menu-item desktop account-icon-menu-item\">\n    <div class=\"widget widget-SeamlessAccess widget-instance-SitePageHeader\">\n            <a href=\"javascript:;\" class=\"js-shibboleth-action seamless-access-button seamless-button-header button-call-to-action at-institutional-sign-in\" rel=\"nofollow\" data-action-type=\"\" data-entity-id=\"\" data-google-interstitial=\"false\">\n        <span class=\"seamless-access-text\">Sign in through your institution</span>\n    </a>\n\n \n    </div>\n\n        </li>\n\n\n                \n\n            </ul>\n\n            <div class=\"login-box-placeholder js-login-box-placeholder hide\" style=\"z-index: auto;\">\n                <div class=\"spinner\"></div>\n            </div>\n        </div>\n    </div>\n<div class=\"dropdown-panel-wrap\">\n\n    \n    <div class=\"dropdown-panel mobile-search-dropdown\">\n        <div class=\"mobile-search-inner-wrap\">\n\n\n<div class=\"navbar-search\">\n    <div class=\"mobile-microsite-search\">\n            <label for=\"SitePageHeader-mobile-navbar-search-filter\" class=\"screenreader-text js-mobile-navbar-search-filter-label\">\n                Navbar Search Filter\n            </label>\n            <select class=\"mobile-navbar-search-filter js-mobile-navbar-search-filter at-navbar-search-filter\" id=\"SitePageHeader-mobile-navbar-search-filter\">\n\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"\">Clinical Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Issue\">This issue</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Parent\">IDSA Journals</option>\n                    <optgroup class=\"navbar-search-optgroup\" label=\"Search across Oxford Academic\">\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"AcademicSubjects/MED00290\">Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Books\">Books</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Journals\">Journals</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Umbrella\">Oxford Academic</option>                    </optgroup>\n            </select>\n\n        <label for=\"SitePageHeader-mobile-microsite-search-term\" class=\"screenreader-text js-mobile-microsite-search-term-label\">\n            Mobile Enter search term\n        </label>\n        <input class=\"mobile-search-input mobile-microsite-search-term js-mobile-microsite-search-term at-microsite-search-term\" type=\"text\" maxlength=\"255\" placeholder=\"Search\" id=\"SitePageHeader-mobile-microsite-search-term\">\n\n        <a href=\"javascript:;\" class=\"mobile-microsite-search-icon mobile-search-submit icon-menu_search\" data-google-interstitial=\"false\">\n            <span class=\"screenreader-text\">Search</span>\n        </a>\n\n    </div>\n</div>\n\n\n        </div>\n    </div>\n   \n    <div class=\"dropdown-panel mobile-nav-dropdown\">\n\n\n    <ul class=\"site-menu site-menu-lvl-0 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742963\">\n\n                <a href=\"/cid/issue\" class=\"nav-link\">\n                    Issues\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742959\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    More Content\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742964\">\n\n                <a href=\"/cid/advance-articles\" class=\"nav-link\">\n                    Advance articles\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742965\">\n\n                <a href=\"https://academic.oup.com/cid/search-results?page=1&amp;f_OUPSeries=Editor%27s+Choice\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Editor's Choice\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742966\">\n\n                <a href=\"/cid/supplements\" class=\"nav-link\">\n                    Supplement Archive\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742967\">\n\n                <a href=\"https://academic.oup.com/cid/issue-covers/\" class=\"nav-link\">\n                    Cover Archive\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742968\">\n\n                <a href=\"/cid/pages/clinical-practice-guidelines\" class=\"nav-link\">\n                    IDSA Guidelines\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742969\">\n\n                <a href=\"https://academic.oup.com/idsa\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA Journals\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742970\">\n\n                <a href=\"https://academic.oup.com/jid\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    The Journal of Infectious Diseases\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742971\">\n\n                <a href=\"https://academic.oup.com/ofid\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Open Forum Infectious Diseases\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742972\">\n\n                <a href=\"/cid/pages/clinical-dilemmas\" class=\"nav-link\">\n                    Clinical Dilemmas in ID\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742973\">\n\n                <a href=\"/cid/pages/photo-quizzes\" class=\"nav-link\">\n                    Photo Quizzes\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742974\">\n\n                <a href=\"https://academic.oup.com/cid/pages/state-of-the-art-reviews\" class=\"nav-link\">\n                    State-of-the-Art Reviews\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742975\">\n\n                <a href=\"https://academic.oup.com/cid/pages/voices-of-id\" class=\"nav-link\">\n                    Voices of ID\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742976\">\n\n                <a href=\"https://academic.oup.com/idsa/pages/content-collections\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA Content Collections\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742960\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    Publish\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742977\">\n\n                <a href=\"/cid/pages/General_Instructions\" class=\"nav-link\">\n                    Author Guidelines\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742978\">\n\n                <a href=\"http://www.editorialmanager.com/cid\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Submit\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742979\">\n\n                <a href=\"/cid/pages/General_Instructions\" class=\"nav-link\">\n                    Open Access\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742980\">\n\n                <a href=\"https://academic.oup.com/cid/pages/why-publish\" class=\"nav-link\">\n                    Why Publish\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742981\">\n\n                <a href=\"https://academic.oup.com/idsa/pages/calls-for-papers\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA Journals Calls for Papers\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742982\">\n\n                <a href=\"/cid/subscribe\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Purchase\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742961\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    Advertise\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742983\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Advertising and Corporate Services\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742984\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Advertising\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742985\">\n\n                <a href=\"http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;search=&amp;t732=469972&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Journals Career Network\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742986\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Mediakit\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742987\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/reprints\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Reprints and ePrints\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742988\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/supplements\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Sponsored Supplements\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742989\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/branded-books\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Branded Books\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742962\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    About\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742990\">\n\n                <a href=\"/cid/pages/About\" class=\"nav-link\">\n                    About Clinical Infectious Diseases\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742991\">\n\n                <a href=\"https://www.idsociety.org\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    About the Infectious Diseases Society of America\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742992\">\n\n                <a href=\"https://www.hivma.org/\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    About the HIV Medicine Association\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742993\">\n\n                <a href=\"/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA COI Policy\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742994\">\n\n                <a href=\"/cid/pages/Editorial_Board\" class=\"nav-link\">\n                    Editorial Board\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742995\">\n\n                <a href=\"/my-account/email-alerts\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Alerts\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742996\">\n\n                <a href=\"https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Self-Archiving Policy\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742997\">\n\n                <a href=\"/cid/pages/For_Reviewers\" class=\"nav-link\">\n                    For Reviewers\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742998\">\n\n                <a href=\"https://academic.oup.com/idsa/pages/for_press_offices\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    For Press Offices\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n                <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-custom\">\n            <a href=\"/journals\" class=\"nav-link\" data-google-interstitial=\"false\">Journals on Oxford Academic</a>\n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-custom\">\n            <a href=\"/books\" class=\"nav-link\" data-google-interstitial=\"false\">Books on Oxford Academic</a>\n        </li>\n    </ul>\n    </div>\n\n</div>\n\n    <div class=\"journal-header journal-bg\">\n        <div class=\"center-inner-row\">\n                <div class=\"site-parent-link-wrap\">\n                    <a href=\"//academic.oup.com/idsa\" class=\"site-parent-link\" data-google-interstitial=\"false\">IDSA Journals</a>\n                </div>\n                            <a href=\"/cid\" class=\"journal-logo-container\">\n                    <img id=\"logo-ClinicalInfectiousDiseases\" class=\"journal-logo\" src=\"//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_title-1229789578.svg\" alt=\"Clinical Infectious Diseases\" width=\"300\" height=\"18\">\n                </a>\n\n            <div class=\"society-logo-block\">\n                    <div class=\"society-block-inner-wrap\">\n                            <a href=\"https://www.idsociety.org\" target=\"\" class=\"society-logo-container\" data-google-interstitial=\"false\">\n                                <img id=\"logo-InfectiousDiseasesSocietyofAmerica\" class=\"society-logo\" src=\"//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_h1682603575.svg\" alt=\"Infectious Diseases Society of America\" width=\"300\" height=\"68\">\n                            </a>\n                                                    <a href=\"https://www.hivma.org/\" target=\"\" class=\"society-logo-container\" data-google-interstitial=\"false\">\n                                <img id=\"logo-HIVMedicineAssociation\" class=\"society-logo\" src=\"//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_h2-371465688.svg\" alt=\"HIV Medicine Association\" width=\"300\" height=\"134\">\n                            </a>\n                    </div>            </div> \n        </div>\n    </div>\n<div class=\"navbar\">\n    <div class=\"center-inner-row\">\n        <nav class=\"navbar-menu\">\n\n    <ul class=\"site-menu site-menu-lvl-0 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742963\">\n\n                <a href=\"/cid/issue\" class=\"nav-link\">\n                    Issues\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742959\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    More Content\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742964\">\n\n                <a href=\"/cid/advance-articles\" class=\"nav-link\">\n                    Advance articles\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742965\">\n\n                <a href=\"https://academic.oup.com/cid/search-results?page=1&amp;f_OUPSeries=Editor%27s+Choice\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Editor's Choice\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742966\">\n\n                <a href=\"/cid/supplements\" class=\"nav-link\">\n                    Supplement Archive\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742967\">\n\n                <a href=\"https://academic.oup.com/cid/issue-covers/\" class=\"nav-link\">\n                    Cover Archive\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742968\">\n\n                <a href=\"/cid/pages/clinical-practice-guidelines\" class=\"nav-link\">\n                    IDSA Guidelines\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742969\">\n\n                <a href=\"https://academic.oup.com/idsa\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA Journals\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742970\">\n\n                <a href=\"https://academic.oup.com/jid\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    The Journal of Infectious Diseases\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742971\">\n\n                <a href=\"https://academic.oup.com/ofid\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Open Forum Infectious Diseases\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742972\">\n\n                <a href=\"/cid/pages/clinical-dilemmas\" class=\"nav-link\">\n                    Clinical Dilemmas in ID\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742973\">\n\n                <a href=\"/cid/pages/photo-quizzes\" class=\"nav-link\">\n                    Photo Quizzes\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742974\">\n\n                <a href=\"https://academic.oup.com/cid/pages/state-of-the-art-reviews\" class=\"nav-link\">\n                    State-of-the-Art Reviews\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742975\">\n\n                <a href=\"https://academic.oup.com/cid/pages/voices-of-id\" class=\"nav-link\">\n                    Voices of ID\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742976\">\n\n                <a href=\"https://academic.oup.com/idsa/pages/content-collections\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA Content Collections\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742960\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    Publish\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742977\">\n\n                <a href=\"/cid/pages/General_Instructions\" class=\"nav-link\">\n                    Author Guidelines\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742978\">\n\n                <a href=\"http://www.editorialmanager.com/cid\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Submit\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742979\">\n\n                <a href=\"/cid/pages/General_Instructions\" class=\"nav-link\">\n                    Open Access\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742980\">\n\n                <a href=\"https://academic.oup.com/cid/pages/why-publish\" class=\"nav-link\">\n                    Why Publish\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742981\">\n\n                <a href=\"https://academic.oup.com/idsa/pages/calls-for-papers\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA Journals Calls for Papers\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742982\">\n\n                <a href=\"/cid/subscribe\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Purchase\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742961\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    Advertise\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742983\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Advertising and Corporate Services\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742984\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Advertising\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742985\">\n\n                <a href=\"http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;search=&amp;t732=469972&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Journals Career Network\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742986\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Mediakit\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742987\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/reprints\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Reprints and ePrints\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742988\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/supplements\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Sponsored Supplements\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742989\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/branded-books\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Branded Books\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742962\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    About\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742990\">\n\n                <a href=\"/cid/pages/About\" class=\"nav-link\">\n                    About Clinical Infectious Diseases\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742991\">\n\n                <a href=\"https://www.idsociety.org\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    About the Infectious Diseases Society of America\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742992\">\n\n                <a href=\"https://www.hivma.org/\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    About the HIV Medicine Association\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742993\">\n\n                <a href=\"/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA COI Policy\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742994\">\n\n                <a href=\"/cid/pages/Editorial_Board\" class=\"nav-link\">\n                    Editorial Board\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742995\">\n\n                <a href=\"/my-account/email-alerts\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Alerts\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742996\">\n\n                <a href=\"https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Self-Archiving Policy\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742997\">\n\n                <a href=\"/cid/pages/For_Reviewers\" class=\"nav-link\">\n                    For Reviewers\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742998\">\n\n                <a href=\"https://academic.oup.com/idsa/pages/for_press_offices\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    For Press Offices\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n            </ul>\n        </nav>\n            <div class=\"navbar-right-container\">\n                <div class=\"navbar-search-container js-navbar-search-container\">\n                    <a href=\"javascript:;\" class=\"navbar-search-close js_close-navsearch\" data-google-interstitial=\"false\">Close</a>\n\n\n<div class=\"navbar-search\">\n    <div class=\"microsite-search\">\n            <label for=\"SitePageHeader-navbar-search-filter\" class=\"screenreader-text js-navbar-search-filter-label\">\n                Navbar Search Filter\n            </label>\n            <select class=\"navbar-search-filter js-navbar-search-filter at-navbar-search-filter\" id=\"SitePageHeader-navbar-search-filter\">\n\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"\">Clinical Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Issue\">This issue</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Parent\">IDSA Journals</option>\n                    <optgroup class=\"navbar-search-optgroup\" label=\"Search across Oxford Academic\">\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"AcademicSubjects/MED00290\">Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Books\">Books</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Journals\">Journals</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Umbrella\">Oxford Academic</option>                    </optgroup>\n            </select>\n\n        <label for=\"SitePageHeader-microsite-search-term\" class=\"screenreader-text js-microsite-search-term-label\">\n            Enter search term\n        </label>\n        <input class=\"navbar-search-input microsite-search-term js-microsite-search-term at-microsite-search-term\" type=\"text\" maxlength=\"255\" placeholder=\"Search\" id=\"SitePageHeader-microsite-search-term\">\n\n        <a href=\"javascript:;\" class=\"microsite-search-icon navbar-search-submit icon-menu_search\" data-google-interstitial=\"false\">\n            <span class=\"screenreader-text\">Search</span>\n        </a>\n\n    </div>\n</div>\n\n<input id=\"hfCurrentBookSearch\" name=\"hfCurrentBookSearch\" type=\"hidden\" value=\"\"><input id=\"hfCurrentBookScope\" name=\"hfCurrentBookScope\" type=\"hidden\" value=\"CurrentBook\"><input id=\"hfBookSiteScope\" name=\"hfBookSiteScope\" type=\"hidden\" value=\"Books\"><input id=\"hfSeriesScope\" name=\"hfSeriesScope\" type=\"hidden\" value=\"taxWithOr\"><input id=\"hfParentSiteName\" name=\"hfParentSiteName\" type=\"hidden\" value=\"IDSA Journals\"><input id=\"hfParentSiteUrl\" name=\"hfParentSiteUrl\" type=\"hidden\" value=\"academic.oup.com/idsa\"><input id=\"hfSiteID\" name=\"hfSiteID\" type=\"hidden\" value=\"5269\"><input id=\"hfParentSiteID\" name=\"hfParentSiteID\" type=\"hidden\" value=\"5532\"><input id=\"hfJournalSiteScope\" name=\"hfJournalSiteScope\" type=\"hidden\" value=\"Journals\"><input id=\"hfParentSiteScope\" name=\"hfParentSiteScope\" type=\"hidden\" value=\"Parent\"><input id=\"hfDefaultSearchURL\" name=\"hfDefaultSearchURL\" type=\"hidden\" value=\"search-results?page=1&amp;q=\"><input id=\"hfIssueSearch\" name=\"hfIssueSearch\" type=\"hidden\" value=\"&amp;fl_IssueID=115396\"><input id=\"hfIssueSiteScope\" name=\"hfIssueSiteScope\" type=\"hidden\" value=\"Issue\"><input id=\"hfUmbrellaScope\" name=\"hfUmbrellaScope\" type=\"hidden\" value=\"Umbrella\"><input id=\"hfUmbrellaSiteUrl\" name=\"hfUmbrellaSiteUrl\" type=\"hidden\" value=\"academic.oup.com\"><input id=\"hfUmbrellaSiteId\" name=\"hfUmbrellaSiteId\" type=\"hidden\" value=\"191\"><input id=\"hfDefaultAdvancedSearchUrl\" name=\"hfDefaultAdvancedSearchUrl\" type=\"hidden\" value=\"advanced-search?page=1&amp;q=\"><input id=\"hfTaggedCollectionScope\" name=\"hfTaggedCollectionScope\" type=\"hidden\" value=\"\"><input id=\"hfApplyLatestEditionSearchFacet\" name=\"hfApplyLatestEditionSearchFacet\" type=\"hidden\" value=\"False\"><input id=\"hfIsLatestBookEdition\" name=\"hfIsLatestBookEdition\" type=\"hidden\" value=\"False\">\n                    <div class=\"navbar-search-advanced\"><a href=\"https://academic.oup.com/cid/advanced-search?page=1&amp;fl_SiteID=5269&amp;SearchSourceType=1\" class=\"advanced-search js-advanced-search\" data-google-interstitial=\"false\">Advanced Search</a></div>\n                </div>\n                \n                <div class=\"navbar-search-collapsed\"><a href=\"javascript:;\" class=\"icon-menu_search js_expand-navsearch\" data-google-interstitial=\"false\"><span class=\"screenreader-text\">Search Menu</span></a></div>\n\n        <div class=\"navbar-menu navbar-ai-assistant-container site-menu-item\">\n            <a href=\"javascript:;\" class=\"navbar-ai-assistant-link js-navbar-ai-assistant-link\" data-google-interstitial=\"false\">\n                <span aria-label=\"AI Discovery Assistant\" class=\"navbar-ai-assistant-span\">\n                    <i class=\"icon-spark navbar-icon-spark\"></i>\n                    AI Discovery Assistant\n                </span>\n            </a>\n        </div>\n\n            </div>\n    </div>\n</div>\n    <input type=\"hidden\" name=\"searchScope\" id=\"hfSolrJournalID\" value=\"\">\n    <input type=\"hidden\" id=\"hfSolrJournalName\" value=\"\">\n    <input type=\"hidden\" id=\"hfSolrMaxAllowSearchChar\" value=\"100\">\n    <input type=\"hidden\" id=\"hfJournalShortName\" value=\"\">\n    <input type=\"hidden\" id=\"hfSearchPlaceholder\" value=\"\">\n    <input type=\"hidden\" name=\"hfGlobalSearchSiteURL\" id=\"hfGlobalSearchSiteURL\" value=\"\">\n    <input type=\"hidden\" name=\"hfSearchSiteURL\" id=\"hfSiteURL\" value=\"academic.oup.com/cid\">\n    <input type=\"hidden\" name=\"RedirectSiteUrl\" id=\"RedirectSiteUrl\" value=\"httpszazjzjacademiczwoupzwcom\">\n    <script type=\"text/javascript\">\n        (function () {\n            var hfSiteUrl = document.getElementById('hfSiteURL');\n            var siteUrl = hfSiteUrl.value;\n            var subdomainIndex = siteUrl.indexOf('/');\n\n            hfSiteUrl.value = location.host + (subdomainIndex >= 0 ? siteUrl.substring(subdomainIndex) : '');\n        })();\n    </script>\n<input id=\"routename\" name=\"RouteName\" type=\"hidden\" value=\"cid\"> \n    </div>\n\n</section>\n        <div class=\"widget widget-SitewideBanner widget-instance-\" style=\"\">\n        \n\n \n    </div>\n\n\n    <div id=\"main\" class=\"content-main js-main ui-base\">\n            <section class=\"master-main row\">\n                <div class=\"center-inner-row no-overflow\">\n                    <div id=\"skipNav\" tabindex=\"-1\"></div>\n                    \n\n\n\n<div class=\"page-column-wrap\">\n<div id=\"InfoColumn\" class=\"page-column page-column--left js-left-nav-col\" style=\"z-index: 6000;\">\n    <div class=\"mobile-content-topbar hide\">\n        <button class=\"toggle-left-col toggle-left-col__article\">Article Navigation</button>\n    </div>\n    <div class=\"info-inner-wrap js-left-nav\" style=\"top: 0px;\">\n        <button class=\"toggle-left-col__close btn-as-icon icon-general-close\">\n            <span class=\"screenreader-text\">Close mobile search navigation</span>\n        </button>\n        <div class=\"responsive-nav-title\">Article Navigation</div>\n        <div class=\"info-widget-wrap\">\n    <div class=\"widget widget-IssueInfo widget-instance-OUP_IssueInfo_Article\">\n        \n\n<div id=\"issueInfo-OUP_IssueInfo_Article\" class=\"article-info-wrap clearfix\">\n    <i class=\"icon-general-close mobile-nav-btn nav-open\"></i>\n    <a class=\"article-issue-link\" href=\"/cid/issue/68/9\">\n        <div class=\"article-issue-img\">\n                <img id=\"issueImage\" class=\"fb-featured-image\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/Issue/68/9/5/m_cover.jpeg?Expires=1752631924&amp;Signature=VzkJpzpYIXCozHbdsaIS60qWT14TRuSLuGC1eukUyrcYSb6veXmlbdxxi4bsCqv56PfMH7dlbqN9LPLYakKnZ6uSxmWg0YAZOHfQIA39tvpONvJ71boTMCgDn8RhjNDckqV16RNIXTme4fSXo-Pb1NEzqABs9EzPZHe9bQMD6FT68PV8Vap~eeaNsVp85gS3jKjGejPEgn2-XCGy4vrE3MaPHJYIAkNxsVP0hL~5pIyLW4I1ZSyrhJhH-eg8MKmfcqb5InNKbRmJkLh~-95lJfZl5LOkCkFEzHqU5URne1xaCnWjdQWfdfTDCJXggdBa~HkCJsQ92f~1fLxypv7dIQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"Clinical Infectious Diseases Cover Image for Volume 68, Issue 9\" width=\"520\" height=\"685\">\n        </div>\n        <div class=\"article-issue-info\">\n            <div class=\"volume-issue__wrap\">\n\n                        <div class=\"volume trailing-comma\">Volume 68</div>\n                        <div class=\"issue\">Issue 9</div>\n\n\n\n            </div>\n            <div class=\"ii-pub-date\">\n1 May 2019            </div>\n            \n        </div>\n    </a>\n</div> \n    </div>\n\n            <div class=\"content-nav\">\n    <div class=\"widget widget-ArticleJumpLinks widget-instance-OUP_ArticleJumpLinks_Widget\">\n        \n\n<h3 class=\"contents-title\">Article Contents</h3>\n<ul class=\"jumplink-list js-jumplink-list\">\n        <li class=\"section-jump-link head-1\" link-destination=\"134170092\">\n            <div class=\"section-jump-link__link-wrap\">\n\n                <a class=\"js-jumplink scrollTo\" href=\"#134170092\">Abstract</a>\n            </div>\n        </li>\n        <li class=\"section-jump-link head-1\" link-destination=\"134170097\">\n            <div class=\"section-jump-link__link-wrap\">\n\n                <a class=\"js-jumplink scrollTo\" href=\"#134170097\">MATERIALS AND METHODS</a>\n            </div>\n        </li>\n        <li class=\"section-jump-link head-1\" link-destination=\"134170111\">\n            <div class=\"section-jump-link__link-wrap\">\n\n                <a class=\"js-jumplink scrollTo\" href=\"#134170111\">RESULTS</a>\n            </div>\n        </li>\n        <li class=\"section-jump-link head-1\" link-destination=\"134170130\">\n            <div class=\"section-jump-link__link-wrap\">\n\n                <a class=\"js-jumplink scrollTo\" href=\"#134170130\">DISCUSSION</a>\n            </div>\n        </li>\n        <li class=\"section-jump-link head-1\" link-destination=\"134170142\">\n            <div class=\"section-jump-link__link-wrap\">\n\n                <a class=\"js-jumplink scrollTo\" href=\"#134170142\">Supplementary Data</a>\n            </div>\n        </li>\n        <li class=\"section-jump-link head-1\" link-destination=\"134170144\">\n            <div class=\"section-jump-link__link-wrap\">\n\n                <a class=\"js-jumplink scrollTo\" href=\"#134170144\">Notes</a>\n            </div>\n        </li>\n        <li class=\"section-jump-link head-1 backReferenceLink\" link-destination=\"134170150\">\n            <div class=\"section-jump-link__link-wrap\">\n\n                <a class=\"js-jumplink scrollTo\" href=\"#134170150\">References</a>\n            </div>\n        </li>\n<li class=\"section-jump-link head-1 dataSupplements-jumplink\">\n            <div class=\"section-jump-link__link-wrap\">\n                <a class=\"jumplink js-jumplink scrollTo\" href=\"#supplementary-data\">Supplementary data</a>\n            </div>\n        </li></ul>\n \n    </div>\n\n            </div>\n    <div class=\"widget widget-ArticleNavLinks widget-instance-OUP_ArticleNavLinks_Article\">\n        <ul class=\"inline-list\">\n        <li class=\"prev arrow\">\n            <a href=\"/cid/article/68/9/1472/5089945\">&lt; Previous</a>\n        </li>        \n            <li class=\"next arrow\">\n            <a href=\"/cid/article/68/9/1494/5087661\">Next &gt;</a>\n        </li>\n</ul> \n    </div>\n\n        </div>\n    </div>\n</div>\n<div class=\"sticky-toolbar js-sticky-toolbar\"></div>\n<div id=\"ContentColumn\" class=\"page-column page-column--center\">\n\n    <div class=\"article-browse-top article-browse-mobile-nav js-mobile-nav\" style=\"\">\n    <div class=\"article-browse-mobile-nav-inner js-mobile-nav-inner\">\n        <button class=\"toggle-left-col toggle-left-col__article btn-as-link\">\n            Article Navigation\n        </button>\n    </div>\n</div>\n<div class=\"article-browse-top article-browse-mobile-nav mobile-sticky-toolbar js-mobile-nav-sticky\">\n    <div class=\"article-browse-mobile-nav-inner\">\n        <button class=\"toggle-left-col toggle-left-col__article btn-as-link\">\n            Article Navigation\n        </button>\n    </div>\n</div>\n\n    <div class=\"content-inner-wrap\">\n    <div class=\"widget widget-ArticleTopInfo widget-instance-OUP_ArticleTop_Info_Widget\">\n        <div class=\"module-widget article-top-widget\">\n\n    \n\n    \n        <div class=\"access-state-logos all-viewports\">\n    <span class=\"journal-info__format-label\">Journal Article</span>\n                </div>\n\n\n    <div class=\"widget-items\">\n                <div class=\"title-wrap\">\n                    <h1 class=\"wi-article-title article-title-main accessible-content-title at-articleTitle\">\n                        Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\n<i class=\"icon-availability_free\" title=\"Free\"><span class=\"screenreader-text\">Free</span></i>                    </h1>\n\n                </div>\n                <div class=\"wi-authors at-ArticleAuthors\">\n                    <div class=\"al-authors-list\">\n                            <div class=\"meta-authors--limited\">\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Marta Francesca Di Pasquale</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Marta Francesca Di Pasquale\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n    </div>\n\n    <div class=\"info-card-location\">\n        <a id=\"contrib-orcid-0000-0002-1450-5830\" href=\"https://orcid.org/0000-0002-1450-5830\" data-google-interstitial=\"false\">\n            <img class=\"orchid-icon\" alt=\"ORCID logo\" aria-hidden=\"true\" src=\"//oup.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png\">&nbsp;&nbsp;https://orcid.org/0000-0002-1450-5830\n        </a>\n    </div>\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Marta+Francesca+Di+Pasquale\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Di Pasquale M\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Di Pasquale Marta Francesca%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Giovanni Sotgiu</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Giovanni Sotgiu\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Giovanni+Sotgiu\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Sotgiu G\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Sotgiu Giovanni%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Andrea Gramegna</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Andrea Gramegna\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Andrea+Gramegna\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Gramegna A\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Gramegna Andrea%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Dejan Radovanovic</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Dejan Radovanovic\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Pulmonary Unit, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Dejan+Radovanovic\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Radovanovic D\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Radovanovic Dejan%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Silvia Terraneo</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Silvia Terraneo\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Italy</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Silvia+Terraneo\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Terraneo S\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Terraneo Silvia%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Luis F Reyes</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Luis F Reyes\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Microbiology Department, Universidad de La Sabana, Chia, Colombia</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Luis+F+Reyes\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Reyes L\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Reyes Luis F%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Jan Rupp</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Jan Rupp\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Jan+Rupp\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Rupp J\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Rupp Jan%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Juan González del Castillo</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Juan González del Castillo\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Emergency Department, Hospital Clínico San Carlos, Universidad Complutense</div><div class=\"aff\">Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, IdISSC, Madrid, Spain</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Juan+Gonz%c3%a1lez+del+Castillo\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=González del Castillo J\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22González del Castillo Juan%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Francesco Blasi</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Francesco Blasi\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Francesco+Blasi\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Blasi F\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Blasi Francesco%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Stefano Aliberti<i class=\"icon-general-mail\"></i></a>\n                                        <span class=\"delimiter-hidden\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Stefano Aliberti\n            <span class=\"info-card-footnote\"><span class=\"xrefLink\" id=\"jumplink-c1\"></span><a href=\"javascript:;\" reveal-id=\"c1\" data-open=\"c1\" class=\"link link-ref link-reveal xref-default\" data-google-interstitial=\"false\"><!----></a></span>\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n    </div>\n\n    <div class=\"info-author-correspondence\">\n        <div content-id=\"c1\">Correspondence: S. Aliberti, Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy (<a href=\"mailto:stefano.aliberti@unimi.it\" target=\"\" data-google-interstitial=\"false\">stefano.aliberti@unimi.it</a>).</div>\n    </div>\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Stefano+Aliberti\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Aliberti S\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Aliberti Stefano%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                <a class=\"meta-authors--etal is-active\" id=\"show-meta-authors\" aria-controls=\"remaining-authors\" href=\"#\">\n                                    <span>...</span> Show more\n                                </a>\n                                <div id=\"remaining-authors\" class=\"meta-authors--remaining\" aria-hidden=\"true\" aria-labeledby=\"show-meta-authors\">\n                                        <span class=\"al-author-name-more js-flyout-wrap\">\n\n\n\n\n                                            <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Marcos I Restrepo</a>\n                                            <span class=\"delimiter\"></span>\n                                            <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Marcos I Restrepo\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Marcos+I+Restrepo\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Restrepo M\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Restrepo Marcos I%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                            </span>\n                                        </span>\n                                </div>\n                            </div>\n\n                    </div>\n                </div>\n<div class=\"pub-history-wrap clearfix js-history-dropdown-wrap\">\n\n        <div class=\"pub-history-row clearfix\">\n            <div class=\"ww-citation-primary\"><em>Clinical Infectious Diseases</em>, Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, <a href=\"https://doi.org/10.1093/cid/ciy723\" data-google-interstitial=\"false\">https://doi.org/10.1093/cid/ciy723</a></div>\n        </div>\n        <div class=\"pub-history-row clearfix\">\n            <div class=\"ww-citation-date-wrap\">\n                <div class=\"citation-label\">Published:</div>\n                <div class=\"citation-date\">23 August 2018</div>\n            </div>\n                <a href=\"javascript:;\" class=\"history-label js-history-dropdown-trigger st-article-history at-ArticleHistory\" data-google-interstitial=\"false\">\n                    <span>Article history</span><i class=\"icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                    </div>\n            <div class=\"ww-history js-history-entries-wrap at-history-entries-wrap\">\n                <div class=\"history-entry at-history-entry\">\n                    <div class=\"wi-state\">Received:</div>\n                    <div class=\"wi-date\">24 May 2018</div>\n                </div>\n                <div class=\"history-entry at-history-entry\">\n                    <div class=\"wi-state\">Accepted:</div>\n                    <div class=\"wi-date\">20 August 2018</div>\n                </div>\n                <div class=\"history-entry at-history-entry\">\n                    <div class=\"wi-state\">Published:</div>\n                    <div class=\"wi-date\">23 August 2018</div>\n                </div>\n        </div>\n        </div>\n    </div>\n</div>\n\n<script>\n    $(document).ready(function () {\n        $('.article-top-widget').on('click', '.ati-toggle-trigger', function () {\n            $(this).find('.icon-general-add, .icon-minus').toggleClass('icon-minus icon-general-add');\n            $(this).siblings('.ati-toggle-content').toggleClass('hide');\n        });\n\n        // In Chrome, an anchor tag with target=\"_blank\" and a \"mailto:\" href opens a new tab/window as well as the email client\n        // I suspect this behavior will be corrected in the future\n        // Remove the target=\"_blank\"\n        $('ul.wi-affiliationList').find('a[href^=\"mailto:\"]').each(function () {\n            $(this).removeAttr('target');\n        });\n    });\n</script>\n\n \n    </div>\n    <div class=\"widget widget-ArticleLinks widget-instance-OUP_Article_Links_Widget\">\n         \n    </div>\n\n\n        <div class=\"article-body js-content-body\">\n            <div class=\"toolbar-wrap js-toolbar-wrap\">\n                <div class=\"toolbar-inner-wrap\">\n                    <ul id=\"Toolbar\" role=\"navigation\">\n    <li class=\"toolbar-item item-pdf js-item-pdf\">\n        <a class=\"al-link pdf article-pdfLink\" data-article-id=\"5078600\" href=\"/cid/article-pdf/68/9/1482/28520951/ciy723.pdf\">\n            <img src=\"//oup.silverchair-cdn.com/UI/app/svg/pdf.svg\" alt=\"pdf\"><span class=\"pdf-link-text\">PDF</span>\n        </a>\n    </li>\n                                                    <li class=\"toolbar-item item-link item-split-view\">\n                                <a href=\"javascript:;\" class=\"split-view js-split-view st-split-view at-split-view\" target=\"\" data-google-interstitial=\"false\">\n                                    <i class=\"icon-menu-split\"></i>\n                                    Split View\n                                </a>\n                            </li>\n\n                        <li class=\"toolbar-item item-with-dropdown item-views\">\n                            <a class=\"at-views-dropdown drop-trigger\" href=\"javascript:;\" data-dropdown=\"FilterDrop\" aria-haspopup=\"true\" data-google-interstitial=\"false\">\n                                <i class=\"icon-menu_views\"></i>\n                                <div class=\"toolbar-label\">\n                                    <div class=\"toolbar-text\">Views</div>\n                                    <i class=\"icon-general-arrow-filled-down arrow-icon\"></i>\n                                </div>\n                            </a>\n                            <ul id=\"ViewsDrop\" class=\"f-dropdown js-dropdown-content\" data-dropdown-content=\"\" aria-label=\"submenu\">\n                                <div class=\"arrow-up\" style=\"display: block;\"></div>\n                                <li class=\"article-content-filter js-article-content-filter\" data-content-filter=\"article-content\" style=\"display: none;\">\n                                    <a href=\"javascript:;\" data-google-interstitial=\"false\"><span>Article contents</span></a>\n                                </li>\n                                <li class=\"at-figures-tables article-content-filter js-article-content-filter\" data-content-filter=\"figures-tables\">\n                                    <a href=\"javascript:;\" data-google-interstitial=\"false\"><span>Figures &amp; tables</span></a>\n                                </li>\n                                \n                                \n                                <li class=\"article-content-filter js-article-content-filter\" data-content-filter=\"supplementary-data\">\n                                    <a href=\"javascript:;\" data-google-interstitial=\"false\"><span>Supplementary Data</span></a>\n                                </li>\n                            </ul>\n                        </li>\n\n\n                        <li class=\"toolbar-item item-cite js-item-cite\">\n    <div class=\"widget widget-ToolboxGetCitation widget-instance-OUP_Get_Citation\">\n        <a href=\"#\" class=\"js-cite-button at-CiteButton\" data-reveal-id=\"getCitation\" data-reveal=\"\">\n    <i class=\"icon-read-more\"></i>\n    <span>Cite</span>\n</a>\n\n<div id=\"getCitation\" class=\"reveal-modal js-citation-modal\" data-reveal=\"\">\n    <h3 class=\"modal-title\">Cite</h3>\n        <div class=\"oxford-citation-text\">\n            <p>Marta Francesca Di Pasquale, Giovanni Sotgiu, Andrea Gramegna, Dejan Radovanovic, Silvia Terraneo, Luis F Reyes, Jan Rupp, Juan González del Castillo, Francesco Blasi, Stefano Aliberti, Marcos I Restrepo,  Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients, <em>Clinical Infectious Diseases</em>, Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, <a href=\"https://doi.org/10.1093/cid/ciy723\" data-google-interstitial=\"false\">https://doi.org/10.1093/cid/ciy723</a></p>\n        </div>\n\n    <div class=\"citation-download-wrap\">\n        <form action=\"/Citation/Download\" method=\"get\" id=\"citationModal\">\n            <input type=\"hidden\" name=\"resourceId\" value=\"5078600\">\n            <input type=\"hidden\" name=\"resourceType\" value=\"3\">\n            <label for=\"selectFormat\" class=\"hide js-citation-format-label\">Select Format</label>\n            <select required=\"\" name=\"citationFormat\" class=\"citation-download-format js-citation-format\" id=\"selectFormat\">\n                <option selected=\"\" disabled=\"\">Select format</option>\n                        <option value=\"0\">.ris (Mendeley, Papers, Zotero)</option>\n                        <option value=\"1\">.enw (EndNote)</option>\n                        <option value=\"2\">.bibtex (BibTex)</option>\n                        <option value=\"3\">.txt (Medlars, RefWorks)</option>\n\n            </select>\n            <button class=\"btn citation-download-link disabled\" type=\"submit\">Download citation</button>\n        </form>\n    </div>\n\n    <a class=\"close-reveal-modal\" href=\"javascript:;\" data-google-interstitial=\"false\"><i class=\"icon-general-close\"></i><span class=\"screenreader-text\">Close</span></a>\n</div>\n \n    </div>\n\n                        </li>\n                        <li class=\"toolbar-item item-tools\">\n    <div class=\"widget widget-ToolboxPermissions widget-instance-OUP_Get_Permissions\">\n            <div class=\"module-widget\">\n        <a href=\"https://s100.copyright.com/AppDispatchServlet?publisherName=OUP&amp;publication=1537-6591&amp;title=Prevalence%20and%20Etiology%20of%20Community-acquired%20Pneumonia%20in%20Immunocompromised%20Patients&amp;publicationDate=2018-08-23&amp;volumeNum=68&amp;issueNum=9&amp;author=Di%20Pasquale%2C%20Marta%20Francesca%3B%20Sotgiu%2C%20Giovanni&amp;startPage=1482&amp;endPage=1493&amp;contentId=10.1093%2Fcid%2Fciy723&amp;oa=&amp;copyright=%C2%A9%20The%20Author%28s%29%202018.%20Published%20by%20Oxford%20University%20Press%20for%20the%20Infectious%20Diseases%20Society%20of%20America.%20All%20rights%20reserved.%20For%20permissions%2C%20e-mail%3A%20journals.permissions%40oup.com.&amp;orderBeanReset=True\" id=\"PermissionsLink\" class=\"\" target=\"\" rel=\"nofollow\" data-google-interstitial=\"false\">\n            <i class=\"icon-menu_permissions\">\n                <span class=\"screenreader-text\">Permissions Icon</span>\n            </i>\n            Permissions\n        </a>\n    </div>\n \n    </div>\n\n                        </li>\n                        \n    <li class=\"toolbar-item item-with-dropdown item-share\">\n        <a href=\"javascript:;\" class=\"drop-trigger js-toolbar-dropdown at-ShareButton\" data-dropdown=\"ShareDrop\" data-google-interstitial=\"false\">\n            <i class=\"icon-menu_share\"><span class=\"screenreader-text\">Share Icon</span></i>\n            <span class=\"toolbar-label\">\n                <span class=\"toolbar-text\">Share</span>\n                <i class=\"arrow-icon icon-general-arrow-filled-down js-toolbar-arrow-icon\"></i>\n            </span>\n        </a>\n        <ul id=\"ShareDrop\" class=\"addthis_toolbox addthis_default_style addthis_20x20_style f-dropdown js-dropdown-content\" data-dropdown-content=\"\">\n    <li>\n        <a class=\"st-custom-button addthis_button_bluesky js-share-link\" data-network=\"bluesky\" data-title=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" data-url=\"https://academic.oup.com/cid/article/68/9/1482/5078600\" data-email-subject=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" href=\"javascript:;\" rel=\"nofollow\" data-google-interstitial=\"false\"><span>Bluesky</span></a>\n    </li>\n    <li>\n        <a class=\"st-custom-button addthis_button_facebook js-share-link\" data-network=\"facebook\" data-title=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" data-url=\"https://academic.oup.com/cid/article/68/9/1482/5078600\" data-email-subject=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" href=\"javascript:;\" rel=\"nofollow\" data-google-interstitial=\"false\"><span>Facebook</span></a>\n    </li>\n    <li>\n        <a class=\"st-custom-button addthis_button_twitter js-share-link\" data-network=\"twitter\" data-title=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" data-url=\"https://academic.oup.com/cid/article/68/9/1482/5078600\" data-email-subject=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" href=\"javascript:;\" rel=\"nofollow\" data-google-interstitial=\"false\"><span>X</span></a>\n    </li>\n    <li>\n        <a class=\"st-custom-button addthis_button_linkedin js-share-link\" data-network=\"linkedin\" data-title=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" data-url=\"https://academic.oup.com/cid/article/68/9/1482/5078600\" data-email-subject=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" href=\"javascript:;\" rel=\"nofollow\" data-google-interstitial=\"false\"><span>LinkedIn</span></a>\n    </li>\n    <li>\n        <a class=\"st-custom-button addthis_button_email js-share-link\" data-network=\"email\" data-title=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" data-url=\"https://academic.oup.com/cid/article/68/9/1482/5078600\" data-email-subject=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" href=\"javascript:;\" rel=\"nofollow\" data-google-interstitial=\"false\"><span>Email</span></a>\n    </li>\n\n\n\n        </ul>\n    </li>\n\n                        \n                    </ul>\n                    <div class=\"toolbar-search\">\n    <div class=\"widget widget-SitePageHeader widget-instance-OUP_ArticleToolbarSearchBox\">\n        \n\n\n\n<div class=\"dropdown-panel-wrap\">\n\n    \n    <div class=\"dropdown-panel mobile-search-dropdown\">\n        <div class=\"mobile-search-inner-wrap\">\n\n\n<div class=\"navbar-search\">\n    <div class=\"mobile-microsite-search\">\n            <label for=\"OUP_ArticleToolbarSearchBox-mobile-navbar-search-filter\" class=\"screenreader-text js-mobile-navbar-search-filter-label\">\n                Navbar Search Filter\n            </label>\n            <select class=\"mobile-navbar-search-filter js-mobile-navbar-search-filter at-navbar-search-filter\" id=\"OUP_ArticleToolbarSearchBox-mobile-navbar-search-filter\">\n\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"\">Clinical Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Issue\">This issue</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Parent\">IDSA Journals</option>\n                    <optgroup class=\"navbar-search-optgroup\" label=\"Search across Oxford Academic\">\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"AcademicSubjects/MED00290\">Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Books\">Books</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Journals\">Journals</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Umbrella\">Oxford Academic</option>                    </optgroup>\n            </select>\n\n        <label for=\"OUP_ArticleToolbarSearchBox-mobile-microsite-search-term\" class=\"screenreader-text js-mobile-microsite-search-term-label\">\n            Mobile Enter search term\n        </label>\n        <input class=\"mobile-search-input mobile-microsite-search-term js-mobile-microsite-search-term at-microsite-search-term\" type=\"text\" maxlength=\"255\" placeholder=\"Search\" id=\"OUP_ArticleToolbarSearchBox-mobile-microsite-search-term\">\n\n        <a href=\"javascript:;\" class=\"mobile-microsite-search-icon mobile-search-submit icon-menu_search\" data-google-interstitial=\"false\">\n            <span class=\"screenreader-text\">Search</span>\n        </a>\n\n    </div>\n</div>\n\n\n        </div>\n    </div>\n   \n    <div class=\"dropdown-panel mobile-nav-dropdown\">\n\n    </div>\n\n</div>\n\n\n<div class=\"navbar\">\n    <div class=\"center-inner-row\">\n        <nav class=\"navbar-menu\">\n        </nav>\n            <div class=\"navbar-right-container\">\n                <div class=\"navbar-search-container js-navbar-search-container\">\n                    <a href=\"javascript:;\" class=\"navbar-search-close js_close-navsearch\" data-google-interstitial=\"false\">Close</a>\n\n\n<div class=\"navbar-search\">\n    <div class=\"microsite-search\">\n            <label for=\"OUP_ArticleToolbarSearchBox-navbar-search-filter\" class=\"screenreader-text js-navbar-search-filter-label\">\n                Navbar Search Filter\n            </label>\n            <select class=\"navbar-search-filter js-navbar-search-filter at-navbar-search-filter\" id=\"OUP_ArticleToolbarSearchBox-navbar-search-filter\">\n\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"\">Clinical Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Issue\">This issue</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Parent\">IDSA Journals</option>\n                    <optgroup class=\"navbar-search-optgroup\" label=\"Search across Oxford Academic\">\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"AcademicSubjects/MED00290\">Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Books\">Books</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Journals\">Journals</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Umbrella\">Oxford Academic</option>                    </optgroup>\n            </select>\n\n        <label for=\"OUP_ArticleToolbarSearchBox-microsite-search-term\" class=\"screenreader-text js-microsite-search-term-label\">\n            Enter search term\n        </label>\n        <input class=\"navbar-search-input microsite-search-term js-microsite-search-term at-microsite-search-term\" type=\"text\" maxlength=\"255\" placeholder=\"Search\" id=\"OUP_ArticleToolbarSearchBox-microsite-search-term\">\n\n        <a href=\"javascript:;\" class=\"microsite-search-icon navbar-search-submit icon-menu_search\" data-google-interstitial=\"false\">\n            <span class=\"screenreader-text\">Search</span>\n        </a>\n\n    </div>\n</div>\n\n\n                    <div class=\"navbar-search-advanced\"><a href=\"https://academic.oup.com/cid/advanced-search?page=1&amp;fl_SiteID=5269&amp;SearchSourceType=1\" class=\"advanced-search js-advanced-search\" data-google-interstitial=\"false\">Advanced Search</a></div>\n                </div>\n                \n                <div class=\"navbar-search-collapsed\"><a href=\"javascript:;\" class=\"icon-menu_search js_expand-navsearch\" data-google-interstitial=\"false\"><span class=\"screenreader-text\">Search Menu</span></a></div>\n\n        <div class=\"navbar-menu navbar-ai-assistant-container site-menu-item\">\n            <a href=\"javascript:;\" class=\"navbar-ai-assistant-link js-navbar-ai-assistant-link\" data-google-interstitial=\"false\">\n                <span aria-label=\"AI Discovery Assistant\" class=\"navbar-ai-assistant-span\">\n                    <i class=\"icon-spark navbar-icon-spark\"></i>\n                    AI Discovery Assistant\n                </span>\n            </a>\n        </div>\n\n            </div>\n    </div>\n</div>\n<input id=\"routename\" name=\"RouteName\" type=\"hidden\" value=\"cid\"> \n    </div>\n\n                    </div>\n                </div>\n            </div>\n            <div id=\"ContentTab\" class=\"content active\">\n    <div class=\"widget widget-ArticleFulltext widget-instance-OUP_Article_FullText_Widget\">\n        <div class=\"module-widget\">\n    <div class=\"widget-items\" data-widgetname=\"ArticleFulltext\">\n\n\n\n\n\n                    <h2 scrollto-destination=\"134170092\" id=\"134170092\" class=\"abstract-title js-splitscreen-abstract-title\">Abstract</h2>\n<section class=\"abstract\"><div class=\" sec\"><div class=\"title\">Background</div><p class=\"chapter-para\">The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia.</p></div><div class=\" sec\"><div class=\"title\">Methods</div><p class=\"chapter-para\">We conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor.</p></div><div class=\" sec\"><div class=\"title\">Results</div><p class=\"chapter-para\">At least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors significantly differed across continents and countries, with chronic steroid use (45%), hematological cancer (25%), and chemotherapy (22%) the most common. Among immunocompromised patients, community-acquired pneumonia (CAP) pathogens were the most frequently identified, and prevalences did not differ from those in immunocompetent patients. Risk factors for immunocompromise were independently associated with neither <em>Pseudomonas aeruginosa</em> nor non–community-acquired bacteria. Specific risk factors were independently associated with fungal infections (odds ratio for AIDS and hematological cancer, 15.10 and 4.65, respectively; both <em>P</em> = .001), mycobacterial infections (AIDS; <em>P</em> = .006), and viral infections other than influenza (hematological cancer, 5.49; <em>P</em> &lt; .001).</p></div><div class=\" sec\"><div class=\"title\">Conclusions</div><p class=\"chapter-para\">Our findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses.</p></div></section>                    <div class=\"article-metadata-panel clearfix at-ArticleMetadata\"></div>\n<div class=\"kwd-group\"><a class=\"kwd-part kwd-main\" href=\"javascript:;\" data-keyword=\"pneumonia\" data-google-interstitial=\"false\">pneumonia</a>, <a class=\"kwd-part kwd-main\" href=\"javascript:;\" data-keyword=\"&quot;multidrug-resistant pathogens&quot;\" data-google-interstitial=\"false\">multidrug-resistant pathogens</a>, <a class=\"kwd-part kwd-main\" href=\"javascript:;\" data-keyword=\"microbiology\" data-google-interstitial=\"false\">microbiology</a>, <a class=\"kwd-part kwd-main\" href=\"javascript:;\" data-keyword=\"MRSA\" data-google-interstitial=\"false\">MRSA</a>, <a class=\"kwd-part kwd-main\" href=\"javascript:;\" data-keyword=\"immunocompromise\" data-google-interstitial=\"false\">immunocompromise</a></div><p class=\"chapter-para\">During initial evaluation of a patient coming from the community with pneumonia, the identification of possible risk factors for multidrug-resistant organisms or unusual pathogens is crucial [<span class=\"xrefLink\" id=\"jumplink-CIT0001 CIT0002 CIT0003\"></span><a href=\"javascript:;\" reveal-id=\"CIT0001 CIT0002 CIT0003\" data-open=\"CIT0001 CIT0002 CIT0003\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">1–3</a>]. Because a microbiological identification is found in about 30% of hospitalized patients with pneumonia coming from the community, and usually requires 24–48 hours to be available, most of patients are treated empirically [<span class=\"xrefLink\" id=\"jumplink-CIT0004\"></span><a href=\"javascript:;\" reveal-id=\"CIT0004\" data-open=\"CIT0004\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">4</a>]. Delay in initiation of appropriate empiric antibiotic therapy is a known risk factor for worse clinical outcomes [<span class=\"xrefLink\" id=\"jumplink-CIT0005 CIT0006 CIT0007\"></span><a href=\"javascript:;\" reveal-id=\"CIT0005 CIT0006 CIT0007\" data-open=\"CIT0005 CIT0006 CIT0007\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">5–7</a>]; therefore, it is relevant to promptly recognize patients at risk for specific pathogens, specially multidrug-resistant or atypical microbes [<span class=\"xrefLink\" id=\"jumplink-CIT0001 CIT0002 CIT0003\"></span><a href=\"javascript:;\" reveal-id=\"CIT0001 CIT0002 CIT0003\" data-open=\"CIT0001 CIT0002 CIT0003\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">1–3</a>].</p><p class=\"chapter-para\">The aging of the population and advancements in therapeutic protocols have led to an increase prevalence of chronic diseases as well as long-term treatments with immunosuppressive agents [<span class=\"xrefLink\" id=\"jumplink-CIT0008\"></span><a href=\"javascript:;\" reveal-id=\"CIT0008\" data-open=\"CIT0008\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">8</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0009\"></span><a href=\"javascript:;\" reveal-id=\"CIT0009\" data-open=\"CIT0009\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">9</a>]. Thus, among patients with pneumonia coming from the community and admitted to the hospital, the number who might not be fully immunocompetent is constantly increasing [<span class=\"xrefLink\" id=\"jumplink-CIT0008\"></span><a href=\"javascript:;\" reveal-id=\"CIT0008\" data-open=\"CIT0008\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">8</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0009\"></span><a href=\"javascript:;\" reveal-id=\"CIT0009\" data-open=\"CIT0009\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">9</a>]. Nevertheless, the real prevalence of immunocompromise among patients with pneumonia coming from the community is still unknown. Moreover, guidelines for community-acquired and hospital-acquired pneumonia did not address this topic—what is more, they specifically excluded patients with clinical characteristics determining immunocompromise [<span class=\"xrefLink\" id=\"jumplink-CIT0005 CIT0006 CIT0007\"></span><a href=\"javascript:;\" reveal-id=\"CIT0005 CIT0006 CIT0007\" data-open=\"CIT0005 CIT0006 CIT0007\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">5–7</a>], and current evidence in literature is also scarce.</p><p class=\"chapter-para\">To our knowledge, there are no studies addressing the clinical evaluation and initial empirical antibiotic coverage of patients coming from the community with pneumonia and immunocompromise. Moreover, specific risk factors to assess the causative microbiology and help clinicians choose more appropriate management for these patients have not been clearly identified. Thus, the aim of the current study was to identify the prevalence, type, microbiology, and intercorrelations between different risk factors for immunocompromise in hospitalized patients with pneumonia coming from the community.</p>                    <h2 scrollto-destination=\"134170097\" id=\"134170097\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s5\">MATERIALS AND METHODS</h2>\n                    <h3 scrollto-destination=\"134170098\" id=\"134170098\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s6\">Study Design and Population</h3>\n<p class=\"chapter-para\">This is a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) database [<span class=\"xrefLink\" id=\"jumplink-CIT0010\"></span><a href=\"javascript:;\" reveal-id=\"CIT0010\" data-open=\"CIT0010\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">10</a>]. The GLIMP study was an international, multicenter, observational, point-prevalence study of adult patients hospitalized for community-onset pneumonia in 54 countries worldwide. Patients were enrolled on a single day during the months of March, April, May, and June 2015. The methods of the GLIMP study have been published elsewhere [<span class=\"xrefLink\" id=\"jumplink-CIT0010\"></span><a href=\"javascript:;\" reveal-id=\"CIT0010\" data-open=\"CIT0010\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">10</a>]. The coordinating center (University of Texas Health Science Center, San Antonio) received approval from its institutional review board (No. HSC20150184E).</p><p class=\"chapter-para\">All adult patients (aged &gt;18 years old) coming from the community and hospitalized with pneumonia during study period were included. Pneumonia was defined as the presence of a new pulmonary infiltrate on chest radiograph at the time of hospitalization, associated with ≥1 of the following criteria: (1) new or increased cough with/without sputum production and/or purulent respiratory secretions, (2) fever or hypothermia, and (3) evidence of systemic inflammation (ie, abnormal white blood cell count or increased C-reactive protein or procalcitonin level). Hospitalized patients with a diagnosis of hospital-acquired or ventilator-associated pneumonia were excluded.</p>                    <h3 scrollto-destination=\"134170101\" id=\"134170101\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s7\">Data Collection</h3>\n<p class=\"chapter-para\">Data were collected from medical records at the time of hospital admission. Data gathered included demographics; respiratory and cardiovascular comorbid conditions; immunocompromised status and other chronic medical conditions; severity of pneumonia (defined as either intensive care unit admission, use of invasive or noninvasive mechanical ventilation, or use of vasopressors/inotropes during the first 24 hours after hospital admission); and specific risk factors for resistant pathogens infection, including chronic aspiration, being bedridden, malnutrition, presence of enteric tube feeding and indwelling catheters (including central venous and urinary catheters), previous infections, chronic microbial colonization, and previous healthcare exposures. The number and type of microbiological samples obtained within 24 hours after hospital admission were also collected. Culture-positive tests, kind of sample, and antibiotic resistance patterns were also gathered, along with empiric antibiotic treatment, given within 24 hours after hospital admission.</p>                    <h3 scrollto-destination=\"134170103\" id=\"134170103\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s8\">Microbiological Workup</h3>\n<p class=\"chapter-para\">Diagnostic testing was performed according to local standard operating procedures and included collection of respiratory and blood cultures and testing for urinary antigens. Microbiological examinations and susceptibility testing were performed according to local standard protocols within the first 24 hours after hospital admission [<span class=\"xrefLink\" id=\"jumplink-CIT0011\"></span><a href=\"javascript:;\" reveal-id=\"CIT0011\" data-open=\"CIT0011\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">11</a>]. Multivariable logistic regression models were performed for patients who had a positive culture, to identify specific risk factors for single pathogens.</p><p class=\"chapter-para\">Causative pathogens were stratified according to the coverage of standard therapy for community-acquired pneumonia (CAP) [<span class=\"xrefLink\" id=\"jumplink-CIT0005 CIT0006 CIT0007\"></span><a href=\"javascript:;\" reveal-id=\"CIT0005 CIT0006 CIT0007\" data-open=\"CIT0005 CIT0006 CIT0007\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">5–7</a>]. Those not covered by standard CAP therapy included the following: non–community-acquired bacteria (<em>Acinetobacter baumanii</em>, <em>Enterococcus</em> vancomycin-resistant, <em>Nocardia</em> spp.), mycobacteria, fungi (<em>Aspergillus fumigatus, Coccidioides, Criptococcus</em>, <em>Pneumocystis jirovecii</em>), and viruses other than influenza [<span class=\"xrefLink\" id=\"jumplink-CIT0005 CIT0006 CIT0007\"></span><a href=\"javascript:;\" reveal-id=\"CIT0005 CIT0006 CIT0007\" data-open=\"CIT0005 CIT0006 CIT0007\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">5–7</a>]. Those covered by standard CAP therapy included <em>Pseudomonas aeruginosa,</em> methicillin-resistant <em>Staphylococcus aureus</em>, methicillin-sensitive <em>S. aureus</em>, <em>Enterobacter</em> spp., <em>Enterococcus</em> spp., <em>Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae</em>, <em>Moraxella catarrhalis, Proteus mirabilis, Serratia marcescens, Streptococcus pneumoniae, Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella pneumophilia,</em> anaerobes bacteria, and influenza viruses. Atypical pathogens included <em>C. pneumoniae, M. pneumoniae,</em> and <em>L. pneumophilia.</em> CAP therapy was defined as β-lactams (ceftriaxone, ampicillin-sulbactam, amoxicillin-clavulanate, cefepime, ceftazidime, piperacillin-tazobactam) plus macrolide, or fluoroquinolones alone, and, eventually, in association with vancomycin, linezolid, or oseltamivir [<span class=\"xrefLink\" id=\"jumplink-CIT0005 CIT0006 CIT0007\"></span><a href=\"javascript:;\" reveal-id=\"CIT0005 CIT0006 CIT0007\" data-open=\"CIT0005 CIT0006 CIT0007\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">5–7</a>].</p>                    <h3 scrollto-destination=\"134170106\" id=\"134170106\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s9\">Definition of Immunocompromised and Study Groups</h3>\n<p class=\"chapter-para\">Immunocompromise was defined as the presence of ≥1 of the following risk factors: (1) AIDS, defined either as human immunodeficiency virus infection with CD4<sup>+</sup> lymphocyte count &lt;200/µL or by the occurrence of AIDS-defining conditions; (2) aplastic anemia; (3) asplenia; (4) hematological cancer, defined as lymphoma, acute or chronic leukemia, or multiple myeloma; (5) chemotherapy during the last 3 months; (6) neutropenia, defined as a neutrophil count &lt;500/dL at complete blood cell count; (7) biological drug use (including trastuzumab and therapies for autoimmune diseases, eg, anti–tumor necrosis factor α, prescribed during ≥6 months before hospital admission); (8) lung transplantation; (9) chronic steroid use (&gt;10 mg/d of prednisone or equivalent ≥3 months before hospital admission); (10) lung cancer with either neutropenia or chemotherapy; (11) other solid tumor with either neutropenia or chemotherapy; (12) other immunocompromise (any immunocompromised state, including congenital/genetic immunocompromise and immunosuppressive therapy due to hematological cancer/solid organ transplantation other than lung). Two study groups were identified: those with versus those without 1 risk factor for immunocompromise.</p>                    <h3 scrollto-destination=\"134170108\" id=\"134170108\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s10\">Statistical Analysis</h3>\n<p class=\"chapter-para\">Categorical variables, expressed as counts (percentages), were compared using the χ<sup>2</sup> test. Continuous variables were compared using the unpaired Student <em>t</em> test or the Mann-Whitney test, when appropriate. Statistical significance was defined as <em>P</em> &lt; .05. A network analysis was conducted to represent the frequencies of all immunocompromise variables and their relationships. The size of the circles (the circles visible in Figure 4 [network analysis], each representing a single risk factor for immunocompromise) represents both prevalence of the risk factor and strength of association with other variables.</p><p class=\"chapter-para\">The predictive value of each variable was categorized by quartiles and analyzed using a univariate regression logistic analysis. A multivariable model was obtained using a Cox regression analysis to identify independent predictors of specific pathogens, using an entry level of P value ≤0.05 and a removal level of P value ≥0.10. Hazard ratios and adjusted analyses were obtained. All statistical analyses were performed with IBM SPSS software (version 22, Statistics for Mac; version 22.0, IBM Crop), and Stata 13 software (StataCorp).</p>                    <h2 scrollto-destination=\"134170111\" id=\"134170111\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s11\">RESULTS</h2>\n                    <h3 scrollto-destination=\"134170112\" id=\"134170112\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s12\">Prevalence of Risk Factors for Immunocompromise</h3>\n<p class=\"chapter-para\">Among 3702 patients enrolled in the GLIMP database, ≥1 risk factor for immunocompromise was identified in 652 (17.6%). The prevalences of patients with pneumonia coming from the community and with ≥1 risk factor for immunocompromise differed among continents and countries, as depicted in <span class=\"xrefLink\" id=\"jumplink-F1\"></span><a href=\"javascript:;\" data-modal-source-id=\"F1\" class=\"link xref-fig\" data-google-interstitial=\"false\">Figure 1</a> and <span class=\"link link-data-supplement\" data-supplement-target=\"sup1\"></span><span class=\"content-section supplementary-material\"><a path-from-xml=\"sup1\" href=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy723_suppl_supplementary_materials.docx?Expires=1752554619&amp;Signature=IHcdpKKqq~8UybDtfcD3STezArBwHL7jBx5GEabm~T8HKox8a8ufCpx98eRu5Y5YzE4WIM1s0Xpj7nClWNCeBi4YRTDR57TohDDSroY~vSBlwQzK8CRM7QW3Z65UbTyzL~YYiLwtnWqW0IU3zgHI7Tnp-RT8kWIUUokUdE4hNwa5b1nHYIQZxjKpKj7y4kj~4O0VCssH2lKwxvLln0i2MGypxy5wJMEUlSehjBb6g33eg1EkSTst1441miASNAtSTWYhmp5bB3dtOm56p90128BwTLIACROocJREvycDJKAKuGqE6bHS4cJpTqaoOpMBi-MMG4Nv329NM6avRo0few__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" data-google-interstitial=\"false\">Supplementary Tables 1 and 2</a></span>. The prevalence of immunocompromise was significantly higher in both North and South America than in the rest of the world (24.0% vs 16.5 [<em>P</em> &lt; .001] and 24.8% vs 17.2 [<em>P</em> = .006], respectively) (<span class=\"link link-data-supplement\" data-supplement-target=\"sup1\"></span><span class=\"content-section supplementary-material\"><a path-from-xml=\"sup1\" href=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy723_suppl_supplementary_materials.docx?Expires=1752554619&amp;Signature=IHcdpKKqq~8UybDtfcD3STezArBwHL7jBx5GEabm~T8HKox8a8ufCpx98eRu5Y5YzE4WIM1s0Xpj7nClWNCeBi4YRTDR57TohDDSroY~vSBlwQzK8CRM7QW3Z65UbTyzL~YYiLwtnWqW0IU3zgHI7Tnp-RT8kWIUUokUdE4hNwa5b1nHYIQZxjKpKj7y4kj~4O0VCssH2lKwxvLln0i2MGypxy5wJMEUlSehjBb6g33eg1EkSTst1441miASNAtSTWYhmp5bB3dtOm56p90128BwTLIACROocJREvycDJKAKuGqE6bHS4cJpTqaoOpMBi-MMG4Nv329NM6avRo0few__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" data-google-interstitial=\"false\">Supplementary Table 1</a></span>).</p>                    <a id=\"134170114\" scrollto-destination=\"134170114\" data-google-interstitial=\"false\"></a>\n<div data-id=\"f1\" data-content-id=\"f1\" class=\"fig fig-section js-fig-section\" swap-content-for-modal=\"true\"><div class=\"graphic-wrap\"><img class=\"content-image\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1752554620&amp;Signature=LKXAyrV74Aa9owXe0o-cQ75pOeSoID0-pehgygNtPZSFXNZMuhHSvh2bH2dv7qW8hH1yagXom1UIMLOtWgjAeeVu2LBuha-~CcDB2tnoDsCwd0W--ENWiqmCFTxq3yC2TQ0Umx7W~VJXwN6SRKyfDOflOkKvPGRNUobFX0ugYVCV63UYBnlhdsPfvI-fsKpp2D2I1PP6zBaXvsJbvI-0aIPK7XN9D-bkImy~2jyh7YxMl-ml056-m9M~e1NXIC1G-eMlJ-D0ihNbxsU~I2x~~h2BWrtr8AE9Sfu1WTqiFahp57mH4~iFGY9EkQkC4xJpjMyNKtQFhxpXjvQtYLzecQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases.\" data-path-from-xml=\"ciy72301.jpg\" width=\"520\" height=\"462\"><div class=\"graphic-bottom\"><div class=\"label fig-label\" id=\"label-134170114\">Figure 1.</div><div class=\"caption fig-caption\"><p class=\"chapter-para\">Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, &lt;5%, 5%–10%, 11%–20%, 21%–30%, or &gt;30% of total cases.</p></div><div class=\"ajax-articleAbstract-exclude-regex fig-orig original-slide figure-button-wrap\"><a class=\"fig-view-orig js-view-large at-figureViewLarge openInAnotherWindow\" role=\"button\" aria-describedby=\"label-134170114\" href=\"/view-large/figure/134170114/ciy72301.jpg\" data-path-from-xml=\"ciy72301.jpg\" target=\"_blank\" data-google-interstitial=\"false\">Open in new tab</a><a class=\"download-slide\" role=\"button\" aria-describedby=\"label-134170114\" data-section=\"134170114\" href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72301.jpeg?Expires=1752554620&amp;Signature=NHcEJwNnhhuu~V7litr8igr9GFWfZ0zM0SxlfYOwAgN3ag3nsCMd9zXKoM9GZWcSFeGB~KznckX3sjRs7eZI6UovzOYWd5ChB8QCKT6DbvXvsAyPCY~~tvyw1nLgnCRXHxsEp9~pCDA4jyfmGwdzBmIxjxK32DKPE3r03H1NwaFfFuqtTjvCIQz2eID2dBiK~4lTbznS4INQ66i-Fh9DwTzI-HwYqclm24aYv1pSYlAiswZHOwaE-fO6wkuUxDcfD3pvVFQ~xscKfiFVbOt91lXVNkOd7p4CKoSAgaQv6yr5WZ9-7z1VyiIThnhC9G~HPkbIlB2Do4fo0jz7V2xwPA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170114&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\" data-path-from-xml=\"ciy72301.jpg\" data-google-interstitial=\"false\">Download slide</a></div></div></div></div><p class=\"chapter-para\">The prevalence of each risk factor for immunocompromise is depicted in <span class=\"xrefLink\" id=\"jumplink-F2\"></span><a href=\"javascript:;\" data-modal-source-id=\"F2\" class=\"link xref-fig\" data-google-interstitial=\"false\">Figure 2</a>, with chronic steroid use (45.0%), hematological cancer (25.0%), and chemotherapy (22.0%) being the most frequent ones. A total of 312 patients (8.4%) had &gt;1 risk factor for immunocompromise (<span class=\"xrefLink\" id=\"jumplink-F3\"></span><a href=\"javascript:;\" data-modal-source-id=\"F3\" class=\"link xref-fig\" data-google-interstitial=\"false\">Figure 3</a>).</p>                    <a id=\"134170116\" scrollto-destination=\"134170116\" data-google-interstitial=\"false\"></a>\n<div data-id=\"f2\" data-content-id=\"f2\" class=\"fig fig-section js-fig-section\" swap-content-for-modal=\"true\"><div class=\"graphic-wrap\"><img class=\"content-image\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72302.jpeg?Expires=1752554620&amp;Signature=tN-5VXAN-IRDKK8axKZA8P~Y5z--s9j8Erc8SOjWl6DrKKH4QL5os9eZxhVeV6eWVN~f~VDG9tfzyHUF6i7OVsMNB2vsk6C~94Qv-2aRHoy5JP-aM-LrL8khDyqEa4Lg2BfInF3Q0qGwXrmt25GlH1qSBKirMgS~VlVo9FK3dUDe2-XgCIv-DixycDR1NbxEUad1obLBQi7T-cMZnDc0-hSXzSelH07q4yY8dbVGxrERuy5IWOvusZ1u83w1jCK4dSvt3hPFFdMZMOmGLi~Fj-dVSs0cAjfbIHoEDmqErTby4pVDEijEs5muQVm-Ux~YEjgN-VhvWj8YtpZKL4eSXA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"Prevalence of each single risk factor for immunocompromise.\" data-path-from-xml=\"ciy72302.jpg\" width=\"520\" height=\"304\"><div class=\"graphic-bottom\"><div class=\"label fig-label\" id=\"label-134170116\">Figure 2.</div><div class=\"caption fig-caption\"><p class=\"chapter-para\">Prevalence of each single risk factor for immunocompromise.</p></div><div class=\"ajax-articleAbstract-exclude-regex fig-orig original-slide figure-button-wrap\"><a class=\"fig-view-orig js-view-large at-figureViewLarge openInAnotherWindow\" role=\"button\" aria-describedby=\"label-134170116\" href=\"/view-large/figure/134170116/ciy72302.jpg\" data-path-from-xml=\"ciy72302.jpg\" target=\"_blank\" data-google-interstitial=\"false\">Open in new tab</a><a class=\"download-slide\" role=\"button\" aria-describedby=\"label-134170116\" data-section=\"134170116\" href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72302.jpeg?Expires=1752554620&amp;Signature=urCgidlWbN7Br1gKnVthRjYFEVioagJuBFmiXPuQQBoD2qmTrm4Heidc21Yt1dgPswbIwC7DPhnYrlHrjxMxL-tPDfinKG-olgkospAEDA-ocZW5BuK9lYsha0rJ0NF76fxfhqDzGVUbNAug3anPLTq4c4Wm9hmTgaDN4Qc2ECcT8hDYAnEm3od96dWn52Zy09JsZa4zT41kMG~qQJEZG62~24b5nEIG7eSCncOceqVPqOOaaIMniBLrAQuB7Hvqr~6AtHN5IBjBuLUjU1xYJcFJXX6WtIhnqkXKN21GOO7O7AU0AC7FLWQuEd1zCcVocKQxVv4RndCQeZ3XzZvegA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170116&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\" data-path-from-xml=\"ciy72302.jpg\" data-google-interstitial=\"false\">Download slide</a></div></div></div></div>                    <a id=\"134170117\" scrollto-destination=\"134170117\" data-google-interstitial=\"false\"></a>\n<div data-id=\"f3\" data-content-id=\"f3\" class=\"fig fig-section js-fig-section\" swap-content-for-modal=\"true\"><div class=\"graphic-wrap\"><img class=\"content-image\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72303.jpeg?Expires=1752554620&amp;Signature=Xts16a6pXvQbNfwKtUeejfXsqF17z~2gviy7VcLQhhckWHmCw0zRSSEtsyrG9SkI2LRw39TbhqnqYNb1VTXQKD-ybyHkb~R3s-eIxJ~94DOxaaXBbUvpzbvwY1vDACc5LpVzJJ8dZMntZ7nekvhgMs6NtlpySVWDDC~7ybF0bySgW6i55FBFevIdcUxB3ipChEHL9XiTlmDkdiHssMser494UBvbDyg4DUKM-Cpd988M8qpSwp-eg-3Yhkr9q2~L66QQUhwgYNILWRRA1azwsTAJvrWUq52Dpikbj4mzbXXstnhvc7GNMw5xxz6nFPKuHVKJlcE-HQsiIvj5ZOVUxg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"Prevalence of the number of risk factors present simultaneously in a single patient.\" data-path-from-xml=\"ciy72303.jpg\" width=\"520\" height=\"245\"><div class=\"graphic-bottom\"><div class=\"label fig-label\" id=\"label-134170117\">Figure 3.</div><div class=\"caption fig-caption\"><p class=\"chapter-para\">Prevalence of the number of risk factors present simultaneously in a single patient.</p></div><div class=\"ajax-articleAbstract-exclude-regex fig-orig original-slide figure-button-wrap\"><a class=\"fig-view-orig js-view-large at-figureViewLarge openInAnotherWindow\" role=\"button\" aria-describedby=\"label-134170117\" href=\"/view-large/figure/134170117/ciy72303.jpg\" data-path-from-xml=\"ciy72303.jpg\" target=\"_blank\" data-google-interstitial=\"false\">Open in new tab</a><a class=\"download-slide\" role=\"button\" aria-describedby=\"label-134170117\" data-section=\"134170117\" href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72303.jpeg?Expires=1752554620&amp;Signature=aODZPs-HRl9QmymSK-5bkx~xp6iLrndvYFKxy1ge9DczmeUzsNnr5McNlvqrMcXHLvgMkhfK7yT7VuvVZQyJiTDmkR2j-SEc5zFcORnQPNUjDvGORdypfvcWI0ap8MKwHNe5lyBn4KtJz~tW8Oy3Gx54ukE8wke7~kZBzMvO8MTOkttiu8JkRKLQBqO6IcM2MoQBEcRSt-iQJjHBC9eSqzTw9hfjbhfc1npEBjHchP6v69RipZnUipM4HSTXcHzcLlv5ZrElufmBjKlaCOuMXehhls70RLfvTvOnOA3AyEmOSecyKEGpTAKKWMZCZcKwFjPqwgrO2KIMNHBcdECFyg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170117&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\" data-path-from-xml=\"ciy72303.jpg\" data-google-interstitial=\"false\">Download slide</a></div></div></div></div>                    <h3 scrollto-destination=\"134170118\" id=\"134170118\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s13\">Network Analysis Among Risk Factors for Immunocompromise</h3>\n<p class=\"chapter-para\">The results of the network analysis of all risk factors for immunocompromise are depicted in <span class=\"xrefLink\" id=\"jumplink-F4\"></span><a href=\"javascript:;\" data-modal-source-id=\"F4\" class=\"link xref-fig\" data-google-interstitial=\"false\">Figure 4</a>. Relationships were identified between chemotherapy and solid tumor other than lung cancer, hematological cancer, and chronic steroid use, and between other immunocompromise and chronic steroid use.</p>                    <a id=\"134170120\" scrollto-destination=\"134170120\" data-google-interstitial=\"false\"></a>\n<div data-id=\"f4\" data-content-id=\"f4\" class=\"fig fig-section js-fig-section\" swap-content-for-modal=\"true\"><div class=\"graphic-wrap\"><img class=\"content-image\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72304.jpeg?Expires=1752554620&amp;Signature=GuJUcrEhLaMR89vfrhqqYuGyB4HuDlfLUgnHqNu6Ksi5VkLMWjSpH0hVJWv0i4hnesvCDRYbQ~uAyBQyQ0AiLXq2xGVhq3CJd~~Uo~xFEO2RNWWcv5izwBv2Xd~h9Hdfe0hTA-AXnTA7hKM-ThAaURdGnReCFddtKpqnLFFI8QBpZfiXaSjcJTGzuOJpCX41BN9EmgqXfVfeCV2WjdANqIm2R0p4fJbe8r3T6ykoQ1g-IoQnAttT~9TBNl6irCxSuhZHs693bn8ZNDwodNBEKnNGVKaV3sMa8zH8GthYrKb1ARcjtit4vlO4Amlu5qUEW4FRAzxNeE5ch2OPPqoZ6g__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"Network analysis between risk factors for immunocompromise.\" data-path-from-xml=\"ciy72304.jpg\"><div class=\"graphic-bottom\"><div class=\"label fig-label\" id=\"label-134170120\">Figure 4.</div><div class=\"caption fig-caption\"><p class=\"chapter-para\">Network analysis between risk factors for immunocompromise.</p></div><div class=\"ajax-articleAbstract-exclude-regex fig-orig original-slide figure-button-wrap\"><a class=\"fig-view-orig js-view-large at-figureViewLarge openInAnotherWindow\" role=\"button\" aria-describedby=\"label-134170120\" href=\"/view-large/figure/134170120/ciy72304.jpg\" data-path-from-xml=\"ciy72304.jpg\" target=\"_blank\" data-google-interstitial=\"false\">Open in new tab</a><a class=\"download-slide\" role=\"button\" aria-describedby=\"label-134170120\" data-section=\"134170120\" href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72304.jpeg?Expires=1752554620&amp;Signature=YZzJ1wJWugBQStvfJV4l4KYj3Wo9NRpieCO~yvNqxtUBWQdjFeAYbw2G-Y6DLCVNq9Va5VeID5cdns-ikSqf31HJSxkU6nJ2ORJtfKpX9YRK1R4udPlHilZw7ywCq-EzR6AMwb3sY-BfsBS4sDesTOwvKTu1-DzRuTpqruza-~yCWEOuDxUkBBBhGOjezpmaPE1pK9FuWVCTdWQjhWi0Q1hWTQx8Y41~JVb3kGWNigqT8AD4v9JX1c4I3Lv7PwLI68bVFaY9GUswC-yS1tvJbrugsyrYyCUrS~h7Si20MQ14RfW5c61orGDtUvAkaoknOVddjBXj5tv5wBq7Hieh4A__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170120&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\" data-path-from-xml=\"ciy72304.jpg\" data-google-interstitial=\"false\">Download slide</a></div></div></div></div>                    <h3 scrollto-destination=\"134170121\" id=\"134170121\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s14\">Clinical and Microbiological Characteristics of Patients With Immunocompromise</h3>\n<p class=\"chapter-para\">Clinical features and disease severity of immunocompetent versus immunocompromised patients are shown in <span class=\"xrefLink\" id=\"jumplink-T1\"></span><a href=\"javascript:;\" reveal-id=\"T1\" data-open=\"T1\" class=\"link link-reveal link-table xref-fig\" data-google-interstitial=\"false\">Table 1</a> and <span class=\"link link-data-supplement\" data-supplement-target=\"sup1\"></span><span class=\"content-section supplementary-material\"><a path-from-xml=\"sup1\" href=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy723_suppl_supplementary_materials.docx?Expires=1752554620&amp;Signature=h15TLzB~iVdXq3mg6ERhsysxUJRdhy3kLeYQ4F92iCbc3pocFnl8FwvX3RQC8nlYDTyE-O-a~2nqmo9b7hLsR6tqwrT9vRY41V9ilDQiSPOIm6SNs5Vt2w60ygDmzeatDy1PnRyi2g~VSjY4BEk~G32iZQmxfjMNlHuKF6QQkUa808du7-UT7jAmdQsjnigHZsW275wHf0oI-BEhu33D6B3MFU2d5knLITgSIvG1m9Uql9dd8Iwe0Ti-PYfBKoU7Pb9DLF9EE~wV1fT1oJVp0RK0Eg6kGxWd7bCamQsPB00clz5TXI~lPCnGFq14~Oui~jj9qPGmqYLmCbUgWg2zTQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" data-google-interstitial=\"false\">Supplementary Table 3</a></span>. Immunocompromised patients were significantly younger and malnourished, had a higher frequency of comorbid conditions, previous infections, and colonization by resistant pathogens, and had more frequent contacts with the healthcare system. The prevalences of severe pneumonia did not differ among the 2 study groups.</p>                    <a id=\"134170123\" scrollto-destination=\"134170123\" data-google-interstitial=\"false\"></a>\n<div content-id=\"T1\" class=\"table-modal table-full-width-wrap\" style=\"display: block;\"><div class=\"table-wrap table-wide standard-table\"><div class=\"table-wrap-title\" id=\"T1\" data-id=\"T1\"><span class=\"label title-label\" id=\"label-72200\">Table 1.</span><div class=\"\n                            graphic-wrap table-open-button-wrap\n                            \"><a class=\"fig-view-orig at-tableViewLarge openInAnotherWindow btn js-view-large\" role=\"button\" target=\"_blank\" href=\"\n                                /view-large/134170123\" aria-describedby=\"label-72200\" data-google-interstitial=\"false\">\n                            Open in new tab\n                        </a></div><div class=\"caption caption-id-\" id=\"caption-72200\"><p class=\"chapter-para\">Clinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised)</p></div> </div><div class=\"table-overflow\"><table role=\"table\" aria-labelledby=\"\n                        label-72200\" aria-describedby=\"\n                        caption-72200\"><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<sup>a</sup><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 3050)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised<br>(n = 652)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div class=\"table-modal\"><table><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<sup>a</sup><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 3050)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised<br>(n = 652)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div class=\"table-wrap-foot\"><span id=\"fn-fn-0001\"></span><div content-id=\"fn-0001\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Abbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors.</p></span></div><span id=\"fn-fn-0002\"></span><div content-id=\"fn-0002\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\"><sup>a</sup>Data represent No. (%) unless otherwise specified.</p></span></div></div></div></div><div class=\"table-full-width-wrap\"><div class=\"table-wrap table-wide standard-table\"><div class=\"table-wrap-title\" id=\"T1\" data-id=\"T1\"><span class=\"label title-label\" id=\"label-72200\">Table 1.</span><div class=\"\n                            graphic-wrap table-open-button-wrap\n                            \"><a class=\"fig-view-orig at-tableViewLarge openInAnotherWindow btn js-view-large\" role=\"button\" target=\"_blank\" href=\"\n                                /view-large/134170123\" aria-describedby=\"label-72200\" data-google-interstitial=\"false\">\n                            Open in new tab\n                        </a></div><div class=\"caption caption-id-\" id=\"caption-72200\"><p class=\"chapter-para\">Clinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised)</p></div> </div><div class=\"table-overflow\"><table role=\"table\" aria-labelledby=\"\n                        label-72200\" aria-describedby=\"\n                        caption-72200\"><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<sup>a</sup><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 3050)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised<br>(n = 652)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div class=\"table-modal\"><table><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<sup>a</sup><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 3050)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised<br>(n = 652)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div class=\"table-wrap-foot\"><span id=\"fn-fn-0001\"></span><div content-id=\"fn-0001\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Abbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors.</p></span></div><span id=\"fn-fn-0002\"></span><div content-id=\"fn-0002\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\"><sup>a</sup>Data represent No. (%) unless otherwise specified.</p></span></div></div></div></div><p class=\"chapter-para\">Microbiological testing was performed in 91.0% (596 of 652) of immunocompromised and 86.0% (2626 of 3050) of immunocompetent patients (<em>P</em> &lt; .001). Bacteremia was found in 6.0% (36 of 596) of immunocompromised and 5.5% (145 of 2626; <em>P</em> = .62) of immunocompetent patients. At least 1 positive culture was obtained in 40.0% (238 of 596) immunocompromised and 36.0% (935 of 2626) immunocompetent patients (<em>P</em> = .047). Microbiological findings are provided in <span class=\"xrefLink\" id=\"jumplink-T2\"></span><a href=\"javascript:;\" reveal-id=\"T2\" data-open=\"T2\" class=\"link link-reveal link-table xref-fig\" data-google-interstitial=\"false\">Table 2</a> and <a class=\"link link-uri openInAnotherWindow\" href=\"http://Supplementary Table 4\" target=\"_blank\" data-google-interstitial=\"false\">Supplementary Table 4</a>. Among pathogens covered by standard therapy, <em>P. aeruginosa</em> was more prevalent in immunocompromised patients (35 [5.9%] vs 98 [3.7%] patients; <em>P</em> &lt; .02). Among pathogens not usually covered by standard therapy, immunocompromised patients were more likely to be infected by <em>Nocardia</em> spp. (4 [0.7%] vs 0 [0%] patients; <em>P</em> &lt; .001), nontuberculous mycobacteria (NTM) (5 [0.8%] vs 2 [0.1%]; <em>P</em> &lt; .002), <em>A. fumigatus</em> (8 [1.3%] vs 10 [0.4%]; <em>P</em> &lt; .01), <em>P. jirovecii</em> (12 [2.0%] vs 5 [0.2%]; <em>P</em> &lt; .02), and viruses, such as coronavirus (3 [0.5%] vs 3 [0.1%]; <em>P</em> &lt; .047), and respiratory syncytial virus (6 [1.0%] vs 7 [0.3%]; <em>P</em> &lt; .03).</p>                    <a id=\"134170125\" scrollto-destination=\"134170125\" data-google-interstitial=\"false\"></a>\n<div content-id=\"T2\" class=\"table-modal table-full-width-wrap\" style=\"display: block;\"><div class=\"table-wrap table-wide standard-table\"><div class=\"table-wrap-title\" id=\"T2\" data-id=\"T2\"><span class=\"label title-label\" id=\"label-72200\">Table 2.</span><div class=\"\n                            graphic-wrap table-open-button-wrap\n                            \"><a class=\"fig-view-orig at-tableViewLarge openInAnotherWindow btn js-view-large\" role=\"button\" target=\"_blank\" href=\"\n                                /view-large/134170125\" aria-describedby=\"label-72200\" data-google-interstitial=\"false\">\n                            Open in new tab\n                        </a></div><div class=\"caption caption-id-\" id=\"caption-72200\"><p class=\"chapter-para\">Pathogens in the 2 Study Groups</p></div> </div><div class=\"table-overflow\"><table role=\"table\" aria-labelledby=\"\n                        label-72200\" aria-describedby=\"\n                        caption-72200\"><thead><tr><th rowspan=\"2\">Pathogen<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 2626)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised (n = 596)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div class=\"table-modal\"><table><thead><tr><th rowspan=\"2\">Pathogen<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 2626)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised (n = 596)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div class=\"table-wrap-foot\"><span id=\"fn-fn-0003\"></span><div content-id=\"fn-0003\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Abbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant <em>Staphylococcus aureus</em>; MSSA, methicillin-sensitive <em>S. aureus</em>; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus.</p></span></div></div></div></div><div class=\"table-full-width-wrap\"><div class=\"table-wrap table-wide standard-table\"><div class=\"table-wrap-title\" id=\"T2\" data-id=\"T2\"><span class=\"label title-label\" id=\"label-72200\">Table 2.</span><div class=\"\n                            graphic-wrap table-open-button-wrap\n                            \"><a class=\"fig-view-orig at-tableViewLarge openInAnotherWindow btn js-view-large\" role=\"button\" target=\"_blank\" href=\"\n                                /view-large/134170125\" aria-describedby=\"label-72200\" data-google-interstitial=\"false\">\n                            Open in new tab\n                        </a></div><div class=\"caption caption-id-\" id=\"caption-72200\"><p class=\"chapter-para\">Pathogens in the 2 Study Groups</p></div> </div><div class=\"table-overflow\"><table role=\"table\" aria-labelledby=\"\n                        label-72200\" aria-describedby=\"\n                        caption-72200\"><thead><tr><th rowspan=\"2\">Pathogen<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 2626)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised (n = 596)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div class=\"table-modal\"><table><thead><tr><th rowspan=\"2\">Pathogen<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 2626)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised (n = 596)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div class=\"table-wrap-foot\"><span id=\"fn-fn-0003\"></span><div content-id=\"fn-0003\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Abbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant <em>Staphylococcus aureus</em>; MSSA, methicillin-sensitive <em>S. aureus</em>; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus.</p></span></div></div></div></div><p class=\"chapter-para\">Once adjusted for confounders, no risk factors of immunocompromise have been recognized for <em>P. aeruginosa</em> infection. Likewise, pathogens not covered by usual CAP therapy were found to be associated not with immunocompromise but with chronic obstructive pulmonary disease (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.07–2.99; <em>P</em> = .03), tracheostomy (2.91; 1.01–8.38; <em>P</em> = .048), and severe pneumonia (2.36; 1.42–3.93; <em>P</em> = .001) (<span class=\"xrefLink\" id=\"jumplink-T3\"></span><a href=\"javascript:;\" reveal-id=\"T3\" data-open=\"T3\" class=\"link link-reveal link-table xref-fig\" data-google-interstitial=\"false\">Table 3</a>).</p>                    <a id=\"134170127\" scrollto-destination=\"134170127\" data-google-interstitial=\"false\"></a>\n<div content-id=\"T3\" class=\"table-modal table-full-width-wrap\" style=\"display: block;\"><div class=\"table-wrap table-wide standard-table\"><div class=\"table-wrap-title\" id=\"T3\" data-id=\"T3\"><span class=\"label title-label\" id=\"label-72200\">Table 3.</span><div class=\"\n                            graphic-wrap table-open-button-wrap\n                            \"><a class=\"fig-view-orig at-tableViewLarge openInAnotherWindow btn js-view-large\" role=\"button\" target=\"_blank\" href=\"\n                                /view-large/134170127\" aria-describedby=\"label-72200\" data-google-interstitial=\"false\">\n                            Open in new tab\n                        </a></div><div class=\"caption caption-id-\" id=\"caption-72200\"><p class=\"chapter-para\">Multivariable Logistic Regression Analysis</p></div> </div><div class=\"table-overflow\"><table role=\"table\" aria-labelledby=\"\n                        label-72200\" aria-describedby=\"\n                        caption-72200\"><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"5\">OR (CI 95%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Non-CAP Bacteria<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Fungi<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th><em>Mycobacterium tuberculosis</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Virus Other Than Influenza<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91<br>(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20<br>(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78<br>(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36<br>(1.42–3.93)</td><td>…</td><td>…</td><td>2.56<br>(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10<br>(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65<br>(1.85–11.69)</td><td>…</td><td>5.49<br>(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div class=\"table-modal\"><table><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"5\">OR (CI 95%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Non-CAP Bacteria<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Fungi<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th><em>Mycobacterium tuberculosis</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Virus Other Than Influenza<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91<br>(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20<br>(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78<br>(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36<br>(1.42–3.93)</td><td>…</td><td>…</td><td>2.56<br>(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10<br>(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65<br>(1.85–11.69)</td><td>…</td><td>5.49<br>(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div class=\"table-wrap-foot\"><span id=\"fn-fn-0004\"></span><div content-id=\"fn-0004\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Blank cells indicate no statistical significancy.</p></span></div><span id=\"fn-fn-0005\"></span><div content-id=\"fn-0005\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Abbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio.</p></span></div></div></div></div><div class=\"table-full-width-wrap\"><div class=\"table-wrap table-wide standard-table\"><div class=\"table-wrap-title\" id=\"T3\" data-id=\"T3\"><span class=\"label title-label\" id=\"label-72200\">Table 3.</span><div class=\"\n                            graphic-wrap table-open-button-wrap\n                            \"><a class=\"fig-view-orig at-tableViewLarge openInAnotherWindow btn js-view-large\" role=\"button\" target=\"_blank\" href=\"\n                                /view-large/134170127\" aria-describedby=\"label-72200\" data-google-interstitial=\"false\">\n                            Open in new tab\n                        </a></div><div class=\"caption caption-id-\" id=\"caption-72200\"><p class=\"chapter-para\">Multivariable Logistic Regression Analysis</p></div> </div><div class=\"table-overflow\"><table role=\"table\" aria-labelledby=\"\n                        label-72200\" aria-describedby=\"\n                        caption-72200\"><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"5\">OR (CI 95%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Non-CAP Bacteria<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Fungi<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th><em>Mycobacterium tuberculosis</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Virus Other Than Influenza<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91<br>(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20<br>(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78<br>(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36<br>(1.42–3.93)</td><td>…</td><td>…</td><td>2.56<br>(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10<br>(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65<br>(1.85–11.69)</td><td>…</td><td>5.49<br>(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div class=\"table-modal\"><table><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"5\">OR (CI 95%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Non-CAP Bacteria<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Fungi<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th><em>Mycobacterium tuberculosis</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Virus Other Than Influenza<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91<br>(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20<br>(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78<br>(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36<br>(1.42–3.93)</td><td>…</td><td>…</td><td>2.56<br>(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10<br>(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65<br>(1.85–11.69)</td><td>…</td><td>5.49<br>(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div class=\"table-wrap-foot\"><span id=\"fn-fn-0004\"></span><div content-id=\"fn-0004\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Blank cells indicate no statistical significancy.</p></span></div><span id=\"fn-fn-0005\"></span><div content-id=\"fn-0005\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Abbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio.</p></span></div></div></div></div><p class=\"chapter-para\">Results showed that AIDS (OR, 15.10; 95% CI, 6.36–35.88; <em>P</em> ≤ .001) and hematological cancer (4.65; 91.85–11.69; <em>P</em> = .001) were independently associated with fungal infections; hematological cancer (5.49; 2.20–13.70; <em>P</em> &lt; .001) and severe pneumonia (2.56; 1.27–5.19; <em>P</em> = .009) with infection by viruses other than influenza; and AIDS (4.41; 1.53–12.73; <em>P</em> = .006) and malnutrition (4.50; 2.08–9.72; <em>P</em> &lt; .001) with mycobacterial infections. An additional analysis was conducted on mycobacteria, including <em>M. tuberculosis</em> and NTM. At multivariable analysis, <em>M. tuberculosis</em> was independently associated with malnutrition only (OR, 5.14; 95% CI, 2.21–11.93; <em>P</em> &lt; .001). At univariate analysis, patients with AIDS were at higher risk for NTM (23.06; 4.39–121.12; <em>P</em> &lt; .001).</p><p class=\"chapter-para\">A subanalysis was conducted among patients with chronic steroid use versus other risk factors for immunocompromise. Patients with chronic steroid use seemed to be more frequently affected by bacteria not covered by standard CAP therapy (10 [3.4%] vs 1 [0.3%] patients; <em>P</em> = .002), <em>Nocardia</em> spp. in particular (4 [0.4%] vs 0 [0.0%]; <em>P</em> = .03). No differences in the severity of the disease were found (see <span class=\"link link-data-supplement\" data-supplement-target=\"sup1\"></span><span class=\"content-section supplementary-material\"><a path-from-xml=\"sup1\" href=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy723_suppl_supplementary_materials.docx?Expires=1752554620&amp;Signature=h15TLzB~iVdXq3mg6ERhsysxUJRdhy3kLeYQ4F92iCbc3pocFnl8FwvX3RQC8nlYDTyE-O-a~2nqmo9b7hLsR6tqwrT9vRY41V9ilDQiSPOIm6SNs5Vt2w60ygDmzeatDy1PnRyi2g~VSjY4BEk~G32iZQmxfjMNlHuKF6QQkUa808du7-UT7jAmdQsjnigHZsW275wHf0oI-BEhu33D6B3MFU2d5knLITgSIvG1m9Uql9dd8Iwe0Ti-PYfBKoU7Pb9DLF9EE~wV1fT1oJVp0RK0Eg6kGxWd7bCamQsPB00clz5TXI~lPCnGFq14~Oui~jj9qPGmqYLmCbUgWg2zTQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" data-google-interstitial=\"false\">Supplementary Table 5</a></span>).</p>                    <h2 scrollto-destination=\"134170130\" id=\"134170130\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s15\">DISCUSSION</h2>\n<p class=\"chapter-para\">The main findings of the present study are as follows: (1) 17.6% of patients admitted with pneumonia from the community have ≥1 risk factor for immunocompromise, with significant differences among continents and countries (ranging from 15.4% to 24.8% by continent and from 80.0% to 4.1% by country); (2) chronic steroid use is by far the most prevalent risk factor leading to immunocompromise, followed by hematological cancer and chemotherapy; (3) 1 of 2 immunocompromised patients has an overlap of ≥2 risk factors, which are also associated between one another in different ways; and (4) the 2 risk factors for immunocompromise independently associated with specific pathogens are AIDS (ie, fungal and mycobacterial infections) and hematological cancer (ie, fungal infection and viral infections other than influenza).</p><p class=\"chapter-para\">Almost 1 in 5 hospitalized patients with CAP are not immunocompetent. Therefore, it is mandatory to provide clinicians with recommendations or guidelines for the management of hospitalized patients with pneumonia coming from the community who have risk factors for immunocompromise. Currently, there are no guidelines for assessing pneumonia in immunocompromised patients coming from the community. Randomized controlled trials (RCTs) and observational prospective studies are missing owing to the fact that, generally, studies assessing management strategies for pneumonia exclude immunocompromised patients or take into account only a single specific risk factor [<span class=\"xrefLink\" id=\"jumplink-CIT0012 CIT0013 CIT0014 CIT0015 CIT0016 CIT0017 CIT0018 CIT0019 CIT0020 CIT0021\"></span><a href=\"javascript:;\" reveal-id=\"CIT0012 CIT0013 CIT0014 CIT0015 CIT0016 CIT0017 CIT0018 CIT0019 CIT0020 CIT0021\" data-open=\"CIT0012 CIT0013 CIT0014 CIT0015 CIT0016 CIT0017 CIT0018 CIT0019 CIT0020 CIT0021\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">12–21</a>]. This lack of information about immunocompromise could lead to both underestimation of the real prevalence with a higher rate of treatment failure and to overestimation and overuse of wide-spectrum antibiotics.</p><p class=\"chapter-para\">We found a 17.6% global prevalence of immunocompromise among patients coming from the community with pneumonia, with a significantly higher frequency in South and North America. This variability among continents and countries is probably attributable to different healthcare systems and rates of hospitalization of immunocompromised patients. Our analysis showed that the most frequent risk factor for immunocompromise is the chronic use of systemic steroids. Aging of the population and therapeutic advancements have favored the increased burden of chronic diseases and long-term therapies with immunosuppressive agents [<span class=\"xrefLink\" id=\"jumplink-CIT0008\"></span><a href=\"javascript:;\" reveal-id=\"CIT0008\" data-open=\"CIT0008\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">8</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0009\"></span><a href=\"javascript:;\" reveal-id=\"CIT0009\" data-open=\"CIT0009\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">9</a>]. In particular, steroids are the agents most frequently prescribed, for their wide spectrum of efficacy in several diseases [<span class=\"xrefLink\" id=\"jumplink-CIT0013\"></span><a href=\"javascript:;\" reveal-id=\"CIT0013\" data-open=\"CIT0013\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">13</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0017\"></span><a href=\"javascript:;\" reveal-id=\"CIT0017\" data-open=\"CIT0017\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">17</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0019\"></span><a href=\"javascript:;\" reveal-id=\"CIT0019\" data-open=\"CIT0019\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">19</a>]. Therefore, many patients presenting to the emergency room with pneumonia are receiving chronic steroid treatment. No data are available on this population group, and further studies are needed to characterize these patients and provide individualized management.</p><p class=\"chapter-para\">Hematological cancer and chemotherapy were other leading immunocompromised factors. These findings are consistent with those in previous studies; patients recruited in observational studies include patients with solid or hematological cancer and those who underwent chemotherapy with associated neutropenia [<span class=\"xrefLink\" id=\"jumplink-CIT0015 CIT0016 CIT0017 CIT0018 CIT0019 CIT0020\"></span><a href=\"javascript:;\" reveal-id=\"CIT0015 CIT0016 CIT0017 CIT0018 CIT0019 CIT0020\" data-open=\"CIT0015 CIT0016 CIT0017 CIT0018 CIT0019 CIT0020\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">15–20</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0022\"></span><a href=\"javascript:;\" reveal-id=\"CIT0022\" data-open=\"CIT0022\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">22</a>]. Dedicated guidelines and recommendations are available, especially on respiratory viruses, fungi, and <em>P. jirovecii</em> [<span class=\"xrefLink\" id=\"jumplink-CIT0023 CIT0024 CIT0025 CIT0026\"></span><a href=\"javascript:;\" reveal-id=\"CIT0023 CIT0024 CIT0025 CIT0026\" data-open=\"CIT0023 CIT0024 CIT0025 CIT0026\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">23–26</a>].</p><p class=\"chapter-para\">Our network analysis showed that several risk factors for immunocompromise show associations, especially chemotherapy, associated with hematological cancer and solid tumor, and other immunocompromise, associated with chronic steroid use. Moreover, neutropenic patients are well represented and mainly affected also by hematological cancer or under treatment with chemotherapy. Our results suggest that patients may have &gt;1 risk factor characteristic and clinical assessment should be comprehensive, taking into consideration risk factors for immunocompromise and their associated biological mechanisms. In contrast, AIDS, lung transplantation, asplenia, and aplastic anemia seem to be less frequent at admission and to represent distinct clinical entities. Findings of previous studies seem to be in line with our results, with AIDS patients considered as a distinct patient population and with very few observational studies available on asplenia and aplastic anemia [<span class=\"xrefLink\" id=\"jumplink-CIT0021\"></span><a href=\"javascript:;\" reveal-id=\"CIT0021\" data-open=\"CIT0021\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">21</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0027 CIT0028 CIT0029 CIT0030 CIT0031\"></span><a href=\"javascript:;\" reveal-id=\"CIT0027 CIT0028 CIT0029 CIT0030 CIT0031\" data-open=\"CIT0027 CIT0028 CIT0029 CIT0030 CIT0031\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">27–31</a>]</p><p class=\"chapter-para\">In agreement with previous reports, <em>S. pneumoniae</em> is the leading microorganism in both immunocompromised and immunocompetent groups [<span class=\"xrefLink\" id=\"jumplink-CIT0032\"></span><a href=\"javascript:;\" reveal-id=\"CIT0032\" data-open=\"CIT0032\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">32</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0033\"></span><a href=\"javascript:;\" reveal-id=\"CIT0033\" data-open=\"CIT0033\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">33</a>]. Among pathogens covered by standard CAP therapy, only <em>P. aeruginosa</em> was more frequently isolated in immunocompromised compared with immunocompetent patients. These findings differ from microbiological results of previous studies. Gram-positive bacteria, especially <em>S. aureus</em>, were more frequently identified in patients with immunocompromise of different causes [<span class=\"xrefLink\" id=\"jumplink-CIT0022\"></span><a href=\"javascript:;\" reveal-id=\"CIT0022\" data-open=\"CIT0022\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">22</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0030\"></span><a href=\"javascript:;\" reveal-id=\"CIT0030\" data-open=\"CIT0030\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">30</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0034\"></span><a href=\"javascript:;\" reveal-id=\"CIT0034\" data-open=\"CIT0034\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">34</a>]. Only Li and coauthors [<span class=\"xrefLink\" id=\"jumplink-CIT0013\"></span><a href=\"javascript:;\" reveal-id=\"CIT0013\" data-open=\"CIT0013\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">13</a>] found patients with immunological disorders, treated with systemic steroids and cytotoxic agents, to have a higher incidence of infections caused by gram-negative bacteria, mainly <em>P. aeruginosa</em>. This similarity with our findings could be explained by the prevalence of patients exposed to chronic steroids in our cohort.</p><p class=\"chapter-para\">Among pathogens not covered by standard CAP therapy, immunocompromised patients were more frequently infected by <em>Nocardia</em> spp., NTM, <em>P. jirovecii</em>, <em>A. fumigatus</em>, and viruses other than influenza. Infections by <em>P. jirovecii</em> and NTM are frequently identified in patients with AIDS [<span class=\"xrefLink\" id=\"jumplink-CIT0035\"></span><a href=\"javascript:;\" reveal-id=\"CIT0035\" data-open=\"CIT0035\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">35</a>]. <em>P. jirovecii</em> is also frequent in other types of immunocompromise, such as solid or hematological cancer in patients who underwent chemotherapy [<span class=\"xrefLink\" id=\"jumplink-CIT0018\"></span><a href=\"javascript:;\" reveal-id=\"CIT0018\" data-open=\"CIT0018\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">18</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0019\"></span><a href=\"javascript:;\" reveal-id=\"CIT0019\" data-open=\"CIT0019\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">19</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0036\"></span><a href=\"javascript:;\" reveal-id=\"CIT0036\" data-open=\"CIT0036\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">36</a>]. Fungal infections (eg, <em>Candida</em> spp. and <em>A. fumigatus</em>) are highly incident in neutropenic hematological cancer patients [<span class=\"xrefLink\" id=\"jumplink-CIT0022\"></span><a href=\"javascript:;\" reveal-id=\"CIT0022\" data-open=\"CIT0022\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">22</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0037\"></span><a href=\"javascript:;\" reveal-id=\"CIT0037\" data-open=\"CIT0037\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">37</a>]. Viral infections other than influenza, especially respiratory syncytial virus, are more frequent in patients who underwent hematopoietic stem cell or lung transplantation [<span class=\"xrefLink\" id=\"jumplink-CIT0038\"></span><a href=\"javascript:;\" reveal-id=\"CIT0038\" data-open=\"CIT0038\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">38</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0039\"></span><a href=\"javascript:;\" reveal-id=\"CIT0039\" data-open=\"CIT0039\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">39</a>]. Conversely, <em>Nocardia</em> spp. infections are mainly described in solid organ transplant recipients [<span class=\"xrefLink\" id=\"jumplink-CIT0040\"></span><a href=\"javascript:;\" reveal-id=\"CIT0040\" data-open=\"CIT0040\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">40</a>]. These results, consistent with previous findings, suggest the need for a more in-depth microbiological workup, including community-acquired pathogens and microorganisms not covered by standard therapy.</p><p class=\"chapter-para\">Surprisingly, we found that risk factors for immunocompromise were not independently associated with <em>P. aeruginosa</em> or non–community-acquired bacteria; in contrast, AIDS and hematological cancer are both associated with fungal, mycobacterial, and noninfluenza viral pneumonia, respectively. Empirical therapy should include <em>P. aeruginosa</em> coverage, which is highly prevalent in immunocompromised patients. On the contrary, particular attention should be given to fungal, mycobacterial, and viral causes should be for patients admitted with AIDS and hematological cancer [<span class=\"xrefLink\" id=\"jumplink-CIT0021 CIT0022 CIT0023 CIT0024 CIT0025 CIT0026 CIT0027 CIT0028 CIT0029\"></span><a href=\"javascript:;\" reveal-id=\"CIT0021 CIT0022 CIT0023 CIT0024 CIT0025 CIT0026 CIT0027 CIT0028 CIT0029\" data-open=\"CIT0021 CIT0022 CIT0023 CIT0024 CIT0025 CIT0026 CIT0027 CIT0028 CIT0029\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">21–29</a>].</p><p class=\"chapter-para\">Finally, bacteremia rates did not differ between study groups. To our knowledge, there are no studies on bacteremia and immunocompromise in general. The majority of studies have focused on bacteremia in hematopoietic stem cell transplantation, with prevalences varying from 6% to 44% depending on the type of bacteria and host-related factors [<span class=\"xrefLink\" id=\"jumplink-CIT0041 CIT0042 CIT0043\"></span><a href=\"javascript:;\" reveal-id=\"CIT0041 CIT0042 CIT0043\" data-open=\"CIT0041 CIT0042 CIT0043\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">41–43</a>]. Few studies addressed this topic in kidney transplant recipients, reporting a prevalence of bacteremia ranging from 25% to 69% [<span class=\"xrefLink\" id=\"jumplink-CIT0044\"></span><a href=\"javascript:;\" reveal-id=\"CIT0044\" data-open=\"CIT0044\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">44</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0045\"></span><a href=\"javascript:;\" reveal-id=\"CIT0045\" data-open=\"CIT0045\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">45</a>]. Finally, few studies have addressed HIV and bacteremia, with prevalences ranging from 10% to 25%, depending on the pathogen and grade of immunosuppression [<span class=\"xrefLink\" id=\"jumplink-CIT0046\"></span><a href=\"javascript:;\" reveal-id=\"CIT0046\" data-open=\"CIT0046\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">46</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0047\"></span><a href=\"javascript:;\" reveal-id=\"CIT0047\" data-open=\"CIT0047\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">47</a>]. The prevalence of bacteremia in our study was 5T–6% in both immunocompetent and immunocompromised patients. Differences in the prevalence of bacteremia are due mainly to differences between the risk factors for immunocompromise in our study (chronic steroid use, hematological cancer, and chemotherapy) and those previously reported in the literature.</p><p class=\"chapter-para\">The current study has both limitations and strengths. First of all, to our knowledge, this is the first study showing a worldwide perspective on immunocompromise among patients coming from the community with pneumonia, with a large and diverse sample of patients enrolled across different countries in 6 continents. However, we were not able to involve many investigators from Asia and Africa, and most cases occurred in North America and Europe, thus limiting the generalizability of our findings. Another major limitation is the unfeasibility of grading the severity of immunocompromise and, therefore, stratifying patients and defining the physiopathological interaction between different risk factors, especially with regard to the use of biological drugs and chronic steroids. Furthermore, potentially important risk factors for an immunocompromised state, such as solid organ transplants other than lung, have not been specifically investigated. Finally, no outcome data have been collected, and this strongly limits our speculations as to the correct empiric antibiotic therapy for use in immunocompromised patients with CAP.</p><p class=\"chapter-para\">In conclusion, our study offers to the scientific community a perspective on immunocompromised patients coming from the community with pneumonia. Future prospective studies on patients with specific risk factors for immunocompromise could provide practical recommendations. In particular, it will be crucial to prepare guidelines on certain prevalent population groups, such as patients exposed to chronic steroids and those with hematological cancer.</p>                    <h2 scrollto-destination=\"134170142\" id=\"134170142\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s16\">Supplementary Data</h2>\n<p class=\"chapter-para\">Supplementary materials are available at <em>Clinical Infectious Diseases</em> online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.</p>                    <h2 scrollto-destination=\"134170144\" id=\"134170144\" class=\"backnotes-title js-splitscreen-backnotes-title\" data-legacy-id=\"n1\">Notes</h2>\n<p class=\"chapter-para\"><strong><em>Author contributions.</em></strong> M. F. D. P., G. S., S. A., and M. I. R. participated in study design, analysis of data, and writing of the manuscript and take responsibility for the integrity of the work. A. G., D. R., S. T., L. F. R., J. R., J. G. d. C., and F. B. critically reviewed the final manuscript.</p><p class=\"chapter-para\"><strong><em>Acknowledgments.</em></strong> We thank the Asociacion Latinoamericana de Torax, European Respiratory Society, World Federation of Societies of Intensive and Critical Care Medicine, and American College of Chest Physicians for their support of this project. We also thank the following study contributors for their valuable collaboration. <strong>Argentina:</strong> Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires), Silvia Attorri (Hospital Luis Lago Maggiore, Mendoza), Enrique Barimboim (Hospital Central de Mendoza), Juan Pablo Caeiro and María I. Garzón (Hospital Privado Universitario, Córdoba), Victor Hugo Cambursano, A. Cazaux (Servicio de Neumologia, Hospital Rawson, Córdoba), Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas), Julio Chertcoff, Florencia Lascar, and Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital), Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza), Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires) Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos Vicente Lopez y Planes from General Rodriguez, Buenos Aires), Sandra Lambert (Hospital El Cruce–Alta Complejidad en Red), Gustavo Lopardo (Hospital Bernardo Houssay, Vicente López), Carlos M. Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires), Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen), Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos), Antonio A. Cetrangolo (an individual who is being acknowledged for his contribution to the study), Claudia Pensotti (Infectious Diseases and Infection Control Department, Clinica Privada Monte Grande, Buenos Aires), Betiana Pereyra (Hospital San Roque, Córdoba), Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D. F. Santojanni), Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela); <strong>Australia:</strong> Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg); <strong>Austria:</strong> Felix Lötsch and Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna); <strong>Belgium:</strong> Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp), Camille A. Francois (Anesthesia and Critical Care Department, Erasme University Hospital, Brussels), Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital), Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels); <strong>Benin:</strong> Marcel Zannou Djimon, Jules Bashi and Roger Dodo (Centre Hospitalier Universitaire HKM of Cotonou); <strong>Brazil:</strong> Simone Aranha Nouér (Federal University of Rio de Janeiro); <strong>Bulgaria:</strong> Peter Chipev and Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofia), Darina Miteva, (UMHAT St Marina, Varna), Diana Petkova (University Hospital Varna); <strong>Cameroon:</strong> Adamou Dodo Balkissou (Yaounde Jamot Hospital, Yaounde), Eric Walter Pefura Yone (Département de Médecine Interne, University of Yaounde), Bertrand Hugo Mbatchou Ngahane (Douala General Hospital); <strong>China:</strong> Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing), Jin-fu Xu (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University); <strong>Colombia:</strong> Carlos Andres Bustamante Rico and Ricardo Buitrago (Clinica Shaio, Bogota), Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin); <strong>Congo:</strong> Jean-Marie Kayembe Ntumba (Cliniques Universitaires de Kinshasa); <strong>Croatia:</strong> Vesna Vladic Carevic (Interne Medicine, Dubrovnik), Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb), Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases), Zinka Matkovic (University Hospital Dubrava, Zagreb), Ivan Mitrecic (Karlovac General Hospital); <strong>Denmark:</strong> Marie-Laure Bouchy Jacobsson (Emergency Department, North Zealand’s Hospital–Hillerød), Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital), Uffe Christian Heitmann Bødtger (Department of Pulmonology, Naestved Hospital), Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde), Andreas Vestergaard Jensen, Gertrud Baunbæk-Knudsen, Pelle Trier Petersen, and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød); <strong>Egypt:</strong> Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University), Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University), Hanaa Shafiek (Chest Diseases Department, Faculty of Medicine, Alexandria University), Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo); <strong>Ethiopia:</strong> Kedir Abdella Abdulsemed (Department of Medical Laboratory Science and Pathology, College of Health Sciences, Mycobacteriology Research Centre, Institute of Biotechnology Research, Jimma University); <strong>France:</strong> Fabrice Bertrand (Critical Care Unit, Robert Ballanger Hospital, Aulnay sous Bois), Christian Brun-Buisson (University Hospital of Henri-Mondor, Créteil), Etienne de Montmollin (Intensive Care Unit, Hôpital Delafontaine, Centre Hospitalier de Saint-Denis), Muriel Fartoukh (Unité de Réanimation Médico-Chirurgicale, Pôle Thorax Voies Aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien), Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médico-chirurgicale, Hôpital Louis Mourier, Colombes, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité), Pierre Tattevin (Infectious Diseases and ICU, Pontchaillou University Hospital, Rennes), Abdo Khoury (Department of Emergency Medicine and Critical Care, University of Franche–Comté, Medical Center); <strong>Gambia:</strong> Bernard Ebruke (Medical Research Council Unit, Fajara, Gambia); <strong>Germany:</strong> Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen), Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden), Matthias Meisinger, Klinikum Niederlausitz, Klinik für Innere Medizin und Intensivmedizin, Senftenberg), Mathias W. Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital), Jan Rupp (Department of Infectious Diseases and Microbiology, University of Lübeck), Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg), Marc Spielmanns (Internal Medicine Department, Pulmonary Rehabilitation and Department of Health, School of Medicine, University Witten-Herdecke, St Remigius Hospital, Leverkusen) Petra Creutz and Norton Suttorp (Department of Infectious Disease and Respiratory Medicine, Charité–University Medicine, Berlin); <strong>Ghana</strong>: Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi); <strong>Greece</strong>: Katerina Dimakou (5th Respiratory Medicine Department, SOTIRIA Chest Hospital, Athens), Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens), Evdoxia Tsigou and Dimitrios Ampazis (Agioi Anargiroi Hospital, Kifissia, Athens), Evangelos Kaimakamis (Intensive Care Unit, G. Papanikolaou General Hospital of Thessaloniki); <strong>India</strong>: Mohit Bhatia (S. S. Hospital IMS BHU Varanasi), Raja Dhar (Fortis Hospitals, Kolkata), George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore), Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow), Parvaiz A. Koul (Department of Internal and Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar), P. A. Mahesh and B. S. Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore), Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala), Hirennappa B. Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka), Surya Kant (Department of Respiratory Medicine, King George’s Medical University, Chowk, Lucknow, Uttar Pradesh), Rajesh Swarnakar (Getwell Hospital and Research Institute, Dhantoli, Nagpur), Sneha Limaye and Sundeep Salvi (on behalf of the Respiratory Research Network of India from the Chest Research Foundation in Pune); <strong>Iran</strong>: Keihan Golshani (Isfahan University of Medical Sciences); <strong>Ireland</strong>: Vera M. Keatings (Letterkenny General Hospital, County Donegal), Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization, St James’s University Hospital, Trinity Centre for Health Sciences Dublin); <strong>Israel</strong>: Yasmin Maor (Infectious Disease Unit, affiliated with Tel Aviv University, Wolfson Medical Center, Holon), Jacob Strahilevitz (Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem); <strong>Italy</strong>: Salvatore Battaglia, University of Palermo, Pneumologia DiBiMIS, Palermo), Maria Carrabba (Internal Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca’ Granda Ospedale Maggiore Policlinico, Milano), Piero Ceriana (Pulmonary Rehabilitation, IRCCS Fondazione Maugeri, Pavia), Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste), Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan), Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples), Marino De Rosa (Unità Operativa Complessa [UOC] Pneumologia PO San Filippo Neri Azienda Sanitaria Locale Roma E Roma), Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena), Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria Azienda Ospedaliera Ospedali dei Colli PO Monaldi), Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, Sardegna), Francesco Menzella (Department of Cardiac-Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS–Arcispedale Santa Maria Nuova, Reggio Emilia), Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S. Anna Nuovo, Unità Operativa di Pneumologia, Como), Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital), Gerardo Palmiero (Respiratory Unit, Versilia Hospital, Lido di Camaiore, Lucca), Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli), Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero–Universitaria S. Maria della Misericordia, Udine), Claudio Sorino, Pulmonology Unit, A. O. Sant’Anna di Como), Gundi Steinhilber (Spedali Civili Brescia, U. O. Pneumologia e Fisiopatologia Respiratoria, Brescia), Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta), Fabio Franzetti, Manuela Carugati, Manuela Morosi, and Elisa Monge (Department of Biomedical and Clinical Sciences, Division of Infectious Diseases, Luigi Sacco Hospital, Università degli Studi di Milano), Mauro Carone, (Fondazione Salvatore Maugeri, IRCCS, Cassano Murge), Vincenzo Patella (Allergology and Clinical Immunology Unit, Department of Medical Sciences, Battipaglia Hospital, Battipaglia, Salerno), Simone Scarlata (Geriatrics, Unit of Respiratory Pathophysiology and Thoracic Endoscopy, Campus Bio Medico University and Teaching Hospital, Rome), Andrea Comel, UO Pneumologia, Ospedale Pederzoli, Peschiera del Garda); <strong>Japan</strong>: Kiyoyasu Kurahashi (Yokohama City University Medical Center); <strong>Lebanon</strong>: Zeina Aoun Bacha (Medicine School, St Joseph University, Beyrouth); <strong>Mexico</strong>: Daniel Barajas Ugalde (National Institute of Respiratory Diseases), Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California), José F. Villegas (Hospital Universitario Monterrey); <strong>Montenegro</strong>: Milic Medenica (Hospital for Lung Diseases–Brezovik, Niksic); <strong>Netherlands</strong>: E. M. W. van de Garde (Department of Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein); <strong>Nepal</strong>: Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences), Poojan Shrestha (Oxford University Clinical Research Unit, Patan Hospital); <strong>New Zealand</strong>: Elliott Ridgeon (Medical Research Institute of New Zealand); <strong>Nigeria</strong>: Babatunde Ishola Awokola (Department of Family Medicine and Primary Care, Lily Hospitals Limited, Warri), Ogonna N. O. Nwankwo (University of Calabar Teaching Hospital), Adefuye Bolanle Olufunlola (Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State), Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan), Kingsley N. Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State); <strong>Pakistan</strong>: Muhammad Irfan, Section of Pulmonary and Critical Care Medicine (Department of Medicine, Aga Khan University, Karachi); <strong>Poland</strong>: Lukasz Minarowski (Department of Lung Diseases and Tuberculosis, Medical University of Bialystok), Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec); <strong>Portugal</strong>: Felipe Froes (Hospital Pulido Valente–CHLN, Lisboa), Pedro Leuschner, (Centro Hospitalar do Porto), Mariana Meireles, Cláudia Ferrão, Pedro Leuschner, and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo Prof Abel Salazar, Porto), Sofia B. Ravara (Faculty of Health Sciences, University of Beira Interior, Cova da Beira Hospital Center, Covilhã); <strong>Republic of Moldova</strong>: Victoria Brocovschii (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu), Chesov Ion (Clinic of Anesthesia and Intensive Care Valeriu Ghrerg, Institute of Emergency Medicine, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau), Doina Rusu (SMFU N. Testemitanu, Chisinau), Cristina Toma (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau); <strong>Romania</strong>: Daniela Chirita (Hospital Sfantul Stefan, Bucharest), Carmen Mihaela Dorobat (Universitatea de Medicină şi Farmacie Gr T. Popa I a ş i Facultatea de Medicină Stomatologică, Spitalul Clinic de Boli Infecţioase Sfânta Parascheva I a ş i Iaşi); <strong>Russia</strong>: Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S. I. Georgievsky), Anna Kaluzhenina (Volgograd State Medical University); <strong>Saudi Arabia</strong>: Abdullah Almotairi (King Fahad Medical City, Riyadh), Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina), Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh), Amal Fathy (Pulmonary and Respiratory Critical Care Medicine, Mansoura University Egypt, Affiliate at Taibah University), Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh), Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa), Abdelhaleem Bella (Dammam University–Saudi Arabia and King Fahad Hospital); <strong>Serbia</strong>: Nada Bogdanović (Pulmonary Department of KHC, Dragiša Mišović, Belgrade), Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade), Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade); <strong>Spain</strong>: Luis Borderìas (Respiratory and Sleep Unit, Hospital San Jorge, Huesca), Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at Sant Joan Despí), Hugo Cabello Alarcón (Sant Hospital Seu de Urgell, Catalonia), Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona), Vicens Diaz-Brito and Xavier Casas (Infectious Diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona), Alicia Encabo González (Hospital Complex of Pontevedra), Maria Luisa Fernández-Almira (Medicina Interna, Hospital Universitario Central de Asturias), Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, and CIBER de Enfermedades Respiratorias, CIBERES, Bunyola), Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga), Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid), Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante), Elena Laserna Martínez (Hospital Mollet, Barcelona), Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid), Pedro J. Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña, INIBIC, Sergas, Universidade de A Coruña), Rosario Menéndez (Pneumology Service, University and Polytechnic Hospital La Fe, Valencia), Ana Pando-Sandoval (Hospital Universitario Central de Asturias, Area de Gestion Clinica de Pulmon, Servicio de Neumologia, Oviedo), Cristina Prat Aymerich, Alicia Lacoma de la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, and Universitat Autònoma de Barcelona, CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III), Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d’Hebron, Barcelona), Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia), Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona), Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria), Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo), Job F. M. van Boven (Hospital Universitari Son Espases, Palma de Mallorca), Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró); <strong>South Africa</strong>: Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand); <strong>South Korea</strong>: Ho Kee Yum (Inje University Seoul Paik Hospital); <strong>Togo</strong>: Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University Hospital of Sylvanus Olympio, Lomé); <strong>Tunisia</strong>: Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security, Marsa, Tunis); <strong>Turkey</strong>: Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir), Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul), Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir); <strong>Ukraine</strong>: Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa Regional Antituberculosis Hospital, Vinnitsa); <strong>United Arab Emirates</strong>: Naheed Elahi (Dubai Hospital); <strong>United Kingdom</strong>: Devesh J. Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife), Andrew Feneley, Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann, University Hospitals of Leicester NHS Trust and University of Leicester), Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool), Adam T. Hill (Royal Infirmary and University of Edinburgh), Banu Rudran (The Royal London Hospital, Barts Health Trust, London), Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, East Kilbride), Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds), Alexander Youzguin (Southport and Ormskirk Hospitals NHS Trust), Anika Singanayagam (Imperial College Healthcare NHS Trust, London); <strong>United States</strong>: Karen S. Allen (University of Oklahoma Health Sciences Center, Oklahoma City), Veronica Brito (Texas A&amp;M Health Science Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Baylor Scott &amp; White Health, Temple); Jessica Dietz (Fargo VA Health Care System, Fargo, North Dakota), Claire E. Dysart and Susan M. Kellie (Clement J. Zablocki VA Medical Center, Milwaukee, Wisconsin; Division of Infectious Diseases, University of New Mexico School of Medicine; and Raymond G. Murphy VA Medical Center, Albuquerque, New Mexico), Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, Illinois), Mina Gaga (7th Respiratory Medical Department and Asthma Center, Athens Chest Hospital), Thomas L. Holland and Stephen P. Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, Durham), Fayez Kheir (Department of Pulmonary Diseases, Critical Care and Environmental Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana), Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, Illinois), Manuel Lois (John Peter Smith Hospital, Fort Worth, Texas), Girish B. Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook, and Winthrop University Hospital, Mineola, New York), Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, Denver), Katherine Reyes (Henry Ford Hospital, Detroit, Illinois), William Rodriguez-Cintron, (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, San Juan Puerto Rico), Shigeki Saito (Tulane University, New Orleans), Nilam J. Soni, Julio Noda, Cecilia I. Hinojosa, Stephanie M. Levine, Luis F. Angel, and Antonio Anzueto (Divisions of Hospital Medicine and Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio), K. Scott Whitlow, John Hipskind, Kunal Sukhija, and Vicken Totten (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, California), Richard G. Wunderink and Ray D. Shah (Northwestern University Feinberg School of Medicine, Chicago, Illinois); <strong>Zambia</strong>: Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka). <strong>Other investigators</strong>: Lorena Noriega, Ezequiel Alvarado, Mohamed Aman, and Lucía Labra.</p><p class=\"chapter-para\"><strong><em>Disclaimer.</em></strong> The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute, the National Institutes of Health, or the Department of Veterans Affairs.</p><p class=\"chapter-para\"><strong><em>Financial support.</em></strong> This project was not funded and relied solely on voluntary site and investigator participation. M. I. R.’s time is partially protected by the National Heart, Lung, and Blood Institute (award K23HL096054).</p><p class=\"chapter-para\"><strong><em>Potential conflicts of interest.</em></strong> F. B. reports personal fees from AstraZeneca, GlaxoSmithKline, Guidotti, Grifols, Menarini, and Novartis, and grants and personal fees from Bayer, Chiesi, Insmed, Pfizer, Teva, and Zambon, outside the submitted work. All other authors report no potential conflicts.</p>                    <h2 scrollto-destination=\"134170150\" id=\"134170150\" class=\"backreferences-title js-splitscreen-backreferences-title\" data-legacy-id=\"r1\">References</h2>\n<div class=\"ref-list js-splitview-ref-list\"><div content-id=\"CIT0001\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0001\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0001\" href=\"javascript:;\" aria-label=\"jumplink-CIT0001\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0001\" class=\"ref-content \" data-id=\"CIT0001\"><span class=\"label title-label\">1.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Aliberti</div> <div class=\"given-names\">S</div>, <span class=\"name string-name\"><div class=\"surname\">Di Pasquale</div> <div class=\"given-names\">M</div></span>, <span class=\"name string-name\"><div class=\"surname\">Zanaboni</div> <div class=\"given-names\">AM</div></span>, et al. <div class=\"article-title\">Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia</div>. <div class=\"source \">Clin Infect Dis</div><div class=\"year\">2012</div>; <div class=\"volume\">54</div>:<div class=\"fpage\">470</div>–<div class=\"lpage\">8</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Stratifying%20risk%20factors%20for%20multidrug-resistant%20pathogens%20in%20hospitalized%20patients%20coming%20from%20the%20community%20with%20pneumonia&amp;author=S%20Aliberti&amp;author=M%20Di%20Pasquale&amp;author=AM%20Zanaboni&amp;publication_year=2012&amp;journal=Clin%20Infect%20Dis&amp;volume=54&amp;pages=470-8\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1093/cid/cir840\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Fcid%2Fcir840\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1093%2Fcid%2Fcir840\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22109954\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Stratifying%20risk%20factors%20for%20multidrug-resistant%20pathogens%20in%20hospitalized%20patients%20coming%20from%20the%20community%20with%20pneumonia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0002\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0002\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0002\" href=\"javascript:;\" aria-label=\"jumplink-CIT0002\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0002\" class=\"ref-content \" data-id=\"CIT0002\"><span class=\"label title-label\">2.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Aliberti</div> <div class=\"given-names\">S</div>, <span class=\"name string-name\"><div class=\"surname\">Cilloniz</div> <div class=\"given-names\">C</div></span>, <span class=\"name string-name\"><div class=\"surname\">Chalmers</div> <div class=\"given-names\">JD</div></span>, et al. <div class=\"article-title\">Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective</div>. <div class=\"source \">Thorax</div><div class=\"year\">2013</div>; <div class=\"volume\">68</div>:<div class=\"fpage\">997</div>–<div class=\"lpage\">9</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Multidrug-resistant%20pathogens%20in%20hospitalised%20patients%20coming%20from%20the%20community%20with%20pneumonia%3A%20a%20European%20perspective&amp;author=S%20Aliberti&amp;author=C%20Cilloniz&amp;author=JD%20Chalmers&amp;publication_year=2013&amp;journal=Thorax&amp;volume=68&amp;pages=997-9\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1136/thoraxjnl-2013-203384\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1136%2Fthoraxjnl-2013-203384\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1136%2Fthoraxjnl-2013-203384\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23774884\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Multidrug-resistant%20pathogens%20in%20hospitalised%20patients%20coming%20from%20the%20community%20with%20pneumonia%3A%20a%20European%20perspective&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0003\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0003\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0003\" href=\"javascript:;\" aria-label=\"jumplink-CIT0003\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0003\" class=\"ref-content \" data-id=\"CIT0003\"><span class=\"label title-label\">3.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Shindo</div> <div class=\"given-names\">Y</div>, <span class=\"name string-name\"><div class=\"surname\">Ito</div> <div class=\"given-names\">R</div></span>, <span class=\"name string-name\"><div class=\"surname\">Kobayashi</div> <div class=\"given-names\">D</div></span>, et al. <div class=\"article-title\">Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia</div>. <div class=\"source \">Am J Respir Crit Care Med</div><div class=\"year\">2013</div>; <div class=\"volume\">188</div>:<div class=\"fpage\">985</div>–<div class=\"lpage\">95</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Risk%20factors%20for%20drug-resistant%20pathogens%20in%20community-acquired%20and%20healthcare-associated%20pneumonia&amp;author=Y%20Shindo&amp;author=R%20Ito&amp;author=D%20Kobayashi&amp;publication_year=2013&amp;journal=Am%20J%20Respir%20Crit%20Care%20Med&amp;volume=188&amp;pages=985-95\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1164/rccm.201301-0079OC\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1164%2Frccm.201301-0079OC\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1164%2Frccm.201301-0079OC\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23855620\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Risk%20factors%20for%20drug-resistant%20pathogens%20in%20community-acquired%20and%20healthcare-associated%20pneumonia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0004\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0004\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0004\" href=\"javascript:;\" aria-label=\"jumplink-CIT0004\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0004\" class=\"ref-content \" data-id=\"CIT0004\"><span class=\"label title-label\">4.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Musher</div> <div class=\"given-names\">DM</div>, <span class=\"name string-name\"><div class=\"surname\">Thorner</div> <div class=\"given-names\">AR</div></span>. <div class=\"article-title\">Community-acquired pneumonia</div>. <div class=\"source \">N Engl J Med</div><div class=\"year\">2014</div>; <div class=\"volume\">371</div>:<div class=\"fpage\">1619</div>–<div class=\"lpage\">28</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Community-acquired%20pneumonia&amp;author=DM%20Musher&amp;author=AR%20Thorner&amp;publication_year=2014&amp;journal=N%20Engl%20J%20Med&amp;volume=371&amp;pages=1619-28\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1056/NEJMra1312885\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1056%2FNEJMra1312885\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1056%2FNEJMra1312885\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/25337751\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Community-acquired%20pneumonia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0005\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0005\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0005\" href=\"javascript:;\" aria-label=\"jumplink-CIT0005\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0005\" class=\"ref-content \" data-id=\"CIT0005\"><span class=\"label title-label\">5.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Mandell</div> <div class=\"given-names\">LA</div>, <span class=\"name string-name\"><div class=\"surname\">Wunderink</div> <div class=\"given-names\">RG</div></span>, <span class=\"name string-name\"><div class=\"surname\">Anzueto</div> <div class=\"given-names\">A</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">Infectious Diseases Society of America; American Thoracic Society</div></span>. <div class=\"article-title\">Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults</div>. <div class=\"source \">Clin Infect Dis</div><div class=\"year\">2007</div>; <div class=\"volume\">44</div>(<div class=\"supplement\">suppl 2</div>):<div class=\"fpage\">S27</div>–<div class=\"lpage\">72</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Infectious%20Diseases%20Society%20of%20America%2FAmerican%20Thoracic%20Society%20consensus%20guidelines%20on%20the%20management%20of%20community-acquired%20pneumonia%20in%20adults&amp;author=LA%20Mandell&amp;author=RG%20Wunderink&amp;author=A%20Anzueto&amp;publication_year=2007&amp;journal=Clin%20Infect%20Dis&amp;volume=44&amp;pages=S27-72\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1086/511159\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1086%2F511159\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1086%2F511159\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17278083\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Infectious%20Diseases%20Society%20of%20America%2FAmerican%20Thoracic%20Society%20consensus%20guidelines%20on%20the%20management%20of%20community-acquired%20pneumonia%20in%20adults&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0006\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0006\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0006\" href=\"javascript:;\" aria-label=\"jumplink-CIT0006\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0006\" class=\"ref-content \" data-id=\"CIT0006\"><span class=\"label title-label\">6.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Lim</div> <div class=\"given-names\">WS</div>, <span class=\"name string-name\"><div class=\"surname\">Baudouin</div> <div class=\"given-names\">SV</div></span>, <span class=\"name string-name\"><div class=\"surname\">George</div> <div class=\"given-names\">RC</div></span>, et al.  <div class=\"article-title\">BTS guidelines for the management of community acquired pneumonia in adults</div>. <div class=\"source \">Thorax</div><div class=\"year\">2009</div>; <div class=\"volume\">64</div>(<div class=\"supplement\">suppl III</div>):<div class=\"fpage\">iii1</div>–<div class=\"lpage\">55</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=BTS%20guidelines%20for%20the%20management%20of%20community%20acquired%20pneumonia%20in%20adults&amp;author=WS%20Lim&amp;author=SV%20Baudouin&amp;author=RC%20George&amp;publication_year=2009&amp;journal=Thorax&amp;volume=64&amp;pages=iii1-55\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1136/thx.2009.121434\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1136%2Fthx.2009.121434\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1136%2Fthx.2009.121434\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19783532\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:BTS%20guidelines%20for%20the%20management%20of%20community%20acquired%20pneumonia%20in%20adults&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0007\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0007\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0007\" href=\"javascript:;\" aria-label=\"jumplink-CIT0007\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0007\" class=\"ref-content \" data-id=\"CIT0007\"><span class=\"label title-label\">7.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Woodhead</div> <div class=\"given-names\">M</div>, <span class=\"name string-name\"><div class=\"surname\">Blasi</div> <div class=\"given-names\">F</div></span>, <span class=\"name string-name\"><div class=\"surname\">Ewig</div> <div class=\"given-names\">S</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases</div></span>. <div class=\"article-title\">Guidelines for the management of adult lower respiratory tract infections—full version</div>. <div class=\"source \">Clin Microbiol Infect</div><div class=\"year\">2011</div>; <div class=\"volume\">17(suppl 6)</div>:<div class=\"fpage\">E1</div>–<div class=\"lpage\">59</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Guidelines%20for%20the%20management%20of%20adult%20lower%20respiratory%20tract%20infections%E2%80%94full%20version&amp;author=M%20Woodhead&amp;author=F%20Blasi&amp;author=S%20Ewig&amp;publication_year=2011&amp;journal=Clin%20Microbiol%20Infect&amp;volume=17(suppl 6)&amp;pages=E1-59\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1111/j.1469-0691.2011.03672.x\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1111%2Fj.1469-0691.2011.03672.x\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1111%2Fj.1469-0691.2011.03672.x\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21951385\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Guidelines%20for%20the%20management%20of%20adult%20lower%20respiratory%20tract%20infections%E2%80%94full%20version&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0008\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0008\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0008\" href=\"javascript:;\" aria-label=\"jumplink-CIT0008\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0008\" class=\"ref-content \" data-id=\"CIT0008\"><span class=\"label title-label\">8.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Furman</div> <div class=\"given-names\">CD</div>, <span class=\"name string-name\"><div class=\"surname\">Rayner</div> <div class=\"given-names\">AV</div></span>, <span class=\"name string-name\"><div class=\"surname\">Tobin</div> <div class=\"given-names\">EP</div></span>. <div class=\"article-title\">Pneumonia in older residents of long-term care facilities</div>. <div class=\"source \">Am Fam Physician</div><div class=\"year\">2004</div>; <div class=\"volume\">70</div>:<div class=\"fpage\">1495</div>–<div class=\"lpage\">500</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Pneumonia%20in%20older%20residents%20of%20long-term%20care%20facilities&amp;author=CD%20Furman&amp;author=AV%20Rayner&amp;author=EP%20Tobin&amp;publication_year=2004&amp;journal=Am%20Fam%20Physician&amp;volume=70&amp;pages=1495-500\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15526736\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><div class=\"xslopenurl empty-target\"><span class=\"js-inst-open-url-holders-nodoi\"><a class=\"js-open-url-link\" data-href-template=\"{targetURL}?sid=oup:orr&amp;genre=article&amp;atitle=Pneumonia+in+older+residents+of+long-term+care+facilities&amp;aulast=Furman&amp;title=Am+Fam+Physician&amp;date=2004&amp;spage=1495&amp;epage=500&amp;volume=70\" href=\"javascript:;\" data-google-interstitial=\"false\"><span class=\"screenreader-text\">OpenURL Placeholder Text</span></a></span></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Pneumonia%20in%20older%20residents%20of%20long-term%20care%20facilities&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0009\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0009\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0009\" href=\"javascript:;\" aria-label=\"jumplink-CIT0009\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0009\" class=\"ref-content \" data-id=\"CIT0009\"><span class=\"label title-label\">9.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Cillóniz</div> <div class=\"given-names\">C</div>, <span class=\"name string-name\"><div class=\"surname\">Polverino</div> <div class=\"given-names\">E</div></span>, <span class=\"name string-name\"><div class=\"surname\">Ewig</div> <div class=\"given-names\">S</div></span>, et al. <div class=\"article-title\">Impact of age and comorbidity on cause and outcome in community-acquired pneumonia</div>. <div class=\"source \">Chest</div><div class=\"year\">2013</div>; <div class=\"volume\">144</div>:<div class=\"fpage\">999</div>–<div class=\"lpage\">1007</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Impact%20of%20age%20and%20comorbidity%20on%20cause%20and%20outcome%20in%20community-acquired%20pneumonia&amp;author=C%20Cill%C3%B3niz&amp;author=E%20Polverino&amp;author=S%20Ewig&amp;publication_year=2013&amp;journal=Chest&amp;volume=144&amp;pages=999-1007\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1378/chest.13-0062\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1378%2Fchest.13-0062\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1378%2Fchest.13-0062\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23670047\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Impact%20of%20age%20and%20comorbidity%20on%20cause%20and%20outcome%20in%20community-acquired%20pneumonia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0010\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0010\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0010\" href=\"javascript:;\" aria-label=\"jumplink-CIT0010\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0010\" class=\"ref-content \" data-id=\"CIT0010\"><span class=\"label title-label\">10.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Aliberti</div> <div class=\"given-names\">S</div>, <span class=\"name string-name\"><div class=\"surname\">Reyes</div> <div class=\"given-names\">LF</div></span>, <span class=\"name string-name\"><div class=\"surname\">Faverio</div> <div class=\"given-names\">P</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">GLIMP investigators</div></span>. <div class=\"article-title\">Global Initiative for Meticillin-Resistant <em>Staphylococcus aureus</em> Pneumonia (GLIMP): an international, observational cohort study</div>. <div class=\"source \">Lancet Infect Dis</div><div class=\"year\">2016</div>; <div class=\"volume\">16</div>:<div class=\"fpage\">1364</div>–<div class=\"lpage\">76</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Global%20Initiative%20for%20Meticillin-Resistant%20Staphylococcus%20aureus%20Pneumonia%20%28GLIMP%29%3A%20an%20international%2C%20observational%20cohort%20study&amp;author=S%20Aliberti&amp;author=LF%20Reyes&amp;author=P%20Faverio&amp;publication_year=2016&amp;journal=Lancet%20Infect%20Dis&amp;volume=16&amp;pages=1364-76\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/S1473-3099(16)30267-5\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2FS1473-3099(16)30267-5\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2FS1473-3099(16)30267-5\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/27593581\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Global%20Initiative%20for%20Meticillin-Resistant%20Staphylococcus%20aureus%20Pneumonia%20%28GLIMP%29%3A%20an%20international%2C%20observational%20cohort%20study&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0011\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0011\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0011\" href=\"javascript:;\" aria-label=\"jumplink-CIT0011\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0011\" class=\"ref-content \" data-id=\"CIT0011\"><span class=\"label title-label\">11.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Magiorakos</div> <div class=\"given-names\">AP</div>, <span class=\"name string-name\"><div class=\"surname\">Srinivasan</div> <div class=\"given-names\">A</div></span>, <span class=\"name string-name\"><div class=\"surname\">Carey</div> <div class=\"given-names\">RB</div></span>, et al. <div class=\"article-title\">Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance</div>. <div class=\"source \">Clin Microbiol Infect</div><div class=\"year\">2012</div>; <div class=\"volume\">18</div>:<div class=\"fpage\">268</div>–<div class=\"lpage\">81</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Multidrug-resistant%2C%20extensively%20drug-resistant%20and%20pandrug-resistant%20bacteria%3A%20an%20international%20expert%20proposal%20for%20interim%20standard%20definitions%20for%20acquired%20resistance&amp;author=AP%20Magiorakos&amp;author=A%20Srinivasan&amp;author=RB%20Carey&amp;publication_year=2012&amp;journal=Clin%20Microbiol%20Infect&amp;volume=18&amp;pages=268-81\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1111%2Fj.1469-0691.2011.03570.x\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1111%2Fj.1469-0691.2011.03570.x\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21793988\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Multidrug-resistant%2C%20extensively%20drug-resistant%20and%20pandrug-resistant%20bacteria%3A%20an%20international%20expert%20proposal%20for%20interim%20standard%20definitions%20for%20acquired%20resistance&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0012\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0012\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0012\" href=\"javascript:;\" aria-label=\"jumplink-CIT0012\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0012\" class=\"ref-content \" data-id=\"CIT0012\"><span class=\"label title-label\">12.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Wan</div> <div class=\"given-names\">QJ</div>, <span class=\"name string-name\"><div class=\"surname\">Hu</div> <div class=\"given-names\">HF</div></span>, <span class=\"name string-name\"><div class=\"surname\">He</div> <div class=\"given-names\">YC</div></span>, et al. <div class=\"article-title\">Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy</div>. <div class=\"source \">Kaohsiung J Med Sci</div><div class=\"year\">2015</div>; <div class=\"volume\">31</div>:<div class=\"fpage\">42</div>–<div class=\"lpage\">6</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Severe%20pneumonia%20in%20mycophenolate%20mofetil%20combined%20with%20low-dose%20corticosteroids-treated%20patients%20with%20immunoglobulin%20A%20nephropathy&amp;author=QJ%20Wan&amp;author=HF%20Hu&amp;author=YC%20He&amp;publication_year=2015&amp;journal=Kaohsiung%20J%20Med%20Sci&amp;volume=31&amp;pages=42-6\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/j.kjms.2014.10.004\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.kjms.2014.10.004\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2Fj.kjms.2014.10.004\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/25600919\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Severe%20pneumonia%20in%20mycophenolate%20mofetil%20combined%20with%20low-dose%20corticosteroids-treated%20patients%20with%20immunoglobulin%20A%20nephropathy&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0013\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0013\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0013\" href=\"javascript:;\" aria-label=\"jumplink-CIT0013\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0013\" class=\"ref-content \" data-id=\"CIT0013\"><span class=\"label title-label\">13.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Li</div> <div class=\"given-names\">F</div>, <span class=\"name string-name\"><div class=\"surname\">Jin</div> <div class=\"given-names\">HZ</div></span>, <span class=\"name string-name\"><div class=\"surname\">Su</div> <div class=\"given-names\">F</div></span>, <span class=\"name string-name\"><div class=\"surname\">Jia</div> <div class=\"given-names\">L</div></span>, <span class=\"name string-name\"><div class=\"surname\">Sun</div> <div class=\"given-names\">QN</div></span>. <div class=\"article-title\">Pneumocystis pneumonia in patients with immunobullous dermatoses</div>. <div class=\"source \">Int J Dermatol</div><div class=\"year\">2011</div>; <div class=\"volume\">50</div>:<div class=\"fpage\">1144</div>–<div class=\"lpage\">9</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Pneumocystis%20pneumonia%20in%20patients%20with%20immunobullous%20dermatoses&amp;author=F%20Li&amp;author=HZ%20Jin&amp;author=F%20Su&amp;author=L%20Jia&amp;author=QN%20Sun&amp;publication_year=2011&amp;journal=Int%20J%20Dermatol&amp;volume=50&amp;pages=1144-9\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1111/ijd.2011.50.issue-9\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1111%2Fijd.2011.50.issue-9\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1111%2Fijd.2011.50.issue-9\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22126881\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Pneumocystis%20pneumonia%20in%20patients%20with%20immunobullous%20dermatoses&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0014\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0014\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0014\" href=\"javascript:;\" aria-label=\"jumplink-CIT0014\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0014\" class=\"ref-content \" data-id=\"CIT0014\"><span class=\"label title-label\">14.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Gruson</div> <div class=\"given-names\">D</div>, <span class=\"name string-name\"><div class=\"surname\">Vargas</div> <div class=\"given-names\">F</div></span>, <span class=\"name string-name\"><div class=\"surname\">Hilbert</div> <div class=\"given-names\">G</div></span>, et al. <div class=\"article-title\">Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia</div>. <div class=\"source \">Intensive Care Med</div><div class=\"year\">2004</div>; <div class=\"volume\">30</div>:<div class=\"fpage\">965</div>–<div class=\"lpage\">71</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Predictive%20factors%20of%20intensive%20care%20unit%20admission%20in%20patients%20with%20haematological%20malignancies%20and%20pneumonia&amp;author=D%20Gruson&amp;author=F%20Vargas&amp;author=G%20Hilbert&amp;publication_year=2004&amp;journal=Intensive%20Care%20Med&amp;volume=30&amp;pages=965-71\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1007/s00134-004-2237-1\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1007%2Fs00134-004-2237-1\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1007%2Fs00134-004-2237-1\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15052383\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Predictive%20factors%20of%20intensive%20care%20unit%20admission%20in%20patients%20with%20haematological%20malignancies%20and%20pneumonia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0015\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0015\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0015\" href=\"javascript:;\" aria-label=\"jumplink-CIT0015\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0015\" class=\"ref-content \" data-id=\"CIT0015\"><span class=\"label title-label\">15.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Garcia</div> <div class=\"given-names\">JB</div>, <span class=\"name string-name\"><div class=\"surname\">Lei</div> <div class=\"given-names\">X</div></span>, <span class=\"name string-name\"><div class=\"surname\">Wierda</div> <div class=\"given-names\">W</div></span>, et al. <div class=\"article-title\">Pneumonia during remission induction chemotherapy in patients with acute leukemia</div>. <div class=\"source \">Ann Am Thorac Soc</div><div class=\"year\">2013</div>; <div class=\"volume\">10</div>:<div class=\"fpage\">432</div>–<div class=\"lpage\">40</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Pneumonia%20during%20remission%20induction%20chemotherapy%20in%20patients%20with%20acute%20leukemia&amp;author=JB%20Garcia&amp;author=X%20Lei&amp;author=W%20Wierda&amp;publication_year=2013&amp;journal=Ann%20Am%20Thorac%20Soc&amp;volume=10&amp;pages=432-40\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1513/AnnalsATS.201304-097OC\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1513%2FAnnalsATS.201304-097OC\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1513%2FAnnalsATS.201304-097OC\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23987587\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Pneumonia%20during%20remission%20induction%20chemotherapy%20in%20patients%20with%20acute%20leukemia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0016\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0016\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0016\" href=\"javascript:;\" aria-label=\"jumplink-CIT0016\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0016\" class=\"ref-content \" data-id=\"CIT0016\"><span class=\"label title-label\">16.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Lee</div> <div class=\"given-names\">JO</div>, <span class=\"name string-name\"><div class=\"surname\">Kim</div> <div class=\"given-names\">DY</div></span>, <span class=\"name string-name\"><div class=\"surname\">Lim</div> <div class=\"given-names\">JH</div></span>, et al. <div class=\"article-title\">Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients</div>. <div class=\"source \">Lung Cancer</div><div class=\"year\">2008</div>; <div class=\"volume\">62</div>:<div class=\"fpage\">381</div>–<div class=\"lpage\">4</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Risk%20factors%20for%20bacterial%20pneumonia%20after%20cytotoxic%20chemotherapy%20in%20advanced%20lung%20cancer%20patients&amp;author=JO%20Lee&amp;author=DY%20Kim&amp;author=JH%20Lim&amp;publication_year=2008&amp;journal=Lung%20Cancer&amp;volume=62&amp;pages=381-4\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/j.lungcan.2008.03.015\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.lungcan.2008.03.015\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2Fj.lungcan.2008.03.015\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18466999\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Risk%20factors%20for%20bacterial%20pneumonia%20after%20cytotoxic%20chemotherapy%20in%20advanced%20lung%20cancer%20patients&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0017\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0017\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0017\" href=\"javascript:;\" aria-label=\"jumplink-CIT0017\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0017\" class=\"ref-content \" data-id=\"CIT0017\"><span class=\"label title-label\">17.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Lim</div> <div class=\"given-names\">KH</div>, <span class=\"name string-name\"><div class=\"surname\">Yoon</div> <div class=\"given-names\">HI</div></span>, <span class=\"name string-name\"><div class=\"surname\">Kang</div> <div class=\"given-names\">YA</div></span>, et al. <div class=\"article-title\">Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab</div>. <div class=\"source \">Korean J Intern Med</div><div class=\"year\">2010</div>; <div class=\"volume\">25</div>:<div class=\"fpage\">86</div>–<div class=\"lpage\">92</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Severe%20pulmonary%20adverse%20effects%20in%20lymphoma%20patients%20treated%20with%20cyclophosphamide%2C%20doxorubicin%2C%20vincristine%2C%20and%20prednisone%20%28CHOP%29%20regimen%20plus%20rituximab&amp;author=KH%20Lim&amp;author=HI%20Yoon&amp;author=YA%20Kang&amp;publication_year=2010&amp;journal=Korean%20J%20Intern%20Med&amp;volume=25&amp;pages=86-92\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.3904/kjim.2010.25.1.86\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.3904%2Fkjim.2010.25.1.86\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.3904%2Fkjim.2010.25.1.86\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20195409\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Severe%20pulmonary%20adverse%20effects%20in%20lymphoma%20patients%20treated%20with%20cyclophosphamide%2C%20doxorubicin%2C%20vincristine%2C%20and%20prednisone%20%28CHOP%29%20regimen%20plus%20rituximab&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0018\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0018\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0018\" href=\"javascript:;\" aria-label=\"jumplink-CIT0018\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0018\" class=\"ref-content \" data-id=\"CIT0018\"><span class=\"label title-label\">18.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Waks</div> <div class=\"given-names\">AG</div>, <span class=\"name string-name\"><div class=\"surname\">Tolaney</div> <div class=\"given-names\">SM</div></span>, <span class=\"name string-name\"><div class=\"surname\">Galar</div> <div class=\"given-names\">A</div></span>, et al. <div class=\"article-title\"><em>Pneumocystis jiroveci</em> pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors</div>. <div class=\"source \">Breast Cancer Res Treat</div><div class=\"year\">2015</div>; <div class=\"volume\">154</div>:<div class=\"fpage\">359</div>–<div class=\"lpage\">67</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Pneumocystis%20jiroveci%20pneumonia%20%28PCP%29%20in%20patients%20receiving%20neoadjuvant%20and%20adjuvant%20anthracycline-based%20chemotherapy%20for%20breast%20cancer%3A%20incidence%20and%20risk%20factors&amp;author=AG%20Waks&amp;author=SM%20Tolaney&amp;author=A%20Galar&amp;publication_year=2015&amp;journal=Breast%20Cancer%20Res%20Treat&amp;volume=154&amp;pages=359-67\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1007/s10549-015-3573-2\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1007%2Fs10549-015-3573-2\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1007%2Fs10549-015-3573-2\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/26420402\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Pneumocystis%20jiroveci%20pneumonia%20%28PCP%29%20in%20patients%20receiving%20neoadjuvant%20and%20adjuvant%20anthracycline-based%20chemotherapy%20for%20breast%20cancer%3A%20incidence%20and%20risk%20factors&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0019\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0019\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0019\" href=\"javascript:;\" aria-label=\"jumplink-CIT0019\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0019\" class=\"ref-content \" data-id=\"CIT0019\"><span class=\"label title-label\">19.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Kim</div> <div class=\"given-names\">T</div>, <span class=\"name string-name\"><div class=\"surname\">Choi</div> <div class=\"given-names\">SH</div></span>, <span class=\"name string-name\"><div class=\"surname\">Kim</div> <div class=\"given-names\">SH</div></span>, et al. <div class=\"article-title\">Point prevalence of <em>Pneumocystis</em> pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy</div>. <div class=\"source \">Ann Hematol</div><div class=\"year\">2013</div>; <div class=\"volume\">92</div>:<div class=\"fpage\">231</div>–<div class=\"lpage\">8</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Point%20prevalence%20of%20Pneumocystis%20pneumonia%20in%20patients%20with%20non-Hodgkin%20lymphoma%20according%20to%20the%20number%20of%20cycles%20of%20R-CHOP%20chemotherapy&amp;author=T%20Kim&amp;author=SH%20Choi&amp;author=SH%20Kim&amp;publication_year=2013&amp;journal=Ann%20Hematol&amp;volume=92&amp;pages=231-8\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1007/s00277-012-1592-1\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1007%2Fs00277-012-1592-1\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1007%2Fs00277-012-1592-1\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23053189\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Point%20prevalence%20of%20Pneumocystis%20pneumonia%20in%20patients%20with%20non-Hodgkin%20lymphoma%20according%20to%20the%20number%20of%20cycles%20of%20R-CHOP%20chemotherapy&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0020\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0020\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0020\" href=\"javascript:;\" aria-label=\"jumplink-CIT0020\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0020\" class=\"ref-content \" data-id=\"CIT0020\"><span class=\"label title-label\">20.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Aliberti</div> <div class=\"given-names\">S</div>, <span class=\"name string-name\"><div class=\"surname\">Myers</div> <div class=\"given-names\">JA</div></span>, <span class=\"name string-name\"><div class=\"surname\">Peyrani</div> <div class=\"given-names\">P</div></span>, et al. <div class=\"article-title\">The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia</div>. <div class=\"source \">Eur Respir J</div><div class=\"year\">2009</div>; <div class=\"volume\">33</div>:<div class=\"fpage\">142</div>–<div class=\"lpage\">7</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=The%20role%20of%20neutropenia%20on%20outcomes%20of%20cancer%20patients%20with%20community-acquired%20pneumonia&amp;author=S%20Aliberti&amp;author=JA%20Myers&amp;author=P%20Peyrani&amp;publication_year=2009&amp;journal=Eur%20Respir%20J&amp;volume=33&amp;pages=142-7\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1183/09031936.00167707\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1183%2F09031936.00167707\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1183%2F09031936.00167707\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18829671\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:The%20role%20of%20neutropenia%20on%20outcomes%20of%20cancer%20patients%20with%20community-acquired%20pneumonia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0021\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0021\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0021\" href=\"javascript:;\" aria-label=\"jumplink-CIT0021\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0021\" class=\"ref-content \" data-id=\"CIT0021\"><span class=\"label title-label\">21.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Sogaard</div> <div class=\"given-names\">OS</div>, <span class=\"name string-name\"><div class=\"surname\">Lohse</div> <div class=\"given-names\">N</div></span>, <span class=\"name string-name\"><div class=\"surname\">Gerstoft</div> <div class=\"given-names\">J</div></span>, et al. <div class=\"article-title\">Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study</div>. <div class=\"source \">Clin Infect Dis</div><div class=\"year\">2008</div>; <div class=\"volume\">47</div>:<div class=\"fpage\">1345</div>–<div class=\"lpage\">53</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Hospitalization%20for%20pneumonia%20among%20individuals%20with%20and%20without%20HIV%20infection%2C%201995-2007%3A%20a%20Danish%20population-based%2C%20nationwide%20cohort%20study&amp;author=OS%20Sogaard&amp;author=N%20Lohse&amp;author=J%20Gerstoft&amp;publication_year=2008&amp;journal=Clin%20Infect%20Dis&amp;volume=47&amp;pages=1345-53\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1086/595712\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1086%2F595712\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1086%2F595712\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18834317\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Hospitalization%20for%20pneumonia%20among%20individuals%20with%20and%20without%20HIV%20infection%2C%201995-2007%3A%20a%20Danish%20population-based%2C%20nationwide%20cohort%20study&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0022\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0022\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0022\" href=\"javascript:;\" aria-label=\"jumplink-CIT0022\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0022\" class=\"ref-content \" data-id=\"CIT0022\"><span class=\"label title-label\">22.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Kuehnhardt</div> <div class=\"given-names\">D</div>, <span class=\"name string-name\"><div class=\"surname\">Hannemann</div> <div class=\"given-names\">M</div></span>, <span class=\"name string-name\"><div class=\"surname\">Schmidt</div> <div class=\"given-names\">B</div></span>, <span class=\"name string-name\"><div class=\"surname\">Heider</div> <div class=\"given-names\">U</div></span>, <span class=\"name string-name\"><div class=\"surname\">Possinger</div> <div class=\"given-names\">K</div></span>, <span class=\"name string-name\"><div class=\"surname\">Eucker</div> <div class=\"given-names\">J</div></span>. <div class=\"article-title\">Therapeutic implication of BAL in patients with neutropenia</div>. <div class=\"source \">Ann Hematol</div><div class=\"year\">2009</div>; <div class=\"volume\">88</div>:<div class=\"fpage\">1249</div>–<div class=\"lpage\">56</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Therapeutic%20implication%20of%20BAL%20in%20patients%20with%20neutropenia&amp;author=D%20Kuehnhardt&amp;author=M%20Hannemann&amp;author=B%20Schmidt&amp;author=U%20Heider&amp;author=K%20Possinger&amp;author=J%20Eucker&amp;publication_year=2009&amp;journal=Ann%20Hematol&amp;volume=88&amp;pages=1249-56\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1007/s00277-009-0747-1\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1007%2Fs00277-009-0747-1\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1007%2Fs00277-009-0747-1\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19415277\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Therapeutic%20implication%20of%20BAL%20in%20patients%20with%20neutropenia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0023\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0023\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0023\" href=\"javascript:;\" aria-label=\"jumplink-CIT0023\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0023\" class=\"ref-content \" data-id=\"CIT0023\"><span class=\"label title-label\">23.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Maschmeyer</div> <div class=\"given-names\">G</div>, <span class=\"name string-name\"><div class=\"surname\">Beinert</div> <div class=\"given-names\">T</div></span>, <span class=\"name string-name\"><div class=\"surname\">Buchheidt</div> <div class=\"given-names\">D</div></span>, et al. <div class=\"article-title\">Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the Infectious Diseases Working Party of the German Society of Haematology and Oncology</div>. <div class=\"source \">Eur J Cancer</div><div class=\"year\">2009</div>; <div class=\"volume\">45</div>:<div class=\"fpage\">2462</div>–<div class=\"lpage\">72</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Diagnosis%20and%20antimicrobial%20therapy%20of%20lung%20infiltrates%20in%20febrile%20neutropenic%20patients%3A%20guidelines%20of%20the%20Infectious%20Diseases%20Working%20Party%20of%20the%20German%20Society%20of%20Haematology%20and%20Oncology&amp;author=G%20Maschmeyer&amp;author=T%20Beinert&amp;author=D%20Buchheidt&amp;publication_year=2009&amp;journal=Eur%20J%20Cancer&amp;volume=45&amp;pages=2462-72\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/j.ejca.2009.05.001\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.ejca.2009.05.001\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2Fj.ejca.2009.05.001\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19467584\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Diagnosis%20and%20antimicrobial%20therapy%20of%20lung%20infiltrates%20in%20febrile%20neutropenic%20patients%3A%20guidelines%20of%20the%20Infectious%20Diseases%20Working%20Party%20of%20the%20German%20Society%20of%20Haematology%20and%20Oncology&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0024\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0024\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0024\" href=\"javascript:;\" aria-label=\"jumplink-CIT0024\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0024\" class=\"ref-content \" data-id=\"CIT0024\"><span class=\"label title-label\">24.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Alanio</div> <div class=\"given-names\">A</div>, <span class=\"name string-name\"><div class=\"surname\">Hauser</div> <div class=\"given-names\">PM</div></span>, <span class=\"name string-name\"><div class=\"surname\">Lagrou</div> <div class=\"given-names\">K</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">5th European Conference on Infections in Leukemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN)</div></span>. <div class=\"article-title\">ECIL guidelines for the diagnosis of <em>Pneumocystis jirovecii</em> pneumonia in patients with haematological malignancies and stem cell transplant recipients</div>. <div class=\"source \">J Antimicrob Chemother</div><div class=\"year\">2016</div>; <div class=\"volume\">71</div>:<div class=\"fpage\">2386</div>–<div class=\"lpage\">96</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=ECIL%20guidelines%20for%20the%20diagnosis%20of%20Pneumocystis%20jirovecii%20pneumonia%20in%20patients%20with%20haematological%20malignancies%20and%20stem%20cell%20transplant%20recipients&amp;author=A%20Alanio&amp;author=PM%20Hauser&amp;author=K%20Lagrou&amp;publication_year=2016&amp;journal=J%20Antimicrob%20Chemother&amp;volume=71&amp;pages=2386-96\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1093/jac/dkw156\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Fjac%2Fdkw156\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1093%2Fjac%2Fdkw156\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/27550991\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:ECIL%20guidelines%20for%20the%20diagnosis%20of%20Pneumocystis%20jirovecii%20pneumonia%20in%20patients%20with%20haematological%20malignancies%20and%20stem%20cell%20transplant%20recipients&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0025\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0025\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0025\" href=\"javascript:;\" aria-label=\"jumplink-CIT0025\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0025\" class=\"ref-content \" data-id=\"CIT0025\"><span class=\"label title-label\">25.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Freifeld</div> <div class=\"given-names\">AG</div>, <span class=\"name string-name\"><div class=\"surname\">Bow</div> <div class=\"given-names\">EJ</div></span>, <span class=\"name string-name\"><div class=\"surname\">Sepkowitz</div> <div class=\"given-names\">KA</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">Infectious Diseases Society of America</div></span>. <div class=\"article-title\">Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America</div>. <div class=\"source \">Clin Infect Dis</div><div class=\"year\">2011</div>; <div class=\"volume\">52</div>:<div class=\"fpage\">e56</div>–<div class=\"lpage\">93</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Clinical%20practice%20guideline%20for%20the%20use%20of%20antimicrobial%20agents%20in%20neutropenic%20patients%20with%20cancer%3A%202010%20update%20by%20the%20Infectious%20Diseases%20Society%20of%20America&amp;author=AG%20Freifeld&amp;author=EJ%20Bow&amp;author=KA%20Sepkowitz&amp;publication_year=2011&amp;journal=Clin%20Infect%20Dis&amp;volume=52&amp;pages=e56-93\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1093/cid/cir073\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Fcid%2Fcir073\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1093%2Fcid%2Fcir073\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21258094\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Clinical%20practice%20guideline%20for%20the%20use%20of%20antimicrobial%20agents%20in%20neutropenic%20patients%20with%20cancer%3A%202010%20update%20by%20the%20Infectious%20Diseases%20Society%20of%20America&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0026\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0026\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0026\" href=\"javascript:;\" aria-label=\"jumplink-CIT0026\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0026\" class=\"ref-content \" data-id=\"CIT0026\"><span class=\"label title-label\">26.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Chemaly</div> <div class=\"given-names\">RF</div>, <span class=\"name string-name\"><div class=\"surname\">Shah</div> <div class=\"given-names\">DP</div></span>, <span class=\"name string-name\"><div class=\"surname\">Boeckh</div> <div class=\"given-names\">MJ</div></span>. <div class=\"article-title\">Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies</div>. <div class=\"source \">Clin Infect Dis</div><div class=\"year\">2014</div>; <div class=\"volume\">59</div>(<div class=\"supplement\">suppl 5</div>):<div class=\"fpage\">S344</div>–<div class=\"lpage\">51</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Management%20of%20respiratory%20viral%20infections%20in%20hematopoietic%20cell%20transplant%20recipients%20and%20patients%20with%20hematologic%20malignancies&amp;author=RF%20Chemaly&amp;author=DP%20Shah&amp;author=MJ%20Boeckh&amp;publication_year=2014&amp;journal=Clin%20Infect%20Dis&amp;volume=59&amp;pages=S344-51\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1093/cid/ciu623\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Fcid%2Fciu623\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1093%2Fcid%2Fciu623\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/25352629\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Management%20of%20respiratory%20viral%20infections%20in%20hematopoietic%20cell%20transplant%20recipients%20and%20patients%20with%20hematologic%20malignancies&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0027\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0027\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0027\" href=\"javascript:;\" aria-label=\"jumplink-CIT0027\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0027\" class=\"ref-content \" data-id=\"CIT0027\"><span class=\"label title-label\">27.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Buchacz</div> <div class=\"given-names\">K</div>, <span class=\"name string-name\"><div class=\"surname\">Lau</div> <div class=\"given-names\">B</div></span>, <span class=\"name string-name\"><div class=\"surname\">Jing</div> <div class=\"given-names\">Y</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA</div></span>. <div class=\"article-title\">Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010</div>. <div class=\"source \">J Infect Dis</div><div class=\"year\">2016</div>; <div class=\"volume\">214</div>:<div class=\"fpage\">862</div>–<div class=\"lpage\">72</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Incidence%20of%20AIDS-defining%20opportunistic%20infections%20in%20a%20multicohort%20analysis%20of%20HIV-infected%20persons%20in%20the%20United%20States%20and%20Canada%2C%202000-2010&amp;author=K%20Buchacz&amp;author=B%20Lau&amp;author=Y%20Jing&amp;publication_year=2016&amp;journal=J%20Infect%20Dis&amp;volume=214&amp;pages=862-72\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1093/infdis/jiw085\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Finfdis%2Fjiw085\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1093%2Finfdis%2Fjiw085\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/27559122\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Incidence%20of%20AIDS-defining%20opportunistic%20infections%20in%20a%20multicohort%20analysis%20of%20HIV-infected%20persons%20in%20the%20United%20States%20and%20Canada%2C%202000-2010&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0028\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0028\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0028\" href=\"javascript:;\" aria-label=\"jumplink-CIT0028\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0028\" class=\"ref-content \" data-id=\"CIT0028\"><span class=\"label title-label\">28.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Madeddu</div> <div class=\"given-names\">G</div>, <span class=\"name string-name\"><div class=\"surname\">Porqueddu</div> <div class=\"given-names\">EM</div></span>, <span class=\"name string-name\"><div class=\"surname\">Cambosu</div> <div class=\"given-names\">F</div></span>, et al. <div class=\"article-title\">Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era</div>. <div class=\"source \">Infection</div><div class=\"year\">2008</div>; <div class=\"volume\">36</div>:<div class=\"fpage\">231</div>–<div class=\"lpage\">6</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Bacterial%20community%20acquired%20pneumonia%20in%20HIV-infected%20inpatients%20in%20the%20highly%20active%20antiretroviral%20therapy%20era&amp;author=G%20Madeddu&amp;author=EM%20Porqueddu&amp;author=F%20Cambosu&amp;publication_year=2008&amp;journal=Infection&amp;volume=36&amp;pages=231-6\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1007/s15010-007-7162-0\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1007%2Fs15010-007-7162-0\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1007%2Fs15010-007-7162-0\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18463787\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Bacterial%20community%20acquired%20pneumonia%20in%20HIV-infected%20inpatients%20in%20the%20highly%20active%20antiretroviral%20therapy%20era&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0029\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0029\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0029\" href=\"javascript:;\" aria-label=\"jumplink-CIT0029\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0029\" class=\"ref-content \" data-id=\"CIT0029\"><span class=\"label title-label\">29.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Park</div> <div class=\"given-names\">DR</div>, <span class=\"name string-name\"><div class=\"surname\">Sherbin</div> <div class=\"given-names\">VL</div></span>, <span class=\"name string-name\"><div class=\"surname\">Goodman</div> <div class=\"given-names\">MS</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">Harborview CAP Study Group</div></span>. <div class=\"article-title\">The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness</div>. <div class=\"source \">J Infect Dis</div><div class=\"year\">2001</div>; <div class=\"volume\">184</div>:<div class=\"fpage\">268</div>–<div class=\"lpage\">77</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=The%20etiology%20of%20community-acquired%20pneumonia%20at%20an%20urban%20public%20hospital%3A%20influence%20of%20human%20immunodeficiency%20virus%20infection%20and%20initial%20severity%20of%20illness&amp;author=DR%20Park&amp;author=VL%20Sherbin&amp;author=MS%20Goodman&amp;publication_year=2001&amp;journal=J%20Infect%20Dis&amp;volume=184&amp;pages=268-77\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1086/jid.2001.184.issue-3\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1086%2Fjid.2001.184.issue-3\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1086%2Fjid.2001.184.issue-3\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11443551\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:The%20etiology%20of%20community-acquired%20pneumonia%20at%20an%20urban%20public%20hospital%3A%20influence%20of%20human%20immunodeficiency%20virus%20infection%20and%20initial%20severity%20of%20illness&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0030\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0030\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0030\" href=\"javascript:;\" aria-label=\"jumplink-CIT0030\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0030\" class=\"ref-content \" data-id=\"CIT0030\"><span class=\"label title-label\">30.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Torres</div> <div class=\"given-names\">HA</div>, <span class=\"name string-name\"><div class=\"surname\">Bodey</div> <div class=\"given-names\">GP</div></span>, <span class=\"name string-name\"><div class=\"surname\">Rolston</div> <div class=\"given-names\">KV</div></span>, <span class=\"name string-name\"><div class=\"surname\">Kantarjian</div> <div class=\"given-names\">HM</div></span>, <span class=\"name string-name\"><div class=\"surname\">Raad</div> <div class=\"given-names\">II</div></span>, <span class=\"name string-name\"><div class=\"surname\">Kontoyiannis</div> <div class=\"given-names\">DP</div></span>. <div class=\"article-title\">Infections in patients with aplastic anemia: experience at a tertiary care cancer center</div>. <div class=\"source \">Cancer</div><div class=\"year\">2003</div>; <div class=\"volume\">98</div>:<div class=\"fpage\">86</div>–<div class=\"lpage\">93</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Infections%20in%20patients%20with%20aplastic%20anemia%3A%20experience%20at%20a%20tertiary%20care%20cancer%20center&amp;author=HA%20Torres&amp;author=GP%20Bodey&amp;author=KV%20Rolston&amp;author=HM%20Kantarjian&amp;author=II%20Raad&amp;author=DP%20Kontoyiannis&amp;publication_year=2003&amp;journal=Cancer&amp;volume=98&amp;pages=86-93\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1002/(ISSN)1097-0142\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1002%2F(ISSN)1097-0142\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1002%2F(ISSN)1097-0142\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12833460\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Infections%20in%20patients%20with%20aplastic%20anemia%3A%20experience%20at%20a%20tertiary%20care%20cancer%20center&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0031\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0031\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0031\" href=\"javascript:;\" aria-label=\"jumplink-CIT0031\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0031\" class=\"ref-content \" data-id=\"CIT0031\"><span class=\"label title-label\">31.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Gil-Prieto</div> <div class=\"given-names\">R</div>, <span class=\"name string-name\"><div class=\"surname\">Pascual-Garcia</div> <div class=\"given-names\">R</div></span>, <span class=\"name string-name\"><div class=\"surname\">Walter</div> <div class=\"given-names\">S</div></span>, <span class=\"name string-name\"><div class=\"surname\">Álvaro-Meca</div> <div class=\"given-names\">A</div></span>, <span class=\"name string-name\"><div class=\"surname\">Gil-De-Miguel</div> <div class=\"given-names\">Á</div></span>. <div class=\"article-title\">Risk of hospitalization due to pneumococcal disease in adults in Spain: the CORIENNE study</div>. <div class=\"source \">Hum Vaccin Immunother</div><div class=\"year\">2016</div>; <div class=\"volume\">12</div>:<div class=\"fpage\">1900</div>–<div class=\"lpage\">5</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Risk%20of%20hospitalization%20due%20to%20pneumococcal%20disease%20in%20adults%20in%20Spain%3A%20the%20CORIENNE%20study&amp;author=R%20Gil-Prieto&amp;author=R%20Pascual-Garcia&amp;author=S%20Walter&amp;author=A%20%C3%81lvaro-Meca&amp;author=%C3%81%20Gil-De-Miguel&amp;publication_year=2016&amp;journal=Hum%20Vaccin%20Immunother&amp;volume=12&amp;pages=1900-5\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/26901683\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><div class=\"xslopenurl empty-target\"><span class=\"js-inst-open-url-holders-nodoi\"><a class=\"js-open-url-link\" data-href-template=\"{targetURL}?sid=oup:orr&amp;genre=article&amp;atitle=Risk+of+hospitalization+due+to+pneumococcal+disease+in+adults+in+Spain%3a+the+CORIENNE+study&amp;aulast=Gil-Prieto&amp;title=Hum+Vaccin+Immunother&amp;date=2016&amp;spage=1900&amp;epage=5&amp;volume=12\" href=\"javascript:;\" data-google-interstitial=\"false\"><span class=\"screenreader-text\">OpenURL Placeholder Text</span></a></span></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Risk%20of%20hospitalization%20due%20to%20pneumococcal%20disease%20in%20adults%20in%20Spain%3A%20the%20CORIENNE%20study&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0032\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0032\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0032\" href=\"javascript:;\" aria-label=\"jumplink-CIT0032\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0032\" class=\"ref-content \" data-id=\"CIT0032\"><span class=\"label title-label\">32.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Putot</div> <div class=\"given-names\">A</div>, <span class=\"name string-name\"><div class=\"surname\">Tetu</div> <div class=\"given-names\">J</div></span>, <span class=\"name string-name\"><div class=\"surname\">Perrin</div> <div class=\"given-names\">S</div></span>, et al. <div class=\"article-title\">Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients</div>. <div class=\"source \">Eur J Clin Microbiol Infect Dis</div><div class=\"year\">2016</div>; <div class=\"volume\">35</div>:<div class=\"fpage\">489</div>–<div class=\"lpage\">95</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Impact%20of%20microbiological%20samples%20in%20the%20hospital%20management%20of%20community-acquired%2C%20nursing%20home-acquired%20and%20hospital-acquired%20pneumonia%20in%20older%20patients&amp;author=A%20Putot&amp;author=J%20Tetu&amp;author=S%20Perrin&amp;publication_year=2016&amp;journal=Eur%20J%20Clin%20Microbiol%20Infect%20Dis&amp;volume=35&amp;pages=489-95\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1007/s10096-015-2565-9\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1007%2Fs10096-015-2565-9\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1007%2Fs10096-015-2565-9\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/26753994\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Impact%20of%20microbiological%20samples%20in%20the%20hospital%20management%20of%20community-acquired%2C%20nursing%20home-acquired%20and%20hospital-acquired%20pneumonia%20in%20older%20patients&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0033\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0033\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0033\" href=\"javascript:;\" aria-label=\"jumplink-CIT0033\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0033\" class=\"ref-content \" data-id=\"CIT0033\"><span class=\"label title-label\">33.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Polverino</div> <div class=\"given-names\">E</div>, <span class=\"name string-name\"><div class=\"surname\">Dambrava</div> <div class=\"given-names\">P</div></span>, <span class=\"name string-name\"><div class=\"surname\">Cillóniz</div> <div class=\"given-names\">C</div></span>, et al. <div class=\"article-title\">Nursing home-acquired pneumonia: a 10 year single-centre experience</div>. <div class=\"source \">Thorax</div><div class=\"year\">2010</div>; <div class=\"volume\">65</div>:<div class=\"fpage\">354</div>–<div class=\"lpage\">9</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Nursing%20home-acquired%20pneumonia%3A%20a%2010%20year%20single-centre%20experience&amp;author=E%20Polverino&amp;author=P%20Dambrava&amp;author=C%20Cill%C3%B3niz&amp;publication_year=2010&amp;journal=Thorax&amp;volume=65&amp;pages=354-9\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1136/thx.2009.124776\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1136%2Fthx.2009.124776\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1136%2Fthx.2009.124776\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20388763\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Nursing%20home-acquired%20pneumonia%3A%20a%2010%20year%20single-centre%20experience&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0034\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0034\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0034\" href=\"javascript:;\" aria-label=\"jumplink-CIT0034\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0034\" class=\"ref-content \" data-id=\"CIT0034\"><span class=\"label title-label\">34.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Kohli</div> <div class=\"given-names\">R</div>, <span class=\"name string-name\"><div class=\"surname\">Lo</div> <div class=\"given-names\">Y</div></span>, <span class=\"name string-name\"><div class=\"surname\">Homel</div> <div class=\"given-names\">P</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">HER Study Group</div></span>. <div class=\"article-title\">Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study</div>. <div class=\"source \">Clin Infect Dis</div><div class=\"year\">2006</div>; <div class=\"volume\">43</div>:<div class=\"fpage\">90</div>–<div class=\"lpage\">8</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Bacterial%20pneumonia%2C%20HIV%20therapy%2C%20and%20disease%20progression%20among%20HIV-infected%20women%20in%20the%20HIV%20epidemiologic%20research%20%28HER%29%20study&amp;author=R%20Kohli&amp;author=Y%20Lo&amp;author=P%20Homel&amp;publication_year=2006&amp;journal=Clin%20Infect%20Dis&amp;volume=43&amp;pages=90-8\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1086/cid.2006.43.issue-1\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1086%2Fcid.2006.43.issue-1\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1086%2Fcid.2006.43.issue-1\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16758423\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Bacterial%20pneumonia%2C%20HIV%20therapy%2C%20and%20disease%20progression%20among%20HIV-infected%20women%20in%20the%20HIV%20epidemiologic%20research%20%28HER%29%20study&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0035\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0035\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0035\" href=\"javascript:;\" aria-label=\"jumplink-CIT0035\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0035\" class=\"ref-content \" data-id=\"CIT0035\"><span class=\"label title-label\">35.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Benito</div> <div class=\"given-names\">N</div>, <span class=\"name string-name\"><div class=\"surname\">Rañó</div> <div class=\"given-names\">A</div></span>, <span class=\"name string-name\"><div class=\"surname\">Moreno</div> <div class=\"given-names\">A</div></span>, et al. <div class=\"article-title\">Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain</div>. <div class=\"source \">J Acquir Immune Defic Syndr</div><div class=\"year\">2001</div>; <div class=\"volume\">27</div>:<div class=\"fpage\">35</div>–<div class=\"lpage\">43</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Pulmonary%20infiltrates%20in%20HIV-infected%20patients%20in%20the%20highly%20active%20antiretroviral%20therapy%20era%20in%20Spain&amp;author=N%20Benito&amp;author=A%20Ra%C3%B1%C3%B3&amp;author=A%20Moreno&amp;publication_year=2001&amp;journal=J%20Acquir%20Immune%20Defic%20Syndr&amp;volume=27&amp;pages=35-43\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1097/00126334-200105010-00006\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1097%2F00126334-200105010-00006\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1097%2F00126334-200105010-00006\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11404518\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Pulmonary%20infiltrates%20in%20HIV-infected%20patients%20in%20the%20highly%20active%20antiretroviral%20therapy%20era%20in%20Spain&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0036\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0036\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0036\" href=\"javascript:;\" aria-label=\"jumplink-CIT0036\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0036\" class=\"ref-content \" data-id=\"CIT0036\"><span class=\"label title-label\">36.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Mori</div> <div class=\"given-names\">H</div>, <span class=\"name string-name\"><div class=\"surname\">Ohno</div> <div class=\"given-names\">Y</div></span>, <span class=\"name string-name\"><div class=\"surname\">Ito</div> <div class=\"given-names\">F</div></span>, et al. <div class=\"article-title\">Polymerase chain reaction positivity of <em>Pneumocystis jirovecii</em> during primary lung cancer treatment</div>. <div class=\"source \">Jpn J Clin Oncol</div><div class=\"year\">2010</div>; <div class=\"volume\">40</div>:<div class=\"fpage\">658</div>–<div class=\"lpage\">62</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Polymerase%20chain%20reaction%20positivity%20of%20Pneumocystis%20jirovecii%20during%20primary%20lung%20cancer%20treatment&amp;author=H%20Mori&amp;author=Y%20Ohno&amp;author=F%20Ito&amp;publication_year=2010&amp;journal=Jpn%20J%20Clin%20Oncol&amp;volume=40&amp;pages=658-62\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1093/jjco/hyq040\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Fjjco%2Fhyq040\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1093%2Fjjco%2Fhyq040\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20395244\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Polymerase%20chain%20reaction%20positivity%20of%20Pneumocystis%20jirovecii%20during%20primary%20lung%20cancer%20treatment&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0037\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0037\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0037\" href=\"javascript:;\" aria-label=\"jumplink-CIT0037\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0037\" class=\"ref-content \" data-id=\"CIT0037\"><span class=\"label title-label\">37.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Boersma</div> <div class=\"given-names\">WG</div>, <span class=\"name string-name\"><div class=\"surname\">Erjavec</div> <div class=\"given-names\">Z</div></span>, <span class=\"name string-name\"><div class=\"surname\">van der Werf</div> <div class=\"given-names\">TS</div></span>, <span class=\"name string-name\"><div class=\"surname\">de Vries-Hosper</div> <div class=\"given-names\">HG</div></span>, <span class=\"name string-name\"><div class=\"surname\">Gouw</div> <div class=\"given-names\">AS</div></span>, <span class=\"name string-name\"><div class=\"surname\">Manson</div> <div class=\"given-names\">WL</div></span>. <div class=\"article-title\">Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL</div>. <div class=\"source \">Respir Med</div><div class=\"year\">2007</div>; <div class=\"volume\">101</div>:<div class=\"fpage\">317</div>–<div class=\"lpage\">25</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Bronchoscopic%20diagnosis%20of%20pulmonary%20infiltrates%20in%20granulocytopenic%20patients%20with%20hematologic%20malignancies%3A%20BAL%20versus%20PSB%20and%20PBAL&amp;author=WG%20Boersma&amp;author=Z%20Erjavec&amp;author=TS%20van%20der%20Werf&amp;author=HG%20de%20Vries-Hosper&amp;author=AS%20Gouw&amp;author=WL%20Manson&amp;publication_year=2007&amp;journal=Respir%20Med&amp;volume=101&amp;pages=317-25\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/j.rmed.2006.04.021\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.rmed.2006.04.021\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2Fj.rmed.2006.04.021\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16774815\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Bronchoscopic%20diagnosis%20of%20pulmonary%20infiltrates%20in%20granulocytopenic%20patients%20with%20hematologic%20malignancies%3A%20BAL%20versus%20PSB%20and%20PBAL&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0038\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0038\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0038\" href=\"javascript:;\" aria-label=\"jumplink-CIT0038\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0038\" class=\"ref-content \" data-id=\"CIT0038\"><span class=\"label title-label\">38.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Mikulska</div> <div class=\"given-names\">M</div>, <span class=\"name string-name\"><div class=\"surname\">Del Bono</div> <div class=\"given-names\">V</div></span>, <span class=\"name string-name\"><div class=\"surname\">Gandolfo</div> <div class=\"given-names\">N</div></span>, et al. <div class=\"article-title\">Epidemiology of viral respiratory tract infections in an outpatient haematology facility</div>. <div class=\"source \">Ann Hematol</div><div class=\"year\">2014</div>; <div class=\"volume\">93</div>:<div class=\"fpage\">669</div>–<div class=\"lpage\">76</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Epidemiology%20of%20viral%20respiratory%20tract%20infections%20in%20an%20outpatient%20haematology%20facility&amp;author=M%20Mikulska&amp;author=V%20Del%20Bono&amp;author=N%20Gandolfo&amp;publication_year=2014&amp;journal=Ann%20Hematol&amp;volume=93&amp;pages=669-76\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1007/s00277-013-1912-0\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1007%2Fs00277-013-1912-0\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1007%2Fs00277-013-1912-0\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/24097084\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Epidemiology%20of%20viral%20respiratory%20tract%20infections%20in%20an%20outpatient%20haematology%20facility&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0039\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0039\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0039\" href=\"javascript:;\" aria-label=\"jumplink-CIT0039\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0039\" class=\"ref-content \" data-id=\"CIT0039\"><span class=\"label title-label\">39.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Beaird</div> <div class=\"given-names\">OE</div>, <span class=\"name string-name\"><div class=\"surname\">Freifeld</div> <div class=\"given-names\">A</div></span>, <span class=\"name string-name\"><div class=\"surname\">Ison</div> <div class=\"given-names\">MG</div></span>, et al. <div class=\"article-title\">Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative</div>. <div class=\"source \">Transpl Infect Dis</div><div class=\"year\">2016</div>; <div class=\"volume\">18</div>:<div class=\"fpage\">210</div>–<div class=\"lpage\">5</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Current%20practices%20for%20treatment%20of%20respiratory%20syncytial%20virus%20and%20other%20non-influenza%20respiratory%20viruses%20in%20high-risk%20patient%20populations%3A%20a%20survey%20of%20institutions%20in%20the%20Midwestern%20Respiratory%20Virus%20Collaborative&amp;author=OE%20Beaird&amp;author=A%20Freifeld&amp;author=MG%20Ison&amp;publication_year=2016&amp;journal=Transpl%20Infect%20Dis&amp;volume=18&amp;pages=210-5\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1111/tid.2016.18.issue-2\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1111%2Ftid.2016.18.issue-2\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1111%2Ftid.2016.18.issue-2\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/26923867\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Current%20practices%20for%20treatment%20of%20respiratory%20syncytial%20virus%20and%20other%20non-influenza%20respiratory%20viruses%20in%20high-risk%20patient%20populations%3A%20a%20survey%20of%20institutions%20in%20the%20Midwestern%20Respiratory%20Virus%20Collaborative&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0040\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0040\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0040\" href=\"javascript:;\" aria-label=\"jumplink-CIT0040\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0040\" class=\"ref-content \" data-id=\"CIT0040\"><span class=\"label title-label\">40.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Poonyagariyagorn</div> <div class=\"given-names\">HK</div>, <span class=\"name string-name\"><div class=\"surname\">Gershman</div> <div class=\"given-names\">A</div></span>, <span class=\"name string-name\"><div class=\"surname\">Avery</div> <div class=\"given-names\">R</div></span>, et al. <div class=\"article-title\">Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients</div>. <div class=\"source \">Transpl Infect Dis</div><div class=\"year\">2008</div>; <div class=\"volume\">10</div>:<div class=\"fpage\">403</div>–<div class=\"lpage\">8</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Challenges%20in%20the%20diagnosis%20and%20management%20of%20Nocardia%20infections%20in%20lung%20transplant%20recipients&amp;author=HK%20Poonyagariyagorn&amp;author=A%20Gershman&amp;author=R%20Avery&amp;publication_year=2008&amp;journal=Transpl%20Infect%20Dis&amp;volume=10&amp;pages=403-8\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1111/tid.2008.10.issue-6\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1111%2Ftid.2008.10.issue-6\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1111%2Ftid.2008.10.issue-6\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18823356\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Challenges%20in%20the%20diagnosis%20and%20management%20of%20Nocardia%20infections%20in%20lung%20transplant%20recipients&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0041\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0041\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0041\" href=\"javascript:;\" aria-label=\"jumplink-CIT0041\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0041\" class=\"ref-content \" data-id=\"CIT0041\"><span class=\"label title-label\">41.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Tavadze</div> <div class=\"given-names\">M</div>, <span class=\"name string-name\"><div class=\"surname\">Rybicki</div> <div class=\"given-names\">L</div></span>, <span class=\"name string-name\"><div class=\"surname\">Mossad</div> <div class=\"given-names\">S</div></span>, et al. <div class=\"article-title\">Risk factors for vancomycin-resistant <em>Enterococcus</em> bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation</div>. <div class=\"source \">Bone Marrow Transplant</div><div class=\"year\">2014</div>; <div class=\"volume\">49</div>:<div class=\"fpage\">1310</div>–<div class=\"lpage\">6</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Risk%20factors%20for%20vancomycin-resistant%20Enterococcus%20bacteremia%20and%20its%20influence%20on%20survival%20after%20allogeneic%20hematopoietic%20cell%20transplantation&amp;author=M%20Tavadze&amp;author=L%20Rybicki&amp;author=S%20Mossad&amp;publication_year=2014&amp;journal=Bone%20Marrow%20Transplant&amp;volume=49&amp;pages=1310-6\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1038/bmt.2014.150\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1038%2Fbmt.2014.150\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1038%2Fbmt.2014.150\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/25111516\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Risk%20factors%20for%20vancomycin-resistant%20Enterococcus%20bacteremia%20and%20its%20influence%20on%20survival%20after%20allogeneic%20hematopoietic%20cell%20transplantation&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0042\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0042\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0042\" href=\"javascript:;\" aria-label=\"jumplink-CIT0042\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0042\" class=\"ref-content \" data-id=\"CIT0042\"><span class=\"label title-label\">42.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Bock</div> <div class=\"given-names\">AM</div>, <span class=\"name string-name\"><div class=\"surname\">Cao</div> <div class=\"given-names\">Q</div></span>, <span class=\"name string-name\"><div class=\"surname\">Ferrieri</div> <div class=\"given-names\">P</div></span>, <span class=\"name string-name\"><div class=\"surname\">Young</div> <div class=\"given-names\">JA</div></span>, <span class=\"name string-name\"><div class=\"surname\">Weisdorf</div> <div class=\"given-names\">DJ</div></span>. <div class=\"article-title\">Bacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance</div>. <div class=\"source \">Biol Blood Marrow Transplant</div><div class=\"year\">2013</div>; <div class=\"volume\">19</div>:<div class=\"fpage\">102</div>–<div class=\"lpage\">8</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Bacteremia%20in%20blood%20or%20marrow%20transplantation%20patients%3A%20clinical%20risk%20factors%20for%20infection%20and%20emerging%20antibiotic%20resistance&amp;author=AM%20Bock&amp;author=Q%20Cao&amp;author=P%20Ferrieri&amp;author=JA%20Young&amp;author=DJ%20Weisdorf&amp;publication_year=2013&amp;journal=Biol%20Blood%20Marrow%20Transplant&amp;volume=19&amp;pages=102-8\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/j.bbmt.2012.08.016\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.bbmt.2012.08.016\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2Fj.bbmt.2012.08.016\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22940054\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Bacteremia%20in%20blood%20or%20marrow%20transplantation%20patients%3A%20clinical%20risk%20factors%20for%20infection%20and%20emerging%20antibiotic%20resistance&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0043\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0043\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0043\" href=\"javascript:;\" aria-label=\"jumplink-CIT0043\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0043\" class=\"ref-content \" data-id=\"CIT0043\"><span class=\"label title-label\">43.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Herbers</div> <div class=\"given-names\">AH</div>, <span class=\"name string-name\"><div class=\"surname\">de Haan</div> <div class=\"given-names\">AF</div></span>, <span class=\"name string-name\"><div class=\"surname\">van der Velden</div> <div class=\"given-names\">WJ</div></span>, <span class=\"name string-name\"><div class=\"surname\">Donnelly</div> <div class=\"given-names\">JP</div></span>, <span class=\"name string-name\"><div class=\"surname\">Blijlevens</div> <div class=\"given-names\">NM</div></span>. <div class=\"article-title\">Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients</div>. <div class=\"source \">Transpl Infect Dis</div><div class=\"year\">2014</div>; <div class=\"volume\">16</div>:<div class=\"fpage\">279</div>–<div class=\"lpage\">85</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Mucositis%20not%20neutropenia%20determines%20bacteremia%20among%20hematopoietic%20stem%20cell%20transplant%20recipients&amp;author=AH%20Herbers&amp;author=AF%20de%20Haan&amp;author=WJ%20van%20der%20Velden&amp;author=JP%20Donnelly&amp;author=NM%20Blijlevens&amp;publication_year=2014&amp;journal=Transpl%20Infect%20Dis&amp;volume=16&amp;pages=279-85\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1111/tid.2014.16.issue-2\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1111%2Ftid.2014.16.issue-2\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1111%2Ftid.2014.16.issue-2\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/24621081\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Mucositis%20not%20neutropenia%20determines%20bacteremia%20among%20hematopoietic%20stem%20cell%20transplant%20recipients&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0044\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0044\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0044\" href=\"javascript:;\" aria-label=\"jumplink-CIT0044\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0044\" class=\"ref-content \" data-id=\"CIT0044\"><span class=\"label title-label\">44.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Wu</div> <div class=\"given-names\">SW</div>, <span class=\"name string-name\"><div class=\"surname\">Liu</div> <div class=\"given-names\">KS</div></span>, <span class=\"name string-name\"><div class=\"surname\">Lin</div> <div class=\"given-names\">CK</div></span>, et al. <div class=\"article-title\">Community-acquired urinary tract infection in kidney transplantation: risk factors for bacteremia and recurrent infection</div>. <div class=\"source \">J Formos Med Assoc</div><div class=\"year\">2013</div>; <div class=\"volume\">112</div>:<div class=\"fpage\">138</div>–<div class=\"lpage\">43</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Community-acquired%20urinary%20tract%20infection%20in%20kidney%20transplantation%3A%20risk%20factors%20for%20bacteremia%20and%20recurrent%20infection&amp;author=SW%20Wu&amp;author=KS%20Liu&amp;author=CK%20Lin&amp;publication_year=2013&amp;journal=J%20Formos%20Med%20Assoc&amp;volume=112&amp;pages=138-43\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/j.jfma.2012.01.010\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.jfma.2012.01.010\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2Fj.jfma.2012.01.010\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23473526\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Community-acquired%20urinary%20tract%20infection%20in%20kidney%20transplantation%3A%20risk%20factors%20for%20bacteremia%20and%20recurrent%20infection&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0045\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0045\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0045\" href=\"javascript:;\" aria-label=\"jumplink-CIT0045\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0045\" class=\"ref-content \" data-id=\"CIT0045\"><span class=\"label title-label\">45.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Daskalaki</div> <div class=\"given-names\">E</div>, <span class=\"name string-name\"><div class=\"surname\">Koukoulaki</div> <div class=\"given-names\">M</div></span>, <span class=\"name string-name\"><div class=\"surname\">Bakalis</div> <div class=\"given-names\">A</div></span>, et al. <div class=\"article-title\">Blood stream infections in renal transplant recipients: a single-center study</div>. <div class=\"source \">Transplant Proc</div><div class=\"year\">2014</div>; <div class=\"volume\">46</div>:<div class=\"fpage\">3191</div>–<div class=\"lpage\">3</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Blood%20stream%20infections%20in%20renal%20transplant%20recipients%3A%20a%20single-center%20study&amp;author=E%20Daskalaki&amp;author=M%20Koukoulaki&amp;author=A%20Bakalis&amp;publication_year=2014&amp;journal=Transplant%20Proc&amp;volume=46&amp;pages=3191-3\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/j.transproceed.2014.10.033\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.transproceed.2014.10.033\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2Fj.transproceed.2014.10.033\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/25420856\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Blood%20stream%20infections%20in%20renal%20transplant%20recipients%3A%20a%20single-center%20study&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0046\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0046\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0046\" href=\"javascript:;\" aria-label=\"jumplink-CIT0046\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0046\" class=\"ref-content \" data-id=\"CIT0046\"><span class=\"label title-label\">46.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Huson</div> <div class=\"given-names\">MA</div>, <span class=\"name string-name\"><div class=\"surname\">Stolp</div> <div class=\"given-names\">SM</div></span>, <span class=\"name string-name\"><div class=\"surname\">van der Poll</div> <div class=\"given-names\">T</div></span>, <span class=\"name string-name\"><div class=\"surname\">Grobusch</div> <div class=\"given-names\">MP</div></span>. <div class=\"article-title\">Community-acquired bacterial bloodstream infections in HIV-infected patients: a systematic review</div>. <div class=\"source \">Clin Infect Dis</div><div class=\"year\">2014</div>; <div class=\"volume\">58</div>:<div class=\"fpage\">79</div>–<div class=\"lpage\">92</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Community-acquired%20bacterial%20bloodstream%20infections%20in%20HIV-infected%20patients%3A%20a%20systematic%20review&amp;author=MA%20Huson&amp;author=SM%20Stolp&amp;author=T%20van%20der%20Poll&amp;author=MP%20Grobusch&amp;publication_year=2014&amp;journal=Clin%20Infect%20Dis&amp;volume=58&amp;pages=79-92\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1093/cid/cit596\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Fcid%2Fcit596\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1093%2Fcid%2Fcit596\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/24046307\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Community-acquired%20bacterial%20bloodstream%20infections%20in%20HIV-infected%20patients%3A%20a%20systematic%20review&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0047\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0047\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0047\" href=\"javascript:;\" aria-label=\"jumplink-CIT0047\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0047\" class=\"ref-content \" data-id=\"CIT0047\"><span class=\"label title-label\">47.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Taramasso</div> <div class=\"given-names\">L</div>, <span class=\"name string-name\"><div class=\"surname\">Tatarelli</div> <div class=\"given-names\">P</div></span>, <span class=\"name string-name\"><div class=\"surname\">Di Biagio</div> <div class=\"given-names\">A</div></span>. <div class=\"article-title\">Bloodstream infections in HIV-infected patients</div>. <div class=\"source \">Virulence</div><div class=\"year\">2016</div>; <div class=\"volume\">7</div>:<div class=\"fpage\">320</div>–<div class=\"lpage\">8</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Bloodstream%20infections%20in%20HIV-infected%20patients&amp;author=L%20Taramasso&amp;author=P%20Tatarelli&amp;author=A%20Di%20Biagio&amp;publication_year=2016&amp;journal=Virulence&amp;volume=7&amp;pages=320-8\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1080/21505594.2016.1158359\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1080%2F21505594.2016.1158359\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1080%2F21505594.2016.1158359\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/26950194\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Bloodstream%20infections%20in%20HIV-infected%20patients&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div></div>    <!-- /foreach in Model.Sections -->\n    <div class=\"widget widget-ArticlePubStateInfo widget-instance-OUP_ArticlePubStateInfo\">\n         \n    </div>\n\n\n\n        <div class=\"article-metadata-standalone-panel clearfix\" style=\"display: none;\"></div>\n\n        \n<div class=\"copyright copyright-statement\">© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</div><div class=\"license\"><div class=\"license-p\">This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<a class=\"link link-uri openInAnotherWindow\" href=\"https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model\" target=\"_blank\" data-google-interstitial=\"false\">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</a>)</div></div><!-- /foreach -->\n\n        <span id=\"UserHasAccess\" data-userhasaccess=\"True\"></span>\n\n    </div><!-- /.widget-items -->\n</div><!-- /.module-widget -->\n\n\n\n\n\n \n    </div>\n    <div class=\"widget widget-RelatedTags widget-instance-OUP_Article_RelatedTags_Widget\">\n            <div class=\"related-topic-tags\">\n        <div class=\"related-topic-tag-label\">Topic:</div>\n        <ul class=\"related-topic-tag-list\">\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"acquired immunodeficiency syndrome\" data-google-interstitial=\"false\"><span>acquired immunodeficiency syndrome</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"chemotherapy regimen\" data-google-interstitial=\"false\"><span>chemotherapy regimen</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"community acquired pneumonia\" data-google-interstitial=\"false\"><span>community acquired pneumonia</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"hematologic neoplasms\" data-google-interstitial=\"false\"><span>hematologic neoplasms</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"immunocompetence\" data-google-interstitial=\"false\"><span>immunocompetence</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"immunocompromised host\" data-google-interstitial=\"false\"><span>immunocompromised host</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"pneumonia\" data-google-interstitial=\"false\"><span>pneumonia</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"steroids\" data-google-interstitial=\"false\"><span>steroids</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"bacteria\" data-google-interstitial=\"false\"><span>bacteria</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"microbiology\" data-google-interstitial=\"false\"><span>microbiology</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"viruses\" data-google-interstitial=\"false\"><span>viruses</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"pathogenic organism\" data-google-interstitial=\"false\"><span>pathogenic organism</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"community\" data-google-interstitial=\"false\"><span>community</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"causality\" data-google-interstitial=\"false\"><span>causality</span></a>\n                </li>\n        </ul>\n    </div>\n \n    </div>\n    <div class=\"widget widget-SolrResourceMetadata widget-instance-OUP_Article_ResourceMetadata_Widget\">\n        \n    <div class=\"article-metadata-panel solr-resource-metadata js-metadata-panel at-ContentMetadata\">\n                <div class=\"article-metadata-tocSections\">\n                    <div class=\"article-metadata-tocSections-title\">Issue Section:</div>\n                        <a href=\"/cid/search-results?f_TocHeadingTitleList=Articles+and+Commentaries\" data-google-interstitial=\"false\">Articles and Commentaries</a>\n                </div>\n\n    </div>\n\n\n \n    </div>\n    <div class=\"widget widget-EditorInformation widget-instance-OUP_Article_EditorInformation_Widget\">\n        \n \n    </div>\n\n                <div id=\"ContentTabFilteredView\"></div>\n                <div class=\"downloadImagesppt js-download-images-ppt st-download-images-ppt\" style=\"display: none;\">\n                    <a id=\"lnkDownloadAllImages\" class=\"js-download-all-images-link btn\" href=\"/DownloadFile/DownloadImage.aspx?image=&amp;PPTtype=SlideSet&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;siteId=5269\" data-google-interstitial=\"false\">Download all slides</a>\n                </div>\n    <div class=\"widget widget-ArticleDataSupplements widget-instance-OUP_Data_Supplements_Tab\">\n            <a name=\"SupplementalTab\" id=\"SupplementalTab\" data-google-interstitial=\"false\"></a>\n        \n        <h2 scrollto-destination=\"supplementary-data\" id=\"supplementary-data\" class=\"section-title\">Supplementary data</h2>\n        <div class=\"dataSuppLink\"><a href=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy723_suppl_supplementary_materials.docx?Expires=1752631925&amp;Signature=AVGv5Vmnt343clttPsfDvp-kShC92fvNSLnXclgdRYiMp65Po8acqni-lz065f4xqeS2URUeYWwiTCI959Bo~dBCIGGstLYQgcbmDHSpvSwntw5uj11C7V7~p-QH5poMISApOd3NfEyZY8AZlrzAdM5q3aEGX21mqhLwYJNhCdVXhyqIp4UVAz5xc~UOfIBiHDNGkSaGgl03mqxZFRw9kwuLfuQGdClhpNDl00~DZZL1n4kDhC9lQQsEknRVMPABBXAYENlIT6hVAgWnWZbVPXt9XipreQe-LBmzzmHaFXfTIHNc3p32iIoTpALkFdYP3AUgYKaNfHQLgjwgVe5Ydw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" rel=\"nofollow\" data-google-interstitial=\"false\"><span class=\"label title-label\">Supplementary Material</span></a> - docx file</div>\n \n    </div>\n                    <div class=\"widget widget-ArticleDataRepositories widget-instance-Article_DryadLink\">\n         \n    </div>\n\n                <div class=\"comments\">\n    <div class=\"widget widget-UserCommentBody widget-instance-UserCommentBody_Article\">\n        \n\n \n    </div>\n    <div class=\"widget widget-UserComment widget-instance-OUP_UserComment_Article\">\n         \n    </div>\n\n                </div>\n            </div>\n        </div>\n\n    </div>\n</div>\n<div id=\"Sidebar\" class=\"page-column page-column--right\">\n    <div class=\"widget widget-AdBlock widget-instance-ArticlePageTopSidebar\">\n        <div class=\"js-adBlock-parent-wrap adblock-parent-wrap\">\n    <div class=\"adBlockMainBodyTop-wrap js-adBlockMainBodyTop hide\">\n        <div id=\"adBlockMainBodyTop\" class=\"js-adblock at-adblock\" data-lazy-load-margin=\"150\">\n            <script>\n                googletag.cmd.push(function () {\n                    googletag.display('adBlockMainBodyTop');\n                });\n            </script>\n        </div>\n            <div class=\"advertisement-text at-adblock js-adblock-advertisement-text hide\">Advertisement</div>\n            </div>\n</div> \n    </div>\n<div class=\"widget widget-dynamic \" data-count=\"1\"> \n\n    <div class=\"widget-dynamic-inner-wrap\">\n\n<div class=\"widget widget-dynamic \" data-count=\"10\"> \n\n    <div class=\"widget-dynamic-inner-wrap\">\n\n    <div class=\"widget widget-ArticleLevelMetrics widget-instance-Article_RightRailB0Article_RightRail_ArticleLevelMetrics\">\n        \n\n\n\n        <div class=\"artmet-wrapper horizontal-artmet\">\n\n<div class=\"contentmet-border\">\n    <div class=\"contentmet-wrapper horizontal-contentmet\">\n            <div class=\"contentmet-citations contentmet-badges-wrap js-contentmet-citations\">\n                <h3 class=\"contentmet-text\">Citations</h3>\n                    <div class=\"contentmet-item contentmet-dimensions\">\n    <div class=\"widget widget-DimensionsBadge widget-instance-ArticleLevelMetrics_DimensionsBadge\">\n        <span class=\"__dimensions_badge_embed__\" data-doi=\"10.1093/cid/ciy723\" data-legend=\"never\" data-style=\"small_circle\" data-hide-zero-citations=\"false\" data-dimensions-badge-installed=\"true\"><a class=\"__dimensions_Link\" href=\"https://badge.dimensions.ai/details/doi/10.1093/cid/ciy723?domain=https://academic.oup.com\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" aria-label=\"? total citations on Dimensions.\" style=\"display: none;\"><div class=\"__dimensions_Badge __dimensions_Badge_style_small_circle\"><div class=\"__dimensions_Badge_Image\">\n  <svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 600 600\">\n    <defs>\n      <filter id=\"ne3rfk-blur\" color-interpolation-filters=\"sRGB\">\n        <feGaussianBlur in=\"SourceGraphic\" stdDeviation=\"40\"></feGaussianBlur>\n      </filter>\n      <mask id=\"ne3rfk-shape-mask\">\n        <path fill=\"white\" d=\"M546.5,287.3l-111.8-194c-1.8-3-4.1-5.6-6.7-7.7c-2.2-2.7-5.4-4.3-8.9-4.5c-2.3-0.7-4.7-1-7-1\n          L188.2,80c-9.3,0-18,5-22.6,13.1l-112,193.8c-4.7,8.1-4.7,18,0,26.1l111.9,193.9c4.7,8.1,13.3,13,22.6,13.1l223.9,0.1\n          c9.3,0,17.9-4.8,22.6-12.8l112-193.7l0,0C551.1,305.1,551.2,295.4,546.5,287.3z M516.6,287.4l-41.5,0.1l-26.7-118.2L516.6,287.4z\n           M337.2,106.2l-114.5,36.3l-20.3-36.4L337.2,106.2z M180.7,119l20.1,36.2L112,237.7L180.7,119z M181,481.8l-69.3-120l89.2,84\n          L181,481.8z M203.3,493.8l19.6-35.6l114.6,35.7L203.3,493.8z M408.1,489.3l-152.7-47.5l-32.3-10.6l-25.3-23.2L82.6,299.6\n          l114.6-106.9l25-23.1v-0.2l0.7-0.2l32.4-10.7l153.6-48.7l35.5,156.6l7.5,33.4l-7.6,33.5L408.1,489.3z M447.1,432.9l27.9-120.3\n          l41.7-0.1L447.1,432.9z\"></path>\n      </mask>\n      <g id=\"ne3rfk-gradient\" filter=\"url(#ne3rfk-blur)\">\n        <g>\n          <path fill=\"#006EB6\" d=\"M0,0l300,300v-424.4C182.9-124.4,76.8-76.9,0,0z\"></path>\n          <path fill=\"#28348A\" d=\"M300-124.4V300L600,0C523.2-76.9,417.1-124.4,300-124.4z\"></path>\n          <path fill=\"#E20613\" d=\"M600,600c76.8-76.8,124.3-182.9,124.3-300H300L600,600z\"></path>\n          <path fill=\"#DA0078\" d=\"M300,300h424.4c0-117.1-47.5-223.2-124.3-300L300,300z\"></path>\n          <path fill=\"#5BC4F1\" d=\"M-124.4,300H300L0,0C-76.9,76.8-124.4,182.9-124.4,300z\"></path>\n          <path fill=\"#A1C517\" d=\"M0,600l300-300h-424.4C-124.4,417.1-76.9,523.2,0,600z\"></path>\n          <path fill=\"#F08800\" d=\"M300,724.4c117.1,0,223.2-47.5,300-124.3L300,300V724.4z\"></path>\n          <path fill=\"#FFCB00\" d=\"M300,724.4V300L0,600C76.8,676.9,182.9,724.4,300,724.4z\"></path>\n        </g>\n      </g>\n    </defs>\n  </svg>\n\n  <div class=\"__db_background\"></div>\n\n  <div class=\"__db_shape\">\n    <svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 600 600\" xmlns:xlink=\"http://www.w3.org/1999/xlink\">\n      <use mask=\"url(#ne3rfk-shape-mask)\" xlink:href=\"#ne3rfk-gradient\"></use>\n    </svg>\n  </div>\n\n  <div class=\"__db_score __db_score_normal\">?</div>\n  <div class=\"__db_label\">CITATIONS</div>\n\n  <img src=\"https://badge.dimensions.ai/badge?count=?\" class=\"__dimensions_png\" alt=\"? total citations on Dimensions.\">\n</div>\n</div></a></span>\n<script async=\"\" src=\"https://badge.dimensions.ai/badge.js\" charset=\"utf-8\"></script>\n \n    </div>\n\n                    </div>\n                            </div>\n                    <div class=\"contentmet-views contentmet-badges-wrap js-contentmet-views\">\n                <h3 class=\"contentmet-text\">Views</h3>\n                <div class=\"contentmet-item circle-text circle-text-views\">\n                    <div class=\"contentmet-number\">18,086</div>\n                </div>\n            </div>\n                    <div class=\"contentmet-item contentmet-badges-wrap\">\n                    <h3 class=\"contentmet-text\">Altmetric</h3>\n                    <div class=\"contentmet-item contentmet-altmetric\">\n    <div class=\"widget widget-AltmetricLink widget-instance-ArticleLevelMetrics_AltmetricLinkSummary\">\n            <!-- Altmetrics -->\n    <div id=\"altmetricEmbedId\" runat=\"server\" class=\"altmetric-embed\" data-badge-type=\"donut\" data-hide-no-mentions=\"false\" data-doi=\"10.1093/cid/ciy723\" data-uuid=\"7dbe6f2f-1e74-3e47-e7f3-a4fda40156d2\"><a target=\"_self\" href=\"https://www.altmetric.com/details.php?domain=academic.oup.com&amp;citation_id=47565307\" style=\"display:inline-block;\">\n        <img alt=\"Article has an altmetric score of 5\" src=\"https://badges.altmetric.com/?size=128&amp;score=5&amp;types=tttttttt\" width=\"64\" height=\"64\" style=\"border:0; margin:0; max-width: none;\">\n</a></div>\n         <script type=\"text/javascript\" src=\"https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js\"></script>\n \n    </div>\n\n                    </div>\n\n\n            </div>\n                    <div class=\"contentmet-modal-trigger-wrap clearfix\">\n                <a href=\"javascript:;\" class=\"artmet-modal-trigger js-artmet-modal-trigger at-alm-metrics-modal-trigger\" data-resource-id=\"5078600\" data-resource-type=\"3\" rel=\"nofollow\" data-google-interstitial=\"false\">\n                    <img class=\"contentmet-info-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/i.svg\" alt=\"Information\">\n                    <span class=\"contentmet-more-info\">More metrics information</span>\n                </a>\n            </div>\n    </div>\n</div>\n\n                <div class=\"artmet-modal js-artmet-modal\" id=\"MetricsModal\" role=\"dialog\" aria-hidden=\"true\" aria-live=\"assertive\" aria-labelledby=\"widget-title-1-id\">\n                    <div class=\"artmet-modal-contents js-metric-modal-contents at-alm-modal-contents\">\n\n\n\n\n    <div class=\"artmet-full-wrap clearfix js-metric-full-wrap hide\">\n            <h3 id=\"widget-title-1-id\" class=\"widget-title-1 artmet-widget-title-1\">Metrics</h3>\n\n            <div class=\"artmet-item artmet-views-wrap\">\n                <div class=\"artmet-views clearfix\">\n                    <div class=\"artmet-total-views\">\n                        <span class=\"artmet-text\">Total Views</span>\n                        <span class=\"artmet-number\">18,086</span>\n                    </div>\n                    <div class=\"artmet-breakdown-views-wrap\">\n                        <div class=\"artmet-breakdown-view breakdown-border\">\n                            <span class=\"artmet-number\">11,927</span>\n                            <span class=\"artmet-text\">Pageviews</span>\n                        </div>\n                        <div class=\"artmet-breakdown-view\">\n                            <span class=\"artmet-number\">6,159</span>\n                            <span class=\"artmet-text\">PDF Downloads</span>\n                        </div>\n                                            </div>\n                </div>\n                <div class=\"artmet-views-since\">Since 8/1/2018</div>\n            </div>\n\n            <script>\n                var ChartistData = ChartistData || {};\n\n                ChartistData.data = {\n                    labels: ['Aug 2018', 'Sep 2018', 'Oct 2018', 'Nov 2018', 'Dec 2018', 'Jan 2019', 'Feb 2019', 'Mar 2019', 'Apr 2019', 'May 2019', 'Jun 2019', 'Jul 2019', 'Aug 2019', 'Sep 2019', 'Oct 2019', 'Nov 2019', 'Dec 2019', 'Jan 2020', 'Feb 2020', 'Mar 2020', 'Apr 2020', 'May 2020', 'Jun 2020', 'Jul 2020', 'Aug 2020', 'Sep 2020', 'Oct 2020', 'Nov 2020', 'Dec 2020', 'Jan 2021', 'Feb 2021', 'Mar 2021', 'Apr 2021', 'May 2021', 'Jun 2021', 'Jul 2021', 'Aug 2021', 'Sep 2021', 'Oct 2021', 'Nov 2021', 'Dec 2021', 'Jan 2022', 'Feb 2022', 'Mar 2022', 'Apr 2022', 'May 2022', 'Jun 2022', 'Jul 2022', 'Aug 2022', 'Sep 2022', 'Oct 2022', 'Nov 2022', 'Dec 2022', 'Jan 2023', 'Feb 2023', 'Mar 2023', 'Apr 2023', 'May 2023', 'Jun 2023', 'Jul 2023', 'Aug 2023', 'Sep 2023', 'Oct 2023', 'Nov 2023', 'Dec 2023', 'Jan 2024', 'Feb 2024', 'Mar 2024', 'Apr 2024', 'May 2024', 'Jun 2024', 'Jul 2024', 'Aug 2024', 'Sep 2024', 'Oct 2024', 'Nov 2024', 'Dec 2024', 'Jan 2025', 'Feb 2025', 'Mar 2025', 'Apr 2025', 'May 2025', 'Jun 2025'],\n                    series: [[66, 28, 23, 70, 46, 53, 62, 31, 408, 355, 182, 176, 159, 111, 90, 66, 44, 69, 36, 223, 208, 140, 179, 162, 154, 217, 238, 237, 165, 140, 137, 236, 239, 239, 172, 131, 160, 205, 250, 227, 183, 202, 247, 301, 242, 240, 161, 159, 292, 404, 533, 300, 477, 287, 191, 310, 395, 248, 198, 185, 213, 248, 340, 311, 269, 301, 353, 372, 323, 341, 275, 268, 218, 253, 274, 312, 242, 250, 296, 396, 228, 228, 86]]\n                };\n            </script>\n            <div class=\"artmet-item artmet-chart\">\n                <div class=\"ct-chart ct-octave js-ct-chart\"></div>\n\n                <div class=\"artmet-table\">\n                    <table>\n                        <thead>\n                            <tr>\n                                <th>Month:</th>\n                                <th>Total Views:</th>\n                            </tr>\n                        </thead>\n                        <tbody>\n                                <tr>\n                                    <td>August 2018</td>\n                                    <td>66</td>\n                                </tr>\n                                <tr>\n                                    <td>September 2018</td>\n                                    <td>28</td>\n                                </tr>\n                                <tr>\n                                    <td>October 2018</td>\n                                    <td>23</td>\n                                </tr>\n                                <tr>\n                                    <td>November 2018</td>\n                                    <td>70</td>\n                                </tr>\n                                <tr>\n                                    <td>December 2018</td>\n                                    <td>46</td>\n                                </tr>\n                                <tr>\n                                    <td>January 2019</td>\n                                    <td>53</td>\n                                </tr>\n                                <tr>\n                                    <td>February 2019</td>\n                                    <td>62</td>\n                                </tr>\n                                <tr>\n                                    <td>March 2019</td>\n                                    <td>31</td>\n                                </tr>\n                                <tr>\n                                    <td>April 2019</td>\n                                    <td>408</td>\n                                </tr>\n                                <tr>\n                                    <td>May 2019</td>\n                                    <td>355</td>\n                                </tr>\n                                <tr>\n                                    <td>June 2019</td>\n                                    <td>182</td>\n                                </tr>\n                                <tr>\n                                    <td>July 2019</td>\n                                    <td>176</td>\n                                </tr>\n                                <tr>\n                                    <td>August 2019</td>\n                                    <td>159</td>\n                                </tr>\n                                <tr>\n                                    <td>September 2019</td>\n                                    <td>111</td>\n                                </tr>\n                                <tr>\n                                    <td>October 2019</td>\n                                    <td>90</td>\n                                </tr>\n                                <tr>\n                                    <td>November 2019</td>\n                                    <td>66</td>\n                                </tr>\n                                <tr>\n                                    <td>December 2019</td>\n                                    <td>44</td>\n                                </tr>\n                                <tr>\n                                    <td>January 2020</td>\n                                    <td>69</td>\n                                </tr>\n                                <tr>\n                                    <td>February 2020</td>\n                                    <td>36</td>\n                                </tr>\n                                <tr>\n                                    <td>March 2020</td>\n                                    <td>223</td>\n                                </tr>\n                                <tr>\n                                    <td>April 2020</td>\n                                    <td>208</td>\n                                </tr>\n                                <tr>\n                                    <td>May 2020</td>\n                                    <td>140</td>\n                                </tr>\n                                <tr>\n                                    <td>June 2020</td>\n                                    <td>179</td>\n                                </tr>\n                                <tr>\n                                    <td>July 2020</td>\n                                    <td>162</td>\n                                </tr>\n                                <tr>\n                                    <td>August 2020</td>\n                                    <td>154</td>\n                                </tr>\n                                <tr>\n                                    <td>September 2020</td>\n                                    <td>217</td>\n                                </tr>\n                                <tr>\n                                    <td>October 2020</td>\n                                    <td>238</td>\n                                </tr>\n                                <tr>\n                                    <td>November 2020</td>\n                                    <td>237</td>\n                                </tr>\n                                <tr>\n                                    <td>December 2020</td>\n                                    <td>165</td>\n                                </tr>\n                                <tr>\n                                    <td>January 2021</td>\n                                    <td>140</td>\n                                </tr>\n                                <tr>\n                                    <td>February 2021</td>\n                                    <td>137</td>\n                                </tr>\n                                <tr>\n                                    <td>March 2021</td>\n                                    <td>236</td>\n                                </tr>\n                                <tr>\n                                    <td>April 2021</td>\n                                    <td>239</td>\n                                </tr>\n                                <tr>\n                                    <td>May 2021</td>\n                                    <td>239</td>\n                                </tr>\n                                <tr>\n                                    <td>June 2021</td>\n                                    <td>172</td>\n                                </tr>\n                                <tr>\n                                    <td>July 2021</td>\n                                    <td>131</td>\n                                </tr>\n                                <tr>\n                                    <td>August 2021</td>\n                                    <td>160</td>\n                                </tr>\n                                <tr>\n                                    <td>September 2021</td>\n                                    <td>205</td>\n                                </tr>\n                                <tr>\n                                    <td>October 2021</td>\n                                    <td>250</td>\n                                </tr>\n                                <tr>\n                                    <td>November 2021</td>\n                                    <td>227</td>\n                                </tr>\n                                <tr>\n                                    <td>December 2021</td>\n                                    <td>183</td>\n                                </tr>\n                                <tr>\n                                    <td>January 2022</td>\n                                    <td>202</td>\n                                </tr>\n                                <tr>\n                                    <td>February 2022</td>\n                                    <td>247</td>\n                                </tr>\n                                <tr>\n                                    <td>March 2022</td>\n                                    <td>301</td>\n                                </tr>\n                                <tr>\n                                    <td>April 2022</td>\n                                    <td>242</td>\n                                </tr>\n                                <tr>\n                                    <td>May 2022</td>\n                                    <td>240</td>\n                                </tr>\n                                <tr>\n                                    <td>June 2022</td>\n                                    <td>161</td>\n                                </tr>\n                                <tr>\n                                    <td>July 2022</td>\n                                    <td>159</td>\n                                </tr>\n                                <tr>\n                                    <td>August 2022</td>\n                                    <td>292</td>\n                                </tr>\n                                <tr>\n                                    <td>September 2022</td>\n                                    <td>404</td>\n                                </tr>\n                                <tr>\n                                    <td>October 2022</td>\n                                    <td>533</td>\n                                </tr>\n                                <tr>\n                                    <td>November 2022</td>\n                                    <td>300</td>\n                                </tr>\n                                <tr>\n                                    <td>December 2022</td>\n                                    <td>477</td>\n                                </tr>\n                                <tr>\n                                    <td>January 2023</td>\n                                    <td>287</td>\n                                </tr>\n                                <tr>\n                                    <td>February 2023</td>\n                                    <td>191</td>\n                                </tr>\n                                <tr>\n                                    <td>March 2023</td>\n                                    <td>310</td>\n                                </tr>\n                                <tr>\n                                    <td>April 2023</td>\n                                    <td>395</td>\n                                </tr>\n                                <tr>\n                                    <td>May 2023</td>\n                                    <td>248</td>\n                                </tr>\n                                <tr>\n                                    <td>June 2023</td>\n                                    <td>198</td>\n                                </tr>\n                                <tr>\n                                    <td>July 2023</td>\n                                    <td>185</td>\n                                </tr>\n                                <tr>\n                                    <td>August 2023</td>\n                                    <td>213</td>\n                                </tr>\n                                <tr>\n                                    <td>September 2023</td>\n                                    <td>248</td>\n                                </tr>\n                                <tr>\n                                    <td>October 2023</td>\n                                    <td>340</td>\n                                </tr>\n                                <tr>\n                                    <td>November 2023</td>\n                                    <td>311</td>\n                                </tr>\n                                <tr>\n                                    <td>December 2023</td>\n                                    <td>269</td>\n                                </tr>\n                                <tr>\n                                    <td>January 2024</td>\n                                    <td>301</td>\n                                </tr>\n                                <tr>\n                                    <td>February 2024</td>\n                                    <td>353</td>\n                                </tr>\n                                <tr>\n                                    <td>March 2024</td>\n                                    <td>372</td>\n                                </tr>\n                                <tr>\n                                    <td>April 2024</td>\n                                    <td>323</td>\n                                </tr>\n                                <tr>\n                                    <td>May 2024</td>\n                                    <td>341</td>\n                                </tr>\n                                <tr>\n                                    <td>June 2024</td>\n                                    <td>275</td>\n                                </tr>\n                                <tr>\n                                    <td>July 2024</td>\n                                    <td>268</td>\n                                </tr>\n                                <tr>\n                                    <td>August 2024</td>\n                                    <td>218</td>\n                                </tr>\n                                <tr>\n                                    <td>September 2024</td>\n                                    <td>253</td>\n                                </tr>\n                                <tr>\n                                    <td>October 2024</td>\n                                    <td>274</td>\n                                </tr>\n                                <tr>\n                                    <td>November 2024</td>\n                                    <td>312</td>\n                                </tr>\n                                <tr>\n                                    <td>December 2024</td>\n                                    <td>242</td>\n                                </tr>\n                                <tr>\n                                    <td>January 2025</td>\n                                    <td>250</td>\n                                </tr>\n                                <tr>\n                                    <td>February 2025</td>\n                                    <td>296</td>\n                                </tr>\n                                <tr>\n                                    <td>March 2025</td>\n                                    <td>396</td>\n                                </tr>\n                                <tr>\n                                    <td>April 2025</td>\n                                    <td>228</td>\n                                </tr>\n                                <tr>\n                                    <td>May 2025</td>\n                                    <td>228</td>\n                                </tr>\n                                <tr>\n                                    <td>June 2025</td>\n                                    <td>86</td>\n                                </tr>\n                        </tbody>\n                    </table>\n                </div>\n            </div>\n\n<div class=\"artmet-stats-wrap clearfix\">\n        <div class=\"artmet-item artmet-citations\">\n            <div class=\"widget-title-2 artmet-widget-title-2\">Citations</div>\n                <div class=\"artmet-badges-wrap artmet-dimensions\">\n    <div class=\"widget widget-DimensionsBadge widget-instance-ArticleLevelMetrics_DimensionsBadgeDetails\">\n        <span class=\"__dimensions_badge_embed__\" data-doi=\"10.1093/cid/ciy723\" data-legend=\"always\" data-style=\"\" data-hide-zero-citations=\"false\" data-dimensions-badge-installed=\"true\"><a class=\"__dimensions_Link\" href=\"https://badge.dimensions.ai/details/doi/10.1093/cid/ciy723?domain=https://academic.oup.com\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" aria-label=\"? total citations on Dimensions.\" style=\"display: none;\"><div class=\"__dimensions_Badge __dimensions_Badge_style_medium_circle\"><div class=\"__dimensions_Badge_Image\">\n  <svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 600 600\">\n    <defs>\n      <filter id=\"rr15o9-blur\" color-interpolation-filters=\"sRGB\">\n        <feGaussianBlur in=\"SourceGraphic\" stdDeviation=\"40\"></feGaussianBlur>\n      </filter>\n      <mask id=\"rr15o9-shape-mask\">\n        <path fill=\"white\" d=\"M546.5,287.3l-111.8-194c-1.8-3-4.1-5.6-6.7-7.7c-2.2-2.7-5.4-4.3-8.9-4.5c-2.3-0.7-4.7-1-7-1\n          L188.2,80c-9.3,0-18,5-22.6,13.1l-112,193.8c-4.7,8.1-4.7,18,0,26.1l111.9,193.9c4.7,8.1,13.3,13,22.6,13.1l223.9,0.1\n          c9.3,0,17.9-4.8,22.6-12.8l112-193.7l0,0C551.1,305.1,551.2,295.4,546.5,287.3z M516.6,287.4l-41.5,0.1l-26.7-118.2L516.6,287.4z\n           M337.2,106.2l-114.5,36.3l-20.3-36.4L337.2,106.2z M180.7,119l20.1,36.2L112,237.7L180.7,119z M181,481.8l-69.3-120l89.2,84\n          L181,481.8z M203.3,493.8l19.6-35.6l114.6,35.7L203.3,493.8z M408.1,489.3l-152.7-47.5l-32.3-10.6l-25.3-23.2L82.6,299.6\n          l114.6-106.9l25-23.1v-0.2l0.7-0.2l32.4-10.7l153.6-48.7l35.5,156.6l7.5,33.4l-7.6,33.5L408.1,489.3z M447.1,432.9l27.9-120.3\n          l41.7-0.1L447.1,432.9z\"></path>\n      </mask>\n      <g id=\"rr15o9-gradient\" filter=\"url(#rr15o9-blur)\">\n        <g>\n          <path fill=\"#006EB6\" d=\"M0,0l300,300v-424.4C182.9-124.4,76.8-76.9,0,0z\"></path>\n          <path fill=\"#28348A\" d=\"M300-124.4V300L600,0C523.2-76.9,417.1-124.4,300-124.4z\"></path>\n          <path fill=\"#E20613\" d=\"M600,600c76.8-76.8,124.3-182.9,124.3-300H300L600,600z\"></path>\n          <path fill=\"#DA0078\" d=\"M300,300h424.4c0-117.1-47.5-223.2-124.3-300L300,300z\"></path>\n          <path fill=\"#5BC4F1\" d=\"M-124.4,300H300L0,0C-76.9,76.8-124.4,182.9-124.4,300z\"></path>\n          <path fill=\"#A1C517\" d=\"M0,600l300-300h-424.4C-124.4,417.1-76.9,523.2,0,600z\"></path>\n          <path fill=\"#F08800\" d=\"M300,724.4c117.1,0,223.2-47.5,300-124.3L300,300V724.4z\"></path>\n          <path fill=\"#FFCB00\" d=\"M300,724.4V300L0,600C76.8,676.9,182.9,724.4,300,724.4z\"></path>\n        </g>\n      </g>\n    </defs>\n  </svg>\n\n  <div class=\"__db_background\"></div>\n\n  <div class=\"__db_shape\">\n    <svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 600 600\" xmlns:xlink=\"http://www.w3.org/1999/xlink\">\n      <use mask=\"url(#rr15o9-shape-mask)\" xlink:href=\"#rr15o9-gradient\"></use>\n    </svg>\n  </div>\n\n  <div class=\"__db_score __db_score_normal\">?</div>\n  <div class=\"__db_label\">CITATIONS</div>\n\n  <img src=\"https://badge.dimensions.ai/badge?count=?\" class=\"__dimensions_png\" alt=\"? total citations on Dimensions.\">\n</div>\n</div><div class=\"__dimensions_Badge_Legend_padding __dimensions_Badge_Legend_hover-right  __dimensions_Badge_Legend_style_medium_circle __dimensions_Badge_Legend_always\"><div class=\"__dimensions_Badge_Legend\">\n      <div class=\"__dimensions_Badge_stat_group __dimensions_Badge_stat_group_citations\">\n        <div class=\"__dimensions_Badge_stat __dimensions_Badge_stat_total_citations\">\n          <span class=\"__dimensions_Badge_stat_icon\"></span>\n          <span class=\"__dimensions_Badge_stat_count\">?</span>\n          <span class=\"__dimensions_Badge_stat_text\">Total citations</span>\n        </div>\n        <div class=\"__dimensions_Badge_stat __dimensions_Badge_stat_recent_citations\">\n          <span class=\"__dimensions_Badge_stat_icon\"></span>\n          <span class=\"__dimensions_Badge_stat_count\">?</span>\n          <span class=\"__dimensions_Badge_stat_text\">Recent citations</span>\n        </div>\n      </div>\n      <div class=\"__dimensions_Badge_stat_group __dimensions_Badge_stat_group_cr\">\n        <div class=\"__dimensions_Badge_stat __dimensions_Badge_stat_fcr\">\n          <span class=\"__dimensions_Badge_stat_icon\"></span>\n          <span class=\"__dimensions_Badge_stat_count\">n/a</span>\n          <span class=\"__dimensions_Badge_stat_text\">Field Citation Ratio</span>\n        </div>\n        <div class=\"__dimensions_Badge_stat __dimensions_Badge_stat_rcr\">\n          <span class=\"__dimensions_Badge_stat_icon\"></span>\n          <span class=\"__dimensions_Badge_stat_count\">n/a</span>\n          <span class=\"__dimensions_Badge_stat_text\">Relative Citation Ratio</span>\n        </div>\n      </div></div></div></a></span>\n<script async=\"\" src=\"https://badge.dimensions.ai/badge.js\" charset=\"utf-8\"></script>\n \n    </div>\n\n                    <span class=\"artmet-dimensions-text\">Powered by Dimensions</span>\n                </div>\n                                <div class=\"artmet-wos\">\n                        <span class=\"artmet-number\">\n                                <a href=\"https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=silverchair&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000482136200011&amp;DestLinkType=CitingArticles&amp;DestApp=WOS_CPL\" target=\"\" rel=\"nofollow\" data-google-interstitial=\"false\">137</a>\n                        </span>\n                        <span class=\"artmet-text\">Web of Science</span>\n                    </div>\n        </div>\n\n\n        <div class=\"artmet-item artmet-altmetric artmet-position-right js-show-if-unknown\">\n            <div class=\"widget-title-2 artmet-widget-title-2\">Altmetrics</div>\n            <div class=\"artmet-badges-wrap js-artmet-badges\">\n\n    <div class=\"widget widget-AltmetricLink widget-instance-ArticleLevelMetrics_AltmetricLinkDetails\">\n            <!-- Altmetrics -->\n    <div id=\"altmetricEmbedId\" runat=\"server\" class=\"altmetric-embed\" data-badge-type=\"donut\" data-hide-no-mentions=\"false\" data-doi=\"10.1093/cid/ciy723\" data-badge-details=\"right\" data-uuid=\"9c51f920-9bb1-29d5-4e9c-758833cb9263\"><div style=\"overflow:hidden;\">\n    <div class=\"altmetric-normal-legend\">\n        <a target=\"_self\" href=\"https://www.altmetric.com/details.php?domain=academic.oup.com&amp;citation_id=47565307\" style=\"display:inline-block;\">\n                <img alt=\"Article has an altmetric score of 5\" src=\"https://badges.altmetric.com/?size=128&amp;score=5&amp;types=tttttttt\" width=\"64\" height=\"64\" style=\"border:0; margin:0; max-width: none;\">\n        </a>\n        <p class=\"altmetric-see-more-details\" style=\"padding-top: 10px; text-align: center;\"><a target=\"_self\" href=\"https://www.altmetric.com/details.php?domain=academic.oup.com&amp;citation_id=47565307\">See more details</a></p>\n    </div>\n    <div id=\"_altmetric_popover_el_9c51f920-9bb1-29d5-4e9c-758833cb9263\" class=\"altmetric-embed right\" style=\"margin:0; padding:0; display:inline-block; float:left; position:relative;\">\n        <div class=\"altmetric_container\">\n            <div class=\"altmetric-embed altmetric-popover-inner right\">\n                <div style=\"padding:0; margin: 0;\" class=\"altmetric-embed altmetric-popover-content\">\n                        <div style=\"padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;\">\n      <a class=\"link-to-altmetric-details-tab\" target=\"_self\" href=\"https://www.altmetric.com/details.php?domain=academic.oup.com&amp;citation_id=47565307&amp;tab=twitter\">\n          Posted by <b>7</b> X users\n      </a>\n    </div>\n\n    <div class=\"altmetric-embed readers\" style=\"margin-top: 10px;\">\n          <div class=\"altmetric-embed tip_mendeley\" style=\"padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;\">\n              <b>346</b> readers on Mendeley\n          </div>\n    </div>\n\n                </div>\n            </div>\n        </div>\n    </div>\n</div></div>\n         <script type=\"text/javascript\" src=\"https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js\"></script>\n \n    </div>\n            </div>\n        </div>\n\n</div>\n\n\n    </div>\n                        <a href=\"javascript:;\" role=\"button\" class=\"artmet-close-modal js-artmet-close-modal\" aria-label=\"Close metrics modal\" data-google-interstitial=\"false\">\n                            <span aria-hidden=\"true\">×</span>\n                            <span class=\"screenreader-text\">Close Modal</span>\n                        </a>\n                    </div>\n                </div>\n        </div>\n\n \n    </div>\n    <div class=\"widget widget-OUPEmailAlerts widget-instance-Article_RightRailB0Article_RightRail_OUPEmailAlerts\">\n        \n    <div class=\"alertsWidget js-alerts-widget\">\n        <h3>Email alerts</h3>\n            <div class=\"userAlert alertType-LatestIssue\">\n                        <a href=\"/cid/new-journals-alert\" class=\"js-my-email-alert email-alert-link\" data-google-interstitial=\"false\">\n                            New journal issues\n                        </a>\n            </div>\n            <div class=\"userAlert alertType-NewJournalArticles\">\n                        <a href=\"/cid/new-journal-articles-alert\" class=\"js-my-email-alert email-alert-link\" data-google-interstitial=\"false\">\n                            New journal articles\n                        </a>\n            </div>\n            <div class=\"userAlert alertType-ContentActivity\">\n                        <button type=\"button\" class=\"js-activity-alert-button email-alert-link\" data-user-logged-in=\"False\" data-alert-type=\"ContentActivity\" data-is-content-page=\"True\" data-alert-signup-link=\"\" data-resourceid=\"5078600\" data-resourcetypeid=\"Article\" data-reveal-id=\"activityAlertModal\" aria-expanded=\"false\">\n                            Activity related to this article\n                        </button>\n            </div>\n\n        <div class=\"userAlert alertType-MarketingLink\">\n            <a href=\"/my-account/communication-preferences\" data-google-interstitial=\"false\">Sign up for marketing</a>\n        </div>\n    </div>\n\n    <div id=\"journalIssuesAlertModal\" class=\"alert-resources-modal fix-width reveal-modal js-content-alert-modal\" role=\"dialog\" aria-modal=\"true\" aria-labelledby=\"journalsIssuesAlertModalTitle\" data-reveal=\"\">\n    <div class=\"widget widget-JournalsIssuesAlert widget-instance-JournalIssuesAlert\">\n        <div class=\"alerts-sign-up-wrapper js-journals-alerts-sign-up-wrapper page-column\">\n    <div class=\"modal-head border-bottom\">\n        <h2 id=\"journalsIssuesAlertModalTitle\">New journal issues alert</h2>\n    </div>\n\n        <div class=\"modal-body\">\n            <div class=\"alert-loginbox-wrapper\">\n    <div class=\"widget widget-LoginBoxOnlyUser widget-instance-OUP_IssuesAlert\">\n            <div class=\"error-message\"><p>To set up an email alert, please <a class=\"js-sign-in-link\" data-linktype=\"user-pass\" href=\"javascript:;\" data-google-interstitial=\"false\">sign in</a> to your personal account, or <a class=\"js-register-link\" href=\"https://academic.oup.com/my-account/register?siteId=5269&amp;returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\" data-google-interstitial=\"false\">register</a></p></div>\n\n<div class=\"login-box\" data-google-interstitial=\"false\">\n    <div class=\"login-box__main-section-wrap\">\n        <div class=\"login-box__section-wrap login-box_heading\">\n            <div class=\"login-box__main-heading-wrap\">\n               <h2>Sign in</h2>\n               \n            </div>\n        </div>\n\n        <div class=\"login-box__section-wrap cols login-box_sign-in-accounts\">\n    <div class=\"login-box__section column-border login-box_personal-account\">\n            <h3 class=\"login-box__heading\">Personal account</h3>\n\n    <ul class=\"bullets\">\n        <li>Sign in with email/username &amp; password</li>\n        <li>Get email alerts</li>\n        <li>Save searches</li>\n        <li>Purchase content</li>\n        <li>Activate your purchase/trial code</li>\n            <li>Add your ORCID iD</li>\n    </ul>\n\n            <div class=\"login-box__button-row\">\n                    <a rel=\"nofollow\" class=\"button-call-to-action at-personal-sign-in js-sign-in-link\" data-linktype=\"user-pass\" href=\"javascript:;\" data-google-interstitial=\"false\">\n                    <span>Sign in</span>\n                    <img class=\"society-link-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/chevron-right-white.svg\" alt=\"Arrow\" aria-hidden=\"true\">\n\n                </a>\n                                    <a rel=\"nofollow\" class=\"at-personal-register-link js-register-link\" href=\"/my-account/register?siteId=5269&amp;returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\" data-google-interstitial=\"false\">Register</a>\n            </div>\n    </div>\n\n        </div>\n    </div>\n</div>\n \n    </div>\n\n            </div>\n        </div>\n</div> \n    </div>\n\n\n        <button type=\"button\" class=\"close-reveal-modal js-close-reveal-modal\"><i class=\"icon-general-close\" alt=\"Close modal\"></i></button>\n    </div>\n\n    <div id=\"activityAlertModal\" role=\"dialog\" aria-modal=\"true\" class=\"alert-resources-modal fix-width reveal-modal js-content-alert-modal js-activity-modal\" data-reveal=\"\">\n        <div class=\"js-activity-alert-widget\">\n    <div class=\"widget widget-ActivityAlert widget-instance-Article_RightRailB0Article_RightRail_OUPEmailAlerts\">\n        <div class=\"alerts-sign-up-wrapper js-activity-alert-wrapper\">\n    <div class=\"modal-head border-bottom\">\n        <h2 aria-labelledby=\"activityAlertModal\">Journal article activity alert</h2>\n    </div>\n\n        <div class=\"modal-body alert-loginbox-modal-wrapper\">\n            <div class=\"alert-loginbox-wrapper\">\n    <div class=\"widget widget-LoginBoxOnlyUser widget-instance-OUP_IssuesAlert\">\n            <div class=\"error-message\"><p>To set up an email alert, please <a class=\"js-sign-in-link\" data-linktype=\"user-pass\" href=\"javascript:;\" data-google-interstitial=\"false\">sign in</a> to your personal account, or <a class=\"js-register-link\" href=\"https://academic.oup.com/my-account/register?siteId=5269&amp;returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\" data-google-interstitial=\"false\">register</a></p></div>\n\n<div class=\"login-box\" data-google-interstitial=\"false\">\n    <div class=\"login-box__main-section-wrap\">\n        <div class=\"login-box__section-wrap login-box_heading\">\n            <div class=\"login-box__main-heading-wrap\">\n               <h2>Sign in</h2>\n               \n            </div>\n        </div>\n\n        <div class=\"login-box__section-wrap cols login-box_sign-in-accounts\">\n    <div class=\"login-box__section column-border login-box_personal-account\">\n            <h3 class=\"login-box__heading\">Personal account</h3>\n\n    <ul class=\"bullets\">\n        <li>Sign in with email/username &amp; password</li>\n        <li>Get email alerts</li>\n        <li>Save searches</li>\n        <li>Purchase content</li>\n        <li>Activate your purchase/trial code</li>\n            <li>Add your ORCID iD</li>\n    </ul>\n\n            <div class=\"login-box__button-row\">\n                    <a rel=\"nofollow\" class=\"button-call-to-action at-personal-sign-in js-sign-in-link\" data-linktype=\"user-pass\" href=\"javascript:;\" data-google-interstitial=\"false\">\n                    <span>Sign in</span>\n                    <img class=\"society-link-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/chevron-right-white.svg\" alt=\"Arrow\" aria-hidden=\"true\">\n\n                </a>\n                                    <a rel=\"nofollow\" class=\"at-personal-register-link js-register-link\" href=\"/my-account/register?siteId=5269&amp;returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\" data-google-interstitial=\"false\">Register</a>\n            </div>\n    </div>\n\n        </div>\n    </div>\n</div>\n \n    </div>\n\n            </div>\n        </div>\n</div>\n \n    </div>\n\n        </div>\n        <button type=\"button\" class=\"close-reveal-modal js-close-reveal-modal\"><i class=\"icon-general-close\" alt=\"Close modal\"></i><span class=\"screenreader-text\">Close Modal</span></button>\n    </div>\n \n    </div>\n    <div class=\"widget widget-RelatedContent widget-instance-Article_RightRailB0Article_RightRail_RelatedContent\">\n                <h3 class=\"article-widget-head\">More on this topic</h3>\n    <div class=\"widget-related-content at-related-content\">\n            <div class=\"article-title\"><a href=\"/cid/article/50/2/202/328880\">Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods</a></div>\n            <div class=\"article-title\"><a href=\"/cid/article/12/Supplement_8/S915/296667\">Microbial Agents Associated with Pneumonia in Children from Uruguay</a></div>\n            <div class=\"article-title\"><a href=\"/cid/article/59/9/iii/419445\">In the Literature</a></div>\n            <div class=\"article-title\"><a href=\"/cid/advance-article/7985365\">Comparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study</a></div>\n    </div>\n \n    </div>\n    <div class=\"widget widget-RelatedPubMed widget-instance-Article_RightRailB0Article_RightRail_RelatedPubMed\">\n        <h3 class=\"article-widget-head\">Related articles in PubMed</h3>\n<div class=\"widget-related-pubmed\">\n        <div class=\"inner-content-wrap\">\n            <div class=\"inner-content\">\n                <div class=\"article-title\">    <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/40410780\" id=\"article_ArticleTitle\" target=\"\" data-google-interstitial=\"false\">High-dose third-generation EGFR-TKIs combined with intrathecal pemetrexed in advanced EGFR-mutant NSCLC with leptomeningeal metastases following EGFR-TKI therapy.</a></div>\n                <!-- <div class=\"citation\"><span>BMC Cancer</span> 2025;25(1):926.</div> -->\n            </div>\n        </div>\n        <div class=\"inner-content-wrap\">\n            <div class=\"inner-content\">\n                <div class=\"article-title\">    <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/40410758\" id=\"article_ArticleTitle\" target=\"\" data-google-interstitial=\"false\">Quality and reliability of pediatric pneumonia related short videos on mainstream platforms: cross-sectional study.</a></div>\n                <!-- <div class=\"citation\"><span>BMC Public Health</span> 2025;25(1):1896.</div> -->\n            </div>\n        </div>\n        <div class=\"inner-content-wrap\">\n            <div class=\"inner-content\">\n                <div class=\"article-title\">    <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/40410755\" id=\"article_ArticleTitle\" target=\"\" data-google-interstitial=\"false\">A case of hospital-acquired pneumonia associated with Chryseobacterium indologenes infection in a patient with HIV infection and review of the literature.</a></div>\n                <!-- <div class=\"citation\"><span>AIDS Res Ther</span> 2025;22(1):53.</div> -->\n            </div>\n        </div>\n        <div class=\"inner-content-wrap\">\n            <div class=\"inner-content\">\n                <div class=\"article-title\">    <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/40410748\" id=\"article_ArticleTitle\" target=\"\" data-google-interstitial=\"false\">Health inequities: a persistent global challenge from past to future.</a></div>\n                <!-- <div class=\"citation\"><span>Int J Equity Health</span> 2025;24(1):148.</div> -->\n            </div>\n        </div>\n</div>\n<!-- <div class=\"article-widget-foot\">\n    <div class=\"view-more\">\n            <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?term=((community+AND+acquired+AND+pneumonia)+OR+(immunocompromised+AND+host)+OR+(pneumonia)+OR+(pathogenic+AND+organism))\" id=\"Config_ViewMoreLink\" class=\"view-more-link\" target=\"_blank\">View More</a>\n    </div>\n</div> -->\n \n    </div>\n    <div class=\"widget widget-ArticleCitedBy widget-instance-Article_RightRailB0Article_RightRail_ArticleCitedBy\">\n        <div class=\"rail-widget_wrap vt-articles-cited-by\">\n    <h3 class=\"article-cited-title\">Citing articles via</h3>\n    <div class=\"widget-links_wrap\">\n            <div class=\"article-cited-link-wrap web-of-science\">\n                <a href=\"https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=silverchair&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000482136200011&amp;DestLinkType=CitingArticles&amp;DestApp=WOS_CPL\" target=\"\" rel=\"nofollow\" data-google-interstitial=\"false\">Web of Science (137)</a>\n            </div>\n                    <div class=\"article-cited-link-wrap google-scholar-url\">\n                <a href=\"http://scholar.google.com/scholar?q=link:https%3A%2F%2Facademic.oup.com%2Fcid%2Farticle%2F68%2F9%2F1482%2F5078600\" target=\"\" rel=\"nofollow\" data-google-interstitial=\"false\">Google Scholar</a>\n            </div>\n            </div>\n</div> \n    </div>\n    <div class=\"widget widget-ArticleListNewAndPopular widget-instance-Article_RightRailB0Article_RightRail_ArticleNewPopularCombined\">\n            <ul class=\"articleListNewAndPopularCombinedView\">\n            <li>\n                <h3>\n                    <a href=\"javascript:;\" class=\"articleListNewAndPopular-mode active\" data-mode=\"MostRecent\" data-google-interstitial=\"false\">Latest</a>\n                </h3>\n            </li>\n            <li>\n                <h3>\n                    <a href=\"javascript:;\" class=\"articleListNewAndPopular-mode \" data-mode=\"MostRead\" data-google-interstitial=\"false\">Most Read</a>\n                </h3>\n            </li>\n            <li>\n                <h3>\n                    <a href=\"javascript:;\" class=\"articleListNewAndPopular-mode \" data-mode=\"MostCited\" data-google-interstitial=\"false\">Most Cited</a>\n                </h3>\n            </li>\n    </ul>\n        <section class=\"articleListNewPopContent articleListNewAndPopular-ContentView-MostRecent hasContent\">\n\n\n\n\n<div id=\"newPopularList-Article_RightRailB0Article_RightRail_ArticleNewPopularCombined\" class=\"fb\">\n\n    \n\n\n\n<div class=\"widget-layout widget-layout--vert \">\n            <div class=\"widget-columns widget-col-1\">\n                    <div class=\"col\">\n\n<div class=\"widget-dynamic-entry journalArticleItem at-widget-entry-SCL\">\n    <span class=\"hfDoi\" data-attribute=\"10.1093/cid/ciaf302\" aria-hidden=\"true\"></span>\n\n\n    \n\n\n<a class=\"journal-link\" href=\"/cid/advance-article/doi/10.1093/cid/ciaf302/8159933?searchresult=1\">\n        <div class=\"widget-dynamic-journal-title\">\nEffectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial Study    </div>\n</a>\n\n\n\n\n\n\n\n\n<div class=\"widget-dynamic-journal-image-synopsis\">\n        <div class=\"widget-dynamic-journal-synopsis\">\n            \n        </div>\n</div>\n\n</div>\n<div class=\"widget-dynamic-entry journalArticleItem at-widget-entry-SCL\">\n    <span class=\"hfDoi\" data-attribute=\"10.1093/cid/ciaf311\" aria-hidden=\"true\"></span>\n\n\n    \n\n\n<a class=\"journal-link\" href=\"/cid/advance-article/doi/10.1093/cid/ciaf311/8159932?searchresult=1\">\n        <div class=\"widget-dynamic-journal-title\">\nCharacteristics Associated with Disseminated Gonococcal Infections vs Uncomplicated Gonorrhea: A California Case-Control Study, 2021-2022    </div>\n</a>\n\n\n\n\n\n\n\n\n<div class=\"widget-dynamic-journal-image-synopsis\">\n        <div class=\"widget-dynamic-journal-synopsis\">\n            \n        </div>\n</div>\n\n</div>\n<div class=\"widget-dynamic-entry journalArticleItem at-widget-entry-SCL\">\n    <span class=\"hfDoi\" data-attribute=\"10.1093/cid/ciaf304\" aria-hidden=\"true\"></span>\n\n\n    \n\n\n<a class=\"journal-link\" href=\"/cid/advance-article/doi/10.1093/cid/ciaf304/8157607?searchresult=1\">\n        <div class=\"widget-dynamic-journal-title\">\nNon-Operative versus Neurosurgical Treatment of Brain Abscess: An Emulated Trial Nested within a Nationwide, Population-Based Cohort    </div>\n</a>\n\n\n\n\n\n\n\n\n<div class=\"widget-dynamic-journal-image-synopsis\">\n        <div class=\"widget-dynamic-journal-synopsis\">\n            \n        </div>\n</div>\n\n</div>\n<div class=\"widget-dynamic-entry journalArticleItem at-widget-entry-SCL\">\n    <span class=\"hfDoi\" data-attribute=\"10.1093/cid/ciaf300\" aria-hidden=\"true\"></span>\n\n\n    \n\n\n<a class=\"journal-link\" href=\"/cid/advance-article/doi/10.1093/cid/ciaf300/8157063?searchresult=1\">\n        <div class=\"widget-dynamic-journal-title\">\nIncidence of AIDS-defining Conditions among Adults with Perinatally Acquired HIV after Transition to Adult HIV Care in the United States and Canada, 2000-2022    </div>\n</a>\n\n\n\n\n\n\n\n\n<div class=\"widget-dynamic-journal-image-synopsis\">\n        <div class=\"widget-dynamic-journal-synopsis\">\n            \n        </div>\n</div>\n\n</div>\n<div class=\"widget-dynamic-entry journalArticleItem at-widget-entry-SCL\">\n    <span class=\"hfDoi\" data-attribute=\"10.1093/cid/ciaf009\" aria-hidden=\"true\"></span>\n\n\n    \n\n\n<a class=\"journal-link\" href=\"/cid/article/80/5/e65/8156727?searchresult=1\">\n        <div class=\"widget-dynamic-journal-title\">\nState-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists    </div>\n</a>\n\n\n\n\n\n\n\n\n<div class=\"widget-dynamic-journal-image-synopsis\">\n        <div class=\"widget-dynamic-journal-synopsis\">\n            \n        </div>\n</div>\n\n</div>\n                    </div>\n            </div>\n\n</div></div>\n        </section>\n        <section class=\"articleListNewPopContent articleListNewAndPopular-ContentView-MostRead hide\">\n        </section>\n        <section class=\"articleListNewPopContent articleListNewAndPopular-ContentView-MostCited hide\">\n        </section>\n \n    </div>\n    <div class=\"widget widget-RelatedTaxonomies widget-instance-Article_RightRailB0Article_RightRail_RelatedTaxonomies\">\n            <div class=\"widget-related-taxonomies-wrap vt-related-taxonomies\">\n        <div class=\"widget-related-taxonomies_title\">More from Oxford Academic</div>\n            <div class=\"widget-related-taxonomies\">\n                <a id=\"more-from-oa-AcademicSubjects_MED00160\" class=\"related-taxonomies-link\" href=\"/search-results?tax=AcademicSubjects/MED00160\" data-google-interstitial=\"false\">Clinical Medicine</a>\n            </div>\n            <div class=\"widget-related-taxonomies\">\n                <a id=\"more-from-oa-AcademicSubjects_MED00290\" class=\"related-taxonomies-link\" href=\"/search-results?tax=AcademicSubjects/MED00290\" data-google-interstitial=\"false\">Infectious Diseases</a>\n            </div>\n            <div class=\"widget-related-taxonomies\">\n                <a id=\"more-from-oa-AcademicSubjects_MED00010\" class=\"related-taxonomies-link\" href=\"/search-results?tax=AcademicSubjects/MED00010\" data-google-interstitial=\"false\">Medicine and Health</a>\n            </div>\n\n            <div class=\"widget-related-taxonomies\">\n                <a id=\"more-from-oa-format-Books\" class=\"related-taxonomies-link\" href=\"/books\" data-google-interstitial=\"false\">Books</a>\n            </div>\n            <div class=\"widget-related-taxonomies\">\n                <a id=\"more-from-oa-format-Journals\" class=\"related-taxonomies-link\" href=\"/journals\" data-google-interstitial=\"false\">Journals</a>\n            </div>\n    </div>\n \n    </div>\n    <div class=\"widget widget-JobTarget widget-instance-Article_RightRailB0Article_RightRail_JobTarget\">\n        <div class=\"wrapper\">\n    <div class=\"header\">\n        <h3>\n            <a href=\"http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/\" data-google-interstitial=\"false\">Looking for your next opportunity?</a>\n        </h3>\n    </div>\n\n        <div class=\"network-or-parsing-error\">\n            Having trouble contacting the network. Please try again in a moment or two.\n        </div>\n\n    <div class=\"sponsor-and-jobnetwork-links\">\n        <div class=\"job-sponsor\"><a href=\"http://global.oup.com/\" data-google-interstitial=\"false\"><img src=\"https://oup.silverchair-cdn.com/data/Multimedia/oup-logo.svg\" alt=\"Oxford University Press\"></a></div>\n        <div class=\"job-network\"><a href=\"http://globaljobs-careernetwork.oxfordjournals.org/home/index.cfm?site_id=20101\" data-google-interstitial=\"false\"><img src=\"https://oup.silverchair-cdn.com/data/Multimedia/journals-careers-network.svg\" alt=\"Journals Career Network\"></a></div>\n    </div>\n</div>\n \n    </div>\n\n    </div>\n\n</div>\n    </div>\n\n</div>    <div class=\"widget widget-AdBlock widget-instance-ArticlePageTopMainBodyBottom\">\n        <div class=\"js-adBlock-parent-wrap adblock-parent-wrap\">\n    <div class=\"adBlockMainBodyBottom-wrap js-adBlockMainBodyBottom hide\">\n        <div id=\"adBlockMainBodyBottom\" class=\"js-adblock at-adblock js-adblock-lazy-loading\" data-lazy-load-margin=\"150\">\n            <script>\n                googletag.cmd.push(function () {\n                    googletag.display('adBlockMainBodyBottom');\n                });\n            </script>\n        </div>\n            <div class=\"advertisement-text at-adblock js-adblock-advertisement-text hide\">Advertisement</div>\n            </div>\n</div> \n    </div>\n\n</div>\n\n</div>\n<input id=\"hfArticleTitle\" name=\"hfArticleTitle\" type=\"hidden\" value=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients | Clinical Infectious Diseases | Oxford Academic\">\n<input id=\"hfLeftNavStickyOffset\" name=\"hfLeftNavStickyOffset\" type=\"hidden\" value=\"29\">\n\n\n\n                </div><!-- /.center-inner-row no-overflow -->\n            </section>\n    </div>\n\n        <div class=\"mobile-mask\">\n        </div>\n\n        <section class=\"footer_wrap vt-site-footer\">\n            \n\n\n    <div class=\"ad-banner-footer sticky-footer-ad js-sticky-footer-ad\">\n    <div class=\"widget widget-AdBlock widget-instance-StickyFooterAd\">\n        <div class=\"js-adBlock-parent-wrap adblock-parent-wrap\">\n    <div class=\"adBlockStickyFooter-wrap js-adBlockStickyFooter hide\">\n        <div id=\"adBlockStickyFooter\" class=\"js-adblock at-adblock\" data-lazy-load-margin=\"150\">\n            <script>\n                googletag.cmd.push(function () {\n                    googletag.display('adBlockStickyFooter');\n                });\n            </script>\n        </div>\n            <div class=\"advertisement-text at-adblock js-adblock-advertisement-text hide\">Advertisement</div>\n                    <button type=\"button\" class=\"close-footer-ad js-close-footer-ad\">\n                <span class=\"screenreader-text\">close advertisement</span>\n            </button>\n    </div>\n</div> \n    </div>\n\n    </div>\n\n    <div class=\"widget widget-SitePageFooter widget-instance-SitePageFooter\">\n            <div class=\"ad-banner ad-banner-footer\">\n    <div class=\"widget widget-AdBlock widget-instance-FooterAd\">\n        <div class=\"js-adBlock-parent-wrap adblock-parent-wrap\">\n    <div class=\"adBlockFooter-wrap js-adBlockFooter hide\">\n        <div id=\"adBlockFooter\" class=\"js-adblock at-adblock js-adblock-lazy-loading\" data-lazy-load-margin=\"150\">\n            <script>\n                googletag.cmd.push(function () {\n                    googletag.display('adBlockFooter');\n                });\n            </script>\n        </div>\n            <div class=\"advertisement-text at-adblock js-adblock-advertisement-text hide\">Advertisement</div>\n            </div>\n</div> \n    </div>\n\n    </div>\n\n<div class=\"journal-footer journal-bg\">\n    <div class=\"center-inner-row\">\n\n<div class=\"journal-footer-menu\">\n\n    <ul>\n<li class=\"link-1\">\n    <a href=\"/cid/pages/About\">About Clinical Infectious Diseases</a>\n</li> <li class=\"link-2\">\n    <a href=\"/cid/pages/Editorial_Board\">Editorial Board</a>\n</li> <li class=\"link-3\">\n    <a href=\"/cid/pages/General_Instructions\">Author Guidelines</a>\n</li> <li class=\"link-4\">\n    <a href=\"https://www.facebook.com/#!/IDSociety/\" data-google-interstitial=\"false\">Facebook</a>\n</li> <li class=\"link-5\">\n    <a href=\"https://twitter.com/IDSAInfo\" data-google-interstitial=\"false\">X (formerly Twitter)</a>\n</li> </ul><ul><li class=\"link-1\">\n    <a href=\"https://bsky.app/profile/idsainfo.bsky.social\" data-google-interstitial=\"false\">Bluesky</a>\n</li> <li class=\"link-2\">\n    <a href=\"/cid/subscribe\" data-google-interstitial=\"false\">Purchase</a>\n</li> <li class=\"link-3\">\n    <a href=\"http://www.oxfordjournals.org/en/library-recommendation-form.html\" data-google-interstitial=\"false\">Recommend to your Library</a>\n</li> <li class=\"link-4\">\n    <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\" data-google-interstitial=\"false\">Advertising and Corporate Services</a>\n</li> <li class=\"link-5\">\n    <a href=\"http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;search=&amp;t732=469972&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102\" data-google-interstitial=\"false\">Journals Career Network</a>\n</li> \n    </ul>\n\n\n</div><!-- /.journal-footer-menu -->\n        <div class=\"journal-footer-affiliations\">\n            <!-- <h3>Affiliations</h3> -->\n<a href=\"https://academic.oup.com/cid\" target=\"\">\n    <img id=\"footer-logo-ClinicalInfectiousDiseases\" class=\"journal-footer-affiliations-logo\" src=\"//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_f1483155260.svg\" alt=\"Clinical Infectious Diseases\">\n</a>                        </div><!-- /.journal-footer-affiliations -->\n\n        <div class=\"journal-footer-colophon\">\n            <ul>\n<li>Online ISSN 1537-6591</li>                <li>Print ISSN 1058-4838</li>                <li>Copyright © 2025 Infectious Diseases Society of America</li>\n            </ul>\n        </div><!-- /.journal-footer-colophon -->\n\n\n    </div><!-- /.center-inner-row -->\n</div><!-- /.journal-footer --> \n    </div>\n\n    <div class=\"oup-footer\">\n        <div class=\"center-inner-row\">\n    <div class=\"widget widget-SelfServeContent widget-instance-OupUmbrellaFooterSelfServe\">\n        \n\n\n\n    <input type=\"hidden\" class=\"SelfServeContentId\" value=\"GlobalFooter_Links\">\n    <input type=\"hidden\" class=\"SelfServeVersionId\" value=\"0\">\n\n<div class=\"oup-footer-row journal-links\">\n<div class=\"global-footer selfservelinks\">\n<ul>\n    <li><a href=\"/pages/about-oxford-academic\" data-google-interstitial=\"false\">About Oxford Academic</a></li>\n    <li><a href=\"/pages/about-oxford-academic/publish-journals-with-us\" data-google-interstitial=\"false\">Publish journals with us</a></li>\n    <li><a href=\"/pages/about-oxford-academic/our-university-press-partners\" data-google-interstitial=\"false\">University press partners</a></li>\n    <li><a href=\"/pages/what-we-publish\" data-google-interstitial=\"false\">What we publish</a></li>\n    <li><a href=\"/pages/new-features\" data-google-interstitial=\"false\">New features</a>&nbsp;</li>\n</ul>\n</div>\n<div class=\"global-footer selfservelinks\">\n<ul>\n    <li><a href=\"/pages/for-authors\" data-google-interstitial=\"false\">For authors</a></li>\n    <li><a href=\"/pages/open-research/open-access\" data-google-interstitial=\"false\">Open access</a></li>\n    <li><a href=\"/pages/purchasing\" data-google-interstitial=\"false\">Purchasing</a></li>\n    <li><a href=\"/pages/institutional-account-management\" data-google-interstitial=\"false\">Institutional account management</a></li>\n    <li><a href=\"https://academic.oup.com/pages/purchasing/rights-and-permissions\" data-google-interstitial=\"false\">Rights and permissions</a></li>\n</ul>\n</div>\n<div class=\"global-footer selfservelinks\">\n<ul>\n    <li><a href=\"/pages/get-help-with-access\" data-google-interstitial=\"false\">Get help with access</a></li>\n    <li><a href=\"/pages/about-oxford-academic/accessibility\" data-google-interstitial=\"false\">Accessibility</a></li>\n    <li><a href=\"/pages/contact-us\" data-google-interstitial=\"false\">Contact us</a></li>\n    <li><a href=\"/pages/advertising\" data-google-interstitial=\"false\">Advertising</a></li>\n    <li><a href=\"/pages/media-enquiries\" data-google-interstitial=\"false\">Media enquiries</a></li>\n</ul>\n</div>\n<div class=\"global-footer selfservelinks global-footer-external\">\n<ul>\n    <li><a href=\"https://global.oup.com/\" data-google-interstitial=\"false\">Oxford University Press</a></li>\n    <li><a href=\"https://corp.oup.com/press-office\" data-google-interstitial=\"false\">News</a></li>\n    <li><a href=\"https://languages.oup.com/\" data-google-interstitial=\"false\">Oxford Languages</a></li>\n    <li><a href=\"https://www.ox.ac.uk/\" data-google-interstitial=\"false\">University of Oxford</a></li>\n</ul>\n</div>\n<div class=\"OUP-mission\">\n<p>Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide</p>\n<img class=\"journal-footer-logo\" src=\"//oup.silverchair-cdn.com/UI/app/svg/umbrella/oup-logo.svg\" alt=\"Oxford University Press\" width=\"300\" height=\"69\">\n</div>\n</div>\n<div class=\"oup-footer-row\">\n<div class=\"oup-footer-row-links\">\n<ul>\n    <li>Copyright © 2025 Oxford University Press</li>\n    <li><button id=\"Change-Preferences\" type=\"button\" onclick=\"window.top.document.dispatchEvent(new Event('changeConsent'))\">Cookie settings</button></li>\n    <li><a href=\"https://global.oup.com/cookiepolicy\" data-google-interstitial=\"false\">Cookie policy</a></li>\n    <li><a href=\"https://global.oup.com/privacy\" data-google-interstitial=\"false\">Privacy policy</a></li>\n    <li><a href=\"https://academic.oup.com/pages/legal-notice\" data-google-interstitial=\"false\">Legal notice</a></li>\n</ul>\n</div>\n</div>\n<style type=\"text/css\">\n    /* Issue right column fix for tablet/mobile */\n    @media (max-width: 1200px) {\n    .pg_issue .widget-instance-OUP_Issue {\n    width: 100%;\n    }\n    }\n    .sf-facet-list .sf-facet label,\n    .sf-facet-list .taxonomy-label-wrap label {\n    font-size: 0.9375rem;\n    }\n    .issue-pagination-wrap .pagination-container {\n    float: right;\n    }\n</style>\n\n\n\n \n    </div>\n\n        </div>\n    </div>\n    <div class=\"ss-ui-only\">\n\n    </div>\n\n        </section>\n</div>\n\n\n\n\n\n\n    \n\n\n\n    <div class=\"widget widget-SiteWideModals widget-instance-SiteWideModals\">\n        <div id=\"revealModal\" class=\"reveal-modal\" data-reveal=\"\">\n    <div id=\"revealContent\"></div>\n    <a class=\"close-reveal-modal\" href=\"javascript:;\" data-google-interstitial=\"false\"><i class=\"icon-general-close\"></i><span class=\"screenreader-text\">Close</span></a>\n</div>\n\n<div id=\"globalModalContainer\" class=\"modal-global-container\">\n    <div id=\"globalModalContent\">\n        <div class=\"js-globalModalPlaceholder\"></div>\n    </div>\n    <a class=\"close-modal js-close-modal\" href=\"javascript:;\" data-google-interstitial=\"false\"><i class=\"icon-general-close\"><span class=\"screenreader-text\">Close</span></i></a>\n</div>\n<div id=\"globalModalOverlay\" class=\"modal-overlay js-modal-overlay\"></div>\n\n<div id=\"NeedSubscription\" class=\"reveal-modal small\" data-reveal=\"\">\n    <div class=\"subscription-needed\">\n        <h5>This Feature Is Available To Subscribers Only</h5>\n        <p><a href=\"/sign-in\" data-google-interstitial=\"false\">Sign In</a> or <a href=\"/my-account/register?siteId=5269&amp;returnUrl=%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\" data-google-interstitial=\"false\">Create an Account</a></p>\n    </div>\n    <a class=\"close-reveal-modal\" href=\"javascript:;\" data-google-interstitial=\"false\"><i class=\"icon-general-close\"></i><span class=\"screenreader-text\">Close</span></a>\n</div>\n\n<div id=\"noAccessReveal\" class=\"reveal-modal tiny\" data-reveal=\"\">\n    <p>This PDF is available to Subscribers Only</p>\n    <a class=\"hide-for-article-page\" id=\"articleLinkToPurchase\" data-reveal=\"\" data-google-interstitial=\"false\"><span>View Article Abstract &amp; Purchase Options</span></a>\n    <div class=\"issue-purchase-modal\">\n        <p>For full access to this pdf, sign in to an existing account, or purchase an annual subscription.</p>\n    </div>\n    <a class=\"close-reveal-modal\" href=\"javascript:;\" data-google-interstitial=\"false\"><i class=\"icon-general-close\"></i><span class=\"screenreader-text\">Close</span></a>\n</div>\n \n    </div>\n\n    \n\n\n\n<script type=\"text/javascript\">\n    MathJax = {\n        tex: {\n            inlineMath: [['|$', '$|'], ['\\\\(', '\\\\)']]\n        }\n    };\n</script>\n<script id=\"MathJax-script\" async=\"\" src=\"//cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js\"></script>\n\n\n    <!-- CookiePro Default Categories -->\n    <!-- When the Cookie Compliance code loads, if cookies for the associated group have consent...\n         it will dynamically change the tag to: script type=text/JavaScript...\n         the code inside the tags will then be recognized and run as normal. -->\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n    <script>\n        var NTPT_PGEXTRA = 'event_type=full-text\\u0026supplier_tag=SC_Journals\\u0026object_type=Article\\u0026taxonomy=taxId%3a39%7ctaxLabel%3aAcademicSubjects%7cnodeId%3aMED00290%7cnodeLabel%3aInfectious+Diseases%7cnodeLevel%3a3\\u0026siteid=cid\\u0026authzrequired=false\\u0026doi=10.1093/cid/ciy723';\n    </script>\n    <!-- Copyright 2001-2010, IBM Corporation All rights reserved. -->\n    <script type=\"text/javascript\" src=\"//ouptag.scholarlyiq.com/ntpagetag.js\"></script>\n        <noscript>\n            <img src=\"//ouptag.scholarlyiq.com/ntpagetag.gif?js=0\" height=\"1\" width=\"1\" border=\"0\" hspace=\"0\" vspace=\"0\" alt=\"Scholarly IQ\" />\n        </noscript>\n\n\n\n\n\n\n\n\n\n\n    <script type=\"text/javascript\" src=\"//oup.silverchair-cdn.com/Themes/Client/app/jsdist/v-638847457987179340/site.min.js\"></script>\n\n\n    \n    \n    \n    <script type=\"text/javascript\" src=\"https://cdn.jsdelivr.net/chartist.js/latest/chartist.min.js\"></script>\n\n    <script type=\"text/javascript\" src=\"//oup.silverchair-cdn.com/Themes/Client/app/jsdist/v-638847457910763332/article-page.min.js\"></script>\n\n\n\n    \n\n    \n    \n\n\n\n\n    <div class=\"ad-banner js-ad-riser ad-banner-riser\">\n    <div class=\"widget widget-AdBlock widget-instance-RiserAd\">\n        \n \n    </div>\n\n    </div>\n\n\n\n                <script src=\"//oup.silverchair-cdn.com/oup/scm.proxylogging.js\"></script>\n\n    <div class=\"end-of-page-js\"></div>\n<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML=\"window.__CF$cv$params={r:'94dd94d139d9c7f9',t:'MTc0OTYwNzkyNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);\";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height=\"1\" width=\"1\" style=\"position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;\"></iframe>\n\n\n<div data-reveal=\"math-jax-load\" id=\"math-jax-modal\" class=\"reveal-modal\" style=\"display: none;\"></div><iframe id=\"ps_sfnfo\" src=\"https://service.seamlessaccess.org/ps/\" style=\"display: none; position: absolute; top: -999px; left: -999px;\"></iframe><iframe id=\"ps_nmchahr\" src=\"https://service.seamlessaccess.org/ps/\" style=\"display: none; position: absolute; top: -999px; left: -999px;\"></iframe><script type=\"text/javascript\" src=\"https://api.altmetric.com/v1/internal-556fdf0f/doi/10.1093/cid/ciy723?callback=_altmetric.embed_callback&amp;domain=academic.oup.com&amp;cache_until=5-11\"></script><script type=\"text/javascript\" src=\"https://api.altmetric.com/v1/internal-556fdf0f/doi/10.1093/cid/ciy723?callback=_altmetric.embed_callback&amp;domain=academic.oup.com&amp;cache_until=5-11\"></script><script type=\"text/javascript\" src=\"https://api.altmetric.com/v1/internal-556fdf0f/doi/10.1093/cid/ciy723?callback=_altmetric.embed_callback&amp;domain=academic.oup.com&amp;cache_until=5-11\"></script><iframe height=\"0\" width=\"0\" style=\"display: none; visibility: hidden;\"></iframe><script type=\"text/javascript\" src=\"https://api.altmetric.com/v1/internal-556fdf0f/doi/10.1093/cid/ciy723?callback=_altmetric.embed_callback&amp;domain=academic.oup.com&amp;cache_until=5-11\"></script><iframe name=\"__tcfapiLocator\" style=\"display: none;\"></iframe><div id=\"manage-cookies\" class=\"manage-cookies-modal-sidepanel\" style=\"display: none; --primary-background: #555555; --primary-text-color: #ffffff; --primary-button-background: #9b9b9b; --modal-notice-text-color: #ffffff;\">\n      <div class=\"modal-notice-heading\">\n        <span id=\"modal-heading-icon\" class=\"modal-heading-icon\">\n          <svg stroke=\"currentColor\" fill=\"currentColor\" stroke-width=\"60px\" viewBox=\"0 0 1024 1024\" height=\"1em\" width=\"1em\" xmlns=\"http://www.w3.org/2000/svg\">\n            <path d=\"M724 218.3V141c0-6.7-7.7-10.4-12.9-6.3L260.3 486.8a31.86 31.86 0 0 0 0 50.3l450.8 352.1c5.3 4.1 12.9.4 12.9-6.3v-77.3c0-4.9-2.3-9.6-6.1-12.6l-360-281 360-281.1c3.8-3 6.1-7.7 6.1-12.6z\">\n            </path>\n          </svg>\n        </span>\n       <span>Manage Cookies</span>\n      </div>\n      <div class=\"manage-cookies-modal-wrapper\" style=\"min-height: calc(100% - 78px - 4px - 64px);\">\n        <div class=\"manage-cookies-modal-content\" id=\"manage-cookies-modal-content\">\n          <p class=\"privado-para modal-notice-text\" style=\"\n                font-weight: ;\n                text-decoration: ;\n                font-style: ;\n                \">\n                When you visit web sites, they may store or retrieve data in your web browser. This storage is often necessary for basic functionality of the web site or the storage may be used for the purposes of marketing, analytics, and personalization of the web site such as storing your preferences.\n          </p>\n              <div id=\"manage-cookies-cookielist\" class=\"manage-cookies-cookielist\">\n              </div>\n\n        </div>\n        <p id=\"privado-branding-wrap\" class=\"privado-para privado-power\" style=\"font-size: 14px; text-align: center;\">\n          Powered by <a style=\"text-decoration: none; color: inherit;\" href=\"https://privado.ai/cookie-consent\">Privado</a>\n        </p>\n      </div>\n      <div class=\"manage-cookies-save-container\" style=\"display: flex; flex-direction:row;\">\n        <button class=\"save-button-cookie-policy\" id=\"save-button\">\n          Save\n        </button>\n      </div>\n    </div><div id=\"cookie-consent-banner\" class=\"edit-modal-banner fullWidth\" style=\"background: rgb(42, 42, 42); width: 100%; margin: 0px; bottom: 0px; align-content: center;\">\n        <span id=\"banner-close-icon\" class=\"banner-close-icon\" style=\"color: #ffffff;\">\n          <svg stroke=\"currentColor\" fill=\"currentColor\" stroke-width=\"0\" viewBox=\"0 0 24 24\" height=\"1em\" width=\"1em\" xmlns=\"http://www.w3.org/2000/svg\">\n            <path d=\"M19 6.41L17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z\">\n            </path>\n          </svg>\n        </span>\n        <div class=\"banner-content-wrapper-banner\">\n          <p class=\"privado-para banner-notice-text\" style=\"\n              font-weight: ;\n              text-decoration: ;\n              fontStyle: ;\n              color: #ffffff;\n            \">\n            Oxford University Press uses cookies to enhance your experience on our website. By selecting ‘accept all’ you are agreeing to our use of cookies. You can change your cookie settings at any time. More information can be found in our <a href=\"https://global.oup.com/cookiepolicy/?cc=gb\" target=\"_blank\" style=\"text-decoration: inherit;\">Cookie Policy</a>.\n            \n          </p>\n          <div class=\"banner-button-container\">\n            <button id=\"manage-settings-button\" class=\"banner-filled-button\" style=\"\n                display: unset;\n                background-color: #ffffff;\n                border-color: none;\n                color: #2a2a2a;\n                font-weight: ;\n                        text-decoration: ;\n                        fontStyle: ;\n              \">\n              Reject and manage\n            </button>\n            \n            <button id=\"deny-button\" class=\"banner-filled-button\" style=\"\n                display: none;\n                background-color: #ffffff;\n                border-color: none;\n                color: #2a2a2a;\n                font-weight: ;\n                text-decoration: ;\n                fontStyle: ;\n              \">\n              Deny all\n            </button>\n            <button id=\"accept-button\" class=\"banner-filled-button\" style=\"\n                display: unset;\n                background-color: #ffffff;\n                border-color: none;\n                color: #2a2a2a;\n                font-weight: ;\n                text-decoration: ;\n                fontStyle: ;\n              \">\n              Accept all\n            </button>\n          </div>\n        </div>\n      </div></body><iframe name=\"goog_topics_frame\" src=\"https://securepubads.g.doubleclick.net/static/topics/topics_frame.html\" style=\"display: none;\"></iframe></html>",
    "cleaned_content": "\n\n\n<a href=\"#skipNav\">Skip to Main Content</a>\n<div>\n<section>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>Advertisement</div>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<a href=\"/\">\n<img alt=\"Oxford Academic\" class=\"oup-header-image at-oup-header-image\" height=\"74\" src=\"//oup.silverchair-cdn.com/UI/app/svg/umbrella/oxford-academic-logo.svg\" width=\"300\"/>\n</a>\n</div> <div>\n<div>\n<div>\n<a href=\"/journals\">Journals</a>\n</div>\n<div>\n<a href=\"/books\">Books</a>\n</div>\n</div>\n</div>\n<ul>\n\n<li>\n<a href=\"/pages/information\">\n<img alt=\"Information\" class=\"sigma-info-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/i.svg\"/>\n</a>\n</li>\n\n<li>\n<a href=\"/pages/information\">\n<img alt=\"Information\" class=\"sigma-info-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/i.svg\"/>\n</a>\n</li>\n\n</ul>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<label>\n        Navbar Search Filter\n      </label>\n<select>\n<option>Clinical Infectious Diseases</option><option>This issue</option><option>IDSA Journals</option>\n<optgroup>\n<option>Infectious Diseases</option><option>Books</option><option>Journals</option><option>Oxford Academic</option> </optgroup>\n</select>\n<label>\n      Mobile Enter search term\n    </label>\n\n</div>\n</div>\n</div>\n</div>\n<div>\n<ul>\n<li>\n<a href=\"/cid/issue\">\n          Issues\n        </a>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"/cid/advance-articles\">\n          Advance articles\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/search-results?page=1&amp;f_OUPSeries=Editor%27s+Choice\">\n          Editor's Choice\n        </a>\n</li>\n<li>\n<a href=\"/cid/supplements\">\n          Supplement Archive\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/issue-covers/\">\n          Cover Archive\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/clinical-practice-guidelines\">\n          IDSA Guidelines\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa\">\n          IDSA Journals\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/jid\">\n          The Journal of Infectious Diseases\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/ofid\">\n          Open Forum Infectious Diseases\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/clinical-dilemmas\">\n          Clinical Dilemmas in ID\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/photo-quizzes\">\n          Photo Quizzes\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/pages/state-of-the-art-reviews\">\n          State-of-the-Art Reviews\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/pages/voices-of-id\">\n          Voices of ID\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa/pages/content-collections\">\n          IDSA Content Collections\n        </a>\n</li>\n</ul>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"/cid/pages/General_Instructions\">\n          Author Guidelines\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/General_Instructions\">\n          Open Access\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/pages/why-publish\">\n          Why Publish\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa/pages/calls-for-papers\">\n          IDSA Journals Calls for Papers\n        </a>\n</li>\n</ul>\n</li>\n<li>\n<a href=\"/cid/subscribe\">\n          Purchase\n        </a>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\">\n          Advertising and Corporate Services\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising\">\n          Advertising\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\">\n          Mediakit\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/reprints\">\n          Reprints and ePrints\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/supplements\">\n          Sponsored Supplements\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/branded-books\">\n          Branded Books\n        </a>\n</li>\n</ul>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"/cid/pages/About\">\n          About Clinical Infectious Diseases\n        </a>\n</li>\n\n<li>\n<a href=\"/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf\">\n          IDSA COI Policy\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/Editorial_Board\">\n          Editorial Board\n        </a>\n</li>\n<li>\n<a href=\"/my-account/email-alerts\">\n          Alerts\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b\">\n          Self-Archiving Policy\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/For_Reviewers\">\n          For Reviewers\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa/pages/for_press_offices\">\n          For Press Offices\n        </a>\n</li>\n</ul>\n</li>\n<li>\n<a href=\"/journals\">Journals on Oxford Academic</a>\n</li>\n<li>\n<a href=\"/books\">Books on Oxford Academic</a>\n</li>\n</ul>\n</div>\n</div>\n<div>\n<div>\n<div>\n<a href=\"//academic.oup.com/idsa\">IDSA Journals</a>\n</div>\n<a href=\"/cid\">\n<img alt=\"Clinical Infectious Diseases\" class=\"journal-logo\" height=\"18\" id=\"logo-ClinicalInfectiousDiseases\" src=\"//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_title-1229789578.svg\" width=\"300\"/>\n</a>\n</div>\n</div>\n<div>\n<div>\n<nav>\n<ul>\n<li>\n<a href=\"/cid/issue\">\n          Issues\n        </a>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"/cid/advance-articles\">\n          Advance articles\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/search-results?page=1&amp;f_OUPSeries=Editor%27s+Choice\">\n          Editor's Choice\n        </a>\n</li>\n<li>\n<a href=\"/cid/supplements\">\n          Supplement Archive\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/issue-covers/\">\n          Cover Archive\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/clinical-practice-guidelines\">\n          IDSA Guidelines\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa\">\n          IDSA Journals\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/jid\">\n          The Journal of Infectious Diseases\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/ofid\">\n          Open Forum Infectious Diseases\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/clinical-dilemmas\">\n          Clinical Dilemmas in ID\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/photo-quizzes\">\n          Photo Quizzes\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/pages/state-of-the-art-reviews\">\n          State-of-the-Art Reviews\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/pages/voices-of-id\">\n          Voices of ID\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa/pages/content-collections\">\n          IDSA Content Collections\n        </a>\n</li>\n</ul>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"/cid/pages/General_Instructions\">\n          Author Guidelines\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/General_Instructions\">\n          Open Access\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/pages/why-publish\">\n          Why Publish\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa/pages/calls-for-papers\">\n          IDSA Journals Calls for Papers\n        </a>\n</li>\n</ul>\n</li>\n<li>\n<a href=\"/cid/subscribe\">\n          Purchase\n        </a>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\">\n          Advertising and Corporate Services\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising\">\n          Advertising\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\">\n          Mediakit\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/reprints\">\n          Reprints and ePrints\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/supplements\">\n          Sponsored Supplements\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/branded-books\">\n          Branded Books\n        </a>\n</li>\n</ul>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"/cid/pages/About\">\n          About Clinical Infectious Diseases\n        </a>\n</li>\n\n<li>\n<a href=\"/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf\">\n          IDSA COI Policy\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/Editorial_Board\">\n          Editorial Board\n        </a>\n</li>\n<li>\n<a href=\"/my-account/email-alerts\">\n          Alerts\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b\">\n          Self-Archiving Policy\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/For_Reviewers\">\n          For Reviewers\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa/pages/for_press_offices\">\n          For Press Offices\n        </a>\n</li>\n</ul>\n</li>\n</ul>\n</nav>\n<div>\n<div>\n<div>\n<div>\n<label>\n        Navbar Search Filter\n      </label>\n<select>\n<option>Clinical Infectious Diseases</option><option>This issue</option><option>IDSA Journals</option>\n<optgroup>\n<option>Infectious Diseases</option><option>Books</option><option>Journals</option><option>Oxford Academic</option> </optgroup>\n</select>\n<label>\n      Enter search term\n    </label>\n\n</div>\n</div>\n<div><a href=\"https://academic.oup.com/cid/advanced-search?page=1&amp;fl_SiteID=5269&amp;SearchSourceType=1\">Advanced Search</a></div>\n</div>\n\n</div>\n</div>\n</div>\n\n\n\n\n\n</div>\n</section>\n<div>\n<section>\n<div>\n<div>\n<div>\n<div>\n<button>Article Navigation</button>\n</div>\n<div>\n<button>\n<span>Close mobile search navigation</span>\n</button>\n<div>Article Navigation</div>\n<div>\n<div>\n<div>\n<a href=\"/cid/issue/68/9\">\n<div>\n<img alt=\"Clinical Infectious Diseases Cover Image for Volume 68, Issue 9\" class=\"fb-featured-image\" height=\"685\" id=\"issueImage\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/Issue/68/9/5/m_cover.jpeg?Expires=1752631924&amp;Signature=VzkJpzpYIXCozHbdsaIS60qWT14TRuSLuGC1eukUyrcYSb6veXmlbdxxi4bsCqv56PfMH7dlbqN9LPLYakKnZ6uSxmWg0YAZOHfQIA39tvpONvJ71boTMCgDn8RhjNDckqV16RNIXTme4fSXo-Pb1NEzqABs9EzPZHe9bQMD6FT68PV8Vap~eeaNsVp85gS3jKjGejPEgn2-XCGy4vrE3MaPHJYIAkNxsVP0hL~5pIyLW4I1ZSyrhJhH-eg8MKmfcqb5InNKbRmJkLh~-95lJfZl5LOkCkFEzHqU5URne1xaCnWjdQWfdfTDCJXggdBa~HkCJsQ92f~1fLxypv7dIQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" width=\"520\"/>\n</div>\n<div>\n<div>\n<div>Volume 68</div>\n<div>Issue 9</div>\n</div>\n<div>\n1 May 2019      </div>\n</div>\n</a>\n</div>\n</div>\n<div>\n<div>\n<h3>Article Contents</h3>\n<ul>\n<li>\n<div>\n<a href=\"#134170092\">Abstract</a>\n</div>\n</li>\n<li>\n<div>\n<a href=\"#134170097\">MATERIALS AND METHODS</a>\n</div>\n</li>\n<li>\n<div>\n<a href=\"#134170111\">RESULTS</a>\n</div>\n</li>\n<li>\n<div>\n<a href=\"#134170130\">DISCUSSION</a>\n</div>\n</li>\n<li>\n<div>\n<a href=\"#134170142\">Supplementary Data</a>\n</div>\n</li>\n<li>\n<div>\n<a href=\"#134170144\">Notes</a>\n</div>\n</li>\n<li>\n<div>\n<a href=\"#134170150\">References</a>\n</div>\n</li>\n<li>\n<div>\n<a href=\"#supplementary-data\">Supplementary data</a>\n</div>\n</li></ul>\n</div>\n</div>\n<div>\n<ul>\n<li>\n<a href=\"/cid/article/68/9/1472/5089945\">&lt; Previous</a>\n</li>\n<li>\n<a href=\"/cid/article/68/9/1494/5087661\">Next &gt;</a>\n</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<button>\n      Article Navigation\n    </button>\n</div>\n</div>\n<div>\n<div>\n<button>\n      Article Navigation\n    </button>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<span>Journal Article</span>\n</div>\n<div>\n<div>\n<h1>\n            Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\n<i title=\"Free\"><span>Free</span></i> </h1>\n</div>\n<div>\n<div>\n<div>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Marta Francesca Di Pasquale\n</div>\n</div>\n<div>\n<div>Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Marta+Francesca+Di+Pasquale\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Giovanni Sotgiu\n</div>\n</div>\n<div>\n<div>Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Giovanni+Sotgiu\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Andrea Gramegna\n</div>\n</div>\n<div>\n<div>Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Andrea+Gramegna\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Dejan Radovanovic\n</div>\n</div>\n<div>\n<div>Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Pulmonary Unit, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Dejan+Radovanovic\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Silvia Terraneo\n</div>\n</div>\n<div>\n<div>Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Italy</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Silvia+Terraneo\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Luis F Reyes\n</div>\n</div>\n<div>\n<div>Microbiology Department, Universidad de La Sabana, Chia, Colombia</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Luis+F+Reyes\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Jan Rupp\n</div>\n</div>\n<div>\n<div>Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Jan+Rupp\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Juan González del Castillo\n</div>\n</div>\n<div>\n<div>Emergency Department, Hospital Clínico San Carlos, Universidad Complutense</div><div>Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, IdISSC, Madrid, Spain</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Juan+Gonz%c3%a1lez+del+Castillo\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Francesco Blasi\n</div>\n</div>\n<div>\n<div>Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Francesco+Blasi\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Stefano Aliberti\n      \n</div>\n</div>\n<div>\n<div>Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n</div>\n<div>\n<div>Correspondence: S. Aliberti, Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy ().</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Stefano+Aliberti\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<a href=\"#\">\n<span>...</span> Show more\n                </a>\n<div>\n<span>\n\n<span>\n<div>\n<div>\n<div>\n  Marcos I Restrepo\n</div>\n</div>\n<div>\n<div>Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Marcos+I+Restrepo\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div><em>Clinical Infectious Diseases</em>, Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, </div>\n</div>\n<div>\n<div>\n<div>Published:</div>\n<div>23 August 2018</div>\n</div>\n</div>\n<div>\n<div>\n<div>Received:</div>\n<div>24 May 2018</div>\n</div>\n<div>\n<div>Accepted:</div>\n<div>20 August 2018</div>\n</div>\n<div>\n<div>Published:</div>\n<div>23 August 2018</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<ul>\n<li>\n<a href=\"/cid/article-pdf/68/9/1482/28520951/ciy723.pdf\">\n<img alt=\"pdf\" src=\"//oup.silverchair-cdn.com/UI/app/svg/pdf.svg\"/><span>PDF</span>\n</a>\n</li>\n\n<li>\n<div>\n<a href=\"#\">\n<span>Cite</span>\n</a>\n<div>\n<h3>Cite</h3>\n<div>\n<p>Marta Francesca Di Pasquale, Giovanni Sotgiu, Andrea Gramegna, Dejan Radovanovic, Silvia Terraneo, Luis F Reyes, Jan Rupp, Juan González del Castillo, Francesco Blasi, Stefano Aliberti, Marcos I Restrepo, Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients, <em>Clinical Infectious Diseases</em>, Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, </p>\n</div>\n<div>\n<form>\n\n<label>Select Format</label>\n<select>\n<option>Select format</option>\n<option>.ris (Mendeley, Papers, Zotero)</option>\n<option>.enw (EndNote)</option>\n<option>.bibtex (BibTex)</option>\n<option>.txt (Medlars, RefWorks)</option>\n</select>\n<button>Download citation</button>\n</form>\n</div>\n</div>\n</div>\n</li>\n\n</ul>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<label>\n        Navbar Search Filter\n      </label>\n<select>\n<option>Clinical Infectious Diseases</option><option>This issue</option><option>IDSA Journals</option>\n<optgroup>\n<option>Infectious Diseases</option><option>Books</option><option>Journals</option><option>Oxford Academic</option> </optgroup>\n</select>\n<label>\n      Mobile Enter search term\n    </label>\n\n</div>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<label>\n        Navbar Search Filter\n      </label>\n<select>\n<option>Clinical Infectious Diseases</option><option>This issue</option><option>IDSA Journals</option>\n<optgroup>\n<option>Infectious Diseases</option><option>Books</option><option>Journals</option><option>Oxford Academic</option> </optgroup>\n</select>\n<label>\n      Enter search term\n    </label>\n\n</div>\n</div>\n<div><a href=\"https://academic.oup.com/cid/advanced-search?page=1&amp;fl_SiteID=5269&amp;SearchSourceType=1\">Advanced Search</a></div>\n</div>\n\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<h2>Abstract</h2>\n<section><div><div>Background</div><p>The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia.</p></div><div><div>Methods</div><p>We conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor.</p></div><div><div>Results</div><p>At least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors significantly differed across continents and countries, with chronic steroid use (45%), hematological cancer (25%), and chemotherapy (22%) the most common. Among immunocompromised patients, community-acquired pneumonia (CAP) pathogens were the most frequently identified, and prevalences did not differ from those in immunocompetent patients. Risk factors for immunocompromise were independently associated with neither <em>Pseudomonas aeruginosa</em> nor non–community-acquired bacteria. Specific risk factors were independently associated with fungal infections (odds ratio for AIDS and hematological cancer, 15.10 and 4.65, respectively; both <em>P</em> = .001), mycobacterial infections (AIDS; <em>P</em> = .006), and viral infections other than influenza (hematological cancer, 5.49; <em>P</em> &lt; .001).</p></div><div><div>Conclusions</div><p>Our findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses.</p></div></section> \n<div>, , , , </div><p>During initial evaluation of a patient coming from the community with pneumonia, the identification of possible risk factors for multidrug-resistant organisms or unusual pathogens is crucial []. Because a microbiological identification is found in about 30% of hospitalized patients with pneumonia coming from the community, and usually requires 24–48 hours to be available, most of patients are treated empirically []. Delay in initiation of appropriate empiric antibiotic therapy is a known risk factor for worse clinical outcomes []; therefore, it is relevant to promptly recognize patients at risk for specific pathogens, specially multidrug-resistant or atypical microbes [].</p><p>The aging of the population and advancements in therapeutic protocols have led to an increase prevalence of chronic diseases as well as long-term treatments with immunosuppressive agents [, ]. Thus, among patients with pneumonia coming from the community and admitted to the hospital, the number who might not be fully immunocompetent is constantly increasing [, ]. Nevertheless, the real prevalence of immunocompromise among patients with pneumonia coming from the community is still unknown. Moreover, guidelines for community-acquired and hospital-acquired pneumonia did not address this topic—what is more, they specifically excluded patients with clinical characteristics determining immunocompromise [], and current evidence in literature is also scarce.</p><p>To our knowledge, there are no studies addressing the clinical evaluation and initial empirical antibiotic coverage of patients coming from the community with pneumonia and immunocompromise. Moreover, specific risk factors to assess the causative microbiology and help clinicians choose more appropriate management for these patients have not been clearly identified. Thus, the aim of the current study was to identify the prevalence, type, microbiology, and intercorrelations between different risk factors for immunocompromise in hospitalized patients with pneumonia coming from the community.</p> <h2>MATERIALS AND METHODS</h2>\n<h3>Study Design and Population</h3>\n<p>This is a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) database []. The GLIMP study was an international, multicenter, observational, point-prevalence study of adult patients hospitalized for community-onset pneumonia in 54 countries worldwide. Patients were enrolled on a single day during the months of March, April, May, and June 2015. The methods of the GLIMP study have been published elsewhere []. The coordinating center (University of Texas Health Science Center, San Antonio) received approval from its institutional review board (No. HSC20150184E).</p><p>All adult patients (aged &gt;18 years old) coming from the community and hospitalized with pneumonia during study period were included. Pneumonia was defined as the presence of a new pulmonary infiltrate on chest radiograph at the time of hospitalization, associated with ≥1 of the following criteria: (1) new or increased cough with/without sputum production and/or purulent respiratory secretions, (2) fever or hypothermia, and (3) evidence of systemic inflammation (ie, abnormal white blood cell count or increased C-reactive protein or procalcitonin level). Hospitalized patients with a diagnosis of hospital-acquired or ventilator-associated pneumonia were excluded.</p> <h3>Data Collection</h3>\n<p>Data were collected from medical records at the time of hospital admission. Data gathered included demographics; respiratory and cardiovascular comorbid conditions; immunocompromised status and other chronic medical conditions; severity of pneumonia (defined as either intensive care unit admission, use of invasive or noninvasive mechanical ventilation, or use of vasopressors/inotropes during the first 24 hours after hospital admission); and specific risk factors for resistant pathogens infection, including chronic aspiration, being bedridden, malnutrition, presence of enteric tube feeding and indwelling catheters (including central venous and urinary catheters), previous infections, chronic microbial colonization, and previous healthcare exposures. The number and type of microbiological samples obtained within 24 hours after hospital admission were also collected. Culture-positive tests, kind of sample, and antibiotic resistance patterns were also gathered, along with empiric antibiotic treatment, given within 24 hours after hospital admission.</p> <h3>Microbiological Workup</h3>\n<p>Diagnostic testing was performed according to local standard operating procedures and included collection of respiratory and blood cultures and testing for urinary antigens. Microbiological examinations and susceptibility testing were performed according to local standard protocols within the first 24 hours after hospital admission []. Multivariable logistic regression models were performed for patients who had a positive culture, to identify specific risk factors for single pathogens.</p><p>Causative pathogens were stratified according to the coverage of standard therapy for community-acquired pneumonia (CAP) []. Those not covered by standard CAP therapy included the following: non–community-acquired bacteria (<em>Acinetobacter baumanii</em>, <em>Enterococcus</em> vancomycin-resistant, <em>Nocardia</em> spp.), mycobacteria, fungi (<em>Aspergillus fumigatus, Coccidioides, Criptococcus</em>, <em>Pneumocystis jirovecii</em>), and viruses other than influenza []. Those covered by standard CAP therapy included <em>Pseudomonas aeruginosa,</em> methicillin-resistant <em>Staphylococcus aureus</em>, methicillin-sensitive <em>S. aureus</em>, <em>Enterobacter</em> spp., <em>Enterococcus</em> spp., <em>Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae</em>, <em>Moraxella catarrhalis, Proteus mirabilis, Serratia marcescens, Streptococcus pneumoniae, Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella pneumophilia,</em> anaerobes bacteria, and influenza viruses. Atypical pathogens included <em>C. pneumoniae, M. pneumoniae,</em> and <em>L. pneumophilia.</em> CAP therapy was defined as β-lactams (ceftriaxone, ampicillin-sulbactam, amoxicillin-clavulanate, cefepime, ceftazidime, piperacillin-tazobactam) plus macrolide, or fluoroquinolones alone, and, eventually, in association with vancomycin, linezolid, or oseltamivir [].</p> <h3>Definition of Immunocompromised and Study Groups</h3>\n<p>Immunocompromise was defined as the presence of ≥1 of the following risk factors: (1) AIDS, defined either as human immunodeficiency virus infection with CD4<sup>+</sup> lymphocyte count &lt;200/µL or by the occurrence of AIDS-defining conditions; (2) aplastic anemia; (3) asplenia; (4) hematological cancer, defined as lymphoma, acute or chronic leukemia, or multiple myeloma; (5) chemotherapy during the last 3 months; (6) neutropenia, defined as a neutrophil count &lt;500/dL at complete blood cell count; (7) biological drug use (including trastuzumab and therapies for autoimmune diseases, eg, anti–tumor necrosis factor α, prescribed during ≥6 months before hospital admission); (8) lung transplantation; (9) chronic steroid use (&gt;10 mg/d of prednisone or equivalent ≥3 months before hospital admission); (10) lung cancer with either neutropenia or chemotherapy; (11) other solid tumor with either neutropenia or chemotherapy; (12) other immunocompromise (any immunocompromised state, including congenital/genetic immunocompromise and immunosuppressive therapy due to hematological cancer/solid organ transplantation other than lung). Two study groups were identified: those with versus those without 1 risk factor for immunocompromise.</p> <h3>Statistical Analysis</h3>\n<p>Categorical variables, expressed as counts (percentages), were compared using the χ<sup>2</sup> test. Continuous variables were compared using the unpaired Student <em>t</em> test or the Mann-Whitney test, when appropriate. Statistical significance was defined as <em>P</em> &lt; .05. A network analysis was conducted to represent the frequencies of all immunocompromise variables and their relationships. The size of the circles (the circles visible in Figure 4 [network analysis], each representing a single risk factor for immunocompromise) represents both prevalence of the risk factor and strength of association with other variables.</p><p>The predictive value of each variable was categorized by quartiles and analyzed using a univariate regression logistic analysis. A multivariable model was obtained using a Cox regression analysis to identify independent predictors of specific pathogens, using an entry level of P value ≤0.05 and a removal level of P value ≥0.10. Hazard ratios and adjusted analyses were obtained. All statistical analyses were performed with IBM SPSS software (version 22, Statistics for Mac; version 22.0, IBM Crop), and Stata 13 software (StataCorp).</p> <h2>RESULTS</h2>\n<h3>Prevalence of Risk Factors for Immunocompromise</h3>\n<p>Among 3702 patients enrolled in the GLIMP database, ≥1 risk factor for immunocompromise was identified in 652 (17.6%). The prevalences of patients with pneumonia coming from the community and with ≥1 risk factor for immunocompromise differed among continents and countries, as depicted in and . The prevalence of immunocompromise was significantly higher in both North and South America than in the rest of the world (24.0% vs 16.5 [<em>P</em> &lt; .001] and 24.8% vs 17.2 [<em>P</em> = .006], respectively) ().</p> \n<div><div><img alt=\"Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, &lt;5%, 5%–10%, 11%–20%, 21%–30%, or &gt;30% of total cases.\" class=\"content-image\" data-path-from-xml=\"ciy72301.jpg\" height=\"462\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1752554620&amp;Signature=LKXAyrV74Aa9owXe0o-cQ75pOeSoID0-pehgygNtPZSFXNZMuhHSvh2bH2dv7qW8hH1yagXom1UIMLOtWgjAeeVu2LBuha-~CcDB2tnoDsCwd0W--ENWiqmCFTxq3yC2TQ0Umx7W~VJXwN6SRKyfDOflOkKvPGRNUobFX0ugYVCV63UYBnlhdsPfvI-fsKpp2D2I1PP6zBaXvsJbvI-0aIPK7XN9D-bkImy~2jyh7YxMl-ml056-m9M~e1NXIC1G-eMlJ-D0ihNbxsU~I2x~~h2BWrtr8AE9Sfu1WTqiFahp57mH4~iFGY9EkQkC4xJpjMyNKtQFhxpXjvQtYLzecQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" width=\"520\"/><div><div>Figure 1.</div><div><p>Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, &lt;5%, 5%–10%, 11%–20%, 21%–30%, or &gt;30% of total cases.</p></div><div><a href=\"/view-large/figure/134170114/ciy72301.jpg\">Open in new tab</a><a href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72301.jpeg?Expires=1752554620&amp;Signature=NHcEJwNnhhuu~V7litr8igr9GFWfZ0zM0SxlfYOwAgN3ag3nsCMd9zXKoM9GZWcSFeGB~KznckX3sjRs7eZI6UovzOYWd5ChB8QCKT6DbvXvsAyPCY~~tvyw1nLgnCRXHxsEp9~pCDA4jyfmGwdzBmIxjxK32DKPE3r03H1NwaFfFuqtTjvCIQz2eID2dBiK~4lTbznS4INQ66i-Fh9DwTzI-HwYqclm24aYv1pSYlAiswZHOwaE-fO6wkuUxDcfD3pvVFQ~xscKfiFVbOt91lXVNkOd7p4CKoSAgaQv6yr5WZ9-7z1VyiIThnhC9G~HPkbIlB2Do4fo0jz7V2xwPA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170114&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\">Download slide</a></div></div></div></div><p>The prevalence of each risk factor for immunocompromise is depicted in , with chronic steroid use (45.0%), hematological cancer (25.0%), and chemotherapy (22.0%) being the most frequent ones. A total of 312 patients (8.4%) had &gt;1 risk factor for immunocompromise ().</p> \n<div><div><img alt=\"Prevalence of each single risk factor for immunocompromise.\" class=\"content-image\" data-path-from-xml=\"ciy72302.jpg\" height=\"304\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72302.jpeg?Expires=1752554620&amp;Signature=tN-5VXAN-IRDKK8axKZA8P~Y5z--s9j8Erc8SOjWl6DrKKH4QL5os9eZxhVeV6eWVN~f~VDG9tfzyHUF6i7OVsMNB2vsk6C~94Qv-2aRHoy5JP-aM-LrL8khDyqEa4Lg2BfInF3Q0qGwXrmt25GlH1qSBKirMgS~VlVo9FK3dUDe2-XgCIv-DixycDR1NbxEUad1obLBQi7T-cMZnDc0-hSXzSelH07q4yY8dbVGxrERuy5IWOvusZ1u83w1jCK4dSvt3hPFFdMZMOmGLi~Fj-dVSs0cAjfbIHoEDmqErTby4pVDEijEs5muQVm-Ux~YEjgN-VhvWj8YtpZKL4eSXA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" width=\"520\"/><div><div>Figure 2.</div><div><p>Prevalence of each single risk factor for immunocompromise.</p></div><div><a href=\"/view-large/figure/134170116/ciy72302.jpg\">Open in new tab</a><a href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72302.jpeg?Expires=1752554620&amp;Signature=urCgidlWbN7Br1gKnVthRjYFEVioagJuBFmiXPuQQBoD2qmTrm4Heidc21Yt1dgPswbIwC7DPhnYrlHrjxMxL-tPDfinKG-olgkospAEDA-ocZW5BuK9lYsha0rJ0NF76fxfhqDzGVUbNAug3anPLTq4c4Wm9hmTgaDN4Qc2ECcT8hDYAnEm3od96dWn52Zy09JsZa4zT41kMG~qQJEZG62~24b5nEIG7eSCncOceqVPqOOaaIMniBLrAQuB7Hvqr~6AtHN5IBjBuLUjU1xYJcFJXX6WtIhnqkXKN21GOO7O7AU0AC7FLWQuEd1zCcVocKQxVv4RndCQeZ3XzZvegA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170116&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\">Download slide</a></div></div></div></div> \n<div><div><img alt=\"Prevalence of the number of risk factors present simultaneously in a single patient.\" class=\"content-image\" data-path-from-xml=\"ciy72303.jpg\" height=\"245\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72303.jpeg?Expires=1752554620&amp;Signature=Xts16a6pXvQbNfwKtUeejfXsqF17z~2gviy7VcLQhhckWHmCw0zRSSEtsyrG9SkI2LRw39TbhqnqYNb1VTXQKD-ybyHkb~R3s-eIxJ~94DOxaaXBbUvpzbvwY1vDACc5LpVzJJ8dZMntZ7nekvhgMs6NtlpySVWDDC~7ybF0bySgW6i55FBFevIdcUxB3ipChEHL9XiTlmDkdiHssMser494UBvbDyg4DUKM-Cpd988M8qpSwp-eg-3Yhkr9q2~L66QQUhwgYNILWRRA1azwsTAJvrWUq52Dpikbj4mzbXXstnhvc7GNMw5xxz6nFPKuHVKJlcE-HQsiIvj5ZOVUxg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" width=\"520\"/><div><div>Figure 3.</div><div><p>Prevalence of the number of risk factors present simultaneously in a single patient.</p></div><div><a href=\"/view-large/figure/134170117/ciy72303.jpg\">Open in new tab</a><a href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72303.jpeg?Expires=1752554620&amp;Signature=aODZPs-HRl9QmymSK-5bkx~xp6iLrndvYFKxy1ge9DczmeUzsNnr5McNlvqrMcXHLvgMkhfK7yT7VuvVZQyJiTDmkR2j-SEc5zFcORnQPNUjDvGORdypfvcWI0ap8MKwHNe5lyBn4KtJz~tW8Oy3Gx54ukE8wke7~kZBzMvO8MTOkttiu8JkRKLQBqO6IcM2MoQBEcRSt-iQJjHBC9eSqzTw9hfjbhfc1npEBjHchP6v69RipZnUipM4HSTXcHzcLlv5ZrElufmBjKlaCOuMXehhls70RLfvTvOnOA3AyEmOSecyKEGpTAKKWMZCZcKwFjPqwgrO2KIMNHBcdECFyg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170117&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\">Download slide</a></div></div></div></div> <h3>Network Analysis Among Risk Factors for Immunocompromise</h3>\n<p>The results of the network analysis of all risk factors for immunocompromise are depicted in . Relationships were identified between chemotherapy and solid tumor other than lung cancer, hematological cancer, and chronic steroid use, and between other immunocompromise and chronic steroid use.</p> \n<div><div><img alt=\"Network analysis between risk factors for immunocompromise.\" class=\"content-image\" data-path-from-xml=\"ciy72304.jpg\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72304.jpeg?Expires=1752554620&amp;Signature=GuJUcrEhLaMR89vfrhqqYuGyB4HuDlfLUgnHqNu6Ksi5VkLMWjSpH0hVJWv0i4hnesvCDRYbQ~uAyBQyQ0AiLXq2xGVhq3CJd~~Uo~xFEO2RNWWcv5izwBv2Xd~h9Hdfe0hTA-AXnTA7hKM-ThAaURdGnReCFddtKpqnLFFI8QBpZfiXaSjcJTGzuOJpCX41BN9EmgqXfVfeCV2WjdANqIm2R0p4fJbe8r3T6ykoQ1g-IoQnAttT~9TBNl6irCxSuhZHs693bn8ZNDwodNBEKnNGVKaV3sMa8zH8GthYrKb1ARcjtit4vlO4Amlu5qUEW4FRAzxNeE5ch2OPPqoZ6g__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\"/><div><div>Figure 4.</div><div><p>Network analysis between risk factors for immunocompromise.</p></div><div><a href=\"/view-large/figure/134170120/ciy72304.jpg\">Open in new tab</a><a href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72304.jpeg?Expires=1752554620&amp;Signature=YZzJ1wJWugBQStvfJV4l4KYj3Wo9NRpieCO~yvNqxtUBWQdjFeAYbw2G-Y6DLCVNq9Va5VeID5cdns-ikSqf31HJSxkU6nJ2ORJtfKpX9YRK1R4udPlHilZw7ywCq-EzR6AMwb3sY-BfsBS4sDesTOwvKTu1-DzRuTpqruza-~yCWEOuDxUkBBBhGOjezpmaPE1pK9FuWVCTdWQjhWi0Q1hWTQx8Y41~JVb3kGWNigqT8AD4v9JX1c4I3Lv7PwLI68bVFaY9GUswC-yS1tvJbrugsyrYyCUrS~h7Si20MQ14RfW5c61orGDtUvAkaoknOVddjBXj5tv5wBq7Hieh4A__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170120&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\">Download slide</a></div></div></div></div> <h3>Clinical and Microbiological Characteristics of Patients With Immunocompromise</h3>\n<p>Clinical features and disease severity of immunocompetent versus immunocompromised patients are shown in and . Immunocompromised patients were significantly younger and malnourished, had a higher frequency of comorbid conditions, previous infections, and colonization by resistant pathogens, and had more frequent contacts with the healthcare system. The prevalences of severe pneumonia did not differ among the 2 study groups.</p> \n<div><div><div><span>Table 1.</span><div><a href=\"\n                /view-large/134170123\">\n              Open in new tab\n            </a></div><div><p>Clinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised)</p></div> </div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>Patients, No. (%)<sup>a</sup><span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 3050)<span>\n      . </span></th><th>Immunocompromised(n = 652)<span>\n      . </span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>Patients, No. (%)<sup>a</sup><span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 3050)<span>\n      . </span></th><th>Immunocompromised(n = 652)<span>\n      . </span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div><div><span><p>Abbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors.</p></span></div><div><span><p><sup>a</sup>Data represent No. (%) unless otherwise specified.</p></span></div></div></div></div><div><div><div><span>Table 1.</span><div><a href=\"\n                /view-large/134170123\">\n              Open in new tab\n            </a></div><div><p>Clinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised)</p></div> </div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>Patients, No. (%)<sup>a</sup><span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 3050)<span>\n      . </span></th><th>Immunocompromised(n = 652)<span>\n      . </span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>Patients, No. (%)<sup>a</sup><span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 3050)<span>\n      . </span></th><th>Immunocompromised(n = 652)<span>\n      . </span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div><div><span><p>Abbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors.</p></span></div><div><span><p><sup>a</sup>Data represent No. (%) unless otherwise specified.</p></span></div></div></div></div><p>Microbiological testing was performed in 91.0% (596 of 652) of immunocompromised and 86.0% (2626 of 3050) of immunocompetent patients (<em>P</em> &lt; .001). Bacteremia was found in 6.0% (36 of 596) of immunocompromised and 5.5% (145 of 2626; <em>P</em> = .62) of immunocompetent patients. At least 1 positive culture was obtained in 40.0% (238 of 596) immunocompromised and 36.0% (935 of 2626) immunocompetent patients (<em>P</em> = .047). Microbiological findings are provided in and . Among pathogens covered by standard therapy, <em>P. aeruginosa</em> was more prevalent in immunocompromised patients (35 [5.9%] vs 98 [3.7%] patients; <em>P</em> &lt; .02). Among pathogens not usually covered by standard therapy, immunocompromised patients were more likely to be infected by <em>Nocardia</em> spp. (4 [0.7%] vs 0 [0%] patients; <em>P</em> &lt; .001), nontuberculous mycobacteria (NTM) (5 [0.8%] vs 2 [0.1%]; <em>P</em> &lt; .002), <em>A. fumigatus</em> (8 [1.3%] vs 10 [0.4%]; <em>P</em> &lt; .01), <em>P. jirovecii</em> (12 [2.0%] vs 5 [0.2%]; <em>P</em> &lt; .02), and viruses, such as coronavirus (3 [0.5%] vs 3 [0.1%]; <em>P</em> &lt; .047), and respiratory syncytial virus (6 [1.0%] vs 7 [0.3%]; <em>P</em> &lt; .03).</p> \n<div><div><div><span>Table 2.</span><div><a href=\"\n                /view-large/134170125\">\n              Open in new tab\n            </a></div><div><p>Pathogens in the 2 Study Groups</p></div> </div><div><table><thead><tr><th>Pathogen<span>\n      . </span></th><th>Patients, No. (%)<span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 2626)<span>\n      . </span></th><th>Immunocompromised (n = 596)<span>\n      . </span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div><table><thead><tr><th>Pathogen<span>\n      . </span></th><th>Patients, No. (%)<span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 2626)<span>\n      . </span></th><th>Immunocompromised (n = 596)<span>\n      . </span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div><div><span><p>Abbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant <em>Staphylococcus aureus</em>; MSSA, methicillin-sensitive <em>S. aureus</em>; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus.</p></span></div></div></div></div><div><div><div><span>Table 2.</span><div><a href=\"\n                /view-large/134170125\">\n              Open in new tab\n            </a></div><div><p>Pathogens in the 2 Study Groups</p></div> </div><div><table><thead><tr><th>Pathogen<span>\n      . </span></th><th>Patients, No. (%)<span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 2626)<span>\n      . </span></th><th>Immunocompromised (n = 596)<span>\n      . </span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div><table><thead><tr><th>Pathogen<span>\n      . </span></th><th>Patients, No. (%)<span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 2626)<span>\n      . </span></th><th>Immunocompromised (n = 596)<span>\n      . </span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div><div><span><p>Abbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant <em>Staphylococcus aureus</em>; MSSA, methicillin-sensitive <em>S. aureus</em>; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus.</p></span></div></div></div></div><p>Once adjusted for confounders, no risk factors of immunocompromise have been recognized for <em>P. aeruginosa</em> infection. Likewise, pathogens not covered by usual CAP therapy were found to be associated not with immunocompromise but with chronic obstructive pulmonary disease (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.07–2.99; <em>P</em> = .03), tracheostomy (2.91; 1.01–8.38; <em>P</em> = .048), and severe pneumonia (2.36; 1.42–3.93; <em>P</em> = .001) ().</p> \n<div><div><div><span>Table 3.</span><div><a href=\"\n                /view-large/134170127\">\n              Open in new tab\n            </a></div><div><p>Multivariable Logistic Regression Analysis</p></div> </div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>OR (CI 95%)<span>\n      . </span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span>\n      . </span></th><th>Non-CAP Bacteria<span>\n      . </span></th><th>Fungi<span>\n      . </span></th><th><em>Mycobacterium tuberculosis</em><span>\n      . </span></th><th>Virus Other Than Influenza<span>\n      . </span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36(1.42–3.93)</td><td>…</td><td>…</td><td>2.56(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65(1.85–11.69)</td><td>…</td><td>5.49(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>OR (CI 95%)<span>\n      . </span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span>\n      . </span></th><th>Non-CAP Bacteria<span>\n      . </span></th><th>Fungi<span>\n      . </span></th><th><em>Mycobacterium tuberculosis</em><span>\n      . </span></th><th>Virus Other Than Influenza<span>\n      . </span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36(1.42–3.93)</td><td>…</td><td>…</td><td>2.56(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65(1.85–11.69)</td><td>…</td><td>5.49(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div><div><span><p>Blank cells indicate no statistical significancy.</p></span></div><div><span><p>Abbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio.</p></span></div></div></div></div><div><div><div><span>Table 3.</span><div><a href=\"\n                /view-large/134170127\">\n              Open in new tab\n            </a></div><div><p>Multivariable Logistic Regression Analysis</p></div> </div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>OR (CI 95%)<span>\n      . </span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span>\n      . </span></th><th>Non-CAP Bacteria<span>\n      . </span></th><th>Fungi<span>\n      . </span></th><th><em>Mycobacterium tuberculosis</em><span>\n      . </span></th><th>Virus Other Than Influenza<span>\n      . </span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36(1.42–3.93)</td><td>…</td><td>…</td><td>2.56(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65(1.85–11.69)</td><td>…</td><td>5.49(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>OR (CI 95%)<span>\n      . </span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span>\n      . </span></th><th>Non-CAP Bacteria<span>\n      . </span></th><th>Fungi<span>\n      . </span></th><th><em>Mycobacterium tuberculosis</em><span>\n      . </span></th><th>Virus Other Than Influenza<span>\n      . </span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36(1.42–3.93)</td><td>…</td><td>…</td><td>2.56(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65(1.85–11.69)</td><td>…</td><td>5.49(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div><div><span><p>Blank cells indicate no statistical significancy.</p></span></div><div><span><p>Abbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio.</p></span></div></div></div></div><p>Results showed that AIDS (OR, 15.10; 95% CI, 6.36–35.88; <em>P</em> ≤ .001) and hematological cancer (4.65; 91.85–11.69; <em>P</em> = .001) were independently associated with fungal infections; hematological cancer (5.49; 2.20–13.70; <em>P</em> &lt; .001) and severe pneumonia (2.56; 1.27–5.19; <em>P</em> = .009) with infection by viruses other than influenza; and AIDS (4.41; 1.53–12.73; <em>P</em> = .006) and malnutrition (4.50; 2.08–9.72; <em>P</em> &lt; .001) with mycobacterial infections. An additional analysis was conducted on mycobacteria, including <em>M. tuberculosis</em> and NTM. At multivariable analysis, <em>M. tuberculosis</em> was independently associated with malnutrition only (OR, 5.14; 95% CI, 2.21–11.93; <em>P</em> &lt; .001). At univariate analysis, patients with AIDS were at higher risk for NTM (23.06; 4.39–121.12; <em>P</em> &lt; .001).</p><p>A subanalysis was conducted among patients with chronic steroid use versus other risk factors for immunocompromise. Patients with chronic steroid use seemed to be more frequently affected by bacteria not covered by standard CAP therapy (10 [3.4%] vs 1 [0.3%] patients; <em>P</em> = .002), <em>Nocardia</em> spp. in particular (4 [0.4%] vs 0 [0.0%]; <em>P</em> = .03). No differences in the severity of the disease were found (see ).</p> <h2>DISCUSSION</h2>\n<p>The main findings of the present study are as follows: (1) 17.6% of patients admitted with pneumonia from the community have ≥1 risk factor for immunocompromise, with significant differences among continents and countries (ranging from 15.4% to 24.8% by continent and from 80.0% to 4.1% by country); (2) chronic steroid use is by far the most prevalent risk factor leading to immunocompromise, followed by hematological cancer and chemotherapy; (3) 1 of 2 immunocompromised patients has an overlap of ≥2 risk factors, which are also associated between one another in different ways; and (4) the 2 risk factors for immunocompromise independently associated with specific pathogens are AIDS (ie, fungal and mycobacterial infections) and hematological cancer (ie, fungal infection and viral infections other than influenza).</p><p>Almost 1 in 5 hospitalized patients with CAP are not immunocompetent. Therefore, it is mandatory to provide clinicians with recommendations or guidelines for the management of hospitalized patients with pneumonia coming from the community who have risk factors for immunocompromise. Currently, there are no guidelines for assessing pneumonia in immunocompromised patients coming from the community. Randomized controlled trials (RCTs) and observational prospective studies are missing owing to the fact that, generally, studies assessing management strategies for pneumonia exclude immunocompromised patients or take into account only a single specific risk factor []. This lack of information about immunocompromise could lead to both underestimation of the real prevalence with a higher rate of treatment failure and to overestimation and overuse of wide-spectrum antibiotics.</p><p>We found a 17.6% global prevalence of immunocompromise among patients coming from the community with pneumonia, with a significantly higher frequency in South and North America. This variability among continents and countries is probably attributable to different healthcare systems and rates of hospitalization of immunocompromised patients. Our analysis showed that the most frequent risk factor for immunocompromise is the chronic use of systemic steroids. Aging of the population and therapeutic advancements have favored the increased burden of chronic diseases and long-term therapies with immunosuppressive agents [, ]. In particular, steroids are the agents most frequently prescribed, for their wide spectrum of efficacy in several diseases [, , ]. Therefore, many patients presenting to the emergency room with pneumonia are receiving chronic steroid treatment. No data are available on this population group, and further studies are needed to characterize these patients and provide individualized management.</p><p>Hematological cancer and chemotherapy were other leading immunocompromised factors. These findings are consistent with those in previous studies; patients recruited in observational studies include patients with solid or hematological cancer and those who underwent chemotherapy with associated neutropenia [, ]. Dedicated guidelines and recommendations are available, especially on respiratory viruses, fungi, and <em>P. jirovecii</em> [].</p><p>Our network analysis showed that several risk factors for immunocompromise show associations, especially chemotherapy, associated with hematological cancer and solid tumor, and other immunocompromise, associated with chronic steroid use. Moreover, neutropenic patients are well represented and mainly affected also by hematological cancer or under treatment with chemotherapy. Our results suggest that patients may have &gt;1 risk factor characteristic and clinical assessment should be comprehensive, taking into consideration risk factors for immunocompromise and their associated biological mechanisms. In contrast, AIDS, lung transplantation, asplenia, and aplastic anemia seem to be less frequent at admission and to represent distinct clinical entities. Findings of previous studies seem to be in line with our results, with AIDS patients considered as a distinct patient population and with very few observational studies available on asplenia and aplastic anemia [, ]</p><p>In agreement with previous reports, <em>S. pneumoniae</em> is the leading microorganism in both immunocompromised and immunocompetent groups [, ]. Among pathogens covered by standard CAP therapy, only <em>P. aeruginosa</em> was more frequently isolated in immunocompromised compared with immunocompetent patients. These findings differ from microbiological results of previous studies. Gram-positive bacteria, especially <em>S. aureus</em>, were more frequently identified in patients with immunocompromise of different causes [, , ]. Only Li and coauthors [] found patients with immunological disorders, treated with systemic steroids and cytotoxic agents, to have a higher incidence of infections caused by gram-negative bacteria, mainly <em>P. aeruginosa</em>. This similarity with our findings could be explained by the prevalence of patients exposed to chronic steroids in our cohort.</p><p>Among pathogens not covered by standard CAP therapy, immunocompromised patients were more frequently infected by <em>Nocardia</em> spp., NTM, <em>P. jirovecii</em>, <em>A. fumigatus</em>, and viruses other than influenza. Infections by <em>P. jirovecii</em> and NTM are frequently identified in patients with AIDS []. <em>P. jirovecii</em> is also frequent in other types of immunocompromise, such as solid or hematological cancer in patients who underwent chemotherapy [, , ]. Fungal infections (eg, <em>Candida</em> spp. and <em>A. fumigatus</em>) are highly incident in neutropenic hematological cancer patients [, ]. Viral infections other than influenza, especially respiratory syncytial virus, are more frequent in patients who underwent hematopoietic stem cell or lung transplantation [, ]. Conversely, <em>Nocardia</em> spp. infections are mainly described in solid organ transplant recipients []. These results, consistent with previous findings, suggest the need for a more in-depth microbiological workup, including community-acquired pathogens and microorganisms not covered by standard therapy.</p><p>Surprisingly, we found that risk factors for immunocompromise were not independently associated with <em>P. aeruginosa</em> or non–community-acquired bacteria; in contrast, AIDS and hematological cancer are both associated with fungal, mycobacterial, and noninfluenza viral pneumonia, respectively. Empirical therapy should include <em>P. aeruginosa</em> coverage, which is highly prevalent in immunocompromised patients. On the contrary, particular attention should be given to fungal, mycobacterial, and viral causes should be for patients admitted with AIDS and hematological cancer [].</p><p>Finally, bacteremia rates did not differ between study groups. To our knowledge, there are no studies on bacteremia and immunocompromise in general. The majority of studies have focused on bacteremia in hematopoietic stem cell transplantation, with prevalences varying from 6% to 44% depending on the type of bacteria and host-related factors []. Few studies addressed this topic in kidney transplant recipients, reporting a prevalence of bacteremia ranging from 25% to 69% [, ]. Finally, few studies have addressed HIV and bacteremia, with prevalences ranging from 10% to 25%, depending on the pathogen and grade of immunosuppression [, ]. The prevalence of bacteremia in our study was 5T–6% in both immunocompetent and immunocompromised patients. Differences in the prevalence of bacteremia are due mainly to differences between the risk factors for immunocompromise in our study (chronic steroid use, hematological cancer, and chemotherapy) and those previously reported in the literature.</p><p>The current study has both limitations and strengths. First of all, to our knowledge, this is the first study showing a worldwide perspective on immunocompromise among patients coming from the community with pneumonia, with a large and diverse sample of patients enrolled across different countries in 6 continents. However, we were not able to involve many investigators from Asia and Africa, and most cases occurred in North America and Europe, thus limiting the generalizability of our findings. Another major limitation is the unfeasibility of grading the severity of immunocompromise and, therefore, stratifying patients and defining the physiopathological interaction between different risk factors, especially with regard to the use of biological drugs and chronic steroids. Furthermore, potentially important risk factors for an immunocompromised state, such as solid organ transplants other than lung, have not been specifically investigated. Finally, no outcome data have been collected, and this strongly limits our speculations as to the correct empiric antibiotic therapy for use in immunocompromised patients with CAP.</p><p>In conclusion, our study offers to the scientific community a perspective on immunocompromised patients coming from the community with pneumonia. Future prospective studies on patients with specific risk factors for immunocompromise could provide practical recommendations. In particular, it will be crucial to prepare guidelines on certain prevalent population groups, such as patients exposed to chronic steroids and those with hematological cancer.</p> <h2>Supplementary Data</h2>\n<p>Supplementary materials are available at <em>Clinical Infectious Diseases</em> online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.</p> <h2>Notes</h2>\n<p><strong><em>Author contributions.</em></strong> M. F. D. P., G. S., S. A., and M. I. R. participated in study design, analysis of data, and writing of the manuscript and take responsibility for the integrity of the work. A. G., D. R., S. T., L. F. R., J. R., J. G. d. C., and F. B. critically reviewed the final manuscript.</p><p><strong><em>Acknowledgments.</em></strong> We thank the Asociacion Latinoamericana de Torax, European Respiratory Society, World Federation of Societies of Intensive and Critical Care Medicine, and American College of Chest Physicians for their support of this project. We also thank the following study contributors for their valuable collaboration. <strong>Argentina:</strong> Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires), Silvia Attorri (Hospital Luis Lago Maggiore, Mendoza), Enrique Barimboim (Hospital Central de Mendoza), Juan Pablo Caeiro and María I. Garzón (Hospital Privado Universitario, Córdoba), Victor Hugo Cambursano, A. Cazaux (Servicio de Neumologia, Hospital Rawson, Córdoba), Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas), Julio Chertcoff, Florencia Lascar, and Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital), Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza), Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires) Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos Vicente Lopez y Planes from General Rodriguez, Buenos Aires), Sandra Lambert (Hospital El Cruce–Alta Complejidad en Red), Gustavo Lopardo (Hospital Bernardo Houssay, Vicente López), Carlos M. Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires), Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen), Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos), Antonio A. Cetrangolo (an individual who is being acknowledged for his contribution to the study), Claudia Pensotti (Infectious Diseases and Infection Control Department, Clinica Privada Monte Grande, Buenos Aires), Betiana Pereyra (Hospital San Roque, Córdoba), Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D. F. Santojanni), Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela); <strong>Australia:</strong> Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg); <strong>Austria:</strong> Felix Lötsch and Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna); <strong>Belgium:</strong> Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp), Camille A. Francois (Anesthesia and Critical Care Department, Erasme University Hospital, Brussels), Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital), Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels); <strong>Benin:</strong> Marcel Zannou Djimon, Jules Bashi and Roger Dodo (Centre Hospitalier Universitaire HKM of Cotonou); <strong>Brazil:</strong> Simone Aranha Nouér (Federal University of Rio de Janeiro); <strong>Bulgaria:</strong> Peter Chipev and Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofia), Darina Miteva, (UMHAT St Marina, Varna), Diana Petkova (University Hospital Varna); <strong>Cameroon:</strong> Adamou Dodo Balkissou (Yaounde Jamot Hospital, Yaounde), Eric Walter Pefura Yone (Département de Médecine Interne, University of Yaounde), Bertrand Hugo Mbatchou Ngahane (Douala General Hospital); <strong>China:</strong> Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing), Jin-fu Xu (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University); <strong>Colombia:</strong> Carlos Andres Bustamante Rico and Ricardo Buitrago (Clinica Shaio, Bogota), Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin); <strong>Congo:</strong> Jean-Marie Kayembe Ntumba (Cliniques Universitaires de Kinshasa); <strong>Croatia:</strong> Vesna Vladic Carevic (Interne Medicine, Dubrovnik), Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb), Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases), Zinka Matkovic (University Hospital Dubrava, Zagreb), Ivan Mitrecic (Karlovac General Hospital); <strong>Denmark:</strong> Marie-Laure Bouchy Jacobsson (Emergency Department, North Zealand’s Hospital–Hillerød), Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital), Uffe Christian Heitmann Bødtger (Department of Pulmonology, Naestved Hospital), Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde), Andreas Vestergaard Jensen, Gertrud Baunbæk-Knudsen, Pelle Trier Petersen, and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød); <strong>Egypt:</strong> Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University), Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University), Hanaa Shafiek (Chest Diseases Department, Faculty of Medicine, Alexandria University), Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo); <strong>Ethiopia:</strong> Kedir Abdella Abdulsemed (Department of Medical Laboratory Science and Pathology, College of Health Sciences, Mycobacteriology Research Centre, Institute of Biotechnology Research, Jimma University); <strong>France:</strong> Fabrice Bertrand (Critical Care Unit, Robert Ballanger Hospital, Aulnay sous Bois), Christian Brun-Buisson (University Hospital of Henri-Mondor, Créteil), Etienne de Montmollin (Intensive Care Unit, Hôpital Delafontaine, Centre Hospitalier de Saint-Denis), Muriel Fartoukh (Unité de Réanimation Médico-Chirurgicale, Pôle Thorax Voies Aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien), Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médico-chirurgicale, Hôpital Louis Mourier, Colombes, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité), Pierre Tattevin (Infectious Diseases and ICU, Pontchaillou University Hospital, Rennes), Abdo Khoury (Department of Emergency Medicine and Critical Care, University of Franche–Comté, Medical Center); <strong>Gambia:</strong> Bernard Ebruke (Medical Research Council Unit, Fajara, Gambia); <strong>Germany:</strong> Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen), Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden), Matthias Meisinger, Klinikum Niederlausitz, Klinik für Innere Medizin und Intensivmedizin, Senftenberg), Mathias W. Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital), Jan Rupp (Department of Infectious Diseases and Microbiology, University of Lübeck), Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg), Marc Spielmanns (Internal Medicine Department, Pulmonary Rehabilitation and Department of Health, School of Medicine, University Witten-Herdecke, St Remigius Hospital, Leverkusen) Petra Creutz and Norton Suttorp (Department of Infectious Disease and Respiratory Medicine, Charité–University Medicine, Berlin); <strong>Ghana</strong>: Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi); <strong>Greece</strong>: Katerina Dimakou (5th Respiratory Medicine Department, SOTIRIA Chest Hospital, Athens), Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens), Evdoxia Tsigou and Dimitrios Ampazis (Agioi Anargiroi Hospital, Kifissia, Athens), Evangelos Kaimakamis (Intensive Care Unit, G. Papanikolaou General Hospital of Thessaloniki); <strong>India</strong>: Mohit Bhatia (S. S. Hospital IMS BHU Varanasi), Raja Dhar (Fortis Hospitals, Kolkata), George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore), Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow), Parvaiz A. Koul (Department of Internal and Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar), P. A. Mahesh and B. S. Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore), Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala), Hirennappa B. Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka), Surya Kant (Department of Respiratory Medicine, King George’s Medical University, Chowk, Lucknow, Uttar Pradesh), Rajesh Swarnakar (Getwell Hospital and Research Institute, Dhantoli, Nagpur), Sneha Limaye and Sundeep Salvi (on behalf of the Respiratory Research Network of India from the Chest Research Foundation in Pune); <strong>Iran</strong>: Keihan Golshani (Isfahan University of Medical Sciences); <strong>Ireland</strong>: Vera M. Keatings (Letterkenny General Hospital, County Donegal), Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization, St James’s University Hospital, Trinity Centre for Health Sciences Dublin); <strong>Israel</strong>: Yasmin Maor (Infectious Disease Unit, affiliated with Tel Aviv University, Wolfson Medical Center, Holon), Jacob Strahilevitz (Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem); <strong>Italy</strong>: Salvatore Battaglia, University of Palermo, Pneumologia DiBiMIS, Palermo), Maria Carrabba (Internal Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca’ Granda Ospedale Maggiore Policlinico, Milano), Piero Ceriana (Pulmonary Rehabilitation, IRCCS Fondazione Maugeri, Pavia), Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste), Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan), Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples), Marino De Rosa (Unità Operativa Complessa [UOC] Pneumologia PO San Filippo Neri Azienda Sanitaria Locale Roma E Roma), Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena), Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria Azienda Ospedaliera Ospedali dei Colli PO Monaldi), Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, Sardegna), Francesco Menzella (Department of Cardiac-Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS–Arcispedale Santa Maria Nuova, Reggio Emilia), Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S. Anna Nuovo, Unità Operativa di Pneumologia, Como), Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital), Gerardo Palmiero (Respiratory Unit, Versilia Hospital, Lido di Camaiore, Lucca), Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli), Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero–Universitaria S. Maria della Misericordia, Udine), Claudio Sorino, Pulmonology Unit, A. O. Sant’Anna di Como), Gundi Steinhilber (Spedali Civili Brescia, U. O. Pneumologia e Fisiopatologia Respiratoria, Brescia), Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta), Fabio Franzetti, Manuela Carugati, Manuela Morosi, and Elisa Monge (Department of Biomedical and Clinical Sciences, Division of Infectious Diseases, Luigi Sacco Hospital, Università degli Studi di Milano), Mauro Carone, (Fondazione Salvatore Maugeri, IRCCS, Cassano Murge), Vincenzo Patella (Allergology and Clinical Immunology Unit, Department of Medical Sciences, Battipaglia Hospital, Battipaglia, Salerno), Simone Scarlata (Geriatrics, Unit of Respiratory Pathophysiology and Thoracic Endoscopy, Campus Bio Medico University and Teaching Hospital, Rome), Andrea Comel, UO Pneumologia, Ospedale Pederzoli, Peschiera del Garda); <strong>Japan</strong>: Kiyoyasu Kurahashi (Yokohama City University Medical Center); <strong>Lebanon</strong>: Zeina Aoun Bacha (Medicine School, St Joseph University, Beyrouth); <strong>Mexico</strong>: Daniel Barajas Ugalde (National Institute of Respiratory Diseases), Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California), José F. Villegas (Hospital Universitario Monterrey); <strong>Montenegro</strong>: Milic Medenica (Hospital for Lung Diseases–Brezovik, Niksic); <strong>Netherlands</strong>: E. M. W. van de Garde (Department of Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein); <strong>Nepal</strong>: Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences), Poojan Shrestha (Oxford University Clinical Research Unit, Patan Hospital); <strong>New Zealand</strong>: Elliott Ridgeon (Medical Research Institute of New Zealand); <strong>Nigeria</strong>: Babatunde Ishola Awokola (Department of Family Medicine and Primary Care, Lily Hospitals Limited, Warri), Ogonna N. O. Nwankwo (University of Calabar Teaching Hospital), Adefuye Bolanle Olufunlola (Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State), Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan), Kingsley N. Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State); <strong>Pakistan</strong>: Muhammad Irfan, Section of Pulmonary and Critical Care Medicine (Department of Medicine, Aga Khan University, Karachi); <strong>Poland</strong>: Lukasz Minarowski (Department of Lung Diseases and Tuberculosis, Medical University of Bialystok), Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec); <strong>Portugal</strong>: Felipe Froes (Hospital Pulido Valente–CHLN, Lisboa), Pedro Leuschner, (Centro Hospitalar do Porto), Mariana Meireles, Cláudia Ferrão, Pedro Leuschner, and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo Prof Abel Salazar, Porto), Sofia B. Ravara (Faculty of Health Sciences, University of Beira Interior, Cova da Beira Hospital Center, Covilhã); <strong>Republic of Moldova</strong>: Victoria Brocovschii (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu), Chesov Ion (Clinic of Anesthesia and Intensive Care Valeriu Ghrerg, Institute of Emergency Medicine, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau), Doina Rusu (SMFU N. Testemitanu, Chisinau), Cristina Toma (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau); <strong>Romania</strong>: Daniela Chirita (Hospital Sfantul Stefan, Bucharest), Carmen Mihaela Dorobat (Universitatea de Medicină şi Farmacie Gr T. Popa I a ş i Facultatea de Medicină Stomatologică, Spitalul Clinic de Boli Infecţioase Sfânta Parascheva I a ş i Iaşi); <strong>Russia</strong>: Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S. I. Georgievsky), Anna Kaluzhenina (Volgograd State Medical University); <strong>Saudi Arabia</strong>: Abdullah Almotairi (King Fahad Medical City, Riyadh), Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina), Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh), Amal Fathy (Pulmonary and Respiratory Critical Care Medicine, Mansoura University Egypt, Affiliate at Taibah University), Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh), Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa), Abdelhaleem Bella (Dammam University–Saudi Arabia and King Fahad Hospital); <strong>Serbia</strong>: Nada Bogdanović (Pulmonary Department of KHC, Dragiša Mišović, Belgrade), Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade), Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade); <strong>Spain</strong>: Luis Borderìas (Respiratory and Sleep Unit, Hospital San Jorge, Huesca), Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at Sant Joan Despí), Hugo Cabello Alarcón (Sant Hospital Seu de Urgell, Catalonia), Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona), Vicens Diaz-Brito and Xavier Casas (Infectious Diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona), Alicia Encabo González (Hospital Complex of Pontevedra), Maria Luisa Fernández-Almira (Medicina Interna, Hospital Universitario Central de Asturias), Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, and CIBER de Enfermedades Respiratorias, CIBERES, Bunyola), Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga), Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid), Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante), Elena Laserna Martínez (Hospital Mollet, Barcelona), Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid), Pedro J. Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña, INIBIC, Sergas, Universidade de A Coruña), Rosario Menéndez (Pneumology Service, University and Polytechnic Hospital La Fe, Valencia), Ana Pando-Sandoval (Hospital Universitario Central de Asturias, Area de Gestion Clinica de Pulmon, Servicio de Neumologia, Oviedo), Cristina Prat Aymerich, Alicia Lacoma de la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, and Universitat Autònoma de Barcelona, CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III), Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d’Hebron, Barcelona), Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia), Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona), Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria), Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo), Job F. M. van Boven (Hospital Universitari Son Espases, Palma de Mallorca), Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró); <strong>South Africa</strong>: Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand); <strong>South Korea</strong>: Ho Kee Yum (Inje University Seoul Paik Hospital); <strong>Togo</strong>: Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University Hospital of Sylvanus Olympio, Lomé); <strong>Tunisia</strong>: Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security, Marsa, Tunis); <strong>Turkey</strong>: Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir), Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul), Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir); <strong>Ukraine</strong>: Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa Regional Antituberculosis Hospital, Vinnitsa); <strong>United Arab Emirates</strong>: Naheed Elahi (Dubai Hospital); <strong>United Kingdom</strong>: Devesh J. Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife), Andrew Feneley, Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann, University Hospitals of Leicester NHS Trust and University of Leicester), Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool), Adam T. Hill (Royal Infirmary and University of Edinburgh), Banu Rudran (The Royal London Hospital, Barts Health Trust, London), Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, East Kilbride), Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds), Alexander Youzguin (Southport and Ormskirk Hospitals NHS Trust), Anika Singanayagam (Imperial College Healthcare NHS Trust, London); <strong>United States</strong>: Karen S. Allen (University of Oklahoma Health Sciences Center, Oklahoma City), Veronica Brito (Texas A&amp;M Health Science Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Baylor Scott &amp; White Health, Temple); Jessica Dietz (Fargo VA Health Care System, Fargo, North Dakota), Claire E. Dysart and Susan M. Kellie (Clement J. Zablocki VA Medical Center, Milwaukee, Wisconsin; Division of Infectious Diseases, University of New Mexico School of Medicine; and Raymond G. Murphy VA Medical Center, Albuquerque, New Mexico), Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, Illinois), Mina Gaga (7th Respiratory Medical Department and Asthma Center, Athens Chest Hospital), Thomas L. Holland and Stephen P. Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, Durham), Fayez Kheir (Department of Pulmonary Diseases, Critical Care and Environmental Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana), Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, Illinois), Manuel Lois (John Peter Smith Hospital, Fort Worth, Texas), Girish B. Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook, and Winthrop University Hospital, Mineola, New York), Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, Denver), Katherine Reyes (Henry Ford Hospital, Detroit, Illinois), William Rodriguez-Cintron, (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, San Juan Puerto Rico), Shigeki Saito (Tulane University, New Orleans), Nilam J. Soni, Julio Noda, Cecilia I. Hinojosa, Stephanie M. Levine, Luis F. Angel, and Antonio Anzueto (Divisions of Hospital Medicine and Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio), K. Scott Whitlow, John Hipskind, Kunal Sukhija, and Vicken Totten (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, California), Richard G. Wunderink and Ray D. Shah (Northwestern University Feinberg School of Medicine, Chicago, Illinois); <strong>Zambia</strong>: Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka). <strong>Other investigators</strong>: Lorena Noriega, Ezequiel Alvarado, Mohamed Aman, and Lucía Labra.</p><p><strong><em>Disclaimer.</em></strong> The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute, the National Institutes of Health, or the Department of Veterans Affairs.</p><p><strong><em>Financial support.</em></strong> This project was not funded and relied solely on voluntary site and investigator participation. M. I. R.’s time is partially protected by the National Heart, Lung, and Blood Institute (award K23HL096054).</p><p><strong><em>Potential conflicts of interest.</em></strong> F. B. reports personal fees from AstraZeneca, GlaxoSmithKline, Guidotti, Grifols, Menarini, and Novartis, and grants and personal fees from Bayer, Chiesi, Insmed, Pfizer, Teva, and Zambon, outside the submitted work. All other authors report no potential conflicts.</p> <h2>References</h2>\n<div><div><div><div><span>1.</span><div><div>Aliberti</div> <div>S</div>, <span><div>Di Pasquale</div> <div>M</div></span>, <span><div>Zanaboni</div> <div>AM</div></span>, et al. <div>Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia</div>. <div>Clin Infect Dis</div><div>2012</div>; <div>54</div>:<div>470</div>–<div>8</div>.</div></div></div></div><div><div><div><span>2.</span><div><div>Aliberti</div> <div>S</div>, <span><div>Cilloniz</div> <div>C</div></span>, <span><div>Chalmers</div> <div>JD</div></span>, et al. <div>Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective</div>. <div>Thorax</div><div>2013</div>; <div>68</div>:<div>997</div>–<div>9</div>.</div></div></div></div><div><div><div><span>3.</span><div><div>Shindo</div> <div>Y</div>, <span><div>Ito</div> <div>R</div></span>, <span><div>Kobayashi</div> <div>D</div></span>, et al. <div>Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia</div>. <div>Am J Respir Crit Care Med</div><div>2013</div>; <div>188</div>:<div>985</div>–<div>95</div>.</div></div></div></div><div><div><div><span>4.</span><div><div>Musher</div> <div>DM</div>, <span><div>Thorner</div> <div>AR</div></span>. <div>Community-acquired pneumonia</div>. <div>N Engl J Med</div><div>2014</div>; <div>371</div>:<div>1619</div>–<div>28</div>.</div></div></div></div><div><div><div><span>5.</span><div><div>Mandell</div> <div>LA</div>, <span><div>Wunderink</div> <div>RG</div></span>, <span><div>Anzueto</div> <div>A</div></span>, et al. ; <span><div>Infectious Diseases Society of America; American Thoracic Society</div></span>. <div>Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults</div>. <div>Clin Infect Dis</div><div>2007</div>; <div>44</div>(<div>suppl 2</div>):<div>S27</div>–<div>72</div>.</div></div></div></div><div><div><div><span>6.</span><div><div>Lim</div> <div>WS</div>, <span><div>Baudouin</div> <div>SV</div></span>, <span><div>George</div> <div>RC</div></span>, et al. <div>BTS guidelines for the management of community acquired pneumonia in adults</div>. <div>Thorax</div><div>2009</div>; <div>64</div>(<div>suppl III</div>):<div>iii1</div>–<div>55</div>.</div></div></div></div><div><div><div><span>7.</span><div><div>Woodhead</div> <div>M</div>, <span><div>Blasi</div> <div>F</div></span>, <span><div>Ewig</div> <div>S</div></span>, et al. ; <span><div>Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases</div></span>. <div>Guidelines for the management of adult lower respiratory tract infections—full version</div>. <div>Clin Microbiol Infect</div><div>2011</div>; <div>17(suppl 6)</div>:<div>E1</div>–<div>59</div>.</div></div></div></div><div><div><div><span>8.</span><div><div>Furman</div> <div>CD</div>, <span><div>Rayner</div> <div>AV</div></span>, <span><div>Tobin</div> <div>EP</div></span>. <div>Pneumonia in older residents of long-term care facilities</div>. <div>Am Fam Physician</div><div>2004</div>; <div>70</div>:<div>1495</div>–<div>500</div>.</div></div></div></div><div><div><div><span>9.</span><div><div>Cillóniz</div> <div>C</div>, <span><div>Polverino</div> <div>E</div></span>, <span><div>Ewig</div> <div>S</div></span>, et al. <div>Impact of age and comorbidity on cause and outcome in community-acquired pneumonia</div>. <div>Chest</div><div>2013</div>; <div>144</div>:<div>999</div>–<div>1007</div>.</div></div></div></div><div><div><div><span>10.</span><div><div>Aliberti</div> <div>S</div>, <span><div>Reyes</div> <div>LF</div></span>, <span><div>Faverio</div> <div>P</div></span>, et al. ; <span><div>GLIMP investigators</div></span>. <div>Global Initiative for Meticillin-Resistant <em>Staphylococcus aureus</em> Pneumonia (GLIMP): an international, observational cohort study</div>. <div>Lancet Infect Dis</div><div>2016</div>; <div>16</div>:<div>1364</div>–<div>76</div>.</div></div></div></div><div><div><div><span>11.</span><div><div>Magiorakos</div> <div>AP</div>, <span><div>Srinivasan</div> <div>A</div></span>, <span><div>Carey</div> <div>RB</div></span>, et al. <div>Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance</div>. <div>Clin Microbiol Infect</div><div>2012</div>; <div>18</div>:<div>268</div>–<div>81</div>.</div></div></div></div><div><div><div><span>12.</span><div><div>Wan</div> <div>QJ</div>, <span><div>Hu</div> <div>HF</div></span>, <span><div>He</div> <div>YC</div></span>, et al. <div>Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy</div>. <div>Kaohsiung J Med Sci</div><div>2015</div>; <div>31</div>:<div>42</div>–<div>6</div>.</div></div></div></div><div><div><div><span>13.</span><div><div>Li</div> <div>F</div>, <span><div>Jin</div> <div>HZ</div></span>, <span><div>Su</div> <div>F</div></span>, <span><div>Jia</div> <div>L</div></span>, <span><div>Sun</div> <div>QN</div></span>. <div>Pneumocystis pneumonia in patients with immunobullous dermatoses</div>. <div>Int J Dermatol</div><div>2011</div>; <div>50</div>:<div>1144</div>–<div>9</div>.</div></div></div></div><div><div><div><span>14.</span><div><div>Gruson</div> <div>D</div>, <span><div>Vargas</div> <div>F</div></span>, <span><div>Hilbert</div> <div>G</div></span>, et al. <div>Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia</div>. <div>Intensive Care Med</div><div>2004</div>; <div>30</div>:<div>965</div>–<div>71</div>.</div></div></div></div><div><div><div><span>15.</span><div><div>Garcia</div> <div>JB</div>, <span><div>Lei</div> <div>X</div></span>, <span><div>Wierda</div> <div>W</div></span>, et al. <div>Pneumonia during remission induction chemotherapy in patients with acute leukemia</div>. <div>Ann Am Thorac Soc</div><div>2013</div>; <div>10</div>:<div>432</div>–<div>40</div>.</div></div></div></div><div><div><div><span>16.</span><div><div>Lee</div> <div>JO</div>, <span><div>Kim</div> <div>DY</div></span>, <span><div>Lim</div> <div>JH</div></span>, et al. <div>Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients</div>. <div>Lung Cancer</div><div>2008</div>; <div>62</div>:<div>381</div>–<div>4</div>.</div></div></div></div><div><div><div><span>17.</span><div><div>Lim</div> <div>KH</div>, <span><div>Yoon</div> <div>HI</div></span>, <span><div>Kang</div> <div>YA</div></span>, et al. <div>Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab</div>. <div>Korean J Intern Med</div><div>2010</div>; <div>25</div>:<div>86</div>–<div>92</div>.</div></div></div></div><div><div><div><span>18.</span><div><div>Waks</div> <div>AG</div>, <span><div>Tolaney</div> <div>SM</div></span>, <span><div>Galar</div> <div>A</div></span>, et al. <div><em>Pneumocystis jiroveci</em> pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors</div>. <div>Breast Cancer Res Treat</div><div>2015</div>; <div>154</div>:<div>359</div>–<div>67</div>.</div></div></div></div><div><div><div><span>19.</span><div><div>Kim</div> <div>T</div>, <span><div>Choi</div> <div>SH</div></span>, <span><div>Kim</div> <div>SH</div></span>, et al. <div>Point prevalence of <em>Pneumocystis</em> pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy</div>. <div>Ann Hematol</div><div>2013</div>; <div>92</div>:<div>231</div>–<div>8</div>.</div></div></div></div><div><div><div><span>20.</span><div><div>Aliberti</div> <div>S</div>, <span><div>Myers</div> <div>JA</div></span>, <span><div>Peyrani</div> <div>P</div></span>, et al. <div>The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia</div>. <div>Eur Respir J</div><div>2009</div>; <div>33</div>:<div>142</div>–<div>7</div>.</div></div></div></div><div><div><div><span>21.</span><div><div>Sogaard</div> <div>OS</div>, <span><div>Lohse</div> <div>N</div></span>, <span><div>Gerstoft</div> <div>J</div></span>, et al. <div>Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study</div>. <div>Clin Infect Dis</div><div>2008</div>; <div>47</div>:<div>1345</div>–<div>53</div>.</div></div></div></div><div><div><div><span>22.</span><div><div>Kuehnhardt</div> <div>D</div>, <span><div>Hannemann</div> <div>M</div></span>, <span><div>Schmidt</div> <div>B</div></span>, <span><div>Heider</div> <div>U</div></span>, <span><div>Possinger</div> <div>K</div></span>, <span><div>Eucker</div> <div>J</div></span>. <div>Therapeutic implication of BAL in patients with neutropenia</div>. <div>Ann Hematol</div><div>2009</div>; <div>88</div>:<div>1249</div>–<div>56</div>.</div></div></div></div><div><div><div><span>23.</span><div><div>Maschmeyer</div> <div>G</div>, <span><div>Beinert</div> <div>T</div></span>, <span><div>Buchheidt</div> <div>D</div></span>, et al. <div>Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the Infectious Diseases Working Party of the German Society of Haematology and Oncology</div>. <div>Eur J Cancer</div><div>2009</div>; <div>45</div>:<div>2462</div>–<div>72</div>.</div></div></div></div><div><div><div><span>24.</span><div><div>Alanio</div> <div>A</div>, <span><div>Hauser</div> <div>PM</div></span>, <span><div>Lagrou</div> <div>K</div></span>, et al. ; <span><div>5th European Conference on Infections in Leukemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN)</div></span>. <div>ECIL guidelines for the diagnosis of <em>Pneumocystis jirovecii</em> pneumonia in patients with haematological malignancies and stem cell transplant recipients</div>. <div>J Antimicrob Chemother</div><div>2016</div>; <div>71</div>:<div>2386</div>–<div>96</div>.</div></div></div></div><div><div><div><span>25.</span><div><div>Freifeld</div> <div>AG</div>, <span><div>Bow</div> <div>EJ</div></span>, <span><div>Sepkowitz</div> <div>KA</div></span>, et al. ; <span><div>Infectious Diseases Society of America</div></span>. <div>Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America</div>. <div>Clin Infect Dis</div><div>2011</div>; <div>52</div>:<div>e56</div>–<div>93</div>.</div></div></div></div><div><div><div><span>26.</span><div><div>Chemaly</div> <div>RF</div>, <span><div>Shah</div> <div>DP</div></span>, <span><div>Boeckh</div> <div>MJ</div></span>. <div>Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies</div>. <div>Clin Infect Dis</div><div>2014</div>; <div>59</div>(<div>suppl 5</div>):<div>S344</div>–<div>51</div>.</div></div></div></div><div><div><div><span>27.</span><div><div>Buchacz</div> <div>K</div>, <span><div>Lau</div> <div>B</div></span>, <span><div>Jing</div> <div>Y</div></span>, et al. ; <span><div>North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA</div></span>. <div>Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010</div>. <div>J Infect Dis</div><div>2016</div>; <div>214</div>:<div>862</div>–<div>72</div>.</div></div></div></div><div><div><div><span>28.</span><div><div>Madeddu</div> <div>G</div>, <span><div>Porqueddu</div> <div>EM</div></span>, <span><div>Cambosu</div> <div>F</div></span>, et al. <div>Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era</div>. <div>Infection</div><div>2008</div>; <div>36</div>:<div>231</div>–<div>6</div>.</div></div></div></div><div><div><div><span>29.</span><div><div>Park</div> <div>DR</div>, <span><div>Sherbin</div> <div>VL</div></span>, <span><div>Goodman</div> <div>MS</div></span>, et al. ; <span><div>Harborview CAP Study Group</div></span>. <div>The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness</div>. <div>J Infect Dis</div><div>2001</div>; <div>184</div>:<div>268</div>–<div>77</div>.</div></div></div></div><div><div><div><span>30.</span><div><div>Torres</div> <div>HA</div>, <span><div>Bodey</div> <div>GP</div></span>, <span><div>Rolston</div> <div>KV</div></span>, <span><div>Kantarjian</div> <div>HM</div></span>, <span><div>Raad</div> <div>II</div></span>, <span><div>Kontoyiannis</div> <div>DP</div></span>. <div>Infections in patients with aplastic anemia: experience at a tertiary care cancer center</div>. <div>Cancer</div><div>2003</div>; <div>98</div>:<div>86</div>–<div>93</div>.</div></div></div></div><div><div><div><span>31.</span><div><div>Gil-Prieto</div> <div>R</div>, <span><div>Pascual-Garcia</div> <div>R</div></span>, <span><div>Walter</div> <div>S</div></span>, <span><div>Álvaro-Meca</div> <div>A</div></span>, <span><div>Gil-De-Miguel</div> <div>Á</div></span>. <div>Risk of hospitalization due to pneumococcal disease in adults in Spain: the CORIENNE study</div>. <div>Hum Vaccin Immunother</div><div>2016</div>; <div>12</div>:<div>1900</div>–<div>5</div>.</div></div></div></div><div><div><div><span>32.</span><div><div>Putot</div> <div>A</div>, <span><div>Tetu</div> <div>J</div></span>, <span><div>Perrin</div> <div>S</div></span>, et al. <div>Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients</div>. <div>Eur J Clin Microbiol Infect Dis</div><div>2016</div>; <div>35</div>:<div>489</div>–<div>95</div>.</div></div></div></div><div><div><div><span>33.</span><div><div>Polverino</div> <div>E</div>, <span><div>Dambrava</div> <div>P</div></span>, <span><div>Cillóniz</div> <div>C</div></span>, et al. <div>Nursing home-acquired pneumonia: a 10 year single-centre experience</div>. <div>Thorax</div><div>2010</div>; <div>65</div>:<div>354</div>–<div>9</div>.</div></div></div></div><div><div><div><span>34.</span><div><div>Kohli</div> <div>R</div>, <span><div>Lo</div> <div>Y</div></span>, <span><div>Homel</div> <div>P</div></span>, et al. ; <span><div>HER Study Group</div></span>. <div>Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study</div>. <div>Clin Infect Dis</div><div>2006</div>; <div>43</div>:<div>90</div>–<div>8</div>.</div></div></div></div><div><div><div><span>35.</span><div><div>Benito</div> <div>N</div>, <span><div>Rañó</div> <div>A</div></span>, <span><div>Moreno</div> <div>A</div></span>, et al. <div>Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain</div>. <div>J Acquir Immune Defic Syndr</div><div>2001</div>; <div>27</div>:<div>35</div>–<div>43</div>.</div></div></div></div><div><div><div><span>36.</span><div><div>Mori</div> <div>H</div>, <span><div>Ohno</div> <div>Y</div></span>, <span><div>Ito</div> <div>F</div></span>, et al. <div>Polymerase chain reaction positivity of <em>Pneumocystis jirovecii</em> during primary lung cancer treatment</div>. <div>Jpn J Clin Oncol</div><div>2010</div>; <div>40</div>:<div>658</div>–<div>62</div>.</div></div></div></div><div><div><div><span>37.</span><div><div>Boersma</div> <div>WG</div>, <span><div>Erjavec</div> <div>Z</div></span>, <span><div>van der Werf</div> <div>TS</div></span>, <span><div>de Vries-Hosper</div> <div>HG</div></span>, <span><div>Gouw</div> <div>AS</div></span>, <span><div>Manson</div> <div>WL</div></span>. <div>Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL</div>. <div>Respir Med</div><div>2007</div>; <div>101</div>:<div>317</div>–<div>25</div>.</div></div></div></div><div><div><div><span>38.</span><div><div>Mikulska</div> <div>M</div>, <span><div>Del Bono</div> <div>V</div></span>, <span><div>Gandolfo</div> <div>N</div></span>, et al. <div>Epidemiology of viral respiratory tract infections in an outpatient haematology facility</div>. <div>Ann Hematol</div><div>2014</div>; <div>93</div>:<div>669</div>–<div>76</div>.</div></div></div></div><div><div><div><span>39.</span><div><div>Beaird</div> <div>OE</div>, <span><div>Freifeld</div> <div>A</div></span>, <span><div>Ison</div> <div>MG</div></span>, et al. <div>Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative</div>. <div>Transpl Infect Dis</div><div>2016</div>; <div>18</div>:<div>210</div>–<div>5</div>.</div></div></div></div><div><div><div><span>40.</span><div><div>Poonyagariyagorn</div> <div>HK</div>, <span><div>Gershman</div> <div>A</div></span>, <span><div>Avery</div> <div>R</div></span>, et al. <div>Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients</div>. <div>Transpl Infect Dis</div><div>2008</div>; <div>10</div>:<div>403</div>–<div>8</div>.</div></div></div></div><div><div><div><span>41.</span><div><div>Tavadze</div> <div>M</div>, <span><div>Rybicki</div> <div>L</div></span>, <span><div>Mossad</div> <div>S</div></span>, et al. <div>Risk factors for vancomycin-resistant <em>Enterococcus</em> bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation</div>. <div>Bone Marrow Transplant</div><div>2014</div>; <div>49</div>:<div>1310</div>–<div>6</div>.</div></div></div></div><div><div><div><span>42.</span><div><div>Bock</div> <div>AM</div>, <span><div>Cao</div> <div>Q</div></span>, <span><div>Ferrieri</div> <div>P</div></span>, <span><div>Young</div> <div>JA</div></span>, <span><div>Weisdorf</div> <div>DJ</div></span>. <div>Bacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance</div>. <div>Biol Blood Marrow Transplant</div><div>2013</div>; <div>19</div>:<div>102</div>–<div>8</div>.</div></div></div></div><div><div><div><span>43.</span><div><div>Herbers</div> <div>AH</div>, <span><div>de Haan</div> <div>AF</div></span>, <span><div>van der Velden</div> <div>WJ</div></span>, <span><div>Donnelly</div> <div>JP</div></span>, <span><div>Blijlevens</div> <div>NM</div></span>. <div>Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients</div>. <div>Transpl Infect Dis</div><div>2014</div>; <div>16</div>:<div>279</div>–<div>85</div>.</div></div></div></div><div><div><div><span>44.</span><div><div>Wu</div> <div>SW</div>, <span><div>Liu</div> <div>KS</div></span>, <span><div>Lin</div> <div>CK</div></span>, et al. <div>Community-acquired urinary tract infection in kidney transplantation: risk factors for bacteremia and recurrent infection</div>. <div>J Formos Med Assoc</div><div>2013</div>; <div>112</div>:<div>138</div>–<div>43</div>.</div></div></div></div><div><div><div><span>45.</span><div><div>Daskalaki</div> <div>E</div>, <span><div>Koukoulaki</div> <div>M</div></span>, <span><div>Bakalis</div> <div>A</div></span>, et al. <div>Blood stream infections in renal transplant recipients: a single-center study</div>. <div>Transplant Proc</div><div>2014</div>; <div>46</div>:<div>3191</div>–<div>3</div>.</div></div></div></div><div><div><div><span>46.</span><div><div>Huson</div> <div>MA</div>, <span><div>Stolp</div> <div>SM</div></span>, <span><div>van der Poll</div> <div>T</div></span>, <span><div>Grobusch</div> <div>MP</div></span>. <div>Community-acquired bacterial bloodstream infections in HIV-infected patients: a systematic review</div>. <div>Clin Infect Dis</div><div>2014</div>; <div>58</div>:<div>79</div>–<div>92</div>.</div></div></div></div><div><div><div><span>47.</span><div><div>Taramasso</div> <div>L</div>, <span><div>Tatarelli</div> <div>P</div></span>, <span><div>Di Biagio</div> <div>A</div></span>. <div>Bloodstream infections in HIV-infected patients</div>. <div>Virulence</div><div>2016</div>; <div>7</div>:<div>320</div>–<div>8</div>.</div></div></div></div></div> \n\n<div>© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</div><div><div>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<a href=\"https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model\">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</a>)</div></div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>Topic:</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>Issue Section:</div>\n<a href=\"/cid/search-results?f_TocHeadingTitleList=Articles+and+Commentaries\">Articles and Commentaries</a>\n</div>\n</div>\n</div>\n\n<div>\n<a href=\"/DownloadFile/DownloadImage.aspx?image=&amp;PPTtype=SlideSet&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;siteId=5269\">Download all slides</a>\n</div>\n<div>\n<h2>Supplementary data</h2>\n<div> - docx file</div>\n</div>\n\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<div>Advertisement</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<h3>Citations</h3>\n</div>\n<div>\n<h3>Views</h3>\n<div>\n<div>18,086</div>\n</div>\n</div>\n<div>\n<h3>Altmetric</h3>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<h3>Metrics</h3>\n<div>\n<div>\n<div>\n<span>Total Views</span>\n<span>18,086</span>\n</div>\n<div>\n<div>\n<span>11,927</span>\n<span>Pageviews</span>\n</div>\n<div>\n<span>6,159</span>\n<span>PDF Downloads</span>\n</div>\n</div>\n</div>\n<div>Since 8/1/2018</div>\n</div>\n<div>\n<div>\n<table>\n<thead>\n<tr>\n<th>Month:</th>\n<th>Total Views:</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>August 2018</td>\n<td>66</td>\n</tr>\n<tr>\n<td>September 2018</td>\n<td>28</td>\n</tr>\n<tr>\n<td>October 2018</td>\n<td>23</td>\n</tr>\n<tr>\n<td>November 2018</td>\n<td>70</td>\n</tr>\n<tr>\n<td>December 2018</td>\n<td>46</td>\n</tr>\n<tr>\n<td>January 2019</td>\n<td>53</td>\n</tr>\n<tr>\n<td>February 2019</td>\n<td>62</td>\n</tr>\n<tr>\n<td>March 2019</td>\n<td>31</td>\n</tr>\n<tr>\n<td>April 2019</td>\n<td>408</td>\n</tr>\n<tr>\n<td>May 2019</td>\n<td>355</td>\n</tr>\n<tr>\n<td>June 2019</td>\n<td>182</td>\n</tr>\n<tr>\n<td>July 2019</td>\n<td>176</td>\n</tr>\n<tr>\n<td>August 2019</td>\n<td>159</td>\n</tr>\n<tr>\n<td>September 2019</td>\n<td>111</td>\n</tr>\n<tr>\n<td>October 2019</td>\n<td>90</td>\n</tr>\n<tr>\n<td>November 2019</td>\n<td>66</td>\n</tr>\n<tr>\n<td>December 2019</td>\n<td>44</td>\n</tr>\n<tr>\n<td>January 2020</td>\n<td>69</td>\n</tr>\n<tr>\n<td>February 2020</td>\n<td>36</td>\n</tr>\n<tr>\n<td>March 2020</td>\n<td>223</td>\n</tr>\n<tr>\n<td>April 2020</td>\n<td>208</td>\n</tr>\n<tr>\n<td>May 2020</td>\n<td>140</td>\n</tr>\n<tr>\n<td>June 2020</td>\n<td>179</td>\n</tr>\n<tr>\n<td>July 2020</td>\n<td>162</td>\n</tr>\n<tr>\n<td>August 2020</td>\n<td>154</td>\n</tr>\n<tr>\n<td>September 2020</td>\n<td>217</td>\n</tr>\n<tr>\n<td>October 2020</td>\n<td>238</td>\n</tr>\n<tr>\n<td>November 2020</td>\n<td>237</td>\n</tr>\n<tr>\n<td>December 2020</td>\n<td>165</td>\n</tr>\n<tr>\n<td>January 2021</td>\n<td>140</td>\n</tr>\n<tr>\n<td>February 2021</td>\n<td>137</td>\n</tr>\n<tr>\n<td>March 2021</td>\n<td>236</td>\n</tr>\n<tr>\n<td>April 2021</td>\n<td>239</td>\n</tr>\n<tr>\n<td>May 2021</td>\n<td>239</td>\n</tr>\n<tr>\n<td>June 2021</td>\n<td>172</td>\n</tr>\n<tr>\n<td>July 2021</td>\n<td>131</td>\n</tr>\n<tr>\n<td>August 2021</td>\n<td>160</td>\n</tr>\n<tr>\n<td>September 2021</td>\n<td>205</td>\n</tr>\n<tr>\n<td>October 2021</td>\n<td>250</td>\n</tr>\n<tr>\n<td>November 2021</td>\n<td>227</td>\n</tr>\n<tr>\n<td>December 2021</td>\n<td>183</td>\n</tr>\n<tr>\n<td>January 2022</td>\n<td>202</td>\n</tr>\n<tr>\n<td>February 2022</td>\n<td>247</td>\n</tr>\n<tr>\n<td>March 2022</td>\n<td>301</td>\n</tr>\n<tr>\n<td>April 2022</td>\n<td>242</td>\n</tr>\n<tr>\n<td>May 2022</td>\n<td>240</td>\n</tr>\n<tr>\n<td>June 2022</td>\n<td>161</td>\n</tr>\n<tr>\n<td>July 2022</td>\n<td>159</td>\n</tr>\n<tr>\n<td>August 2022</td>\n<td>292</td>\n</tr>\n<tr>\n<td>September 2022</td>\n<td>404</td>\n</tr>\n<tr>\n<td>October 2022</td>\n<td>533</td>\n</tr>\n<tr>\n<td>November 2022</td>\n<td>300</td>\n</tr>\n<tr>\n<td>December 2022</td>\n<td>477</td>\n</tr>\n<tr>\n<td>January 2023</td>\n<td>287</td>\n</tr>\n<tr>\n<td>February 2023</td>\n<td>191</td>\n</tr>\n<tr>\n<td>March 2023</td>\n<td>310</td>\n</tr>\n<tr>\n<td>April 2023</td>\n<td>395</td>\n</tr>\n<tr>\n<td>May 2023</td>\n<td>248</td>\n</tr>\n<tr>\n<td>June 2023</td>\n<td>198</td>\n</tr>\n<tr>\n<td>July 2023</td>\n<td>185</td>\n</tr>\n<tr>\n<td>August 2023</td>\n<td>213</td>\n</tr>\n<tr>\n<td>September 2023</td>\n<td>248</td>\n</tr>\n<tr>\n<td>October 2023</td>\n<td>340</td>\n</tr>\n<tr>\n<td>November 2023</td>\n<td>311</td>\n</tr>\n<tr>\n<td>December 2023</td>\n<td>269</td>\n</tr>\n<tr>\n<td>January 2024</td>\n<td>301</td>\n</tr>\n<tr>\n<td>February 2024</td>\n<td>353</td>\n</tr>\n<tr>\n<td>March 2024</td>\n<td>372</td>\n</tr>\n<tr>\n<td>April 2024</td>\n<td>323</td>\n</tr>\n<tr>\n<td>May 2024</td>\n<td>341</td>\n</tr>\n<tr>\n<td>June 2024</td>\n<td>275</td>\n</tr>\n<tr>\n<td>July 2024</td>\n<td>268</td>\n</tr>\n<tr>\n<td>August 2024</td>\n<td>218</td>\n</tr>\n<tr>\n<td>September 2024</td>\n<td>253</td>\n</tr>\n<tr>\n<td>October 2024</td>\n<td>274</td>\n</tr>\n<tr>\n<td>November 2024</td>\n<td>312</td>\n</tr>\n<tr>\n<td>December 2024</td>\n<td>242</td>\n</tr>\n<tr>\n<td>January 2025</td>\n<td>250</td>\n</tr>\n<tr>\n<td>February 2025</td>\n<td>296</td>\n</tr>\n<tr>\n<td>March 2025</td>\n<td>396</td>\n</tr>\n<tr>\n<td>April 2025</td>\n<td>228</td>\n</tr>\n<tr>\n<td>May 2025</td>\n<td>228</td>\n</tr>\n<tr>\n<td>June 2025</td>\n<td>86</td>\n</tr>\n</tbody>\n</table>\n</div>\n</div>\n<div>\n<div>\n<div>Citations</div>\n<div>\n<span>Powered by Dimensions</span>\n</div>\n<div>\n<span>Web of Science</span>\n</div>\n</div>\n<div>\n<div>Altmetrics</div>\n<div>\n<div>\n<div><div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<b>346</b> readers on Mendeley\n     </div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div></div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<h3>Email alerts</h3>\n<div>\n<a href=\"/cid/new-journals-alert\">\n              New journal issues\n            </a>\n</div>\n<div>\n<a href=\"/cid/new-journal-articles-alert\">\n              New journal articles\n            </a>\n</div>\n<div>\n<button>\n              Activity related to this article\n            </button>\n</div>\n<div>\n<a href=\"/my-account/communication-preferences\">Sign up for marketing</a>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<h2>New journal issues alert</h2>\n</div>\n<div>\n<div>\n<div>\n<div><p>To set up an email alert, please to your personal account, or <a href=\"https://academic.oup.com/my-account/register?siteId=5269&amp;returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\">register</a></p></div>\n<div>\n<div>\n<div>\n<div>\n<h2>Sign in</h2>\n</div>\n</div>\n<div>\n<div>\n<h3>Personal account</h3>\n<ul>\n<li>Sign in with email/username &amp; password</li>\n<li>Get email alerts</li>\n<li>Save searches</li>\n<li>Purchase content</li>\n<li>Activate your purchase/trial code</li>\n<li>Add your ORCID iD</li>\n</ul>\n<div>\n<a href=\"/my-account/register?siteId=5269&amp;returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\">Register</a>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<h2>Journal article activity alert</h2>\n</div>\n<div>\n<div>\n<div>\n<div><p>To set up an email alert, please to your personal account, or <a href=\"https://academic.oup.com/my-account/register?siteId=5269&amp;returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\">register</a></p></div>\n<div>\n<div>\n<div>\n<div>\n<h2>Sign in</h2>\n</div>\n</div>\n<div>\n<div>\n<h3>Personal account</h3>\n<ul>\n<li>Sign in with email/username &amp; password</li>\n<li>Get email alerts</li>\n<li>Save searches</li>\n<li>Purchase content</li>\n<li>Activate your purchase/trial code</li>\n<li>Add your ORCID iD</li>\n</ul>\n<div>\n<a href=\"/my-account/register?siteId=5269&amp;returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\">Register</a>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<button><span>Close Modal</span></button>\n</div>\n</div>\n<div>\n<h3>More on this topic</h3>\n<div>\n<div><a href=\"/cid/article/50/2/202/328880\">Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods</a></div>\n<div><a href=\"/cid/article/12/Supplement_8/S915/296667\">Microbial Agents Associated with Pneumonia in Children from Uruguay</a></div>\n<div><a href=\"/cid/article/59/9/iii/419445\">In the Literature</a></div>\n<div><a href=\"/cid/advance-article/7985365\">Comparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study</a></div>\n</div>\n</div>\n<div>\n<h3>Related articles in PubMed</h3>\n\n</div>\n<div>\n<div>\n<h3>Citing articles via</h3>\n</div>\n</div>\n<div>\n<section>\n<div>\n<div>\n<div>\n<div>\n<div>\n<a href=\"/cid/advance-article/doi/10.1093/cid/ciaf302/8159933?searchresult=1\">\n<div>\nEffectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial Study  </div>\n</a>\n</div>\n<div>\n<a href=\"/cid/advance-article/doi/10.1093/cid/ciaf311/8159932?searchresult=1\">\n<div>\nCharacteristics Associated with Disseminated Gonococcal Infections vs Uncomplicated Gonorrhea: A California Case-Control Study, 2021-2022  </div>\n</a>\n</div>\n<div>\n<a href=\"/cid/advance-article/doi/10.1093/cid/ciaf304/8157607?searchresult=1\">\n<div>\nNon-Operative versus Neurosurgical Treatment of Brain Abscess: An Emulated Trial Nested within a Nationwide, Population-Based Cohort  </div>\n</a>\n</div>\n<div>\n<a href=\"/cid/advance-article/doi/10.1093/cid/ciaf300/8157063?searchresult=1\">\n<div>\nIncidence of AIDS-defining Conditions among Adults with Perinatally Acquired HIV after Transition to Adult HIV Care in the United States and Canada, 2000-2022  </div>\n</a>\n</div>\n<div>\n<a href=\"/cid/article/80/5/e65/8156727?searchresult=1\">\n<div>\nState-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists  </div>\n</a>\n</div>\n</div>\n</div>\n</div></div>\n</section>\n\n</div>\n<div>\n<div>\n<div>More from Oxford Academic</div>\n<div>\n<a href=\"/search-results?tax=AcademicSubjects/MED00160\">Clinical Medicine</a>\n</div>\n<div>\n<a href=\"/search-results?tax=AcademicSubjects/MED00290\">Infectious Diseases</a>\n</div>\n<div>\n<a href=\"/search-results?tax=AcademicSubjects/MED00010\">Medicine and Health</a>\n</div>\n<div>\n<a href=\"/books\">Books</a>\n</div>\n<div>\n<a href=\"/journals\">Journals</a>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n      Having trouble contacting the network. Please try again in a moment or two.\n    </div>\n<div>\n<div><a href=\"http://global.oup.com/\"><img alt=\"Oxford University Press\" src=\"https://oup.silverchair-cdn.com/data/Multimedia/oup-logo.svg\"/></a></div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div> <div>\n<div>\n<div>\n<div>Advertisement</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n\n</div>\n</section>\n</div>\n<section>\n<div>\n<div>\n<div>\n<div>\n<div>Advertisement</div>\n<button>\n<span>close advertisement</span>\n</button>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>Advertisement</div>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<ul>\n<li>\n<a href=\"/cid/pages/About\">About Clinical Infectious Diseases</a>\n</li> <li>\n<a href=\"/cid/pages/Editorial_Board\">Editorial Board</a>\n</li> <li>\n<a href=\"/cid/pages/General_Instructions\">Author Guidelines</a>\n</li>  </ul><ul> <li>\n<a href=\"/cid/subscribe\">Purchase</a>\n</li> <li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\">Advertising and Corporate Services</a>\n</li> \n</ul>\n</div>\n<div>\n<a href=\"https://academic.oup.com/cid\">\n<img alt=\"Clinical Infectious Diseases\" class=\"journal-footer-affiliations-logo\" id=\"footer-logo-ClinicalInfectiousDiseases\" src=\"//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_f1483155260.svg\"/>\n</a> </div>\n<div>\n<ul>\n<li>Online ISSN 1537-6591</li> <li>Print ISSN 1058-4838</li> <li>Copyright © 2025 Infectious Diseases Society of America</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n\n<div>\n<div>\n<ul>\n<li><a href=\"/pages/about-oxford-academic\">About Oxford Academic</a></li>\n<li><a href=\"/pages/about-oxford-academic/publish-journals-with-us\">Publish journals with us</a></li>\n<li><a href=\"/pages/about-oxford-academic/our-university-press-partners\">University press partners</a></li>\n<li><a href=\"/pages/what-we-publish\">What we publish</a></li>\n<li><a href=\"/pages/new-features\">New features</a> </li>\n</ul>\n</div>\n<div>\n<ul>\n<li><a href=\"/pages/for-authors\">For authors</a></li>\n<li><a href=\"/pages/open-research/open-access\">Open access</a></li>\n<li><a href=\"/pages/purchasing\">Purchasing</a></li>\n<li><a href=\"/pages/institutional-account-management\">Institutional account management</a></li>\n<li><a href=\"https://academic.oup.com/pages/purchasing/rights-and-permissions\">Rights and permissions</a></li>\n</ul>\n</div>\n<div>\n<ul>\n<li><a href=\"/pages/get-help-with-access\">Get help with access</a></li>\n<li><a href=\"/pages/about-oxford-academic/accessibility\">Accessibility</a></li>\n<li><a href=\"/pages/contact-us\">Contact us</a></li>\n<li><a href=\"/pages/advertising\">Advertising</a></li>\n<li><a href=\"/pages/media-enquiries\">Media enquiries</a></li>\n</ul>\n</div>\n<div>\n<ul>\n<li><a href=\"https://global.oup.com/\">Oxford University Press</a></li>\n<li><a href=\"https://corp.oup.com/press-office\">News</a></li>\n<li><a href=\"https://languages.oup.com/\">Oxford Languages</a></li>\n</ul>\n</div>\n<div>\n<p>Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide</p>\n<img alt=\"Oxford University Press\" class=\"journal-footer-logo\" height=\"69\" src=\"//oup.silverchair-cdn.com/UI/app/svg/umbrella/oup-logo.svg\" width=\"300\"/>\n</div>\n</div>\n<div>\n<div>\n<ul>\n<li>Copyright © 2025 Oxford University Press</li>\n<li><button>Cookie settings</button></li>\n<li><a href=\"https://global.oup.com/cookiepolicy\">Cookie policy</a></li>\n<li><a href=\"https://global.oup.com/privacy\">Privacy policy</a></li>\n<li><a href=\"https://academic.oup.com/pages/legal-notice\">Legal notice</a></li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</section>\n</div>\n<div>\n\n<div>\n<div>\n<h5>This Feature Is Available To Subscribers Only</h5>\n<p><a href=\"/sign-in\">Sign In</a> or <a href=\"/my-account/register?siteId=5269&amp;returnUrl=%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\">Create an Account</a></p>\n</div>\n</div>\n<div>\n<p>This PDF is available to Subscribers Only</p>\n<a><span>View Article Abstract &amp; Purchase Options</span></a>\n<div>\n<p>For full access to this pdf, sign in to an existing account, or purchase an annual subscription.</p>\n</div>\n</div>\n</div>\n\n\n\n\n\n\n\n<div>\n<div>\n<span>Manage Cookies</span>\n</div>\n<div>\n<div>\n<p>\n        When you visit web sites, they may store or retrieve data in your web browser. This storage is often necessary for basic functionality of the web site or the storage may be used for the purposes of marketing, analytics, and personalization of the web site such as storing your preferences.\n     </p>\n</div>\n<p>\n     Powered by \n</p>\n</div>\n<div>\n<button>\n     Save\n    </button>\n</div>\n</div><div>\n<div>\n<p>\n      Oxford University Press uses cookies to enhance your experience on our website. By selecting ‘accept all’ you are agreeing to our use of cookies. You can change your cookie settings at any time. More information can be found in our <a href=\"https://global.oup.com/cookiepolicy/?cc=gb\">Cookie Policy</a>.\n      \n     </p>\n<div>\n<button>\n       Reject and manage\n      </button>\n<button>\n       Deny all\n      </button>\n<button>\n       Accept all\n      </button>\n</div>\n</div>\n</div>",
    "markdown_content": "[Skip to Main Content](https://academic.oup.com/cid/article/68/9/1482/5078600#skipNav)\nAdvertisement\n[ ![Oxford Academic](https://oup.silverchair-cdn.com/UI/app/svg/umbrella/oxford-academic-logo.svg) ](https://academic.oup.com/)\n[Journals](https://academic.oup.com/journals)\n[Books](https://academic.oup.com/books)\n  * [ ![Information](https://oup.silverchair-cdn.com/UI/app/svg/i.svg) ](https://academic.oup.com/pages/information)\n  * [ ![Information](https://oup.silverchair-cdn.com/UI/app/svg/i.svg) ](https://academic.oup.com/pages/information)\n\n\nNavbar Search Filter  Clinical Infectious DiseasesThis issueIDSA Journals Infectious DiseasesBooksJournalsOxford Academic Mobile Enter search term \n  * [ Issues ](https://academic.oup.com/cid/issue)\n  *     * [ Advance articles ](https://academic.oup.com/cid/advance-articles)\n    * [ Editor's Choice ](https://academic.oup.com/cid/search-results?page=1&f_OUPSeries=Editor%27s+Choice)\n    * [ Supplement Archive ](https://academic.oup.com/cid/supplements)\n    * [ Cover Archive ](https://academic.oup.com/cid/issue-covers/)\n    * [ IDSA Guidelines ](https://academic.oup.com/cid/pages/clinical-practice-guidelines)\n    * [ IDSA Journals ](https://academic.oup.com/idsa)\n    * [ The Journal of Infectious Diseases ](https://academic.oup.com/jid)\n    * [ Open Forum Infectious Diseases ](https://academic.oup.com/ofid)\n    * [ Clinical Dilemmas in ID ](https://academic.oup.com/cid/pages/clinical-dilemmas)\n    * [ Photo Quizzes ](https://academic.oup.com/cid/pages/photo-quizzes)\n    * [ State-of-the-Art Reviews ](https://academic.oup.com/cid/pages/state-of-the-art-reviews)\n    * [ Voices of ID ](https://academic.oup.com/cid/pages/voices-of-id)\n    * [ IDSA Content Collections ](https://academic.oup.com/idsa/pages/content-collections)\n  *     * [ Author Guidelines ](https://academic.oup.com/cid/pages/General_Instructions)\n    * [ Open Access ](https://academic.oup.com/cid/pages/General_Instructions)\n    * [ Why Publish ](https://academic.oup.com/cid/pages/why-publish)\n    * [ IDSA Journals Calls for Papers ](https://academic.oup.com/idsa/pages/calls-for-papers)\n  * [ Purchase ](https://academic.oup.com/cid/subscribe)\n  *     * [ Advertising and Corporate Services ](https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit)\n    * [ Advertising ](https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising)\n    * [ Mediakit ](https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit)\n    * [ Reprints and ePrints ](https://academic.oup.com/advertising-and-corporate-services/pages/reprints)\n    * [ Sponsored Supplements ](https://academic.oup.com/advertising-and-corporate-services/pages/supplements)\n    * [ Branded Books ](https://academic.oup.com/advertising-and-corporate-services/pages/branded-books)\n  *     * [ About Clinical Infectious Diseases ](https://academic.oup.com/cid/pages/About)\n    * [ IDSA COI Policy ](https://academic.oup.com/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf)\n    * [ Editorial Board ](https://academic.oup.com/cid/pages/Editorial_Board)\n    * [ Alerts ](https://academic.oup.com/my-account/email-alerts)\n    * [ Self-Archiving Policy ](https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b)\n    * [ For Reviewers ](https://academic.oup.com/cid/pages/For_Reviewers)\n    * [ For Press Offices ](https://academic.oup.com/idsa/pages/for_press_offices)\n  * [Journals on Oxford Academic](https://academic.oup.com/journals)\n  * [Books on Oxford Academic](https://academic.oup.com/books)\n\n\n[IDSA Journals](https://academic.oup.com/idsa)\n[ ![Clinical Infectious Diseases](https://oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_title-1229789578.svg) ](https://academic.oup.com/cid)\n  * [ Issues ](https://academic.oup.com/cid/issue)\n  *     * [ Advance articles ](https://academic.oup.com/cid/advance-articles)\n    * [ Editor's Choice ](https://academic.oup.com/cid/search-results?page=1&f_OUPSeries=Editor%27s+Choice)\n    * [ Supplement Archive ](https://academic.oup.com/cid/supplements)\n    * [ Cover Archive ](https://academic.oup.com/cid/issue-covers/)\n    * [ IDSA Guidelines ](https://academic.oup.com/cid/pages/clinical-practice-guidelines)\n    * [ IDSA Journals ](https://academic.oup.com/idsa)\n    * [ The Journal of Infectious Diseases ](https://academic.oup.com/jid)\n    * [ Open Forum Infectious Diseases ](https://academic.oup.com/ofid)\n    * [ Clinical Dilemmas in ID ](https://academic.oup.com/cid/pages/clinical-dilemmas)\n    * [ Photo Quizzes ](https://academic.oup.com/cid/pages/photo-quizzes)\n    * [ State-of-the-Art Reviews ](https://academic.oup.com/cid/pages/state-of-the-art-reviews)\n    * [ Voices of ID ](https://academic.oup.com/cid/pages/voices-of-id)\n    * [ IDSA Content Collections ](https://academic.oup.com/idsa/pages/content-collections)\n  *     * [ Author Guidelines ](https://academic.oup.com/cid/pages/General_Instructions)\n    * [ Open Access ](https://academic.oup.com/cid/pages/General_Instructions)\n    * [ Why Publish ](https://academic.oup.com/cid/pages/why-publish)\n    * [ IDSA Journals Calls for Papers ](https://academic.oup.com/idsa/pages/calls-for-papers)\n  * [ Purchase ](https://academic.oup.com/cid/subscribe)\n  *     * [ Advertising and Corporate Services ](https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit)\n    * [ Advertising ](https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising)\n    * [ Mediakit ](https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit)\n    * [ Reprints and ePrints ](https://academic.oup.com/advertising-and-corporate-services/pages/reprints)\n    * [ Sponsored Supplements ](https://academic.oup.com/advertising-and-corporate-services/pages/supplements)\n    * [ Branded Books ](https://academic.oup.com/advertising-and-corporate-services/pages/branded-books)\n  *     * [ About Clinical Infectious Diseases ](https://academic.oup.com/cid/pages/About)\n    * [ IDSA COI Policy ](https://academic.oup.com/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf)\n    * [ Editorial Board ](https://academic.oup.com/cid/pages/Editorial_Board)\n    * [ Alerts ](https://academic.oup.com/my-account/email-alerts)\n    * [ Self-Archiving Policy ](https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b)\n    * [ For Reviewers ](https://academic.oup.com/cid/pages/For_Reviewers)\n    * [ For Press Offices ](https://academic.oup.com/idsa/pages/for_press_offices)\n\n\nNavbar Search Filter  Clinical Infectious DiseasesThis issueIDSA Journals Infectious DiseasesBooksJournalsOxford Academic Enter search term \n[Advanced Search](https://academic.oup.com/cid/advanced-search?page=1&fl_SiteID=5269&SearchSourceType=1)\nArticle Navigation\nClose mobile search navigation\nArticle Navigation\n[ ![Clinical Infectious Diseases Cover Image for Volume 68, Issue 9](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/Issue/68/9/5/m_cover.jpeg?Expires=1752631924&Signature=VzkJpzpYIXCozHbdsaIS60qWT14TRuSLuGC1eukUyrcYSb6veXmlbdxxi4bsCqv56PfMH7dlbqN9LPLYakKnZ6uSxmWg0YAZOHfQIA39tvpONvJ71boTMCgDn8RhjNDckqV16RNIXTme4fSXo-Pb1NEzqABs9EzPZHe9bQMD6FT68PV8Vap~eeaNsVp85gS3jKjGejPEgn2-XCGy4vrE3MaPHJYIAkNxsVP0hL~5pIyLW4I1ZSyrhJhH-eg8MKmfcqb5InNKbRmJkLh~-95lJfZl5LOkCkFEzHqU5URne1xaCnWjdQWfdfTDCJXggdBa~HkCJsQ92f~1fLxypv7dIQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA) Volume 68 Issue 9 1 May 2019  ](https://academic.oup.com/cid/issue/68/9)\n### Article Contents\n  * [Abstract](https://academic.oup.com/cid/article/68/9/1482/5078600#134170092)\n  * [MATERIALS AND METHODS](https://academic.oup.com/cid/article/68/9/1482/5078600#134170097)\n  * [RESULTS](https://academic.oup.com/cid/article/68/9/1482/5078600#134170111)\n  * [DISCUSSION](https://academic.oup.com/cid/article/68/9/1482/5078600#134170130)\n  * [Supplementary Data](https://academic.oup.com/cid/article/68/9/1482/5078600#134170142)\n  * [Notes](https://academic.oup.com/cid/article/68/9/1482/5078600#134170144)\n  * [References](https://academic.oup.com/cid/article/68/9/1482/5078600#134170150)\n  * [Supplementary data](https://academic.oup.com/cid/article/68/9/1482/5078600#supplementary-data)\n\n\n  * [< Previous](https://academic.oup.com/cid/article/68/9/1472/5089945)\n  * [Next >](https://academic.oup.com/cid/article/68/9/1494/5087661)\n\n\nArticle Navigation \nArticle Navigation \nJournal Article\n#  Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients _Free_\n, \nMarta Francesca Di Pasquale \nDepartment of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Marta+Francesca+Di+Pasquale)\n, \nGiovanni Sotgiu \nClinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Giovanni+Sotgiu)\n, \nAndrea Gramegna \nDepartment of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Andrea+Gramegna)\n, \nDejan Radovanovic \nDepartment of Biomedical and Clinical Sciences (DIBIC), University of Milan, Pulmonary Unit, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Dejan+Radovanovic)\n, \nSilvia Terraneo \nRespiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Italy\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Silvia+Terraneo)\n, \nLuis F Reyes \nMicrobiology Department, Universidad de La Sabana, Chia, Colombia\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Luis+F+Reyes)\n, \nJan Rupp \nDepartment of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Jan+Rupp)\n, \nJuan González del Castillo \nEmergency Department, Hospital Clínico San Carlos, Universidad Complutense\nInstituto de Investigación Sanitaria del Hospital Clínico San Carlos, IdISSC, Madrid, Spain\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Juan+Gonz%c3%a1lez+del+Castillo)\n, \nFrancesco Blasi \nDepartment of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Francesco+Blasi)\n, \nStefano Aliberti \nDepartment of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\nCorrespondence: S. Aliberti, Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy ().\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Stefano+Aliberti)\n[ ... Show more ](https://academic.oup.com/cid/article/68/9/1482/5078600)\nMarcos I Restrepo \nDivision of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Marcos+I+Restrepo)\n_Clinical Infectious Diseases_ , Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, \nPublished:\n23 August 2018\nReceived:\n24 May 2018\nAccepted:\n20 August 2018\nPublished:\n23 August 2018\n  * [ ![pdf](https://oup.silverchair-cdn.com/UI/app/svg/pdf.svg)PDF ](https://academic.oup.com/cid/article-pdf/68/9/1482/28520951/ciy723.pdf)\n  * [ Cite ](https://academic.oup.com/cid/article/68/9/1482/5078600)\n### Cite\nMarta Francesca Di Pasquale, Giovanni Sotgiu, Andrea Gramegna, Dejan Radovanovic, Silvia Terraneo, Luis F Reyes, Jan Rupp, Juan González del Castillo, Francesco Blasi, Stefano Aliberti, Marcos I Restrepo, Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients, _Clinical Infectious Diseases_ , Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, \nSelect Format Select format .ris (Mendeley, Papers, Zotero) .enw (EndNote) .bibtex (BibTex) .txt (Medlars, RefWorks) Download citation\n\n\nNavbar Search Filter  Clinical Infectious DiseasesThis issueIDSA Journals Infectious DiseasesBooksJournalsOxford Academic Mobile Enter search term \nNavbar Search Filter  Clinical Infectious DiseasesThis issueIDSA Journals Infectious DiseasesBooksJournalsOxford Academic Enter search term \n[Advanced Search](https://academic.oup.com/cid/advanced-search?page=1&fl_SiteID=5269&SearchSourceType=1)\n## Abstract\nBackground\nThe correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia.\nMethods\nWe conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor.\nResults\nAt least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors significantly differed across continents and countries, with chronic steroid use (45%), hematological cancer (25%), and chemotherapy (22%) the most common. Among immunocompromised patients, community-acquired pneumonia (CAP) pathogens were the most frequently identified, and prevalences did not differ from those in immunocompetent patients. Risk factors for immunocompromise were independently associated with neither _Pseudomonas aeruginosa_ nor non–community-acquired bacteria. Specific risk factors were independently associated with fungal infections (odds ratio for AIDS and hematological cancer, 15.10 and 4.65, respectively; both _P_ = .001), mycobacterial infections (AIDS; _P_ = .006), and viral infections other than influenza (hematological cancer, 5.49; _P_ < .001).\nConclusions\nOur findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses.\n, , , , \nDuring initial evaluation of a patient coming from the community with pneumonia, the identification of possible risk factors for multidrug-resistant organisms or unusual pathogens is crucial []. Because a microbiological identification is found in about 30% of hospitalized patients with pneumonia coming from the community, and usually requires 24–48 hours to be available, most of patients are treated empirically []. Delay in initiation of appropriate empiric antibiotic therapy is a known risk factor for worse clinical outcomes []; therefore, it is relevant to promptly recognize patients at risk for specific pathogens, specially multidrug-resistant or atypical microbes [].\nThe aging of the population and advancements in therapeutic protocols have led to an increase prevalence of chronic diseases as well as long-term treatments with immunosuppressive agents [, ]. Thus, among patients with pneumonia coming from the community and admitted to the hospital, the number who might not be fully immunocompetent is constantly increasing [, ]. Nevertheless, the real prevalence of immunocompromise among patients with pneumonia coming from the community is still unknown. Moreover, guidelines for community-acquired and hospital-acquired pneumonia did not address this topic—what is more, they specifically excluded patients with clinical characteristics determining immunocompromise [], and current evidence in literature is also scarce.\nTo our knowledge, there are no studies addressing the clinical evaluation and initial empirical antibiotic coverage of patients coming from the community with pneumonia and immunocompromise. Moreover, specific risk factors to assess the causative microbiology and help clinicians choose more appropriate management for these patients have not been clearly identified. Thus, the aim of the current study was to identify the prevalence, type, microbiology, and intercorrelations between different risk factors for immunocompromise in hospitalized patients with pneumonia coming from the community.\n## MATERIALS AND METHODS\n### Study Design and Population\nThis is a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) database []. The GLIMP study was an international, multicenter, observational, point-prevalence study of adult patients hospitalized for community-onset pneumonia in 54 countries worldwide. Patients were enrolled on a single day during the months of March, April, May, and June 2015. The methods of the GLIMP study have been published elsewhere []. The coordinating center (University of Texas Health Science Center, San Antonio) received approval from its institutional review board (No. HSC20150184E).\nAll adult patients (aged >18 years old) coming from the community and hospitalized with pneumonia during study period were included. Pneumonia was defined as the presence of a new pulmonary infiltrate on chest radiograph at the time of hospitalization, associated with ≥1 of the following criteria: (1) new or increased cough with/without sputum production and/or purulent respiratory secretions, (2) fever or hypothermia, and (3) evidence of systemic inflammation (ie, abnormal white blood cell count or increased C-reactive protein or procalcitonin level). Hospitalized patients with a diagnosis of hospital-acquired or ventilator-associated pneumonia were excluded.\n### Data Collection\nData were collected from medical records at the time of hospital admission. Data gathered included demographics; respiratory and cardiovascular comorbid conditions; immunocompromised status and other chronic medical conditions; severity of pneumonia (defined as either intensive care unit admission, use of invasive or noninvasive mechanical ventilation, or use of vasopressors/inotropes during the first 24 hours after hospital admission); and specific risk factors for resistant pathogens infection, including chronic aspiration, being bedridden, malnutrition, presence of enteric tube feeding and indwelling catheters (including central venous and urinary catheters), previous infections, chronic microbial colonization, and previous healthcare exposures. The number and type of microbiological samples obtained within 24 hours after hospital admission were also collected. Culture-positive tests, kind of sample, and antibiotic resistance patterns were also gathered, along with empiric antibiotic treatment, given within 24 hours after hospital admission.\n### Microbiological Workup\nDiagnostic testing was performed according to local standard operating procedures and included collection of respiratory and blood cultures and testing for urinary antigens. Microbiological examinations and susceptibility testing were performed according to local standard protocols within the first 24 hours after hospital admission []. Multivariable logistic regression models were performed for patients who had a positive culture, to identify specific risk factors for single pathogens.\nCausative pathogens were stratified according to the coverage of standard therapy for community-acquired pneumonia (CAP) []. Those not covered by standard CAP therapy included the following: non–community-acquired bacteria (_Acinetobacter baumanii_ , _Enterococcus_ vancomycin-resistant, _Nocardia_ spp.), mycobacteria, fungi (_Aspergillus fumigatus, Coccidioides, Criptococcus_ , _Pneumocystis jirovecii_), and viruses other than influenza []. Those covered by standard CAP therapy included _Pseudomonas aeruginosa,_ methicillin-resistant _Staphylococcus aureus_ , methicillin-sensitive _S. aureus_ , _Enterobacter_ spp., _Enterococcus_ spp., _Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae_ , _Moraxella catarrhalis, Proteus mirabilis, Serratia marcescens, Streptococcus pneumoniae, Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella pneumophilia,_ anaerobes bacteria, and influenza viruses. Atypical pathogens included _C. pneumoniae, M. pneumoniae,_ and _L. pneumophilia._ CAP therapy was defined as β-lactams (ceftriaxone, ampicillin-sulbactam, amoxicillin-clavulanate, cefepime, ceftazidime, piperacillin-tazobactam) plus macrolide, or fluoroquinolones alone, and, eventually, in association with vancomycin, linezolid, or oseltamivir [].\n### Definition of Immunocompromised and Study Groups\nImmunocompromise was defined as the presence of ≥1 of the following risk factors: (1) AIDS, defined either as human immunodeficiency virus infection with CD4+ lymphocyte count <200/µL or by the occurrence of AIDS-defining conditions; (2) aplastic anemia; (3) asplenia; (4) hematological cancer, defined as lymphoma, acute or chronic leukemia, or multiple myeloma; (5) chemotherapy during the last 3 months; (6) neutropenia, defined as a neutrophil count <500/dL at complete blood cell count; (7) biological drug use (including trastuzumab and therapies for autoimmune diseases, eg, anti–tumor necrosis factor α, prescribed during ≥6 months before hospital admission); (8) lung transplantation; (9) chronic steroid use (>10 mg/d of prednisone or equivalent ≥3 months before hospital admission); (10) lung cancer with either neutropenia or chemotherapy; (11) other solid tumor with either neutropenia or chemotherapy; (12) other immunocompromise (any immunocompromised state, including congenital/genetic immunocompromise and immunosuppressive therapy due to hematological cancer/solid organ transplantation other than lung). Two study groups were identified: those with versus those without 1 risk factor for immunocompromise.\n### Statistical Analysis\nCategorical variables, expressed as counts (percentages), were compared using the χ2 test. Continuous variables were compared using the unpaired Student _t_ test or the Mann-Whitney test, when appropriate. Statistical significance was defined as _P_ < .05. A network analysis was conducted to represent the frequencies of all immunocompromise variables and their relationships. The size of the circles (the circles visible in Figure 4 [network analysis], each representing a single risk factor for immunocompromise) represents both prevalence of the risk factor and strength of association with other variables.\nThe predictive value of each variable was categorized by quartiles and analyzed using a univariate regression logistic analysis. A multivariable model was obtained using a Cox regression analysis to identify independent predictors of specific pathogens, using an entry level of P value ≤0.05 and a removal level of P value ≥0.10. Hazard ratios and adjusted analyses were obtained. All statistical analyses were performed with IBM SPSS software (version 22, Statistics for Mac; version 22.0, IBM Crop), and Stata 13 software (StataCorp).\n## RESULTS\n### Prevalence of Risk Factors for Immunocompromise\nAmong 3702 patients enrolled in the GLIMP database, ≥1 risk factor for immunocompromise was identified in 652 (17.6%). The prevalences of patients with pneumonia coming from the community and with ≥1 risk factor for immunocompromise differed among continents and countries, as depicted in and . The prevalence of immunocompromise was significantly higher in both North and South America than in the rest of the world (24.0% vs 16.5 [_P_ < .001] and 24.8% vs 17.2 [_P_ = .006], respectively) ().\n![Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases.](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1752554620&Signature=LKXAyrV74Aa9owXe0o-cQ75pOeSoID0-pehgygNtPZSFXNZMuhHSvh2bH2dv7qW8hH1yagXom1UIMLOtWgjAeeVu2LBuha-~CcDB2tnoDsCwd0W--ENWiqmCFTxq3yC2TQ0Umx7W~VJXwN6SRKyfDOflOkKvPGRNUobFX0ugYVCV63UYBnlhdsPfvI-fsKpp2D2I1PP6zBaXvsJbvI-0aIPK7XN9D-bkImy~2jyh7YxMl-ml056-m9M~e1NXIC1G-eMlJ-D0ihNbxsU~I2x~~h2BWrtr8AE9Sfu1WTqiFahp57mH4~iFGY9EkQkC4xJpjMyNKtQFhxpXjvQtYLzecQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\nFigure 1.\nDistribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases.\n[Open in new tab](https://academic.oup.com/view-large/figure/134170114/ciy72301.jpg)[Download slide](https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72301.jpeg?Expires=1752554620&Signature=NHcEJwNnhhuu~V7litr8igr9GFWfZ0zM0SxlfYOwAgN3ag3nsCMd9zXKoM9GZWcSFeGB~KznckX3sjRs7eZI6UovzOYWd5ChB8QCKT6DbvXvsAyPCY~~tvyw1nLgnCRXHxsEp9~pCDA4jyfmGwdzBmIxjxK32DKPE3r03H1NwaFfFuqtTjvCIQz2eID2dBiK~4lTbznS4INQ66i-Fh9DwTzI-HwYqclm24aYv1pSYlAiswZHOwaE-fO6wkuUxDcfD3pvVFQ~xscKfiFVbOt91lXVNkOd7p4CKoSAgaQv6yr5WZ9-7z1VyiIThnhC9G~HPkbIlB2Do4fo0jz7V2xwPA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170114&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269)\nThe prevalence of each risk factor for immunocompromise is depicted in , with chronic steroid use (45.0%), hematological cancer (25.0%), and chemotherapy (22.0%) being the most frequent ones. A total of 312 patients (8.4%) had >1 risk factor for immunocompromise ().\n![Prevalence of each single risk factor for immunocompromise.](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72302.jpeg?Expires=1752554620&Signature=tN-5VXAN-IRDKK8axKZA8P~Y5z--s9j8Erc8SOjWl6DrKKH4QL5os9eZxhVeV6eWVN~f~VDG9tfzyHUF6i7OVsMNB2vsk6C~94Qv-2aRHoy5JP-aM-LrL8khDyqEa4Lg2BfInF3Q0qGwXrmt25GlH1qSBKirMgS~VlVo9FK3dUDe2-XgCIv-DixycDR1NbxEUad1obLBQi7T-cMZnDc0-hSXzSelH07q4yY8dbVGxrERuy5IWOvusZ1u83w1jCK4dSvt3hPFFdMZMOmGLi~Fj-dVSs0cAjfbIHoEDmqErTby4pVDEijEs5muQVm-Ux~YEjgN-VhvWj8YtpZKL4eSXA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\nFigure 2.\nPrevalence of each single risk factor for immunocompromise.\n[Open in new tab](https://academic.oup.com/view-large/figure/134170116/ciy72302.jpg)[Download slide](https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72302.jpeg?Expires=1752554620&Signature=urCgidlWbN7Br1gKnVthRjYFEVioagJuBFmiXPuQQBoD2qmTrm4Heidc21Yt1dgPswbIwC7DPhnYrlHrjxMxL-tPDfinKG-olgkospAEDA-ocZW5BuK9lYsha0rJ0NF76fxfhqDzGVUbNAug3anPLTq4c4Wm9hmTgaDN4Qc2ECcT8hDYAnEm3od96dWn52Zy09JsZa4zT41kMG~qQJEZG62~24b5nEIG7eSCncOceqVPqOOaaIMniBLrAQuB7Hvqr~6AtHN5IBjBuLUjU1xYJcFJXX6WtIhnqkXKN21GOO7O7AU0AC7FLWQuEd1zCcVocKQxVv4RndCQeZ3XzZvegA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170116&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269)\n![Prevalence of the number of risk factors present simultaneously in a single patient.](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72303.jpeg?Expires=1752554620&Signature=Xts16a6pXvQbNfwKtUeejfXsqF17z~2gviy7VcLQhhckWHmCw0zRSSEtsyrG9SkI2LRw39TbhqnqYNb1VTXQKD-ybyHkb~R3s-eIxJ~94DOxaaXBbUvpzbvwY1vDACc5LpVzJJ8dZMntZ7nekvhgMs6NtlpySVWDDC~7ybF0bySgW6i55FBFevIdcUxB3ipChEHL9XiTlmDkdiHssMser494UBvbDyg4DUKM-Cpd988M8qpSwp-eg-3Yhkr9q2~L66QQUhwgYNILWRRA1azwsTAJvrWUq52Dpikbj4mzbXXstnhvc7GNMw5xxz6nFPKuHVKJlcE-HQsiIvj5ZOVUxg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\nFigure 3.\nPrevalence of the number of risk factors present simultaneously in a single patient.\n[Open in new tab](https://academic.oup.com/view-large/figure/134170117/ciy72303.jpg)[Download slide](https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72303.jpeg?Expires=1752554620&Signature=aODZPs-HRl9QmymSK-5bkx~xp6iLrndvYFKxy1ge9DczmeUzsNnr5McNlvqrMcXHLvgMkhfK7yT7VuvVZQyJiTDmkR2j-SEc5zFcORnQPNUjDvGORdypfvcWI0ap8MKwHNe5lyBn4KtJz~tW8Oy3Gx54ukE8wke7~kZBzMvO8MTOkttiu8JkRKLQBqO6IcM2MoQBEcRSt-iQJjHBC9eSqzTw9hfjbhfc1npEBjHchP6v69RipZnUipM4HSTXcHzcLlv5ZrElufmBjKlaCOuMXehhls70RLfvTvOnOA3AyEmOSecyKEGpTAKKWMZCZcKwFjPqwgrO2KIMNHBcdECFyg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170117&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269)\n### Network Analysis Among Risk Factors for Immunocompromise\nThe results of the network analysis of all risk factors for immunocompromise are depicted in . Relationships were identified between chemotherapy and solid tumor other than lung cancer, hematological cancer, and chronic steroid use, and between other immunocompromise and chronic steroid use.\n![Network analysis between risk factors for immunocompromise.](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72304.jpeg?Expires=1752554620&Signature=GuJUcrEhLaMR89vfrhqqYuGyB4HuDlfLUgnHqNu6Ksi5VkLMWjSpH0hVJWv0i4hnesvCDRYbQ~uAyBQyQ0AiLXq2xGVhq3CJd~~Uo~xFEO2RNWWcv5izwBv2Xd~h9Hdfe0hTA-AXnTA7hKM-ThAaURdGnReCFddtKpqnLFFI8QBpZfiXaSjcJTGzuOJpCX41BN9EmgqXfVfeCV2WjdANqIm2R0p4fJbe8r3T6ykoQ1g-IoQnAttT~9TBNl6irCxSuhZHs693bn8ZNDwodNBEKnNGVKaV3sMa8zH8GthYrKb1ARcjtit4vlO4Amlu5qUEW4FRAzxNeE5ch2OPPqoZ6g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\nFigure 4.\nNetwork analysis between risk factors for immunocompromise.\n[Open in new tab](https://academic.oup.com/view-large/figure/134170120/ciy72304.jpg)[Download slide](https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72304.jpeg?Expires=1752554620&Signature=YZzJ1wJWugBQStvfJV4l4KYj3Wo9NRpieCO~yvNqxtUBWQdjFeAYbw2G-Y6DLCVNq9Va5VeID5cdns-ikSqf31HJSxkU6nJ2ORJtfKpX9YRK1R4udPlHilZw7ywCq-EzR6AMwb3sY-BfsBS4sDesTOwvKTu1-DzRuTpqruza-~yCWEOuDxUkBBBhGOjezpmaPE1pK9FuWVCTdWQjhWi0Q1hWTQx8Y41~JVb3kGWNigqT8AD4v9JX1c4I3Lv7PwLI68bVFaY9GUswC-yS1tvJbrugsyrYyCUrS~h7Si20MQ14RfW5c61orGDtUvAkaoknOVddjBXj5tv5wBq7Hieh4A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170120&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269)\n### Clinical and Microbiological Characteristics of Patients With Immunocompromise\nClinical features and disease severity of immunocompetent versus immunocompromised patients are shown in and . Immunocompromised patients were significantly younger and malnourished, had a higher frequency of comorbid conditions, previous infections, and colonization by resistant pathogens, and had more frequent contacts with the healthcare system. The prevalences of severe pneumonia did not differ among the 2 study groups.\nTable 1.\n[ Open in new tab ](https://academic.oup.com/view-large/134170123)\nClinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised)\nVariable . | Patients, No. (%)a . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 3050) . | Immunocompromised(n = 652) .   \nAge, median (IQR)| 69 (54–81)| 65 (52–74)| <.001  \nUnderweight| 125 (6.5)| 41 (10.5)| .004  \nMalnutrition| 243 (8.0)| 80 (12.3)| <.001  \nBedridden| 355 (11.6)| 60 (9.2)| .04  \nChronic aspiration| 224 (7.3)| 33 (5.1)| .02  \nBronchiectasis| 136 (4.5)| 42 (6.4)| .03  \nSevere COPD| 72 (2.4)| 28 (4.3)| .006  \nInterstitial lung disease| 60 (2.0)| 35 (5.4)| <.001  \nLung transplantation| 0 (0.0)| 7 (1.1)| <.001  \nTracheostomy| 37 (1.2)| 16 (2.5)| .02  \nHypertension| 1401 (45.9)| 254 (39.0)| .001  \nLiver disease| 103 (3.4)| 37 (5.7)| .005  \nCirrhosis| 50 (1.6)| 20 (3.1)| .02  \nDementia| 372 (12.2)| 36 (5.5)| <.001  \nEnteral tube feeding| 36 (1.2)| 16 (2.5)| .01  \nChronic renal failure| 315 (10.3)| 85 (13.0)| .04  \nHemodialysis| 34 (1.1)| 18 (2.8)| .001  \nICS use| 462 (15.2)| 128 (19.6)| .005  \nPPI use| 777 (25.5)| 251 (38.5)| <.001  \nIndwelling catheter| 52 (1.7)| 27 (4.1)| <.001  \nPrior mycobacteria diseases| 70 (2.3)| 26 (4.0)| .01  \nPrior ESBL| 39 (1.3)| 16 (2.5)| .02  \nPrior _Pseudomonas_|  68 (2.2)| 33 (5.1)| <.001  \nSevere CAP| 840 (27.5)| 190 (29.1)| .41  \nVariable . | Patients, No. (%)a . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 3050) . | Immunocompromised(n = 652) .   \nAge, median (IQR)| 69 (54–81)| 65 (52–74)| <.001  \nUnderweight| 125 (6.5)| 41 (10.5)| .004  \nMalnutrition| 243 (8.0)| 80 (12.3)| <.001  \nBedridden| 355 (11.6)| 60 (9.2)| .04  \nChronic aspiration| 224 (7.3)| 33 (5.1)| .02  \nBronchiectasis| 136 (4.5)| 42 (6.4)| .03  \nSevere COPD| 72 (2.4)| 28 (4.3)| .006  \nInterstitial lung disease| 60 (2.0)| 35 (5.4)| <.001  \nLung transplantation| 0 (0.0)| 7 (1.1)| <.001  \nTracheostomy| 37 (1.2)| 16 (2.5)| .02  \nHypertension| 1401 (45.9)| 254 (39.0)| .001  \nLiver disease| 103 (3.4)| 37 (5.7)| .005  \nCirrhosis| 50 (1.6)| 20 (3.1)| .02  \nDementia| 372 (12.2)| 36 (5.5)| <.001  \nEnteral tube feeding| 36 (1.2)| 16 (2.5)| .01  \nChronic renal failure| 315 (10.3)| 85 (13.0)| .04  \nHemodialysis| 34 (1.1)| 18 (2.8)| .001  \nICS use| 462 (15.2)| 128 (19.6)| .005  \nPPI use| 777 (25.5)| 251 (38.5)| <.001  \nIndwelling catheter| 52 (1.7)| 27 (4.1)| <.001  \nPrior mycobacteria diseases| 70 (2.3)| 26 (4.0)| .01  \nPrior ESBL| 39 (1.3)| 16 (2.5)| .02  \nPrior _Pseudomonas_|  68 (2.2)| 33 (5.1)| <.001  \nSevere CAP| 840 (27.5)| 190 (29.1)| .41  \nAbbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors.\naData represent No. (%) unless otherwise specified.\nTable 1.\n[ Open in new tab ](https://academic.oup.com/view-large/134170123)\nClinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised)\nVariable . | Patients, No. (%)a . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 3050) . | Immunocompromised(n = 652) .   \nAge, median (IQR)| 69 (54–81)| 65 (52–74)| <.001  \nUnderweight| 125 (6.5)| 41 (10.5)| .004  \nMalnutrition| 243 (8.0)| 80 (12.3)| <.001  \nBedridden| 355 (11.6)| 60 (9.2)| .04  \nChronic aspiration| 224 (7.3)| 33 (5.1)| .02  \nBronchiectasis| 136 (4.5)| 42 (6.4)| .03  \nSevere COPD| 72 (2.4)| 28 (4.3)| .006  \nInterstitial lung disease| 60 (2.0)| 35 (5.4)| <.001  \nLung transplantation| 0 (0.0)| 7 (1.1)| <.001  \nTracheostomy| 37 (1.2)| 16 (2.5)| .02  \nHypertension| 1401 (45.9)| 254 (39.0)| .001  \nLiver disease| 103 (3.4)| 37 (5.7)| .005  \nCirrhosis| 50 (1.6)| 20 (3.1)| .02  \nDementia| 372 (12.2)| 36 (5.5)| <.001  \nEnteral tube feeding| 36 (1.2)| 16 (2.5)| .01  \nChronic renal failure| 315 (10.3)| 85 (13.0)| .04  \nHemodialysis| 34 (1.1)| 18 (2.8)| .001  \nICS use| 462 (15.2)| 128 (19.6)| .005  \nPPI use| 777 (25.5)| 251 (38.5)| <.001  \nIndwelling catheter| 52 (1.7)| 27 (4.1)| <.001  \nPrior mycobacteria diseases| 70 (2.3)| 26 (4.0)| .01  \nPrior ESBL| 39 (1.3)| 16 (2.5)| .02  \nPrior _Pseudomonas_|  68 (2.2)| 33 (5.1)| <.001  \nSevere CAP| 840 (27.5)| 190 (29.1)| .41  \nVariable . | Patients, No. (%)a . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 3050) . | Immunocompromised(n = 652) .   \nAge, median (IQR)| 69 (54–81)| 65 (52–74)| <.001  \nUnderweight| 125 (6.5)| 41 (10.5)| .004  \nMalnutrition| 243 (8.0)| 80 (12.3)| <.001  \nBedridden| 355 (11.6)| 60 (9.2)| .04  \nChronic aspiration| 224 (7.3)| 33 (5.1)| .02  \nBronchiectasis| 136 (4.5)| 42 (6.4)| .03  \nSevere COPD| 72 (2.4)| 28 (4.3)| .006  \nInterstitial lung disease| 60 (2.0)| 35 (5.4)| <.001  \nLung transplantation| 0 (0.0)| 7 (1.1)| <.001  \nTracheostomy| 37 (1.2)| 16 (2.5)| .02  \nHypertension| 1401 (45.9)| 254 (39.0)| .001  \nLiver disease| 103 (3.4)| 37 (5.7)| .005  \nCirrhosis| 50 (1.6)| 20 (3.1)| .02  \nDementia| 372 (12.2)| 36 (5.5)| <.001  \nEnteral tube feeding| 36 (1.2)| 16 (2.5)| .01  \nChronic renal failure| 315 (10.3)| 85 (13.0)| .04  \nHemodialysis| 34 (1.1)| 18 (2.8)| .001  \nICS use| 462 (15.2)| 128 (19.6)| .005  \nPPI use| 777 (25.5)| 251 (38.5)| <.001  \nIndwelling catheter| 52 (1.7)| 27 (4.1)| <.001  \nPrior mycobacteria diseases| 70 (2.3)| 26 (4.0)| .01  \nPrior ESBL| 39 (1.3)| 16 (2.5)| .02  \nPrior _Pseudomonas_|  68 (2.2)| 33 (5.1)| <.001  \nSevere CAP| 840 (27.5)| 190 (29.1)| .41  \nAbbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors.\naData represent No. (%) unless otherwise specified.\nMicrobiological testing was performed in 91.0% (596 of 652) of immunocompromised and 86.0% (2626 of 3050) of immunocompetent patients (_P_ < .001). Bacteremia was found in 6.0% (36 of 596) of immunocompromised and 5.5% (145 of 2626; _P_ = .62) of immunocompetent patients. At least 1 positive culture was obtained in 40.0% (238 of 596) immunocompromised and 36.0% (935 of 2626) immunocompetent patients (_P_ = .047). Microbiological findings are provided in and . Among pathogens covered by standard therapy, _P. aeruginosa_ was more prevalent in immunocompromised patients (35 [5.9%] vs 98 [3.7%] patients; _P_ < .02). Among pathogens not usually covered by standard therapy, immunocompromised patients were more likely to be infected by _Nocardia_ spp. (4 [0.7%] vs 0 [0%] patients; _P_ < .001), nontuberculous mycobacteria (NTM) (5 [0.8%] vs 2 [0.1%]; _P_ < .002), _A. fumigatus_ (8 [1.3%] vs 10 [0.4%]; _P_ < .01), _P. jirovecii_ (12 [2.0%] vs 5 [0.2%]; _P_ < .02), and viruses, such as coronavirus (3 [0.5%] vs 3 [0.1%]; _P_ < .047), and respiratory syncytial virus (6 [1.0%] vs 7 [0.3%]; _P_ < .03).\nTable 2.\n[ Open in new tab ](https://academic.oup.com/view-large/134170125)\nPathogens in the 2 Study Groups\nPathogen . | Patients, No. (%) . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 2626) . | Immunocompromised (n = 596) .   \nPathogens covered by CAP therapy| | |   \n _Streptococcus pneumoniae_|  218 (8.3)| 50 (8.4)| >.99  \nAtypical| 50 (1.9)| 13 (2.2)| .78  \n _Legionella_|  21 (0.8)| 10 (1.7)| .08  \nMRSA| 83 (3.2)| 12 (2.0)| .17  \nMSSA| 73 (2.8)| 20 (3.4)| .53  \n _Pseudomonas aeruginosa_|  98 (3.7)| 35 (5.9)| .02  \n _Haemophilus influenzae_|  65 (2.5)| 10 (1.7)| .31  \n _Klebsiella pneumoniae_|  89 (3.4)| 22 (3.7)| .81  \nInfluenza virus| 126 (4.8)| 28 (4.7)| >.99  \nPathogens not covered by CAP therapy| | |   \nNon-CAP bacteria| | |   \n _Acinetobacter baumanii_|  33 (1.3)| 7 (1.2)| >.99  \n _Nocardia_ spp.| 0 (0.0)| 4 (0.7)| <.001  \nMycobacteria| | |   \n _Mycobacterium tuberculosis_|  21 (0.8)| 5 (0.8)| >.99  \nNTM| 2 (0.1)| 5 (0.8)| .002  \nFungi| | |   \n _Aspergillus fumigatus_|  10 (0.4)| 8 (1.3)| .01  \n _Actinomyces_|  2 (0.1)| 0 (0.0)| >.99  \n _Cryptococcus_|  3 (0.1)| 0 (0.0)| .94  \n _Pneumocystis jirovecii_|  5 (0.2)| 13 (2.2)| <.001  \nViruses| | |   \nAdenovirus| 5 (0.2)| 0 (0.0)| .62  \nCoronavirus| 3 (0.1)| 3 (0.5)| .047  \nMetapneumovirus| 3 (0.1)| 2 (0.3)| .51  \nRSV| 7 (0.3)| 6 (1.0)| .03  \nMDR pathogens| 231 (8.8)| 54 (9.0)| .54  \nPathogen . | Patients, No. (%) . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 2626) . | Immunocompromised (n = 596) .   \nPathogens covered by CAP therapy| | |   \n _Streptococcus pneumoniae_|  218 (8.3)| 50 (8.4)| >.99  \nAtypical| 50 (1.9)| 13 (2.2)| .78  \n _Legionella_|  21 (0.8)| 10 (1.7)| .08  \nMRSA| 83 (3.2)| 12 (2.0)| .17  \nMSSA| 73 (2.8)| 20 (3.4)| .53  \n _Pseudomonas aeruginosa_|  98 (3.7)| 35 (5.9)| .02  \n _Haemophilus influenzae_|  65 (2.5)| 10 (1.7)| .31  \n _Klebsiella pneumoniae_|  89 (3.4)| 22 (3.7)| .81  \nInfluenza virus| 126 (4.8)| 28 (4.7)| >.99  \nPathogens not covered by CAP therapy| | |   \nNon-CAP bacteria| | |   \n _Acinetobacter baumanii_|  33 (1.3)| 7 (1.2)| >.99  \n _Nocardia_ spp.| 0 (0.0)| 4 (0.7)| <.001  \nMycobacteria| | |   \n _Mycobacterium tuberculosis_|  21 (0.8)| 5 (0.8)| >.99  \nNTM| 2 (0.1)| 5 (0.8)| .002  \nFungi| | |   \n _Aspergillus fumigatus_|  10 (0.4)| 8 (1.3)| .01  \n _Actinomyces_|  2 (0.1)| 0 (0.0)| >.99  \n _Cryptococcus_|  3 (0.1)| 0 (0.0)| .94  \n _Pneumocystis jirovecii_|  5 (0.2)| 13 (2.2)| <.001  \nViruses| | |   \nAdenovirus| 5 (0.2)| 0 (0.0)| .62  \nCoronavirus| 3 (0.1)| 3 (0.5)| .047  \nMetapneumovirus| 3 (0.1)| 2 (0.3)| .51  \nRSV| 7 (0.3)| 6 (1.0)| .03  \nMDR pathogens| 231 (8.8)| 54 (9.0)| .54  \nAbbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant _Staphylococcus aureus_ ; MSSA, methicillin-sensitive _S. aureus_ ; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus.\nTable 2.\n[ Open in new tab ](https://academic.oup.com/view-large/134170125)\nPathogens in the 2 Study Groups\nPathogen . | Patients, No. (%) . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 2626) . | Immunocompromised (n = 596) .   \nPathogens covered by CAP therapy| | |   \n _Streptococcus pneumoniae_|  218 (8.3)| 50 (8.4)| >.99  \nAtypical| 50 (1.9)| 13 (2.2)| .78  \n _Legionella_|  21 (0.8)| 10 (1.7)| .08  \nMRSA| 83 (3.2)| 12 (2.0)| .17  \nMSSA| 73 (2.8)| 20 (3.4)| .53  \n _Pseudomonas aeruginosa_|  98 (3.7)| 35 (5.9)| .02  \n _Haemophilus influenzae_|  65 (2.5)| 10 (1.7)| .31  \n _Klebsiella pneumoniae_|  89 (3.4)| 22 (3.7)| .81  \nInfluenza virus| 126 (4.8)| 28 (4.7)| >.99  \nPathogens not covered by CAP therapy| | |   \nNon-CAP bacteria| | |   \n _Acinetobacter baumanii_|  33 (1.3)| 7 (1.2)| >.99  \n _Nocardia_ spp.| 0 (0.0)| 4 (0.7)| <.001  \nMycobacteria| | |   \n _Mycobacterium tuberculosis_|  21 (0.8)| 5 (0.8)| >.99  \nNTM| 2 (0.1)| 5 (0.8)| .002  \nFungi| | |   \n _Aspergillus fumigatus_|  10 (0.4)| 8 (1.3)| .01  \n _Actinomyces_|  2 (0.1)| 0 (0.0)| >.99  \n _Cryptococcus_|  3 (0.1)| 0 (0.0)| .94  \n _Pneumocystis jirovecii_|  5 (0.2)| 13 (2.2)| <.001  \nViruses| | |   \nAdenovirus| 5 (0.2)| 0 (0.0)| .62  \nCoronavirus| 3 (0.1)| 3 (0.5)| .047  \nMetapneumovirus| 3 (0.1)| 2 (0.3)| .51  \nRSV| 7 (0.3)| 6 (1.0)| .03  \nMDR pathogens| 231 (8.8)| 54 (9.0)| .54  \nPathogen . | Patients, No. (%) . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 2626) . | Immunocompromised (n = 596) .   \nPathogens covered by CAP therapy| | |   \n _Streptococcus pneumoniae_|  218 (8.3)| 50 (8.4)| >.99  \nAtypical| 50 (1.9)| 13 (2.2)| .78  \n _Legionella_|  21 (0.8)| 10 (1.7)| .08  \nMRSA| 83 (3.2)| 12 (2.0)| .17  \nMSSA| 73 (2.8)| 20 (3.4)| .53  \n _Pseudomonas aeruginosa_|  98 (3.7)| 35 (5.9)| .02  \n _Haemophilus influenzae_|  65 (2.5)| 10 (1.7)| .31  \n _Klebsiella pneumoniae_|  89 (3.4)| 22 (3.7)| .81  \nInfluenza virus| 126 (4.8)| 28 (4.7)| >.99  \nPathogens not covered by CAP therapy| | |   \nNon-CAP bacteria| | |   \n _Acinetobacter baumanii_|  33 (1.3)| 7 (1.2)| >.99  \n _Nocardia_ spp.| 0 (0.0)| 4 (0.7)| <.001  \nMycobacteria| | |   \n _Mycobacterium tuberculosis_|  21 (0.8)| 5 (0.8)| >.99  \nNTM| 2 (0.1)| 5 (0.8)| .002  \nFungi| | |   \n _Aspergillus fumigatus_|  10 (0.4)| 8 (1.3)| .01  \n _Actinomyces_|  2 (0.1)| 0 (0.0)| >.99  \n _Cryptococcus_|  3 (0.1)| 0 (0.0)| .94  \n _Pneumocystis jirovecii_|  5 (0.2)| 13 (2.2)| <.001  \nViruses| | |   \nAdenovirus| 5 (0.2)| 0 (0.0)| .62  \nCoronavirus| 3 (0.1)| 3 (0.5)| .047  \nMetapneumovirus| 3 (0.1)| 2 (0.3)| .51  \nRSV| 7 (0.3)| 6 (1.0)| .03  \nMDR pathogens| 231 (8.8)| 54 (9.0)| .54  \nAbbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant _Staphylococcus aureus_ ; MSSA, methicillin-sensitive _S. aureus_ ; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus.\nOnce adjusted for confounders, no risk factors of immunocompromise have been recognized for _P. aeruginosa_ infection. Likewise, pathogens not covered by usual CAP therapy were found to be associated not with immunocompromise but with chronic obstructive pulmonary disease (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.07–2.99; _P_ = .03), tracheostomy (2.91; 1.01–8.38; _P_ = .048), and severe pneumonia (2.36; 1.42–3.93; _P_ = .001) ().\nTable 3.\n[ Open in new tab ](https://academic.oup.com/view-large/134170127)\nMultivariable Logistic Regression Analysis\nVariable . | OR (CI 95%) .   \n---|---  \n _Pseudomonas aeruginosa_ . | Non-CAP Bacteria . | Fungi . |  _Mycobacterium tuberculosis_ . | Virus Other Than Influenza .   \nSevere COPD| 2.89 (1.34–6.22)| …| …| …| …  \nTracheostomy| 6.95 (2.87–16.85)| 2.91(1.01–8.38)| …| …| …  \nICS use| 1.76 (1.09–2.82)| …| …| …| …  \nIndwelling catheter| 2.49 (1.02–6.06)| …| …| …| …  \nPrior _Pseudomonas_|  19.20(11.71–31.50)| …| …| …| …  \nCOPD| …| 1.78(1.07–2.99)| …| …| …  \nSevere CAP| …| 2.36(1.42–3.93)| …| …| 2.56(1.27–5.19)  \nAIDS| …| …| 15.10(6.36–35.88)| …| …  \nHematological cancer| …| …| 4.65(1.85–11.69)| …| 5.49(2.20–13.70)  \nMalnutrition| …| …| …| 5.14 (2.21–11.93)| …  \nVariable . | OR (CI 95%) .   \n---|---  \n _Pseudomonas aeruginosa_ . | Non-CAP Bacteria . | Fungi . |  _Mycobacterium tuberculosis_ . | Virus Other Than Influenza .   \nSevere COPD| 2.89 (1.34–6.22)| …| …| …| …  \nTracheostomy| 6.95 (2.87–16.85)| 2.91(1.01–8.38)| …| …| …  \nICS use| 1.76 (1.09–2.82)| …| …| …| …  \nIndwelling catheter| 2.49 (1.02–6.06)| …| …| …| …  \nPrior _Pseudomonas_|  19.20(11.71–31.50)| …| …| …| …  \nCOPD| …| 1.78(1.07–2.99)| …| …| …  \nSevere CAP| …| 2.36(1.42–3.93)| …| …| 2.56(1.27–5.19)  \nAIDS| …| …| 15.10(6.36–35.88)| …| …  \nHematological cancer| …| …| 4.65(1.85–11.69)| …| 5.49(2.20–13.70)  \nMalnutrition| …| …| …| 5.14 (2.21–11.93)| …  \nBlank cells indicate no statistical significancy.\nAbbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio.\nTable 3.\n[ Open in new tab ](https://academic.oup.com/view-large/134170127)\nMultivariable Logistic Regression Analysis\nVariable . | OR (CI 95%) .   \n---|---  \n _Pseudomonas aeruginosa_ . | Non-CAP Bacteria . | Fungi . |  _Mycobacterium tuberculosis_ . | Virus Other Than Influenza .   \nSevere COPD| 2.89 (1.34–6.22)| …| …| …| …  \nTracheostomy| 6.95 (2.87–16.85)| 2.91(1.01–8.38)| …| …| …  \nICS use| 1.76 (1.09–2.82)| …| …| …| …  \nIndwelling catheter| 2.49 (1.02–6.06)| …| …| …| …  \nPrior _Pseudomonas_|  19.20(11.71–31.50)| …| …| …| …  \nCOPD| …| 1.78(1.07–2.99)| …| …| …  \nSevere CAP| …| 2.36(1.42–3.93)| …| …| 2.56(1.27–5.19)  \nAIDS| …| …| 15.10(6.36–35.88)| …| …  \nHematological cancer| …| …| 4.65(1.85–11.69)| …| 5.49(2.20–13.70)  \nMalnutrition| …| …| …| 5.14 (2.21–11.93)| …  \nVariable . | OR (CI 95%) .   \n---|---  \n _Pseudomonas aeruginosa_ . | Non-CAP Bacteria . | Fungi . |  _Mycobacterium tuberculosis_ . | Virus Other Than Influenza .   \nSevere COPD| 2.89 (1.34–6.22)| …| …| …| …  \nTracheostomy| 6.95 (2.87–16.85)| 2.91(1.01–8.38)| …| …| …  \nICS use| 1.76 (1.09–2.82)| …| …| …| …  \nIndwelling catheter| 2.49 (1.02–6.06)| …| …| …| …  \nPrior _Pseudomonas_|  19.20(11.71–31.50)| …| …| …| …  \nCOPD| …| 1.78(1.07–2.99)| …| …| …  \nSevere CAP| …| 2.36(1.42–3.93)| …| …| 2.56(1.27–5.19)  \nAIDS| …| …| 15.10(6.36–35.88)| …| …  \nHematological cancer| …| …| 4.65(1.85–11.69)| …| 5.49(2.20–13.70)  \nMalnutrition| …| …| …| 5.14 (2.21–11.93)| …  \nBlank cells indicate no statistical significancy.\nAbbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio.\nResults showed that AIDS (OR, 15.10; 95% CI, 6.36–35.88; _P_ ≤ .001) and hematological cancer (4.65; 91.85–11.69; _P_ = .001) were independently associated with fungal infections; hematological cancer (5.49; 2.20–13.70; _P_ < .001) and severe pneumonia (2.56; 1.27–5.19; _P_ = .009) with infection by viruses other than influenza; and AIDS (4.41; 1.53–12.73; _P_ = .006) and malnutrition (4.50; 2.08–9.72; _P_ < .001) with mycobacterial infections. An additional analysis was conducted on mycobacteria, including _M. tuberculosis_ and NTM. At multivariable analysis, _M. tuberculosis_ was independently associated with malnutrition only (OR, 5.14; 95% CI, 2.21–11.93; _P_ < .001). At univariate analysis, patients with AIDS were at higher risk for NTM (23.06; 4.39–121.12; _P_ < .001).\nA subanalysis was conducted among patients with chronic steroid use versus other risk factors for immunocompromise. Patients with chronic steroid use seemed to be more frequently affected by bacteria not covered by standard CAP therapy (10 [3.4%] vs 1 [0.3%] patients; _P_ = .002), _Nocardia_ spp. in particular (4 [0.4%] vs 0 [0.0%]; _P_ = .03). No differences in the severity of the disease were found (see ).\n## DISCUSSION\nThe main findings of the present study are as follows: (1) 17.6% of patients admitted with pneumonia from the community have ≥1 risk factor for immunocompromise, with significant differences among continents and countries (ranging from 15.4% to 24.8% by continent and from 80.0% to 4.1% by country); (2) chronic steroid use is by far the most prevalent risk factor leading to immunocompromise, followed by hematological cancer and chemotherapy; (3) 1 of 2 immunocompromised patients has an overlap of ≥2 risk factors, which are also associated between one another in different ways; and (4) the 2 risk factors for immunocompromise independently associated with specific pathogens are AIDS (ie, fungal and mycobacterial infections) and hematological cancer (ie, fungal infection and viral infections other than influenza).\nAlmost 1 in 5 hospitalized patients with CAP are not immunocompetent. Therefore, it is mandatory to provide clinicians with recommendations or guidelines for the management of hospitalized patients with pneumonia coming from the community who have risk factors for immunocompromise. Currently, there are no guidelines for assessing pneumonia in immunocompromised patients coming from the community. Randomized controlled trials (RCTs) and observational prospective studies are missing owing to the fact that, generally, studies assessing management strategies for pneumonia exclude immunocompromised patients or take into account only a single specific risk factor []. This lack of information about immunocompromise could lead to both underestimation of the real prevalence with a higher rate of treatment failure and to overestimation and overuse of wide-spectrum antibiotics.\nWe found a 17.6% global prevalence of immunocompromise among patients coming from the community with pneumonia, with a significantly higher frequency in South and North America. This variability among continents and countries is probably attributable to different healthcare systems and rates of hospitalization of immunocompromised patients. Our analysis showed that the most frequent risk factor for immunocompromise is the chronic use of systemic steroids. Aging of the population and therapeutic advancements have favored the increased burden of chronic diseases and long-term therapies with immunosuppressive agents [, ]. In particular, steroids are the agents most frequently prescribed, for their wide spectrum of efficacy in several diseases [, , ]. Therefore, many patients presenting to the emergency room with pneumonia are receiving chronic steroid treatment. No data are available on this population group, and further studies are needed to characterize these patients and provide individualized management.\nHematological cancer and chemotherapy were other leading immunocompromised factors. These findings are consistent with those in previous studies; patients recruited in observational studies include patients with solid or hematological cancer and those who underwent chemotherapy with associated neutropenia [, ]. Dedicated guidelines and recommendations are available, especially on respiratory viruses, fungi, and _P. jirovecii_ [].\nOur network analysis showed that several risk factors for immunocompromise show associations, especially chemotherapy, associated with hematological cancer and solid tumor, and other immunocompromise, associated with chronic steroid use. Moreover, neutropenic patients are well represented and mainly affected also by hematological cancer or under treatment with chemotherapy. Our results suggest that patients may have >1 risk factor characteristic and clinical assessment should be comprehensive, taking into consideration risk factors for immunocompromise and their associated biological mechanisms. In contrast, AIDS, lung transplantation, asplenia, and aplastic anemia seem to be less frequent at admission and to represent distinct clinical entities. Findings of previous studies seem to be in line with our results, with AIDS patients considered as a distinct patient population and with very few observational studies available on asplenia and aplastic anemia [, ]\nIn agreement with previous reports, _S. pneumoniae_ is the leading microorganism in both immunocompromised and immunocompetent groups [, ]. Among pathogens covered by standard CAP therapy, only _P. aeruginosa_ was more frequently isolated in immunocompromised compared with immunocompetent patients. These findings differ from microbiological results of previous studies. Gram-positive bacteria, especially _S. aureus_ , were more frequently identified in patients with immunocompromise of different causes [, , ]. Only Li and coauthors [] found patients with immunological disorders, treated with systemic steroids and cytotoxic agents, to have a higher incidence of infections caused by gram-negative bacteria, mainly _P. aeruginosa_. This similarity with our findings could be explained by the prevalence of patients exposed to chronic steroids in our cohort.\nAmong pathogens not covered by standard CAP therapy, immunocompromised patients were more frequently infected by _Nocardia_ spp., NTM, _P. jirovecii_ , _A. fumigatus_ , and viruses other than influenza. Infections by _P. jirovecii_ and NTM are frequently identified in patients with AIDS []. _P. jirovecii_ is also frequent in other types of immunocompromise, such as solid or hematological cancer in patients who underwent chemotherapy [, , ]. Fungal infections (eg, _Candida_ spp. and _A. fumigatus_) are highly incident in neutropenic hematological cancer patients [, ]. Viral infections other than influenza, especially respiratory syncytial virus, are more frequent in patients who underwent hematopoietic stem cell or lung transplantation [, ]. Conversely, _Nocardia_ spp. infections are mainly described in solid organ transplant recipients []. These results, consistent with previous findings, suggest the need for a more in-depth microbiological workup, including community-acquired pathogens and microorganisms not covered by standard therapy.\nSurprisingly, we found that risk factors for immunocompromise were not independently associated with _P. aeruginosa_ or non–community-acquired bacteria; in contrast, AIDS and hematological cancer are both associated with fungal, mycobacterial, and noninfluenza viral pneumonia, respectively. Empirical therapy should include _P. aeruginosa_ coverage, which is highly prevalent in immunocompromised patients. On the contrary, particular attention should be given to fungal, mycobacterial, and viral causes should be for patients admitted with AIDS and hematological cancer [].\nFinally, bacteremia rates did not differ between study groups. To our knowledge, there are no studies on bacteremia and immunocompromise in general. The majority of studies have focused on bacteremia in hematopoietic stem cell transplantation, with prevalences varying from 6% to 44% depending on the type of bacteria and host-related factors []. Few studies addressed this topic in kidney transplant recipients, reporting a prevalence of bacteremia ranging from 25% to 69% [, ]. Finally, few studies have addressed HIV and bacteremia, with prevalences ranging from 10% to 25%, depending on the pathogen and grade of immunosuppression [, ]. The prevalence of bacteremia in our study was 5T–6% in both immunocompetent and immunocompromised patients. Differences in the prevalence of bacteremia are due mainly to differences between the risk factors for immunocompromise in our study (chronic steroid use, hematological cancer, and chemotherapy) and those previously reported in the literature.\nThe current study has both limitations and strengths. First of all, to our knowledge, this is the first study showing a worldwide perspective on immunocompromise among patients coming from the community with pneumonia, with a large and diverse sample of patients enrolled across different countries in 6 continents. However, we were not able to involve many investigators from Asia and Africa, and most cases occurred in North America and Europe, thus limiting the generalizability of our findings. Another major limitation is the unfeasibility of grading the severity of immunocompromise and, therefore, stratifying patients and defining the physiopathological interaction between different risk factors, especially with regard to the use of biological drugs and chronic steroids. Furthermore, potentially important risk factors for an immunocompromised state, such as solid organ transplants other than lung, have not been specifically investigated. Finally, no outcome data have been collected, and this strongly limits our speculations as to the correct empiric antibiotic therapy for use in immunocompromised patients with CAP.\nIn conclusion, our study offers to the scientific community a perspective on immunocompromised patients coming from the community with pneumonia. Future prospective studies on patients with specific risk factors for immunocompromise could provide practical recommendations. In particular, it will be crucial to prepare guidelines on certain prevalent population groups, such as patients exposed to chronic steroids and those with hematological cancer.\n## Supplementary Data\nSupplementary materials are available at _Clinical Infectious Diseases_ online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.\n## Notes\n**_Author contributions._** M. F. D. P., G. S., S. A., and M. I. R. participated in study design, analysis of data, and writing of the manuscript and take responsibility for the integrity of the work. A. G., D. R., S. T., L. F. R., J. R., J. G. d. C., and F. B. critically reviewed the final manuscript.\n**_Acknowledgments._** We thank the Asociacion Latinoamericana de Torax, European Respiratory Society, World Federation of Societies of Intensive and Critical Care Medicine, and American College of Chest Physicians for their support of this project. We also thank the following study contributors for their valuable collaboration. **Argentina:** Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires), Silvia Attorri (Hospital Luis Lago Maggiore, Mendoza), Enrique Barimboim (Hospital Central de Mendoza), Juan Pablo Caeiro and María I. Garzón (Hospital Privado Universitario, Córdoba), Victor Hugo Cambursano, A. Cazaux (Servicio de Neumologia, Hospital Rawson, Córdoba), Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas), Julio Chertcoff, Florencia Lascar, and Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital), Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza), Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires) Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos Vicente Lopez y Planes from General Rodriguez, Buenos Aires), Sandra Lambert (Hospital El Cruce–Alta Complejidad en Red), Gustavo Lopardo (Hospital Bernardo Houssay, Vicente López), Carlos M. Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires), Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen), Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos), Antonio A. Cetrangolo (an individual who is being acknowledged for his contribution to the study), Claudia Pensotti (Infectious Diseases and Infection Control Department, Clinica Privada Monte Grande, Buenos Aires), Betiana Pereyra (Hospital San Roque, Córdoba), Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D. F. Santojanni), Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela); **Australia:** Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg); **Austria:** Felix Lötsch and Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna); **Belgium:** Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp), Camille A. Francois (Anesthesia and Critical Care Department, Erasme University Hospital, Brussels), Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital), Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels); **Benin:** Marcel Zannou Djimon, Jules Bashi and Roger Dodo (Centre Hospitalier Universitaire HKM of Cotonou); **Brazil:** Simone Aranha Nouér (Federal University of Rio de Janeiro); **Bulgaria:** Peter Chipev and Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofia), Darina Miteva, (UMHAT St Marina, Varna), Diana Petkova (University Hospital Varna); **Cameroon:** Adamou Dodo Balkissou (Yaounde Jamot Hospital, Yaounde), Eric Walter Pefura Yone (Département de Médecine Interne, University of Yaounde), Bertrand Hugo Mbatchou Ngahane (Douala General Hospital); **China:** Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing), Jin-fu Xu (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University); **Colombia:** Carlos Andres Bustamante Rico and Ricardo Buitrago (Clinica Shaio, Bogota), Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin); **Congo:** Jean-Marie Kayembe Ntumba (Cliniques Universitaires de Kinshasa); **Croatia:** Vesna Vladic Carevic (Interne Medicine, Dubrovnik), Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb), Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases), Zinka Matkovic (University Hospital Dubrava, Zagreb), Ivan Mitrecic (Karlovac General Hospital); **Denmark:** Marie-Laure Bouchy Jacobsson (Emergency Department, North Zealand’s Hospital–Hillerød), Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital), Uffe Christian Heitmann Bødtger (Department of Pulmonology, Naestved Hospital), Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde), Andreas Vestergaard Jensen, Gertrud Baunbæk-Knudsen, Pelle Trier Petersen, and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød); **Egypt:** Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University), Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University), Hanaa Shafiek (Chest Diseases Department, Faculty of Medicine, Alexandria University), Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo); **Ethiopia:** Kedir Abdella Abdulsemed (Department of Medical Laboratory Science and Pathology, College of Health Sciences, Mycobacteriology Research Centre, Institute of Biotechnology Research, Jimma University); **France:** Fabrice Bertrand (Critical Care Unit, Robert Ballanger Hospital, Aulnay sous Bois), Christian Brun-Buisson (University Hospital of Henri-Mondor, Créteil), Etienne de Montmollin (Intensive Care Unit, Hôpital Delafontaine, Centre Hospitalier de Saint-Denis), Muriel Fartoukh (Unité de Réanimation Médico-Chirurgicale, Pôle Thorax Voies Aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien), Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médico-chirurgicale, Hôpital Louis Mourier, Colombes, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité), Pierre Tattevin (Infectious Diseases and ICU, Pontchaillou University Hospital, Rennes), Abdo Khoury (Department of Emergency Medicine and Critical Care, University of Franche–Comté, Medical Center); **Gambia:** Bernard Ebruke (Medical Research Council Unit, Fajara, Gambia); **Germany:** Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen), Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden), Matthias Meisinger, Klinikum Niederlausitz, Klinik für Innere Medizin und Intensivmedizin, Senftenberg), Mathias W. Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital), Jan Rupp (Department of Infectious Diseases and Microbiology, University of Lübeck), Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg), Marc Spielmanns (Internal Medicine Department, Pulmonary Rehabilitation and Department of Health, School of Medicine, University Witten-Herdecke, St Remigius Hospital, Leverkusen) Petra Creutz and Norton Suttorp (Department of Infectious Disease and Respiratory Medicine, Charité–University Medicine, Berlin); **Ghana** : Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi); **Greece** : Katerina Dimakou (5th Respiratory Medicine Department, SOTIRIA Chest Hospital, Athens), Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens), Evdoxia Tsigou and Dimitrios Ampazis (Agioi Anargiroi Hospital, Kifissia, Athens), Evangelos Kaimakamis (Intensive Care Unit, G. Papanikolaou General Hospital of Thessaloniki); **India** : Mohit Bhatia (S. S. Hospital IMS BHU Varanasi), Raja Dhar (Fortis Hospitals, Kolkata), George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore), Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow), Parvaiz A. Koul (Department of Internal and Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar), P. A. Mahesh and B. S. Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore), Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala), Hirennappa B. Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka), Surya Kant (Department of Respiratory Medicine, King George’s Medical University, Chowk, Lucknow, Uttar Pradesh), Rajesh Swarnakar (Getwell Hospital and Research Institute, Dhantoli, Nagpur), Sneha Limaye and Sundeep Salvi (on behalf of the Respiratory Research Network of India from the Chest Research Foundation in Pune); **Iran** : Keihan Golshani (Isfahan University of Medical Sciences); **Ireland** : Vera M. Keatings (Letterkenny General Hospital, County Donegal), Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization, St James’s University Hospital, Trinity Centre for Health Sciences Dublin); **Israel** : Yasmin Maor (Infectious Disease Unit, affiliated with Tel Aviv University, Wolfson Medical Center, Holon), Jacob Strahilevitz (Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem); **Italy** : Salvatore Battaglia, University of Palermo, Pneumologia DiBiMIS, Palermo), Maria Carrabba (Internal Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca’ Granda Ospedale Maggiore Policlinico, Milano), Piero Ceriana (Pulmonary Rehabilitation, IRCCS Fondazione Maugeri, Pavia), Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste), Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan), Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples), Marino De Rosa (Unità Operativa Complessa [UOC] Pneumologia PO San Filippo Neri Azienda Sanitaria Locale Roma E Roma), Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena), Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria Azienda Ospedaliera Ospedali dei Colli PO Monaldi), Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, Sardegna), Francesco Menzella (Department of Cardiac-Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS–Arcispedale Santa Maria Nuova, Reggio Emilia), Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S. Anna Nuovo, Unità Operativa di Pneumologia, Como), Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital), Gerardo Palmiero (Respiratory Unit, Versilia Hospital, Lido di Camaiore, Lucca), Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli), Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero–Universitaria S. Maria della Misericordia, Udine), Claudio Sorino, Pulmonology Unit, A. O. Sant’Anna di Como), Gundi Steinhilber (Spedali Civili Brescia, U. O. Pneumologia e Fisiopatologia Respiratoria, Brescia), Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta), Fabio Franzetti, Manuela Carugati, Manuela Morosi, and Elisa Monge (Department of Biomedical and Clinical Sciences, Division of Infectious Diseases, Luigi Sacco Hospital, Università degli Studi di Milano), Mauro Carone, (Fondazione Salvatore Maugeri, IRCCS, Cassano Murge), Vincenzo Patella (Allergology and Clinical Immunology Unit, Department of Medical Sciences, Battipaglia Hospital, Battipaglia, Salerno), Simone Scarlata (Geriatrics, Unit of Respiratory Pathophysiology and Thoracic Endoscopy, Campus Bio Medico University and Teaching Hospital, Rome), Andrea Comel, UO Pneumologia, Ospedale Pederzoli, Peschiera del Garda); **Japan** : Kiyoyasu Kurahashi (Yokohama City University Medical Center); **Lebanon** : Zeina Aoun Bacha (Medicine School, St Joseph University, Beyrouth); **Mexico** : Daniel Barajas Ugalde (National Institute of Respiratory Diseases), Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California), José F. Villegas (Hospital Universitario Monterrey); **Montenegro** : Milic Medenica (Hospital for Lung Diseases–Brezovik, Niksic); **Netherlands** : E. M. W. van de Garde (Department of Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein); **Nepal** : Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences), Poojan Shrestha (Oxford University Clinical Research Unit, Patan Hospital); **New Zealand** : Elliott Ridgeon (Medical Research Institute of New Zealand); **Nigeria** : Babatunde Ishola Awokola (Department of Family Medicine and Primary Care, Lily Hospitals Limited, Warri), Ogonna N. O. Nwankwo (University of Calabar Teaching Hospital), Adefuye Bolanle Olufunlola (Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State), Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan), Kingsley N. Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State); **Pakistan** : Muhammad Irfan, Section of Pulmonary and Critical Care Medicine (Department of Medicine, Aga Khan University, Karachi); **Poland** : Lukasz Minarowski (Department of Lung Diseases and Tuberculosis, Medical University of Bialystok), Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec); **Portugal** : Felipe Froes (Hospital Pulido Valente–CHLN, Lisboa), Pedro Leuschner, (Centro Hospitalar do Porto), Mariana Meireles, Cláudia Ferrão, Pedro Leuschner, and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo Prof Abel Salazar, Porto), Sofia B. Ravara (Faculty of Health Sciences, University of Beira Interior, Cova da Beira Hospital Center, Covilhã); **Republic of Moldova** : Victoria Brocovschii (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu), Chesov Ion (Clinic of Anesthesia and Intensive Care Valeriu Ghrerg, Institute of Emergency Medicine, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau), Doina Rusu (SMFU N. Testemitanu, Chisinau), Cristina Toma (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau); **Romania** : Daniela Chirita (Hospital Sfantul Stefan, Bucharest), Carmen Mihaela Dorobat (Universitatea de Medicină şi Farmacie Gr T. Popa I a ş i Facultatea de Medicină Stomatologică, Spitalul Clinic de Boli Infecţioase Sfânta Parascheva I a ş i Iaşi); **Russia** : Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S. I. Georgievsky), Anna Kaluzhenina (Volgograd State Medical University); **Saudi Arabia** : Abdullah Almotairi (King Fahad Medical City, Riyadh), Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina), Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh), Amal Fathy (Pulmonary and Respiratory Critical Care Medicine, Mansoura University Egypt, Affiliate at Taibah University), Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh), Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa), Abdelhaleem Bella (Dammam University–Saudi Arabia and King Fahad Hospital); **Serbia** : Nada Bogdanović (Pulmonary Department of KHC, Dragiša Mišović, Belgrade), Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade), Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade); **Spain** : Luis Borderìas (Respiratory and Sleep Unit, Hospital San Jorge, Huesca), Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at Sant Joan Despí), Hugo Cabello Alarcón (Sant Hospital Seu de Urgell, Catalonia), Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona), Vicens Diaz-Brito and Xavier Casas (Infectious Diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona), Alicia Encabo González (Hospital Complex of Pontevedra), Maria Luisa Fernández-Almira (Medicina Interna, Hospital Universitario Central de Asturias), Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, and CIBER de Enfermedades Respiratorias, CIBERES, Bunyola), Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga), Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid), Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante), Elena Laserna Martínez (Hospital Mollet, Barcelona), Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid), Pedro J. Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña, INIBIC, Sergas, Universidade de A Coruña), Rosario Menéndez (Pneumology Service, University and Polytechnic Hospital La Fe, Valencia), Ana Pando-Sandoval (Hospital Universitario Central de Asturias, Area de Gestion Clinica de Pulmon, Servicio de Neumologia, Oviedo), Cristina Prat Aymerich, Alicia Lacoma de la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, and Universitat Autònoma de Barcelona, CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III), Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d’Hebron, Barcelona), Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia), Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona), Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria), Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo), Job F. M. van Boven (Hospital Universitari Son Espases, Palma de Mallorca), Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró); **South Africa** : Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand); **South Korea** : Ho Kee Yum (Inje University Seoul Paik Hospital); **Togo** : Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University Hospital of Sylvanus Olympio, Lomé); **Tunisia** : Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security, Marsa, Tunis); **Turkey** : Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir), Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul), Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir); **Ukraine** : Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa Regional Antituberculosis Hospital, Vinnitsa); **United Arab Emirates** : Naheed Elahi (Dubai Hospital); **United Kingdom** : Devesh J. Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife), Andrew Feneley, Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann, University Hospitals of Leicester NHS Trust and University of Leicester), Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool), Adam T. Hill (Royal Infirmary and University of Edinburgh), Banu Rudran (The Royal London Hospital, Barts Health Trust, London), Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, East Kilbride), Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds), Alexander Youzguin (Southport and Ormskirk Hospitals NHS Trust), Anika Singanayagam (Imperial College Healthcare NHS Trust, London); **United States** : Karen S. Allen (University of Oklahoma Health Sciences Center, Oklahoma City), Veronica Brito (Texas A&M Health Science Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Baylor Scott & White Health, Temple); Jessica Dietz (Fargo VA Health Care System, Fargo, North Dakota), Claire E. Dysart and Susan M. Kellie (Clement J. Zablocki VA Medical Center, Milwaukee, Wisconsin; Division of Infectious Diseases, University of New Mexico School of Medicine; and Raymond G. Murphy VA Medical Center, Albuquerque, New Mexico), Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, Illinois), Mina Gaga (7th Respiratory Medical Department and Asthma Center, Athens Chest Hospital), Thomas L. Holland and Stephen P. Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, Durham), Fayez Kheir (Department of Pulmonary Diseases, Critical Care and Environmental Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana), Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, Illinois), Manuel Lois (John Peter Smith Hospital, Fort Worth, Texas), Girish B. Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook, and Winthrop University Hospital, Mineola, New York), Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, Denver), Katherine Reyes (Henry Ford Hospital, Detroit, Illinois), William Rodriguez-Cintron, (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, San Juan Puerto Rico), Shigeki Saito (Tulane University, New Orleans), Nilam J. Soni, Julio Noda, Cecilia I. Hinojosa, Stephanie M. Levine, Luis F. Angel, and Antonio Anzueto (Divisions of Hospital Medicine and Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio), K. Scott Whitlow, John Hipskind, Kunal Sukhija, and Vicken Totten (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, California), Richard G. Wunderink and Ray D. Shah (Northwestern University Feinberg School of Medicine, Chicago, Illinois); **Zambia** : Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka). **Other investigators** : Lorena Noriega, Ezequiel Alvarado, Mohamed Aman, and Lucía Labra.\n**_Disclaimer._** The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute, the National Institutes of Health, or the Department of Veterans Affairs.\n**_Financial support._** This project was not funded and relied solely on voluntary site and investigator participation. M. I. R.’s time is partially protected by the National Heart, Lung, and Blood Institute (award K23HL096054).\n**_Potential conflicts of interest._** F. B. reports personal fees from AstraZeneca, GlaxoSmithKline, Guidotti, Grifols, Menarini, and Novartis, and grants and personal fees from Bayer, Chiesi, Insmed, Pfizer, Teva, and Zambon, outside the submitted work. All other authors report no potential conflicts.\n## References\n1.\nAliberti\nS\n, \nDi Pasquale\nM\n, \nZanaboni\nAM\n, et al. \nStratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia\n. \nClin Infect Dis\n2012\n; \n54\n:\n470\n–\n8\n.\n2.\nAliberti\nS\n, \nCilloniz\nC\n, \nChalmers\nJD\n, et al. \nMultidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective\n. \nThorax\n2013\n; \n68\n:\n997\n–\n9\n.\n3.\nShindo\nY\n, \nIto\nR\n, \nKobayashi\nD\n, et al. \nRisk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia\n. \nAm J Respir Crit Care Med\n2013\n; \n188\n:\n985\n–\n95\n.\n4.\nMusher\nDM\n, \nThorner\nAR\n. \nCommunity-acquired pneumonia\n. \nN Engl J Med\n2014\n; \n371\n:\n1619\n–\n28\n.\n5.\nMandell\nLA\n, \nWunderink\nRG\n, \nAnzueto\nA\n, et al. ; \nInfectious Diseases Society of America; American Thoracic Society\n. \nInfectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults\n. \nClin Infect Dis\n2007\n; \n44\n(\nsuppl 2\n):\nS27\n–\n72\n.\n6.\nLim\nWS\n, \nBaudouin\nSV\n, \nGeorge\nRC\n, et al. \nBTS guidelines for the management of community acquired pneumonia in adults\n. \nThorax\n2009\n; \n64\n(\nsuppl III\n):\niii1\n–\n55\n.\n7.\nWoodhead\nM\n, \nBlasi\nF\n, \nEwig\nS\n, et al. ; \nJoint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases\n. \nGuidelines for the management of adult lower respiratory tract infections—full version\n. \nClin Microbiol Infect\n2011\n; \n17(suppl 6)\n:\nE1\n–\n59\n.\n8.\nFurman\nCD\n, \nRayner\nAV\n, \nTobin\nEP\n. \nPneumonia in older residents of long-term care facilities\n. \nAm Fam Physician\n2004\n; \n70\n:\n1495\n–\n500\n.\n9.\nCillóniz\nC\n, \nPolverino\nE\n, \nEwig\nS\n, et al. \nImpact of age and comorbidity on cause and outcome in community-acquired pneumonia\n. \nChest\n2013\n; \n144\n:\n999\n–\n1007\n.\n10.\nAliberti\nS\n, \nReyes\nLF\n, \nFaverio\nP\n, et al. ; \nGLIMP investigators\n. \nGlobal Initiative for Meticillin-Resistant _Staphylococcus aureus_ Pneumonia (GLIMP): an international, observational cohort study\n. \nLancet Infect Dis\n2016\n; \n16\n:\n1364\n–\n76\n.\n11.\nMagiorakos\nAP\n, \nSrinivasan\nA\n, \nCarey\nRB\n, et al. \nMultidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance\n. \nClin Microbiol Infect\n2012\n; \n18\n:\n268\n–\n81\n.\n12.\nWan\nQJ\n, \nHu\nHF\n, \nHe\nYC\n, et al. \nSevere pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy\n. \nKaohsiung J Med Sci\n2015\n; \n31\n:\n42\n–\n6\n.\n13.\nLi\nF\n, \nJin\nHZ\n, \nSu\nF\n, \nJia\nL\n, \nSun\nQN\n. \nPneumocystis pneumonia in patients with immunobullous dermatoses\n. \nInt J Dermatol\n2011\n; \n50\n:\n1144\n–\n9\n.\n14.\nGruson\nD\n, \nVargas\nF\n, \nHilbert\nG\n, et al. \nPredictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia\n. \nIntensive Care Med\n2004\n; \n30\n:\n965\n–\n71\n.\n15.\nGarcia\nJB\n, \nLei\nX\n, \nWierda\nW\n, et al. \nPneumonia during remission induction chemotherapy in patients with acute leukemia\n. \nAnn Am Thorac Soc\n2013\n; \n10\n:\n432\n–\n40\n.\n16.\nLee\nJO\n, \nKim\nDY\n, \nLim\nJH\n, et al. \nRisk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients\n. \nLung Cancer\n2008\n; \n62\n:\n381\n–\n4\n.\n17.\nLim\nKH\n, \nYoon\nHI\n, \nKang\nYA\n, et al. \nSevere pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab\n. \nKorean J Intern Med\n2010\n; \n25\n:\n86\n–\n92\n.\n18.\nWaks\nAG\n, \nTolaney\nSM\n, \nGalar\nA\n, et al. \n_Pneumocystis jiroveci_ pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors\n. \nBreast Cancer Res Treat\n2015\n; \n154\n:\n359\n–\n67\n.\n19.\nKim\nT\n, \nChoi\nSH\n, \nKim\nSH\n, et al. \nPoint prevalence of _Pneumocystis_ pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy\n. \nAnn Hematol\n2013\n; \n92\n:\n231\n–\n8\n.\n20.\nAliberti\nS\n, \nMyers\nJA\n, \nPeyrani\nP\n, et al. \nThe role of neutropenia on outcomes of cancer patients with community-acquired pneumonia\n. \nEur Respir J\n2009\n; \n33\n:\n142\n–\n7\n.\n21.\nSogaard\nOS\n, \nLohse\nN\n, \nGerstoft\nJ\n, et al. \nHospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study\n. \nClin Infect Dis\n2008\n; \n47\n:\n1345\n–\n53\n.\n22.\nKuehnhardt\nD\n, \nHannemann\nM\n, \nSchmidt\nB\n, \nHeider\nU\n, \nPossinger\nK\n, \nEucker\nJ\n. \nTherapeutic implication of BAL in patients with neutropenia\n. \nAnn Hematol\n2009\n; \n88\n:\n1249\n–\n56\n.\n23.\nMaschmeyer\nG\n, \nBeinert\nT\n, \nBuchheidt\nD\n, et al. \nDiagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the Infectious Diseases Working Party of the German Society of Haematology and Oncology\n. \nEur J Cancer\n2009\n; \n45\n:\n2462\n–\n72\n.\n24.\nAlanio\nA\n, \nHauser\nPM\n, \nLagrou\nK\n, et al. ; \n5th European Conference on Infections in Leukemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN)\n. \nECIL guidelines for the diagnosis of _Pneumocystis jirovecii_ pneumonia in patients with haematological malignancies and stem cell transplant recipients\n. \nJ Antimicrob Chemother\n2016\n; \n71\n:\n2386\n–\n96\n.\n25.\nFreifeld\nAG\n, \nBow\nEJ\n, \nSepkowitz\nKA\n, et al. ; \nInfectious Diseases Society of America\n. \nClinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America\n. \nClin Infect Dis\n2011\n; \n52\n:\ne56\n–\n93\n.\n26.\nChemaly\nRF\n, \nShah\nDP\n, \nBoeckh\nMJ\n. \nManagement of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies\n. \nClin Infect Dis\n2014\n; \n59\n(\nsuppl 5\n):\nS344\n–\n51\n.\n27.\nBuchacz\nK\n, \nLau\nB\n, \nJing\nY\n, et al. ; \nNorth American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA\n. \nIncidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010\n. \nJ Infect Dis\n2016\n; \n214\n:\n862\n–\n72\n.\n28.\nMadeddu\nG\n, \nPorqueddu\nEM\n, \nCambosu\nF\n, et al. \nBacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era\n. \nInfection\n2008\n; \n36\n:\n231\n–\n6\n.\n29.\nPark\nDR\n, \nSherbin\nVL\n, \nGoodman\nMS\n, et al. ; \nHarborview CAP Study Group\n. \nThe etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness\n. \nJ Infect Dis\n2001\n; \n184\n:\n268\n–\n77\n.\n30.\nTorres\nHA\n, \nBodey\nGP\n, \nRolston\nKV\n, \nKantarjian\nHM\n, \nRaad\nII\n, \nKontoyiannis\nDP\n. \nInfections in patients with aplastic anemia: experience at a tertiary care cancer center\n. \nCancer\n2003\n; \n98\n:\n86\n–\n93\n.\n31.\nGil-Prieto\nR\n, \nPascual-Garcia\nR\n, \nWalter\nS\n, \nÁlvaro-Meca\nA\n, \nGil-De-Miguel\nÁ\n. \nRisk of hospitalization due to pneumococcal disease in adults in Spain: the CORIENNE study\n. \nHum Vaccin Immunother\n2016\n; \n12\n:\n1900\n–\n5\n.\n32.\nPutot\nA\n, \nTetu\nJ\n, \nPerrin\nS\n, et al. \nImpact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients\n. \nEur J Clin Microbiol Infect Dis\n2016\n; \n35\n:\n489\n–\n95\n.\n33.\nPolverino\nE\n, \nDambrava\nP\n, \nCillóniz\nC\n, et al. \nNursing home-acquired pneumonia: a 10 year single-centre experience\n. \nThorax\n2010\n; \n65\n:\n354\n–\n9\n.\n34.\nKohli\nR\n, \nLo\nY\n, \nHomel\nP\n, et al. ; \nHER Study Group\n. \nBacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study\n. \nClin Infect Dis\n2006\n; \n43\n:\n90\n–\n8\n.\n35.\nBenito\nN\n, \nRañó\nA\n, \nMoreno\nA\n, et al. \nPulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain\n. \nJ Acquir Immune Defic Syndr\n2001\n; \n27\n:\n35\n–\n43\n.\n36.\nMori\nH\n, \nOhno\nY\n, \nIto\nF\n, et al. \nPolymerase chain reaction positivity of _Pneumocystis jirovecii_ during primary lung cancer treatment\n. \nJpn J Clin Oncol\n2010\n; \n40\n:\n658\n–\n62\n.\n37.\nBoersma\nWG\n, \nErjavec\nZ\n, \nvan der Werf\nTS\n, \nde Vries-Hosper\nHG\n, \nGouw\nAS\n, \nManson\nWL\n. \nBronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL\n. \nRespir Med\n2007\n; \n101\n:\n317\n–\n25\n.\n38.\nMikulska\nM\n, \nDel Bono\nV\n, \nGandolfo\nN\n, et al. \nEpidemiology of viral respiratory tract infections in an outpatient haematology facility\n. \nAnn Hematol\n2014\n; \n93\n:\n669\n–\n76\n.\n39.\nBeaird\nOE\n, \nFreifeld\nA\n, \nIson\nMG\n, et al. \nCurrent practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative\n. \nTranspl Infect Dis\n2016\n; \n18\n:\n210\n–\n5\n.\n40.\nPoonyagariyagorn\nHK\n, \nGershman\nA\n, \nAvery\nR\n, et al. \nChallenges in the diagnosis and management of Nocardia infections in lung transplant recipients\n. \nTranspl Infect Dis\n2008\n; \n10\n:\n403\n–\n8\n.\n41.\nTavadze\nM\n, \nRybicki\nL\n, \nMossad\nS\n, et al. \nRisk factors for vancomycin-resistant _Enterococcus_ bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation\n. \nBone Marrow Transplant\n2014\n; \n49\n:\n1310\n–\n6\n.\n42.\nBock\nAM\n, \nCao\nQ\n, \nFerrieri\nP\n, \nYoung\nJA\n, \nWeisdorf\nDJ\n. \nBacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance\n. \nBiol Blood Marrow Transplant\n2013\n; \n19\n:\n102\n–\n8\n.\n43.\nHerbers\nAH\n, \nde Haan\nAF\n, \nvan der Velden\nWJ\n, \nDonnelly\nJP\n, \nBlijlevens\nNM\n. \nMucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients\n. \nTranspl Infect Dis\n2014\n; \n16\n:\n279\n–\n85\n.\n44.\nWu\nSW\n, \nLiu\nKS\n, \nLin\nCK\n, et al. \nCommunity-acquired urinary tract infection in kidney transplantation: risk factors for bacteremia and recurrent infection\n. \nJ Formos Med Assoc\n2013\n; \n112\n:\n138\n–\n43\n.\n45.\nDaskalaki\nE\n, \nKoukoulaki\nM\n, \nBakalis\nA\n, et al. \nBlood stream infections in renal transplant recipients: a single-center study\n. \nTransplant Proc\n2014\n; \n46\n:\n3191\n–\n3\n.\n46.\nHuson\nMA\n, \nStolp\nSM\n, \nvan der Poll\nT\n, \nGrobusch\nMP\n. \nCommunity-acquired bacterial bloodstream infections in HIV-infected patients: a systematic review\n. \nClin Infect Dis\n2014\n; \n58\n:\n79\n–\n92\n.\n47.\nTaramasso\nL\n, \nTatarelli\nP\n, \nDi Biagio\nA\n. \nBloodstream infections in HIV-infected patients\n. \nVirulence\n2016\n; \n7\n:\n320\n–\n8\n.\n© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.\nThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model>)\nTopic:\nIssue Section:\n[Articles and Commentaries](https://academic.oup.com/cid/search-results?f_TocHeadingTitleList=Articles+and+Commentaries)\n[Download all slides](https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=&PPTtype=SlideSet&ar=5078600&xsltPath=~/UI/app/XSLT&siteId=5269)\n## Supplementary data\n- docx file\nAdvertisement\n### Citations\n### Views\n18,086\n### Altmetric\n### Metrics\nTotal Views 18,086\n11,927 Pageviews\n6,159 PDF Downloads\nSince 8/1/2018\nMonth: | Total Views:  \n---|---  \nAugust 2018 | 66  \nSeptember 2018 | 28  \nOctober 2018 | 23  \nNovember 2018 | 70  \nDecember 2018 | 46  \nJanuary 2019 | 53  \nFebruary 2019 | 62  \nMarch 2019 | 31  \nApril 2019 | 408  \nMay 2019 | 355  \nJune 2019 | 182  \nJuly 2019 | 176  \nAugust 2019 | 159  \nSeptember 2019 | 111  \nOctober 2019 | 90  \nNovember 2019 | 66  \nDecember 2019 | 44  \nJanuary 2020 | 69  \nFebruary 2020 | 36  \nMarch 2020 | 223  \nApril 2020 | 208  \nMay 2020 | 140  \nJune 2020 | 179  \nJuly 2020 | 162  \nAugust 2020 | 154  \nSeptember 2020 | 217  \nOctober 2020 | 238  \nNovember 2020 | 237  \nDecember 2020 | 165  \nJanuary 2021 | 140  \nFebruary 2021 | 137  \nMarch 2021 | 236  \nApril 2021 | 239  \nMay 2021 | 239  \nJune 2021 | 172  \nJuly 2021 | 131  \nAugust 2021 | 160  \nSeptember 2021 | 205  \nOctober 2021 | 250  \nNovember 2021 | 227  \nDecember 2021 | 183  \nJanuary 2022 | 202  \nFebruary 2022 | 247  \nMarch 2022 | 301  \nApril 2022 | 242  \nMay 2022 | 240  \nJune 2022 | 161  \nJuly 2022 | 159  \nAugust 2022 | 292  \nSeptember 2022 | 404  \nOctober 2022 | 533  \nNovember 2022 | 300  \nDecember 2022 | 477  \nJanuary 2023 | 287  \nFebruary 2023 | 191  \nMarch 2023 | 310  \nApril 2023 | 395  \nMay 2023 | 248  \nJune 2023 | 198  \nJuly 2023 | 185  \nAugust 2023 | 213  \nSeptember 2023 | 248  \nOctober 2023 | 340  \nNovember 2023 | 311  \nDecember 2023 | 269  \nJanuary 2024 | 301  \nFebruary 2024 | 353  \nMarch 2024 | 372  \nApril 2024 | 323  \nMay 2024 | 341  \nJune 2024 | 275  \nJuly 2024 | 268  \nAugust 2024 | 218  \nSeptember 2024 | 253  \nOctober 2024 | 274  \nNovember 2024 | 312  \nDecember 2024 | 242  \nJanuary 2025 | 250  \nFebruary 2025 | 296  \nMarch 2025 | 396  \nApril 2025 | 228  \nMay 2025 | 228  \nJune 2025 | 86  \nCitations\nPowered by Dimensions\nWeb of Science\nAltmetrics\n**346** readers on Mendeley \n### Email alerts\n[ New journal issues ](https://academic.oup.com/cid/new-journals-alert)\n[ New journal articles ](https://academic.oup.com/cid/new-journal-articles-alert)\nActivity related to this article \n[Sign up for marketing](https://academic.oup.com/my-account/communication-preferences)\n## New journal issues alert\nTo set up an email alert, please to your personal account, or [register](https://academic.oup.com/my-account/register?siteId=5269&returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600)\n## Sign in\n### Personal account\n  * Sign in with email/username & password\n  * Get email alerts\n  * Save searches\n  * Purchase content\n  * Activate your purchase/trial code\n  * Add your ORCID iD\n\n\n[Register](https://academic.oup.com/my-account/register?siteId=5269&returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600)\n## Journal article activity alert\nTo set up an email alert, please to your personal account, or [register](https://academic.oup.com/my-account/register?siteId=5269&returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600)\n## Sign in\n### Personal account\n  * Sign in with email/username & password\n  * Get email alerts\n  * Save searches\n  * Purchase content\n  * Activate your purchase/trial code\n  * Add your ORCID iD\n\n\n[Register](https://academic.oup.com/my-account/register?siteId=5269&returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600)\nClose Modal\n### More on this topic\n[Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods](https://academic.oup.com/cid/article/50/2/202/328880)\n[Microbial Agents Associated with Pneumonia in Children from Uruguay](https://academic.oup.com/cid/article/12/Supplement_8/S915/296667)\n[In the Literature](https://academic.oup.com/cid/article/59/9/iii/419445)\n[Comparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study](https://academic.oup.com/cid/advance-article/7985365)\n### Related articles in PubMed\n### Citing articles via\n[ Effectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial Study  ](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf302/8159933?searchresult=1)\n[ Characteristics Associated with Disseminated Gonococcal Infections vs Uncomplicated Gonorrhea: A California Case-Control Study, 2021-2022  ](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf311/8159932?searchresult=1)\n[ Non-Operative versus Neurosurgical Treatment of Brain Abscess: An Emulated Trial Nested within a Nationwide, Population-Based Cohort  ](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf304/8157607?searchresult=1)\n[ Incidence of AIDS-defining Conditions among Adults with Perinatally Acquired HIV after Transition to Adult HIV Care in the United States and Canada, 2000-2022  ](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf300/8157063?searchresult=1)\n[ State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists  ](https://academic.oup.com/cid/article/80/5/e65/8156727?searchresult=1)\nMore from Oxford Academic\n[Clinical Medicine](https://academic.oup.com/search-results?tax=AcademicSubjects/MED00160)\n[Infectious Diseases](https://academic.oup.com/search-results?tax=AcademicSubjects/MED00290)\n[Medicine and Health](https://academic.oup.com/search-results?tax=AcademicSubjects/MED00010)\n[Books](https://academic.oup.com/books)\n[Journals](https://academic.oup.com/journals)\nHaving trouble contacting the network. Please try again in a moment or two. \n[![Oxford University Press](https://oup.silverchair-cdn.com/data/Multimedia/oup-logo.svg)](http://global.oup.com/)\nAdvertisement\nAdvertisement\nclose advertisement\nAdvertisement\n  * [About Clinical Infectious Diseases](https://academic.oup.com/cid/pages/About)\n  * [Editorial Board](https://academic.oup.com/cid/pages/Editorial_Board)\n  * [Author Guidelines](https://academic.oup.com/cid/pages/General_Instructions)\n\n\n  * [Purchase](https://academic.oup.com/cid/subscribe)\n  * [Advertising and Corporate Services](https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit)\n\n\n[ ![Clinical Infectious Diseases](https://oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_f1483155260.svg) ](https://academic.oup.com/cid)\n  * Online ISSN 1537-6591\n  * Print ISSN 1058-4838\n  * Copyright © 2025 Infectious Diseases Society of America\n\n\n  * [About Oxford Academic](https://academic.oup.com/pages/about-oxford-academic)\n  * [Publish journals with us](https://academic.oup.com/pages/about-oxford-academic/publish-journals-with-us)\n  * [University press partners](https://academic.oup.com/pages/about-oxford-academic/our-university-press-partners)\n  * [What we publish](https://academic.oup.com/pages/what-we-publish)\n  * [New features](https://academic.oup.com/pages/new-features)\n\n\n  * [For authors](https://academic.oup.com/pages/for-authors)\n  * [Open access](https://academic.oup.com/pages/open-research/open-access)\n  * [Purchasing](https://academic.oup.com/pages/purchasing)\n  * [Institutional account management](https://academic.oup.com/pages/institutional-account-management)\n  * [Rights and permissions](https://academic.oup.com/pages/purchasing/rights-and-permissions)\n\n\n  * [Get help with access](https://academic.oup.com/pages/get-help-with-access)\n  * [Accessibility](https://academic.oup.com/pages/about-oxford-academic/accessibility)\n  * [Contact us](https://academic.oup.com/pages/contact-us)\n  * [Advertising](https://academic.oup.com/pages/advertising)\n  * [Media enquiries](https://academic.oup.com/pages/media-enquiries)\n\n\n  * [Oxford University Press](https://global.oup.com/)\n  * [News](https://corp.oup.com/press-office)\n  * [Oxford Languages](https://languages.oup.com/)\n\n\nOxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide\n![Oxford University Press](https://oup.silverchair-cdn.com/UI/app/svg/umbrella/oup-logo.svg)\n  * Copyright © 2025 Oxford University Press\n  * Cookie settings\n  * [Cookie policy](https://global.oup.com/cookiepolicy)\n  * [Privacy policy](https://global.oup.com/privacy)\n  * [Legal notice](https://academic.oup.com/pages/legal-notice)\n\n\n##### This Feature Is Available To Subscribers Only\n[Sign In](https://academic.oup.com/sign-in) or [Create an Account](https://academic.oup.com/my-account/register?siteId=5269&returnUrl=%2fcid%2farticle%2f68%2f9%2f1482%2f5078600)\nThis PDF is available to Subscribers Only\nView Article Abstract & Purchase Options\nFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.\nManage Cookies\nWhen you visit web sites, they may store or retrieve data in your web browser. This storage is often necessary for basic functionality of the web site or the storage may be used for the purposes of marketing, analytics, and personalization of the web site such as storing your preferences. \nPowered by \nSave \nOxford University Press uses cookies to enhance your experience on our website. By selecting ‘accept all’ you are agreeing to our use of cookies. You can change your cookie settings at any time. More information can be found in our [Cookie Policy](https://global.oup.com/cookiepolicy/?cc=gb). \nReject and manage  Deny all  Accept all \n",
    "extracted_content": null,
    "links": [
      {
        "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#skipNav",
        "text": "Skip to Main Content",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/",
        "text": "",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/journals",
        "text": "Journals",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/books",
        "text": "Books",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/pages/information",
        "text": "",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/cid/issue",
        "text": "Issues",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/cid/advance-articles",
        "text": "Advance articles",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/cid/search-results?page=1&f_OUPSeries=Editor%27s+Choice",
        "text": "Editor's Choice",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/cid/supplements",
        "text": "Supplement Archive",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/cid/issue-covers/",
        "text": "Cover Archive",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/cid/pages/clinical-practice-guidelines",
        "text": "IDSA Guidelines",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/idsa",
        "text": "IDSA Journals",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/jid",
        "text": "The Journal of Infectious Diseases",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/ofid",
        "text": "Open Forum Infectious Diseases",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/cid/pages/clinical-dilemmas",
        "text": "Clinical Dilemmas in ID",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/cid/pages/photo-quizzes",
        "text": "Photo Quizzes",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/cid/pages/state-of-the-art-reviews",
        "text": "State-of-the-Art Reviews",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/cid/pages/voices-of-id",
        "text": "Voices of ID",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/idsa/pages/content-collections",
        "text": "IDSA Content Collections",
        "title": "",
        "base_domain": "oup.com"
      },
      {
        "href": "https://academic.oup.com/cid/pages/General_Instructions",
        "text": "Author Guidelines",
        "title": "",
        "base_domain": "oup.com"
      }
    ],
    "images": [
      {
        "src": "//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_title-1229789578.svg",
        "data": "",
        "alt": "Clinical Infectious Diseases",
        "desc": "IDSA Journals",
        "score": 3,
        "type": "image",
        "group_id": 3,
        "format": null,
        "width": null
      },
      {
        "src": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/Issue/68/9/5/m_cover.jpeg?Expires=1752631924&Signature=VzkJpzpYIXCozHbdsaIS60qWT14TRuSLuGC1eukUyrcYSb6veXmlbdxxi4bsCqv56PfMH7dlbqN9LPLYakKnZ6uSxmWg0YAZOHfQIA39tvpONvJ71boTMCgDn8RhjNDckqV16RNIXTme4fSXo-Pb1NEzqABs9EzPZHe9bQMD6FT68PV8Vap~eeaNsVp85gS3jKjGejPEgn2-XCGy4vrE3MaPHJYIAkNxsVP0hL~5pIyLW4I1ZSyrhJhH-eg8MKmfcqb5InNKbRmJkLh~-95lJfZl5LOkCkFEzHqU5URne1xaCnWjdQWfdfTDCJXggdBa~HkCJsQ92f~1fLxypv7dIQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
        "data": "",
        "alt": "Clinical Infectious Diseases Cover Image for Volume 68, Issue 9",
        "desc": "Volume 68 Issue 9 1 May 2019",
        "score": 5,
        "type": "image",
        "group_id": 4,
        "format": "jpeg",
        "width": null
      },
      {
        "src": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1752554620&Signature=LKXAyrV74Aa9owXe0o-cQ75pOeSoID0-pehgygNtPZSFXNZMuhHSvh2bH2dv7qW8hH1yagXom1UIMLOtWgjAeeVu2LBuha-~CcDB2tnoDsCwd0W--ENWiqmCFTxq3yC2TQ0Umx7W~VJXwN6SRKyfDOflOkKvPGRNUobFX0ugYVCV63UYBnlhdsPfvI-fsKpp2D2I1PP6zBaXvsJbvI-0aIPK7XN9D-bkImy~2jyh7YxMl-ml056-m9M~e1NXIC1G-eMlJ-D0ihNbxsU~I2x~~h2BWrtr8AE9Sfu1WTqiFahp57mH4~iFGY9EkQkC4xJpjMyNKtQFhxpXjvQtYLzecQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
        "data": "",
        "alt": "Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases.",
        "desc": "Figure 1. Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases. Open in new tab Download slide",
        "score": 5,
        "type": "image",
        "group_id": 6,
        "format": "jpeg",
        "width": null
      },
      {
        "src": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72302.jpeg?Expires=1752554620&Signature=tN-5VXAN-IRDKK8axKZA8P~Y5z--s9j8Erc8SOjWl6DrKKH4QL5os9eZxhVeV6eWVN~f~VDG9tfzyHUF6i7OVsMNB2vsk6C~94Qv-2aRHoy5JP-aM-LrL8khDyqEa4Lg2BfInF3Q0qGwXrmt25GlH1qSBKirMgS~VlVo9FK3dUDe2-XgCIv-DixycDR1NbxEUad1obLBQi7T-cMZnDc0-hSXzSelH07q4yY8dbVGxrERuy5IWOvusZ1u83w1jCK4dSvt3hPFFdMZMOmGLi~Fj-dVSs0cAjfbIHoEDmqErTby4pVDEijEs5muQVm-Ux~YEjgN-VhvWj8YtpZKL4eSXA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
        "data": "",
        "alt": "Prevalence of each single risk factor for immunocompromise.",
        "desc": "Figure 2. Prevalence of each single risk factor for immunocompromise. Open in new tab Download slide",
        "score": 4,
        "type": "image",
        "group_id": 7,
        "format": "jpeg",
        "width": null
      },
      {
        "src": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72303.jpeg?Expires=1752554620&Signature=Xts16a6pXvQbNfwKtUeejfXsqF17z~2gviy7VcLQhhckWHmCw0zRSSEtsyrG9SkI2LRw39TbhqnqYNb1VTXQKD-ybyHkb~R3s-eIxJ~94DOxaaXBbUvpzbvwY1vDACc5LpVzJJ8dZMntZ7nekvhgMs6NtlpySVWDDC~7ybF0bySgW6i55FBFevIdcUxB3ipChEHL9XiTlmDkdiHssMser494UBvbDyg4DUKM-Cpd988M8qpSwp-eg-3Yhkr9q2~L66QQUhwgYNILWRRA1azwsTAJvrWUq52Dpikbj4mzbXXstnhvc7GNMw5xxz6nFPKuHVKJlcE-HQsiIvj5ZOVUxg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
        "data": "",
        "alt": "Prevalence of the number of risk factors present simultaneously in a single patient.",
        "desc": "Figure 3. Prevalence of the number of risk factors present simultaneously in a single patient. Open in new tab Download slide",
        "score": 4,
        "type": "image",
        "group_id": 8,
        "format": "jpeg",
        "width": null
      }
    ],
    "processed_content": {
      "success": true,
      "status_code": 200,
      "error_message": "",
      "timestamp": "2025-06-11T05:12:08.876617",
      "url": "https://doi.org/10.1093/cid/ciy723",
      "institution_type": "hospital",
      "metadata": {
        "title": "Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients | Clinical Infectious Diseases | Oxford Academic",
        "description": "Of patients with pneumonia coming from the community, 18% are immunocompromised. Specific immunocompromised states are associated with specific microbiolog",
        "keywords": null,
        "author": null,
        "og:site_name": "OUP Academic",
        "og:title": "Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients",
        "og:description": "Of patients with pneumonia coming from the community, 18% are immunocompromised. Specific immunocompromised states are associated with specific microbiolog",
        "og:type": "article",
        "og:url": "https://dx.doi.org/10.1093/cid/ciy723",
        "og:image": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
        "og:image:url": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
        "og:image:secure_url": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
        "og:image:alt": "Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases.",
        "twitter:card": "summary_large_image"
      },
      "title": "Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients | Clinical Infectious Diseases | Oxford Academic",
      "description": "Of patients with pneumonia coming from the community, 18% are immunocompromised. Specific immunocompromised states are associated with specific microbiolog",
      "language": "unknown",
      "keywords": null,
      "author": null,
      "charset": "",
      "viewport": "",
      "content_formats": {
        "raw_html": "<!DOCTYPE html><html lang=\"en\" class=\"no-js\"><head><meta class=\"foundation-mq-small\"><meta class=\"foundation-mq-small-only\"><meta class=\"foundation-mq-medium\"><meta class=\"foundation-mq-medium-only\"><meta class=\"foundation-mq-large\"><meta class=\"foundation-mq-large-only\"><meta class=\"foundation-mq-xlarge\"><meta class=\"foundation-mq-xlarge-only\"><meta class=\"foundation-mq-xxlarge\"><meta class=\"foundation-data-attribute-namespace\">\n    <!-- charset must appear in the first 1024 bytes of the document -->\n    <meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\">\n        <title>Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients | Clinical Infectious Diseases | Oxford Academic</title>\n        \n                \n\n\n        <script async=\"\" src=\"https://buttons-config.sharethis.com/js/643701de45aa460012e1032e.js\"></script><script type=\"text/javascript\" async=\"\" src=\"https://www.googletagmanager.com/gtag/js?id=G-GLF90ZEMKF&amp;cx=c&amp;gtm=45He5690h1v79429524za200&amp;tag_exp=101509157~103116026~103200004~103233427~103351869~103351871~104617979~104617981~104661466~104661468~104684208~104684211\"></script><script type=\"text/javascript\" async=\"\" src=\"https://www.cdn.privado.ai/b230e0658a2d4f23bd9374dc1930f2c9.js\"></script><script async=\"\" src=\"https://www.googletagmanager.com/gtm.js?id=GTM-W6DD7HV\"></script><script type=\"text/javascript\" defer=\"\" src=\"//js.trendmd.com/trendmd.min.js\" data-trendmdconfig=\"{&quot;element&quot;:&quot;#trendmd-suggestions&quot;}\"></script>\n\n\n\n    <script src=\"https://ajax.googleapis.com/ajax/libs/jquery/3.7.1/jquery.min.js\" type=\"text/javascript\"></script>\n<script>window.jQuery || document.write('<script src=\"//oup.silverchair-cdn.com/Themes/Silver/app/js/jquery.3.7.1.min.js\" type=\"text/javascript\">\\x3C/script>')</script>\n<script src=\"//oup.silverchair-cdn.com/Themes/Silver/app/vendor/v-638830270403470925/jquery-migrate-1.4.1.min.js\" type=\"text/javascript\"></script>\n\n    <script type=\"text/javascript\" src=\"https://platform-api.sharethis.com/js/sharethis.js#property=643701de45aa460012e1032e&amp;product=sop\" async=\"async\"></script>\n\n\n    <meta name=\"viewport\" content=\"width=device-width, initial-scale=1, maximum-scale=10\">\n\n    \n    <meta http-equiv=\"X-UA-Compatible\" content=\"IE=Edge\">\n    <!-- Turn off telephone number detection. -->\n    <meta name=\"format-detection\" content=\"telephone=no\">\n\n<!-- Bookmark Icons -->\n  <link rel=\"apple-touch-icon\" sizes=\"180x180\" href=\"//oup.silverchair-cdn.com/UI/app/img/v-638830269404973882/apple-touch-icon.png\">\n  <link rel=\"icon\" type=\"image/png\" href=\"//oup.silverchair-cdn.com/UI/app/img/v-638830269405123889/favicon-32x32.png\" sizes=\"32x32\">\n  <link rel=\"icon\" type=\"image/png\" href=\"//oup.silverchair-cdn.com/UI/app/img/v-638830269405073884/favicon-16x16.png\" sizes=\"16x16\">\n  <link rel=\"mask-icon\" href=\"//oup.silverchair-cdn.com/UI/app/img/v-638830269422336701/safari-pinned-tab.svg\" color=\"#001C54\">\n  <link rel=\"icon\" href=\"//oup.silverchair-cdn.com/UI/app/img/v-638830269421737312/favicon.ico\">\n  <link rel=\"manifest\" href=\"//oup.silverchair-cdn.com/UI/app/img/v-638830269422036734/manifest.json\">\n  <meta name=\"msapplication-config\" content=\"//oup.silverchair-cdn.com/UI/app/img/v-638830269404973882/browserconfig.xml\">\n  <meta name=\"theme-color\" content=\"#002f65\">\n\n\n    \n\n\n\n\n<link rel=\"stylesheet\" type=\"text/css\" href=\"//oup.silverchair-cdn.com/UI/app/fonts/icons.css\">\n\n<link rel=\"stylesheet\" type=\"text/css\" href=\"//oup.silverchair-cdn.com/Themes/Client/app/css/v-638847457879323408/site.min.css\">\n\n\n    <link rel=\"stylesheet\" href=\"https://fonts.googleapis.com/css?family=Merriweather:300,400,400italic,700,700italic|Source+Sans+Pro:400,400italic,700,700italic\" as=\"style\" onload=\"this.onload=null;this.rel='stylesheet'\">\n\n\n        <link href=\"//oup.silverchair-cdn.com/data/SiteBuilderAssetsOriginals/Live/CSS/journals/v-638833379356521055/global.css\" rel=\"stylesheet\" type=\"text/css\">\n            <link href=\"//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/CSS/cid/v-638814360517039884/Site.css\" rel=\"stylesheet\" type=\"text/css\">\n\n\n\n<script> var dataLayer = [{\"full_title\":\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\",\"short_title\":\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\",\"authors\":\"Marta Francesca Di Pasquale,Giovanni Sotgiu,Andrea Gramegna,Dejan Radovanovic,Silvia Terraneo,Luis F Reyes,Jan Rupp,Juan González del Castillo,Francesco Blasi,Stefano Aliberti,Marcos I Restrepo\",\"issue_and_volume\":\"Volume 68 | Issue 9\",\"type\":\"research-article\",\"online_publication_date\":\"2018-08-23\",\"access_type\":\"Free\",\"license_type\":\"free\",\"event_type\":\"full-text\",\"supplier_tag\":\"SC_Journals\",\"object_type\":\"Article\",\"taxonomy\":\"taxId%3a39%7ctaxLabel%3aAcademicSubjects%7cnodeId%3aMED00290%7cnodeLabel%3aInfectious+Diseases%7cnodeLevel%3a3\",\"siteid\":\"cid\",\"authzrequired\":\"false\",\"doi\":\"10.1093/cid/ciy723\"}]; </script>\n            <script>\n                (function (w, d, s, l, i) {\n                    w[l] = w[l] || []; w[l].push({\n                        'gtm.start':\n                            new Date().getTime(), event: 'gtm.js'\n                    }); var f = d.getElementsByTagName(s)[0],\n                        j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : '';\n                        j.async = true; j.src =\n                        'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);\n                })(window, document, 'script', 'dataLayer', 'GTM-W6DD7HV');\n            </script>\n\n    \n\n        <script type=\"text/javascript\">\n            var App = App || {};\n            App.LoginUserInfo = {\n                isInstLoggedIn: 0,\n                isIndividualLoggedIn: 0\n            };\n\n            App.CurrentSubdomain = 'cid';\n            App.SiteURL = 'academic.oup.com/cid';\n        </script>\n    \n    \n    <link href=\"https://cdn.jsdelivr.net/chartist.js/latest/chartist.min.css\" onload=\"this.onload=null;this.removeAttribute('media');\" rel=\"stylesheet\" type=\"text/css\">\n    <script type=\"application/ld+json\">\n        {\"@context\":\"https://schema.org\",\"@type\":\"ScholarlyArticle\",\"@id\":\"https://academic.oup.com/cid/article/68/9/1482/5078600\",\"name\":\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\",\"about\":[\"acquired immunodeficiency syndrome\",\"chemotherapy regimen\",\"community acquired pneumonia\",\"hematologic neoplasms\",\"immunocompetence\",\"immunocompromised host\",\"pneumonia\",\"steroids\",\"bacteria\",\"microbiology\",\"viruses\",\"pathogenic organism\",\"community\",\"causality\"],\"datePublished\":\"2018-08-23\",\"isPartOf\":{\"@id\":\"https://academic.oup.com/cid/issue/68/9\",\"@type\":\"PublicationIssue\",\"issueNumber\":\"9\",\"datePublished\":\"2019-04-24\",\"isPartOf\":{\"@id\":\"https://academic.oup.com/cid/cid\",\"@type\":\"Periodical\",\"name\":\"Clinical Infectious Diseases\",\"issn\":[\"1537-6591\"]}},\"url\":\"https://dx.doi.org/10.1093/cid/ciy723\",\"keywords\":[\"acquired immunodeficiency syndrome\",\"chemotherapy regimen\",\"community acquired pneumonia\",\"hematologic neoplasms\",\"immunocompetence\",\"immunocompromised host\",\"pneumonia\",\"steroids\",\"bacteria\",\"microbiology\",\"viruses\",\"pathogenic organism\",\"community\",\"causality\",\"pneumonia\",\"multidrug-resistant pathogens\",\"microbiology\",\"MRSA\",\"immunocompromise\"],\"inLanguage\":\"en\",\"copyrightHolder\":\"Infectious Diseases Society of America\",\"copyrightYear\":\"2025\",\"publisher\":\"Oxford University Press\",\"author\":[{\"name\":\"Di Pasquale, Marta Francesca\",\"affiliation\":\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\",\"@type\":\"Person\",\"sameAs\":\"https://orcid.org/0000-0002-1450-5830\"},{\"name\":\"Sotgiu, Giovanni\",\"affiliation\":\"Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari\",\"@type\":\"Person\"},{\"name\":\"Gramegna, Andrea\",\"affiliation\":\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\",\"@type\":\"Person\"},{\"name\":\"Radovanovic, Dejan\",\"affiliation\":\"Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Pulmonary Unit, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco\",\"@type\":\"Person\"},{\"name\":\"Terraneo, Silvia\",\"affiliation\":\"Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Italy\",\"@type\":\"Person\"},{\"name\":\"Reyes, Luis F\",\"affiliation\":\"Microbiology Department, Universidad de La Sabana, Chia, Colombia\",\"@type\":\"Person\"},{\"name\":\"Rupp, Jan\",\"affiliation\":\"Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany\",\"@type\":\"Person\"},{\"name\":\"González del Castillo, Juan\",\"affiliation\":\"Emergency Department, Hospital Clínico San Carlos, Universidad Complutense  Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, IdISSC, Madrid, Spain\",\"@type\":\"Person\"},{\"name\":\"Blasi, Francesco\",\"affiliation\":\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\",\"@type\":\"Person\"},{\"name\":\"Aliberti, Stefano\",\"affiliation\":\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\",\"@type\":\"Person\"},{\"name\":\"Restrepo, Marcos I\",\"affiliation\":\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio\",\"@type\":\"Person\"}],\"description\":\"Of patients with pneumonia coming from the community, 18% are immunocompromised. Specific immunocompromised states are associated with specific microbiolog\",\"pageStart\":\"1482\",\"pageEnd\":\"1493\",\"siteName\":\"OUP Academic\",\"thumbnailURL\":\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\",\"headline\":\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\",\"image\":\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\",\"image:alt\":\"Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, &lt;5%, 5%–10%, 11%–20%, 21%–30%, or &gt;30% of total cases.\"}\n    </script>\n<meta property=\"og:site_name\" content=\"OUP Academic\">\n<meta property=\"og:title\" content=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\">\n<meta property=\"og:description\" content=\"Of patients with pneumonia coming from the community, 18% are immunocompromised. Specific immunocompromised states are associated with specific microbiolog\">\n<meta property=\"og:type\" content=\"article\">\n<meta property=\"og:url\" content=\"https://dx.doi.org/10.1093/cid/ciy723\">\n<meta property=\"og:updated_time\" content=\"\">\n<meta property=\"og:image\" content=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&amp;Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\">\n<meta property=\"og:image:url\" content=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&amp;Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\">\n<meta property=\"og:image:secure_url\" content=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&amp;Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\">\n<meta property=\"og:image:alt\" content=\"Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases.\">\n<meta name=\"twitter:card\" content=\"summary_large_image\">\n<meta name=\"citation_author\" content=\"Di Pasquale, Marta Francesca\"><meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\"><meta name=\"citation_author\" content=\"Sotgiu, Giovanni\"><meta name=\"citation_author_institution\" content=\"Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari\"><meta name=\"citation_author\" content=\"Gramegna, Andrea\"><meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\"><meta name=\"citation_author\" content=\"Radovanovic, Dejan\"><meta name=\"citation_author_institution\" content=\"Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Pulmonary Unit, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco\"><meta name=\"citation_author\" content=\"Terraneo, Silvia\"><meta name=\"citation_author_institution\" content=\"Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Italy\"><meta name=\"citation_author\" content=\"Reyes, Luis F\"><meta name=\"citation_author_institution\" content=\"Microbiology Department, Universidad de La Sabana, Chia, Colombia\"><meta name=\"citation_author\" content=\"Rupp, Jan\"><meta name=\"citation_author_institution\" content=\"Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany\"><meta name=\"citation_author\" content=\"González del Castillo, Juan\"><meta name=\"citation_author_institution\" content=\"Emergency Department, Hospital Clínico San Carlos, Universidad Complutense\"><meta name=\"citation_author_institution\" content=\"Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, IdISSC, Madrid, Spain\"><meta name=\"citation_author\" content=\"Blasi, Francesco\"><meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\"><meta name=\"citation_author\" content=\"Aliberti, Stefano\"><meta name=\"citation_author_institution\" content=\"Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\"><meta name=\"citation_author\" content=\"Restrepo, Marcos I\"><meta name=\"citation_author_institution\" content=\"Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio\"><meta name=\"citation_title\" content=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\"><meta name=\"citation_firstpage\" content=\"1482\"><meta name=\"citation_lastpage\" content=\"1493\"><meta name=\"citation_doi\" content=\"10.1093/cid/ciy723\"><meta name=\"citation_keyword\" content=\"community acquired pneumonia\"><meta name=\"citation_keyword\" content=\"immunocompromised host\"><meta name=\"citation_keyword\" content=\"pneumonia\"><meta name=\"citation_keyword\" content=\"pathogenic organism\"><meta name=\"citation_keyword\" content=\"community\"><meta name=\"citation_keyword\" content=\"hematologic neoplasms\"><meta name=\"citation_keyword\" content=\"steroids\"><meta name=\"citation_keyword\" content=\"microbiology\"><meta name=\"citation_keyword\" content=\"acquired immunodeficiency syndrome\"><meta name=\"citation_keyword\" content=\"chemotherapy regimen\"><meta name=\"citation_keyword\" content=\"immunocompetence\"><meta name=\"citation_keyword\" content=\"viruses\"><meta name=\"citation_keyword\" content=\"causality\"><meta name=\"citation_keyword\" content=\"bacteria\"><meta name=\"citation_journal_title\" content=\"Clinical Infectious Diseases\"><meta name=\"citation_journal_abbrev\" content=\"Clin Infect Dis\"><meta name=\"citation_volume\" content=\"68\"><meta name=\"citation_issue\" content=\"9\"><meta name=\"citation_publication_date\" content=\"2019/04/24\"><meta name=\"citation_issn\" content=\"1058-4838\"><meta name=\"citation_publisher\" content=\"Oxford Academic\"><meta name=\"citation_reference\" content=\"citation_title=Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia; citation_author=Aliberti  S; citation_author=Di Pasquale  M; citation_author=Zanaboni  AM;  citation_journal_title=Clin Infect Dis;  citation_year=2012;  citation_volume=54;  citation_pages=470-8; \"><meta name=\"citation_reference\" content=\"citation_title=Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective; citation_author=Aliberti  S; citation_author=Cilloniz  C; citation_author=Chalmers  JD;  citation_journal_title=Thorax;  citation_year=2013;  citation_volume=68;  citation_pages=997-9; \"><meta name=\"citation_reference\" content=\"citation_title=Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia; citation_author=Shindo  Y; citation_author=Ito  R; citation_author=Kobayashi  D;  citation_journal_title=Am J Respir Crit Care Med;  citation_year=2013;  citation_volume=188;  citation_pages=985-95; \"><meta name=\"citation_reference\" content=\"citation_title=Community-acquired pneumonia; citation_author=Musher  DM; citation_author=Thorner  AR;  citation_journal_title=N Engl J Med;  citation_year=2014;  citation_volume=371;  citation_pages=1619-28; \"><meta name=\"citation_reference\" content=\"citation_title=Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults; citation_author=Infectious Diseases Society of America; American Thoracic Society; citation_author=Mandell  LA; citation_author=Wunderink  RG; citation_author=Anzueto  A;  citation_journal_title=Clin Infect Dis;  citation_year=2007;  citation_volume=44;  citation_pages=S27-72; \"><meta name=\"citation_reference\" content=\"citation_title=BTS guidelines for the management of community acquired pneumonia in adults; citation_author=Lim  WS; citation_author=Baudouin  SV; citation_author=George  RC;  citation_journal_title=Thorax;  citation_year=2009;  citation_volume=64;  citation_pages=iii1-55; \"><meta name=\"citation_reference\" content=\"citation_title=Guidelines for the management of adult lower respiratory tract infections—full version; citation_author=Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases; citation_author=Woodhead  M; citation_author=Blasi  F; citation_author=Ewig  S;  citation_journal_title=Clin Microbiol Infect;  citation_year=2011;  citation_volume=17(suppl 6);  citation_pages=E1-59; \"><meta name=\"citation_reference\" content=\"citation_title=Pneumonia in older residents of long-term care facilities; citation_author=Furman  CD; citation_author=Rayner  AV; citation_author=Tobin  EP;  citation_journal_title=Am Fam Physician;  citation_year=2004;  citation_volume=70;  citation_pages=1495-500; \"><meta name=\"citation_reference\" content=\"citation_title=Impact of age and comorbidity on cause and outcome in community-acquired pneumonia; citation_author=Cillóniz  C; citation_author=Polverino  E; citation_author=Ewig  S;  citation_journal_title=Chest;  citation_year=2013;  citation_volume=144;  citation_pages=999-1007; \"><meta name=\"citation_reference\" content=\"citation_title=Global Initiative for Meticillin-Resistant Staphylococcus aureus Pneumonia (GLIMP): an international, observational cohort study; citation_author=GLIMP investigators; citation_author=Aliberti  S; citation_author=Reyes  LF; citation_author=Faverio  P;  citation_journal_title=Lancet Infect Dis;  citation_year=2016;  citation_volume=16;  citation_pages=1364-76; \"><meta name=\"citation_reference\" content=\"citation_title=Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance; citation_author=Magiorakos  AP; citation_author=Srinivasan  A; citation_author=Carey  RB;  citation_journal_title=Clin Microbiol Infect;  citation_year=2012;  citation_volume=18;  citation_pages=268-81; \"><meta name=\"citation_reference\" content=\"citation_title=Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy; citation_author=Wan  QJ; citation_author=Hu  HF; citation_author=He  YC;  citation_journal_title=Kaohsiung J Med Sci;  citation_year=2015;  citation_volume=31;  citation_pages=42-6; \"><meta name=\"citation_reference\" content=\"citation_title=Pneumocystis pneumonia in patients with immunobullous dermatoses; citation_author=Li  F; citation_author=Jin  HZ; citation_author=Su  F; citation_author=Jia  L; citation_author=Sun  QN;  citation_journal_title=Int J Dermatol;  citation_year=2011;  citation_volume=50;  citation_pages=1144-9; \"><meta name=\"citation_reference\" content=\"citation_title=Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia; citation_author=Gruson  D; citation_author=Vargas  F; citation_author=Hilbert  G;  citation_journal_title=Intensive Care Med;  citation_year=2004;  citation_volume=30;  citation_pages=965-71; \"><meta name=\"citation_reference\" content=\"citation_title=Pneumonia during remission induction chemotherapy in patients with acute leukemia; citation_author=Garcia  JB; citation_author=Lei  X; citation_author=Wierda  W;  citation_journal_title=Ann Am Thorac Soc;  citation_year=2013;  citation_volume=10;  citation_pages=432-40; \"><meta name=\"citation_reference\" content=\"citation_title=Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients; citation_author=Lee  JO; citation_author=Kim  DY; citation_author=Lim  JH;  citation_journal_title=Lung Cancer;  citation_year=2008;  citation_volume=62;  citation_pages=381-4; \"><meta name=\"citation_reference\" content=\"citation_title=Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab; citation_author=Lim  KH; citation_author=Yoon  HI; citation_author=Kang  YA;  citation_journal_title=Korean J Intern Med;  citation_year=2010;  citation_volume=25;  citation_pages=86-92; \"><meta name=\"citation_reference\" content=\"citation_title=Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors; citation_author=Waks  AG; citation_author=Tolaney  SM; citation_author=Galar  A;  citation_journal_title=Breast Cancer Res Treat;  citation_year=2015;  citation_volume=154;  citation_pages=359-67; \"><meta name=\"citation_reference\" content=\"citation_title=Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy; citation_author=Kim  T; citation_author=Choi  SH; citation_author=Kim  SH;  citation_journal_title=Ann Hematol;  citation_year=2013;  citation_volume=92;  citation_pages=231-8; \"><meta name=\"citation_reference\" content=\"citation_title=The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia; citation_author=Aliberti  S; citation_author=Myers  JA; citation_author=Peyrani  P;  citation_journal_title=Eur Respir J;  citation_year=2009;  citation_volume=33;  citation_pages=142-7; \"><meta name=\"citation_reference\" content=\"citation_title=Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study; citation_author=Sogaard  OS; citation_author=Lohse  N; citation_author=Gerstoft  J;  citation_journal_title=Clin Infect Dis;  citation_year=2008;  citation_volume=47;  citation_pages=1345-53; \"><meta name=\"citation_reference\" content=\"citation_title=Therapeutic implication of BAL in patients with neutropenia; citation_author=Kuehnhardt  D; citation_author=Hannemann  M; citation_author=Schmidt  B; citation_author=Heider  U; citation_author=Possinger  K; citation_author=Eucker  J;  citation_journal_title=Ann Hematol;  citation_year=2009;  citation_volume=88;  citation_pages=1249-56; \"><meta name=\"citation_reference\" content=\"citation_title=Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the Infectious Diseases Working Party of the German Society of Haematology and Oncology; citation_author=Maschmeyer  G; citation_author=Beinert  T; citation_author=Buchheidt  D;  citation_journal_title=Eur J Cancer;  citation_year=2009;  citation_volume=45;  citation_pages=2462-72; \"><meta name=\"citation_reference\" content=\"citation_title=ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients; citation_author=5th European Conference on Infections in Leukemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN); citation_author=Alanio  A; citation_author=Hauser  PM; citation_author=Lagrou  K;  citation_journal_title=J Antimicrob Chemother;  citation_year=2016;  citation_volume=71;  citation_pages=2386-96; \"><meta name=\"citation_reference\" content=\"citation_title=Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America; citation_author=Infectious Diseases Society of America; citation_author=Freifeld  AG; citation_author=Bow  EJ; citation_author=Sepkowitz  KA;  citation_journal_title=Clin Infect Dis;  citation_year=2011;  citation_volume=52;  citation_pages=e56-93; \"><meta name=\"citation_reference\" content=\"citation_title=Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies; citation_author=Chemaly  RF; citation_author=Shah  DP; citation_author=Boeckh  MJ;  citation_journal_title=Clin Infect Dis;  citation_year=2014;  citation_volume=59;  citation_pages=S344-51; \"><meta name=\"citation_reference\" content=\"citation_title=Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010; citation_author=North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA; citation_author=Buchacz  K; citation_author=Lau  B; citation_author=Jing  Y;  citation_journal_title=J Infect Dis;  citation_year=2016;  citation_volume=214;  citation_pages=862-72; \"><meta name=\"citation_reference\" content=\"citation_title=Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era; citation_author=Madeddu  G; citation_author=Porqueddu  EM; citation_author=Cambosu  F;  citation_journal_title=Infection;  citation_year=2008;  citation_volume=36;  citation_pages=231-6; \"><meta name=\"citation_reference\" content=\"citation_title=The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness; citation_author=Harborview CAP Study Group; citation_author=Park  DR; citation_author=Sherbin  VL; citation_author=Goodman  MS;  citation_journal_title=J Infect Dis;  citation_year=2001;  citation_volume=184;  citation_pages=268-77; \"><meta name=\"citation_reference\" content=\"citation_title=Infections in patients with aplastic anemia: experience at a tertiary care cancer center; citation_author=Torres  HA; citation_author=Bodey  GP; citation_author=Rolston  KV; citation_author=Kantarjian  HM; citation_author=Raad  II; citation_author=Kontoyiannis  DP;  citation_journal_title=Cancer;  citation_year=2003;  citation_volume=98;  citation_pages=86-93; \"><meta name=\"citation_reference\" content=\"citation_title=Risk of hospitalization due to pneumococcal disease in adults in Spain: the CORIENNE study; citation_author=Gil-Prieto  R; citation_author=Pascual-Garcia  R; citation_author=Walter  S; citation_author=Álvaro-Meca  A; citation_author=Gil-De-Miguel  Á;  citation_journal_title=Hum Vaccin Immunother;  citation_year=2016;  citation_volume=12;  citation_pages=1900-5; \"><meta name=\"citation_reference\" content=\"citation_title=Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients; citation_author=Putot  A; citation_author=Tetu  J; citation_author=Perrin  S;  citation_journal_title=Eur J Clin Microbiol Infect Dis;  citation_year=2016;  citation_volume=35;  citation_pages=489-95; \"><meta name=\"citation_reference\" content=\"citation_title=Nursing home-acquired pneumonia: a 10 year single-centre experience; citation_author=Polverino  E; citation_author=Dambrava  P; citation_author=Cillóniz  C;  citation_journal_title=Thorax;  citation_year=2010;  citation_volume=65;  citation_pages=354-9; \"><meta name=\"citation_reference\" content=\"citation_title=Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study; citation_author=HER Study Group; citation_author=Kohli  R; citation_author=Lo  Y; citation_author=Homel  P;  citation_journal_title=Clin Infect Dis;  citation_year=2006;  citation_volume=43;  citation_pages=90-8; \"><meta name=\"citation_reference\" content=\"citation_title=Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain; citation_author=Benito  N; citation_author=Rañó  A; citation_author=Moreno  A;  citation_journal_title=J Acquir Immune Defic Syndr;  citation_year=2001;  citation_volume=27;  citation_pages=35-43; \"><meta name=\"citation_reference\" content=\"citation_title=Polymerase chain reaction positivity of Pneumocystis jirovecii during primary lung cancer treatment; citation_author=Mori  H; citation_author=Ohno  Y; citation_author=Ito  F;  citation_journal_title=Jpn J Clin Oncol;  citation_year=2010;  citation_volume=40;  citation_pages=658-62; \"><meta name=\"citation_reference\" content=\"citation_title=Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL; citation_author=Boersma  WG; citation_author=Erjavec  Z; citation_author=van der Werf  TS; citation_author=de Vries-Hosper  HG; citation_author=Gouw  AS; citation_author=Manson  WL;  citation_journal_title=Respir Med;  citation_year=2007;  citation_volume=101;  citation_pages=317-25; \"><meta name=\"citation_reference\" content=\"citation_title=Epidemiology of viral respiratory tract infections in an outpatient haematology facility; citation_author=Mikulska  M; citation_author=Del Bono  V; citation_author=Gandolfo  N;  citation_journal_title=Ann Hematol;  citation_year=2014;  citation_volume=93;  citation_pages=669-76; \"><meta name=\"citation_reference\" content=\"citation_title=Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative; citation_author=Beaird  OE; citation_author=Freifeld  A; citation_author=Ison  MG;  citation_journal_title=Transpl Infect Dis;  citation_year=2016;  citation_volume=18;  citation_pages=210-5; \"><meta name=\"citation_reference\" content=\"citation_title=Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients; citation_author=Poonyagariyagorn  HK; citation_author=Gershman  A; citation_author=Avery  R;  citation_journal_title=Transpl Infect Dis;  citation_year=2008;  citation_volume=10;  citation_pages=403-8; \"><meta name=\"citation_reference\" content=\"citation_title=Risk factors for vancomycin-resistant Enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation; citation_author=Tavadze  M; citation_author=Rybicki  L; citation_author=Mossad  S;  citation_journal_title=Bone Marrow Transplant;  citation_year=2014;  citation_volume=49;  citation_pages=1310-6; \"><meta name=\"citation_reference\" content=\"citation_title=Bacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance; citation_author=Bock  AM; citation_author=Cao  Q; citation_author=Ferrieri  P; citation_author=Young  JA; citation_author=Weisdorf  DJ;  citation_journal_title=Biol Blood Marrow Transplant;  citation_year=2013;  citation_volume=19;  citation_pages=102-8; \"><meta name=\"citation_reference\" content=\"citation_title=Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients; citation_author=Herbers  AH; citation_author=de Haan  AF; citation_author=van der Velden  WJ; citation_author=Donnelly  JP; citation_author=Blijlevens  NM;  citation_journal_title=Transpl Infect Dis;  citation_year=2014;  citation_volume=16;  citation_pages=279-85; \"><meta name=\"citation_reference\" content=\"citation_title=Community-acquired urinary tract infection in kidney transplantation: risk factors for bacteremia and recurrent infection; citation_author=Wu  SW; citation_author=Liu  KS; citation_author=Lin  CK;  citation_journal_title=J Formos Med Assoc;  citation_year=2013;  citation_volume=112;  citation_pages=138-43; \"><meta name=\"citation_reference\" content=\"citation_title=Blood stream infections in renal transplant recipients: a single-center study; citation_author=Daskalaki  E; citation_author=Koukoulaki  M; citation_author=Bakalis  A;  citation_journal_title=Transplant Proc;  citation_year=2014;  citation_volume=46;  citation_pages=3191-3; \"><meta name=\"citation_reference\" content=\"citation_title=Community-acquired bacterial bloodstream infections in HIV-infected patients: a systematic review; citation_author=Huson  MA; citation_author=Stolp  SM; citation_author=van der Poll  T; citation_author=Grobusch  MP;  citation_journal_title=Clin Infect Dis;  citation_year=2014;  citation_volume=58;  citation_pages=79-92; \"><meta name=\"citation_reference\" content=\"citation_title=Bloodstream infections in HIV-infected patients; citation_author=Taramasso  L; citation_author=Tatarelli  P; citation_author=Di Biagio  A;  citation_journal_title=Virulence;  citation_year=2016;  citation_volume=7;  citation_pages=320-8; \"><meta name=\"citation_fulltext_world_readable\" content=\"\"><meta name=\"citation_pdf_url\" content=\"https://academic.oup.com/cid/article-pdf/68/9/1482/28520951/ciy723.pdf\"><meta name=\"description\" content=\"Of patients with pneumonia coming from the community, 18% are immunocompromised. Specific immunocompromised states are associated with specific microbiolog\"><meta name=\"citation_xml_url\" content=\"https://academic.oup.com/cid/article-xml/68/9/1482/5078600\">\n\n\n    <link rel=\"canonical\" href=\"https://academic.oup.com/cid/article/68/9/1482/5078600\">\n\n\n\n\n\n\n\n\n    <meta name=\"product_code\" content=\"J_CID_2018_11_13\">\n    <meta name=\"product_code\" content=\"J_cid_2017_01_72\">\n    <meta name=\"product_code\" content=\"J_CID_2019_03_13\">\n    <meta name=\"product_code\" content=\"J_CID_2012_06_91\">\n    <meta name=\"product_code\" content=\"J_cid_2019_01_60\">\n    <meta name=\"product_code\" content=\"J_cid_1996_01_312\">\n    <meta name=\"product_code\" content=\"J_cid_1996_01_336\">\n    <meta name=\"product_code\" content=\"J_CID_2018_09_13\">\n    <meta name=\"product_code\" content=\"J_CID_2018_07_12\">\n    <meta name=\"product_code\" content=\"FBI_1to10YearRollingByJournal\">\n    <meta name=\"product_code\" content=\"J_CID_2018_07_13\">\n    <meta name=\"product_code\" content=\"J_CID_2012_01_96\">\n    <meta name=\"product_code\" content=\"Corona_Virus_Articles\">\n    <meta name=\"product_code\" content=\"J_cid_2019_01_24\">\n    <meta name=\"product_code\" content=\"J_CID_1996_01_9999\">\n    <meta name=\"product_code\" content=\"J_CID_2018_06_13\">\n    <meta name=\"product_code\" content=\"J_CID_2018_08_13\">\n    <meta name=\"product_code\" content=\"J_CID_2019_04_13\">\n    <meta name=\"product_code\" content=\"J_CID_2018_05_13\">\n    <meta name=\"product_code\" content=\"J_CID_2018_04_13\">\n    <meta name=\"product_code\" content=\"J_CID_2014_01_72\">\n    <meta name=\"product_code\" content=\"J_CID_2013_01_84\">\n    <meta name=\"product_code\" content=\"J_cid_2011_01_168\">\n    <meta name=\"product_code\" content=\"J_CID_2018_10_13\">\n    <meta name=\"product_code\" content=\"J_CID_2019_02_13\">\n    <meta name=\"product_code\" content=\"J_CID_2015_01_60\">\n    <meta name=\"product_code\" content=\"J_CID_2019_02_12\">\n    <meta name=\"product_code\" content=\"J_cid_2018_01_36\">\n    <meta name=\"product_code\" content=\"COMP_RetainedFBI\">\n    <meta name=\"product_code\" content=\"J_cid_2018_01_24\">\n    <meta name=\"product_code\" content=\"J_cid_1996_01_324\">\n    <meta name=\"product_code\" content=\"Funded_Free_Content\">\n    <meta name=\"product_code\" content=\"J_cid_1996_01_288\">\n    <meta name=\"product_code\" content=\"J_CID_1996_01_300\">\n    <meta name=\"product_code\" content=\"j_ALLJOURNALS\">\n    <meta name=\"product_code\" content=\"J_CID_2019_01_12\">\n    <meta name=\"product_code\" content=\"J_CID_2011_01_108\">\n    <meta name=\"product_code\" content=\"SOLR_FACET_FREE\">\n    <meta name=\"product_code\" content=\"J_5078600\">\n    <meta name=\"product_code\" content=\"I_115396\">\n\n\n\n\n\n    \n\n\n\n        <script>\n            var SCM = SCM || {};\n            SCM.pubGradeAdsEnabled = true;\n            SCM.pubGradeJSLibrary = 'https://cdn.pbgrd.com/core-oup-new.js';\n        </script>\n    <script async=\"async\" src=\"https://securepubads.g.doubleclick.net/tag/js/gpt.js\"></script>\n    <script>\n        var googletag = googletag || {};\n        googletag.cmd = googletag.cmd || [];\n    </script>\n        \n            <script type=\"text/javascript\">\n            var gptAdSlots = [];\n            googletag.cmd.push(function() {\n                    \n                    var mapping_ad1 = googletag.sizeMapping()\n                        .addSize([1024, 0], [[970, 90], [728, 90]])\n                        .addSize([768, 0], [728, 90])\n                        .addSize([0, 0], [320, 50])\n                        .build();\n                    gptAdSlots[\"ad1\"] = googletag.defineSlot('/116097782/cid_Supplement_Ad1',\n                            [[970, 90], [728, 90], [320, 50]], 'adBlockHeader')\n                        .defineSizeMapping(mapping_ad1)\n                        .addService(googletag.pubads());\n                    \n\n                    \n                    var mapping_ad2 = googletag.sizeMapping()\n                        .addSize([768, 0], [[300, 250], [300, 600], [160, 600]])\n                        .build();\n                    gptAdSlots[\"ad2\"] = googletag.defineSlot('/116097782/cid_Supplement_Ad2',\n                            [[300, 250], [160, 600], [300, 600]], 'adBlockMainBodyTop')\n                        .defineSizeMapping(mapping_ad2)\n                        .addService(googletag.pubads());\n                    \n\n                    \n                    var mapping_ad3 = googletag.sizeMapping()\n                        .addSize([768, 0], [[300, 250], [300, 600], [160, 600]])\n                        .build();\n                    gptAdSlots[\"ad3\"] = googletag.defineSlot('/116097782/cid_Supplement_Ad3',\n                        [[300, 250], [160, 600], [300, 600]], 'adBlockMainBodyBottom')\n                        .defineSizeMapping(mapping_ad3)\n                        .addService(googletag.pubads());\n                    \n\n                    \n                var mapping_ad4 = googletag.sizeMapping()\n                        .addSize([0,0], [320, 50])\n                        .addSize([768, 0], [728, 90])\n                        .build();\n                    gptAdSlots[\"ad4\"] = googletag.defineSlot('/116097782/cid_Supplement_Ad4',\n                        [728, 90], 'adBlockFooter')\n                        .defineSizeMapping(mapping_ad4)\n                        .addService(googletag.pubads());\n                    \n\n                    \n                var mapping_ad6 = googletag.sizeMapping()\n                        .addSize([1024, 0], [[970, 90], [728, 90]])\n                        .addSize([768, 0], [728, 90])\n                        .addSize([0, 0], [320, 50])\n                        .build();\n                    gptAdSlots[\"ad6\"] = googletag.defineSlot('/116097782/cid_Supplement_Ad6',\n                        [[728, 90], [970, 90]], 'adBlockStickyFooter')\n                        .defineSizeMapping(mapping_ad6)\n                        .addService(googletag.pubads());\n                    \n\n                    \n                    gptAdSlots[\"adInterstitial\"] = googletag.defineOutOfPageSlot('/116097782/cid_Interstitial_Ad',\n                        googletag.enums.OutOfPageFormat.INTERSTITIAL)\n                        .addService(googletag.pubads());\n                    \n\n                googletag.pubads().addEventListener('slotRenderEnded', function (event) {\n                    if (!event.isEmpty) {\n                        $('.js-' + event.slot.getSlotElementId()).each(function () {\n                            if ($(this).find('iframe').length) {\n                                $(this).removeClass('hide');\n                            }\n                        });\n                    }\n                });\n\n                googletag.pubads().addEventListener('impressionViewable', function (event) {\n                    if (!event.isEmpty) {\n                        $('.js-' + event.slot.getSlotElementId()).each(function () {\n                            var $adblockDiv = $(this).find('.js-adblock');\n                            var $adText = $(this).find('.js-adblock-advertisement-text');\n                            if ($adblockDiv && $adblockDiv.is(':visible') && $adblockDiv.find('*').length > 1) {\n                                $adText.removeClass('hide');\n                                App.CenterAdBlock.Init($adblockDiv, $adText);\n                            }\n                            else {\n                                $adText.addClass('hide');\n                            }\n\n                            //Initialize logic for Sticky Footer Ad\n                            var $stickyFooterDiv = $(this).parents('.js-sticky-footer-ad');\n                            if ($stickyFooterDiv && $stickyFooterDiv.is(':visible') && $stickyFooterDiv.find('*').length > 1) {\n                                App.StickyFooterAd.Init();\n                            }\n                        });\n                    }\n                });\n\n                googletag.pubads().setTargeting(\"jnlspage\", \"article\");\n                googletag.pubads().setTargeting(\"jnlsurl\", \"cid/article/68/9/1482/5078600\");\n                googletag.pubads().enableSingleRequest();\n                googletag.pubads().disableInitialLoad();\n                googletag.pubads().collapseEmptyDivs();\n            });\n            </script>\n        \n        <script id=\"altmetric-embed-js\" src=\"https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-288192a491f0ad9cc434f05ea175659426f5ab0cfd6befb3f3592f96bb90b0d1.js\"></script><style></style><meta http-equiv=\"origin-trial\" content=\"AlK2UR5SkAlj8jjdEc9p3F3xuFYlF6LYjAML3EOqw1g26eCwWPjdmecULvBH5MVPoqKYrOfPhYVL71xAXI1IBQoAAAB8eyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ==\"><meta http-equiv=\"origin-trial\" content=\"Amm8/NmvvQfhwCib6I7ZsmUxiSCfOxWxHayJwyU1r3gRIItzr7bNQid6O8ZYaE1GSQTa69WwhPC9flq/oYkRBwsAAACCeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiV2ViVmlld1hSZXF1ZXN0ZWRXaXRoRGVwcmVjYXRpb24iLCJleHBpcnkiOjE3NTgwNjcxOTksImlzU3ViZG9tYWluIjp0cnVlfQ==\"><meta http-equiv=\"origin-trial\" content=\"A9wSqI5i0iwGdf6L1CERNdmsTPgVu44ewj8QxTBYgsv1LCPUVF7YmWOvTappqB1139jAymxUW/RO8zmMqo4zlAAAAACNeyJvcmlnaW4iOiJodHRwczovL2RvdWJsZWNsaWNrLm5ldDo0NDMiLCJmZWF0dXJlIjoiRmxlZGdlQmlkZGluZ0FuZEF1Y3Rpb25TZXJ2ZXIiLCJleHBpcnkiOjE3MzY4MTI4MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9\"><meta http-equiv=\"origin-trial\" content=\"A+d7vJfYtay4OUbdtRPZA3y7bKQLsxaMEPmxgfhBGqKXNrdkCQeJlUwqa6EBbSfjwFtJWTrWIioXeMW+y8bWAgQAAACTeyJvcmlnaW4iOiJodHRwczovL2dvb2dsZXN5bmRpY2F0aW9uLmNvbTo0NDMiLCJmZWF0dXJlIjoiRmxlZGdlQmlkZGluZ0FuZEF1Y3Rpb25TZXJ2ZXIiLCJleHBpcnkiOjE3MzY4MTI4MDAsImlzU3ViZG9tYWluIjp0cnVlLCJpc1RoaXJkUGFydHkiOnRydWV9\"><script src=\"https://securepubads.g.doubleclick.net/pagead/managed/js/gpt/m202506050101/pubads_impl.js\" async=\"\"></script><link href=\"https://securepubads.g.doubleclick.net/pagead/managed/dict/m202506100101/gpt\" rel=\"compression-dictionary\"><style type=\"text/css\">.CtxtMenu_InfoClose {  top:.2em; right:.2em;}\n.CtxtMenu_InfoContent {  overflow:auto; text-align:left; font-size:80%;  padding:.4em .6em; border:1px inset; margin:1em 0px;  max-height:20em; max-width:30em; background-color:#EEEEEE;  white-space:normal;}\n.CtxtMenu_Info.CtxtMenu_MousePost {outline:none;}\n.CtxtMenu_Info {  position:fixed; left:50%; width:auto; text-align:center;  border:3px outset; padding:1em 2em; background-color:#DDDDDD;  color:black;  cursor:default; font-family:message-box; font-size:120%;  font-style:normal; text-indent:0; text-transform:none;  line-height:normal; letter-spacing:normal; word-spacing:normal;  word-wrap:normal; white-space:nowrap; float:none; z-index:201;  border-radius: 15px;                     /* Opera 10.5 and IE9 */  -webkit-border-radius:15px;               /* Safari and Chrome */  -moz-border-radius:15px;                  /* Firefox */  -khtml-border-radius:15px;                /* Konqueror */  box-shadow:0px 10px 20px #808080;         /* Opera 10.5 and IE9 */  -webkit-box-shadow:0px 10px 20px #808080; /* Safari 3 & Chrome */  -moz-box-shadow:0px 10px 20px #808080;    /* Forefox 3.5 */  -khtml-box-shadow:0px 10px 20px #808080;  /* Konqueror */  filter:progid:DXImageTransform.Microsoft.dropshadow(OffX=2, OffY=2, Color=\"gray\", Positive=\"true\"); /* IE */}\n</style><style type=\"text/css\">.CtxtMenu_MenuClose {  position:absolute;  cursor:pointer;  display:inline-block;  border:2px solid #AAA;  border-radius:18px;  -webkit-border-radius: 18px;             /* Safari and Chrome */  -moz-border-radius: 18px;                /* Firefox */  -khtml-border-radius: 18px;              /* Konqueror */  font-family: \"Courier New\", Courier;  font-size:24px;  color:#F0F0F0}\n.CtxtMenu_MenuClose span {  display:block; background-color:#AAA; border:1.5px solid;  border-radius:18px;  -webkit-border-radius: 18px;             /* Safari and Chrome */  -moz-border-radius: 18px;                /* Firefox */  -khtml-border-radius: 18px;              /* Konqueror */  line-height:0;  padding:8px 0 6px     /* may need to be browser-specific */}\n.CtxtMenu_MenuClose:hover {  color:white!important;  border:2px solid #CCC!important}\n.CtxtMenu_MenuClose:hover span {  background-color:#CCC!important}\n.CtxtMenu_MenuClose:hover:focus {  outline:none}\n</style><style type=\"text/css\">.CtxtMenu_Menu {  position:absolute;  background-color:white;  color:black;  width:auto; padding:5px 0px;  border:1px solid #CCCCCC; margin:0; cursor:default;  font: menu; text-align:left; text-indent:0; text-transform:none;  line-height:normal; letter-spacing:normal; word-spacing:normal;  word-wrap:normal; white-space:nowrap; float:none; z-index:201;  border-radius: 5px;                     /* Opera 10.5 and IE9 */  -webkit-border-radius: 5px;             /* Safari and Chrome */  -moz-border-radius: 5px;                /* Firefox */  -khtml-border-radius: 5px;              /* Konqueror */  box-shadow:0px 10px 20px #808080;         /* Opera 10.5 and IE9 */  -webkit-box-shadow:0px 10px 20px #808080; /* Safari 3 & Chrome */  -moz-box-shadow:0px 10px 20px #808080;    /* Forefox 3.5 */  -khtml-box-shadow:0px 10px 20px #808080;  /* Konqueror */}\n.CtxtMenu_MenuItem {  padding: 1px 2em;  background:transparent;}\n.CtxtMenu_MenuArrow {  position:absolute; right:.5em; padding-top:.25em; color:#666666;  font-family: null; font-size: .75em}\n.CtxtMenu_MenuActive .CtxtMenu_MenuArrow {color:white}\n.CtxtMenu_MenuArrow.CtxtMenu_RTL {left:.5em; right:auto}\n.CtxtMenu_MenuCheck {  position:absolute; left:.7em;  font-family: null}\n.CtxtMenu_MenuCheck.CtxtMenu_RTL { right:.7em; left:auto }\n.CtxtMenu_MenuRadioCheck {  position:absolute; left: .7em;}\n.CtxtMenu_MenuRadioCheck.CtxtMenu_RTL {  right: .7em; left:auto}\n.CtxtMenu_MenuInputBox {  padding-left: 1em; right:.5em; color:#666666;  font-family: null;}\n.CtxtMenu_MenuInputBox.CtxtMenu_RTL {  left: .1em;}\n.CtxtMenu_MenuComboBox {  left:.1em; padding-bottom:.5em;}\n.CtxtMenu_MenuSlider {  left: .1em;}\n.CtxtMenu_SliderValue {  position:absolute; right:.1em; padding-top:.25em; color:#333333;  font-size: .75em}\n.CtxtMenu_SliderBar {  outline: none; background: #d3d3d3}\n.CtxtMenu_MenuLabel {  padding: 1px 2em 3px 1.33em;  font-style:italic}\n.CtxtMenu_MenuRule {  border-top: 1px solid #DDDDDD;  margin: 4px 3px;}\n.CtxtMenu_MenuDisabled {  color:GrayText}\n.CtxtMenu_MenuActive {  background-color: #606872;  color: white;}\n.CtxtMenu_MenuDisabled:focus {  background-color: #E8E8E8}\n.CtxtMenu_MenuLabel:focus {  background-color: #E8E8E8}\n.CtxtMenu_ContextMenu:focus {  outline:none}\n.CtxtMenu_ContextMenu .CtxtMenu_MenuItem:focus {  outline:none}\n.CtxtMenu_SelectionMenu {  position:relative; float:left;  border-bottom: none; -webkit-box-shadow:none; -webkit-border-radius:0px; }\n.CtxtMenu_SelectionItem {  padding-right: 1em;}\n.CtxtMenu_Selection {  right: 40%; width:50%; }\n.CtxtMenu_SelectionBox {  padding: 0em; max-height:20em; max-width: none;  background-color:#FFFFFF;}\n.CtxtMenu_SelectionDivider {  clear: both; border-top: 2px solid #000000;}\n.CtxtMenu_Menu .CtxtMenu_MenuClose {  top:-10px; left:-10px}\n</style><style id=\"MJX-CHTML-styles\">\nmjx-container[jax=\"CHTML\"] {\n  line-height: 0;\n}\n\nmjx-container [space=\"1\"] {\n  margin-left: .111em;\n}\n\nmjx-container [space=\"2\"] {\n  margin-left: .167em;\n}\n\nmjx-container [space=\"3\"] {\n  margin-left: .222em;\n}\n\nmjx-container [space=\"4\"] {\n  margin-left: .278em;\n}\n\nmjx-container [space=\"5\"] {\n  margin-left: .333em;\n}\n\nmjx-container [rspace=\"1\"] {\n  margin-right: .111em;\n}\n\nmjx-container [rspace=\"2\"] {\n  margin-right: .167em;\n}\n\nmjx-container [rspace=\"3\"] {\n  margin-right: .222em;\n}\n\nmjx-container [rspace=\"4\"] {\n  margin-right: .278em;\n}\n\nmjx-container [rspace=\"5\"] {\n  margin-right: .333em;\n}\n\nmjx-container [size=\"s\"] {\n  font-size: 70.7%;\n}\n\nmjx-container [size=\"ss\"] {\n  font-size: 50%;\n}\n\nmjx-container [size=\"Tn\"] {\n  font-size: 60%;\n}\n\nmjx-container [size=\"sm\"] {\n  font-size: 85%;\n}\n\nmjx-container [size=\"lg\"] {\n  font-size: 120%;\n}\n\nmjx-container [size=\"Lg\"] {\n  font-size: 144%;\n}\n\nmjx-container [size=\"LG\"] {\n  font-size: 173%;\n}\n\nmjx-container [size=\"hg\"] {\n  font-size: 207%;\n}\n\nmjx-container [size=\"HG\"] {\n  font-size: 249%;\n}\n\nmjx-container [width=\"full\"] {\n  width: 100%;\n}\n\nmjx-box {\n  display: inline-block;\n}\n\nmjx-block {\n  display: block;\n}\n\nmjx-itable {\n  display: inline-table;\n}\n\nmjx-row {\n  display: table-row;\n}\n\nmjx-row > * {\n  display: table-cell;\n}\n\nmjx-mtext {\n  display: inline-block;\n}\n\nmjx-mstyle {\n  display: inline-block;\n}\n\nmjx-merror {\n  display: inline-block;\n  color: red;\n  background-color: yellow;\n}\n\nmjx-mphantom {\n  visibility: hidden;\n}\n\n_::-webkit-full-page-media, _:future, :root mjx-container {\n  will-change: opacity;\n}\n\nmjx-assistive-mml {\n  position: absolute !important;\n  top: 0px;\n  left: 0px;\n  clip: rect(1px, 1px, 1px, 1px);\n  padding: 1px 0px 0px 0px !important;\n  border: 0px !important;\n  display: block !important;\n  width: auto !important;\n  overflow: hidden !important;\n  -webkit-touch-callout: none;\n  -webkit-user-select: none;\n  -khtml-user-select: none;\n  -moz-user-select: none;\n  -ms-user-select: none;\n  user-select: none;\n}\n\nmjx-assistive-mml[display=\"block\"] {\n  width: 100% !important;\n}\n\nmjx-c::before {\n  display: block;\n  width: 0;\n}\n\n.MJX-TEX {\n  font-family: MJXZERO, MJXTEX;\n}\n\n.TEX-B {\n  font-family: MJXZERO, MJXTEX-B;\n}\n\n.TEX-I {\n  font-family: MJXZERO, MJXTEX-I;\n}\n\n.TEX-MI {\n  font-family: MJXZERO, MJXTEX-MI;\n}\n\n.TEX-BI {\n  font-family: MJXZERO, MJXTEX-BI;\n}\n\n.TEX-S1 {\n  font-family: MJXZERO, MJXTEX-S1;\n}\n\n.TEX-S2 {\n  font-family: MJXZERO, MJXTEX-S2;\n}\n\n.TEX-S3 {\n  font-family: MJXZERO, MJXTEX-S3;\n}\n\n.TEX-S4 {\n  font-family: MJXZERO, MJXTEX-S4;\n}\n\n.TEX-A {\n  font-family: MJXZERO, MJXTEX-A;\n}\n\n.TEX-C {\n  font-family: MJXZERO, MJXTEX-C;\n}\n\n.TEX-CB {\n  font-family: MJXZERO, MJXTEX-CB;\n}\n\n.TEX-FR {\n  font-family: MJXZERO, MJXTEX-FR;\n}\n\n.TEX-FRB {\n  font-family: MJXZERO, MJXTEX-FRB;\n}\n\n.TEX-SS {\n  font-family: MJXZERO, MJXTEX-SS;\n}\n\n.TEX-SSB {\n  font-family: MJXZERO, MJXTEX-SSB;\n}\n\n.TEX-SSI {\n  font-family: MJXZERO, MJXTEX-SSI;\n}\n\n.TEX-SC {\n  font-family: MJXZERO, MJXTEX-SC;\n}\n\n.TEX-T {\n  font-family: MJXZERO, MJXTEX-T;\n}\n\n.TEX-V {\n  font-family: MJXZERO, MJXTEX-V;\n}\n\n.TEX-VB {\n  font-family: MJXZERO, MJXTEX-VB;\n}\n\nmjx-stretchy-v mjx-c, mjx-stretchy-h mjx-c {\n  font-family: MJXZERO, MJXTEX-S1, MJXTEX-S4, MJXTEX, MJXTEX-A ! important;\n}\n\n@font-face /* 0 */ {\n  font-family: MJXZERO;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Zero.woff\") format(\"woff\");\n}\n\n@font-face /* 1 */ {\n  font-family: MJXTEX;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Main-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 2 */ {\n  font-family: MJXTEX-B;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Main-Bold.woff\") format(\"woff\");\n}\n\n@font-face /* 3 */ {\n  font-family: MJXTEX-I;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Math-Italic.woff\") format(\"woff\");\n}\n\n@font-face /* 4 */ {\n  font-family: MJXTEX-MI;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Main-Italic.woff\") format(\"woff\");\n}\n\n@font-face /* 5 */ {\n  font-family: MJXTEX-BI;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Math-BoldItalic.woff\") format(\"woff\");\n}\n\n@font-face /* 6 */ {\n  font-family: MJXTEX-S1;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Size1-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 7 */ {\n  font-family: MJXTEX-S2;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Size2-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 8 */ {\n  font-family: MJXTEX-S3;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Size3-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 9 */ {\n  font-family: MJXTEX-S4;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Size4-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 10 */ {\n  font-family: MJXTEX-A;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_AMS-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 11 */ {\n  font-family: MJXTEX-C;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Calligraphic-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 12 */ {\n  font-family: MJXTEX-CB;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Calligraphic-Bold.woff\") format(\"woff\");\n}\n\n@font-face /* 13 */ {\n  font-family: MJXTEX-FR;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Fraktur-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 14 */ {\n  font-family: MJXTEX-FRB;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Fraktur-Bold.woff\") format(\"woff\");\n}\n\n@font-face /* 15 */ {\n  font-family: MJXTEX-SS;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_SansSerif-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 16 */ {\n  font-family: MJXTEX-SSB;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_SansSerif-Bold.woff\") format(\"woff\");\n}\n\n@font-face /* 17 */ {\n  font-family: MJXTEX-SSI;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_SansSerif-Italic.woff\") format(\"woff\");\n}\n\n@font-face /* 18 */ {\n  font-family: MJXTEX-SC;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Script-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 19 */ {\n  font-family: MJXTEX-T;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Typewriter-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 20 */ {\n  font-family: MJXTEX-V;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Vector-Regular.woff\") format(\"woff\");\n}\n\n@font-face /* 21 */ {\n  font-family: MJXTEX-VB;\n  src: url(\"https://cdn.jsdelivr.net/npm/mathjax@3/es5/output/chtml/fonts/woff-v2/MathJax_Vector-Bold.woff\") format(\"woff\");\n}\n</style><link id=\"altmetric-embed-css\" rel=\"stylesheet\" type=\"text/css\" href=\"https://d1bxh8uas1mnw7.cloudfront.net/assets/embed-59614f5c46b49b21eeef3bb28c4fb38d1e7069e8d014752fcb66e84942556802.css\"><link rel=\"stylesheet\" href=\"https://badge.dimensions.ai/badge.css\"><link rel=\"stylesheet\" href=\"data:text/css,@import%20url%28%27https%3A//cdn.privado.ai/version/indexV1.css%27%29%3B\"><script type=\"module\" src=\"https://js.trendmd.com/polyfills.js?0.549.0\"></script></head><body data-sitename=\"clinicalinfectiousdiseases\" class=\"off-canvas pg_Article pg_article\" theme-cid=\"\" data-sitestyletemplate=\"Journal\"><input type=\"hidden\" class=\"hfInterstitial\" data-interstitiallinks=\"cid/issue,cid/advance-articles,cid/advance-article,cid/supplements,cid/article,cid/article-abstract,cid/pages\" data-subdomain=\"cid\">\n    \n    \n    <script type=\"text/javascript\">\n                googletag.cmd.push(function () {\n                    \n                    googletag.pubads().setTargeting(\"jnlsdoi\", \"10.1093/cid/ciy723\");\n                    googletag.enableServices();\n                });\n    </script>\n\n\n\n\n    \n\n\n    <script type=\"text/javascript\">\n        var NTPT_PGEXTRA= 'event_type=full-text&supplier_tag=SC_Journals&object_type=Article&taxonomy=taxId%3a39%7ctaxLabel%3aAcademicSubjects%7cnodeId%3aMED00290%7cnodeLabel%3aInfectious+Diseases%7cnodeLevel%3a3&siteid=cid&authzrequired=false&doi=10.1093/cid/ciy723';\n    </script>\n\n\n\n\n    <script src=\"https://scholar.google.com/scholar_js/casa.js\" async=\"\" type=\"javascript/privado-block\"></script>\n\n\n\n            <noscript>\n                <iframe  src=\"https://www.googletagmanager.com/ns.html?id=GTM-W6DD7HV\"\n                        height=\"0\" width=\"0\" style=\"display:none;visibility:hidden\"></iframe>\n            </noscript>\n            <a href=\"#skipNav\" class=\"skipnav\">Skip to Main Content</a>\n<input id=\"hdnSiteID\" name=\"hdnSiteID\" type=\"hidden\" value=\"5269\"><input id=\"hdnAdDelaySeconds\" name=\"hdnAdDelaySeconds\" type=\"hidden\" value=\"8000\"><input id=\"hdnAdConfigurationTop\" name=\"hdnAdConfigurationTop\" type=\"hidden\" value=\"scrolldelay\"><input id=\"hdnAdConfigurationRightRail\" name=\"hdnAdConfigurationRightRail\" type=\"hidden\" value=\"sticky\">\n    \n\n\n\n\n\n\n<div class=\"master-container js-master-container\">\n<section class=\"master-header row js-master-header vt-site-page-header\">\n    <div class=\"widget widget-SitePageHeader widget-instance-SitePageHeader\">\n        \n\n    <div class=\"ad-banner js-ad-banner-header\">\n    <div class=\"widget widget-AdBlock widget-instance-HeaderAd\">\n        <div class=\"js-adBlock-parent-wrap adblock-parent-wrap\">\n    <div class=\"adBlockHeader-wrap js-adBlockHeader hide\">\n        <div id=\"adBlockHeader\" class=\"js-adblock at-adblock\" data-lazy-load-margin=\"150\">\n            <script>\n                googletag.cmd.push(function () {\n                    googletag.display('adBlockHeader');\n                });\n            </script>\n        </div>\n            <div class=\"advertisement-text at-adblock js-adblock-advertisement-text hide\">Advertisement</div>\n            </div>\n</div> \n    </div>\n\n    </div>\n\n    <div class=\"oup-header sigma \">\n        <div class=\"center-inner-row\">\n\n<div class=\"oup-header-logo\">\n\n        <a href=\"/\" data-google-interstitial=\"false\">\n            <img src=\"//oup.silverchair-cdn.com/UI/app/svg/umbrella/oxford-academic-logo.svg\" alt=\"Oxford Academic\" class=\"oup-header-image at-oup-header-image \" width=\"300\" height=\"74\">\n        </a>\n\n</div>                <div class=\"widget widget-CustomNavLinks widget-instance-CustomNavLinksDeskTop\">\n            <div class=\"custom-nav-links-box\">\n            <div class=\"custom-nav-link\">\n                <a href=\"/journals\" data-google-interstitial=\"false\">Journals</a>\n            </div>\n            <div class=\"custom-nav-link\">\n                <a href=\"/books\" data-google-interstitial=\"false\">Books</a>\n            </div>\n\n    </div>\n \n    </div>\n            <ul class=\"oup-header-menu account-menu sigma-account-menu \">\n\n                \n                <li class=\"oup-header-menu-item mobile\">\n                    <a href=\"javascript:;\" class=\"mobile-dropdown-toggle mobile-search-toggle\" data-google-interstitial=\"false\">\n                        <i class=\"icon-menu_search\"><span class=\"screenreader-text\">Search Menu</span></i>\n                    </a>\n                </li>\n                \n        <li class=\"oup-header-menu-item mobile\">\n            <a href=\"javascript:;\" class=\"mobile-dropdown-toggle navbar-ai-assistant-link js-navbar-ai-assistant-link\" data-google-interstitial=\"false\">\n                <i class=\"icon-spark\"><span class=\"screenreader-text\">AI Discovery Assistant</span></i>\n            </a>\n        </li>        \n\n\n                    <li class=\"oup-header-menu-item mobile info-icon-menu-item\">\n        <a href=\"/pages/information\" target=\"\" class=\"at-info-button sigma-info-wrapper\" role=\"button\" data-google-interstitial=\"false\">\n            <img class=\"sigma-info-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/i.svg\" alt=\"Information\">\n        </a>\n    </li>\n    <li class=\"oup-header-menu-item mobile account-icon-menu-item\">\n        <a href=\"javascript:;\" class=\"account-button js-account-button at-account-button \" role=\"button\" data-turnawayparams=\"journal%3dcid\" data-google-interstitial=\"false\">\n            <img class=\"sigma-account-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/account.svg\" alt=\"Account\">\n        </a>\n    </li>\n\n\n                \n                <li class=\"oup-header-menu-item mobile\">\n                    <a href=\"javascript:;\" class=\"mobile-dropdown-toggle mobile-nav-toggle\" data-google-interstitial=\"false\">\n                        <i class=\"icon-menu_hamburger\"><span class=\"screenreader-text\">Menu</span></i>\n                    </a>\n                </li>\n\n                \n\n                    <li class=\"oup-header-menu-item desktop info-icon-menu-item\">\n        <a href=\"/pages/information\" target=\"\" class=\"at-info-button sigma-info-wrapper\" role=\"button\" data-google-interstitial=\"false\">\n            <img class=\"sigma-info-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/i.svg\" alt=\"Information\">\n        </a>\n    </li>\n    <li class=\"oup-header-menu-item desktop account-icon-menu-item\">\n        <a href=\"javascript:;\" class=\"account-button js-account-button at-account-button sigma-logo-wrapper\" role=\"button\" data-turnawayparams=\"journal%3dcid\" data-google-interstitial=\"false\">\n            <img class=\"sigma-account-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/account.svg\" alt=\"Account\">\n        </a>\n    </li>\n        <li class=\"oup-header-menu-item desktop account-icon-menu-item\">\n    <div class=\"widget widget-SeamlessAccess widget-instance-SitePageHeader\">\n            <a href=\"javascript:;\" class=\"js-shibboleth-action seamless-access-button seamless-button-header button-call-to-action at-institutional-sign-in\" rel=\"nofollow\" data-action-type=\"\" data-entity-id=\"\" data-google-interstitial=\"false\">\n        <span class=\"seamless-access-text\">Sign in through your institution</span>\n    </a>\n\n \n    </div>\n\n        </li>\n\n\n                \n\n            </ul>\n\n            <div class=\"login-box-placeholder js-login-box-placeholder hide\" style=\"z-index: auto;\">\n                <div class=\"spinner\"></div>\n            </div>\n        </div>\n    </div>\n<div class=\"dropdown-panel-wrap\">\n\n    \n    <div class=\"dropdown-panel mobile-search-dropdown\">\n        <div class=\"mobile-search-inner-wrap\">\n\n\n<div class=\"navbar-search\">\n    <div class=\"mobile-microsite-search\">\n            <label for=\"SitePageHeader-mobile-navbar-search-filter\" class=\"screenreader-text js-mobile-navbar-search-filter-label\">\n                Navbar Search Filter\n            </label>\n            <select class=\"mobile-navbar-search-filter js-mobile-navbar-search-filter at-navbar-search-filter\" id=\"SitePageHeader-mobile-navbar-search-filter\">\n\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"\">Clinical Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Issue\">This issue</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Parent\">IDSA Journals</option>\n                    <optgroup class=\"navbar-search-optgroup\" label=\"Search across Oxford Academic\">\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"AcademicSubjects/MED00290\">Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Books\">Books</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Journals\">Journals</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Umbrella\">Oxford Academic</option>                    </optgroup>\n            </select>\n\n        <label for=\"SitePageHeader-mobile-microsite-search-term\" class=\"screenreader-text js-mobile-microsite-search-term-label\">\n            Mobile Enter search term\n        </label>\n        <input class=\"mobile-search-input mobile-microsite-search-term js-mobile-microsite-search-term at-microsite-search-term\" type=\"text\" maxlength=\"255\" placeholder=\"Search\" id=\"SitePageHeader-mobile-microsite-search-term\">\n\n        <a href=\"javascript:;\" class=\"mobile-microsite-search-icon mobile-search-submit icon-menu_search\" data-google-interstitial=\"false\">\n            <span class=\"screenreader-text\">Search</span>\n        </a>\n\n    </div>\n</div>\n\n\n        </div>\n    </div>\n   \n    <div class=\"dropdown-panel mobile-nav-dropdown\">\n\n\n    <ul class=\"site-menu site-menu-lvl-0 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742963\">\n\n                <a href=\"/cid/issue\" class=\"nav-link\">\n                    Issues\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742959\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    More Content\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742964\">\n\n                <a href=\"/cid/advance-articles\" class=\"nav-link\">\n                    Advance articles\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742965\">\n\n                <a href=\"https://academic.oup.com/cid/search-results?page=1&amp;f_OUPSeries=Editor%27s+Choice\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Editor's Choice\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742966\">\n\n                <a href=\"/cid/supplements\" class=\"nav-link\">\n                    Supplement Archive\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742967\">\n\n                <a href=\"https://academic.oup.com/cid/issue-covers/\" class=\"nav-link\">\n                    Cover Archive\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742968\">\n\n                <a href=\"/cid/pages/clinical-practice-guidelines\" class=\"nav-link\">\n                    IDSA Guidelines\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742969\">\n\n                <a href=\"https://academic.oup.com/idsa\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA Journals\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742970\">\n\n                <a href=\"https://academic.oup.com/jid\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    The Journal of Infectious Diseases\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742971\">\n\n                <a href=\"https://academic.oup.com/ofid\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Open Forum Infectious Diseases\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742972\">\n\n                <a href=\"/cid/pages/clinical-dilemmas\" class=\"nav-link\">\n                    Clinical Dilemmas in ID\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742973\">\n\n                <a href=\"/cid/pages/photo-quizzes\" class=\"nav-link\">\n                    Photo Quizzes\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742974\">\n\n                <a href=\"https://academic.oup.com/cid/pages/state-of-the-art-reviews\" class=\"nav-link\">\n                    State-of-the-Art Reviews\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742975\">\n\n                <a href=\"https://academic.oup.com/cid/pages/voices-of-id\" class=\"nav-link\">\n                    Voices of ID\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742976\">\n\n                <a href=\"https://academic.oup.com/idsa/pages/content-collections\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA Content Collections\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742960\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    Publish\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742977\">\n\n                <a href=\"/cid/pages/General_Instructions\" class=\"nav-link\">\n                    Author Guidelines\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742978\">\n\n                <a href=\"http://www.editorialmanager.com/cid\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Submit\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742979\">\n\n                <a href=\"/cid/pages/General_Instructions\" class=\"nav-link\">\n                    Open Access\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742980\">\n\n                <a href=\"https://academic.oup.com/cid/pages/why-publish\" class=\"nav-link\">\n                    Why Publish\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742981\">\n\n                <a href=\"https://academic.oup.com/idsa/pages/calls-for-papers\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA Journals Calls for Papers\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742982\">\n\n                <a href=\"/cid/subscribe\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Purchase\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742961\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    Advertise\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742983\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Advertising and Corporate Services\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742984\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Advertising\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742985\">\n\n                <a href=\"http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;search=&amp;t732=469972&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Journals Career Network\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742986\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Mediakit\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742987\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/reprints\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Reprints and ePrints\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742988\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/supplements\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Sponsored Supplements\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742989\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/branded-books\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Branded Books\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742962\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    About\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742990\">\n\n                <a href=\"/cid/pages/About\" class=\"nav-link\">\n                    About Clinical Infectious Diseases\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742991\">\n\n                <a href=\"https://www.idsociety.org\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    About the Infectious Diseases Society of America\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742992\">\n\n                <a href=\"https://www.hivma.org/\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    About the HIV Medicine Association\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742993\">\n\n                <a href=\"/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA COI Policy\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742994\">\n\n                <a href=\"/cid/pages/Editorial_Board\" class=\"nav-link\">\n                    Editorial Board\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742995\">\n\n                <a href=\"/my-account/email-alerts\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Alerts\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742996\">\n\n                <a href=\"https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Self-Archiving Policy\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742997\">\n\n                <a href=\"/cid/pages/For_Reviewers\" class=\"nav-link\">\n                    For Reviewers\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742998\">\n\n                <a href=\"https://academic.oup.com/idsa/pages/for_press_offices\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    For Press Offices\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n                <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-custom\">\n            <a href=\"/journals\" class=\"nav-link\" data-google-interstitial=\"false\">Journals on Oxford Academic</a>\n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-custom\">\n            <a href=\"/books\" class=\"nav-link\" data-google-interstitial=\"false\">Books on Oxford Academic</a>\n        </li>\n    </ul>\n    </div>\n\n</div>\n\n    <div class=\"journal-header journal-bg\">\n        <div class=\"center-inner-row\">\n                <div class=\"site-parent-link-wrap\">\n                    <a href=\"//academic.oup.com/idsa\" class=\"site-parent-link\" data-google-interstitial=\"false\">IDSA Journals</a>\n                </div>\n                            <a href=\"/cid\" class=\"journal-logo-container\">\n                    <img id=\"logo-ClinicalInfectiousDiseases\" class=\"journal-logo\" src=\"//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_title-1229789578.svg\" alt=\"Clinical Infectious Diseases\" width=\"300\" height=\"18\">\n                </a>\n\n            <div class=\"society-logo-block\">\n                    <div class=\"society-block-inner-wrap\">\n                            <a href=\"https://www.idsociety.org\" target=\"\" class=\"society-logo-container\" data-google-interstitial=\"false\">\n                                <img id=\"logo-InfectiousDiseasesSocietyofAmerica\" class=\"society-logo\" src=\"//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_h1682603575.svg\" alt=\"Infectious Diseases Society of America\" width=\"300\" height=\"68\">\n                            </a>\n                                                    <a href=\"https://www.hivma.org/\" target=\"\" class=\"society-logo-container\" data-google-interstitial=\"false\">\n                                <img id=\"logo-HIVMedicineAssociation\" class=\"society-logo\" src=\"//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_h2-371465688.svg\" alt=\"HIV Medicine Association\" width=\"300\" height=\"134\">\n                            </a>\n                    </div>            </div> \n        </div>\n    </div>\n<div class=\"navbar\">\n    <div class=\"center-inner-row\">\n        <nav class=\"navbar-menu\">\n\n    <ul class=\"site-menu site-menu-lvl-0 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742963\">\n\n                <a href=\"/cid/issue\" class=\"nav-link\">\n                    Issues\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742959\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    More Content\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742964\">\n\n                <a href=\"/cid/advance-articles\" class=\"nav-link\">\n                    Advance articles\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742965\">\n\n                <a href=\"https://academic.oup.com/cid/search-results?page=1&amp;f_OUPSeries=Editor%27s+Choice\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Editor's Choice\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742966\">\n\n                <a href=\"/cid/supplements\" class=\"nav-link\">\n                    Supplement Archive\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742967\">\n\n                <a href=\"https://academic.oup.com/cid/issue-covers/\" class=\"nav-link\">\n                    Cover Archive\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742968\">\n\n                <a href=\"/cid/pages/clinical-practice-guidelines\" class=\"nav-link\">\n                    IDSA Guidelines\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742969\">\n\n                <a href=\"https://academic.oup.com/idsa\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA Journals\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742970\">\n\n                <a href=\"https://academic.oup.com/jid\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    The Journal of Infectious Diseases\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742971\">\n\n                <a href=\"https://academic.oup.com/ofid\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Open Forum Infectious Diseases\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742972\">\n\n                <a href=\"/cid/pages/clinical-dilemmas\" class=\"nav-link\">\n                    Clinical Dilemmas in ID\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742973\">\n\n                <a href=\"/cid/pages/photo-quizzes\" class=\"nav-link\">\n                    Photo Quizzes\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742974\">\n\n                <a href=\"https://academic.oup.com/cid/pages/state-of-the-art-reviews\" class=\"nav-link\">\n                    State-of-the-Art Reviews\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742975\">\n\n                <a href=\"https://academic.oup.com/cid/pages/voices-of-id\" class=\"nav-link\">\n                    Voices of ID\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742976\">\n\n                <a href=\"https://academic.oup.com/idsa/pages/content-collections\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA Content Collections\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742960\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    Publish\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742977\">\n\n                <a href=\"/cid/pages/General_Instructions\" class=\"nav-link\">\n                    Author Guidelines\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742978\">\n\n                <a href=\"http://www.editorialmanager.com/cid\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Submit\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742979\">\n\n                <a href=\"/cid/pages/General_Instructions\" class=\"nav-link\">\n                    Open Access\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742980\">\n\n                <a href=\"https://academic.oup.com/cid/pages/why-publish\" class=\"nav-link\">\n                    Why Publish\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742981\">\n\n                <a href=\"https://academic.oup.com/idsa/pages/calls-for-papers\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA Journals Calls for Papers\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742982\">\n\n                <a href=\"/cid/subscribe\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Purchase\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742961\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    Advertise\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742983\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Advertising and Corporate Services\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742984\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Advertising\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742985\">\n\n                <a href=\"http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;search=&amp;t732=469972&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Journals Career Network\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742986\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Mediakit\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742987\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/reprints\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Reprints and ePrints\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742988\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/supplements\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Sponsored Supplements\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742989\">\n\n                <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/branded-books\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Branded Books\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n        <li class=\"site-menu-item site-menu-lvl-0 at-site-menu-item\" id=\"site-menu-item-1742962\">\n\n                <a href=\"javascript:;\" class=\"nav-link js-nav-dropdown at-nav-dropdown\" role=\"button\" aria-expanded=\"false\" data-google-interstitial=\"false\">\n                    About\n                    <i class=\"desktop-nav-arrow icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                <i class=\"mobile-nav-arrow icon-general_arrow-down\"></i>\n                <ul class=\"site-menu site-menu-lvl-1 at-site-menu\">\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742990\">\n\n                <a href=\"/cid/pages/About\" class=\"nav-link\">\n                    About Clinical Infectious Diseases\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742991\">\n\n                <a href=\"https://www.idsociety.org\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    About the Infectious Diseases Society of America\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742992\">\n\n                <a href=\"https://www.hivma.org/\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    About the HIV Medicine Association\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742993\">\n\n                <a href=\"/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    IDSA COI Policy\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742994\">\n\n                <a href=\"/cid/pages/Editorial_Board\" class=\"nav-link\">\n                    Editorial Board\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742995\">\n\n                <a href=\"/my-account/email-alerts\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Alerts\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742996\">\n\n                <a href=\"https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    Self-Archiving Policy\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742997\">\n\n                <a href=\"/cid/pages/For_Reviewers\" class=\"nav-link\">\n                    For Reviewers\n                </a>\n            \n        </li>\n        <li class=\"site-menu-item site-menu-lvl-1 at-site-menu-item\" id=\"site-menu-item-1742998\">\n\n                <a href=\"https://academic.oup.com/idsa/pages/for_press_offices\" class=\"nav-link\" data-google-interstitial=\"false\">\n                    For Press Offices\n                </a>\n            \n        </li>\n            </ul>\n\n        </li>\n            </ul>\n        </nav>\n            <div class=\"navbar-right-container\">\n                <div class=\"navbar-search-container js-navbar-search-container\">\n                    <a href=\"javascript:;\" class=\"navbar-search-close js_close-navsearch\" data-google-interstitial=\"false\">Close</a>\n\n\n<div class=\"navbar-search\">\n    <div class=\"microsite-search\">\n            <label for=\"SitePageHeader-navbar-search-filter\" class=\"screenreader-text js-navbar-search-filter-label\">\n                Navbar Search Filter\n            </label>\n            <select class=\"navbar-search-filter js-navbar-search-filter at-navbar-search-filter\" id=\"SitePageHeader-navbar-search-filter\">\n\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"\">Clinical Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Issue\">This issue</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Parent\">IDSA Journals</option>\n                    <optgroup class=\"navbar-search-optgroup\" label=\"Search across Oxford Academic\">\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"AcademicSubjects/MED00290\">Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Books\">Books</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Journals\">Journals</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Umbrella\">Oxford Academic</option>                    </optgroup>\n            </select>\n\n        <label for=\"SitePageHeader-microsite-search-term\" class=\"screenreader-text js-microsite-search-term-label\">\n            Enter search term\n        </label>\n        <input class=\"navbar-search-input microsite-search-term js-microsite-search-term at-microsite-search-term\" type=\"text\" maxlength=\"255\" placeholder=\"Search\" id=\"SitePageHeader-microsite-search-term\">\n\n        <a href=\"javascript:;\" class=\"microsite-search-icon navbar-search-submit icon-menu_search\" data-google-interstitial=\"false\">\n            <span class=\"screenreader-text\">Search</span>\n        </a>\n\n    </div>\n</div>\n\n<input id=\"hfCurrentBookSearch\" name=\"hfCurrentBookSearch\" type=\"hidden\" value=\"\"><input id=\"hfCurrentBookScope\" name=\"hfCurrentBookScope\" type=\"hidden\" value=\"CurrentBook\"><input id=\"hfBookSiteScope\" name=\"hfBookSiteScope\" type=\"hidden\" value=\"Books\"><input id=\"hfSeriesScope\" name=\"hfSeriesScope\" type=\"hidden\" value=\"taxWithOr\"><input id=\"hfParentSiteName\" name=\"hfParentSiteName\" type=\"hidden\" value=\"IDSA Journals\"><input id=\"hfParentSiteUrl\" name=\"hfParentSiteUrl\" type=\"hidden\" value=\"academic.oup.com/idsa\"><input id=\"hfSiteID\" name=\"hfSiteID\" type=\"hidden\" value=\"5269\"><input id=\"hfParentSiteID\" name=\"hfParentSiteID\" type=\"hidden\" value=\"5532\"><input id=\"hfJournalSiteScope\" name=\"hfJournalSiteScope\" type=\"hidden\" value=\"Journals\"><input id=\"hfParentSiteScope\" name=\"hfParentSiteScope\" type=\"hidden\" value=\"Parent\"><input id=\"hfDefaultSearchURL\" name=\"hfDefaultSearchURL\" type=\"hidden\" value=\"search-results?page=1&amp;q=\"><input id=\"hfIssueSearch\" name=\"hfIssueSearch\" type=\"hidden\" value=\"&amp;fl_IssueID=115396\"><input id=\"hfIssueSiteScope\" name=\"hfIssueSiteScope\" type=\"hidden\" value=\"Issue\"><input id=\"hfUmbrellaScope\" name=\"hfUmbrellaScope\" type=\"hidden\" value=\"Umbrella\"><input id=\"hfUmbrellaSiteUrl\" name=\"hfUmbrellaSiteUrl\" type=\"hidden\" value=\"academic.oup.com\"><input id=\"hfUmbrellaSiteId\" name=\"hfUmbrellaSiteId\" type=\"hidden\" value=\"191\"><input id=\"hfDefaultAdvancedSearchUrl\" name=\"hfDefaultAdvancedSearchUrl\" type=\"hidden\" value=\"advanced-search?page=1&amp;q=\"><input id=\"hfTaggedCollectionScope\" name=\"hfTaggedCollectionScope\" type=\"hidden\" value=\"\"><input id=\"hfApplyLatestEditionSearchFacet\" name=\"hfApplyLatestEditionSearchFacet\" type=\"hidden\" value=\"False\"><input id=\"hfIsLatestBookEdition\" name=\"hfIsLatestBookEdition\" type=\"hidden\" value=\"False\">\n                    <div class=\"navbar-search-advanced\"><a href=\"https://academic.oup.com/cid/advanced-search?page=1&amp;fl_SiteID=5269&amp;SearchSourceType=1\" class=\"advanced-search js-advanced-search\" data-google-interstitial=\"false\">Advanced Search</a></div>\n                </div>\n                \n                <div class=\"navbar-search-collapsed\"><a href=\"javascript:;\" class=\"icon-menu_search js_expand-navsearch\" data-google-interstitial=\"false\"><span class=\"screenreader-text\">Search Menu</span></a></div>\n\n        <div class=\"navbar-menu navbar-ai-assistant-container site-menu-item\">\n            <a href=\"javascript:;\" class=\"navbar-ai-assistant-link js-navbar-ai-assistant-link\" data-google-interstitial=\"false\">\n                <span aria-label=\"AI Discovery Assistant\" class=\"navbar-ai-assistant-span\">\n                    <i class=\"icon-spark navbar-icon-spark\"></i>\n                    AI Discovery Assistant\n                </span>\n            </a>\n        </div>\n\n            </div>\n    </div>\n</div>\n    <input type=\"hidden\" name=\"searchScope\" id=\"hfSolrJournalID\" value=\"\">\n    <input type=\"hidden\" id=\"hfSolrJournalName\" value=\"\">\n    <input type=\"hidden\" id=\"hfSolrMaxAllowSearchChar\" value=\"100\">\n    <input type=\"hidden\" id=\"hfJournalShortName\" value=\"\">\n    <input type=\"hidden\" id=\"hfSearchPlaceholder\" value=\"\">\n    <input type=\"hidden\" name=\"hfGlobalSearchSiteURL\" id=\"hfGlobalSearchSiteURL\" value=\"\">\n    <input type=\"hidden\" name=\"hfSearchSiteURL\" id=\"hfSiteURL\" value=\"academic.oup.com/cid\">\n    <input type=\"hidden\" name=\"RedirectSiteUrl\" id=\"RedirectSiteUrl\" value=\"httpszazjzjacademiczwoupzwcom\">\n    <script type=\"text/javascript\">\n        (function () {\n            var hfSiteUrl = document.getElementById('hfSiteURL');\n            var siteUrl = hfSiteUrl.value;\n            var subdomainIndex = siteUrl.indexOf('/');\n\n            hfSiteUrl.value = location.host + (subdomainIndex >= 0 ? siteUrl.substring(subdomainIndex) : '');\n        })();\n    </script>\n<input id=\"routename\" name=\"RouteName\" type=\"hidden\" value=\"cid\"> \n    </div>\n\n</section>\n        <div class=\"widget widget-SitewideBanner widget-instance-\" style=\"\">\n        \n\n \n    </div>\n\n\n    <div id=\"main\" class=\"content-main js-main ui-base\">\n            <section class=\"master-main row\">\n                <div class=\"center-inner-row no-overflow\">\n                    <div id=\"skipNav\" tabindex=\"-1\"></div>\n                    \n\n\n\n<div class=\"page-column-wrap\">\n<div id=\"InfoColumn\" class=\"page-column page-column--left js-left-nav-col\" style=\"z-index: 6000;\">\n    <div class=\"mobile-content-topbar hide\">\n        <button class=\"toggle-left-col toggle-left-col__article\">Article Navigation</button>\n    </div>\n    <div class=\"info-inner-wrap js-left-nav\" style=\"top: 0px;\">\n        <button class=\"toggle-left-col__close btn-as-icon icon-general-close\">\n            <span class=\"screenreader-text\">Close mobile search navigation</span>\n        </button>\n        <div class=\"responsive-nav-title\">Article Navigation</div>\n        <div class=\"info-widget-wrap\">\n    <div class=\"widget widget-IssueInfo widget-instance-OUP_IssueInfo_Article\">\n        \n\n<div id=\"issueInfo-OUP_IssueInfo_Article\" class=\"article-info-wrap clearfix\">\n    <i class=\"icon-general-close mobile-nav-btn nav-open\"></i>\n    <a class=\"article-issue-link\" href=\"/cid/issue/68/9\">\n        <div class=\"article-issue-img\">\n                <img id=\"issueImage\" class=\"fb-featured-image\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/Issue/68/9/5/m_cover.jpeg?Expires=1752631924&amp;Signature=VzkJpzpYIXCozHbdsaIS60qWT14TRuSLuGC1eukUyrcYSb6veXmlbdxxi4bsCqv56PfMH7dlbqN9LPLYakKnZ6uSxmWg0YAZOHfQIA39tvpONvJ71boTMCgDn8RhjNDckqV16RNIXTme4fSXo-Pb1NEzqABs9EzPZHe9bQMD6FT68PV8Vap~eeaNsVp85gS3jKjGejPEgn2-XCGy4vrE3MaPHJYIAkNxsVP0hL~5pIyLW4I1ZSyrhJhH-eg8MKmfcqb5InNKbRmJkLh~-95lJfZl5LOkCkFEzHqU5URne1xaCnWjdQWfdfTDCJXggdBa~HkCJsQ92f~1fLxypv7dIQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"Clinical Infectious Diseases Cover Image for Volume 68, Issue 9\" width=\"520\" height=\"685\">\n        </div>\n        <div class=\"article-issue-info\">\n            <div class=\"volume-issue__wrap\">\n\n                        <div class=\"volume trailing-comma\">Volume 68</div>\n                        <div class=\"issue\">Issue 9</div>\n\n\n\n            </div>\n            <div class=\"ii-pub-date\">\n1 May 2019            </div>\n            \n        </div>\n    </a>\n</div> \n    </div>\n\n            <div class=\"content-nav\">\n    <div class=\"widget widget-ArticleJumpLinks widget-instance-OUP_ArticleJumpLinks_Widget\">\n        \n\n<h3 class=\"contents-title\">Article Contents</h3>\n<ul class=\"jumplink-list js-jumplink-list\">\n        <li class=\"section-jump-link head-1\" link-destination=\"134170092\">\n            <div class=\"section-jump-link__link-wrap\">\n\n                <a class=\"js-jumplink scrollTo\" href=\"#134170092\">Abstract</a>\n            </div>\n        </li>\n        <li class=\"section-jump-link head-1\" link-destination=\"134170097\">\n            <div class=\"section-jump-link__link-wrap\">\n\n                <a class=\"js-jumplink scrollTo\" href=\"#134170097\">MATERIALS AND METHODS</a>\n            </div>\n        </li>\n        <li class=\"section-jump-link head-1\" link-destination=\"134170111\">\n            <div class=\"section-jump-link__link-wrap\">\n\n                <a class=\"js-jumplink scrollTo\" href=\"#134170111\">RESULTS</a>\n            </div>\n        </li>\n        <li class=\"section-jump-link head-1\" link-destination=\"134170130\">\n            <div class=\"section-jump-link__link-wrap\">\n\n                <a class=\"js-jumplink scrollTo\" href=\"#134170130\">DISCUSSION</a>\n            </div>\n        </li>\n        <li class=\"section-jump-link head-1\" link-destination=\"134170142\">\n            <div class=\"section-jump-link__link-wrap\">\n\n                <a class=\"js-jumplink scrollTo\" href=\"#134170142\">Supplementary Data</a>\n            </div>\n        </li>\n        <li class=\"section-jump-link head-1\" link-destination=\"134170144\">\n            <div class=\"section-jump-link__link-wrap\">\n\n                <a class=\"js-jumplink scrollTo\" href=\"#134170144\">Notes</a>\n            </div>\n        </li>\n        <li class=\"section-jump-link head-1 backReferenceLink\" link-destination=\"134170150\">\n            <div class=\"section-jump-link__link-wrap\">\n\n                <a class=\"js-jumplink scrollTo\" href=\"#134170150\">References</a>\n            </div>\n        </li>\n<li class=\"section-jump-link head-1 dataSupplements-jumplink\">\n            <div class=\"section-jump-link__link-wrap\">\n                <a class=\"jumplink js-jumplink scrollTo\" href=\"#supplementary-data\">Supplementary data</a>\n            </div>\n        </li></ul>\n \n    </div>\n\n            </div>\n    <div class=\"widget widget-ArticleNavLinks widget-instance-OUP_ArticleNavLinks_Article\">\n        <ul class=\"inline-list\">\n        <li class=\"prev arrow\">\n            <a href=\"/cid/article/68/9/1472/5089945\">&lt; Previous</a>\n        </li>        \n            <li class=\"next arrow\">\n            <a href=\"/cid/article/68/9/1494/5087661\">Next &gt;</a>\n        </li>\n</ul> \n    </div>\n\n        </div>\n    </div>\n</div>\n<div class=\"sticky-toolbar js-sticky-toolbar\"></div>\n<div id=\"ContentColumn\" class=\"page-column page-column--center\">\n\n    <div class=\"article-browse-top article-browse-mobile-nav js-mobile-nav\" style=\"\">\n    <div class=\"article-browse-mobile-nav-inner js-mobile-nav-inner\">\n        <button class=\"toggle-left-col toggle-left-col__article btn-as-link\">\n            Article Navigation\n        </button>\n    </div>\n</div>\n<div class=\"article-browse-top article-browse-mobile-nav mobile-sticky-toolbar js-mobile-nav-sticky\">\n    <div class=\"article-browse-mobile-nav-inner\">\n        <button class=\"toggle-left-col toggle-left-col__article btn-as-link\">\n            Article Navigation\n        </button>\n    </div>\n</div>\n\n    <div class=\"content-inner-wrap\">\n    <div class=\"widget widget-ArticleTopInfo widget-instance-OUP_ArticleTop_Info_Widget\">\n        <div class=\"module-widget article-top-widget\">\n\n    \n\n    \n        <div class=\"access-state-logos all-viewports\">\n    <span class=\"journal-info__format-label\">Journal Article</span>\n                </div>\n\n\n    <div class=\"widget-items\">\n                <div class=\"title-wrap\">\n                    <h1 class=\"wi-article-title article-title-main accessible-content-title at-articleTitle\">\n                        Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\n<i class=\"icon-availability_free\" title=\"Free\"><span class=\"screenreader-text\">Free</span></i>                    </h1>\n\n                </div>\n                <div class=\"wi-authors at-ArticleAuthors\">\n                    <div class=\"al-authors-list\">\n                            <div class=\"meta-authors--limited\">\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Marta Francesca Di Pasquale</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Marta Francesca Di Pasquale\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n    </div>\n\n    <div class=\"info-card-location\">\n        <a id=\"contrib-orcid-0000-0002-1450-5830\" href=\"https://orcid.org/0000-0002-1450-5830\" data-google-interstitial=\"false\">\n            <img class=\"orchid-icon\" alt=\"ORCID logo\" aria-hidden=\"true\" src=\"//oup.silverchair-cdn.com/Themes/Silver/app/img/mini-icon.png\">&nbsp;&nbsp;https://orcid.org/0000-0002-1450-5830\n        </a>\n    </div>\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Marta+Francesca+Di+Pasquale\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Di Pasquale M\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Di Pasquale Marta Francesca%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Giovanni Sotgiu</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Giovanni Sotgiu\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Giovanni+Sotgiu\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Sotgiu G\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Sotgiu Giovanni%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Andrea Gramegna</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Andrea Gramegna\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Andrea+Gramegna\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Gramegna A\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Gramegna Andrea%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Dejan Radovanovic</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Dejan Radovanovic\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Pulmonary Unit, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Dejan+Radovanovic\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Radovanovic D\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Radovanovic Dejan%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Silvia Terraneo</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Silvia Terraneo\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Italy</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Silvia+Terraneo\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Terraneo S\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Terraneo Silvia%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Luis F Reyes</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Luis F Reyes\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Microbiology Department, Universidad de La Sabana, Chia, Colombia</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Luis+F+Reyes\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Reyes L\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Reyes Luis F%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Jan Rupp</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Jan Rupp\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Jan+Rupp\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Rupp J\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Rupp Jan%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Juan González del Castillo</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Juan González del Castillo\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Emergency Department, Hospital Clínico San Carlos, Universidad Complutense</div><div class=\"aff\">Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, IdISSC, Madrid, Spain</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Juan+Gonz%c3%a1lez+del+Castillo\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=González del Castillo J\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22González del Castillo Juan%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Francesco Blasi</a>\n                                        <span class=\"delimiter\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Francesco Blasi\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Francesco+Blasi\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Blasi F\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Blasi Francesco%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                    <span class=\"al-author-name js-flyout-wrap\">\n\n\n\n\n\n\n                                        <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Stefano Aliberti<i class=\"icon-general-mail\"></i></a>\n                                        <span class=\"delimiter-hidden\">, </span>\n                                        <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Stefano Aliberti\n            <span class=\"info-card-footnote\"><span class=\"xrefLink\" id=\"jumplink-c1\"></span><a href=\"javascript:;\" reveal-id=\"c1\" data-open=\"c1\" class=\"link link-ref link-reveal xref-default\" data-google-interstitial=\"false\"><!----></a></span>\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n    </div>\n\n    <div class=\"info-author-correspondence\">\n        <div content-id=\"c1\">Correspondence: S. Aliberti, Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy (<a href=\"mailto:stefano.aliberti@unimi.it\" target=\"\" data-google-interstitial=\"false\">stefano.aliberti@unimi.it</a>).</div>\n    </div>\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Stefano+Aliberti\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Aliberti S\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Aliberti Stefano%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                        </span>\n                                    </span>\n                                <a class=\"meta-authors--etal is-active\" id=\"show-meta-authors\" aria-controls=\"remaining-authors\" href=\"#\">\n                                    <span>...</span> Show more\n                                </a>\n                                <div id=\"remaining-authors\" class=\"meta-authors--remaining\" aria-hidden=\"true\" aria-labeledby=\"show-meta-authors\">\n                                        <span class=\"al-author-name-more js-flyout-wrap\">\n\n\n\n\n                                            <a href=\"javascript:;\" class=\"linked-name js-linked-name-trigger btn-as-link\" data-google-interstitial=\"false\">Marcos I Restrepo</a>\n                                            <span class=\"delimiter\"></span>\n                                            <span class=\"al-author-info-wrap arrow-up\">\n<div class=\"info-card-author authorInfo_OUP_ArticleTop_Info_Widget\">\n    <div class=\"name-role-wrap\">\n        <div class=\"info-card-name\">\n    Marcos I Restrepo\n</div>\n\n    </div>\n\n    <div class=\"info-card-affilitation\">\n        <div class=\"aff\">Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio</div>\n    </div>\n\n    <div class=\"info-card-search-label\">\n        Search for other works by this author on:\n    </div>\n\n<div class=\"info-card-search info-card-search-internal\">\n    <a href=\"/cid/search-results?f_Authors=Marcos+I+Restrepo\" rel=\"nofollow\" data-google-interstitial=\"false\">Oxford Academic</a>\n</div>\n\n    <div class=\"info-card-search info-card-search-pubmed\">\n        <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?cmd=search&amp;term=Restrepo M\" data-google-interstitial=\"false\">PubMed</a>\n    </div>\n    <div class=\"info-card-search info-card-search-google\">\n        <a href=\"http://scholar.google.com/scholar?q=author:%22Restrepo Marcos I%22\" data-google-interstitial=\"false\">Google Scholar</a>\n    </div>\n</div>                                            </span>\n                                        </span>\n                                </div>\n                            </div>\n\n                    </div>\n                </div>\n<div class=\"pub-history-wrap clearfix js-history-dropdown-wrap\">\n\n        <div class=\"pub-history-row clearfix\">\n            <div class=\"ww-citation-primary\"><em>Clinical Infectious Diseases</em>, Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, <a href=\"https://doi.org/10.1093/cid/ciy723\" data-google-interstitial=\"false\">https://doi.org/10.1093/cid/ciy723</a></div>\n        </div>\n        <div class=\"pub-history-row clearfix\">\n            <div class=\"ww-citation-date-wrap\">\n                <div class=\"citation-label\">Published:</div>\n                <div class=\"citation-date\">23 August 2018</div>\n            </div>\n                <a href=\"javascript:;\" class=\"history-label js-history-dropdown-trigger st-article-history at-ArticleHistory\" data-google-interstitial=\"false\">\n                    <span>Article history</span><i class=\"icon-general-arrow-filled-down arrow-icon\"></i>\n                </a>\n                    </div>\n            <div class=\"ww-history js-history-entries-wrap at-history-entries-wrap\">\n                <div class=\"history-entry at-history-entry\">\n                    <div class=\"wi-state\">Received:</div>\n                    <div class=\"wi-date\">24 May 2018</div>\n                </div>\n                <div class=\"history-entry at-history-entry\">\n                    <div class=\"wi-state\">Accepted:</div>\n                    <div class=\"wi-date\">20 August 2018</div>\n                </div>\n                <div class=\"history-entry at-history-entry\">\n                    <div class=\"wi-state\">Published:</div>\n                    <div class=\"wi-date\">23 August 2018</div>\n                </div>\n        </div>\n        </div>\n    </div>\n</div>\n\n<script>\n    $(document).ready(function () {\n        $('.article-top-widget').on('click', '.ati-toggle-trigger', function () {\n            $(this).find('.icon-general-add, .icon-minus').toggleClass('icon-minus icon-general-add');\n            $(this).siblings('.ati-toggle-content').toggleClass('hide');\n        });\n\n        // In Chrome, an anchor tag with target=\"_blank\" and a \"mailto:\" href opens a new tab/window as well as the email client\n        // I suspect this behavior will be corrected in the future\n        // Remove the target=\"_blank\"\n        $('ul.wi-affiliationList').find('a[href^=\"mailto:\"]').each(function () {\n            $(this).removeAttr('target');\n        });\n    });\n</script>\n\n \n    </div>\n    <div class=\"widget widget-ArticleLinks widget-instance-OUP_Article_Links_Widget\">\n         \n    </div>\n\n\n        <div class=\"article-body js-content-body\">\n            <div class=\"toolbar-wrap js-toolbar-wrap\">\n                <div class=\"toolbar-inner-wrap\">\n                    <ul id=\"Toolbar\" role=\"navigation\">\n    <li class=\"toolbar-item item-pdf js-item-pdf\">\n        <a class=\"al-link pdf article-pdfLink\" data-article-id=\"5078600\" href=\"/cid/article-pdf/68/9/1482/28520951/ciy723.pdf\">\n            <img src=\"//oup.silverchair-cdn.com/UI/app/svg/pdf.svg\" alt=\"pdf\"><span class=\"pdf-link-text\">PDF</span>\n        </a>\n    </li>\n                                                    <li class=\"toolbar-item item-link item-split-view\">\n                                <a href=\"javascript:;\" class=\"split-view js-split-view st-split-view at-split-view\" target=\"\" data-google-interstitial=\"false\">\n                                    <i class=\"icon-menu-split\"></i>\n                                    Split View\n                                </a>\n                            </li>\n\n                        <li class=\"toolbar-item item-with-dropdown item-views\">\n                            <a class=\"at-views-dropdown drop-trigger\" href=\"javascript:;\" data-dropdown=\"FilterDrop\" aria-haspopup=\"true\" data-google-interstitial=\"false\">\n                                <i class=\"icon-menu_views\"></i>\n                                <div class=\"toolbar-label\">\n                                    <div class=\"toolbar-text\">Views</div>\n                                    <i class=\"icon-general-arrow-filled-down arrow-icon\"></i>\n                                </div>\n                            </a>\n                            <ul id=\"ViewsDrop\" class=\"f-dropdown js-dropdown-content\" data-dropdown-content=\"\" aria-label=\"submenu\">\n                                <div class=\"arrow-up\" style=\"display: block;\"></div>\n                                <li class=\"article-content-filter js-article-content-filter\" data-content-filter=\"article-content\" style=\"display: none;\">\n                                    <a href=\"javascript:;\" data-google-interstitial=\"false\"><span>Article contents</span></a>\n                                </li>\n                                <li class=\"at-figures-tables article-content-filter js-article-content-filter\" data-content-filter=\"figures-tables\">\n                                    <a href=\"javascript:;\" data-google-interstitial=\"false\"><span>Figures &amp; tables</span></a>\n                                </li>\n                                \n                                \n                                <li class=\"article-content-filter js-article-content-filter\" data-content-filter=\"supplementary-data\">\n                                    <a href=\"javascript:;\" data-google-interstitial=\"false\"><span>Supplementary Data</span></a>\n                                </li>\n                            </ul>\n                        </li>\n\n\n                        <li class=\"toolbar-item item-cite js-item-cite\">\n    <div class=\"widget widget-ToolboxGetCitation widget-instance-OUP_Get_Citation\">\n        <a href=\"#\" class=\"js-cite-button at-CiteButton\" data-reveal-id=\"getCitation\" data-reveal=\"\">\n    <i class=\"icon-read-more\"></i>\n    <span>Cite</span>\n</a>\n\n<div id=\"getCitation\" class=\"reveal-modal js-citation-modal\" data-reveal=\"\">\n    <h3 class=\"modal-title\">Cite</h3>\n        <div class=\"oxford-citation-text\">\n            <p>Marta Francesca Di Pasquale, Giovanni Sotgiu, Andrea Gramegna, Dejan Radovanovic, Silvia Terraneo, Luis F Reyes, Jan Rupp, Juan González del Castillo, Francesco Blasi, Stefano Aliberti, Marcos I Restrepo,  Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients, <em>Clinical Infectious Diseases</em>, Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, <a href=\"https://doi.org/10.1093/cid/ciy723\" data-google-interstitial=\"false\">https://doi.org/10.1093/cid/ciy723</a></p>\n        </div>\n\n    <div class=\"citation-download-wrap\">\n        <form action=\"/Citation/Download\" method=\"get\" id=\"citationModal\">\n            <input type=\"hidden\" name=\"resourceId\" value=\"5078600\">\n            <input type=\"hidden\" name=\"resourceType\" value=\"3\">\n            <label for=\"selectFormat\" class=\"hide js-citation-format-label\">Select Format</label>\n            <select required=\"\" name=\"citationFormat\" class=\"citation-download-format js-citation-format\" id=\"selectFormat\">\n                <option selected=\"\" disabled=\"\">Select format</option>\n                        <option value=\"0\">.ris (Mendeley, Papers, Zotero)</option>\n                        <option value=\"1\">.enw (EndNote)</option>\n                        <option value=\"2\">.bibtex (BibTex)</option>\n                        <option value=\"3\">.txt (Medlars, RefWorks)</option>\n\n            </select>\n            <button class=\"btn citation-download-link disabled\" type=\"submit\">Download citation</button>\n        </form>\n    </div>\n\n    <a class=\"close-reveal-modal\" href=\"javascript:;\" data-google-interstitial=\"false\"><i class=\"icon-general-close\"></i><span class=\"screenreader-text\">Close</span></a>\n</div>\n \n    </div>\n\n                        </li>\n                        <li class=\"toolbar-item item-tools\">\n    <div class=\"widget widget-ToolboxPermissions widget-instance-OUP_Get_Permissions\">\n            <div class=\"module-widget\">\n        <a href=\"https://s100.copyright.com/AppDispatchServlet?publisherName=OUP&amp;publication=1537-6591&amp;title=Prevalence%20and%20Etiology%20of%20Community-acquired%20Pneumonia%20in%20Immunocompromised%20Patients&amp;publicationDate=2018-08-23&amp;volumeNum=68&amp;issueNum=9&amp;author=Di%20Pasquale%2C%20Marta%20Francesca%3B%20Sotgiu%2C%20Giovanni&amp;startPage=1482&amp;endPage=1493&amp;contentId=10.1093%2Fcid%2Fciy723&amp;oa=&amp;copyright=%C2%A9%20The%20Author%28s%29%202018.%20Published%20by%20Oxford%20University%20Press%20for%20the%20Infectious%20Diseases%20Society%20of%20America.%20All%20rights%20reserved.%20For%20permissions%2C%20e-mail%3A%20journals.permissions%40oup.com.&amp;orderBeanReset=True\" id=\"PermissionsLink\" class=\"\" target=\"\" rel=\"nofollow\" data-google-interstitial=\"false\">\n            <i class=\"icon-menu_permissions\">\n                <span class=\"screenreader-text\">Permissions Icon</span>\n            </i>\n            Permissions\n        </a>\n    </div>\n \n    </div>\n\n                        </li>\n                        \n    <li class=\"toolbar-item item-with-dropdown item-share\">\n        <a href=\"javascript:;\" class=\"drop-trigger js-toolbar-dropdown at-ShareButton\" data-dropdown=\"ShareDrop\" data-google-interstitial=\"false\">\n            <i class=\"icon-menu_share\"><span class=\"screenreader-text\">Share Icon</span></i>\n            <span class=\"toolbar-label\">\n                <span class=\"toolbar-text\">Share</span>\n                <i class=\"arrow-icon icon-general-arrow-filled-down js-toolbar-arrow-icon\"></i>\n            </span>\n        </a>\n        <ul id=\"ShareDrop\" class=\"addthis_toolbox addthis_default_style addthis_20x20_style f-dropdown js-dropdown-content\" data-dropdown-content=\"\">\n    <li>\n        <a class=\"st-custom-button addthis_button_bluesky js-share-link\" data-network=\"bluesky\" data-title=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" data-url=\"https://academic.oup.com/cid/article/68/9/1482/5078600\" data-email-subject=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" href=\"javascript:;\" rel=\"nofollow\" data-google-interstitial=\"false\"><span>Bluesky</span></a>\n    </li>\n    <li>\n        <a class=\"st-custom-button addthis_button_facebook js-share-link\" data-network=\"facebook\" data-title=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" data-url=\"https://academic.oup.com/cid/article/68/9/1482/5078600\" data-email-subject=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" href=\"javascript:;\" rel=\"nofollow\" data-google-interstitial=\"false\"><span>Facebook</span></a>\n    </li>\n    <li>\n        <a class=\"st-custom-button addthis_button_twitter js-share-link\" data-network=\"twitter\" data-title=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" data-url=\"https://academic.oup.com/cid/article/68/9/1482/5078600\" data-email-subject=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" href=\"javascript:;\" rel=\"nofollow\" data-google-interstitial=\"false\"><span>X</span></a>\n    </li>\n    <li>\n        <a class=\"st-custom-button addthis_button_linkedin js-share-link\" data-network=\"linkedin\" data-title=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" data-url=\"https://academic.oup.com/cid/article/68/9/1482/5078600\" data-email-subject=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" href=\"javascript:;\" rel=\"nofollow\" data-google-interstitial=\"false\"><span>LinkedIn</span></a>\n    </li>\n    <li>\n        <a class=\"st-custom-button addthis_button_email js-share-link\" data-network=\"email\" data-title=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" data-url=\"https://academic.oup.com/cid/article/68/9/1482/5078600\" data-email-subject=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\" href=\"javascript:;\" rel=\"nofollow\" data-google-interstitial=\"false\"><span>Email</span></a>\n    </li>\n\n\n\n        </ul>\n    </li>\n\n                        \n                    </ul>\n                    <div class=\"toolbar-search\">\n    <div class=\"widget widget-SitePageHeader widget-instance-OUP_ArticleToolbarSearchBox\">\n        \n\n\n\n<div class=\"dropdown-panel-wrap\">\n\n    \n    <div class=\"dropdown-panel mobile-search-dropdown\">\n        <div class=\"mobile-search-inner-wrap\">\n\n\n<div class=\"navbar-search\">\n    <div class=\"mobile-microsite-search\">\n            <label for=\"OUP_ArticleToolbarSearchBox-mobile-navbar-search-filter\" class=\"screenreader-text js-mobile-navbar-search-filter-label\">\n                Navbar Search Filter\n            </label>\n            <select class=\"mobile-navbar-search-filter js-mobile-navbar-search-filter at-navbar-search-filter\" id=\"OUP_ArticleToolbarSearchBox-mobile-navbar-search-filter\">\n\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"\">Clinical Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Issue\">This issue</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Parent\">IDSA Journals</option>\n                    <optgroup class=\"navbar-search-optgroup\" label=\"Search across Oxford Academic\">\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"AcademicSubjects/MED00290\">Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Books\">Books</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Journals\">Journals</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Umbrella\">Oxford Academic</option>                    </optgroup>\n            </select>\n\n        <label for=\"OUP_ArticleToolbarSearchBox-mobile-microsite-search-term\" class=\"screenreader-text js-mobile-microsite-search-term-label\">\n            Mobile Enter search term\n        </label>\n        <input class=\"mobile-search-input mobile-microsite-search-term js-mobile-microsite-search-term at-microsite-search-term\" type=\"text\" maxlength=\"255\" placeholder=\"Search\" id=\"OUP_ArticleToolbarSearchBox-mobile-microsite-search-term\">\n\n        <a href=\"javascript:;\" class=\"mobile-microsite-search-icon mobile-search-submit icon-menu_search\" data-google-interstitial=\"false\">\n            <span class=\"screenreader-text\">Search</span>\n        </a>\n\n    </div>\n</div>\n\n\n        </div>\n    </div>\n   \n    <div class=\"dropdown-panel mobile-nav-dropdown\">\n\n    </div>\n\n</div>\n\n\n<div class=\"navbar\">\n    <div class=\"center-inner-row\">\n        <nav class=\"navbar-menu\">\n        </nav>\n            <div class=\"navbar-right-container\">\n                <div class=\"navbar-search-container js-navbar-search-container\">\n                    <a href=\"javascript:;\" class=\"navbar-search-close js_close-navsearch\" data-google-interstitial=\"false\">Close</a>\n\n\n<div class=\"navbar-search\">\n    <div class=\"microsite-search\">\n            <label for=\"OUP_ArticleToolbarSearchBox-navbar-search-filter\" class=\"screenreader-text js-navbar-search-filter-label\">\n                Navbar Search Filter\n            </label>\n            <select class=\"navbar-search-filter js-navbar-search-filter at-navbar-search-filter\" id=\"OUP_ArticleToolbarSearchBox-navbar-search-filter\">\n\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"\">Clinical Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Issue\">This issue</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Parent\">IDSA Journals</option>\n                    <optgroup class=\"navbar-search-optgroup\" label=\"Search across Oxford Academic\">\n<option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"AcademicSubjects/MED00290\">Infectious Diseases</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Books\">Books</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Journals\">Journals</option><option class=\"navbar-search-filter-option at-navbar-search-filter-option\" value=\"Umbrella\">Oxford Academic</option>                    </optgroup>\n            </select>\n\n        <label for=\"OUP_ArticleToolbarSearchBox-microsite-search-term\" class=\"screenreader-text js-microsite-search-term-label\">\n            Enter search term\n        </label>\n        <input class=\"navbar-search-input microsite-search-term js-microsite-search-term at-microsite-search-term\" type=\"text\" maxlength=\"255\" placeholder=\"Search\" id=\"OUP_ArticleToolbarSearchBox-microsite-search-term\">\n\n        <a href=\"javascript:;\" class=\"microsite-search-icon navbar-search-submit icon-menu_search\" data-google-interstitial=\"false\">\n            <span class=\"screenreader-text\">Search</span>\n        </a>\n\n    </div>\n</div>\n\n\n                    <div class=\"navbar-search-advanced\"><a href=\"https://academic.oup.com/cid/advanced-search?page=1&amp;fl_SiteID=5269&amp;SearchSourceType=1\" class=\"advanced-search js-advanced-search\" data-google-interstitial=\"false\">Advanced Search</a></div>\n                </div>\n                \n                <div class=\"navbar-search-collapsed\"><a href=\"javascript:;\" class=\"icon-menu_search js_expand-navsearch\" data-google-interstitial=\"false\"><span class=\"screenreader-text\">Search Menu</span></a></div>\n\n        <div class=\"navbar-menu navbar-ai-assistant-container site-menu-item\">\n            <a href=\"javascript:;\" class=\"navbar-ai-assistant-link js-navbar-ai-assistant-link\" data-google-interstitial=\"false\">\n                <span aria-label=\"AI Discovery Assistant\" class=\"navbar-ai-assistant-span\">\n                    <i class=\"icon-spark navbar-icon-spark\"></i>\n                    AI Discovery Assistant\n                </span>\n            </a>\n        </div>\n\n            </div>\n    </div>\n</div>\n<input id=\"routename\" name=\"RouteName\" type=\"hidden\" value=\"cid\"> \n    </div>\n\n                    </div>\n                </div>\n            </div>\n            <div id=\"ContentTab\" class=\"content active\">\n    <div class=\"widget widget-ArticleFulltext widget-instance-OUP_Article_FullText_Widget\">\n        <div class=\"module-widget\">\n    <div class=\"widget-items\" data-widgetname=\"ArticleFulltext\">\n\n\n\n\n\n                    <h2 scrollto-destination=\"134170092\" id=\"134170092\" class=\"abstract-title js-splitscreen-abstract-title\">Abstract</h2>\n<section class=\"abstract\"><div class=\" sec\"><div class=\"title\">Background</div><p class=\"chapter-para\">The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia.</p></div><div class=\" sec\"><div class=\"title\">Methods</div><p class=\"chapter-para\">We conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor.</p></div><div class=\" sec\"><div class=\"title\">Results</div><p class=\"chapter-para\">At least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors significantly differed across continents and countries, with chronic steroid use (45%), hematological cancer (25%), and chemotherapy (22%) the most common. Among immunocompromised patients, community-acquired pneumonia (CAP) pathogens were the most frequently identified, and prevalences did not differ from those in immunocompetent patients. Risk factors for immunocompromise were independently associated with neither <em>Pseudomonas aeruginosa</em> nor non–community-acquired bacteria. Specific risk factors were independently associated with fungal infections (odds ratio for AIDS and hematological cancer, 15.10 and 4.65, respectively; both <em>P</em> = .001), mycobacterial infections (AIDS; <em>P</em> = .006), and viral infections other than influenza (hematological cancer, 5.49; <em>P</em> &lt; .001).</p></div><div class=\" sec\"><div class=\"title\">Conclusions</div><p class=\"chapter-para\">Our findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses.</p></div></section>                    <div class=\"article-metadata-panel clearfix at-ArticleMetadata\"></div>\n<div class=\"kwd-group\"><a class=\"kwd-part kwd-main\" href=\"javascript:;\" data-keyword=\"pneumonia\" data-google-interstitial=\"false\">pneumonia</a>, <a class=\"kwd-part kwd-main\" href=\"javascript:;\" data-keyword=\"&quot;multidrug-resistant pathogens&quot;\" data-google-interstitial=\"false\">multidrug-resistant pathogens</a>, <a class=\"kwd-part kwd-main\" href=\"javascript:;\" data-keyword=\"microbiology\" data-google-interstitial=\"false\">microbiology</a>, <a class=\"kwd-part kwd-main\" href=\"javascript:;\" data-keyword=\"MRSA\" data-google-interstitial=\"false\">MRSA</a>, <a class=\"kwd-part kwd-main\" href=\"javascript:;\" data-keyword=\"immunocompromise\" data-google-interstitial=\"false\">immunocompromise</a></div><p class=\"chapter-para\">During initial evaluation of a patient coming from the community with pneumonia, the identification of possible risk factors for multidrug-resistant organisms or unusual pathogens is crucial [<span class=\"xrefLink\" id=\"jumplink-CIT0001 CIT0002 CIT0003\"></span><a href=\"javascript:;\" reveal-id=\"CIT0001 CIT0002 CIT0003\" data-open=\"CIT0001 CIT0002 CIT0003\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">1–3</a>]. Because a microbiological identification is found in about 30% of hospitalized patients with pneumonia coming from the community, and usually requires 24–48 hours to be available, most of patients are treated empirically [<span class=\"xrefLink\" id=\"jumplink-CIT0004\"></span><a href=\"javascript:;\" reveal-id=\"CIT0004\" data-open=\"CIT0004\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">4</a>]. Delay in initiation of appropriate empiric antibiotic therapy is a known risk factor for worse clinical outcomes [<span class=\"xrefLink\" id=\"jumplink-CIT0005 CIT0006 CIT0007\"></span><a href=\"javascript:;\" reveal-id=\"CIT0005 CIT0006 CIT0007\" data-open=\"CIT0005 CIT0006 CIT0007\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">5–7</a>]; therefore, it is relevant to promptly recognize patients at risk for specific pathogens, specially multidrug-resistant or atypical microbes [<span class=\"xrefLink\" id=\"jumplink-CIT0001 CIT0002 CIT0003\"></span><a href=\"javascript:;\" reveal-id=\"CIT0001 CIT0002 CIT0003\" data-open=\"CIT0001 CIT0002 CIT0003\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">1–3</a>].</p><p class=\"chapter-para\">The aging of the population and advancements in therapeutic protocols have led to an increase prevalence of chronic diseases as well as long-term treatments with immunosuppressive agents [<span class=\"xrefLink\" id=\"jumplink-CIT0008\"></span><a href=\"javascript:;\" reveal-id=\"CIT0008\" data-open=\"CIT0008\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">8</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0009\"></span><a href=\"javascript:;\" reveal-id=\"CIT0009\" data-open=\"CIT0009\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">9</a>]. Thus, among patients with pneumonia coming from the community and admitted to the hospital, the number who might not be fully immunocompetent is constantly increasing [<span class=\"xrefLink\" id=\"jumplink-CIT0008\"></span><a href=\"javascript:;\" reveal-id=\"CIT0008\" data-open=\"CIT0008\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">8</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0009\"></span><a href=\"javascript:;\" reveal-id=\"CIT0009\" data-open=\"CIT0009\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">9</a>]. Nevertheless, the real prevalence of immunocompromise among patients with pneumonia coming from the community is still unknown. Moreover, guidelines for community-acquired and hospital-acquired pneumonia did not address this topic—what is more, they specifically excluded patients with clinical characteristics determining immunocompromise [<span class=\"xrefLink\" id=\"jumplink-CIT0005 CIT0006 CIT0007\"></span><a href=\"javascript:;\" reveal-id=\"CIT0005 CIT0006 CIT0007\" data-open=\"CIT0005 CIT0006 CIT0007\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">5–7</a>], and current evidence in literature is also scarce.</p><p class=\"chapter-para\">To our knowledge, there are no studies addressing the clinical evaluation and initial empirical antibiotic coverage of patients coming from the community with pneumonia and immunocompromise. Moreover, specific risk factors to assess the causative microbiology and help clinicians choose more appropriate management for these patients have not been clearly identified. Thus, the aim of the current study was to identify the prevalence, type, microbiology, and intercorrelations between different risk factors for immunocompromise in hospitalized patients with pneumonia coming from the community.</p>                    <h2 scrollto-destination=\"134170097\" id=\"134170097\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s5\">MATERIALS AND METHODS</h2>\n                    <h3 scrollto-destination=\"134170098\" id=\"134170098\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s6\">Study Design and Population</h3>\n<p class=\"chapter-para\">This is a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) database [<span class=\"xrefLink\" id=\"jumplink-CIT0010\"></span><a href=\"javascript:;\" reveal-id=\"CIT0010\" data-open=\"CIT0010\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">10</a>]. The GLIMP study was an international, multicenter, observational, point-prevalence study of adult patients hospitalized for community-onset pneumonia in 54 countries worldwide. Patients were enrolled on a single day during the months of March, April, May, and June 2015. The methods of the GLIMP study have been published elsewhere [<span class=\"xrefLink\" id=\"jumplink-CIT0010\"></span><a href=\"javascript:;\" reveal-id=\"CIT0010\" data-open=\"CIT0010\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">10</a>]. The coordinating center (University of Texas Health Science Center, San Antonio) received approval from its institutional review board (No. HSC20150184E).</p><p class=\"chapter-para\">All adult patients (aged &gt;18 years old) coming from the community and hospitalized with pneumonia during study period were included. Pneumonia was defined as the presence of a new pulmonary infiltrate on chest radiograph at the time of hospitalization, associated with ≥1 of the following criteria: (1) new or increased cough with/without sputum production and/or purulent respiratory secretions, (2) fever or hypothermia, and (3) evidence of systemic inflammation (ie, abnormal white blood cell count or increased C-reactive protein or procalcitonin level). Hospitalized patients with a diagnosis of hospital-acquired or ventilator-associated pneumonia were excluded.</p>                    <h3 scrollto-destination=\"134170101\" id=\"134170101\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s7\">Data Collection</h3>\n<p class=\"chapter-para\">Data were collected from medical records at the time of hospital admission. Data gathered included demographics; respiratory and cardiovascular comorbid conditions; immunocompromised status and other chronic medical conditions; severity of pneumonia (defined as either intensive care unit admission, use of invasive or noninvasive mechanical ventilation, or use of vasopressors/inotropes during the first 24 hours after hospital admission); and specific risk factors for resistant pathogens infection, including chronic aspiration, being bedridden, malnutrition, presence of enteric tube feeding and indwelling catheters (including central venous and urinary catheters), previous infections, chronic microbial colonization, and previous healthcare exposures. The number and type of microbiological samples obtained within 24 hours after hospital admission were also collected. Culture-positive tests, kind of sample, and antibiotic resistance patterns were also gathered, along with empiric antibiotic treatment, given within 24 hours after hospital admission.</p>                    <h3 scrollto-destination=\"134170103\" id=\"134170103\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s8\">Microbiological Workup</h3>\n<p class=\"chapter-para\">Diagnostic testing was performed according to local standard operating procedures and included collection of respiratory and blood cultures and testing for urinary antigens. Microbiological examinations and susceptibility testing were performed according to local standard protocols within the first 24 hours after hospital admission [<span class=\"xrefLink\" id=\"jumplink-CIT0011\"></span><a href=\"javascript:;\" reveal-id=\"CIT0011\" data-open=\"CIT0011\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">11</a>]. Multivariable logistic regression models were performed for patients who had a positive culture, to identify specific risk factors for single pathogens.</p><p class=\"chapter-para\">Causative pathogens were stratified according to the coverage of standard therapy for community-acquired pneumonia (CAP) [<span class=\"xrefLink\" id=\"jumplink-CIT0005 CIT0006 CIT0007\"></span><a href=\"javascript:;\" reveal-id=\"CIT0005 CIT0006 CIT0007\" data-open=\"CIT0005 CIT0006 CIT0007\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">5–7</a>]. Those not covered by standard CAP therapy included the following: non–community-acquired bacteria (<em>Acinetobacter baumanii</em>, <em>Enterococcus</em> vancomycin-resistant, <em>Nocardia</em> spp.), mycobacteria, fungi (<em>Aspergillus fumigatus, Coccidioides, Criptococcus</em>, <em>Pneumocystis jirovecii</em>), and viruses other than influenza [<span class=\"xrefLink\" id=\"jumplink-CIT0005 CIT0006 CIT0007\"></span><a href=\"javascript:;\" reveal-id=\"CIT0005 CIT0006 CIT0007\" data-open=\"CIT0005 CIT0006 CIT0007\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">5–7</a>]. Those covered by standard CAP therapy included <em>Pseudomonas aeruginosa,</em> methicillin-resistant <em>Staphylococcus aureus</em>, methicillin-sensitive <em>S. aureus</em>, <em>Enterobacter</em> spp., <em>Enterococcus</em> spp., <em>Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae</em>, <em>Moraxella catarrhalis, Proteus mirabilis, Serratia marcescens, Streptococcus pneumoniae, Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella pneumophilia,</em> anaerobes bacteria, and influenza viruses. Atypical pathogens included <em>C. pneumoniae, M. pneumoniae,</em> and <em>L. pneumophilia.</em> CAP therapy was defined as β-lactams (ceftriaxone, ampicillin-sulbactam, amoxicillin-clavulanate, cefepime, ceftazidime, piperacillin-tazobactam) plus macrolide, or fluoroquinolones alone, and, eventually, in association with vancomycin, linezolid, or oseltamivir [<span class=\"xrefLink\" id=\"jumplink-CIT0005 CIT0006 CIT0007\"></span><a href=\"javascript:;\" reveal-id=\"CIT0005 CIT0006 CIT0007\" data-open=\"CIT0005 CIT0006 CIT0007\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">5–7</a>].</p>                    <h3 scrollto-destination=\"134170106\" id=\"134170106\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s9\">Definition of Immunocompromised and Study Groups</h3>\n<p class=\"chapter-para\">Immunocompromise was defined as the presence of ≥1 of the following risk factors: (1) AIDS, defined either as human immunodeficiency virus infection with CD4<sup>+</sup> lymphocyte count &lt;200/µL or by the occurrence of AIDS-defining conditions; (2) aplastic anemia; (3) asplenia; (4) hematological cancer, defined as lymphoma, acute or chronic leukemia, or multiple myeloma; (5) chemotherapy during the last 3 months; (6) neutropenia, defined as a neutrophil count &lt;500/dL at complete blood cell count; (7) biological drug use (including trastuzumab and therapies for autoimmune diseases, eg, anti–tumor necrosis factor α, prescribed during ≥6 months before hospital admission); (8) lung transplantation; (9) chronic steroid use (&gt;10 mg/d of prednisone or equivalent ≥3 months before hospital admission); (10) lung cancer with either neutropenia or chemotherapy; (11) other solid tumor with either neutropenia or chemotherapy; (12) other immunocompromise (any immunocompromised state, including congenital/genetic immunocompromise and immunosuppressive therapy due to hematological cancer/solid organ transplantation other than lung). Two study groups were identified: those with versus those without 1 risk factor for immunocompromise.</p>                    <h3 scrollto-destination=\"134170108\" id=\"134170108\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s10\">Statistical Analysis</h3>\n<p class=\"chapter-para\">Categorical variables, expressed as counts (percentages), were compared using the χ<sup>2</sup> test. Continuous variables were compared using the unpaired Student <em>t</em> test or the Mann-Whitney test, when appropriate. Statistical significance was defined as <em>P</em> &lt; .05. A network analysis was conducted to represent the frequencies of all immunocompromise variables and their relationships. The size of the circles (the circles visible in Figure 4 [network analysis], each representing a single risk factor for immunocompromise) represents both prevalence of the risk factor and strength of association with other variables.</p><p class=\"chapter-para\">The predictive value of each variable was categorized by quartiles and analyzed using a univariate regression logistic analysis. A multivariable model was obtained using a Cox regression analysis to identify independent predictors of specific pathogens, using an entry level of P value ≤0.05 and a removal level of P value ≥0.10. Hazard ratios and adjusted analyses were obtained. All statistical analyses were performed with IBM SPSS software (version 22, Statistics for Mac; version 22.0, IBM Crop), and Stata 13 software (StataCorp).</p>                    <h2 scrollto-destination=\"134170111\" id=\"134170111\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s11\">RESULTS</h2>\n                    <h3 scrollto-destination=\"134170112\" id=\"134170112\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s12\">Prevalence of Risk Factors for Immunocompromise</h3>\n<p class=\"chapter-para\">Among 3702 patients enrolled in the GLIMP database, ≥1 risk factor for immunocompromise was identified in 652 (17.6%). The prevalences of patients with pneumonia coming from the community and with ≥1 risk factor for immunocompromise differed among continents and countries, as depicted in <span class=\"xrefLink\" id=\"jumplink-F1\"></span><a href=\"javascript:;\" data-modal-source-id=\"F1\" class=\"link xref-fig\" data-google-interstitial=\"false\">Figure 1</a> and <span class=\"link link-data-supplement\" data-supplement-target=\"sup1\"></span><span class=\"content-section supplementary-material\"><a path-from-xml=\"sup1\" href=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy723_suppl_supplementary_materials.docx?Expires=1752554619&amp;Signature=IHcdpKKqq~8UybDtfcD3STezArBwHL7jBx5GEabm~T8HKox8a8ufCpx98eRu5Y5YzE4WIM1s0Xpj7nClWNCeBi4YRTDR57TohDDSroY~vSBlwQzK8CRM7QW3Z65UbTyzL~YYiLwtnWqW0IU3zgHI7Tnp-RT8kWIUUokUdE4hNwa5b1nHYIQZxjKpKj7y4kj~4O0VCssH2lKwxvLln0i2MGypxy5wJMEUlSehjBb6g33eg1EkSTst1441miASNAtSTWYhmp5bB3dtOm56p90128BwTLIACROocJREvycDJKAKuGqE6bHS4cJpTqaoOpMBi-MMG4Nv329NM6avRo0few__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" data-google-interstitial=\"false\">Supplementary Tables 1 and 2</a></span>. The prevalence of immunocompromise was significantly higher in both North and South America than in the rest of the world (24.0% vs 16.5 [<em>P</em> &lt; .001] and 24.8% vs 17.2 [<em>P</em> = .006], respectively) (<span class=\"link link-data-supplement\" data-supplement-target=\"sup1\"></span><span class=\"content-section supplementary-material\"><a path-from-xml=\"sup1\" href=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy723_suppl_supplementary_materials.docx?Expires=1752554619&amp;Signature=IHcdpKKqq~8UybDtfcD3STezArBwHL7jBx5GEabm~T8HKox8a8ufCpx98eRu5Y5YzE4WIM1s0Xpj7nClWNCeBi4YRTDR57TohDDSroY~vSBlwQzK8CRM7QW3Z65UbTyzL~YYiLwtnWqW0IU3zgHI7Tnp-RT8kWIUUokUdE4hNwa5b1nHYIQZxjKpKj7y4kj~4O0VCssH2lKwxvLln0i2MGypxy5wJMEUlSehjBb6g33eg1EkSTst1441miASNAtSTWYhmp5bB3dtOm56p90128BwTLIACROocJREvycDJKAKuGqE6bHS4cJpTqaoOpMBi-MMG4Nv329NM6avRo0few__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" data-google-interstitial=\"false\">Supplementary Table 1</a></span>).</p>                    <a id=\"134170114\" scrollto-destination=\"134170114\" data-google-interstitial=\"false\"></a>\n<div data-id=\"f1\" data-content-id=\"f1\" class=\"fig fig-section js-fig-section\" swap-content-for-modal=\"true\"><div class=\"graphic-wrap\"><img class=\"content-image\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1752554620&amp;Signature=LKXAyrV74Aa9owXe0o-cQ75pOeSoID0-pehgygNtPZSFXNZMuhHSvh2bH2dv7qW8hH1yagXom1UIMLOtWgjAeeVu2LBuha-~CcDB2tnoDsCwd0W--ENWiqmCFTxq3yC2TQ0Umx7W~VJXwN6SRKyfDOflOkKvPGRNUobFX0ugYVCV63UYBnlhdsPfvI-fsKpp2D2I1PP6zBaXvsJbvI-0aIPK7XN9D-bkImy~2jyh7YxMl-ml056-m9M~e1NXIC1G-eMlJ-D0ihNbxsU~I2x~~h2BWrtr8AE9Sfu1WTqiFahp57mH4~iFGY9EkQkC4xJpjMyNKtQFhxpXjvQtYLzecQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases.\" data-path-from-xml=\"ciy72301.jpg\" width=\"520\" height=\"462\"><div class=\"graphic-bottom\"><div class=\"label fig-label\" id=\"label-134170114\">Figure 1.</div><div class=\"caption fig-caption\"><p class=\"chapter-para\">Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, &lt;5%, 5%–10%, 11%–20%, 21%–30%, or &gt;30% of total cases.</p></div><div class=\"ajax-articleAbstract-exclude-regex fig-orig original-slide figure-button-wrap\"><a class=\"fig-view-orig js-view-large at-figureViewLarge openInAnotherWindow\" role=\"button\" aria-describedby=\"label-134170114\" href=\"/view-large/figure/134170114/ciy72301.jpg\" data-path-from-xml=\"ciy72301.jpg\" target=\"_blank\" data-google-interstitial=\"false\">Open in new tab</a><a class=\"download-slide\" role=\"button\" aria-describedby=\"label-134170114\" data-section=\"134170114\" href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72301.jpeg?Expires=1752554620&amp;Signature=NHcEJwNnhhuu~V7litr8igr9GFWfZ0zM0SxlfYOwAgN3ag3nsCMd9zXKoM9GZWcSFeGB~KznckX3sjRs7eZI6UovzOYWd5ChB8QCKT6DbvXvsAyPCY~~tvyw1nLgnCRXHxsEp9~pCDA4jyfmGwdzBmIxjxK32DKPE3r03H1NwaFfFuqtTjvCIQz2eID2dBiK~4lTbznS4INQ66i-Fh9DwTzI-HwYqclm24aYv1pSYlAiswZHOwaE-fO6wkuUxDcfD3pvVFQ~xscKfiFVbOt91lXVNkOd7p4CKoSAgaQv6yr5WZ9-7z1VyiIThnhC9G~HPkbIlB2Do4fo0jz7V2xwPA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170114&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\" data-path-from-xml=\"ciy72301.jpg\" data-google-interstitial=\"false\">Download slide</a></div></div></div></div><p class=\"chapter-para\">The prevalence of each risk factor for immunocompromise is depicted in <span class=\"xrefLink\" id=\"jumplink-F2\"></span><a href=\"javascript:;\" data-modal-source-id=\"F2\" class=\"link xref-fig\" data-google-interstitial=\"false\">Figure 2</a>, with chronic steroid use (45.0%), hematological cancer (25.0%), and chemotherapy (22.0%) being the most frequent ones. A total of 312 patients (8.4%) had &gt;1 risk factor for immunocompromise (<span class=\"xrefLink\" id=\"jumplink-F3\"></span><a href=\"javascript:;\" data-modal-source-id=\"F3\" class=\"link xref-fig\" data-google-interstitial=\"false\">Figure 3</a>).</p>                    <a id=\"134170116\" scrollto-destination=\"134170116\" data-google-interstitial=\"false\"></a>\n<div data-id=\"f2\" data-content-id=\"f2\" class=\"fig fig-section js-fig-section\" swap-content-for-modal=\"true\"><div class=\"graphic-wrap\"><img class=\"content-image\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72302.jpeg?Expires=1752554620&amp;Signature=tN-5VXAN-IRDKK8axKZA8P~Y5z--s9j8Erc8SOjWl6DrKKH4QL5os9eZxhVeV6eWVN~f~VDG9tfzyHUF6i7OVsMNB2vsk6C~94Qv-2aRHoy5JP-aM-LrL8khDyqEa4Lg2BfInF3Q0qGwXrmt25GlH1qSBKirMgS~VlVo9FK3dUDe2-XgCIv-DixycDR1NbxEUad1obLBQi7T-cMZnDc0-hSXzSelH07q4yY8dbVGxrERuy5IWOvusZ1u83w1jCK4dSvt3hPFFdMZMOmGLi~Fj-dVSs0cAjfbIHoEDmqErTby4pVDEijEs5muQVm-Ux~YEjgN-VhvWj8YtpZKL4eSXA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"Prevalence of each single risk factor for immunocompromise.\" data-path-from-xml=\"ciy72302.jpg\" width=\"520\" height=\"304\"><div class=\"graphic-bottom\"><div class=\"label fig-label\" id=\"label-134170116\">Figure 2.</div><div class=\"caption fig-caption\"><p class=\"chapter-para\">Prevalence of each single risk factor for immunocompromise.</p></div><div class=\"ajax-articleAbstract-exclude-regex fig-orig original-slide figure-button-wrap\"><a class=\"fig-view-orig js-view-large at-figureViewLarge openInAnotherWindow\" role=\"button\" aria-describedby=\"label-134170116\" href=\"/view-large/figure/134170116/ciy72302.jpg\" data-path-from-xml=\"ciy72302.jpg\" target=\"_blank\" data-google-interstitial=\"false\">Open in new tab</a><a class=\"download-slide\" role=\"button\" aria-describedby=\"label-134170116\" data-section=\"134170116\" href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72302.jpeg?Expires=1752554620&amp;Signature=urCgidlWbN7Br1gKnVthRjYFEVioagJuBFmiXPuQQBoD2qmTrm4Heidc21Yt1dgPswbIwC7DPhnYrlHrjxMxL-tPDfinKG-olgkospAEDA-ocZW5BuK9lYsha0rJ0NF76fxfhqDzGVUbNAug3anPLTq4c4Wm9hmTgaDN4Qc2ECcT8hDYAnEm3od96dWn52Zy09JsZa4zT41kMG~qQJEZG62~24b5nEIG7eSCncOceqVPqOOaaIMniBLrAQuB7Hvqr~6AtHN5IBjBuLUjU1xYJcFJXX6WtIhnqkXKN21GOO7O7AU0AC7FLWQuEd1zCcVocKQxVv4RndCQeZ3XzZvegA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170116&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\" data-path-from-xml=\"ciy72302.jpg\" data-google-interstitial=\"false\">Download slide</a></div></div></div></div>                    <a id=\"134170117\" scrollto-destination=\"134170117\" data-google-interstitial=\"false\"></a>\n<div data-id=\"f3\" data-content-id=\"f3\" class=\"fig fig-section js-fig-section\" swap-content-for-modal=\"true\"><div class=\"graphic-wrap\"><img class=\"content-image\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72303.jpeg?Expires=1752554620&amp;Signature=Xts16a6pXvQbNfwKtUeejfXsqF17z~2gviy7VcLQhhckWHmCw0zRSSEtsyrG9SkI2LRw39TbhqnqYNb1VTXQKD-ybyHkb~R3s-eIxJ~94DOxaaXBbUvpzbvwY1vDACc5LpVzJJ8dZMntZ7nekvhgMs6NtlpySVWDDC~7ybF0bySgW6i55FBFevIdcUxB3ipChEHL9XiTlmDkdiHssMser494UBvbDyg4DUKM-Cpd988M8qpSwp-eg-3Yhkr9q2~L66QQUhwgYNILWRRA1azwsTAJvrWUq52Dpikbj4mzbXXstnhvc7GNMw5xxz6nFPKuHVKJlcE-HQsiIvj5ZOVUxg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"Prevalence of the number of risk factors present simultaneously in a single patient.\" data-path-from-xml=\"ciy72303.jpg\" width=\"520\" height=\"245\"><div class=\"graphic-bottom\"><div class=\"label fig-label\" id=\"label-134170117\">Figure 3.</div><div class=\"caption fig-caption\"><p class=\"chapter-para\">Prevalence of the number of risk factors present simultaneously in a single patient.</p></div><div class=\"ajax-articleAbstract-exclude-regex fig-orig original-slide figure-button-wrap\"><a class=\"fig-view-orig js-view-large at-figureViewLarge openInAnotherWindow\" role=\"button\" aria-describedby=\"label-134170117\" href=\"/view-large/figure/134170117/ciy72303.jpg\" data-path-from-xml=\"ciy72303.jpg\" target=\"_blank\" data-google-interstitial=\"false\">Open in new tab</a><a class=\"download-slide\" role=\"button\" aria-describedby=\"label-134170117\" data-section=\"134170117\" href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72303.jpeg?Expires=1752554620&amp;Signature=aODZPs-HRl9QmymSK-5bkx~xp6iLrndvYFKxy1ge9DczmeUzsNnr5McNlvqrMcXHLvgMkhfK7yT7VuvVZQyJiTDmkR2j-SEc5zFcORnQPNUjDvGORdypfvcWI0ap8MKwHNe5lyBn4KtJz~tW8Oy3Gx54ukE8wke7~kZBzMvO8MTOkttiu8JkRKLQBqO6IcM2MoQBEcRSt-iQJjHBC9eSqzTw9hfjbhfc1npEBjHchP6v69RipZnUipM4HSTXcHzcLlv5ZrElufmBjKlaCOuMXehhls70RLfvTvOnOA3AyEmOSecyKEGpTAKKWMZCZcKwFjPqwgrO2KIMNHBcdECFyg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170117&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\" data-path-from-xml=\"ciy72303.jpg\" data-google-interstitial=\"false\">Download slide</a></div></div></div></div>                    <h3 scrollto-destination=\"134170118\" id=\"134170118\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s13\">Network Analysis Among Risk Factors for Immunocompromise</h3>\n<p class=\"chapter-para\">The results of the network analysis of all risk factors for immunocompromise are depicted in <span class=\"xrefLink\" id=\"jumplink-F4\"></span><a href=\"javascript:;\" data-modal-source-id=\"F4\" class=\"link xref-fig\" data-google-interstitial=\"false\">Figure 4</a>. Relationships were identified between chemotherapy and solid tumor other than lung cancer, hematological cancer, and chronic steroid use, and between other immunocompromise and chronic steroid use.</p>                    <a id=\"134170120\" scrollto-destination=\"134170120\" data-google-interstitial=\"false\"></a>\n<div data-id=\"f4\" data-content-id=\"f4\" class=\"fig fig-section js-fig-section\" swap-content-for-modal=\"true\"><div class=\"graphic-wrap\"><img class=\"content-image\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72304.jpeg?Expires=1752554620&amp;Signature=GuJUcrEhLaMR89vfrhqqYuGyB4HuDlfLUgnHqNu6Ksi5VkLMWjSpH0hVJWv0i4hnesvCDRYbQ~uAyBQyQ0AiLXq2xGVhq3CJd~~Uo~xFEO2RNWWcv5izwBv2Xd~h9Hdfe0hTA-AXnTA7hKM-ThAaURdGnReCFddtKpqnLFFI8QBpZfiXaSjcJTGzuOJpCX41BN9EmgqXfVfeCV2WjdANqIm2R0p4fJbe8r3T6ykoQ1g-IoQnAttT~9TBNl6irCxSuhZHs693bn8ZNDwodNBEKnNGVKaV3sMa8zH8GthYrKb1ARcjtit4vlO4Amlu5qUEW4FRAzxNeE5ch2OPPqoZ6g__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" alt=\"Network analysis between risk factors for immunocompromise.\" data-path-from-xml=\"ciy72304.jpg\"><div class=\"graphic-bottom\"><div class=\"label fig-label\" id=\"label-134170120\">Figure 4.</div><div class=\"caption fig-caption\"><p class=\"chapter-para\">Network analysis between risk factors for immunocompromise.</p></div><div class=\"ajax-articleAbstract-exclude-regex fig-orig original-slide figure-button-wrap\"><a class=\"fig-view-orig js-view-large at-figureViewLarge openInAnotherWindow\" role=\"button\" aria-describedby=\"label-134170120\" href=\"/view-large/figure/134170120/ciy72304.jpg\" data-path-from-xml=\"ciy72304.jpg\" target=\"_blank\" data-google-interstitial=\"false\">Open in new tab</a><a class=\"download-slide\" role=\"button\" aria-describedby=\"label-134170120\" data-section=\"134170120\" href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72304.jpeg?Expires=1752554620&amp;Signature=YZzJ1wJWugBQStvfJV4l4KYj3Wo9NRpieCO~yvNqxtUBWQdjFeAYbw2G-Y6DLCVNq9Va5VeID5cdns-ikSqf31HJSxkU6nJ2ORJtfKpX9YRK1R4udPlHilZw7ywCq-EzR6AMwb3sY-BfsBS4sDesTOwvKTu1-DzRuTpqruza-~yCWEOuDxUkBBBhGOjezpmaPE1pK9FuWVCTdWQjhWi0Q1hWTQx8Y41~JVb3kGWNigqT8AD4v9JX1c4I3Lv7PwLI68bVFaY9GUswC-yS1tvJbrugsyrYyCUrS~h7Si20MQ14RfW5c61orGDtUvAkaoknOVddjBXj5tv5wBq7Hieh4A__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170120&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\" data-path-from-xml=\"ciy72304.jpg\" data-google-interstitial=\"false\">Download slide</a></div></div></div></div>                    <h3 scrollto-destination=\"134170121\" id=\"134170121\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s14\">Clinical and Microbiological Characteristics of Patients With Immunocompromise</h3>\n<p class=\"chapter-para\">Clinical features and disease severity of immunocompetent versus immunocompromised patients are shown in <span class=\"xrefLink\" id=\"jumplink-T1\"></span><a href=\"javascript:;\" reveal-id=\"T1\" data-open=\"T1\" class=\"link link-reveal link-table xref-fig\" data-google-interstitial=\"false\">Table 1</a> and <span class=\"link link-data-supplement\" data-supplement-target=\"sup1\"></span><span class=\"content-section supplementary-material\"><a path-from-xml=\"sup1\" href=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy723_suppl_supplementary_materials.docx?Expires=1752554620&amp;Signature=h15TLzB~iVdXq3mg6ERhsysxUJRdhy3kLeYQ4F92iCbc3pocFnl8FwvX3RQC8nlYDTyE-O-a~2nqmo9b7hLsR6tqwrT9vRY41V9ilDQiSPOIm6SNs5Vt2w60ygDmzeatDy1PnRyi2g~VSjY4BEk~G32iZQmxfjMNlHuKF6QQkUa808du7-UT7jAmdQsjnigHZsW275wHf0oI-BEhu33D6B3MFU2d5knLITgSIvG1m9Uql9dd8Iwe0Ti-PYfBKoU7Pb9DLF9EE~wV1fT1oJVp0RK0Eg6kGxWd7bCamQsPB00clz5TXI~lPCnGFq14~Oui~jj9qPGmqYLmCbUgWg2zTQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" data-google-interstitial=\"false\">Supplementary Table 3</a></span>. Immunocompromised patients were significantly younger and malnourished, had a higher frequency of comorbid conditions, previous infections, and colonization by resistant pathogens, and had more frequent contacts with the healthcare system. The prevalences of severe pneumonia did not differ among the 2 study groups.</p>                    <a id=\"134170123\" scrollto-destination=\"134170123\" data-google-interstitial=\"false\"></a>\n<div content-id=\"T1\" class=\"table-modal table-full-width-wrap\" style=\"display: block;\"><div class=\"table-wrap table-wide standard-table\"><div class=\"table-wrap-title\" id=\"T1\" data-id=\"T1\"><span class=\"label title-label\" id=\"label-72200\">Table 1.</span><div class=\"\n                            graphic-wrap table-open-button-wrap\n                            \"><a class=\"fig-view-orig at-tableViewLarge openInAnotherWindow btn js-view-large\" role=\"button\" target=\"_blank\" href=\"\n                                /view-large/134170123\" aria-describedby=\"label-72200\" data-google-interstitial=\"false\">\n                            Open in new tab\n                        </a></div><div class=\"caption caption-id-\" id=\"caption-72200\"><p class=\"chapter-para\">Clinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised)</p></div> </div><div class=\"table-overflow\"><table role=\"table\" aria-labelledby=\"\n                        label-72200\" aria-describedby=\"\n                        caption-72200\"><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<sup>a</sup><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 3050)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised<br>(n = 652)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div class=\"table-modal\"><table><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<sup>a</sup><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 3050)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised<br>(n = 652)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div class=\"table-wrap-foot\"><span id=\"fn-fn-0001\"></span><div content-id=\"fn-0001\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Abbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors.</p></span></div><span id=\"fn-fn-0002\"></span><div content-id=\"fn-0002\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\"><sup>a</sup>Data represent No. (%) unless otherwise specified.</p></span></div></div></div></div><div class=\"table-full-width-wrap\"><div class=\"table-wrap table-wide standard-table\"><div class=\"table-wrap-title\" id=\"T1\" data-id=\"T1\"><span class=\"label title-label\" id=\"label-72200\">Table 1.</span><div class=\"\n                            graphic-wrap table-open-button-wrap\n                            \"><a class=\"fig-view-orig at-tableViewLarge openInAnotherWindow btn js-view-large\" role=\"button\" target=\"_blank\" href=\"\n                                /view-large/134170123\" aria-describedby=\"label-72200\" data-google-interstitial=\"false\">\n                            Open in new tab\n                        </a></div><div class=\"caption caption-id-\" id=\"caption-72200\"><p class=\"chapter-para\">Clinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised)</p></div> </div><div class=\"table-overflow\"><table role=\"table\" aria-labelledby=\"\n                        label-72200\" aria-describedby=\"\n                        caption-72200\"><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<sup>a</sup><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 3050)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised<br>(n = 652)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div class=\"table-modal\"><table><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<sup>a</sup><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 3050)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised<br>(n = 652)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div class=\"table-wrap-foot\"><span id=\"fn-fn-0001\"></span><div content-id=\"fn-0001\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Abbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors.</p></span></div><span id=\"fn-fn-0002\"></span><div content-id=\"fn-0002\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\"><sup>a</sup>Data represent No. (%) unless otherwise specified.</p></span></div></div></div></div><p class=\"chapter-para\">Microbiological testing was performed in 91.0% (596 of 652) of immunocompromised and 86.0% (2626 of 3050) of immunocompetent patients (<em>P</em> &lt; .001). Bacteremia was found in 6.0% (36 of 596) of immunocompromised and 5.5% (145 of 2626; <em>P</em> = .62) of immunocompetent patients. At least 1 positive culture was obtained in 40.0% (238 of 596) immunocompromised and 36.0% (935 of 2626) immunocompetent patients (<em>P</em> = .047). Microbiological findings are provided in <span class=\"xrefLink\" id=\"jumplink-T2\"></span><a href=\"javascript:;\" reveal-id=\"T2\" data-open=\"T2\" class=\"link link-reveal link-table xref-fig\" data-google-interstitial=\"false\">Table 2</a> and <a class=\"link link-uri openInAnotherWindow\" href=\"http://Supplementary Table 4\" target=\"_blank\" data-google-interstitial=\"false\">Supplementary Table 4</a>. Among pathogens covered by standard therapy, <em>P. aeruginosa</em> was more prevalent in immunocompromised patients (35 [5.9%] vs 98 [3.7%] patients; <em>P</em> &lt; .02). Among pathogens not usually covered by standard therapy, immunocompromised patients were more likely to be infected by <em>Nocardia</em> spp. (4 [0.7%] vs 0 [0%] patients; <em>P</em> &lt; .001), nontuberculous mycobacteria (NTM) (5 [0.8%] vs 2 [0.1%]; <em>P</em> &lt; .002), <em>A. fumigatus</em> (8 [1.3%] vs 10 [0.4%]; <em>P</em> &lt; .01), <em>P. jirovecii</em> (12 [2.0%] vs 5 [0.2%]; <em>P</em> &lt; .02), and viruses, such as coronavirus (3 [0.5%] vs 3 [0.1%]; <em>P</em> &lt; .047), and respiratory syncytial virus (6 [1.0%] vs 7 [0.3%]; <em>P</em> &lt; .03).</p>                    <a id=\"134170125\" scrollto-destination=\"134170125\" data-google-interstitial=\"false\"></a>\n<div content-id=\"T2\" class=\"table-modal table-full-width-wrap\" style=\"display: block;\"><div class=\"table-wrap table-wide standard-table\"><div class=\"table-wrap-title\" id=\"T2\" data-id=\"T2\"><span class=\"label title-label\" id=\"label-72200\">Table 2.</span><div class=\"\n                            graphic-wrap table-open-button-wrap\n                            \"><a class=\"fig-view-orig at-tableViewLarge openInAnotherWindow btn js-view-large\" role=\"button\" target=\"_blank\" href=\"\n                                /view-large/134170125\" aria-describedby=\"label-72200\" data-google-interstitial=\"false\">\n                            Open in new tab\n                        </a></div><div class=\"caption caption-id-\" id=\"caption-72200\"><p class=\"chapter-para\">Pathogens in the 2 Study Groups</p></div> </div><div class=\"table-overflow\"><table role=\"table\" aria-labelledby=\"\n                        label-72200\" aria-describedby=\"\n                        caption-72200\"><thead><tr><th rowspan=\"2\">Pathogen<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 2626)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised (n = 596)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div class=\"table-modal\"><table><thead><tr><th rowspan=\"2\">Pathogen<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 2626)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised (n = 596)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div class=\"table-wrap-foot\"><span id=\"fn-fn-0003\"></span><div content-id=\"fn-0003\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Abbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant <em>Staphylococcus aureus</em>; MSSA, methicillin-sensitive <em>S. aureus</em>; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus.</p></span></div></div></div></div><div class=\"table-full-width-wrap\"><div class=\"table-wrap table-wide standard-table\"><div class=\"table-wrap-title\" id=\"T2\" data-id=\"T2\"><span class=\"label title-label\" id=\"label-72200\">Table 2.</span><div class=\"\n                            graphic-wrap table-open-button-wrap\n                            \"><a class=\"fig-view-orig at-tableViewLarge openInAnotherWindow btn js-view-large\" role=\"button\" target=\"_blank\" href=\"\n                                /view-large/134170125\" aria-describedby=\"label-72200\" data-google-interstitial=\"false\">\n                            Open in new tab\n                        </a></div><div class=\"caption caption-id-\" id=\"caption-72200\"><p class=\"chapter-para\">Pathogens in the 2 Study Groups</p></div> </div><div class=\"table-overflow\"><table role=\"table\" aria-labelledby=\"\n                        label-72200\" aria-describedby=\"\n                        caption-72200\"><thead><tr><th rowspan=\"2\">Pathogen<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 2626)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised (n = 596)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div class=\"table-modal\"><table><thead><tr><th rowspan=\"2\">Pathogen<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"2\">Patients, No. (%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th rowspan=\"2\"><em>P</em> Value<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th>Immunocompetent (n = 2626)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Immunocompromised (n = 596)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div class=\"table-wrap-foot\"><span id=\"fn-fn-0003\"></span><div content-id=\"fn-0003\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Abbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant <em>Staphylococcus aureus</em>; MSSA, methicillin-sensitive <em>S. aureus</em>; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus.</p></span></div></div></div></div><p class=\"chapter-para\">Once adjusted for confounders, no risk factors of immunocompromise have been recognized for <em>P. aeruginosa</em> infection. Likewise, pathogens not covered by usual CAP therapy were found to be associated not with immunocompromise but with chronic obstructive pulmonary disease (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.07–2.99; <em>P</em> = .03), tracheostomy (2.91; 1.01–8.38; <em>P</em> = .048), and severe pneumonia (2.36; 1.42–3.93; <em>P</em> = .001) (<span class=\"xrefLink\" id=\"jumplink-T3\"></span><a href=\"javascript:;\" reveal-id=\"T3\" data-open=\"T3\" class=\"link link-reveal link-table xref-fig\" data-google-interstitial=\"false\">Table 3</a>).</p>                    <a id=\"134170127\" scrollto-destination=\"134170127\" data-google-interstitial=\"false\"></a>\n<div content-id=\"T3\" class=\"table-modal table-full-width-wrap\" style=\"display: block;\"><div class=\"table-wrap table-wide standard-table\"><div class=\"table-wrap-title\" id=\"T3\" data-id=\"T3\"><span class=\"label title-label\" id=\"label-72200\">Table 3.</span><div class=\"\n                            graphic-wrap table-open-button-wrap\n                            \"><a class=\"fig-view-orig at-tableViewLarge openInAnotherWindow btn js-view-large\" role=\"button\" target=\"_blank\" href=\"\n                                /view-large/134170127\" aria-describedby=\"label-72200\" data-google-interstitial=\"false\">\n                            Open in new tab\n                        </a></div><div class=\"caption caption-id-\" id=\"caption-72200\"><p class=\"chapter-para\">Multivariable Logistic Regression Analysis</p></div> </div><div class=\"table-overflow\"><table role=\"table\" aria-labelledby=\"\n                        label-72200\" aria-describedby=\"\n                        caption-72200\"><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"5\">OR (CI 95%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Non-CAP Bacteria<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Fungi<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th><em>Mycobacterium tuberculosis</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Virus Other Than Influenza<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91<br>(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20<br>(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78<br>(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36<br>(1.42–3.93)</td><td>…</td><td>…</td><td>2.56<br>(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10<br>(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65<br>(1.85–11.69)</td><td>…</td><td>5.49<br>(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div class=\"table-modal\"><table><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"5\">OR (CI 95%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Non-CAP Bacteria<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Fungi<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th><em>Mycobacterium tuberculosis</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Virus Other Than Influenza<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91<br>(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20<br>(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78<br>(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36<br>(1.42–3.93)</td><td>…</td><td>…</td><td>2.56<br>(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10<br>(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65<br>(1.85–11.69)</td><td>…</td><td>5.49<br>(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div class=\"table-wrap-foot\"><span id=\"fn-fn-0004\"></span><div content-id=\"fn-0004\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Blank cells indicate no statistical significancy.</p></span></div><span id=\"fn-fn-0005\"></span><div content-id=\"fn-0005\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Abbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio.</p></span></div></div></div></div><div class=\"table-full-width-wrap\"><div class=\"table-wrap table-wide standard-table\"><div class=\"table-wrap-title\" id=\"T3\" data-id=\"T3\"><span class=\"label title-label\" id=\"label-72200\">Table 3.</span><div class=\"\n                            graphic-wrap table-open-button-wrap\n                            \"><a class=\"fig-view-orig at-tableViewLarge openInAnotherWindow btn js-view-large\" role=\"button\" target=\"_blank\" href=\"\n                                /view-large/134170127\" aria-describedby=\"label-72200\" data-google-interstitial=\"false\">\n                            Open in new tab\n                        </a></div><div class=\"caption caption-id-\" id=\"caption-72200\"><p class=\"chapter-para\">Multivariable Logistic Regression Analysis</p></div> </div><div class=\"table-overflow\"><table role=\"table\" aria-labelledby=\"\n                        label-72200\" aria-describedby=\"\n                        caption-72200\"><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"5\">OR (CI 95%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Non-CAP Bacteria<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Fungi<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th><em>Mycobacterium tuberculosis</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Virus Other Than Influenza<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91<br>(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20<br>(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78<br>(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36<br>(1.42–3.93)</td><td>…</td><td>…</td><td>2.56<br>(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10<br>(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65<br>(1.85–11.69)</td><td>…</td><td>5.49<br>(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div class=\"table-modal\"><table><thead><tr><th rowspan=\"2\">Variable<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th colspan=\"5\">OR (CI 95%)<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Non-CAP Bacteria<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Fungi<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th><em>Mycobacterium tuberculosis</em><span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th><th>Virus Other Than Influenza<span aria-hidden=\"true\" style=\"display: none;\">\n            .&nbsp;</span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91<br>(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20<br>(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78<br>(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36<br>(1.42–3.93)</td><td>…</td><td>…</td><td>2.56<br>(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10<br>(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65<br>(1.85–11.69)</td><td>…</td><td>5.49<br>(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div class=\"table-wrap-foot\"><span id=\"fn-fn-0004\"></span><div content-id=\"fn-0004\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Blank cells indicate no statistical significancy.</p></span></div><span id=\"fn-fn-0005\"></span><div content-id=\"fn-0005\" class=\"footnote\"><span class=\"fn\"><p class=\"chapter-para\">Abbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio.</p></span></div></div></div></div><p class=\"chapter-para\">Results showed that AIDS (OR, 15.10; 95% CI, 6.36–35.88; <em>P</em> ≤ .001) and hematological cancer (4.65; 91.85–11.69; <em>P</em> = .001) were independently associated with fungal infections; hematological cancer (5.49; 2.20–13.70; <em>P</em> &lt; .001) and severe pneumonia (2.56; 1.27–5.19; <em>P</em> = .009) with infection by viruses other than influenza; and AIDS (4.41; 1.53–12.73; <em>P</em> = .006) and malnutrition (4.50; 2.08–9.72; <em>P</em> &lt; .001) with mycobacterial infections. An additional analysis was conducted on mycobacteria, including <em>M. tuberculosis</em> and NTM. At multivariable analysis, <em>M. tuberculosis</em> was independently associated with malnutrition only (OR, 5.14; 95% CI, 2.21–11.93; <em>P</em> &lt; .001). At univariate analysis, patients with AIDS were at higher risk for NTM (23.06; 4.39–121.12; <em>P</em> &lt; .001).</p><p class=\"chapter-para\">A subanalysis was conducted among patients with chronic steroid use versus other risk factors for immunocompromise. Patients with chronic steroid use seemed to be more frequently affected by bacteria not covered by standard CAP therapy (10 [3.4%] vs 1 [0.3%] patients; <em>P</em> = .002), <em>Nocardia</em> spp. in particular (4 [0.4%] vs 0 [0.0%]; <em>P</em> = .03). No differences in the severity of the disease were found (see <span class=\"link link-data-supplement\" data-supplement-target=\"sup1\"></span><span class=\"content-section supplementary-material\"><a path-from-xml=\"sup1\" href=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy723_suppl_supplementary_materials.docx?Expires=1752554620&amp;Signature=h15TLzB~iVdXq3mg6ERhsysxUJRdhy3kLeYQ4F92iCbc3pocFnl8FwvX3RQC8nlYDTyE-O-a~2nqmo9b7hLsR6tqwrT9vRY41V9ilDQiSPOIm6SNs5Vt2w60ygDmzeatDy1PnRyi2g~VSjY4BEk~G32iZQmxfjMNlHuKF6QQkUa808du7-UT7jAmdQsjnigHZsW275wHf0oI-BEhu33D6B3MFU2d5knLITgSIvG1m9Uql9dd8Iwe0Ti-PYfBKoU7Pb9DLF9EE~wV1fT1oJVp0RK0Eg6kGxWd7bCamQsPB00clz5TXI~lPCnGFq14~Oui~jj9qPGmqYLmCbUgWg2zTQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" data-google-interstitial=\"false\">Supplementary Table 5</a></span>).</p>                    <h2 scrollto-destination=\"134170130\" id=\"134170130\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s15\">DISCUSSION</h2>\n<p class=\"chapter-para\">The main findings of the present study are as follows: (1) 17.6% of patients admitted with pneumonia from the community have ≥1 risk factor for immunocompromise, with significant differences among continents and countries (ranging from 15.4% to 24.8% by continent and from 80.0% to 4.1% by country); (2) chronic steroid use is by far the most prevalent risk factor leading to immunocompromise, followed by hematological cancer and chemotherapy; (3) 1 of 2 immunocompromised patients has an overlap of ≥2 risk factors, which are also associated between one another in different ways; and (4) the 2 risk factors for immunocompromise independently associated with specific pathogens are AIDS (ie, fungal and mycobacterial infections) and hematological cancer (ie, fungal infection and viral infections other than influenza).</p><p class=\"chapter-para\">Almost 1 in 5 hospitalized patients with CAP are not immunocompetent. Therefore, it is mandatory to provide clinicians with recommendations or guidelines for the management of hospitalized patients with pneumonia coming from the community who have risk factors for immunocompromise. Currently, there are no guidelines for assessing pneumonia in immunocompromised patients coming from the community. Randomized controlled trials (RCTs) and observational prospective studies are missing owing to the fact that, generally, studies assessing management strategies for pneumonia exclude immunocompromised patients or take into account only a single specific risk factor [<span class=\"xrefLink\" id=\"jumplink-CIT0012 CIT0013 CIT0014 CIT0015 CIT0016 CIT0017 CIT0018 CIT0019 CIT0020 CIT0021\"></span><a href=\"javascript:;\" reveal-id=\"CIT0012 CIT0013 CIT0014 CIT0015 CIT0016 CIT0017 CIT0018 CIT0019 CIT0020 CIT0021\" data-open=\"CIT0012 CIT0013 CIT0014 CIT0015 CIT0016 CIT0017 CIT0018 CIT0019 CIT0020 CIT0021\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">12–21</a>]. This lack of information about immunocompromise could lead to both underestimation of the real prevalence with a higher rate of treatment failure and to overestimation and overuse of wide-spectrum antibiotics.</p><p class=\"chapter-para\">We found a 17.6% global prevalence of immunocompromise among patients coming from the community with pneumonia, with a significantly higher frequency in South and North America. This variability among continents and countries is probably attributable to different healthcare systems and rates of hospitalization of immunocompromised patients. Our analysis showed that the most frequent risk factor for immunocompromise is the chronic use of systemic steroids. Aging of the population and therapeutic advancements have favored the increased burden of chronic diseases and long-term therapies with immunosuppressive agents [<span class=\"xrefLink\" id=\"jumplink-CIT0008\"></span><a href=\"javascript:;\" reveal-id=\"CIT0008\" data-open=\"CIT0008\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">8</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0009\"></span><a href=\"javascript:;\" reveal-id=\"CIT0009\" data-open=\"CIT0009\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">9</a>]. In particular, steroids are the agents most frequently prescribed, for their wide spectrum of efficacy in several diseases [<span class=\"xrefLink\" id=\"jumplink-CIT0013\"></span><a href=\"javascript:;\" reveal-id=\"CIT0013\" data-open=\"CIT0013\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">13</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0017\"></span><a href=\"javascript:;\" reveal-id=\"CIT0017\" data-open=\"CIT0017\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">17</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0019\"></span><a href=\"javascript:;\" reveal-id=\"CIT0019\" data-open=\"CIT0019\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">19</a>]. Therefore, many patients presenting to the emergency room with pneumonia are receiving chronic steroid treatment. No data are available on this population group, and further studies are needed to characterize these patients and provide individualized management.</p><p class=\"chapter-para\">Hematological cancer and chemotherapy were other leading immunocompromised factors. These findings are consistent with those in previous studies; patients recruited in observational studies include patients with solid or hematological cancer and those who underwent chemotherapy with associated neutropenia [<span class=\"xrefLink\" id=\"jumplink-CIT0015 CIT0016 CIT0017 CIT0018 CIT0019 CIT0020\"></span><a href=\"javascript:;\" reveal-id=\"CIT0015 CIT0016 CIT0017 CIT0018 CIT0019 CIT0020\" data-open=\"CIT0015 CIT0016 CIT0017 CIT0018 CIT0019 CIT0020\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">15–20</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0022\"></span><a href=\"javascript:;\" reveal-id=\"CIT0022\" data-open=\"CIT0022\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">22</a>]. Dedicated guidelines and recommendations are available, especially on respiratory viruses, fungi, and <em>P. jirovecii</em> [<span class=\"xrefLink\" id=\"jumplink-CIT0023 CIT0024 CIT0025 CIT0026\"></span><a href=\"javascript:;\" reveal-id=\"CIT0023 CIT0024 CIT0025 CIT0026\" data-open=\"CIT0023 CIT0024 CIT0025 CIT0026\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">23–26</a>].</p><p class=\"chapter-para\">Our network analysis showed that several risk factors for immunocompromise show associations, especially chemotherapy, associated with hematological cancer and solid tumor, and other immunocompromise, associated with chronic steroid use. Moreover, neutropenic patients are well represented and mainly affected also by hematological cancer or under treatment with chemotherapy. Our results suggest that patients may have &gt;1 risk factor characteristic and clinical assessment should be comprehensive, taking into consideration risk factors for immunocompromise and their associated biological mechanisms. In contrast, AIDS, lung transplantation, asplenia, and aplastic anemia seem to be less frequent at admission and to represent distinct clinical entities. Findings of previous studies seem to be in line with our results, with AIDS patients considered as a distinct patient population and with very few observational studies available on asplenia and aplastic anemia [<span class=\"xrefLink\" id=\"jumplink-CIT0021\"></span><a href=\"javascript:;\" reveal-id=\"CIT0021\" data-open=\"CIT0021\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">21</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0027 CIT0028 CIT0029 CIT0030 CIT0031\"></span><a href=\"javascript:;\" reveal-id=\"CIT0027 CIT0028 CIT0029 CIT0030 CIT0031\" data-open=\"CIT0027 CIT0028 CIT0029 CIT0030 CIT0031\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">27–31</a>]</p><p class=\"chapter-para\">In agreement with previous reports, <em>S. pneumoniae</em> is the leading microorganism in both immunocompromised and immunocompetent groups [<span class=\"xrefLink\" id=\"jumplink-CIT0032\"></span><a href=\"javascript:;\" reveal-id=\"CIT0032\" data-open=\"CIT0032\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">32</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0033\"></span><a href=\"javascript:;\" reveal-id=\"CIT0033\" data-open=\"CIT0033\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">33</a>]. Among pathogens covered by standard CAP therapy, only <em>P. aeruginosa</em> was more frequently isolated in immunocompromised compared with immunocompetent patients. These findings differ from microbiological results of previous studies. Gram-positive bacteria, especially <em>S. aureus</em>, were more frequently identified in patients with immunocompromise of different causes [<span class=\"xrefLink\" id=\"jumplink-CIT0022\"></span><a href=\"javascript:;\" reveal-id=\"CIT0022\" data-open=\"CIT0022\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">22</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0030\"></span><a href=\"javascript:;\" reveal-id=\"CIT0030\" data-open=\"CIT0030\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">30</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0034\"></span><a href=\"javascript:;\" reveal-id=\"CIT0034\" data-open=\"CIT0034\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">34</a>]. Only Li and coauthors [<span class=\"xrefLink\" id=\"jumplink-CIT0013\"></span><a href=\"javascript:;\" reveal-id=\"CIT0013\" data-open=\"CIT0013\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">13</a>] found patients with immunological disorders, treated with systemic steroids and cytotoxic agents, to have a higher incidence of infections caused by gram-negative bacteria, mainly <em>P. aeruginosa</em>. This similarity with our findings could be explained by the prevalence of patients exposed to chronic steroids in our cohort.</p><p class=\"chapter-para\">Among pathogens not covered by standard CAP therapy, immunocompromised patients were more frequently infected by <em>Nocardia</em> spp., NTM, <em>P. jirovecii</em>, <em>A. fumigatus</em>, and viruses other than influenza. Infections by <em>P. jirovecii</em> and NTM are frequently identified in patients with AIDS [<span class=\"xrefLink\" id=\"jumplink-CIT0035\"></span><a href=\"javascript:;\" reveal-id=\"CIT0035\" data-open=\"CIT0035\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">35</a>]. <em>P. jirovecii</em> is also frequent in other types of immunocompromise, such as solid or hematological cancer in patients who underwent chemotherapy [<span class=\"xrefLink\" id=\"jumplink-CIT0018\"></span><a href=\"javascript:;\" reveal-id=\"CIT0018\" data-open=\"CIT0018\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">18</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0019\"></span><a href=\"javascript:;\" reveal-id=\"CIT0019\" data-open=\"CIT0019\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">19</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0036\"></span><a href=\"javascript:;\" reveal-id=\"CIT0036\" data-open=\"CIT0036\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">36</a>]. Fungal infections (eg, <em>Candida</em> spp. and <em>A. fumigatus</em>) are highly incident in neutropenic hematological cancer patients [<span class=\"xrefLink\" id=\"jumplink-CIT0022\"></span><a href=\"javascript:;\" reveal-id=\"CIT0022\" data-open=\"CIT0022\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">22</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0037\"></span><a href=\"javascript:;\" reveal-id=\"CIT0037\" data-open=\"CIT0037\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">37</a>]. Viral infections other than influenza, especially respiratory syncytial virus, are more frequent in patients who underwent hematopoietic stem cell or lung transplantation [<span class=\"xrefLink\" id=\"jumplink-CIT0038\"></span><a href=\"javascript:;\" reveal-id=\"CIT0038\" data-open=\"CIT0038\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">38</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0039\"></span><a href=\"javascript:;\" reveal-id=\"CIT0039\" data-open=\"CIT0039\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">39</a>]. Conversely, <em>Nocardia</em> spp. infections are mainly described in solid organ transplant recipients [<span class=\"xrefLink\" id=\"jumplink-CIT0040\"></span><a href=\"javascript:;\" reveal-id=\"CIT0040\" data-open=\"CIT0040\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">40</a>]. These results, consistent with previous findings, suggest the need for a more in-depth microbiological workup, including community-acquired pathogens and microorganisms not covered by standard therapy.</p><p class=\"chapter-para\">Surprisingly, we found that risk factors for immunocompromise were not independently associated with <em>P. aeruginosa</em> or non–community-acquired bacteria; in contrast, AIDS and hematological cancer are both associated with fungal, mycobacterial, and noninfluenza viral pneumonia, respectively. Empirical therapy should include <em>P. aeruginosa</em> coverage, which is highly prevalent in immunocompromised patients. On the contrary, particular attention should be given to fungal, mycobacterial, and viral causes should be for patients admitted with AIDS and hematological cancer [<span class=\"xrefLink\" id=\"jumplink-CIT0021 CIT0022 CIT0023 CIT0024 CIT0025 CIT0026 CIT0027 CIT0028 CIT0029\"></span><a href=\"javascript:;\" reveal-id=\"CIT0021 CIT0022 CIT0023 CIT0024 CIT0025 CIT0026 CIT0027 CIT0028 CIT0029\" data-open=\"CIT0021 CIT0022 CIT0023 CIT0024 CIT0025 CIT0026 CIT0027 CIT0028 CIT0029\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">21–29</a>].</p><p class=\"chapter-para\">Finally, bacteremia rates did not differ between study groups. To our knowledge, there are no studies on bacteremia and immunocompromise in general. The majority of studies have focused on bacteremia in hematopoietic stem cell transplantation, with prevalences varying from 6% to 44% depending on the type of bacteria and host-related factors [<span class=\"xrefLink\" id=\"jumplink-CIT0041 CIT0042 CIT0043\"></span><a href=\"javascript:;\" reveal-id=\"CIT0041 CIT0042 CIT0043\" data-open=\"CIT0041 CIT0042 CIT0043\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">41–43</a>]. Few studies addressed this topic in kidney transplant recipients, reporting a prevalence of bacteremia ranging from 25% to 69% [<span class=\"xrefLink\" id=\"jumplink-CIT0044\"></span><a href=\"javascript:;\" reveal-id=\"CIT0044\" data-open=\"CIT0044\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">44</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0045\"></span><a href=\"javascript:;\" reveal-id=\"CIT0045\" data-open=\"CIT0045\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">45</a>]. Finally, few studies have addressed HIV and bacteremia, with prevalences ranging from 10% to 25%, depending on the pathogen and grade of immunosuppression [<span class=\"xrefLink\" id=\"jumplink-CIT0046\"></span><a href=\"javascript:;\" reveal-id=\"CIT0046\" data-open=\"CIT0046\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">46</a>, <span class=\"xrefLink\" id=\"jumplink-CIT0047\"></span><a href=\"javascript:;\" reveal-id=\"CIT0047\" data-open=\"CIT0047\" class=\"link link-ref link-reveal xref-bibr\" data-google-interstitial=\"false\">47</a>]. The prevalence of bacteremia in our study was 5T–6% in both immunocompetent and immunocompromised patients. Differences in the prevalence of bacteremia are due mainly to differences between the risk factors for immunocompromise in our study (chronic steroid use, hematological cancer, and chemotherapy) and those previously reported in the literature.</p><p class=\"chapter-para\">The current study has both limitations and strengths. First of all, to our knowledge, this is the first study showing a worldwide perspective on immunocompromise among patients coming from the community with pneumonia, with a large and diverse sample of patients enrolled across different countries in 6 continents. However, we were not able to involve many investigators from Asia and Africa, and most cases occurred in North America and Europe, thus limiting the generalizability of our findings. Another major limitation is the unfeasibility of grading the severity of immunocompromise and, therefore, stratifying patients and defining the physiopathological interaction between different risk factors, especially with regard to the use of biological drugs and chronic steroids. Furthermore, potentially important risk factors for an immunocompromised state, such as solid organ transplants other than lung, have not been specifically investigated. Finally, no outcome data have been collected, and this strongly limits our speculations as to the correct empiric antibiotic therapy for use in immunocompromised patients with CAP.</p><p class=\"chapter-para\">In conclusion, our study offers to the scientific community a perspective on immunocompromised patients coming from the community with pneumonia. Future prospective studies on patients with specific risk factors for immunocompromise could provide practical recommendations. In particular, it will be crucial to prepare guidelines on certain prevalent population groups, such as patients exposed to chronic steroids and those with hematological cancer.</p>                    <h2 scrollto-destination=\"134170142\" id=\"134170142\" class=\"section-title js-splitscreen-section-title\" data-legacy-id=\"s16\">Supplementary Data</h2>\n<p class=\"chapter-para\">Supplementary materials are available at <em>Clinical Infectious Diseases</em> online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.</p>                    <h2 scrollto-destination=\"134170144\" id=\"134170144\" class=\"backnotes-title js-splitscreen-backnotes-title\" data-legacy-id=\"n1\">Notes</h2>\n<p class=\"chapter-para\"><strong><em>Author contributions.</em></strong> M. F. D. P., G. S., S. A., and M. I. R. participated in study design, analysis of data, and writing of the manuscript and take responsibility for the integrity of the work. A. G., D. R., S. T., L. F. R., J. R., J. G. d. C., and F. B. critically reviewed the final manuscript.</p><p class=\"chapter-para\"><strong><em>Acknowledgments.</em></strong> We thank the Asociacion Latinoamericana de Torax, European Respiratory Society, World Federation of Societies of Intensive and Critical Care Medicine, and American College of Chest Physicians for their support of this project. We also thank the following study contributors for their valuable collaboration. <strong>Argentina:</strong> Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires), Silvia Attorri (Hospital Luis Lago Maggiore, Mendoza), Enrique Barimboim (Hospital Central de Mendoza), Juan Pablo Caeiro and María I. Garzón (Hospital Privado Universitario, Córdoba), Victor Hugo Cambursano, A. Cazaux (Servicio de Neumologia, Hospital Rawson, Córdoba), Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas), Julio Chertcoff, Florencia Lascar, and Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital), Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza), Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires) Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos Vicente Lopez y Planes from General Rodriguez, Buenos Aires), Sandra Lambert (Hospital El Cruce–Alta Complejidad en Red), Gustavo Lopardo (Hospital Bernardo Houssay, Vicente López), Carlos M. Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires), Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen), Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos), Antonio A. Cetrangolo (an individual who is being acknowledged for his contribution to the study), Claudia Pensotti (Infectious Diseases and Infection Control Department, Clinica Privada Monte Grande, Buenos Aires), Betiana Pereyra (Hospital San Roque, Córdoba), Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D. F. Santojanni), Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela); <strong>Australia:</strong> Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg); <strong>Austria:</strong> Felix Lötsch and Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna); <strong>Belgium:</strong> Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp), Camille A. Francois (Anesthesia and Critical Care Department, Erasme University Hospital, Brussels), Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital), Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels); <strong>Benin:</strong> Marcel Zannou Djimon, Jules Bashi and Roger Dodo (Centre Hospitalier Universitaire HKM of Cotonou); <strong>Brazil:</strong> Simone Aranha Nouér (Federal University of Rio de Janeiro); <strong>Bulgaria:</strong> Peter Chipev and Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofia), Darina Miteva, (UMHAT St Marina, Varna), Diana Petkova (University Hospital Varna); <strong>Cameroon:</strong> Adamou Dodo Balkissou (Yaounde Jamot Hospital, Yaounde), Eric Walter Pefura Yone (Département de Médecine Interne, University of Yaounde), Bertrand Hugo Mbatchou Ngahane (Douala General Hospital); <strong>China:</strong> Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing), Jin-fu Xu (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University); <strong>Colombia:</strong> Carlos Andres Bustamante Rico and Ricardo Buitrago (Clinica Shaio, Bogota), Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin); <strong>Congo:</strong> Jean-Marie Kayembe Ntumba (Cliniques Universitaires de Kinshasa); <strong>Croatia:</strong> Vesna Vladic Carevic (Interne Medicine, Dubrovnik), Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb), Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases), Zinka Matkovic (University Hospital Dubrava, Zagreb), Ivan Mitrecic (Karlovac General Hospital); <strong>Denmark:</strong> Marie-Laure Bouchy Jacobsson (Emergency Department, North Zealand’s Hospital–Hillerød), Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital), Uffe Christian Heitmann Bødtger (Department of Pulmonology, Naestved Hospital), Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde), Andreas Vestergaard Jensen, Gertrud Baunbæk-Knudsen, Pelle Trier Petersen, and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød); <strong>Egypt:</strong> Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University), Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University), Hanaa Shafiek (Chest Diseases Department, Faculty of Medicine, Alexandria University), Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo); <strong>Ethiopia:</strong> Kedir Abdella Abdulsemed (Department of Medical Laboratory Science and Pathology, College of Health Sciences, Mycobacteriology Research Centre, Institute of Biotechnology Research, Jimma University); <strong>France:</strong> Fabrice Bertrand (Critical Care Unit, Robert Ballanger Hospital, Aulnay sous Bois), Christian Brun-Buisson (University Hospital of Henri-Mondor, Créteil), Etienne de Montmollin (Intensive Care Unit, Hôpital Delafontaine, Centre Hospitalier de Saint-Denis), Muriel Fartoukh (Unité de Réanimation Médico-Chirurgicale, Pôle Thorax Voies Aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien), Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médico-chirurgicale, Hôpital Louis Mourier, Colombes, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité), Pierre Tattevin (Infectious Diseases and ICU, Pontchaillou University Hospital, Rennes), Abdo Khoury (Department of Emergency Medicine and Critical Care, University of Franche–Comté, Medical Center); <strong>Gambia:</strong> Bernard Ebruke (Medical Research Council Unit, Fajara, Gambia); <strong>Germany:</strong> Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen), Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden), Matthias Meisinger, Klinikum Niederlausitz, Klinik für Innere Medizin und Intensivmedizin, Senftenberg), Mathias W. Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital), Jan Rupp (Department of Infectious Diseases and Microbiology, University of Lübeck), Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg), Marc Spielmanns (Internal Medicine Department, Pulmonary Rehabilitation and Department of Health, School of Medicine, University Witten-Herdecke, St Remigius Hospital, Leverkusen) Petra Creutz and Norton Suttorp (Department of Infectious Disease and Respiratory Medicine, Charité–University Medicine, Berlin); <strong>Ghana</strong>: Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi); <strong>Greece</strong>: Katerina Dimakou (5th Respiratory Medicine Department, SOTIRIA Chest Hospital, Athens), Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens), Evdoxia Tsigou and Dimitrios Ampazis (Agioi Anargiroi Hospital, Kifissia, Athens), Evangelos Kaimakamis (Intensive Care Unit, G. Papanikolaou General Hospital of Thessaloniki); <strong>India</strong>: Mohit Bhatia (S. S. Hospital IMS BHU Varanasi), Raja Dhar (Fortis Hospitals, Kolkata), George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore), Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow), Parvaiz A. Koul (Department of Internal and Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar), P. A. Mahesh and B. S. Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore), Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala), Hirennappa B. Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka), Surya Kant (Department of Respiratory Medicine, King George’s Medical University, Chowk, Lucknow, Uttar Pradesh), Rajesh Swarnakar (Getwell Hospital and Research Institute, Dhantoli, Nagpur), Sneha Limaye and Sundeep Salvi (on behalf of the Respiratory Research Network of India from the Chest Research Foundation in Pune); <strong>Iran</strong>: Keihan Golshani (Isfahan University of Medical Sciences); <strong>Ireland</strong>: Vera M. Keatings (Letterkenny General Hospital, County Donegal), Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization, St James’s University Hospital, Trinity Centre for Health Sciences Dublin); <strong>Israel</strong>: Yasmin Maor (Infectious Disease Unit, affiliated with Tel Aviv University, Wolfson Medical Center, Holon), Jacob Strahilevitz (Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem); <strong>Italy</strong>: Salvatore Battaglia, University of Palermo, Pneumologia DiBiMIS, Palermo), Maria Carrabba (Internal Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca’ Granda Ospedale Maggiore Policlinico, Milano), Piero Ceriana (Pulmonary Rehabilitation, IRCCS Fondazione Maugeri, Pavia), Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste), Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan), Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples), Marino De Rosa (Unità Operativa Complessa [UOC] Pneumologia PO San Filippo Neri Azienda Sanitaria Locale Roma E Roma), Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena), Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria Azienda Ospedaliera Ospedali dei Colli PO Monaldi), Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, Sardegna), Francesco Menzella (Department of Cardiac-Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS–Arcispedale Santa Maria Nuova, Reggio Emilia), Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S. Anna Nuovo, Unità Operativa di Pneumologia, Como), Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital), Gerardo Palmiero (Respiratory Unit, Versilia Hospital, Lido di Camaiore, Lucca), Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli), Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero–Universitaria S. Maria della Misericordia, Udine), Claudio Sorino, Pulmonology Unit, A. O. Sant’Anna di Como), Gundi Steinhilber (Spedali Civili Brescia, U. O. Pneumologia e Fisiopatologia Respiratoria, Brescia), Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta), Fabio Franzetti, Manuela Carugati, Manuela Morosi, and Elisa Monge (Department of Biomedical and Clinical Sciences, Division of Infectious Diseases, Luigi Sacco Hospital, Università degli Studi di Milano), Mauro Carone, (Fondazione Salvatore Maugeri, IRCCS, Cassano Murge), Vincenzo Patella (Allergology and Clinical Immunology Unit, Department of Medical Sciences, Battipaglia Hospital, Battipaglia, Salerno), Simone Scarlata (Geriatrics, Unit of Respiratory Pathophysiology and Thoracic Endoscopy, Campus Bio Medico University and Teaching Hospital, Rome), Andrea Comel, UO Pneumologia, Ospedale Pederzoli, Peschiera del Garda); <strong>Japan</strong>: Kiyoyasu Kurahashi (Yokohama City University Medical Center); <strong>Lebanon</strong>: Zeina Aoun Bacha (Medicine School, St Joseph University, Beyrouth); <strong>Mexico</strong>: Daniel Barajas Ugalde (National Institute of Respiratory Diseases), Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California), José F. Villegas (Hospital Universitario Monterrey); <strong>Montenegro</strong>: Milic Medenica (Hospital for Lung Diseases–Brezovik, Niksic); <strong>Netherlands</strong>: E. M. W. van de Garde (Department of Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein); <strong>Nepal</strong>: Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences), Poojan Shrestha (Oxford University Clinical Research Unit, Patan Hospital); <strong>New Zealand</strong>: Elliott Ridgeon (Medical Research Institute of New Zealand); <strong>Nigeria</strong>: Babatunde Ishola Awokola (Department of Family Medicine and Primary Care, Lily Hospitals Limited, Warri), Ogonna N. O. Nwankwo (University of Calabar Teaching Hospital), Adefuye Bolanle Olufunlola (Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State), Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan), Kingsley N. Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State); <strong>Pakistan</strong>: Muhammad Irfan, Section of Pulmonary and Critical Care Medicine (Department of Medicine, Aga Khan University, Karachi); <strong>Poland</strong>: Lukasz Minarowski (Department of Lung Diseases and Tuberculosis, Medical University of Bialystok), Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec); <strong>Portugal</strong>: Felipe Froes (Hospital Pulido Valente–CHLN, Lisboa), Pedro Leuschner, (Centro Hospitalar do Porto), Mariana Meireles, Cláudia Ferrão, Pedro Leuschner, and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo Prof Abel Salazar, Porto), Sofia B. Ravara (Faculty of Health Sciences, University of Beira Interior, Cova da Beira Hospital Center, Covilhã); <strong>Republic of Moldova</strong>: Victoria Brocovschii (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu), Chesov Ion (Clinic of Anesthesia and Intensive Care Valeriu Ghrerg, Institute of Emergency Medicine, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau), Doina Rusu (SMFU N. Testemitanu, Chisinau), Cristina Toma (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau); <strong>Romania</strong>: Daniela Chirita (Hospital Sfantul Stefan, Bucharest), Carmen Mihaela Dorobat (Universitatea de Medicină şi Farmacie Gr T. Popa I a ş i Facultatea de Medicină Stomatologică, Spitalul Clinic de Boli Infecţioase Sfânta Parascheva I a ş i Iaşi); <strong>Russia</strong>: Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S. I. Georgievsky), Anna Kaluzhenina (Volgograd State Medical University); <strong>Saudi Arabia</strong>: Abdullah Almotairi (King Fahad Medical City, Riyadh), Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina), Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh), Amal Fathy (Pulmonary and Respiratory Critical Care Medicine, Mansoura University Egypt, Affiliate at Taibah University), Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh), Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa), Abdelhaleem Bella (Dammam University–Saudi Arabia and King Fahad Hospital); <strong>Serbia</strong>: Nada Bogdanović (Pulmonary Department of KHC, Dragiša Mišović, Belgrade), Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade), Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade); <strong>Spain</strong>: Luis Borderìas (Respiratory and Sleep Unit, Hospital San Jorge, Huesca), Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at Sant Joan Despí), Hugo Cabello Alarcón (Sant Hospital Seu de Urgell, Catalonia), Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona), Vicens Diaz-Brito and Xavier Casas (Infectious Diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona), Alicia Encabo González (Hospital Complex of Pontevedra), Maria Luisa Fernández-Almira (Medicina Interna, Hospital Universitario Central de Asturias), Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, and CIBER de Enfermedades Respiratorias, CIBERES, Bunyola), Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga), Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid), Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante), Elena Laserna Martínez (Hospital Mollet, Barcelona), Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid), Pedro J. Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña, INIBIC, Sergas, Universidade de A Coruña), Rosario Menéndez (Pneumology Service, University and Polytechnic Hospital La Fe, Valencia), Ana Pando-Sandoval (Hospital Universitario Central de Asturias, Area de Gestion Clinica de Pulmon, Servicio de Neumologia, Oviedo), Cristina Prat Aymerich, Alicia Lacoma de la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, and Universitat Autònoma de Barcelona, CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III), Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d’Hebron, Barcelona), Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia), Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona), Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria), Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo), Job F. M. van Boven (Hospital Universitari Son Espases, Palma de Mallorca), Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró); <strong>South Africa</strong>: Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand); <strong>South Korea</strong>: Ho Kee Yum (Inje University Seoul Paik Hospital); <strong>Togo</strong>: Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University Hospital of Sylvanus Olympio, Lomé); <strong>Tunisia</strong>: Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security, Marsa, Tunis); <strong>Turkey</strong>: Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir), Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul), Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir); <strong>Ukraine</strong>: Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa Regional Antituberculosis Hospital, Vinnitsa); <strong>United Arab Emirates</strong>: Naheed Elahi (Dubai Hospital); <strong>United Kingdom</strong>: Devesh J. Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife), Andrew Feneley, Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann, University Hospitals of Leicester NHS Trust and University of Leicester), Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool), Adam T. Hill (Royal Infirmary and University of Edinburgh), Banu Rudran (The Royal London Hospital, Barts Health Trust, London), Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, East Kilbride), Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds), Alexander Youzguin (Southport and Ormskirk Hospitals NHS Trust), Anika Singanayagam (Imperial College Healthcare NHS Trust, London); <strong>United States</strong>: Karen S. Allen (University of Oklahoma Health Sciences Center, Oklahoma City), Veronica Brito (Texas A&amp;M Health Science Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Baylor Scott &amp; White Health, Temple); Jessica Dietz (Fargo VA Health Care System, Fargo, North Dakota), Claire E. Dysart and Susan M. Kellie (Clement J. Zablocki VA Medical Center, Milwaukee, Wisconsin; Division of Infectious Diseases, University of New Mexico School of Medicine; and Raymond G. Murphy VA Medical Center, Albuquerque, New Mexico), Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, Illinois), Mina Gaga (7th Respiratory Medical Department and Asthma Center, Athens Chest Hospital), Thomas L. Holland and Stephen P. Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, Durham), Fayez Kheir (Department of Pulmonary Diseases, Critical Care and Environmental Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana), Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, Illinois), Manuel Lois (John Peter Smith Hospital, Fort Worth, Texas), Girish B. Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook, and Winthrop University Hospital, Mineola, New York), Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, Denver), Katherine Reyes (Henry Ford Hospital, Detroit, Illinois), William Rodriguez-Cintron, (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, San Juan Puerto Rico), Shigeki Saito (Tulane University, New Orleans), Nilam J. Soni, Julio Noda, Cecilia I. Hinojosa, Stephanie M. Levine, Luis F. Angel, and Antonio Anzueto (Divisions of Hospital Medicine and Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio), K. Scott Whitlow, John Hipskind, Kunal Sukhija, and Vicken Totten (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, California), Richard G. Wunderink and Ray D. Shah (Northwestern University Feinberg School of Medicine, Chicago, Illinois); <strong>Zambia</strong>: Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka). <strong>Other investigators</strong>: Lorena Noriega, Ezequiel Alvarado, Mohamed Aman, and Lucía Labra.</p><p class=\"chapter-para\"><strong><em>Disclaimer.</em></strong> The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute, the National Institutes of Health, or the Department of Veterans Affairs.</p><p class=\"chapter-para\"><strong><em>Financial support.</em></strong> This project was not funded and relied solely on voluntary site and investigator participation. M. I. R.’s time is partially protected by the National Heart, Lung, and Blood Institute (award K23HL096054).</p><p class=\"chapter-para\"><strong><em>Potential conflicts of interest.</em></strong> F. B. reports personal fees from AstraZeneca, GlaxoSmithKline, Guidotti, Grifols, Menarini, and Novartis, and grants and personal fees from Bayer, Chiesi, Insmed, Pfizer, Teva, and Zambon, outside the submitted work. All other authors report no potential conflicts.</p>                    <h2 scrollto-destination=\"134170150\" id=\"134170150\" class=\"backreferences-title js-splitscreen-backreferences-title\" data-legacy-id=\"r1\">References</h2>\n<div class=\"ref-list js-splitview-ref-list\"><div content-id=\"CIT0001\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0001\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0001\" href=\"javascript:;\" aria-label=\"jumplink-CIT0001\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0001\" class=\"ref-content \" data-id=\"CIT0001\"><span class=\"label title-label\">1.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Aliberti</div> <div class=\"given-names\">S</div>, <span class=\"name string-name\"><div class=\"surname\">Di Pasquale</div> <div class=\"given-names\">M</div></span>, <span class=\"name string-name\"><div class=\"surname\">Zanaboni</div> <div class=\"given-names\">AM</div></span>, et al. <div class=\"article-title\">Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia</div>. <div class=\"source \">Clin Infect Dis</div><div class=\"year\">2012</div>; <div class=\"volume\">54</div>:<div class=\"fpage\">470</div>–<div class=\"lpage\">8</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Stratifying%20risk%20factors%20for%20multidrug-resistant%20pathogens%20in%20hospitalized%20patients%20coming%20from%20the%20community%20with%20pneumonia&amp;author=S%20Aliberti&amp;author=M%20Di%20Pasquale&amp;author=AM%20Zanaboni&amp;publication_year=2012&amp;journal=Clin%20Infect%20Dis&amp;volume=54&amp;pages=470-8\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1093/cid/cir840\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Fcid%2Fcir840\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1093%2Fcid%2Fcir840\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22109954\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Stratifying%20risk%20factors%20for%20multidrug-resistant%20pathogens%20in%20hospitalized%20patients%20coming%20from%20the%20community%20with%20pneumonia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0002\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0002\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0002\" href=\"javascript:;\" aria-label=\"jumplink-CIT0002\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0002\" class=\"ref-content \" data-id=\"CIT0002\"><span class=\"label title-label\">2.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Aliberti</div> <div class=\"given-names\">S</div>, <span class=\"name string-name\"><div class=\"surname\">Cilloniz</div> <div class=\"given-names\">C</div></span>, <span class=\"name string-name\"><div class=\"surname\">Chalmers</div> <div class=\"given-names\">JD</div></span>, et al. <div class=\"article-title\">Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective</div>. <div class=\"source \">Thorax</div><div class=\"year\">2013</div>; <div class=\"volume\">68</div>:<div class=\"fpage\">997</div>–<div class=\"lpage\">9</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Multidrug-resistant%20pathogens%20in%20hospitalised%20patients%20coming%20from%20the%20community%20with%20pneumonia%3A%20a%20European%20perspective&amp;author=S%20Aliberti&amp;author=C%20Cilloniz&amp;author=JD%20Chalmers&amp;publication_year=2013&amp;journal=Thorax&amp;volume=68&amp;pages=997-9\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1136/thoraxjnl-2013-203384\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1136%2Fthoraxjnl-2013-203384\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1136%2Fthoraxjnl-2013-203384\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23774884\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Multidrug-resistant%20pathogens%20in%20hospitalised%20patients%20coming%20from%20the%20community%20with%20pneumonia%3A%20a%20European%20perspective&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0003\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0003\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0003\" href=\"javascript:;\" aria-label=\"jumplink-CIT0003\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0003\" class=\"ref-content \" data-id=\"CIT0003\"><span class=\"label title-label\">3.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Shindo</div> <div class=\"given-names\">Y</div>, <span class=\"name string-name\"><div class=\"surname\">Ito</div> <div class=\"given-names\">R</div></span>, <span class=\"name string-name\"><div class=\"surname\">Kobayashi</div> <div class=\"given-names\">D</div></span>, et al. <div class=\"article-title\">Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia</div>. <div class=\"source \">Am J Respir Crit Care Med</div><div class=\"year\">2013</div>; <div class=\"volume\">188</div>:<div class=\"fpage\">985</div>–<div class=\"lpage\">95</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Risk%20factors%20for%20drug-resistant%20pathogens%20in%20community-acquired%20and%20healthcare-associated%20pneumonia&amp;author=Y%20Shindo&amp;author=R%20Ito&amp;author=D%20Kobayashi&amp;publication_year=2013&amp;journal=Am%20J%20Respir%20Crit%20Care%20Med&amp;volume=188&amp;pages=985-95\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1164/rccm.201301-0079OC\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1164%2Frccm.201301-0079OC\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1164%2Frccm.201301-0079OC\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23855620\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Risk%20factors%20for%20drug-resistant%20pathogens%20in%20community-acquired%20and%20healthcare-associated%20pneumonia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0004\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0004\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0004\" href=\"javascript:;\" aria-label=\"jumplink-CIT0004\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0004\" class=\"ref-content \" data-id=\"CIT0004\"><span class=\"label title-label\">4.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Musher</div> <div class=\"given-names\">DM</div>, <span class=\"name string-name\"><div class=\"surname\">Thorner</div> <div class=\"given-names\">AR</div></span>. <div class=\"article-title\">Community-acquired pneumonia</div>. <div class=\"source \">N Engl J Med</div><div class=\"year\">2014</div>; <div class=\"volume\">371</div>:<div class=\"fpage\">1619</div>–<div class=\"lpage\">28</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Community-acquired%20pneumonia&amp;author=DM%20Musher&amp;author=AR%20Thorner&amp;publication_year=2014&amp;journal=N%20Engl%20J%20Med&amp;volume=371&amp;pages=1619-28\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1056/NEJMra1312885\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1056%2FNEJMra1312885\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1056%2FNEJMra1312885\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/25337751\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Community-acquired%20pneumonia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0005\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0005\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0005\" href=\"javascript:;\" aria-label=\"jumplink-CIT0005\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0005\" class=\"ref-content \" data-id=\"CIT0005\"><span class=\"label title-label\">5.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Mandell</div> <div class=\"given-names\">LA</div>, <span class=\"name string-name\"><div class=\"surname\">Wunderink</div> <div class=\"given-names\">RG</div></span>, <span class=\"name string-name\"><div class=\"surname\">Anzueto</div> <div class=\"given-names\">A</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">Infectious Diseases Society of America; American Thoracic Society</div></span>. <div class=\"article-title\">Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults</div>. <div class=\"source \">Clin Infect Dis</div><div class=\"year\">2007</div>; <div class=\"volume\">44</div>(<div class=\"supplement\">suppl 2</div>):<div class=\"fpage\">S27</div>–<div class=\"lpage\">72</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Infectious%20Diseases%20Society%20of%20America%2FAmerican%20Thoracic%20Society%20consensus%20guidelines%20on%20the%20management%20of%20community-acquired%20pneumonia%20in%20adults&amp;author=LA%20Mandell&amp;author=RG%20Wunderink&amp;author=A%20Anzueto&amp;publication_year=2007&amp;journal=Clin%20Infect%20Dis&amp;volume=44&amp;pages=S27-72\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1086/511159\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1086%2F511159\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1086%2F511159\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/17278083\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Infectious%20Diseases%20Society%20of%20America%2FAmerican%20Thoracic%20Society%20consensus%20guidelines%20on%20the%20management%20of%20community-acquired%20pneumonia%20in%20adults&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0006\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0006\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0006\" href=\"javascript:;\" aria-label=\"jumplink-CIT0006\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0006\" class=\"ref-content \" data-id=\"CIT0006\"><span class=\"label title-label\">6.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Lim</div> <div class=\"given-names\">WS</div>, <span class=\"name string-name\"><div class=\"surname\">Baudouin</div> <div class=\"given-names\">SV</div></span>, <span class=\"name string-name\"><div class=\"surname\">George</div> <div class=\"given-names\">RC</div></span>, et al.  <div class=\"article-title\">BTS guidelines for the management of community acquired pneumonia in adults</div>. <div class=\"source \">Thorax</div><div class=\"year\">2009</div>; <div class=\"volume\">64</div>(<div class=\"supplement\">suppl III</div>):<div class=\"fpage\">iii1</div>–<div class=\"lpage\">55</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=BTS%20guidelines%20for%20the%20management%20of%20community%20acquired%20pneumonia%20in%20adults&amp;author=WS%20Lim&amp;author=SV%20Baudouin&amp;author=RC%20George&amp;publication_year=2009&amp;journal=Thorax&amp;volume=64&amp;pages=iii1-55\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1136/thx.2009.121434\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1136%2Fthx.2009.121434\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1136%2Fthx.2009.121434\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19783532\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:BTS%20guidelines%20for%20the%20management%20of%20community%20acquired%20pneumonia%20in%20adults&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0007\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0007\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0007\" href=\"javascript:;\" aria-label=\"jumplink-CIT0007\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0007\" class=\"ref-content \" data-id=\"CIT0007\"><span class=\"label title-label\">7.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Woodhead</div> <div class=\"given-names\">M</div>, <span class=\"name string-name\"><div class=\"surname\">Blasi</div> <div class=\"given-names\">F</div></span>, <span class=\"name string-name\"><div class=\"surname\">Ewig</div> <div class=\"given-names\">S</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases</div></span>. <div class=\"article-title\">Guidelines for the management of adult lower respiratory tract infections—full version</div>. <div class=\"source \">Clin Microbiol Infect</div><div class=\"year\">2011</div>; <div class=\"volume\">17(suppl 6)</div>:<div class=\"fpage\">E1</div>–<div class=\"lpage\">59</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Guidelines%20for%20the%20management%20of%20adult%20lower%20respiratory%20tract%20infections%E2%80%94full%20version&amp;author=M%20Woodhead&amp;author=F%20Blasi&amp;author=S%20Ewig&amp;publication_year=2011&amp;journal=Clin%20Microbiol%20Infect&amp;volume=17(suppl 6)&amp;pages=E1-59\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1111/j.1469-0691.2011.03672.x\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1111%2Fj.1469-0691.2011.03672.x\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1111%2Fj.1469-0691.2011.03672.x\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21951385\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Guidelines%20for%20the%20management%20of%20adult%20lower%20respiratory%20tract%20infections%E2%80%94full%20version&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0008\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0008\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0008\" href=\"javascript:;\" aria-label=\"jumplink-CIT0008\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0008\" class=\"ref-content \" data-id=\"CIT0008\"><span class=\"label title-label\">8.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Furman</div> <div class=\"given-names\">CD</div>, <span class=\"name string-name\"><div class=\"surname\">Rayner</div> <div class=\"given-names\">AV</div></span>, <span class=\"name string-name\"><div class=\"surname\">Tobin</div> <div class=\"given-names\">EP</div></span>. <div class=\"article-title\">Pneumonia in older residents of long-term care facilities</div>. <div class=\"source \">Am Fam Physician</div><div class=\"year\">2004</div>; <div class=\"volume\">70</div>:<div class=\"fpage\">1495</div>–<div class=\"lpage\">500</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Pneumonia%20in%20older%20residents%20of%20long-term%20care%20facilities&amp;author=CD%20Furman&amp;author=AV%20Rayner&amp;author=EP%20Tobin&amp;publication_year=2004&amp;journal=Am%20Fam%20Physician&amp;volume=70&amp;pages=1495-500\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15526736\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><div class=\"xslopenurl empty-target\"><span class=\"js-inst-open-url-holders-nodoi\"><a class=\"js-open-url-link\" data-href-template=\"{targetURL}?sid=oup:orr&amp;genre=article&amp;atitle=Pneumonia+in+older+residents+of+long-term+care+facilities&amp;aulast=Furman&amp;title=Am+Fam+Physician&amp;date=2004&amp;spage=1495&amp;epage=500&amp;volume=70\" href=\"javascript:;\" data-google-interstitial=\"false\"><span class=\"screenreader-text\">OpenURL Placeholder Text</span></a></span></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Pneumonia%20in%20older%20residents%20of%20long-term%20care%20facilities&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0009\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0009\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0009\" href=\"javascript:;\" aria-label=\"jumplink-CIT0009\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0009\" class=\"ref-content \" data-id=\"CIT0009\"><span class=\"label title-label\">9.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Cillóniz</div> <div class=\"given-names\">C</div>, <span class=\"name string-name\"><div class=\"surname\">Polverino</div> <div class=\"given-names\">E</div></span>, <span class=\"name string-name\"><div class=\"surname\">Ewig</div> <div class=\"given-names\">S</div></span>, et al. <div class=\"article-title\">Impact of age and comorbidity on cause and outcome in community-acquired pneumonia</div>. <div class=\"source \">Chest</div><div class=\"year\">2013</div>; <div class=\"volume\">144</div>:<div class=\"fpage\">999</div>–<div class=\"lpage\">1007</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Impact%20of%20age%20and%20comorbidity%20on%20cause%20and%20outcome%20in%20community-acquired%20pneumonia&amp;author=C%20Cill%C3%B3niz&amp;author=E%20Polverino&amp;author=S%20Ewig&amp;publication_year=2013&amp;journal=Chest&amp;volume=144&amp;pages=999-1007\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1378/chest.13-0062\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1378%2Fchest.13-0062\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1378%2Fchest.13-0062\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23670047\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Impact%20of%20age%20and%20comorbidity%20on%20cause%20and%20outcome%20in%20community-acquired%20pneumonia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0010\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0010\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0010\" href=\"javascript:;\" aria-label=\"jumplink-CIT0010\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0010\" class=\"ref-content \" data-id=\"CIT0010\"><span class=\"label title-label\">10.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Aliberti</div> <div class=\"given-names\">S</div>, <span class=\"name string-name\"><div class=\"surname\">Reyes</div> <div class=\"given-names\">LF</div></span>, <span class=\"name string-name\"><div class=\"surname\">Faverio</div> <div class=\"given-names\">P</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">GLIMP investigators</div></span>. <div class=\"article-title\">Global Initiative for Meticillin-Resistant <em>Staphylococcus aureus</em> Pneumonia (GLIMP): an international, observational cohort study</div>. <div class=\"source \">Lancet Infect Dis</div><div class=\"year\">2016</div>; <div class=\"volume\">16</div>:<div class=\"fpage\">1364</div>–<div class=\"lpage\">76</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Global%20Initiative%20for%20Meticillin-Resistant%20Staphylococcus%20aureus%20Pneumonia%20%28GLIMP%29%3A%20an%20international%2C%20observational%20cohort%20study&amp;author=S%20Aliberti&amp;author=LF%20Reyes&amp;author=P%20Faverio&amp;publication_year=2016&amp;journal=Lancet%20Infect%20Dis&amp;volume=16&amp;pages=1364-76\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/S1473-3099(16)30267-5\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2FS1473-3099(16)30267-5\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2FS1473-3099(16)30267-5\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/27593581\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Global%20Initiative%20for%20Meticillin-Resistant%20Staphylococcus%20aureus%20Pneumonia%20%28GLIMP%29%3A%20an%20international%2C%20observational%20cohort%20study&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0011\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0011\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0011\" href=\"javascript:;\" aria-label=\"jumplink-CIT0011\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0011\" class=\"ref-content \" data-id=\"CIT0011\"><span class=\"label title-label\">11.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Magiorakos</div> <div class=\"given-names\">AP</div>, <span class=\"name string-name\"><div class=\"surname\">Srinivasan</div> <div class=\"given-names\">A</div></span>, <span class=\"name string-name\"><div class=\"surname\">Carey</div> <div class=\"given-names\">RB</div></span>, et al. <div class=\"article-title\">Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance</div>. <div class=\"source \">Clin Microbiol Infect</div><div class=\"year\">2012</div>; <div class=\"volume\">18</div>:<div class=\"fpage\">268</div>–<div class=\"lpage\">81</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Multidrug-resistant%2C%20extensively%20drug-resistant%20and%20pandrug-resistant%20bacteria%3A%20an%20international%20expert%20proposal%20for%20interim%20standard%20definitions%20for%20acquired%20resistance&amp;author=AP%20Magiorakos&amp;author=A%20Srinivasan&amp;author=RB%20Carey&amp;publication_year=2012&amp;journal=Clin%20Microbiol%20Infect&amp;volume=18&amp;pages=268-81\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1111/j.1469-0691.2011.03570.x\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1111%2Fj.1469-0691.2011.03570.x\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1111%2Fj.1469-0691.2011.03570.x\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21793988\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Multidrug-resistant%2C%20extensively%20drug-resistant%20and%20pandrug-resistant%20bacteria%3A%20an%20international%20expert%20proposal%20for%20interim%20standard%20definitions%20for%20acquired%20resistance&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0012\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0012\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0012\" href=\"javascript:;\" aria-label=\"jumplink-CIT0012\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0012\" class=\"ref-content \" data-id=\"CIT0012\"><span class=\"label title-label\">12.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Wan</div> <div class=\"given-names\">QJ</div>, <span class=\"name string-name\"><div class=\"surname\">Hu</div> <div class=\"given-names\">HF</div></span>, <span class=\"name string-name\"><div class=\"surname\">He</div> <div class=\"given-names\">YC</div></span>, et al. <div class=\"article-title\">Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy</div>. <div class=\"source \">Kaohsiung J Med Sci</div><div class=\"year\">2015</div>; <div class=\"volume\">31</div>:<div class=\"fpage\">42</div>–<div class=\"lpage\">6</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Severe%20pneumonia%20in%20mycophenolate%20mofetil%20combined%20with%20low-dose%20corticosteroids-treated%20patients%20with%20immunoglobulin%20A%20nephropathy&amp;author=QJ%20Wan&amp;author=HF%20Hu&amp;author=YC%20He&amp;publication_year=2015&amp;journal=Kaohsiung%20J%20Med%20Sci&amp;volume=31&amp;pages=42-6\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/j.kjms.2014.10.004\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.kjms.2014.10.004\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2Fj.kjms.2014.10.004\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/25600919\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Severe%20pneumonia%20in%20mycophenolate%20mofetil%20combined%20with%20low-dose%20corticosteroids-treated%20patients%20with%20immunoglobulin%20A%20nephropathy&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0013\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0013\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0013\" href=\"javascript:;\" aria-label=\"jumplink-CIT0013\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0013\" class=\"ref-content \" data-id=\"CIT0013\"><span class=\"label title-label\">13.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Li</div> <div class=\"given-names\">F</div>, <span class=\"name string-name\"><div class=\"surname\">Jin</div> <div class=\"given-names\">HZ</div></span>, <span class=\"name string-name\"><div class=\"surname\">Su</div> <div class=\"given-names\">F</div></span>, <span class=\"name string-name\"><div class=\"surname\">Jia</div> <div class=\"given-names\">L</div></span>, <span class=\"name string-name\"><div class=\"surname\">Sun</div> <div class=\"given-names\">QN</div></span>. <div class=\"article-title\">Pneumocystis pneumonia in patients with immunobullous dermatoses</div>. <div class=\"source \">Int J Dermatol</div><div class=\"year\">2011</div>; <div class=\"volume\">50</div>:<div class=\"fpage\">1144</div>–<div class=\"lpage\">9</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Pneumocystis%20pneumonia%20in%20patients%20with%20immunobullous%20dermatoses&amp;author=F%20Li&amp;author=HZ%20Jin&amp;author=F%20Su&amp;author=L%20Jia&amp;author=QN%20Sun&amp;publication_year=2011&amp;journal=Int%20J%20Dermatol&amp;volume=50&amp;pages=1144-9\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1111/ijd.2011.50.issue-9\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1111%2Fijd.2011.50.issue-9\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1111%2Fijd.2011.50.issue-9\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22126881\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Pneumocystis%20pneumonia%20in%20patients%20with%20immunobullous%20dermatoses&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0014\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0014\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0014\" href=\"javascript:;\" aria-label=\"jumplink-CIT0014\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0014\" class=\"ref-content \" data-id=\"CIT0014\"><span class=\"label title-label\">14.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Gruson</div> <div class=\"given-names\">D</div>, <span class=\"name string-name\"><div class=\"surname\">Vargas</div> <div class=\"given-names\">F</div></span>, <span class=\"name string-name\"><div class=\"surname\">Hilbert</div> <div class=\"given-names\">G</div></span>, et al. <div class=\"article-title\">Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia</div>. <div class=\"source \">Intensive Care Med</div><div class=\"year\">2004</div>; <div class=\"volume\">30</div>:<div class=\"fpage\">965</div>–<div class=\"lpage\">71</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Predictive%20factors%20of%20intensive%20care%20unit%20admission%20in%20patients%20with%20haematological%20malignancies%20and%20pneumonia&amp;author=D%20Gruson&amp;author=F%20Vargas&amp;author=G%20Hilbert&amp;publication_year=2004&amp;journal=Intensive%20Care%20Med&amp;volume=30&amp;pages=965-71\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1007/s00134-004-2237-1\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1007%2Fs00134-004-2237-1\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1007%2Fs00134-004-2237-1\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/15052383\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Predictive%20factors%20of%20intensive%20care%20unit%20admission%20in%20patients%20with%20haematological%20malignancies%20and%20pneumonia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0015\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0015\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0015\" href=\"javascript:;\" aria-label=\"jumplink-CIT0015\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0015\" class=\"ref-content \" data-id=\"CIT0015\"><span class=\"label title-label\">15.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Garcia</div> <div class=\"given-names\">JB</div>, <span class=\"name string-name\"><div class=\"surname\">Lei</div> <div class=\"given-names\">X</div></span>, <span class=\"name string-name\"><div class=\"surname\">Wierda</div> <div class=\"given-names\">W</div></span>, et al. <div class=\"article-title\">Pneumonia during remission induction chemotherapy in patients with acute leukemia</div>. <div class=\"source \">Ann Am Thorac Soc</div><div class=\"year\">2013</div>; <div class=\"volume\">10</div>:<div class=\"fpage\">432</div>–<div class=\"lpage\">40</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Pneumonia%20during%20remission%20induction%20chemotherapy%20in%20patients%20with%20acute%20leukemia&amp;author=JB%20Garcia&amp;author=X%20Lei&amp;author=W%20Wierda&amp;publication_year=2013&amp;journal=Ann%20Am%20Thorac%20Soc&amp;volume=10&amp;pages=432-40\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1513/AnnalsATS.201304-097OC\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1513%2FAnnalsATS.201304-097OC\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1513%2FAnnalsATS.201304-097OC\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23987587\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Pneumonia%20during%20remission%20induction%20chemotherapy%20in%20patients%20with%20acute%20leukemia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0016\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0016\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0016\" href=\"javascript:;\" aria-label=\"jumplink-CIT0016\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0016\" class=\"ref-content \" data-id=\"CIT0016\"><span class=\"label title-label\">16.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Lee</div> <div class=\"given-names\">JO</div>, <span class=\"name string-name\"><div class=\"surname\">Kim</div> <div class=\"given-names\">DY</div></span>, <span class=\"name string-name\"><div class=\"surname\">Lim</div> <div class=\"given-names\">JH</div></span>, et al. <div class=\"article-title\">Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients</div>. <div class=\"source \">Lung Cancer</div><div class=\"year\">2008</div>; <div class=\"volume\">62</div>:<div class=\"fpage\">381</div>–<div class=\"lpage\">4</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Risk%20factors%20for%20bacterial%20pneumonia%20after%20cytotoxic%20chemotherapy%20in%20advanced%20lung%20cancer%20patients&amp;author=JO%20Lee&amp;author=DY%20Kim&amp;author=JH%20Lim&amp;publication_year=2008&amp;journal=Lung%20Cancer&amp;volume=62&amp;pages=381-4\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/j.lungcan.2008.03.015\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.lungcan.2008.03.015\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2Fj.lungcan.2008.03.015\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18466999\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Risk%20factors%20for%20bacterial%20pneumonia%20after%20cytotoxic%20chemotherapy%20in%20advanced%20lung%20cancer%20patients&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0017\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0017\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0017\" href=\"javascript:;\" aria-label=\"jumplink-CIT0017\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0017\" class=\"ref-content \" data-id=\"CIT0017\"><span class=\"label title-label\">17.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Lim</div> <div class=\"given-names\">KH</div>, <span class=\"name string-name\"><div class=\"surname\">Yoon</div> <div class=\"given-names\">HI</div></span>, <span class=\"name string-name\"><div class=\"surname\">Kang</div> <div class=\"given-names\">YA</div></span>, et al. <div class=\"article-title\">Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab</div>. <div class=\"source \">Korean J Intern Med</div><div class=\"year\">2010</div>; <div class=\"volume\">25</div>:<div class=\"fpage\">86</div>–<div class=\"lpage\">92</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Severe%20pulmonary%20adverse%20effects%20in%20lymphoma%20patients%20treated%20with%20cyclophosphamide%2C%20doxorubicin%2C%20vincristine%2C%20and%20prednisone%20%28CHOP%29%20regimen%20plus%20rituximab&amp;author=KH%20Lim&amp;author=HI%20Yoon&amp;author=YA%20Kang&amp;publication_year=2010&amp;journal=Korean%20J%20Intern%20Med&amp;volume=25&amp;pages=86-92\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.3904/kjim.2010.25.1.86\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.3904%2Fkjim.2010.25.1.86\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.3904%2Fkjim.2010.25.1.86\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20195409\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Severe%20pulmonary%20adverse%20effects%20in%20lymphoma%20patients%20treated%20with%20cyclophosphamide%2C%20doxorubicin%2C%20vincristine%2C%20and%20prednisone%20%28CHOP%29%20regimen%20plus%20rituximab&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0018\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0018\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0018\" href=\"javascript:;\" aria-label=\"jumplink-CIT0018\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0018\" class=\"ref-content \" data-id=\"CIT0018\"><span class=\"label title-label\">18.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Waks</div> <div class=\"given-names\">AG</div>, <span class=\"name string-name\"><div class=\"surname\">Tolaney</div> <div class=\"given-names\">SM</div></span>, <span class=\"name string-name\"><div class=\"surname\">Galar</div> <div class=\"given-names\">A</div></span>, et al. <div class=\"article-title\"><em>Pneumocystis jiroveci</em> pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors</div>. <div class=\"source \">Breast Cancer Res Treat</div><div class=\"year\">2015</div>; <div class=\"volume\">154</div>:<div class=\"fpage\">359</div>–<div class=\"lpage\">67</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Pneumocystis%20jiroveci%20pneumonia%20%28PCP%29%20in%20patients%20receiving%20neoadjuvant%20and%20adjuvant%20anthracycline-based%20chemotherapy%20for%20breast%20cancer%3A%20incidence%20and%20risk%20factors&amp;author=AG%20Waks&amp;author=SM%20Tolaney&amp;author=A%20Galar&amp;publication_year=2015&amp;journal=Breast%20Cancer%20Res%20Treat&amp;volume=154&amp;pages=359-67\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1007/s10549-015-3573-2\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1007%2Fs10549-015-3573-2\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1007%2Fs10549-015-3573-2\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/26420402\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Pneumocystis%20jiroveci%20pneumonia%20%28PCP%29%20in%20patients%20receiving%20neoadjuvant%20and%20adjuvant%20anthracycline-based%20chemotherapy%20for%20breast%20cancer%3A%20incidence%20and%20risk%20factors&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0019\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0019\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0019\" href=\"javascript:;\" aria-label=\"jumplink-CIT0019\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0019\" class=\"ref-content \" data-id=\"CIT0019\"><span class=\"label title-label\">19.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Kim</div> <div class=\"given-names\">T</div>, <span class=\"name string-name\"><div class=\"surname\">Choi</div> <div class=\"given-names\">SH</div></span>, <span class=\"name string-name\"><div class=\"surname\">Kim</div> <div class=\"given-names\">SH</div></span>, et al. <div class=\"article-title\">Point prevalence of <em>Pneumocystis</em> pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy</div>. <div class=\"source \">Ann Hematol</div><div class=\"year\">2013</div>; <div class=\"volume\">92</div>:<div class=\"fpage\">231</div>–<div class=\"lpage\">8</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Point%20prevalence%20of%20Pneumocystis%20pneumonia%20in%20patients%20with%20non-Hodgkin%20lymphoma%20according%20to%20the%20number%20of%20cycles%20of%20R-CHOP%20chemotherapy&amp;author=T%20Kim&amp;author=SH%20Choi&amp;author=SH%20Kim&amp;publication_year=2013&amp;journal=Ann%20Hematol&amp;volume=92&amp;pages=231-8\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1007/s00277-012-1592-1\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1007%2Fs00277-012-1592-1\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1007%2Fs00277-012-1592-1\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23053189\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Point%20prevalence%20of%20Pneumocystis%20pneumonia%20in%20patients%20with%20non-Hodgkin%20lymphoma%20according%20to%20the%20number%20of%20cycles%20of%20R-CHOP%20chemotherapy&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0020\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0020\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0020\" href=\"javascript:;\" aria-label=\"jumplink-CIT0020\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0020\" class=\"ref-content \" data-id=\"CIT0020\"><span class=\"label title-label\">20.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Aliberti</div> <div class=\"given-names\">S</div>, <span class=\"name string-name\"><div class=\"surname\">Myers</div> <div class=\"given-names\">JA</div></span>, <span class=\"name string-name\"><div class=\"surname\">Peyrani</div> <div class=\"given-names\">P</div></span>, et al. <div class=\"article-title\">The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia</div>. <div class=\"source \">Eur Respir J</div><div class=\"year\">2009</div>; <div class=\"volume\">33</div>:<div class=\"fpage\">142</div>–<div class=\"lpage\">7</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=The%20role%20of%20neutropenia%20on%20outcomes%20of%20cancer%20patients%20with%20community-acquired%20pneumonia&amp;author=S%20Aliberti&amp;author=JA%20Myers&amp;author=P%20Peyrani&amp;publication_year=2009&amp;journal=Eur%20Respir%20J&amp;volume=33&amp;pages=142-7\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1183/09031936.00167707\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1183%2F09031936.00167707\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1183%2F09031936.00167707\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18829671\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:The%20role%20of%20neutropenia%20on%20outcomes%20of%20cancer%20patients%20with%20community-acquired%20pneumonia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0021\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0021\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0021\" href=\"javascript:;\" aria-label=\"jumplink-CIT0021\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0021\" class=\"ref-content \" data-id=\"CIT0021\"><span class=\"label title-label\">21.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Sogaard</div> <div class=\"given-names\">OS</div>, <span class=\"name string-name\"><div class=\"surname\">Lohse</div> <div class=\"given-names\">N</div></span>, <span class=\"name string-name\"><div class=\"surname\">Gerstoft</div> <div class=\"given-names\">J</div></span>, et al. <div class=\"article-title\">Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study</div>. <div class=\"source \">Clin Infect Dis</div><div class=\"year\">2008</div>; <div class=\"volume\">47</div>:<div class=\"fpage\">1345</div>–<div class=\"lpage\">53</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Hospitalization%20for%20pneumonia%20among%20individuals%20with%20and%20without%20HIV%20infection%2C%201995-2007%3A%20a%20Danish%20population-based%2C%20nationwide%20cohort%20study&amp;author=OS%20Sogaard&amp;author=N%20Lohse&amp;author=J%20Gerstoft&amp;publication_year=2008&amp;journal=Clin%20Infect%20Dis&amp;volume=47&amp;pages=1345-53\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1086/595712\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1086%2F595712\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1086%2F595712\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18834317\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Hospitalization%20for%20pneumonia%20among%20individuals%20with%20and%20without%20HIV%20infection%2C%201995-2007%3A%20a%20Danish%20population-based%2C%20nationwide%20cohort%20study&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0022\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0022\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0022\" href=\"javascript:;\" aria-label=\"jumplink-CIT0022\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0022\" class=\"ref-content \" data-id=\"CIT0022\"><span class=\"label title-label\">22.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Kuehnhardt</div> <div class=\"given-names\">D</div>, <span class=\"name string-name\"><div class=\"surname\">Hannemann</div> <div class=\"given-names\">M</div></span>, <span class=\"name string-name\"><div class=\"surname\">Schmidt</div> <div class=\"given-names\">B</div></span>, <span class=\"name string-name\"><div class=\"surname\">Heider</div> <div class=\"given-names\">U</div></span>, <span class=\"name string-name\"><div class=\"surname\">Possinger</div> <div class=\"given-names\">K</div></span>, <span class=\"name string-name\"><div class=\"surname\">Eucker</div> <div class=\"given-names\">J</div></span>. <div class=\"article-title\">Therapeutic implication of BAL in patients with neutropenia</div>. <div class=\"source \">Ann Hematol</div><div class=\"year\">2009</div>; <div class=\"volume\">88</div>:<div class=\"fpage\">1249</div>–<div class=\"lpage\">56</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Therapeutic%20implication%20of%20BAL%20in%20patients%20with%20neutropenia&amp;author=D%20Kuehnhardt&amp;author=M%20Hannemann&amp;author=B%20Schmidt&amp;author=U%20Heider&amp;author=K%20Possinger&amp;author=J%20Eucker&amp;publication_year=2009&amp;journal=Ann%20Hematol&amp;volume=88&amp;pages=1249-56\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1007/s00277-009-0747-1\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1007%2Fs00277-009-0747-1\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1007%2Fs00277-009-0747-1\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19415277\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Therapeutic%20implication%20of%20BAL%20in%20patients%20with%20neutropenia&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0023\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0023\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0023\" href=\"javascript:;\" aria-label=\"jumplink-CIT0023\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0023\" class=\"ref-content \" data-id=\"CIT0023\"><span class=\"label title-label\">23.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Maschmeyer</div> <div class=\"given-names\">G</div>, <span class=\"name string-name\"><div class=\"surname\">Beinert</div> <div class=\"given-names\">T</div></span>, <span class=\"name string-name\"><div class=\"surname\">Buchheidt</div> <div class=\"given-names\">D</div></span>, et al. <div class=\"article-title\">Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the Infectious Diseases Working Party of the German Society of Haematology and Oncology</div>. <div class=\"source \">Eur J Cancer</div><div class=\"year\">2009</div>; <div class=\"volume\">45</div>:<div class=\"fpage\">2462</div>–<div class=\"lpage\">72</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Diagnosis%20and%20antimicrobial%20therapy%20of%20lung%20infiltrates%20in%20febrile%20neutropenic%20patients%3A%20guidelines%20of%20the%20Infectious%20Diseases%20Working%20Party%20of%20the%20German%20Society%20of%20Haematology%20and%20Oncology&amp;author=G%20Maschmeyer&amp;author=T%20Beinert&amp;author=D%20Buchheidt&amp;publication_year=2009&amp;journal=Eur%20J%20Cancer&amp;volume=45&amp;pages=2462-72\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/j.ejca.2009.05.001\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.ejca.2009.05.001\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2Fj.ejca.2009.05.001\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19467584\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Diagnosis%20and%20antimicrobial%20therapy%20of%20lung%20infiltrates%20in%20febrile%20neutropenic%20patients%3A%20guidelines%20of%20the%20Infectious%20Diseases%20Working%20Party%20of%20the%20German%20Society%20of%20Haematology%20and%20Oncology&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0024\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0024\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0024\" href=\"javascript:;\" aria-label=\"jumplink-CIT0024\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0024\" class=\"ref-content \" data-id=\"CIT0024\"><span class=\"label title-label\">24.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Alanio</div> <div class=\"given-names\">A</div>, <span class=\"name string-name\"><div class=\"surname\">Hauser</div> <div class=\"given-names\">PM</div></span>, <span class=\"name string-name\"><div class=\"surname\">Lagrou</div> <div class=\"given-names\">K</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">5th European Conference on Infections in Leukemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN)</div></span>. <div class=\"article-title\">ECIL guidelines for the diagnosis of <em>Pneumocystis jirovecii</em> pneumonia in patients with haematological malignancies and stem cell transplant recipients</div>. <div class=\"source \">J Antimicrob Chemother</div><div class=\"year\">2016</div>; <div class=\"volume\">71</div>:<div class=\"fpage\">2386</div>–<div class=\"lpage\">96</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=ECIL%20guidelines%20for%20the%20diagnosis%20of%20Pneumocystis%20jirovecii%20pneumonia%20in%20patients%20with%20haematological%20malignancies%20and%20stem%20cell%20transplant%20recipients&amp;author=A%20Alanio&amp;author=PM%20Hauser&amp;author=K%20Lagrou&amp;publication_year=2016&amp;journal=J%20Antimicrob%20Chemother&amp;volume=71&amp;pages=2386-96\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1093/jac/dkw156\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Fjac%2Fdkw156\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1093%2Fjac%2Fdkw156\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/27550991\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:ECIL%20guidelines%20for%20the%20diagnosis%20of%20Pneumocystis%20jirovecii%20pneumonia%20in%20patients%20with%20haematological%20malignancies%20and%20stem%20cell%20transplant%20recipients&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0025\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0025\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0025\" href=\"javascript:;\" aria-label=\"jumplink-CIT0025\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0025\" class=\"ref-content \" data-id=\"CIT0025\"><span class=\"label title-label\">25.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Freifeld</div> <div class=\"given-names\">AG</div>, <span class=\"name string-name\"><div class=\"surname\">Bow</div> <div class=\"given-names\">EJ</div></span>, <span class=\"name string-name\"><div class=\"surname\">Sepkowitz</div> <div class=\"given-names\">KA</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">Infectious Diseases Society of America</div></span>. <div class=\"article-title\">Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America</div>. <div class=\"source \">Clin Infect Dis</div><div class=\"year\">2011</div>; <div class=\"volume\">52</div>:<div class=\"fpage\">e56</div>–<div class=\"lpage\">93</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Clinical%20practice%20guideline%20for%20the%20use%20of%20antimicrobial%20agents%20in%20neutropenic%20patients%20with%20cancer%3A%202010%20update%20by%20the%20Infectious%20Diseases%20Society%20of%20America&amp;author=AG%20Freifeld&amp;author=EJ%20Bow&amp;author=KA%20Sepkowitz&amp;publication_year=2011&amp;journal=Clin%20Infect%20Dis&amp;volume=52&amp;pages=e56-93\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1093/cid/cir073\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Fcid%2Fcir073\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1093%2Fcid%2Fcir073\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/21258094\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Clinical%20practice%20guideline%20for%20the%20use%20of%20antimicrobial%20agents%20in%20neutropenic%20patients%20with%20cancer%3A%202010%20update%20by%20the%20Infectious%20Diseases%20Society%20of%20America&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0026\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0026\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0026\" href=\"javascript:;\" aria-label=\"jumplink-CIT0026\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0026\" class=\"ref-content \" data-id=\"CIT0026\"><span class=\"label title-label\">26.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Chemaly</div> <div class=\"given-names\">RF</div>, <span class=\"name string-name\"><div class=\"surname\">Shah</div> <div class=\"given-names\">DP</div></span>, <span class=\"name string-name\"><div class=\"surname\">Boeckh</div> <div class=\"given-names\">MJ</div></span>. <div class=\"article-title\">Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies</div>. <div class=\"source \">Clin Infect Dis</div><div class=\"year\">2014</div>; <div class=\"volume\">59</div>(<div class=\"supplement\">suppl 5</div>):<div class=\"fpage\">S344</div>–<div class=\"lpage\">51</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Management%20of%20respiratory%20viral%20infections%20in%20hematopoietic%20cell%20transplant%20recipients%20and%20patients%20with%20hematologic%20malignancies&amp;author=RF%20Chemaly&amp;author=DP%20Shah&amp;author=MJ%20Boeckh&amp;publication_year=2014&amp;journal=Clin%20Infect%20Dis&amp;volume=59&amp;pages=S344-51\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1093/cid/ciu623\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Fcid%2Fciu623\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1093%2Fcid%2Fciu623\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/25352629\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Management%20of%20respiratory%20viral%20infections%20in%20hematopoietic%20cell%20transplant%20recipients%20and%20patients%20with%20hematologic%20malignancies&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0027\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0027\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0027\" href=\"javascript:;\" aria-label=\"jumplink-CIT0027\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0027\" class=\"ref-content \" data-id=\"CIT0027\"><span class=\"label title-label\">27.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Buchacz</div> <div class=\"given-names\">K</div>, <span class=\"name string-name\"><div class=\"surname\">Lau</div> <div class=\"given-names\">B</div></span>, <span class=\"name string-name\"><div class=\"surname\">Jing</div> <div class=\"given-names\">Y</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA</div></span>. <div class=\"article-title\">Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010</div>. <div class=\"source \">J Infect Dis</div><div class=\"year\">2016</div>; <div class=\"volume\">214</div>:<div class=\"fpage\">862</div>–<div class=\"lpage\">72</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Incidence%20of%20AIDS-defining%20opportunistic%20infections%20in%20a%20multicohort%20analysis%20of%20HIV-infected%20persons%20in%20the%20United%20States%20and%20Canada%2C%202000-2010&amp;author=K%20Buchacz&amp;author=B%20Lau&amp;author=Y%20Jing&amp;publication_year=2016&amp;journal=J%20Infect%20Dis&amp;volume=214&amp;pages=862-72\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1093/infdis/jiw085\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Finfdis%2Fjiw085\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1093%2Finfdis%2Fjiw085\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/27559122\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Incidence%20of%20AIDS-defining%20opportunistic%20infections%20in%20a%20multicohort%20analysis%20of%20HIV-infected%20persons%20in%20the%20United%20States%20and%20Canada%2C%202000-2010&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0028\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0028\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0028\" href=\"javascript:;\" aria-label=\"jumplink-CIT0028\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0028\" class=\"ref-content \" data-id=\"CIT0028\"><span class=\"label title-label\">28.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Madeddu</div> <div class=\"given-names\">G</div>, <span class=\"name string-name\"><div class=\"surname\">Porqueddu</div> <div class=\"given-names\">EM</div></span>, <span class=\"name string-name\"><div class=\"surname\">Cambosu</div> <div class=\"given-names\">F</div></span>, et al. <div class=\"article-title\">Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era</div>. <div class=\"source \">Infection</div><div class=\"year\">2008</div>; <div class=\"volume\">36</div>:<div class=\"fpage\">231</div>–<div class=\"lpage\">6</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Bacterial%20community%20acquired%20pneumonia%20in%20HIV-infected%20inpatients%20in%20the%20highly%20active%20antiretroviral%20therapy%20era&amp;author=G%20Madeddu&amp;author=EM%20Porqueddu&amp;author=F%20Cambosu&amp;publication_year=2008&amp;journal=Infection&amp;volume=36&amp;pages=231-6\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1007/s15010-007-7162-0\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1007%2Fs15010-007-7162-0\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1007%2Fs15010-007-7162-0\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18463787\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Bacterial%20community%20acquired%20pneumonia%20in%20HIV-infected%20inpatients%20in%20the%20highly%20active%20antiretroviral%20therapy%20era&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0029\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0029\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0029\" href=\"javascript:;\" aria-label=\"jumplink-CIT0029\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0029\" class=\"ref-content \" data-id=\"CIT0029\"><span class=\"label title-label\">29.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Park</div> <div class=\"given-names\">DR</div>, <span class=\"name string-name\"><div class=\"surname\">Sherbin</div> <div class=\"given-names\">VL</div></span>, <span class=\"name string-name\"><div class=\"surname\">Goodman</div> <div class=\"given-names\">MS</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">Harborview CAP Study Group</div></span>. <div class=\"article-title\">The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness</div>. <div class=\"source \">J Infect Dis</div><div class=\"year\">2001</div>; <div class=\"volume\">184</div>:<div class=\"fpage\">268</div>–<div class=\"lpage\">77</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=The%20etiology%20of%20community-acquired%20pneumonia%20at%20an%20urban%20public%20hospital%3A%20influence%20of%20human%20immunodeficiency%20virus%20infection%20and%20initial%20severity%20of%20illness&amp;author=DR%20Park&amp;author=VL%20Sherbin&amp;author=MS%20Goodman&amp;publication_year=2001&amp;journal=J%20Infect%20Dis&amp;volume=184&amp;pages=268-77\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1086/jid.2001.184.issue-3\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1086%2Fjid.2001.184.issue-3\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1086%2Fjid.2001.184.issue-3\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11443551\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:The%20etiology%20of%20community-acquired%20pneumonia%20at%20an%20urban%20public%20hospital%3A%20influence%20of%20human%20immunodeficiency%20virus%20infection%20and%20initial%20severity%20of%20illness&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0030\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0030\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0030\" href=\"javascript:;\" aria-label=\"jumplink-CIT0030\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0030\" class=\"ref-content \" data-id=\"CIT0030\"><span class=\"label title-label\">30.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Torres</div> <div class=\"given-names\">HA</div>, <span class=\"name string-name\"><div class=\"surname\">Bodey</div> <div class=\"given-names\">GP</div></span>, <span class=\"name string-name\"><div class=\"surname\">Rolston</div> <div class=\"given-names\">KV</div></span>, <span class=\"name string-name\"><div class=\"surname\">Kantarjian</div> <div class=\"given-names\">HM</div></span>, <span class=\"name string-name\"><div class=\"surname\">Raad</div> <div class=\"given-names\">II</div></span>, <span class=\"name string-name\"><div class=\"surname\">Kontoyiannis</div> <div class=\"given-names\">DP</div></span>. <div class=\"article-title\">Infections in patients with aplastic anemia: experience at a tertiary care cancer center</div>. <div class=\"source \">Cancer</div><div class=\"year\">2003</div>; <div class=\"volume\">98</div>:<div class=\"fpage\">86</div>–<div class=\"lpage\">93</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Infections%20in%20patients%20with%20aplastic%20anemia%3A%20experience%20at%20a%20tertiary%20care%20cancer%20center&amp;author=HA%20Torres&amp;author=GP%20Bodey&amp;author=KV%20Rolston&amp;author=HM%20Kantarjian&amp;author=II%20Raad&amp;author=DP%20Kontoyiannis&amp;publication_year=2003&amp;journal=Cancer&amp;volume=98&amp;pages=86-93\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1002/(ISSN)1097-0142\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1002%2F(ISSN)1097-0142\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1002%2F(ISSN)1097-0142\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/12833460\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Infections%20in%20patients%20with%20aplastic%20anemia%3A%20experience%20at%20a%20tertiary%20care%20cancer%20center&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0031\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0031\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0031\" href=\"javascript:;\" aria-label=\"jumplink-CIT0031\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0031\" class=\"ref-content \" data-id=\"CIT0031\"><span class=\"label title-label\">31.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Gil-Prieto</div> <div class=\"given-names\">R</div>, <span class=\"name string-name\"><div class=\"surname\">Pascual-Garcia</div> <div class=\"given-names\">R</div></span>, <span class=\"name string-name\"><div class=\"surname\">Walter</div> <div class=\"given-names\">S</div></span>, <span class=\"name string-name\"><div class=\"surname\">Álvaro-Meca</div> <div class=\"given-names\">A</div></span>, <span class=\"name string-name\"><div class=\"surname\">Gil-De-Miguel</div> <div class=\"given-names\">Á</div></span>. <div class=\"article-title\">Risk of hospitalization due to pneumococcal disease in adults in Spain: the CORIENNE study</div>. <div class=\"source \">Hum Vaccin Immunother</div><div class=\"year\">2016</div>; <div class=\"volume\">12</div>:<div class=\"fpage\">1900</div>–<div class=\"lpage\">5</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Risk%20of%20hospitalization%20due%20to%20pneumococcal%20disease%20in%20adults%20in%20Spain%3A%20the%20CORIENNE%20study&amp;author=R%20Gil-Prieto&amp;author=R%20Pascual-Garcia&amp;author=S%20Walter&amp;author=A%20%C3%81lvaro-Meca&amp;author=%C3%81%20Gil-De-Miguel&amp;publication_year=2016&amp;journal=Hum%20Vaccin%20Immunother&amp;volume=12&amp;pages=1900-5\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/26901683\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><div class=\"xslopenurl empty-target\"><span class=\"js-inst-open-url-holders-nodoi\"><a class=\"js-open-url-link\" data-href-template=\"{targetURL}?sid=oup:orr&amp;genre=article&amp;atitle=Risk+of+hospitalization+due+to+pneumococcal+disease+in+adults+in+Spain%3a+the+CORIENNE+study&amp;aulast=Gil-Prieto&amp;title=Hum+Vaccin+Immunother&amp;date=2016&amp;spage=1900&amp;epage=5&amp;volume=12\" href=\"javascript:;\" data-google-interstitial=\"false\"><span class=\"screenreader-text\">OpenURL Placeholder Text</span></a></span></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Risk%20of%20hospitalization%20due%20to%20pneumococcal%20disease%20in%20adults%20in%20Spain%3A%20the%20CORIENNE%20study&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0032\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0032\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0032\" href=\"javascript:;\" aria-label=\"jumplink-CIT0032\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0032\" class=\"ref-content \" data-id=\"CIT0032\"><span class=\"label title-label\">32.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Putot</div> <div class=\"given-names\">A</div>, <span class=\"name string-name\"><div class=\"surname\">Tetu</div> <div class=\"given-names\">J</div></span>, <span class=\"name string-name\"><div class=\"surname\">Perrin</div> <div class=\"given-names\">S</div></span>, et al. <div class=\"article-title\">Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients</div>. <div class=\"source \">Eur J Clin Microbiol Infect Dis</div><div class=\"year\">2016</div>; <div class=\"volume\">35</div>:<div class=\"fpage\">489</div>–<div class=\"lpage\">95</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Impact%20of%20microbiological%20samples%20in%20the%20hospital%20management%20of%20community-acquired%2C%20nursing%20home-acquired%20and%20hospital-acquired%20pneumonia%20in%20older%20patients&amp;author=A%20Putot&amp;author=J%20Tetu&amp;author=S%20Perrin&amp;publication_year=2016&amp;journal=Eur%20J%20Clin%20Microbiol%20Infect%20Dis&amp;volume=35&amp;pages=489-95\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1007/s10096-015-2565-9\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1007%2Fs10096-015-2565-9\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1007%2Fs10096-015-2565-9\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/26753994\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Impact%20of%20microbiological%20samples%20in%20the%20hospital%20management%20of%20community-acquired%2C%20nursing%20home-acquired%20and%20hospital-acquired%20pneumonia%20in%20older%20patients&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0033\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0033\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0033\" href=\"javascript:;\" aria-label=\"jumplink-CIT0033\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0033\" class=\"ref-content \" data-id=\"CIT0033\"><span class=\"label title-label\">33.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Polverino</div> <div class=\"given-names\">E</div>, <span class=\"name string-name\"><div class=\"surname\">Dambrava</div> <div class=\"given-names\">P</div></span>, <span class=\"name string-name\"><div class=\"surname\">Cillóniz</div> <div class=\"given-names\">C</div></span>, et al. <div class=\"article-title\">Nursing home-acquired pneumonia: a 10 year single-centre experience</div>. <div class=\"source \">Thorax</div><div class=\"year\">2010</div>; <div class=\"volume\">65</div>:<div class=\"fpage\">354</div>–<div class=\"lpage\">9</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Nursing%20home-acquired%20pneumonia%3A%20a%2010%20year%20single-centre%20experience&amp;author=E%20Polverino&amp;author=P%20Dambrava&amp;author=C%20Cill%C3%B3niz&amp;publication_year=2010&amp;journal=Thorax&amp;volume=65&amp;pages=354-9\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1136/thx.2009.124776\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1136%2Fthx.2009.124776\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1136%2Fthx.2009.124776\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20388763\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Nursing%20home-acquired%20pneumonia%3A%20a%2010%20year%20single-centre%20experience&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0034\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0034\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0034\" href=\"javascript:;\" aria-label=\"jumplink-CIT0034\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0034\" class=\"ref-content \" data-id=\"CIT0034\"><span class=\"label title-label\">34.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Kohli</div> <div class=\"given-names\">R</div>, <span class=\"name string-name\"><div class=\"surname\">Lo</div> <div class=\"given-names\">Y</div></span>, <span class=\"name string-name\"><div class=\"surname\">Homel</div> <div class=\"given-names\">P</div></span>, et al. ; <span class=\"person-group\"><div class=\"collab\">HER Study Group</div></span>. <div class=\"article-title\">Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study</div>. <div class=\"source \">Clin Infect Dis</div><div class=\"year\">2006</div>; <div class=\"volume\">43</div>:<div class=\"fpage\">90</div>–<div class=\"lpage\">8</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Bacterial%20pneumonia%2C%20HIV%20therapy%2C%20and%20disease%20progression%20among%20HIV-infected%20women%20in%20the%20HIV%20epidemiologic%20research%20%28HER%29%20study&amp;author=R%20Kohli&amp;author=Y%20Lo&amp;author=P%20Homel&amp;publication_year=2006&amp;journal=Clin%20Infect%20Dis&amp;volume=43&amp;pages=90-8\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1086/cid.2006.43.issue-1\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1086%2Fcid.2006.43.issue-1\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1086%2Fcid.2006.43.issue-1\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16758423\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Bacterial%20pneumonia%2C%20HIV%20therapy%2C%20and%20disease%20progression%20among%20HIV-infected%20women%20in%20the%20HIV%20epidemiologic%20research%20%28HER%29%20study&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0035\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0035\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0035\" href=\"javascript:;\" aria-label=\"jumplink-CIT0035\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0035\" class=\"ref-content \" data-id=\"CIT0035\"><span class=\"label title-label\">35.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Benito</div> <div class=\"given-names\">N</div>, <span class=\"name string-name\"><div class=\"surname\">Rañó</div> <div class=\"given-names\">A</div></span>, <span class=\"name string-name\"><div class=\"surname\">Moreno</div> <div class=\"given-names\">A</div></span>, et al. <div class=\"article-title\">Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain</div>. <div class=\"source \">J Acquir Immune Defic Syndr</div><div class=\"year\">2001</div>; <div class=\"volume\">27</div>:<div class=\"fpage\">35</div>–<div class=\"lpage\">43</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Pulmonary%20infiltrates%20in%20HIV-infected%20patients%20in%20the%20highly%20active%20antiretroviral%20therapy%20era%20in%20Spain&amp;author=N%20Benito&amp;author=A%20Ra%C3%B1%C3%B3&amp;author=A%20Moreno&amp;publication_year=2001&amp;journal=J%20Acquir%20Immune%20Defic%20Syndr&amp;volume=27&amp;pages=35-43\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1097/00126334-200105010-00006\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1097%2F00126334-200105010-00006\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1097%2F00126334-200105010-00006\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/11404518\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Pulmonary%20infiltrates%20in%20HIV-infected%20patients%20in%20the%20highly%20active%20antiretroviral%20therapy%20era%20in%20Spain&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0036\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0036\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0036\" href=\"javascript:;\" aria-label=\"jumplink-CIT0036\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0036\" class=\"ref-content \" data-id=\"CIT0036\"><span class=\"label title-label\">36.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Mori</div> <div class=\"given-names\">H</div>, <span class=\"name string-name\"><div class=\"surname\">Ohno</div> <div class=\"given-names\">Y</div></span>, <span class=\"name string-name\"><div class=\"surname\">Ito</div> <div class=\"given-names\">F</div></span>, et al. <div class=\"article-title\">Polymerase chain reaction positivity of <em>Pneumocystis jirovecii</em> during primary lung cancer treatment</div>. <div class=\"source \">Jpn J Clin Oncol</div><div class=\"year\">2010</div>; <div class=\"volume\">40</div>:<div class=\"fpage\">658</div>–<div class=\"lpage\">62</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Polymerase%20chain%20reaction%20positivity%20of%20Pneumocystis%20jirovecii%20during%20primary%20lung%20cancer%20treatment&amp;author=H%20Mori&amp;author=Y%20Ohno&amp;author=F%20Ito&amp;publication_year=2010&amp;journal=Jpn%20J%20Clin%20Oncol&amp;volume=40&amp;pages=658-62\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1093/jjco/hyq040\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Fjjco%2Fhyq040\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1093%2Fjjco%2Fhyq040\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/20395244\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Polymerase%20chain%20reaction%20positivity%20of%20Pneumocystis%20jirovecii%20during%20primary%20lung%20cancer%20treatment&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0037\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0037\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0037\" href=\"javascript:;\" aria-label=\"jumplink-CIT0037\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0037\" class=\"ref-content \" data-id=\"CIT0037\"><span class=\"label title-label\">37.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Boersma</div> <div class=\"given-names\">WG</div>, <span class=\"name string-name\"><div class=\"surname\">Erjavec</div> <div class=\"given-names\">Z</div></span>, <span class=\"name string-name\"><div class=\"surname\">van der Werf</div> <div class=\"given-names\">TS</div></span>, <span class=\"name string-name\"><div class=\"surname\">de Vries-Hosper</div> <div class=\"given-names\">HG</div></span>, <span class=\"name string-name\"><div class=\"surname\">Gouw</div> <div class=\"given-names\">AS</div></span>, <span class=\"name string-name\"><div class=\"surname\">Manson</div> <div class=\"given-names\">WL</div></span>. <div class=\"article-title\">Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL</div>. <div class=\"source \">Respir Med</div><div class=\"year\">2007</div>; <div class=\"volume\">101</div>:<div class=\"fpage\">317</div>–<div class=\"lpage\">25</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Bronchoscopic%20diagnosis%20of%20pulmonary%20infiltrates%20in%20granulocytopenic%20patients%20with%20hematologic%20malignancies%3A%20BAL%20versus%20PSB%20and%20PBAL&amp;author=WG%20Boersma&amp;author=Z%20Erjavec&amp;author=TS%20van%20der%20Werf&amp;author=HG%20de%20Vries-Hosper&amp;author=AS%20Gouw&amp;author=WL%20Manson&amp;publication_year=2007&amp;journal=Respir%20Med&amp;volume=101&amp;pages=317-25\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/j.rmed.2006.04.021\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.rmed.2006.04.021\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2Fj.rmed.2006.04.021\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/16774815\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Bronchoscopic%20diagnosis%20of%20pulmonary%20infiltrates%20in%20granulocytopenic%20patients%20with%20hematologic%20malignancies%3A%20BAL%20versus%20PSB%20and%20PBAL&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0038\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0038\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0038\" href=\"javascript:;\" aria-label=\"jumplink-CIT0038\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0038\" class=\"ref-content \" data-id=\"CIT0038\"><span class=\"label title-label\">38.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Mikulska</div> <div class=\"given-names\">M</div>, <span class=\"name string-name\"><div class=\"surname\">Del Bono</div> <div class=\"given-names\">V</div></span>, <span class=\"name string-name\"><div class=\"surname\">Gandolfo</div> <div class=\"given-names\">N</div></span>, et al. <div class=\"article-title\">Epidemiology of viral respiratory tract infections in an outpatient haematology facility</div>. <div class=\"source \">Ann Hematol</div><div class=\"year\">2014</div>; <div class=\"volume\">93</div>:<div class=\"fpage\">669</div>–<div class=\"lpage\">76</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Epidemiology%20of%20viral%20respiratory%20tract%20infections%20in%20an%20outpatient%20haematology%20facility&amp;author=M%20Mikulska&amp;author=V%20Del%20Bono&amp;author=N%20Gandolfo&amp;publication_year=2014&amp;journal=Ann%20Hematol&amp;volume=93&amp;pages=669-76\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1007/s00277-013-1912-0\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1007%2Fs00277-013-1912-0\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1007%2Fs00277-013-1912-0\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/24097084\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Epidemiology%20of%20viral%20respiratory%20tract%20infections%20in%20an%20outpatient%20haematology%20facility&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0039\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0039\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0039\" href=\"javascript:;\" aria-label=\"jumplink-CIT0039\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0039\" class=\"ref-content \" data-id=\"CIT0039\"><span class=\"label title-label\">39.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Beaird</div> <div class=\"given-names\">OE</div>, <span class=\"name string-name\"><div class=\"surname\">Freifeld</div> <div class=\"given-names\">A</div></span>, <span class=\"name string-name\"><div class=\"surname\">Ison</div> <div class=\"given-names\">MG</div></span>, et al. <div class=\"article-title\">Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative</div>. <div class=\"source \">Transpl Infect Dis</div><div class=\"year\">2016</div>; <div class=\"volume\">18</div>:<div class=\"fpage\">210</div>–<div class=\"lpage\">5</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Current%20practices%20for%20treatment%20of%20respiratory%20syncytial%20virus%20and%20other%20non-influenza%20respiratory%20viruses%20in%20high-risk%20patient%20populations%3A%20a%20survey%20of%20institutions%20in%20the%20Midwestern%20Respiratory%20Virus%20Collaborative&amp;author=OE%20Beaird&amp;author=A%20Freifeld&amp;author=MG%20Ison&amp;publication_year=2016&amp;journal=Transpl%20Infect%20Dis&amp;volume=18&amp;pages=210-5\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1111/tid.2016.18.issue-2\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1111%2Ftid.2016.18.issue-2\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1111%2Ftid.2016.18.issue-2\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/26923867\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Current%20practices%20for%20treatment%20of%20respiratory%20syncytial%20virus%20and%20other%20non-influenza%20respiratory%20viruses%20in%20high-risk%20patient%20populations%3A%20a%20survey%20of%20institutions%20in%20the%20Midwestern%20Respiratory%20Virus%20Collaborative&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0040\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0040\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0040\" href=\"javascript:;\" aria-label=\"jumplink-CIT0040\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0040\" class=\"ref-content \" data-id=\"CIT0040\"><span class=\"label title-label\">40.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Poonyagariyagorn</div> <div class=\"given-names\">HK</div>, <span class=\"name string-name\"><div class=\"surname\">Gershman</div> <div class=\"given-names\">A</div></span>, <span class=\"name string-name\"><div class=\"surname\">Avery</div> <div class=\"given-names\">R</div></span>, et al. <div class=\"article-title\">Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients</div>. <div class=\"source \">Transpl Infect Dis</div><div class=\"year\">2008</div>; <div class=\"volume\">10</div>:<div class=\"fpage\">403</div>–<div class=\"lpage\">8</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Challenges%20in%20the%20diagnosis%20and%20management%20of%20Nocardia%20infections%20in%20lung%20transplant%20recipients&amp;author=HK%20Poonyagariyagorn&amp;author=A%20Gershman&amp;author=R%20Avery&amp;publication_year=2008&amp;journal=Transpl%20Infect%20Dis&amp;volume=10&amp;pages=403-8\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1111/tid.2008.10.issue-6\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1111%2Ftid.2008.10.issue-6\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1111%2Ftid.2008.10.issue-6\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/18823356\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Challenges%20in%20the%20diagnosis%20and%20management%20of%20Nocardia%20infections%20in%20lung%20transplant%20recipients&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0041\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0041\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0041\" href=\"javascript:;\" aria-label=\"jumplink-CIT0041\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0041\" class=\"ref-content \" data-id=\"CIT0041\"><span class=\"label title-label\">41.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Tavadze</div> <div class=\"given-names\">M</div>, <span class=\"name string-name\"><div class=\"surname\">Rybicki</div> <div class=\"given-names\">L</div></span>, <span class=\"name string-name\"><div class=\"surname\">Mossad</div> <div class=\"given-names\">S</div></span>, et al. <div class=\"article-title\">Risk factors for vancomycin-resistant <em>Enterococcus</em> bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation</div>. <div class=\"source \">Bone Marrow Transplant</div><div class=\"year\">2014</div>; <div class=\"volume\">49</div>:<div class=\"fpage\">1310</div>–<div class=\"lpage\">6</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Risk%20factors%20for%20vancomycin-resistant%20Enterococcus%20bacteremia%20and%20its%20influence%20on%20survival%20after%20allogeneic%20hematopoietic%20cell%20transplantation&amp;author=M%20Tavadze&amp;author=L%20Rybicki&amp;author=S%20Mossad&amp;publication_year=2014&amp;journal=Bone%20Marrow%20Transplant&amp;volume=49&amp;pages=1310-6\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1038/bmt.2014.150\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1038%2Fbmt.2014.150\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1038%2Fbmt.2014.150\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/25111516\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Risk%20factors%20for%20vancomycin-resistant%20Enterococcus%20bacteremia%20and%20its%20influence%20on%20survival%20after%20allogeneic%20hematopoietic%20cell%20transplantation&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0042\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0042\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0042\" href=\"javascript:;\" aria-label=\"jumplink-CIT0042\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0042\" class=\"ref-content \" data-id=\"CIT0042\"><span class=\"label title-label\">42.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Bock</div> <div class=\"given-names\">AM</div>, <span class=\"name string-name\"><div class=\"surname\">Cao</div> <div class=\"given-names\">Q</div></span>, <span class=\"name string-name\"><div class=\"surname\">Ferrieri</div> <div class=\"given-names\">P</div></span>, <span class=\"name string-name\"><div class=\"surname\">Young</div> <div class=\"given-names\">JA</div></span>, <span class=\"name string-name\"><div class=\"surname\">Weisdorf</div> <div class=\"given-names\">DJ</div></span>. <div class=\"article-title\">Bacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance</div>. <div class=\"source \">Biol Blood Marrow Transplant</div><div class=\"year\">2013</div>; <div class=\"volume\">19</div>:<div class=\"fpage\">102</div>–<div class=\"lpage\">8</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Bacteremia%20in%20blood%20or%20marrow%20transplantation%20patients%3A%20clinical%20risk%20factors%20for%20infection%20and%20emerging%20antibiotic%20resistance&amp;author=AM%20Bock&amp;author=Q%20Cao&amp;author=P%20Ferrieri&amp;author=JA%20Young&amp;author=DJ%20Weisdorf&amp;publication_year=2013&amp;journal=Biol%20Blood%20Marrow%20Transplant&amp;volume=19&amp;pages=102-8\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/j.bbmt.2012.08.016\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.bbmt.2012.08.016\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2Fj.bbmt.2012.08.016\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/22940054\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Bacteremia%20in%20blood%20or%20marrow%20transplantation%20patients%3A%20clinical%20risk%20factors%20for%20infection%20and%20emerging%20antibiotic%20resistance&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0043\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0043\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0043\" href=\"javascript:;\" aria-label=\"jumplink-CIT0043\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0043\" class=\"ref-content \" data-id=\"CIT0043\"><span class=\"label title-label\">43.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Herbers</div> <div class=\"given-names\">AH</div>, <span class=\"name string-name\"><div class=\"surname\">de Haan</div> <div class=\"given-names\">AF</div></span>, <span class=\"name string-name\"><div class=\"surname\">van der Velden</div> <div class=\"given-names\">WJ</div></span>, <span class=\"name string-name\"><div class=\"surname\">Donnelly</div> <div class=\"given-names\">JP</div></span>, <span class=\"name string-name\"><div class=\"surname\">Blijlevens</div> <div class=\"given-names\">NM</div></span>. <div class=\"article-title\">Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients</div>. <div class=\"source \">Transpl Infect Dis</div><div class=\"year\">2014</div>; <div class=\"volume\">16</div>:<div class=\"fpage\">279</div>–<div class=\"lpage\">85</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Mucositis%20not%20neutropenia%20determines%20bacteremia%20among%20hematopoietic%20stem%20cell%20transplant%20recipients&amp;author=AH%20Herbers&amp;author=AF%20de%20Haan&amp;author=WJ%20van%20der%20Velden&amp;author=JP%20Donnelly&amp;author=NM%20Blijlevens&amp;publication_year=2014&amp;journal=Transpl%20Infect%20Dis&amp;volume=16&amp;pages=279-85\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1111/tid.2014.16.issue-2\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1111%2Ftid.2014.16.issue-2\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1111%2Ftid.2014.16.issue-2\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/24621081\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Mucositis%20not%20neutropenia%20determines%20bacteremia%20among%20hematopoietic%20stem%20cell%20transplant%20recipients&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0044\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0044\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0044\" href=\"javascript:;\" aria-label=\"jumplink-CIT0044\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0044\" class=\"ref-content \" data-id=\"CIT0044\"><span class=\"label title-label\">44.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Wu</div> <div class=\"given-names\">SW</div>, <span class=\"name string-name\"><div class=\"surname\">Liu</div> <div class=\"given-names\">KS</div></span>, <span class=\"name string-name\"><div class=\"surname\">Lin</div> <div class=\"given-names\">CK</div></span>, et al. <div class=\"article-title\">Community-acquired urinary tract infection in kidney transplantation: risk factors for bacteremia and recurrent infection</div>. <div class=\"source \">J Formos Med Assoc</div><div class=\"year\">2013</div>; <div class=\"volume\">112</div>:<div class=\"fpage\">138</div>–<div class=\"lpage\">43</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Community-acquired%20urinary%20tract%20infection%20in%20kidney%20transplantation%3A%20risk%20factors%20for%20bacteremia%20and%20recurrent%20infection&amp;author=SW%20Wu&amp;author=KS%20Liu&amp;author=CK%20Lin&amp;publication_year=2013&amp;journal=J%20Formos%20Med%20Assoc&amp;volume=112&amp;pages=138-43\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/j.jfma.2012.01.010\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.jfma.2012.01.010\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2Fj.jfma.2012.01.010\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/23473526\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Community-acquired%20urinary%20tract%20infection%20in%20kidney%20transplantation%3A%20risk%20factors%20for%20bacteremia%20and%20recurrent%20infection&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0045\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0045\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0045\" href=\"javascript:;\" aria-label=\"jumplink-CIT0045\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0045\" class=\"ref-content \" data-id=\"CIT0045\"><span class=\"label title-label\">45.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Daskalaki</div> <div class=\"given-names\">E</div>, <span class=\"name string-name\"><div class=\"surname\">Koukoulaki</div> <div class=\"given-names\">M</div></span>, <span class=\"name string-name\"><div class=\"surname\">Bakalis</div> <div class=\"given-names\">A</div></span>, et al. <div class=\"article-title\">Blood stream infections in renal transplant recipients: a single-center study</div>. <div class=\"source \">Transplant Proc</div><div class=\"year\">2014</div>; <div class=\"volume\">46</div>:<div class=\"fpage\">3191</div>–<div class=\"lpage\">3</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Blood%20stream%20infections%20in%20renal%20transplant%20recipients%3A%20a%20single-center%20study&amp;author=E%20Daskalaki&amp;author=M%20Koukoulaki&amp;author=A%20Bakalis&amp;publication_year=2014&amp;journal=Transplant%20Proc&amp;volume=46&amp;pages=3191-3\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1016/j.transproceed.2014.10.033\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1016%2Fj.transproceed.2014.10.033\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1016%2Fj.transproceed.2014.10.033\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/25420856\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Blood%20stream%20infections%20in%20renal%20transplant%20recipients%3A%20a%20single-center%20study&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0046\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0046\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0046\" href=\"javascript:;\" aria-label=\"jumplink-CIT0046\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0046\" class=\"ref-content \" data-id=\"CIT0046\"><span class=\"label title-label\">46.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Huson</div> <div class=\"given-names\">MA</div>, <span class=\"name string-name\"><div class=\"surname\">Stolp</div> <div class=\"given-names\">SM</div></span>, <span class=\"name string-name\"><div class=\"surname\">van der Poll</div> <div class=\"given-names\">T</div></span>, <span class=\"name string-name\"><div class=\"surname\">Grobusch</div> <div class=\"given-names\">MP</div></span>. <div class=\"article-title\">Community-acquired bacterial bloodstream infections in HIV-infected patients: a systematic review</div>. <div class=\"source \">Clin Infect Dis</div><div class=\"year\">2014</div>; <div class=\"volume\">58</div>:<div class=\"fpage\">79</div>–<div class=\"lpage\">92</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Community-acquired%20bacterial%20bloodstream%20infections%20in%20HIV-infected%20patients%3A%20a%20systematic%20review&amp;author=MA%20Huson&amp;author=SM%20Stolp&amp;author=T%20van%20der%20Poll&amp;author=MP%20Grobusch&amp;publication_year=2014&amp;journal=Clin%20Infect%20Dis&amp;volume=58&amp;pages=79-92\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1093/cid/cit596\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1093%2Fcid%2Fcit596\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1093%2Fcid%2Fcit596\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/24046307\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Community-acquired%20bacterial%20bloodstream%20infections%20in%20HIV-infected%20patients%3A%20a%20systematic%20review&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div><div content-id=\"CIT0047\" class=\"js-splitview-ref-item\" data-legacy-id=\"CIT0047\"><div class=\"refLink-parent\"><span class=\"refLink\"><a name=\"jumplink-CIT0047\" href=\"javascript:;\" aria-label=\"jumplink-CIT0047\" data-id=\"\" data-google-interstitial=\"false\"></a></span></div><div class=\"ref false\"><div id=\"ref-auto-CIT0047\" class=\"ref-content \" data-id=\"CIT0047\"><span class=\"label title-label\">47.</span><div class=\"mixed-citation citation\"><p class=\"mixed-citation-compatibility\"><span class=\"person-group\"><span class=\"name string-name\"></span></span></p><div class=\"surname\">Taramasso</div> <div class=\"given-names\">L</div>, <span class=\"name string-name\"><div class=\"surname\">Tatarelli</div> <div class=\"given-names\">P</div></span>, <span class=\"name string-name\"><div class=\"surname\">Di Biagio</div> <div class=\"given-names\">A</div></span>. <div class=\"article-title\">Bloodstream infections in HIV-infected patients</div>. <div class=\"source \">Virulence</div><div class=\"year\">2016</div>; <div class=\"volume\">7</div>:<div class=\"fpage\">320</div>–<div class=\"lpage\">8</div>.<p></p><!--citationLinks: case 1--><div class=\"citation-links\"></div><div class=\"citation-links\"><p class=\"citation-links-compatibility\"><span class=\"google-scholar-ref-link\"><a class=\"openInAnotherWindow\" href=\"https://scholar.google.com/scholar_lookup?title=Bloodstream%20infections%20in%20HIV-infected%20patients&amp;author=L%20Taramasso&amp;author=P%20Tatarelli&amp;author=A%20Di%20Biagio&amp;publication_year=2016&amp;journal=Virulence&amp;volume=7&amp;pages=320-8\" target=\"_blank\" data-google-interstitial=\"false\">Google Scholar</a></span></p><div class=\"crossref-doi js-ref-link\"><a class=\"openInAnotherWindow\" href=\"http://dx.doi.org/10.1080/21505594.2016.1158359\" target=\"_blank\" data-google-interstitial=\"false\">Crossref</a></div><div class=\"adsDoiReference hide\"><a class=\"openInAnotherWindow\" href=\"http://adsabs.harvard.edu/cgi-bin/basic_connect?qsearch=10.1080%2F21505594.2016.1158359\" target=\"_blank\" data-google-interstitial=\"false\">Search ADS</a></div><div class=\"xslopenurl empty-target\"><span class=\"inst-open-url-holders\" data-targetid=\"10.1080%2F21505594.2016.1158359\"> </span></div><div class=\"pub-id\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/26950194\" class=\"link link-pub-id openInAnotherWindow\" target=\"_blank\" data-google-interstitial=\"false\">PubMed</a></div><p class=\"citation-links-compatibility\"><span class=\"worldcat-reference-ref-link js-worldcat-preview-ref-link\" style=\"\"><a class=\"openInAnotherWindow\" href=\"https://www.worldcat.org/search?q=ti:Bloodstream%20infections%20in%20HIV-infected%20patients&amp;qt=advanced&amp;dblist=638\" target=\"_blank\" data-google-interstitial=\"false\">WorldCat</a></span></p>&nbsp;</div></div></div></div></div></div>    <!-- /foreach in Model.Sections -->\n    <div class=\"widget widget-ArticlePubStateInfo widget-instance-OUP_ArticlePubStateInfo\">\n         \n    </div>\n\n\n\n        <div class=\"article-metadata-standalone-panel clearfix\" style=\"display: none;\"></div>\n\n        \n<div class=\"copyright copyright-statement\">© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</div><div class=\"license\"><div class=\"license-p\">This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<a class=\"link link-uri openInAnotherWindow\" href=\"https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model\" target=\"_blank\" data-google-interstitial=\"false\">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</a>)</div></div><!-- /foreach -->\n\n        <span id=\"UserHasAccess\" data-userhasaccess=\"True\"></span>\n\n    </div><!-- /.widget-items -->\n</div><!-- /.module-widget -->\n\n\n\n\n\n \n    </div>\n    <div class=\"widget widget-RelatedTags widget-instance-OUP_Article_RelatedTags_Widget\">\n            <div class=\"related-topic-tags\">\n        <div class=\"related-topic-tag-label\">Topic:</div>\n        <ul class=\"related-topic-tag-list\">\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"acquired immunodeficiency syndrome\" data-google-interstitial=\"false\"><span>acquired immunodeficiency syndrome</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"chemotherapy regimen\" data-google-interstitial=\"false\"><span>chemotherapy regimen</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"community acquired pneumonia\" data-google-interstitial=\"false\"><span>community acquired pneumonia</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"hematologic neoplasms\" data-google-interstitial=\"false\"><span>hematologic neoplasms</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"immunocompetence\" data-google-interstitial=\"false\"><span>immunocompetence</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"immunocompromised host\" data-google-interstitial=\"false\"><span>immunocompromised host</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"pneumonia\" data-google-interstitial=\"false\"><span>pneumonia</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"steroids\" data-google-interstitial=\"false\"><span>steroids</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"bacteria\" data-google-interstitial=\"false\"><span>bacteria</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"microbiology\" data-google-interstitial=\"false\"><span>microbiology</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"viruses\" data-google-interstitial=\"false\"><span>viruses</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"pathogenic organism\" data-google-interstitial=\"false\"><span>pathogenic organism</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"community\" data-google-interstitial=\"false\"><span>community</span></a>\n                </li>\n                <li>\n                    <a class=\"js-qb-topic-keyword-search\" href=\"javascript:;\" data-topic=\"causality\" data-google-interstitial=\"false\"><span>causality</span></a>\n                </li>\n        </ul>\n    </div>\n \n    </div>\n    <div class=\"widget widget-SolrResourceMetadata widget-instance-OUP_Article_ResourceMetadata_Widget\">\n        \n    <div class=\"article-metadata-panel solr-resource-metadata js-metadata-panel at-ContentMetadata\">\n                <div class=\"article-metadata-tocSections\">\n                    <div class=\"article-metadata-tocSections-title\">Issue Section:</div>\n                        <a href=\"/cid/search-results?f_TocHeadingTitleList=Articles+and+Commentaries\" data-google-interstitial=\"false\">Articles and Commentaries</a>\n                </div>\n\n    </div>\n\n\n \n    </div>\n    <div class=\"widget widget-EditorInformation widget-instance-OUP_Article_EditorInformation_Widget\">\n        \n \n    </div>\n\n                <div id=\"ContentTabFilteredView\"></div>\n                <div class=\"downloadImagesppt js-download-images-ppt st-download-images-ppt\" style=\"display: none;\">\n                    <a id=\"lnkDownloadAllImages\" class=\"js-download-all-images-link btn\" href=\"/DownloadFile/DownloadImage.aspx?image=&amp;PPTtype=SlideSet&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;siteId=5269\" data-google-interstitial=\"false\">Download all slides</a>\n                </div>\n    <div class=\"widget widget-ArticleDataSupplements widget-instance-OUP_Data_Supplements_Tab\">\n            <a name=\"SupplementalTab\" id=\"SupplementalTab\" data-google-interstitial=\"false\"></a>\n        \n        <h2 scrollto-destination=\"supplementary-data\" id=\"supplementary-data\" class=\"section-title\">Supplementary data</h2>\n        <div class=\"dataSuppLink\"><a href=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy723_suppl_supplementary_materials.docx?Expires=1752631925&amp;Signature=AVGv5Vmnt343clttPsfDvp-kShC92fvNSLnXclgdRYiMp65Po8acqni-lz065f4xqeS2URUeYWwiTCI959Bo~dBCIGGstLYQgcbmDHSpvSwntw5uj11C7V7~p-QH5poMISApOd3NfEyZY8AZlrzAdM5q3aEGX21mqhLwYJNhCdVXhyqIp4UVAz5xc~UOfIBiHDNGkSaGgl03mqxZFRw9kwuLfuQGdClhpNDl00~DZZL1n4kDhC9lQQsEknRVMPABBXAYENlIT6hVAgWnWZbVPXt9XipreQe-LBmzzmHaFXfTIHNc3p32iIoTpALkFdYP3AUgYKaNfHQLgjwgVe5Ydw__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" rel=\"nofollow\" data-google-interstitial=\"false\"><span class=\"label title-label\">Supplementary Material</span></a> - docx file</div>\n \n    </div>\n                    <div class=\"widget widget-ArticleDataRepositories widget-instance-Article_DryadLink\">\n         \n    </div>\n\n                <div class=\"comments\">\n    <div class=\"widget widget-UserCommentBody widget-instance-UserCommentBody_Article\">\n        \n\n \n    </div>\n    <div class=\"widget widget-UserComment widget-instance-OUP_UserComment_Article\">\n         \n    </div>\n\n                </div>\n            </div>\n        </div>\n\n    </div>\n</div>\n<div id=\"Sidebar\" class=\"page-column page-column--right\">\n    <div class=\"widget widget-AdBlock widget-instance-ArticlePageTopSidebar\">\n        <div class=\"js-adBlock-parent-wrap adblock-parent-wrap\">\n    <div class=\"adBlockMainBodyTop-wrap js-adBlockMainBodyTop hide\">\n        <div id=\"adBlockMainBodyTop\" class=\"js-adblock at-adblock\" data-lazy-load-margin=\"150\">\n            <script>\n                googletag.cmd.push(function () {\n                    googletag.display('adBlockMainBodyTop');\n                });\n            </script>\n        </div>\n            <div class=\"advertisement-text at-adblock js-adblock-advertisement-text hide\">Advertisement</div>\n            </div>\n</div> \n    </div>\n<div class=\"widget widget-dynamic \" data-count=\"1\"> \n\n    <div class=\"widget-dynamic-inner-wrap\">\n\n<div class=\"widget widget-dynamic \" data-count=\"10\"> \n\n    <div class=\"widget-dynamic-inner-wrap\">\n\n    <div class=\"widget widget-ArticleLevelMetrics widget-instance-Article_RightRailB0Article_RightRail_ArticleLevelMetrics\">\n        \n\n\n\n        <div class=\"artmet-wrapper horizontal-artmet\">\n\n<div class=\"contentmet-border\">\n    <div class=\"contentmet-wrapper horizontal-contentmet\">\n            <div class=\"contentmet-citations contentmet-badges-wrap js-contentmet-citations\">\n                <h3 class=\"contentmet-text\">Citations</h3>\n                    <div class=\"contentmet-item contentmet-dimensions\">\n    <div class=\"widget widget-DimensionsBadge widget-instance-ArticleLevelMetrics_DimensionsBadge\">\n        <span class=\"__dimensions_badge_embed__\" data-doi=\"10.1093/cid/ciy723\" data-legend=\"never\" data-style=\"small_circle\" data-hide-zero-citations=\"false\" data-dimensions-badge-installed=\"true\"><a class=\"__dimensions_Link\" href=\"https://badge.dimensions.ai/details/doi/10.1093/cid/ciy723?domain=https://academic.oup.com\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" aria-label=\"? total citations on Dimensions.\" style=\"display: none;\"><div class=\"__dimensions_Badge __dimensions_Badge_style_small_circle\"><div class=\"__dimensions_Badge_Image\">\n  <svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 600 600\">\n    <defs>\n      <filter id=\"ne3rfk-blur\" color-interpolation-filters=\"sRGB\">\n        <feGaussianBlur in=\"SourceGraphic\" stdDeviation=\"40\"></feGaussianBlur>\n      </filter>\n      <mask id=\"ne3rfk-shape-mask\">\n        <path fill=\"white\" d=\"M546.5,287.3l-111.8-194c-1.8-3-4.1-5.6-6.7-7.7c-2.2-2.7-5.4-4.3-8.9-4.5c-2.3-0.7-4.7-1-7-1\n          L188.2,80c-9.3,0-18,5-22.6,13.1l-112,193.8c-4.7,8.1-4.7,18,0,26.1l111.9,193.9c4.7,8.1,13.3,13,22.6,13.1l223.9,0.1\n          c9.3,0,17.9-4.8,22.6-12.8l112-193.7l0,0C551.1,305.1,551.2,295.4,546.5,287.3z M516.6,287.4l-41.5,0.1l-26.7-118.2L516.6,287.4z\n           M337.2,106.2l-114.5,36.3l-20.3-36.4L337.2,106.2z M180.7,119l20.1,36.2L112,237.7L180.7,119z M181,481.8l-69.3-120l89.2,84\n          L181,481.8z M203.3,493.8l19.6-35.6l114.6,35.7L203.3,493.8z M408.1,489.3l-152.7-47.5l-32.3-10.6l-25.3-23.2L82.6,299.6\n          l114.6-106.9l25-23.1v-0.2l0.7-0.2l32.4-10.7l153.6-48.7l35.5,156.6l7.5,33.4l-7.6,33.5L408.1,489.3z M447.1,432.9l27.9-120.3\n          l41.7-0.1L447.1,432.9z\"></path>\n      </mask>\n      <g id=\"ne3rfk-gradient\" filter=\"url(#ne3rfk-blur)\">\n        <g>\n          <path fill=\"#006EB6\" d=\"M0,0l300,300v-424.4C182.9-124.4,76.8-76.9,0,0z\"></path>\n          <path fill=\"#28348A\" d=\"M300-124.4V300L600,0C523.2-76.9,417.1-124.4,300-124.4z\"></path>\n          <path fill=\"#E20613\" d=\"M600,600c76.8-76.8,124.3-182.9,124.3-300H300L600,600z\"></path>\n          <path fill=\"#DA0078\" d=\"M300,300h424.4c0-117.1-47.5-223.2-124.3-300L300,300z\"></path>\n          <path fill=\"#5BC4F1\" d=\"M-124.4,300H300L0,0C-76.9,76.8-124.4,182.9-124.4,300z\"></path>\n          <path fill=\"#A1C517\" d=\"M0,600l300-300h-424.4C-124.4,417.1-76.9,523.2,0,600z\"></path>\n          <path fill=\"#F08800\" d=\"M300,724.4c117.1,0,223.2-47.5,300-124.3L300,300V724.4z\"></path>\n          <path fill=\"#FFCB00\" d=\"M300,724.4V300L0,600C76.8,676.9,182.9,724.4,300,724.4z\"></path>\n        </g>\n      </g>\n    </defs>\n  </svg>\n\n  <div class=\"__db_background\"></div>\n\n  <div class=\"__db_shape\">\n    <svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 600 600\" xmlns:xlink=\"http://www.w3.org/1999/xlink\">\n      <use mask=\"url(#ne3rfk-shape-mask)\" xlink:href=\"#ne3rfk-gradient\"></use>\n    </svg>\n  </div>\n\n  <div class=\"__db_score __db_score_normal\">?</div>\n  <div class=\"__db_label\">CITATIONS</div>\n\n  <img src=\"https://badge.dimensions.ai/badge?count=?\" class=\"__dimensions_png\" alt=\"? total citations on Dimensions.\">\n</div>\n</div></a></span>\n<script async=\"\" src=\"https://badge.dimensions.ai/badge.js\" charset=\"utf-8\"></script>\n \n    </div>\n\n                    </div>\n                            </div>\n                    <div class=\"contentmet-views contentmet-badges-wrap js-contentmet-views\">\n                <h3 class=\"contentmet-text\">Views</h3>\n                <div class=\"contentmet-item circle-text circle-text-views\">\n                    <div class=\"contentmet-number\">18,086</div>\n                </div>\n            </div>\n                    <div class=\"contentmet-item contentmet-badges-wrap\">\n                    <h3 class=\"contentmet-text\">Altmetric</h3>\n                    <div class=\"contentmet-item contentmet-altmetric\">\n    <div class=\"widget widget-AltmetricLink widget-instance-ArticleLevelMetrics_AltmetricLinkSummary\">\n            <!-- Altmetrics -->\n    <div id=\"altmetricEmbedId\" runat=\"server\" class=\"altmetric-embed\" data-badge-type=\"donut\" data-hide-no-mentions=\"false\" data-doi=\"10.1093/cid/ciy723\" data-uuid=\"7dbe6f2f-1e74-3e47-e7f3-a4fda40156d2\"><a target=\"_self\" href=\"https://www.altmetric.com/details.php?domain=academic.oup.com&amp;citation_id=47565307\" style=\"display:inline-block;\">\n        <img alt=\"Article has an altmetric score of 5\" src=\"https://badges.altmetric.com/?size=128&amp;score=5&amp;types=tttttttt\" width=\"64\" height=\"64\" style=\"border:0; margin:0; max-width: none;\">\n</a></div>\n         <script type=\"text/javascript\" src=\"https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js\"></script>\n \n    </div>\n\n                    </div>\n\n\n            </div>\n                    <div class=\"contentmet-modal-trigger-wrap clearfix\">\n                <a href=\"javascript:;\" class=\"artmet-modal-trigger js-artmet-modal-trigger at-alm-metrics-modal-trigger\" data-resource-id=\"5078600\" data-resource-type=\"3\" rel=\"nofollow\" data-google-interstitial=\"false\">\n                    <img class=\"contentmet-info-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/i.svg\" alt=\"Information\">\n                    <span class=\"contentmet-more-info\">More metrics information</span>\n                </a>\n            </div>\n    </div>\n</div>\n\n                <div class=\"artmet-modal js-artmet-modal\" id=\"MetricsModal\" role=\"dialog\" aria-hidden=\"true\" aria-live=\"assertive\" aria-labelledby=\"widget-title-1-id\">\n                    <div class=\"artmet-modal-contents js-metric-modal-contents at-alm-modal-contents\">\n\n\n\n\n    <div class=\"artmet-full-wrap clearfix js-metric-full-wrap hide\">\n            <h3 id=\"widget-title-1-id\" class=\"widget-title-1 artmet-widget-title-1\">Metrics</h3>\n\n            <div class=\"artmet-item artmet-views-wrap\">\n                <div class=\"artmet-views clearfix\">\n                    <div class=\"artmet-total-views\">\n                        <span class=\"artmet-text\">Total Views</span>\n                        <span class=\"artmet-number\">18,086</span>\n                    </div>\n                    <div class=\"artmet-breakdown-views-wrap\">\n                        <div class=\"artmet-breakdown-view breakdown-border\">\n                            <span class=\"artmet-number\">11,927</span>\n                            <span class=\"artmet-text\">Pageviews</span>\n                        </div>\n                        <div class=\"artmet-breakdown-view\">\n                            <span class=\"artmet-number\">6,159</span>\n                            <span class=\"artmet-text\">PDF Downloads</span>\n                        </div>\n                                            </div>\n                </div>\n                <div class=\"artmet-views-since\">Since 8/1/2018</div>\n            </div>\n\n            <script>\n                var ChartistData = ChartistData || {};\n\n                ChartistData.data = {\n                    labels: ['Aug 2018', 'Sep 2018', 'Oct 2018', 'Nov 2018', 'Dec 2018', 'Jan 2019', 'Feb 2019', 'Mar 2019', 'Apr 2019', 'May 2019', 'Jun 2019', 'Jul 2019', 'Aug 2019', 'Sep 2019', 'Oct 2019', 'Nov 2019', 'Dec 2019', 'Jan 2020', 'Feb 2020', 'Mar 2020', 'Apr 2020', 'May 2020', 'Jun 2020', 'Jul 2020', 'Aug 2020', 'Sep 2020', 'Oct 2020', 'Nov 2020', 'Dec 2020', 'Jan 2021', 'Feb 2021', 'Mar 2021', 'Apr 2021', 'May 2021', 'Jun 2021', 'Jul 2021', 'Aug 2021', 'Sep 2021', 'Oct 2021', 'Nov 2021', 'Dec 2021', 'Jan 2022', 'Feb 2022', 'Mar 2022', 'Apr 2022', 'May 2022', 'Jun 2022', 'Jul 2022', 'Aug 2022', 'Sep 2022', 'Oct 2022', 'Nov 2022', 'Dec 2022', 'Jan 2023', 'Feb 2023', 'Mar 2023', 'Apr 2023', 'May 2023', 'Jun 2023', 'Jul 2023', 'Aug 2023', 'Sep 2023', 'Oct 2023', 'Nov 2023', 'Dec 2023', 'Jan 2024', 'Feb 2024', 'Mar 2024', 'Apr 2024', 'May 2024', 'Jun 2024', 'Jul 2024', 'Aug 2024', 'Sep 2024', 'Oct 2024', 'Nov 2024', 'Dec 2024', 'Jan 2025', 'Feb 2025', 'Mar 2025', 'Apr 2025', 'May 2025', 'Jun 2025'],\n                    series: [[66, 28, 23, 70, 46, 53, 62, 31, 408, 355, 182, 176, 159, 111, 90, 66, 44, 69, 36, 223, 208, 140, 179, 162, 154, 217, 238, 237, 165, 140, 137, 236, 239, 239, 172, 131, 160, 205, 250, 227, 183, 202, 247, 301, 242, 240, 161, 159, 292, 404, 533, 300, 477, 287, 191, 310, 395, 248, 198, 185, 213, 248, 340, 311, 269, 301, 353, 372, 323, 341, 275, 268, 218, 253, 274, 312, 242, 250, 296, 396, 228, 228, 86]]\n                };\n            </script>\n            <div class=\"artmet-item artmet-chart\">\n                <div class=\"ct-chart ct-octave js-ct-chart\"></div>\n\n                <div class=\"artmet-table\">\n                    <table>\n                        <thead>\n                            <tr>\n                                <th>Month:</th>\n                                <th>Total Views:</th>\n                            </tr>\n                        </thead>\n                        <tbody>\n                                <tr>\n                                    <td>August 2018</td>\n                                    <td>66</td>\n                                </tr>\n                                <tr>\n                                    <td>September 2018</td>\n                                    <td>28</td>\n                                </tr>\n                                <tr>\n                                    <td>October 2018</td>\n                                    <td>23</td>\n                                </tr>\n                                <tr>\n                                    <td>November 2018</td>\n                                    <td>70</td>\n                                </tr>\n                                <tr>\n                                    <td>December 2018</td>\n                                    <td>46</td>\n                                </tr>\n                                <tr>\n                                    <td>January 2019</td>\n                                    <td>53</td>\n                                </tr>\n                                <tr>\n                                    <td>February 2019</td>\n                                    <td>62</td>\n                                </tr>\n                                <tr>\n                                    <td>March 2019</td>\n                                    <td>31</td>\n                                </tr>\n                                <tr>\n                                    <td>April 2019</td>\n                                    <td>408</td>\n                                </tr>\n                                <tr>\n                                    <td>May 2019</td>\n                                    <td>355</td>\n                                </tr>\n                                <tr>\n                                    <td>June 2019</td>\n                                    <td>182</td>\n                                </tr>\n                                <tr>\n                                    <td>July 2019</td>\n                                    <td>176</td>\n                                </tr>\n                                <tr>\n                                    <td>August 2019</td>\n                                    <td>159</td>\n                                </tr>\n                                <tr>\n                                    <td>September 2019</td>\n                                    <td>111</td>\n                                </tr>\n                                <tr>\n                                    <td>October 2019</td>\n                                    <td>90</td>\n                                </tr>\n                                <tr>\n                                    <td>November 2019</td>\n                                    <td>66</td>\n                                </tr>\n                                <tr>\n                                    <td>December 2019</td>\n                                    <td>44</td>\n                                </tr>\n                                <tr>\n                                    <td>January 2020</td>\n                                    <td>69</td>\n                                </tr>\n                                <tr>\n                                    <td>February 2020</td>\n                                    <td>36</td>\n                                </tr>\n                                <tr>\n                                    <td>March 2020</td>\n                                    <td>223</td>\n                                </tr>\n                                <tr>\n                                    <td>April 2020</td>\n                                    <td>208</td>\n                                </tr>\n                                <tr>\n                                    <td>May 2020</td>\n                                    <td>140</td>\n                                </tr>\n                                <tr>\n                                    <td>June 2020</td>\n                                    <td>179</td>\n                                </tr>\n                                <tr>\n                                    <td>July 2020</td>\n                                    <td>162</td>\n                                </tr>\n                                <tr>\n                                    <td>August 2020</td>\n                                    <td>154</td>\n                                </tr>\n                                <tr>\n                                    <td>September 2020</td>\n                                    <td>217</td>\n                                </tr>\n                                <tr>\n                                    <td>October 2020</td>\n                                    <td>238</td>\n                                </tr>\n                                <tr>\n                                    <td>November 2020</td>\n                                    <td>237</td>\n                                </tr>\n                                <tr>\n                                    <td>December 2020</td>\n                                    <td>165</td>\n                                </tr>\n                                <tr>\n                                    <td>January 2021</td>\n                                    <td>140</td>\n                                </tr>\n                                <tr>\n                                    <td>February 2021</td>\n                                    <td>137</td>\n                                </tr>\n                                <tr>\n                                    <td>March 2021</td>\n                                    <td>236</td>\n                                </tr>\n                                <tr>\n                                    <td>April 2021</td>\n                                    <td>239</td>\n                                </tr>\n                                <tr>\n                                    <td>May 2021</td>\n                                    <td>239</td>\n                                </tr>\n                                <tr>\n                                    <td>June 2021</td>\n                                    <td>172</td>\n                                </tr>\n                                <tr>\n                                    <td>July 2021</td>\n                                    <td>131</td>\n                                </tr>\n                                <tr>\n                                    <td>August 2021</td>\n                                    <td>160</td>\n                                </tr>\n                                <tr>\n                                    <td>September 2021</td>\n                                    <td>205</td>\n                                </tr>\n                                <tr>\n                                    <td>October 2021</td>\n                                    <td>250</td>\n                                </tr>\n                                <tr>\n                                    <td>November 2021</td>\n                                    <td>227</td>\n                                </tr>\n                                <tr>\n                                    <td>December 2021</td>\n                                    <td>183</td>\n                                </tr>\n                                <tr>\n                                    <td>January 2022</td>\n                                    <td>202</td>\n                                </tr>\n                                <tr>\n                                    <td>February 2022</td>\n                                    <td>247</td>\n                                </tr>\n                                <tr>\n                                    <td>March 2022</td>\n                                    <td>301</td>\n                                </tr>\n                                <tr>\n                                    <td>April 2022</td>\n                                    <td>242</td>\n                                </tr>\n                                <tr>\n                                    <td>May 2022</td>\n                                    <td>240</td>\n                                </tr>\n                                <tr>\n                                    <td>June 2022</td>\n                                    <td>161</td>\n                                </tr>\n                                <tr>\n                                    <td>July 2022</td>\n                                    <td>159</td>\n                                </tr>\n                                <tr>\n                                    <td>August 2022</td>\n                                    <td>292</td>\n                                </tr>\n                                <tr>\n                                    <td>September 2022</td>\n                                    <td>404</td>\n                                </tr>\n                                <tr>\n                                    <td>October 2022</td>\n                                    <td>533</td>\n                                </tr>\n                                <tr>\n                                    <td>November 2022</td>\n                                    <td>300</td>\n                                </tr>\n                                <tr>\n                                    <td>December 2022</td>\n                                    <td>477</td>\n                                </tr>\n                                <tr>\n                                    <td>January 2023</td>\n                                    <td>287</td>\n                                </tr>\n                                <tr>\n                                    <td>February 2023</td>\n                                    <td>191</td>\n                                </tr>\n                                <tr>\n                                    <td>March 2023</td>\n                                    <td>310</td>\n                                </tr>\n                                <tr>\n                                    <td>April 2023</td>\n                                    <td>395</td>\n                                </tr>\n                                <tr>\n                                    <td>May 2023</td>\n                                    <td>248</td>\n                                </tr>\n                                <tr>\n                                    <td>June 2023</td>\n                                    <td>198</td>\n                                </tr>\n                                <tr>\n                                    <td>July 2023</td>\n                                    <td>185</td>\n                                </tr>\n                                <tr>\n                                    <td>August 2023</td>\n                                    <td>213</td>\n                                </tr>\n                                <tr>\n                                    <td>September 2023</td>\n                                    <td>248</td>\n                                </tr>\n                                <tr>\n                                    <td>October 2023</td>\n                                    <td>340</td>\n                                </tr>\n                                <tr>\n                                    <td>November 2023</td>\n                                    <td>311</td>\n                                </tr>\n                                <tr>\n                                    <td>December 2023</td>\n                                    <td>269</td>\n                                </tr>\n                                <tr>\n                                    <td>January 2024</td>\n                                    <td>301</td>\n                                </tr>\n                                <tr>\n                                    <td>February 2024</td>\n                                    <td>353</td>\n                                </tr>\n                                <tr>\n                                    <td>March 2024</td>\n                                    <td>372</td>\n                                </tr>\n                                <tr>\n                                    <td>April 2024</td>\n                                    <td>323</td>\n                                </tr>\n                                <tr>\n                                    <td>May 2024</td>\n                                    <td>341</td>\n                                </tr>\n                                <tr>\n                                    <td>June 2024</td>\n                                    <td>275</td>\n                                </tr>\n                                <tr>\n                                    <td>July 2024</td>\n                                    <td>268</td>\n                                </tr>\n                                <tr>\n                                    <td>August 2024</td>\n                                    <td>218</td>\n                                </tr>\n                                <tr>\n                                    <td>September 2024</td>\n                                    <td>253</td>\n                                </tr>\n                                <tr>\n                                    <td>October 2024</td>\n                                    <td>274</td>\n                                </tr>\n                                <tr>\n                                    <td>November 2024</td>\n                                    <td>312</td>\n                                </tr>\n                                <tr>\n                                    <td>December 2024</td>\n                                    <td>242</td>\n                                </tr>\n                                <tr>\n                                    <td>January 2025</td>\n                                    <td>250</td>\n                                </tr>\n                                <tr>\n                                    <td>February 2025</td>\n                                    <td>296</td>\n                                </tr>\n                                <tr>\n                                    <td>March 2025</td>\n                                    <td>396</td>\n                                </tr>\n                                <tr>\n                                    <td>April 2025</td>\n                                    <td>228</td>\n                                </tr>\n                                <tr>\n                                    <td>May 2025</td>\n                                    <td>228</td>\n                                </tr>\n                                <tr>\n                                    <td>June 2025</td>\n                                    <td>86</td>\n                                </tr>\n                        </tbody>\n                    </table>\n                </div>\n            </div>\n\n<div class=\"artmet-stats-wrap clearfix\">\n        <div class=\"artmet-item artmet-citations\">\n            <div class=\"widget-title-2 artmet-widget-title-2\">Citations</div>\n                <div class=\"artmet-badges-wrap artmet-dimensions\">\n    <div class=\"widget widget-DimensionsBadge widget-instance-ArticleLevelMetrics_DimensionsBadgeDetails\">\n        <span class=\"__dimensions_badge_embed__\" data-doi=\"10.1093/cid/ciy723\" data-legend=\"always\" data-style=\"\" data-hide-zero-citations=\"false\" data-dimensions-badge-installed=\"true\"><a class=\"__dimensions_Link\" href=\"https://badge.dimensions.ai/details/doi/10.1093/cid/ciy723?domain=https://academic.oup.com\" target=\"_blank\" referrerpolicy=\"no-referrer-when-downgrade\" aria-label=\"? total citations on Dimensions.\" style=\"display: none;\"><div class=\"__dimensions_Badge __dimensions_Badge_style_medium_circle\"><div class=\"__dimensions_Badge_Image\">\n  <svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 600 600\">\n    <defs>\n      <filter id=\"rr15o9-blur\" color-interpolation-filters=\"sRGB\">\n        <feGaussianBlur in=\"SourceGraphic\" stdDeviation=\"40\"></feGaussianBlur>\n      </filter>\n      <mask id=\"rr15o9-shape-mask\">\n        <path fill=\"white\" d=\"M546.5,287.3l-111.8-194c-1.8-3-4.1-5.6-6.7-7.7c-2.2-2.7-5.4-4.3-8.9-4.5c-2.3-0.7-4.7-1-7-1\n          L188.2,80c-9.3,0-18,5-22.6,13.1l-112,193.8c-4.7,8.1-4.7,18,0,26.1l111.9,193.9c4.7,8.1,13.3,13,22.6,13.1l223.9,0.1\n          c9.3,0,17.9-4.8,22.6-12.8l112-193.7l0,0C551.1,305.1,551.2,295.4,546.5,287.3z M516.6,287.4l-41.5,0.1l-26.7-118.2L516.6,287.4z\n           M337.2,106.2l-114.5,36.3l-20.3-36.4L337.2,106.2z M180.7,119l20.1,36.2L112,237.7L180.7,119z M181,481.8l-69.3-120l89.2,84\n          L181,481.8z M203.3,493.8l19.6-35.6l114.6,35.7L203.3,493.8z M408.1,489.3l-152.7-47.5l-32.3-10.6l-25.3-23.2L82.6,299.6\n          l114.6-106.9l25-23.1v-0.2l0.7-0.2l32.4-10.7l153.6-48.7l35.5,156.6l7.5,33.4l-7.6,33.5L408.1,489.3z M447.1,432.9l27.9-120.3\n          l41.7-0.1L447.1,432.9z\"></path>\n      </mask>\n      <g id=\"rr15o9-gradient\" filter=\"url(#rr15o9-blur)\">\n        <g>\n          <path fill=\"#006EB6\" d=\"M0,0l300,300v-424.4C182.9-124.4,76.8-76.9,0,0z\"></path>\n          <path fill=\"#28348A\" d=\"M300-124.4V300L600,0C523.2-76.9,417.1-124.4,300-124.4z\"></path>\n          <path fill=\"#E20613\" d=\"M600,600c76.8-76.8,124.3-182.9,124.3-300H300L600,600z\"></path>\n          <path fill=\"#DA0078\" d=\"M300,300h424.4c0-117.1-47.5-223.2-124.3-300L300,300z\"></path>\n          <path fill=\"#5BC4F1\" d=\"M-124.4,300H300L0,0C-76.9,76.8-124.4,182.9-124.4,300z\"></path>\n          <path fill=\"#A1C517\" d=\"M0,600l300-300h-424.4C-124.4,417.1-76.9,523.2,0,600z\"></path>\n          <path fill=\"#F08800\" d=\"M300,724.4c117.1,0,223.2-47.5,300-124.3L300,300V724.4z\"></path>\n          <path fill=\"#FFCB00\" d=\"M300,724.4V300L0,600C76.8,676.9,182.9,724.4,300,724.4z\"></path>\n        </g>\n      </g>\n    </defs>\n  </svg>\n\n  <div class=\"__db_background\"></div>\n\n  <div class=\"__db_shape\">\n    <svg xmlns=\"http://www.w3.org/2000/svg\" viewBox=\"0 0 600 600\" xmlns:xlink=\"http://www.w3.org/1999/xlink\">\n      <use mask=\"url(#rr15o9-shape-mask)\" xlink:href=\"#rr15o9-gradient\"></use>\n    </svg>\n  </div>\n\n  <div class=\"__db_score __db_score_normal\">?</div>\n  <div class=\"__db_label\">CITATIONS</div>\n\n  <img src=\"https://badge.dimensions.ai/badge?count=?\" class=\"__dimensions_png\" alt=\"? total citations on Dimensions.\">\n</div>\n</div><div class=\"__dimensions_Badge_Legend_padding __dimensions_Badge_Legend_hover-right  __dimensions_Badge_Legend_style_medium_circle __dimensions_Badge_Legend_always\"><div class=\"__dimensions_Badge_Legend\">\n      <div class=\"__dimensions_Badge_stat_group __dimensions_Badge_stat_group_citations\">\n        <div class=\"__dimensions_Badge_stat __dimensions_Badge_stat_total_citations\">\n          <span class=\"__dimensions_Badge_stat_icon\"></span>\n          <span class=\"__dimensions_Badge_stat_count\">?</span>\n          <span class=\"__dimensions_Badge_stat_text\">Total citations</span>\n        </div>\n        <div class=\"__dimensions_Badge_stat __dimensions_Badge_stat_recent_citations\">\n          <span class=\"__dimensions_Badge_stat_icon\"></span>\n          <span class=\"__dimensions_Badge_stat_count\">?</span>\n          <span class=\"__dimensions_Badge_stat_text\">Recent citations</span>\n        </div>\n      </div>\n      <div class=\"__dimensions_Badge_stat_group __dimensions_Badge_stat_group_cr\">\n        <div class=\"__dimensions_Badge_stat __dimensions_Badge_stat_fcr\">\n          <span class=\"__dimensions_Badge_stat_icon\"></span>\n          <span class=\"__dimensions_Badge_stat_count\">n/a</span>\n          <span class=\"__dimensions_Badge_stat_text\">Field Citation Ratio</span>\n        </div>\n        <div class=\"__dimensions_Badge_stat __dimensions_Badge_stat_rcr\">\n          <span class=\"__dimensions_Badge_stat_icon\"></span>\n          <span class=\"__dimensions_Badge_stat_count\">n/a</span>\n          <span class=\"__dimensions_Badge_stat_text\">Relative Citation Ratio</span>\n        </div>\n      </div></div></div></a></span>\n<script async=\"\" src=\"https://badge.dimensions.ai/badge.js\" charset=\"utf-8\"></script>\n \n    </div>\n\n                    <span class=\"artmet-dimensions-text\">Powered by Dimensions</span>\n                </div>\n                                <div class=\"artmet-wos\">\n                        <span class=\"artmet-number\">\n                                <a href=\"https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=silverchair&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000482136200011&amp;DestLinkType=CitingArticles&amp;DestApp=WOS_CPL\" target=\"\" rel=\"nofollow\" data-google-interstitial=\"false\">137</a>\n                        </span>\n                        <span class=\"artmet-text\">Web of Science</span>\n                    </div>\n        </div>\n\n\n        <div class=\"artmet-item artmet-altmetric artmet-position-right js-show-if-unknown\">\n            <div class=\"widget-title-2 artmet-widget-title-2\">Altmetrics</div>\n            <div class=\"artmet-badges-wrap js-artmet-badges\">\n\n    <div class=\"widget widget-AltmetricLink widget-instance-ArticleLevelMetrics_AltmetricLinkDetails\">\n            <!-- Altmetrics -->\n    <div id=\"altmetricEmbedId\" runat=\"server\" class=\"altmetric-embed\" data-badge-type=\"donut\" data-hide-no-mentions=\"false\" data-doi=\"10.1093/cid/ciy723\" data-badge-details=\"right\" data-uuid=\"9c51f920-9bb1-29d5-4e9c-758833cb9263\"><div style=\"overflow:hidden;\">\n    <div class=\"altmetric-normal-legend\">\n        <a target=\"_self\" href=\"https://www.altmetric.com/details.php?domain=academic.oup.com&amp;citation_id=47565307\" style=\"display:inline-block;\">\n                <img alt=\"Article has an altmetric score of 5\" src=\"https://badges.altmetric.com/?size=128&amp;score=5&amp;types=tttttttt\" width=\"64\" height=\"64\" style=\"border:0; margin:0; max-width: none;\">\n        </a>\n        <p class=\"altmetric-see-more-details\" style=\"padding-top: 10px; text-align: center;\"><a target=\"_self\" href=\"https://www.altmetric.com/details.php?domain=academic.oup.com&amp;citation_id=47565307\">See more details</a></p>\n    </div>\n    <div id=\"_altmetric_popover_el_9c51f920-9bb1-29d5-4e9c-758833cb9263\" class=\"altmetric-embed right\" style=\"margin:0; padding:0; display:inline-block; float:left; position:relative;\">\n        <div class=\"altmetric_container\">\n            <div class=\"altmetric-embed altmetric-popover-inner right\">\n                <div style=\"padding:0; margin: 0;\" class=\"altmetric-embed altmetric-popover-content\">\n                        <div style=\"padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;\">\n      <a class=\"link-to-altmetric-details-tab\" target=\"_self\" href=\"https://www.altmetric.com/details.php?domain=academic.oup.com&amp;citation_id=47565307&amp;tab=twitter\">\n          Posted by <b>7</b> X users\n      </a>\n    </div>\n\n    <div class=\"altmetric-embed readers\" style=\"margin-top: 10px;\">\n          <div class=\"altmetric-embed tip_mendeley\" style=\"padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;\">\n              <b>346</b> readers on Mendeley\n          </div>\n    </div>\n\n                </div>\n            </div>\n        </div>\n    </div>\n</div></div>\n         <script type=\"text/javascript\" src=\"https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js\"></script>\n \n    </div>\n            </div>\n        </div>\n\n</div>\n\n\n    </div>\n                        <a href=\"javascript:;\" role=\"button\" class=\"artmet-close-modal js-artmet-close-modal\" aria-label=\"Close metrics modal\" data-google-interstitial=\"false\">\n                            <span aria-hidden=\"true\">×</span>\n                            <span class=\"screenreader-text\">Close Modal</span>\n                        </a>\n                    </div>\n                </div>\n        </div>\n\n \n    </div>\n    <div class=\"widget widget-OUPEmailAlerts widget-instance-Article_RightRailB0Article_RightRail_OUPEmailAlerts\">\n        \n    <div class=\"alertsWidget js-alerts-widget\">\n        <h3>Email alerts</h3>\n            <div class=\"userAlert alertType-LatestIssue\">\n                        <a href=\"/cid/new-journals-alert\" class=\"js-my-email-alert email-alert-link\" data-google-interstitial=\"false\">\n                            New journal issues\n                        </a>\n            </div>\n            <div class=\"userAlert alertType-NewJournalArticles\">\n                        <a href=\"/cid/new-journal-articles-alert\" class=\"js-my-email-alert email-alert-link\" data-google-interstitial=\"false\">\n                            New journal articles\n                        </a>\n            </div>\n            <div class=\"userAlert alertType-ContentActivity\">\n                        <button type=\"button\" class=\"js-activity-alert-button email-alert-link\" data-user-logged-in=\"False\" data-alert-type=\"ContentActivity\" data-is-content-page=\"True\" data-alert-signup-link=\"\" data-resourceid=\"5078600\" data-resourcetypeid=\"Article\" data-reveal-id=\"activityAlertModal\" aria-expanded=\"false\">\n                            Activity related to this article\n                        </button>\n            </div>\n\n        <div class=\"userAlert alertType-MarketingLink\">\n            <a href=\"/my-account/communication-preferences\" data-google-interstitial=\"false\">Sign up for marketing</a>\n        </div>\n    </div>\n\n    <div id=\"journalIssuesAlertModal\" class=\"alert-resources-modal fix-width reveal-modal js-content-alert-modal\" role=\"dialog\" aria-modal=\"true\" aria-labelledby=\"journalsIssuesAlertModalTitle\" data-reveal=\"\">\n    <div class=\"widget widget-JournalsIssuesAlert widget-instance-JournalIssuesAlert\">\n        <div class=\"alerts-sign-up-wrapper js-journals-alerts-sign-up-wrapper page-column\">\n    <div class=\"modal-head border-bottom\">\n        <h2 id=\"journalsIssuesAlertModalTitle\">New journal issues alert</h2>\n    </div>\n\n        <div class=\"modal-body\">\n            <div class=\"alert-loginbox-wrapper\">\n    <div class=\"widget widget-LoginBoxOnlyUser widget-instance-OUP_IssuesAlert\">\n            <div class=\"error-message\"><p>To set up an email alert, please <a class=\"js-sign-in-link\" data-linktype=\"user-pass\" href=\"javascript:;\" data-google-interstitial=\"false\">sign in</a> to your personal account, or <a class=\"js-register-link\" href=\"https://academic.oup.com/my-account/register?siteId=5269&amp;returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\" data-google-interstitial=\"false\">register</a></p></div>\n\n<div class=\"login-box\" data-google-interstitial=\"false\">\n    <div class=\"login-box__main-section-wrap\">\n        <div class=\"login-box__section-wrap login-box_heading\">\n            <div class=\"login-box__main-heading-wrap\">\n               <h2>Sign in</h2>\n               \n            </div>\n        </div>\n\n        <div class=\"login-box__section-wrap cols login-box_sign-in-accounts\">\n    <div class=\"login-box__section column-border login-box_personal-account\">\n            <h3 class=\"login-box__heading\">Personal account</h3>\n\n    <ul class=\"bullets\">\n        <li>Sign in with email/username &amp; password</li>\n        <li>Get email alerts</li>\n        <li>Save searches</li>\n        <li>Purchase content</li>\n        <li>Activate your purchase/trial code</li>\n            <li>Add your ORCID iD</li>\n    </ul>\n\n            <div class=\"login-box__button-row\">\n                    <a rel=\"nofollow\" class=\"button-call-to-action at-personal-sign-in js-sign-in-link\" data-linktype=\"user-pass\" href=\"javascript:;\" data-google-interstitial=\"false\">\n                    <span>Sign in</span>\n                    <img class=\"society-link-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/chevron-right-white.svg\" alt=\"Arrow\" aria-hidden=\"true\">\n\n                </a>\n                                    <a rel=\"nofollow\" class=\"at-personal-register-link js-register-link\" href=\"/my-account/register?siteId=5269&amp;returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\" data-google-interstitial=\"false\">Register</a>\n            </div>\n    </div>\n\n        </div>\n    </div>\n</div>\n \n    </div>\n\n            </div>\n        </div>\n</div> \n    </div>\n\n\n        <button type=\"button\" class=\"close-reveal-modal js-close-reveal-modal\"><i class=\"icon-general-close\" alt=\"Close modal\"></i></button>\n    </div>\n\n    <div id=\"activityAlertModal\" role=\"dialog\" aria-modal=\"true\" class=\"alert-resources-modal fix-width reveal-modal js-content-alert-modal js-activity-modal\" data-reveal=\"\">\n        <div class=\"js-activity-alert-widget\">\n    <div class=\"widget widget-ActivityAlert widget-instance-Article_RightRailB0Article_RightRail_OUPEmailAlerts\">\n        <div class=\"alerts-sign-up-wrapper js-activity-alert-wrapper\">\n    <div class=\"modal-head border-bottom\">\n        <h2 aria-labelledby=\"activityAlertModal\">Journal article activity alert</h2>\n    </div>\n\n        <div class=\"modal-body alert-loginbox-modal-wrapper\">\n            <div class=\"alert-loginbox-wrapper\">\n    <div class=\"widget widget-LoginBoxOnlyUser widget-instance-OUP_IssuesAlert\">\n            <div class=\"error-message\"><p>To set up an email alert, please <a class=\"js-sign-in-link\" data-linktype=\"user-pass\" href=\"javascript:;\" data-google-interstitial=\"false\">sign in</a> to your personal account, or <a class=\"js-register-link\" href=\"https://academic.oup.com/my-account/register?siteId=5269&amp;returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\" data-google-interstitial=\"false\">register</a></p></div>\n\n<div class=\"login-box\" data-google-interstitial=\"false\">\n    <div class=\"login-box__main-section-wrap\">\n        <div class=\"login-box__section-wrap login-box_heading\">\n            <div class=\"login-box__main-heading-wrap\">\n               <h2>Sign in</h2>\n               \n            </div>\n        </div>\n\n        <div class=\"login-box__section-wrap cols login-box_sign-in-accounts\">\n    <div class=\"login-box__section column-border login-box_personal-account\">\n            <h3 class=\"login-box__heading\">Personal account</h3>\n\n    <ul class=\"bullets\">\n        <li>Sign in with email/username &amp; password</li>\n        <li>Get email alerts</li>\n        <li>Save searches</li>\n        <li>Purchase content</li>\n        <li>Activate your purchase/trial code</li>\n            <li>Add your ORCID iD</li>\n    </ul>\n\n            <div class=\"login-box__button-row\">\n                    <a rel=\"nofollow\" class=\"button-call-to-action at-personal-sign-in js-sign-in-link\" data-linktype=\"user-pass\" href=\"javascript:;\" data-google-interstitial=\"false\">\n                    <span>Sign in</span>\n                    <img class=\"society-link-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/chevron-right-white.svg\" alt=\"Arrow\" aria-hidden=\"true\">\n\n                </a>\n                                    <a rel=\"nofollow\" class=\"at-personal-register-link js-register-link\" href=\"/my-account/register?siteId=5269&amp;returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\" data-google-interstitial=\"false\">Register</a>\n            </div>\n    </div>\n\n        </div>\n    </div>\n</div>\n \n    </div>\n\n            </div>\n        </div>\n</div>\n \n    </div>\n\n        </div>\n        <button type=\"button\" class=\"close-reveal-modal js-close-reveal-modal\"><i class=\"icon-general-close\" alt=\"Close modal\"></i><span class=\"screenreader-text\">Close Modal</span></button>\n    </div>\n \n    </div>\n    <div class=\"widget widget-RelatedContent widget-instance-Article_RightRailB0Article_RightRail_RelatedContent\">\n                <h3 class=\"article-widget-head\">More on this topic</h3>\n    <div class=\"widget-related-content at-related-content\">\n            <div class=\"article-title\"><a href=\"/cid/article/50/2/202/328880\">Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods</a></div>\n            <div class=\"article-title\"><a href=\"/cid/article/12/Supplement_8/S915/296667\">Microbial Agents Associated with Pneumonia in Children from Uruguay</a></div>\n            <div class=\"article-title\"><a href=\"/cid/article/59/9/iii/419445\">In the Literature</a></div>\n            <div class=\"article-title\"><a href=\"/cid/advance-article/7985365\">Comparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study</a></div>\n    </div>\n \n    </div>\n    <div class=\"widget widget-RelatedPubMed widget-instance-Article_RightRailB0Article_RightRail_RelatedPubMed\">\n        <h3 class=\"article-widget-head\">Related articles in PubMed</h3>\n<div class=\"widget-related-pubmed\">\n        <div class=\"inner-content-wrap\">\n            <div class=\"inner-content\">\n                <div class=\"article-title\">    <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/40410780\" id=\"article_ArticleTitle\" target=\"\" data-google-interstitial=\"false\">High-dose third-generation EGFR-TKIs combined with intrathecal pemetrexed in advanced EGFR-mutant NSCLC with leptomeningeal metastases following EGFR-TKI therapy.</a></div>\n                <!-- <div class=\"citation\"><span>BMC Cancer</span> 2025;25(1):926.</div> -->\n            </div>\n        </div>\n        <div class=\"inner-content-wrap\">\n            <div class=\"inner-content\">\n                <div class=\"article-title\">    <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/40410758\" id=\"article_ArticleTitle\" target=\"\" data-google-interstitial=\"false\">Quality and reliability of pediatric pneumonia related short videos on mainstream platforms: cross-sectional study.</a></div>\n                <!-- <div class=\"citation\"><span>BMC Public Health</span> 2025;25(1):1896.</div> -->\n            </div>\n        </div>\n        <div class=\"inner-content-wrap\">\n            <div class=\"inner-content\">\n                <div class=\"article-title\">    <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/40410755\" id=\"article_ArticleTitle\" target=\"\" data-google-interstitial=\"false\">A case of hospital-acquired pneumonia associated with Chryseobacterium indologenes infection in a patient with HIV infection and review of the literature.</a></div>\n                <!-- <div class=\"citation\"><span>AIDS Res Ther</span> 2025;22(1):53.</div> -->\n            </div>\n        </div>\n        <div class=\"inner-content-wrap\">\n            <div class=\"inner-content\">\n                <div class=\"article-title\">    <a href=\"http://www.ncbi.nlm.nih.gov/pubmed/40410748\" id=\"article_ArticleTitle\" target=\"\" data-google-interstitial=\"false\">Health inequities: a persistent global challenge from past to future.</a></div>\n                <!-- <div class=\"citation\"><span>Int J Equity Health</span> 2025;24(1):148.</div> -->\n            </div>\n        </div>\n</div>\n<!-- <div class=\"article-widget-foot\">\n    <div class=\"view-more\">\n            <a href=\"http://www.ncbi.nlm.nih.gov/pubmed?term=((community+AND+acquired+AND+pneumonia)+OR+(immunocompromised+AND+host)+OR+(pneumonia)+OR+(pathogenic+AND+organism))\" id=\"Config_ViewMoreLink\" class=\"view-more-link\" target=\"_blank\">View More</a>\n    </div>\n</div> -->\n \n    </div>\n    <div class=\"widget widget-ArticleCitedBy widget-instance-Article_RightRailB0Article_RightRail_ArticleCitedBy\">\n        <div class=\"rail-widget_wrap vt-articles-cited-by\">\n    <h3 class=\"article-cited-title\">Citing articles via</h3>\n    <div class=\"widget-links_wrap\">\n            <div class=\"article-cited-link-wrap web-of-science\">\n                <a href=\"https://www.webofscience.com/api/gateway?GWVersion=2&amp;SrcApp=silverchair&amp;SrcAuth=WosAPI&amp;KeyUT=WOS:000482136200011&amp;DestLinkType=CitingArticles&amp;DestApp=WOS_CPL\" target=\"\" rel=\"nofollow\" data-google-interstitial=\"false\">Web of Science (137)</a>\n            </div>\n                    <div class=\"article-cited-link-wrap google-scholar-url\">\n                <a href=\"http://scholar.google.com/scholar?q=link:https%3A%2F%2Facademic.oup.com%2Fcid%2Farticle%2F68%2F9%2F1482%2F5078600\" target=\"\" rel=\"nofollow\" data-google-interstitial=\"false\">Google Scholar</a>\n            </div>\n            </div>\n</div> \n    </div>\n    <div class=\"widget widget-ArticleListNewAndPopular widget-instance-Article_RightRailB0Article_RightRail_ArticleNewPopularCombined\">\n            <ul class=\"articleListNewAndPopularCombinedView\">\n            <li>\n                <h3>\n                    <a href=\"javascript:;\" class=\"articleListNewAndPopular-mode active\" data-mode=\"MostRecent\" data-google-interstitial=\"false\">Latest</a>\n                </h3>\n            </li>\n            <li>\n                <h3>\n                    <a href=\"javascript:;\" class=\"articleListNewAndPopular-mode \" data-mode=\"MostRead\" data-google-interstitial=\"false\">Most Read</a>\n                </h3>\n            </li>\n            <li>\n                <h3>\n                    <a href=\"javascript:;\" class=\"articleListNewAndPopular-mode \" data-mode=\"MostCited\" data-google-interstitial=\"false\">Most Cited</a>\n                </h3>\n            </li>\n    </ul>\n        <section class=\"articleListNewPopContent articleListNewAndPopular-ContentView-MostRecent hasContent\">\n\n\n\n\n<div id=\"newPopularList-Article_RightRailB0Article_RightRail_ArticleNewPopularCombined\" class=\"fb\">\n\n    \n\n\n\n<div class=\"widget-layout widget-layout--vert \">\n            <div class=\"widget-columns widget-col-1\">\n                    <div class=\"col\">\n\n<div class=\"widget-dynamic-entry journalArticleItem at-widget-entry-SCL\">\n    <span class=\"hfDoi\" data-attribute=\"10.1093/cid/ciaf302\" aria-hidden=\"true\"></span>\n\n\n    \n\n\n<a class=\"journal-link\" href=\"/cid/advance-article/doi/10.1093/cid/ciaf302/8159933?searchresult=1\">\n        <div class=\"widget-dynamic-journal-title\">\nEffectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial Study    </div>\n</a>\n\n\n\n\n\n\n\n\n<div class=\"widget-dynamic-journal-image-synopsis\">\n        <div class=\"widget-dynamic-journal-synopsis\">\n            \n        </div>\n</div>\n\n</div>\n<div class=\"widget-dynamic-entry journalArticleItem at-widget-entry-SCL\">\n    <span class=\"hfDoi\" data-attribute=\"10.1093/cid/ciaf311\" aria-hidden=\"true\"></span>\n\n\n    \n\n\n<a class=\"journal-link\" href=\"/cid/advance-article/doi/10.1093/cid/ciaf311/8159932?searchresult=1\">\n        <div class=\"widget-dynamic-journal-title\">\nCharacteristics Associated with Disseminated Gonococcal Infections vs Uncomplicated Gonorrhea: A California Case-Control Study, 2021-2022    </div>\n</a>\n\n\n\n\n\n\n\n\n<div class=\"widget-dynamic-journal-image-synopsis\">\n        <div class=\"widget-dynamic-journal-synopsis\">\n            \n        </div>\n</div>\n\n</div>\n<div class=\"widget-dynamic-entry journalArticleItem at-widget-entry-SCL\">\n    <span class=\"hfDoi\" data-attribute=\"10.1093/cid/ciaf304\" aria-hidden=\"true\"></span>\n\n\n    \n\n\n<a class=\"journal-link\" href=\"/cid/advance-article/doi/10.1093/cid/ciaf304/8157607?searchresult=1\">\n        <div class=\"widget-dynamic-journal-title\">\nNon-Operative versus Neurosurgical Treatment of Brain Abscess: An Emulated Trial Nested within a Nationwide, Population-Based Cohort    </div>\n</a>\n\n\n\n\n\n\n\n\n<div class=\"widget-dynamic-journal-image-synopsis\">\n        <div class=\"widget-dynamic-journal-synopsis\">\n            \n        </div>\n</div>\n\n</div>\n<div class=\"widget-dynamic-entry journalArticleItem at-widget-entry-SCL\">\n    <span class=\"hfDoi\" data-attribute=\"10.1093/cid/ciaf300\" aria-hidden=\"true\"></span>\n\n\n    \n\n\n<a class=\"journal-link\" href=\"/cid/advance-article/doi/10.1093/cid/ciaf300/8157063?searchresult=1\">\n        <div class=\"widget-dynamic-journal-title\">\nIncidence of AIDS-defining Conditions among Adults with Perinatally Acquired HIV after Transition to Adult HIV Care in the United States and Canada, 2000-2022    </div>\n</a>\n\n\n\n\n\n\n\n\n<div class=\"widget-dynamic-journal-image-synopsis\">\n        <div class=\"widget-dynamic-journal-synopsis\">\n            \n        </div>\n</div>\n\n</div>\n<div class=\"widget-dynamic-entry journalArticleItem at-widget-entry-SCL\">\n    <span class=\"hfDoi\" data-attribute=\"10.1093/cid/ciaf009\" aria-hidden=\"true\"></span>\n\n\n    \n\n\n<a class=\"journal-link\" href=\"/cid/article/80/5/e65/8156727?searchresult=1\">\n        <div class=\"widget-dynamic-journal-title\">\nState-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists    </div>\n</a>\n\n\n\n\n\n\n\n\n<div class=\"widget-dynamic-journal-image-synopsis\">\n        <div class=\"widget-dynamic-journal-synopsis\">\n            \n        </div>\n</div>\n\n</div>\n                    </div>\n            </div>\n\n</div></div>\n        </section>\n        <section class=\"articleListNewPopContent articleListNewAndPopular-ContentView-MostRead hide\">\n        </section>\n        <section class=\"articleListNewPopContent articleListNewAndPopular-ContentView-MostCited hide\">\n        </section>\n \n    </div>\n    <div class=\"widget widget-RelatedTaxonomies widget-instance-Article_RightRailB0Article_RightRail_RelatedTaxonomies\">\n            <div class=\"widget-related-taxonomies-wrap vt-related-taxonomies\">\n        <div class=\"widget-related-taxonomies_title\">More from Oxford Academic</div>\n            <div class=\"widget-related-taxonomies\">\n                <a id=\"more-from-oa-AcademicSubjects_MED00160\" class=\"related-taxonomies-link\" href=\"/search-results?tax=AcademicSubjects/MED00160\" data-google-interstitial=\"false\">Clinical Medicine</a>\n            </div>\n            <div class=\"widget-related-taxonomies\">\n                <a id=\"more-from-oa-AcademicSubjects_MED00290\" class=\"related-taxonomies-link\" href=\"/search-results?tax=AcademicSubjects/MED00290\" data-google-interstitial=\"false\">Infectious Diseases</a>\n            </div>\n            <div class=\"widget-related-taxonomies\">\n                <a id=\"more-from-oa-AcademicSubjects_MED00010\" class=\"related-taxonomies-link\" href=\"/search-results?tax=AcademicSubjects/MED00010\" data-google-interstitial=\"false\">Medicine and Health</a>\n            </div>\n\n            <div class=\"widget-related-taxonomies\">\n                <a id=\"more-from-oa-format-Books\" class=\"related-taxonomies-link\" href=\"/books\" data-google-interstitial=\"false\">Books</a>\n            </div>\n            <div class=\"widget-related-taxonomies\">\n                <a id=\"more-from-oa-format-Journals\" class=\"related-taxonomies-link\" href=\"/journals\" data-google-interstitial=\"false\">Journals</a>\n            </div>\n    </div>\n \n    </div>\n    <div class=\"widget widget-JobTarget widget-instance-Article_RightRailB0Article_RightRail_JobTarget\">\n        <div class=\"wrapper\">\n    <div class=\"header\">\n        <h3>\n            <a href=\"http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/\" data-google-interstitial=\"false\">Looking for your next opportunity?</a>\n        </h3>\n    </div>\n\n        <div class=\"network-or-parsing-error\">\n            Having trouble contacting the network. Please try again in a moment or two.\n        </div>\n\n    <div class=\"sponsor-and-jobnetwork-links\">\n        <div class=\"job-sponsor\"><a href=\"http://global.oup.com/\" data-google-interstitial=\"false\"><img src=\"https://oup.silverchair-cdn.com/data/Multimedia/oup-logo.svg\" alt=\"Oxford University Press\"></a></div>\n        <div class=\"job-network\"><a href=\"http://globaljobs-careernetwork.oxfordjournals.org/home/index.cfm?site_id=20101\" data-google-interstitial=\"false\"><img src=\"https://oup.silverchair-cdn.com/data/Multimedia/journals-careers-network.svg\" alt=\"Journals Career Network\"></a></div>\n    </div>\n</div>\n \n    </div>\n\n    </div>\n\n</div>\n    </div>\n\n</div>    <div class=\"widget widget-AdBlock widget-instance-ArticlePageTopMainBodyBottom\">\n        <div class=\"js-adBlock-parent-wrap adblock-parent-wrap\">\n    <div class=\"adBlockMainBodyBottom-wrap js-adBlockMainBodyBottom hide\">\n        <div id=\"adBlockMainBodyBottom\" class=\"js-adblock at-adblock js-adblock-lazy-loading\" data-lazy-load-margin=\"150\">\n            <script>\n                googletag.cmd.push(function () {\n                    googletag.display('adBlockMainBodyBottom');\n                });\n            </script>\n        </div>\n            <div class=\"advertisement-text at-adblock js-adblock-advertisement-text hide\">Advertisement</div>\n            </div>\n</div> \n    </div>\n\n</div>\n\n</div>\n<input id=\"hfArticleTitle\" name=\"hfArticleTitle\" type=\"hidden\" value=\"Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients | Clinical Infectious Diseases | Oxford Academic\">\n<input id=\"hfLeftNavStickyOffset\" name=\"hfLeftNavStickyOffset\" type=\"hidden\" value=\"29\">\n\n\n\n                </div><!-- /.center-inner-row no-overflow -->\n            </section>\n    </div>\n\n        <div class=\"mobile-mask\">\n        </div>\n\n        <section class=\"footer_wrap vt-site-footer\">\n            \n\n\n    <div class=\"ad-banner-footer sticky-footer-ad js-sticky-footer-ad\">\n    <div class=\"widget widget-AdBlock widget-instance-StickyFooterAd\">\n        <div class=\"js-adBlock-parent-wrap adblock-parent-wrap\">\n    <div class=\"adBlockStickyFooter-wrap js-adBlockStickyFooter hide\">\n        <div id=\"adBlockStickyFooter\" class=\"js-adblock at-adblock\" data-lazy-load-margin=\"150\">\n            <script>\n                googletag.cmd.push(function () {\n                    googletag.display('adBlockStickyFooter');\n                });\n            </script>\n        </div>\n            <div class=\"advertisement-text at-adblock js-adblock-advertisement-text hide\">Advertisement</div>\n                    <button type=\"button\" class=\"close-footer-ad js-close-footer-ad\">\n                <span class=\"screenreader-text\">close advertisement</span>\n            </button>\n    </div>\n</div> \n    </div>\n\n    </div>\n\n    <div class=\"widget widget-SitePageFooter widget-instance-SitePageFooter\">\n            <div class=\"ad-banner ad-banner-footer\">\n    <div class=\"widget widget-AdBlock widget-instance-FooterAd\">\n        <div class=\"js-adBlock-parent-wrap adblock-parent-wrap\">\n    <div class=\"adBlockFooter-wrap js-adBlockFooter hide\">\n        <div id=\"adBlockFooter\" class=\"js-adblock at-adblock js-adblock-lazy-loading\" data-lazy-load-margin=\"150\">\n            <script>\n                googletag.cmd.push(function () {\n                    googletag.display('adBlockFooter');\n                });\n            </script>\n        </div>\n            <div class=\"advertisement-text at-adblock js-adblock-advertisement-text hide\">Advertisement</div>\n            </div>\n</div> \n    </div>\n\n    </div>\n\n<div class=\"journal-footer journal-bg\">\n    <div class=\"center-inner-row\">\n\n<div class=\"journal-footer-menu\">\n\n    <ul>\n<li class=\"link-1\">\n    <a href=\"/cid/pages/About\">About Clinical Infectious Diseases</a>\n</li> <li class=\"link-2\">\n    <a href=\"/cid/pages/Editorial_Board\">Editorial Board</a>\n</li> <li class=\"link-3\">\n    <a href=\"/cid/pages/General_Instructions\">Author Guidelines</a>\n</li> <li class=\"link-4\">\n    <a href=\"https://www.facebook.com/#!/IDSociety/\" data-google-interstitial=\"false\">Facebook</a>\n</li> <li class=\"link-5\">\n    <a href=\"https://twitter.com/IDSAInfo\" data-google-interstitial=\"false\">X (formerly Twitter)</a>\n</li> </ul><ul><li class=\"link-1\">\n    <a href=\"https://bsky.app/profile/idsainfo.bsky.social\" data-google-interstitial=\"false\">Bluesky</a>\n</li> <li class=\"link-2\">\n    <a href=\"/cid/subscribe\" data-google-interstitial=\"false\">Purchase</a>\n</li> <li class=\"link-3\">\n    <a href=\"http://www.oxfordjournals.org/en/library-recommendation-form.html\" data-google-interstitial=\"false\">Recommend to your Library</a>\n</li> <li class=\"link-4\">\n    <a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\" data-google-interstitial=\"false\">Advertising and Corporate Services</a>\n</li> <li class=\"link-5\">\n    <a href=\"http://medicine-and-health-careernetwork.oxfordjournals.org/jobseeker/search/results/?t730=&amp;search=&amp;t732=469972&amp;t731=&amp;t733=&amp;t735=&amp;t737=&amp;max=25&amp;site_id=20102\" data-google-interstitial=\"false\">Journals Career Network</a>\n</li> \n    </ul>\n\n\n</div><!-- /.journal-footer-menu -->\n        <div class=\"journal-footer-affiliations\">\n            <!-- <h3>Affiliations</h3> -->\n<a href=\"https://academic.oup.com/cid\" target=\"\">\n    <img id=\"footer-logo-ClinicalInfectiousDiseases\" class=\"journal-footer-affiliations-logo\" src=\"//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_f1483155260.svg\" alt=\"Clinical Infectious Diseases\">\n</a>                        </div><!-- /.journal-footer-affiliations -->\n\n        <div class=\"journal-footer-colophon\">\n            <ul>\n<li>Online ISSN 1537-6591</li>                <li>Print ISSN 1058-4838</li>                <li>Copyright © 2025 Infectious Diseases Society of America</li>\n            </ul>\n        </div><!-- /.journal-footer-colophon -->\n\n\n    </div><!-- /.center-inner-row -->\n</div><!-- /.journal-footer --> \n    </div>\n\n    <div class=\"oup-footer\">\n        <div class=\"center-inner-row\">\n    <div class=\"widget widget-SelfServeContent widget-instance-OupUmbrellaFooterSelfServe\">\n        \n\n\n\n    <input type=\"hidden\" class=\"SelfServeContentId\" value=\"GlobalFooter_Links\">\n    <input type=\"hidden\" class=\"SelfServeVersionId\" value=\"0\">\n\n<div class=\"oup-footer-row journal-links\">\n<div class=\"global-footer selfservelinks\">\n<ul>\n    <li><a href=\"/pages/about-oxford-academic\" data-google-interstitial=\"false\">About Oxford Academic</a></li>\n    <li><a href=\"/pages/about-oxford-academic/publish-journals-with-us\" data-google-interstitial=\"false\">Publish journals with us</a></li>\n    <li><a href=\"/pages/about-oxford-academic/our-university-press-partners\" data-google-interstitial=\"false\">University press partners</a></li>\n    <li><a href=\"/pages/what-we-publish\" data-google-interstitial=\"false\">What we publish</a></li>\n    <li><a href=\"/pages/new-features\" data-google-interstitial=\"false\">New features</a>&nbsp;</li>\n</ul>\n</div>\n<div class=\"global-footer selfservelinks\">\n<ul>\n    <li><a href=\"/pages/for-authors\" data-google-interstitial=\"false\">For authors</a></li>\n    <li><a href=\"/pages/open-research/open-access\" data-google-interstitial=\"false\">Open access</a></li>\n    <li><a href=\"/pages/purchasing\" data-google-interstitial=\"false\">Purchasing</a></li>\n    <li><a href=\"/pages/institutional-account-management\" data-google-interstitial=\"false\">Institutional account management</a></li>\n    <li><a href=\"https://academic.oup.com/pages/purchasing/rights-and-permissions\" data-google-interstitial=\"false\">Rights and permissions</a></li>\n</ul>\n</div>\n<div class=\"global-footer selfservelinks\">\n<ul>\n    <li><a href=\"/pages/get-help-with-access\" data-google-interstitial=\"false\">Get help with access</a></li>\n    <li><a href=\"/pages/about-oxford-academic/accessibility\" data-google-interstitial=\"false\">Accessibility</a></li>\n    <li><a href=\"/pages/contact-us\" data-google-interstitial=\"false\">Contact us</a></li>\n    <li><a href=\"/pages/advertising\" data-google-interstitial=\"false\">Advertising</a></li>\n    <li><a href=\"/pages/media-enquiries\" data-google-interstitial=\"false\">Media enquiries</a></li>\n</ul>\n</div>\n<div class=\"global-footer selfservelinks global-footer-external\">\n<ul>\n    <li><a href=\"https://global.oup.com/\" data-google-interstitial=\"false\">Oxford University Press</a></li>\n    <li><a href=\"https://corp.oup.com/press-office\" data-google-interstitial=\"false\">News</a></li>\n    <li><a href=\"https://languages.oup.com/\" data-google-interstitial=\"false\">Oxford Languages</a></li>\n    <li><a href=\"https://www.ox.ac.uk/\" data-google-interstitial=\"false\">University of Oxford</a></li>\n</ul>\n</div>\n<div class=\"OUP-mission\">\n<p>Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide</p>\n<img class=\"journal-footer-logo\" src=\"//oup.silverchair-cdn.com/UI/app/svg/umbrella/oup-logo.svg\" alt=\"Oxford University Press\" width=\"300\" height=\"69\">\n</div>\n</div>\n<div class=\"oup-footer-row\">\n<div class=\"oup-footer-row-links\">\n<ul>\n    <li>Copyright © 2025 Oxford University Press</li>\n    <li><button id=\"Change-Preferences\" type=\"button\" onclick=\"window.top.document.dispatchEvent(new Event('changeConsent'))\">Cookie settings</button></li>\n    <li><a href=\"https://global.oup.com/cookiepolicy\" data-google-interstitial=\"false\">Cookie policy</a></li>\n    <li><a href=\"https://global.oup.com/privacy\" data-google-interstitial=\"false\">Privacy policy</a></li>\n    <li><a href=\"https://academic.oup.com/pages/legal-notice\" data-google-interstitial=\"false\">Legal notice</a></li>\n</ul>\n</div>\n</div>\n<style type=\"text/css\">\n    /* Issue right column fix for tablet/mobile */\n    @media (max-width: 1200px) {\n    .pg_issue .widget-instance-OUP_Issue {\n    width: 100%;\n    }\n    }\n    .sf-facet-list .sf-facet label,\n    .sf-facet-list .taxonomy-label-wrap label {\n    font-size: 0.9375rem;\n    }\n    .issue-pagination-wrap .pagination-container {\n    float: right;\n    }\n</style>\n\n\n\n \n    </div>\n\n        </div>\n    </div>\n    <div class=\"ss-ui-only\">\n\n    </div>\n\n        </section>\n</div>\n\n\n\n\n\n\n    \n\n\n\n    <div class=\"widget widget-SiteWideModals widget-instance-SiteWideModals\">\n        <div id=\"revealModal\" class=\"reveal-modal\" data-reveal=\"\">\n    <div id=\"revealContent\"></div>\n    <a class=\"close-reveal-modal\" href=\"javascript:;\" data-google-interstitial=\"false\"><i class=\"icon-general-close\"></i><span class=\"screenreader-text\">Close</span></a>\n</div>\n\n<div id=\"globalModalContainer\" class=\"modal-global-container\">\n    <div id=\"globalModalContent\">\n        <div class=\"js-globalModalPlaceholder\"></div>\n    </div>\n    <a class=\"close-modal js-close-modal\" href=\"javascript:;\" data-google-interstitial=\"false\"><i class=\"icon-general-close\"><span class=\"screenreader-text\">Close</span></i></a>\n</div>\n<div id=\"globalModalOverlay\" class=\"modal-overlay js-modal-overlay\"></div>\n\n<div id=\"NeedSubscription\" class=\"reveal-modal small\" data-reveal=\"\">\n    <div class=\"subscription-needed\">\n        <h5>This Feature Is Available To Subscribers Only</h5>\n        <p><a href=\"/sign-in\" data-google-interstitial=\"false\">Sign In</a> or <a href=\"/my-account/register?siteId=5269&amp;returnUrl=%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\" data-google-interstitial=\"false\">Create an Account</a></p>\n    </div>\n    <a class=\"close-reveal-modal\" href=\"javascript:;\" data-google-interstitial=\"false\"><i class=\"icon-general-close\"></i><span class=\"screenreader-text\">Close</span></a>\n</div>\n\n<div id=\"noAccessReveal\" class=\"reveal-modal tiny\" data-reveal=\"\">\n    <p>This PDF is available to Subscribers Only</p>\n    <a class=\"hide-for-article-page\" id=\"articleLinkToPurchase\" data-reveal=\"\" data-google-interstitial=\"false\"><span>View Article Abstract &amp; Purchase Options</span></a>\n    <div class=\"issue-purchase-modal\">\n        <p>For full access to this pdf, sign in to an existing account, or purchase an annual subscription.</p>\n    </div>\n    <a class=\"close-reveal-modal\" href=\"javascript:;\" data-google-interstitial=\"false\"><i class=\"icon-general-close\"></i><span class=\"screenreader-text\">Close</span></a>\n</div>\n \n    </div>\n\n    \n\n\n\n<script type=\"text/javascript\">\n    MathJax = {\n        tex: {\n            inlineMath: [['|$', '$|'], ['\\\\(', '\\\\)']]\n        }\n    };\n</script>\n<script id=\"MathJax-script\" async=\"\" src=\"//cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js\"></script>\n\n\n    <!-- CookiePro Default Categories -->\n    <!-- When the Cookie Compliance code loads, if cookies for the associated group have consent...\n         it will dynamically change the tag to: script type=text/JavaScript...\n         the code inside the tags will then be recognized and run as normal. -->\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n    <script>\n        var NTPT_PGEXTRA = 'event_type=full-text\\u0026supplier_tag=SC_Journals\\u0026object_type=Article\\u0026taxonomy=taxId%3a39%7ctaxLabel%3aAcademicSubjects%7cnodeId%3aMED00290%7cnodeLabel%3aInfectious+Diseases%7cnodeLevel%3a3\\u0026siteid=cid\\u0026authzrequired=false\\u0026doi=10.1093/cid/ciy723';\n    </script>\n    <!-- Copyright 2001-2010, IBM Corporation All rights reserved. -->\n    <script type=\"text/javascript\" src=\"//ouptag.scholarlyiq.com/ntpagetag.js\"></script>\n        <noscript>\n            <img src=\"//ouptag.scholarlyiq.com/ntpagetag.gif?js=0\" height=\"1\" width=\"1\" border=\"0\" hspace=\"0\" vspace=\"0\" alt=\"Scholarly IQ\" />\n        </noscript>\n\n\n\n\n\n\n\n\n\n\n    <script type=\"text/javascript\" src=\"//oup.silverchair-cdn.com/Themes/Client/app/jsdist/v-638847457987179340/site.min.js\"></script>\n\n\n    \n    \n    \n    <script type=\"text/javascript\" src=\"https://cdn.jsdelivr.net/chartist.js/latest/chartist.min.js\"></script>\n\n    <script type=\"text/javascript\" src=\"//oup.silverchair-cdn.com/Themes/Client/app/jsdist/v-638847457910763332/article-page.min.js\"></script>\n\n\n\n    \n\n    \n    \n\n\n\n\n    <div class=\"ad-banner js-ad-riser ad-banner-riser\">\n    <div class=\"widget widget-AdBlock widget-instance-RiserAd\">\n        \n \n    </div>\n\n    </div>\n\n\n\n                <script src=\"//oup.silverchair-cdn.com/oup/scm.proxylogging.js\"></script>\n\n    <div class=\"end-of-page-js\"></div>\n<script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML=\"window.__CF$cv$params={r:'94dd94d139d9c7f9',t:'MTc0OTYwNzkyNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);\";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script><iframe height=\"1\" width=\"1\" style=\"position: absolute; top: 0px; left: 0px; border: none; visibility: hidden;\"></iframe>\n\n\n<div data-reveal=\"math-jax-load\" id=\"math-jax-modal\" class=\"reveal-modal\" style=\"display: none;\"></div><iframe id=\"ps_sfnfo\" src=\"https://service.seamlessaccess.org/ps/\" style=\"display: none; position: absolute; top: -999px; left: -999px;\"></iframe><iframe id=\"ps_nmchahr\" src=\"https://service.seamlessaccess.org/ps/\" style=\"display: none; position: absolute; top: -999px; left: -999px;\"></iframe><script type=\"text/javascript\" src=\"https://api.altmetric.com/v1/internal-556fdf0f/doi/10.1093/cid/ciy723?callback=_altmetric.embed_callback&amp;domain=academic.oup.com&amp;cache_until=5-11\"></script><script type=\"text/javascript\" src=\"https://api.altmetric.com/v1/internal-556fdf0f/doi/10.1093/cid/ciy723?callback=_altmetric.embed_callback&amp;domain=academic.oup.com&amp;cache_until=5-11\"></script><script type=\"text/javascript\" src=\"https://api.altmetric.com/v1/internal-556fdf0f/doi/10.1093/cid/ciy723?callback=_altmetric.embed_callback&amp;domain=academic.oup.com&amp;cache_until=5-11\"></script><iframe height=\"0\" width=\"0\" style=\"display: none; visibility: hidden;\"></iframe><script type=\"text/javascript\" src=\"https://api.altmetric.com/v1/internal-556fdf0f/doi/10.1093/cid/ciy723?callback=_altmetric.embed_callback&amp;domain=academic.oup.com&amp;cache_until=5-11\"></script><iframe name=\"__tcfapiLocator\" style=\"display: none;\"></iframe><div id=\"manage-cookies\" class=\"manage-cookies-modal-sidepanel\" style=\"display: none; --primary-background: #555555; --primary-text-color: #ffffff; --primary-button-background: #9b9b9b; --modal-notice-text-color: #ffffff;\">\n      <div class=\"modal-notice-heading\">\n        <span id=\"modal-heading-icon\" class=\"modal-heading-icon\">\n          <svg stroke=\"currentColor\" fill=\"currentColor\" stroke-width=\"60px\" viewBox=\"0 0 1024 1024\" height=\"1em\" width=\"1em\" xmlns=\"http://www.w3.org/2000/svg\">\n            <path d=\"M724 218.3V141c0-6.7-7.7-10.4-12.9-6.3L260.3 486.8a31.86 31.86 0 0 0 0 50.3l450.8 352.1c5.3 4.1 12.9.4 12.9-6.3v-77.3c0-4.9-2.3-9.6-6.1-12.6l-360-281 360-281.1c3.8-3 6.1-7.7 6.1-12.6z\">\n            </path>\n          </svg>\n        </span>\n       <span>Manage Cookies</span>\n      </div>\n      <div class=\"manage-cookies-modal-wrapper\" style=\"min-height: calc(100% - 78px - 4px - 64px);\">\n        <div class=\"manage-cookies-modal-content\" id=\"manage-cookies-modal-content\">\n          <p class=\"privado-para modal-notice-text\" style=\"\n                font-weight: ;\n                text-decoration: ;\n                font-style: ;\n                \">\n                When you visit web sites, they may store or retrieve data in your web browser. This storage is often necessary for basic functionality of the web site or the storage may be used for the purposes of marketing, analytics, and personalization of the web site such as storing your preferences.\n          </p>\n              <div id=\"manage-cookies-cookielist\" class=\"manage-cookies-cookielist\">\n              </div>\n\n        </div>\n        <p id=\"privado-branding-wrap\" class=\"privado-para privado-power\" style=\"font-size: 14px; text-align: center;\">\n          Powered by <a style=\"text-decoration: none; color: inherit;\" href=\"https://privado.ai/cookie-consent\">Privado</a>\n        </p>\n      </div>\n      <div class=\"manage-cookies-save-container\" style=\"display: flex; flex-direction:row;\">\n        <button class=\"save-button-cookie-policy\" id=\"save-button\">\n          Save\n        </button>\n      </div>\n    </div><div id=\"cookie-consent-banner\" class=\"edit-modal-banner fullWidth\" style=\"background: rgb(42, 42, 42); width: 100%; margin: 0px; bottom: 0px; align-content: center;\">\n        <span id=\"banner-close-icon\" class=\"banner-close-icon\" style=\"color: #ffffff;\">\n          <svg stroke=\"currentColor\" fill=\"currentColor\" stroke-width=\"0\" viewBox=\"0 0 24 24\" height=\"1em\" width=\"1em\" xmlns=\"http://www.w3.org/2000/svg\">\n            <path d=\"M19 6.41L17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12z\">\n            </path>\n          </svg>\n        </span>\n        <div class=\"banner-content-wrapper-banner\">\n          <p class=\"privado-para banner-notice-text\" style=\"\n              font-weight: ;\n              text-decoration: ;\n              fontStyle: ;\n              color: #ffffff;\n            \">\n            Oxford University Press uses cookies to enhance your experience on our website. By selecting ‘accept all’ you are agreeing to our use of cookies. You can change your cookie settings at any time. More information can be found in our <a href=\"https://global.oup.com/cookiepolicy/?cc=gb\" target=\"_blank\" style=\"text-decoration: inherit;\">Cookie Policy</a>.\n            \n          </p>\n          <div class=\"banner-button-container\">\n            <button id=\"manage-settings-button\" class=\"banner-filled-button\" style=\"\n                display: unset;\n                background-color: #ffffff;\n                border-color: none;\n                color: #2a2a2a;\n                font-weight: ;\n                        text-decoration: ;\n                        fontStyle: ;\n              \">\n              Reject and manage\n            </button>\n            \n            <button id=\"deny-button\" class=\"banner-filled-button\" style=\"\n                display: none;\n                background-color: #ffffff;\n                border-color: none;\n                color: #2a2a2a;\n                font-weight: ;\n                text-decoration: ;\n                fontStyle: ;\n              \">\n              Deny all\n            </button>\n            <button id=\"accept-button\" class=\"banner-filled-button\" style=\"\n                display: unset;\n                background-color: #ffffff;\n                border-color: none;\n                color: #2a2a2a;\n                font-weight: ;\n                text-decoration: ;\n                fontStyle: ;\n              \">\n              Accept all\n            </button>\n          </div>\n        </div>\n      </div></body><iframe name=\"goog_topics_frame\" src=\"https://securepubads.g.doubleclick.net/static/topics/topics_frame.html\" style=\"display: none;\"></iframe></html>",
        "cleaned_html": "\n\n\n<a href=\"#skipNav\">Skip to Main Content</a>\n<div>\n<section>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>Advertisement</div>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<a href=\"/\">\n<img alt=\"Oxford Academic\" class=\"oup-header-image at-oup-header-image\" height=\"74\" src=\"//oup.silverchair-cdn.com/UI/app/svg/umbrella/oxford-academic-logo.svg\" width=\"300\"/>\n</a>\n</div> <div>\n<div>\n<div>\n<a href=\"/journals\">Journals</a>\n</div>\n<div>\n<a href=\"/books\">Books</a>\n</div>\n</div>\n</div>\n<ul>\n\n<li>\n<a href=\"/pages/information\">\n<img alt=\"Information\" class=\"sigma-info-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/i.svg\"/>\n</a>\n</li>\n\n<li>\n<a href=\"/pages/information\">\n<img alt=\"Information\" class=\"sigma-info-icon\" src=\"//oup.silverchair-cdn.com/UI/app/svg/i.svg\"/>\n</a>\n</li>\n\n</ul>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<label>\n        Navbar Search Filter\n      </label>\n<select>\n<option>Clinical Infectious Diseases</option><option>This issue</option><option>IDSA Journals</option>\n<optgroup>\n<option>Infectious Diseases</option><option>Books</option><option>Journals</option><option>Oxford Academic</option> </optgroup>\n</select>\n<label>\n      Mobile Enter search term\n    </label>\n\n</div>\n</div>\n</div>\n</div>\n<div>\n<ul>\n<li>\n<a href=\"/cid/issue\">\n          Issues\n        </a>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"/cid/advance-articles\">\n          Advance articles\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/search-results?page=1&amp;f_OUPSeries=Editor%27s+Choice\">\n          Editor's Choice\n        </a>\n</li>\n<li>\n<a href=\"/cid/supplements\">\n          Supplement Archive\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/issue-covers/\">\n          Cover Archive\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/clinical-practice-guidelines\">\n          IDSA Guidelines\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa\">\n          IDSA Journals\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/jid\">\n          The Journal of Infectious Diseases\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/ofid\">\n          Open Forum Infectious Diseases\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/clinical-dilemmas\">\n          Clinical Dilemmas in ID\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/photo-quizzes\">\n          Photo Quizzes\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/pages/state-of-the-art-reviews\">\n          State-of-the-Art Reviews\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/pages/voices-of-id\">\n          Voices of ID\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa/pages/content-collections\">\n          IDSA Content Collections\n        </a>\n</li>\n</ul>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"/cid/pages/General_Instructions\">\n          Author Guidelines\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/General_Instructions\">\n          Open Access\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/pages/why-publish\">\n          Why Publish\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa/pages/calls-for-papers\">\n          IDSA Journals Calls for Papers\n        </a>\n</li>\n</ul>\n</li>\n<li>\n<a href=\"/cid/subscribe\">\n          Purchase\n        </a>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\">\n          Advertising and Corporate Services\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising\">\n          Advertising\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\">\n          Mediakit\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/reprints\">\n          Reprints and ePrints\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/supplements\">\n          Sponsored Supplements\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/branded-books\">\n          Branded Books\n        </a>\n</li>\n</ul>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"/cid/pages/About\">\n          About Clinical Infectious Diseases\n        </a>\n</li>\n\n<li>\n<a href=\"/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf\">\n          IDSA COI Policy\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/Editorial_Board\">\n          Editorial Board\n        </a>\n</li>\n<li>\n<a href=\"/my-account/email-alerts\">\n          Alerts\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b\">\n          Self-Archiving Policy\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/For_Reviewers\">\n          For Reviewers\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa/pages/for_press_offices\">\n          For Press Offices\n        </a>\n</li>\n</ul>\n</li>\n<li>\n<a href=\"/journals\">Journals on Oxford Academic</a>\n</li>\n<li>\n<a href=\"/books\">Books on Oxford Academic</a>\n</li>\n</ul>\n</div>\n</div>\n<div>\n<div>\n<div>\n<a href=\"//academic.oup.com/idsa\">IDSA Journals</a>\n</div>\n<a href=\"/cid\">\n<img alt=\"Clinical Infectious Diseases\" class=\"journal-logo\" height=\"18\" id=\"logo-ClinicalInfectiousDiseases\" src=\"//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_title-1229789578.svg\" width=\"300\"/>\n</a>\n</div>\n</div>\n<div>\n<div>\n<nav>\n<ul>\n<li>\n<a href=\"/cid/issue\">\n          Issues\n        </a>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"/cid/advance-articles\">\n          Advance articles\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/search-results?page=1&amp;f_OUPSeries=Editor%27s+Choice\">\n          Editor's Choice\n        </a>\n</li>\n<li>\n<a href=\"/cid/supplements\">\n          Supplement Archive\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/issue-covers/\">\n          Cover Archive\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/clinical-practice-guidelines\">\n          IDSA Guidelines\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa\">\n          IDSA Journals\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/jid\">\n          The Journal of Infectious Diseases\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/ofid\">\n          Open Forum Infectious Diseases\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/clinical-dilemmas\">\n          Clinical Dilemmas in ID\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/photo-quizzes\">\n          Photo Quizzes\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/pages/state-of-the-art-reviews\">\n          State-of-the-Art Reviews\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/pages/voices-of-id\">\n          Voices of ID\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa/pages/content-collections\">\n          IDSA Content Collections\n        </a>\n</li>\n</ul>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"/cid/pages/General_Instructions\">\n          Author Guidelines\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/General_Instructions\">\n          Open Access\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/cid/pages/why-publish\">\n          Why Publish\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa/pages/calls-for-papers\">\n          IDSA Journals Calls for Papers\n        </a>\n</li>\n</ul>\n</li>\n<li>\n<a href=\"/cid/subscribe\">\n          Purchase\n        </a>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\">\n          Advertising and Corporate Services\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising\">\n          Advertising\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\">\n          Mediakit\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/reprints\">\n          Reprints and ePrints\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/supplements\">\n          Sponsored Supplements\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/branded-books\">\n          Branded Books\n        </a>\n</li>\n</ul>\n</li>\n<li>\n\n<ul>\n<li>\n<a href=\"/cid/pages/About\">\n          About Clinical Infectious Diseases\n        </a>\n</li>\n\n<li>\n<a href=\"/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf\">\n          IDSA COI Policy\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/Editorial_Board\">\n          Editorial Board\n        </a>\n</li>\n<li>\n<a href=\"/my-account/email-alerts\">\n          Alerts\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b\">\n          Self-Archiving Policy\n        </a>\n</li>\n<li>\n<a href=\"/cid/pages/For_Reviewers\">\n          For Reviewers\n        </a>\n</li>\n<li>\n<a href=\"https://academic.oup.com/idsa/pages/for_press_offices\">\n          For Press Offices\n        </a>\n</li>\n</ul>\n</li>\n</ul>\n</nav>\n<div>\n<div>\n<div>\n<div>\n<label>\n        Navbar Search Filter\n      </label>\n<select>\n<option>Clinical Infectious Diseases</option><option>This issue</option><option>IDSA Journals</option>\n<optgroup>\n<option>Infectious Diseases</option><option>Books</option><option>Journals</option><option>Oxford Academic</option> </optgroup>\n</select>\n<label>\n      Enter search term\n    </label>\n\n</div>\n</div>\n<div><a href=\"https://academic.oup.com/cid/advanced-search?page=1&amp;fl_SiteID=5269&amp;SearchSourceType=1\">Advanced Search</a></div>\n</div>\n\n</div>\n</div>\n</div>\n\n\n\n\n\n</div>\n</section>\n<div>\n<section>\n<div>\n<div>\n<div>\n<div>\n<button>Article Navigation</button>\n</div>\n<div>\n<button>\n<span>Close mobile search navigation</span>\n</button>\n<div>Article Navigation</div>\n<div>\n<div>\n<div>\n<a href=\"/cid/issue/68/9\">\n<div>\n<img alt=\"Clinical Infectious Diseases Cover Image for Volume 68, Issue 9\" class=\"fb-featured-image\" height=\"685\" id=\"issueImage\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/Issue/68/9/5/m_cover.jpeg?Expires=1752631924&amp;Signature=VzkJpzpYIXCozHbdsaIS60qWT14TRuSLuGC1eukUyrcYSb6veXmlbdxxi4bsCqv56PfMH7dlbqN9LPLYakKnZ6uSxmWg0YAZOHfQIA39tvpONvJ71boTMCgDn8RhjNDckqV16RNIXTme4fSXo-Pb1NEzqABs9EzPZHe9bQMD6FT68PV8Vap~eeaNsVp85gS3jKjGejPEgn2-XCGy4vrE3MaPHJYIAkNxsVP0hL~5pIyLW4I1ZSyrhJhH-eg8MKmfcqb5InNKbRmJkLh~-95lJfZl5LOkCkFEzHqU5URne1xaCnWjdQWfdfTDCJXggdBa~HkCJsQ92f~1fLxypv7dIQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" width=\"520\"/>\n</div>\n<div>\n<div>\n<div>Volume 68</div>\n<div>Issue 9</div>\n</div>\n<div>\n1 May 2019      </div>\n</div>\n</a>\n</div>\n</div>\n<div>\n<div>\n<h3>Article Contents</h3>\n<ul>\n<li>\n<div>\n<a href=\"#134170092\">Abstract</a>\n</div>\n</li>\n<li>\n<div>\n<a href=\"#134170097\">MATERIALS AND METHODS</a>\n</div>\n</li>\n<li>\n<div>\n<a href=\"#134170111\">RESULTS</a>\n</div>\n</li>\n<li>\n<div>\n<a href=\"#134170130\">DISCUSSION</a>\n</div>\n</li>\n<li>\n<div>\n<a href=\"#134170142\">Supplementary Data</a>\n</div>\n</li>\n<li>\n<div>\n<a href=\"#134170144\">Notes</a>\n</div>\n</li>\n<li>\n<div>\n<a href=\"#134170150\">References</a>\n</div>\n</li>\n<li>\n<div>\n<a href=\"#supplementary-data\">Supplementary data</a>\n</div>\n</li></ul>\n</div>\n</div>\n<div>\n<ul>\n<li>\n<a href=\"/cid/article/68/9/1472/5089945\">&lt; Previous</a>\n</li>\n<li>\n<a href=\"/cid/article/68/9/1494/5087661\">Next &gt;</a>\n</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<button>\n      Article Navigation\n    </button>\n</div>\n</div>\n<div>\n<div>\n<button>\n      Article Navigation\n    </button>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<span>Journal Article</span>\n</div>\n<div>\n<div>\n<h1>\n            Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients\n<i title=\"Free\"><span>Free</span></i> </h1>\n</div>\n<div>\n<div>\n<div>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Marta Francesca Di Pasquale\n</div>\n</div>\n<div>\n<div>Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Marta+Francesca+Di+Pasquale\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Giovanni Sotgiu\n</div>\n</div>\n<div>\n<div>Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Giovanni+Sotgiu\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Andrea Gramegna\n</div>\n</div>\n<div>\n<div>Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Andrea+Gramegna\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Dejan Radovanovic\n</div>\n</div>\n<div>\n<div>Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Pulmonary Unit, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Dejan+Radovanovic\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Silvia Terraneo\n</div>\n</div>\n<div>\n<div>Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Italy</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Silvia+Terraneo\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Luis F Reyes\n</div>\n</div>\n<div>\n<div>Microbiology Department, Universidad de La Sabana, Chia, Colombia</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Luis+F+Reyes\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Jan Rupp\n</div>\n</div>\n<div>\n<div>Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Jan+Rupp\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Juan González del Castillo\n</div>\n</div>\n<div>\n<div>Emergency Department, Hospital Clínico San Carlos, Universidad Complutense</div><div>Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, IdISSC, Madrid, Spain</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Juan+Gonz%c3%a1lez+del+Castillo\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Francesco Blasi\n</div>\n</div>\n<div>\n<div>Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Francesco+Blasi\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<span>\n<span>, </span>\n<span>\n<div>\n<div>\n<div>\n  Stefano Aliberti\n      \n</div>\n</div>\n<div>\n<div>Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan</div>\n</div>\n<div>\n<div>Correspondence: S. Aliberti, Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy ().</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Stefano+Aliberti\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n<a href=\"#\">\n<span>...</span> Show more\n                </a>\n<div>\n<span>\n\n<span>\n<div>\n<div>\n<div>\n  Marcos I Restrepo\n</div>\n</div>\n<div>\n<div>Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio</div>\n</div>\n<div>\n    Search for other works by this author on:\n  </div>\n<div>\n<a href=\"/cid/search-results?f_Authors=Marcos+I+Restrepo\">Oxford Academic</a>\n</div>\n\n</div> </span>\n</span>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div><em>Clinical Infectious Diseases</em>, Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, </div>\n</div>\n<div>\n<div>\n<div>Published:</div>\n<div>23 August 2018</div>\n</div>\n</div>\n<div>\n<div>\n<div>Received:</div>\n<div>24 May 2018</div>\n</div>\n<div>\n<div>Accepted:</div>\n<div>20 August 2018</div>\n</div>\n<div>\n<div>Published:</div>\n<div>23 August 2018</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<ul>\n<li>\n<a href=\"/cid/article-pdf/68/9/1482/28520951/ciy723.pdf\">\n<img alt=\"pdf\" src=\"//oup.silverchair-cdn.com/UI/app/svg/pdf.svg\"/><span>PDF</span>\n</a>\n</li>\n\n<li>\n<div>\n<a href=\"#\">\n<span>Cite</span>\n</a>\n<div>\n<h3>Cite</h3>\n<div>\n<p>Marta Francesca Di Pasquale, Giovanni Sotgiu, Andrea Gramegna, Dejan Radovanovic, Silvia Terraneo, Luis F Reyes, Jan Rupp, Juan González del Castillo, Francesco Blasi, Stefano Aliberti, Marcos I Restrepo, Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients, <em>Clinical Infectious Diseases</em>, Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, </p>\n</div>\n<div>\n<form>\n\n<label>Select Format</label>\n<select>\n<option>Select format</option>\n<option>.ris (Mendeley, Papers, Zotero)</option>\n<option>.enw (EndNote)</option>\n<option>.bibtex (BibTex)</option>\n<option>.txt (Medlars, RefWorks)</option>\n</select>\n<button>Download citation</button>\n</form>\n</div>\n</div>\n</div>\n</li>\n\n</ul>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<label>\n        Navbar Search Filter\n      </label>\n<select>\n<option>Clinical Infectious Diseases</option><option>This issue</option><option>IDSA Journals</option>\n<optgroup>\n<option>Infectious Diseases</option><option>Books</option><option>Journals</option><option>Oxford Academic</option> </optgroup>\n</select>\n<label>\n      Mobile Enter search term\n    </label>\n\n</div>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<label>\n        Navbar Search Filter\n      </label>\n<select>\n<option>Clinical Infectious Diseases</option><option>This issue</option><option>IDSA Journals</option>\n<optgroup>\n<option>Infectious Diseases</option><option>Books</option><option>Journals</option><option>Oxford Academic</option> </optgroup>\n</select>\n<label>\n      Enter search term\n    </label>\n\n</div>\n</div>\n<div><a href=\"https://academic.oup.com/cid/advanced-search?page=1&amp;fl_SiteID=5269&amp;SearchSourceType=1\">Advanced Search</a></div>\n</div>\n\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<h2>Abstract</h2>\n<section><div><div>Background</div><p>The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia.</p></div><div><div>Methods</div><p>We conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor.</p></div><div><div>Results</div><p>At least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors significantly differed across continents and countries, with chronic steroid use (45%), hematological cancer (25%), and chemotherapy (22%) the most common. Among immunocompromised patients, community-acquired pneumonia (CAP) pathogens were the most frequently identified, and prevalences did not differ from those in immunocompetent patients. Risk factors for immunocompromise were independently associated with neither <em>Pseudomonas aeruginosa</em> nor non–community-acquired bacteria. Specific risk factors were independently associated with fungal infections (odds ratio for AIDS and hematological cancer, 15.10 and 4.65, respectively; both <em>P</em> = .001), mycobacterial infections (AIDS; <em>P</em> = .006), and viral infections other than influenza (hematological cancer, 5.49; <em>P</em> &lt; .001).</p></div><div><div>Conclusions</div><p>Our findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses.</p></div></section> \n<div>, , , , </div><p>During initial evaluation of a patient coming from the community with pneumonia, the identification of possible risk factors for multidrug-resistant organisms or unusual pathogens is crucial []. Because a microbiological identification is found in about 30% of hospitalized patients with pneumonia coming from the community, and usually requires 24–48 hours to be available, most of patients are treated empirically []. Delay in initiation of appropriate empiric antibiotic therapy is a known risk factor for worse clinical outcomes []; therefore, it is relevant to promptly recognize patients at risk for specific pathogens, specially multidrug-resistant or atypical microbes [].</p><p>The aging of the population and advancements in therapeutic protocols have led to an increase prevalence of chronic diseases as well as long-term treatments with immunosuppressive agents [, ]. Thus, among patients with pneumonia coming from the community and admitted to the hospital, the number who might not be fully immunocompetent is constantly increasing [, ]. Nevertheless, the real prevalence of immunocompromise among patients with pneumonia coming from the community is still unknown. Moreover, guidelines for community-acquired and hospital-acquired pneumonia did not address this topic—what is more, they specifically excluded patients with clinical characteristics determining immunocompromise [], and current evidence in literature is also scarce.</p><p>To our knowledge, there are no studies addressing the clinical evaluation and initial empirical antibiotic coverage of patients coming from the community with pneumonia and immunocompromise. Moreover, specific risk factors to assess the causative microbiology and help clinicians choose more appropriate management for these patients have not been clearly identified. Thus, the aim of the current study was to identify the prevalence, type, microbiology, and intercorrelations between different risk factors for immunocompromise in hospitalized patients with pneumonia coming from the community.</p> <h2>MATERIALS AND METHODS</h2>\n<h3>Study Design and Population</h3>\n<p>This is a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) database []. The GLIMP study was an international, multicenter, observational, point-prevalence study of adult patients hospitalized for community-onset pneumonia in 54 countries worldwide. Patients were enrolled on a single day during the months of March, April, May, and June 2015. The methods of the GLIMP study have been published elsewhere []. The coordinating center (University of Texas Health Science Center, San Antonio) received approval from its institutional review board (No. HSC20150184E).</p><p>All adult patients (aged &gt;18 years old) coming from the community and hospitalized with pneumonia during study period were included. Pneumonia was defined as the presence of a new pulmonary infiltrate on chest radiograph at the time of hospitalization, associated with ≥1 of the following criteria: (1) new or increased cough with/without sputum production and/or purulent respiratory secretions, (2) fever or hypothermia, and (3) evidence of systemic inflammation (ie, abnormal white blood cell count or increased C-reactive protein or procalcitonin level). Hospitalized patients with a diagnosis of hospital-acquired or ventilator-associated pneumonia were excluded.</p> <h3>Data Collection</h3>\n<p>Data were collected from medical records at the time of hospital admission. Data gathered included demographics; respiratory and cardiovascular comorbid conditions; immunocompromised status and other chronic medical conditions; severity of pneumonia (defined as either intensive care unit admission, use of invasive or noninvasive mechanical ventilation, or use of vasopressors/inotropes during the first 24 hours after hospital admission); and specific risk factors for resistant pathogens infection, including chronic aspiration, being bedridden, malnutrition, presence of enteric tube feeding and indwelling catheters (including central venous and urinary catheters), previous infections, chronic microbial colonization, and previous healthcare exposures. The number and type of microbiological samples obtained within 24 hours after hospital admission were also collected. Culture-positive tests, kind of sample, and antibiotic resistance patterns were also gathered, along with empiric antibiotic treatment, given within 24 hours after hospital admission.</p> <h3>Microbiological Workup</h3>\n<p>Diagnostic testing was performed according to local standard operating procedures and included collection of respiratory and blood cultures and testing for urinary antigens. Microbiological examinations and susceptibility testing were performed according to local standard protocols within the first 24 hours after hospital admission []. Multivariable logistic regression models were performed for patients who had a positive culture, to identify specific risk factors for single pathogens.</p><p>Causative pathogens were stratified according to the coverage of standard therapy for community-acquired pneumonia (CAP) []. Those not covered by standard CAP therapy included the following: non–community-acquired bacteria (<em>Acinetobacter baumanii</em>, <em>Enterococcus</em> vancomycin-resistant, <em>Nocardia</em> spp.), mycobacteria, fungi (<em>Aspergillus fumigatus, Coccidioides, Criptococcus</em>, <em>Pneumocystis jirovecii</em>), and viruses other than influenza []. Those covered by standard CAP therapy included <em>Pseudomonas aeruginosa,</em> methicillin-resistant <em>Staphylococcus aureus</em>, methicillin-sensitive <em>S. aureus</em>, <em>Enterobacter</em> spp., <em>Enterococcus</em> spp., <em>Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae</em>, <em>Moraxella catarrhalis, Proteus mirabilis, Serratia marcescens, Streptococcus pneumoniae, Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella pneumophilia,</em> anaerobes bacteria, and influenza viruses. Atypical pathogens included <em>C. pneumoniae, M. pneumoniae,</em> and <em>L. pneumophilia.</em> CAP therapy was defined as β-lactams (ceftriaxone, ampicillin-sulbactam, amoxicillin-clavulanate, cefepime, ceftazidime, piperacillin-tazobactam) plus macrolide, or fluoroquinolones alone, and, eventually, in association with vancomycin, linezolid, or oseltamivir [].</p> <h3>Definition of Immunocompromised and Study Groups</h3>\n<p>Immunocompromise was defined as the presence of ≥1 of the following risk factors: (1) AIDS, defined either as human immunodeficiency virus infection with CD4<sup>+</sup> lymphocyte count &lt;200/µL or by the occurrence of AIDS-defining conditions; (2) aplastic anemia; (3) asplenia; (4) hematological cancer, defined as lymphoma, acute or chronic leukemia, or multiple myeloma; (5) chemotherapy during the last 3 months; (6) neutropenia, defined as a neutrophil count &lt;500/dL at complete blood cell count; (7) biological drug use (including trastuzumab and therapies for autoimmune diseases, eg, anti–tumor necrosis factor α, prescribed during ≥6 months before hospital admission); (8) lung transplantation; (9) chronic steroid use (&gt;10 mg/d of prednisone or equivalent ≥3 months before hospital admission); (10) lung cancer with either neutropenia or chemotherapy; (11) other solid tumor with either neutropenia or chemotherapy; (12) other immunocompromise (any immunocompromised state, including congenital/genetic immunocompromise and immunosuppressive therapy due to hematological cancer/solid organ transplantation other than lung). Two study groups were identified: those with versus those without 1 risk factor for immunocompromise.</p> <h3>Statistical Analysis</h3>\n<p>Categorical variables, expressed as counts (percentages), were compared using the χ<sup>2</sup> test. Continuous variables were compared using the unpaired Student <em>t</em> test or the Mann-Whitney test, when appropriate. Statistical significance was defined as <em>P</em> &lt; .05. A network analysis was conducted to represent the frequencies of all immunocompromise variables and their relationships. The size of the circles (the circles visible in Figure 4 [network analysis], each representing a single risk factor for immunocompromise) represents both prevalence of the risk factor and strength of association with other variables.</p><p>The predictive value of each variable was categorized by quartiles and analyzed using a univariate regression logistic analysis. A multivariable model was obtained using a Cox regression analysis to identify independent predictors of specific pathogens, using an entry level of P value ≤0.05 and a removal level of P value ≥0.10. Hazard ratios and adjusted analyses were obtained. All statistical analyses were performed with IBM SPSS software (version 22, Statistics for Mac; version 22.0, IBM Crop), and Stata 13 software (StataCorp).</p> <h2>RESULTS</h2>\n<h3>Prevalence of Risk Factors for Immunocompromise</h3>\n<p>Among 3702 patients enrolled in the GLIMP database, ≥1 risk factor for immunocompromise was identified in 652 (17.6%). The prevalences of patients with pneumonia coming from the community and with ≥1 risk factor for immunocompromise differed among continents and countries, as depicted in and . The prevalence of immunocompromise was significantly higher in both North and South America than in the rest of the world (24.0% vs 16.5 [<em>P</em> &lt; .001] and 24.8% vs 17.2 [<em>P</em> = .006], respectively) ().</p> \n<div><div><img alt=\"Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, &lt;5%, 5%–10%, 11%–20%, 21%–30%, or &gt;30% of total cases.\" class=\"content-image\" data-path-from-xml=\"ciy72301.jpg\" height=\"462\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1752554620&amp;Signature=LKXAyrV74Aa9owXe0o-cQ75pOeSoID0-pehgygNtPZSFXNZMuhHSvh2bH2dv7qW8hH1yagXom1UIMLOtWgjAeeVu2LBuha-~CcDB2tnoDsCwd0W--ENWiqmCFTxq3yC2TQ0Umx7W~VJXwN6SRKyfDOflOkKvPGRNUobFX0ugYVCV63UYBnlhdsPfvI-fsKpp2D2I1PP6zBaXvsJbvI-0aIPK7XN9D-bkImy~2jyh7YxMl-ml056-m9M~e1NXIC1G-eMlJ-D0ihNbxsU~I2x~~h2BWrtr8AE9Sfu1WTqiFahp57mH4~iFGY9EkQkC4xJpjMyNKtQFhxpXjvQtYLzecQ__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" width=\"520\"/><div><div>Figure 1.</div><div><p>Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, &lt;5%, 5%–10%, 11%–20%, 21%–30%, or &gt;30% of total cases.</p></div><div><a href=\"/view-large/figure/134170114/ciy72301.jpg\">Open in new tab</a><a href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72301.jpeg?Expires=1752554620&amp;Signature=NHcEJwNnhhuu~V7litr8igr9GFWfZ0zM0SxlfYOwAgN3ag3nsCMd9zXKoM9GZWcSFeGB~KznckX3sjRs7eZI6UovzOYWd5ChB8QCKT6DbvXvsAyPCY~~tvyw1nLgnCRXHxsEp9~pCDA4jyfmGwdzBmIxjxK32DKPE3r03H1NwaFfFuqtTjvCIQz2eID2dBiK~4lTbznS4INQ66i-Fh9DwTzI-HwYqclm24aYv1pSYlAiswZHOwaE-fO6wkuUxDcfD3pvVFQ~xscKfiFVbOt91lXVNkOd7p4CKoSAgaQv6yr5WZ9-7z1VyiIThnhC9G~HPkbIlB2Do4fo0jz7V2xwPA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170114&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\">Download slide</a></div></div></div></div><p>The prevalence of each risk factor for immunocompromise is depicted in , with chronic steroid use (45.0%), hematological cancer (25.0%), and chemotherapy (22.0%) being the most frequent ones. A total of 312 patients (8.4%) had &gt;1 risk factor for immunocompromise ().</p> \n<div><div><img alt=\"Prevalence of each single risk factor for immunocompromise.\" class=\"content-image\" data-path-from-xml=\"ciy72302.jpg\" height=\"304\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72302.jpeg?Expires=1752554620&amp;Signature=tN-5VXAN-IRDKK8axKZA8P~Y5z--s9j8Erc8SOjWl6DrKKH4QL5os9eZxhVeV6eWVN~f~VDG9tfzyHUF6i7OVsMNB2vsk6C~94Qv-2aRHoy5JP-aM-LrL8khDyqEa4Lg2BfInF3Q0qGwXrmt25GlH1qSBKirMgS~VlVo9FK3dUDe2-XgCIv-DixycDR1NbxEUad1obLBQi7T-cMZnDc0-hSXzSelH07q4yY8dbVGxrERuy5IWOvusZ1u83w1jCK4dSvt3hPFFdMZMOmGLi~Fj-dVSs0cAjfbIHoEDmqErTby4pVDEijEs5muQVm-Ux~YEjgN-VhvWj8YtpZKL4eSXA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" width=\"520\"/><div><div>Figure 2.</div><div><p>Prevalence of each single risk factor for immunocompromise.</p></div><div><a href=\"/view-large/figure/134170116/ciy72302.jpg\">Open in new tab</a><a href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72302.jpeg?Expires=1752554620&amp;Signature=urCgidlWbN7Br1gKnVthRjYFEVioagJuBFmiXPuQQBoD2qmTrm4Heidc21Yt1dgPswbIwC7DPhnYrlHrjxMxL-tPDfinKG-olgkospAEDA-ocZW5BuK9lYsha0rJ0NF76fxfhqDzGVUbNAug3anPLTq4c4Wm9hmTgaDN4Qc2ECcT8hDYAnEm3od96dWn52Zy09JsZa4zT41kMG~qQJEZG62~24b5nEIG7eSCncOceqVPqOOaaIMniBLrAQuB7Hvqr~6AtHN5IBjBuLUjU1xYJcFJXX6WtIhnqkXKN21GOO7O7AU0AC7FLWQuEd1zCcVocKQxVv4RndCQeZ3XzZvegA__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170116&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\">Download slide</a></div></div></div></div> \n<div><div><img alt=\"Prevalence of the number of risk factors present simultaneously in a single patient.\" class=\"content-image\" data-path-from-xml=\"ciy72303.jpg\" height=\"245\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72303.jpeg?Expires=1752554620&amp;Signature=Xts16a6pXvQbNfwKtUeejfXsqF17z~2gviy7VcLQhhckWHmCw0zRSSEtsyrG9SkI2LRw39TbhqnqYNb1VTXQKD-ybyHkb~R3s-eIxJ~94DOxaaXBbUvpzbvwY1vDACc5LpVzJJ8dZMntZ7nekvhgMs6NtlpySVWDDC~7ybF0bySgW6i55FBFevIdcUxB3ipChEHL9XiTlmDkdiHssMser494UBvbDyg4DUKM-Cpd988M8qpSwp-eg-3Yhkr9q2~L66QQUhwgYNILWRRA1azwsTAJvrWUq52Dpikbj4mzbXXstnhvc7GNMw5xxz6nFPKuHVKJlcE-HQsiIvj5ZOVUxg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\" width=\"520\"/><div><div>Figure 3.</div><div><p>Prevalence of the number of risk factors present simultaneously in a single patient.</p></div><div><a href=\"/view-large/figure/134170117/ciy72303.jpg\">Open in new tab</a><a href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72303.jpeg?Expires=1752554620&amp;Signature=aODZPs-HRl9QmymSK-5bkx~xp6iLrndvYFKxy1ge9DczmeUzsNnr5McNlvqrMcXHLvgMkhfK7yT7VuvVZQyJiTDmkR2j-SEc5zFcORnQPNUjDvGORdypfvcWI0ap8MKwHNe5lyBn4KtJz~tW8Oy3Gx54ukE8wke7~kZBzMvO8MTOkttiu8JkRKLQBqO6IcM2MoQBEcRSt-iQJjHBC9eSqzTw9hfjbhfc1npEBjHchP6v69RipZnUipM4HSTXcHzcLlv5ZrElufmBjKlaCOuMXehhls70RLfvTvOnOA3AyEmOSecyKEGpTAKKWMZCZcKwFjPqwgrO2KIMNHBcdECFyg__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170117&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\">Download slide</a></div></div></div></div> <h3>Network Analysis Among Risk Factors for Immunocompromise</h3>\n<p>The results of the network analysis of all risk factors for immunocompromise are depicted in . Relationships were identified between chemotherapy and solid tumor other than lung cancer, hematological cancer, and chronic steroid use, and between other immunocompromise and chronic steroid use.</p> \n<div><div><img alt=\"Network analysis between risk factors for immunocompromise.\" class=\"content-image\" data-path-from-xml=\"ciy72304.jpg\" src=\"https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72304.jpeg?Expires=1752554620&amp;Signature=GuJUcrEhLaMR89vfrhqqYuGyB4HuDlfLUgnHqNu6Ksi5VkLMWjSpH0hVJWv0i4hnesvCDRYbQ~uAyBQyQ0AiLXq2xGVhq3CJd~~Uo~xFEO2RNWWcv5izwBv2Xd~h9Hdfe0hTA-AXnTA7hKM-ThAaURdGnReCFddtKpqnLFFI8QBpZfiXaSjcJTGzuOJpCX41BN9EmgqXfVfeCV2WjdANqIm2R0p4fJbe8r3T6ykoQ1g-IoQnAttT~9TBNl6irCxSuhZHs693bn8ZNDwodNBEKnNGVKaV3sMa8zH8GthYrKb1ARcjtit4vlO4Amlu5qUEW4FRAzxNeE5ch2OPPqoZ6g__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA\"/><div><div>Figure 4.</div><div><p>Network analysis between risk factors for immunocompromise.</p></div><div><a href=\"/view-large/figure/134170120/ciy72304.jpg\">Open in new tab</a><a href=\"/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72304.jpeg?Expires=1752554620&amp;Signature=YZzJ1wJWugBQStvfJV4l4KYj3Wo9NRpieCO~yvNqxtUBWQdjFeAYbw2G-Y6DLCVNq9Va5VeID5cdns-ikSqf31HJSxkU6nJ2ORJtfKpX9YRK1R4udPlHilZw7ywCq-EzR6AMwb3sY-BfsBS4sDesTOwvKTu1-DzRuTpqruza-~yCWEOuDxUkBBBhGOjezpmaPE1pK9FuWVCTdWQjhWi0Q1hWTQx8Y41~JVb3kGWNigqT8AD4v9JX1c4I3Lv7PwLI68bVFaY9GUswC-yS1tvJbrugsyrYyCUrS~h7Si20MQ14RfW5c61orGDtUvAkaoknOVddjBXj5tv5wBq7Hieh4A__&amp;Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&amp;sec=134170120&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;imagename=&amp;siteId=5269\">Download slide</a></div></div></div></div> <h3>Clinical and Microbiological Characteristics of Patients With Immunocompromise</h3>\n<p>Clinical features and disease severity of immunocompetent versus immunocompromised patients are shown in and . Immunocompromised patients were significantly younger and malnourished, had a higher frequency of comorbid conditions, previous infections, and colonization by resistant pathogens, and had more frequent contacts with the healthcare system. The prevalences of severe pneumonia did not differ among the 2 study groups.</p> \n<div><div><div><span>Table 1.</span><div><a href=\"\n                /view-large/134170123\">\n              Open in new tab\n            </a></div><div><p>Clinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised)</p></div> </div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>Patients, No. (%)<sup>a</sup><span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 3050)<span>\n      . </span></th><th>Immunocompromised(n = 652)<span>\n      . </span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>Patients, No. (%)<sup>a</sup><span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 3050)<span>\n      . </span></th><th>Immunocompromised(n = 652)<span>\n      . </span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div><div><span><p>Abbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors.</p></span></div><div><span><p><sup>a</sup>Data represent No. (%) unless otherwise specified.</p></span></div></div></div></div><div><div><div><span>Table 1.</span><div><a href=\"\n                /view-large/134170123\">\n              Open in new tab\n            </a></div><div><p>Clinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised)</p></div> </div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>Patients, No. (%)<sup>a</sup><span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 3050)<span>\n      . </span></th><th>Immunocompromised(n = 652)<span>\n      . </span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>Patients, No. (%)<sup>a</sup><span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 3050)<span>\n      . </span></th><th>Immunocompromised(n = 652)<span>\n      . </span></th></tr></thead><tbody><tr><td>Age, median (IQR)</td><td>69 (54–81)</td><td>65 (52–74)</td><td>&lt;.001</td></tr><tr><td>Underweight</td><td>125 (6.5)</td><td>41 (10.5)</td><td>.004</td></tr><tr><td>Malnutrition</td><td>243 (8.0)</td><td>80 (12.3)</td><td>&lt;.001</td></tr><tr><td>Bedridden</td><td>355 (11.6)</td><td>60 (9.2)</td><td>.04</td></tr><tr><td>Chronic aspiration</td><td>224 (7.3)</td><td>33 (5.1)</td><td>.02</td></tr><tr><td>Bronchiectasis</td><td>136 (4.5)</td><td>42 (6.4)</td><td>.03</td></tr><tr><td>Severe COPD</td><td>72 (2.4)</td><td>28 (4.3)</td><td>.006</td></tr><tr><td>Interstitial lung disease</td><td>60 (2.0)</td><td>35 (5.4)</td><td>&lt;.001</td></tr><tr><td>Lung transplantation</td><td>0 (0.0)</td><td>7 (1.1)</td><td>&lt;.001</td></tr><tr><td>Tracheostomy</td><td>37 (1.2)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Hypertension</td><td>1401 (45.9)</td><td>254 (39.0)</td><td>.001</td></tr><tr><td>Liver disease</td><td>103 (3.4)</td><td>37 (5.7)</td><td>.005</td></tr><tr><td>Cirrhosis</td><td>50 (1.6)</td><td>20 (3.1)</td><td>.02</td></tr><tr><td>Dementia</td><td>372 (12.2)</td><td>36 (5.5)</td><td>&lt;.001</td></tr><tr><td>Enteral tube feeding</td><td>36 (1.2)</td><td>16 (2.5)</td><td>.01</td></tr><tr><td>Chronic renal failure</td><td>315 (10.3)</td><td>85 (13.0)</td><td>.04</td></tr><tr><td>Hemodialysis</td><td>34 (1.1)</td><td>18 (2.8)</td><td>.001</td></tr><tr><td>ICS use</td><td>462 (15.2)</td><td>128 (19.6)</td><td>.005</td></tr><tr><td>PPI use</td><td>777 (25.5)</td><td>251 (38.5)</td><td>&lt;.001</td></tr><tr><td>Indwelling catheter</td><td>52 (1.7)</td><td>27 (4.1)</td><td>&lt;.001</td></tr><tr><td>Prior mycobacteria diseases</td><td>70 (2.3)</td><td>26 (4.0)</td><td>.01</td></tr><tr><td>Prior ESBL</td><td>39 (1.3)</td><td>16 (2.5)</td><td>.02</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>68 (2.2)</td><td>33 (5.1)</td><td>&lt;.001</td></tr><tr><td>Severe CAP</td><td>840 (27.5)</td><td>190 (29.1)</td><td>.41</td></tr></tbody></table></div><div><div><span><p>Abbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors.</p></span></div><div><span><p><sup>a</sup>Data represent No. (%) unless otherwise specified.</p></span></div></div></div></div><p>Microbiological testing was performed in 91.0% (596 of 652) of immunocompromised and 86.0% (2626 of 3050) of immunocompetent patients (<em>P</em> &lt; .001). Bacteremia was found in 6.0% (36 of 596) of immunocompromised and 5.5% (145 of 2626; <em>P</em> = .62) of immunocompetent patients. At least 1 positive culture was obtained in 40.0% (238 of 596) immunocompromised and 36.0% (935 of 2626) immunocompetent patients (<em>P</em> = .047). Microbiological findings are provided in and . Among pathogens covered by standard therapy, <em>P. aeruginosa</em> was more prevalent in immunocompromised patients (35 [5.9%] vs 98 [3.7%] patients; <em>P</em> &lt; .02). Among pathogens not usually covered by standard therapy, immunocompromised patients were more likely to be infected by <em>Nocardia</em> spp. (4 [0.7%] vs 0 [0%] patients; <em>P</em> &lt; .001), nontuberculous mycobacteria (NTM) (5 [0.8%] vs 2 [0.1%]; <em>P</em> &lt; .002), <em>A. fumigatus</em> (8 [1.3%] vs 10 [0.4%]; <em>P</em> &lt; .01), <em>P. jirovecii</em> (12 [2.0%] vs 5 [0.2%]; <em>P</em> &lt; .02), and viruses, such as coronavirus (3 [0.5%] vs 3 [0.1%]; <em>P</em> &lt; .047), and respiratory syncytial virus (6 [1.0%] vs 7 [0.3%]; <em>P</em> &lt; .03).</p> \n<div><div><div><span>Table 2.</span><div><a href=\"\n                /view-large/134170125\">\n              Open in new tab\n            </a></div><div><p>Pathogens in the 2 Study Groups</p></div> </div><div><table><thead><tr><th>Pathogen<span>\n      . </span></th><th>Patients, No. (%)<span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 2626)<span>\n      . </span></th><th>Immunocompromised (n = 596)<span>\n      . </span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div><table><thead><tr><th>Pathogen<span>\n      . </span></th><th>Patients, No. (%)<span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 2626)<span>\n      . </span></th><th>Immunocompromised (n = 596)<span>\n      . </span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div><div><span><p>Abbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant <em>Staphylococcus aureus</em>; MSSA, methicillin-sensitive <em>S. aureus</em>; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus.</p></span></div></div></div></div><div><div><div><span>Table 2.</span><div><a href=\"\n                /view-large/134170125\">\n              Open in new tab\n            </a></div><div><p>Pathogens in the 2 Study Groups</p></div> </div><div><table><thead><tr><th>Pathogen<span>\n      . </span></th><th>Patients, No. (%)<span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 2626)<span>\n      . </span></th><th>Immunocompromised (n = 596)<span>\n      . </span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div><table><thead><tr><th>Pathogen<span>\n      . </span></th><th>Patients, No. (%)<span>\n      . </span></th><th><em>P</em> Value<span>\n      . </span></th></tr><tr><th>Immunocompetent (n = 2626)<span>\n      . </span></th><th>Immunocompromised (n = 596)<span>\n      . </span></th></tr></thead><tbody><tr><td>Pathogens covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> <em>Streptococcus pneumoniae</em></td><td>218 (8.3)</td><td>50 (8.4)</td><td>&gt;.99</td></tr><tr><td> Atypical</td><td>50 (1.9)</td><td>13 (2.2)</td><td>.78</td></tr><tr><td> <em>Legionella</em></td><td>21 (0.8)</td><td>10 (1.7)</td><td>.08</td></tr><tr><td> MRSA</td><td>83 (3.2)</td><td>12 (2.0)</td><td>.17</td></tr><tr><td> MSSA</td><td>73 (2.8)</td><td>20 (3.4)</td><td>.53</td></tr><tr><td> <em>Pseudomonas aeruginosa</em></td><td>98 (3.7)</td><td>35 (5.9)</td><td>.02</td></tr><tr><td> <em>Haemophilus influenzae</em></td><td>65 (2.5)</td><td>10 (1.7)</td><td>.31</td></tr><tr><td> <em>Klebsiella pneumoniae</em></td><td>89 (3.4)</td><td>22 (3.7)</td><td>.81</td></tr><tr><td> Influenza virus</td><td>126 (4.8)</td><td>28 (4.7)</td><td>&gt;.99</td></tr><tr><td>Pathogens not covered by CAP therapy</td><td></td><td></td><td></td></tr><tr><td> Non-CAP bacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Acinetobacter baumanii</em></td><td>33 (1.3)</td><td>7 (1.2)</td><td>&gt;.99</td></tr><tr><td>  <em>Nocardia</em> spp.</td><td>0 (0.0)</td><td>4 (0.7)</td><td>&lt;.001</td></tr><tr><td> Mycobacteria</td><td></td><td></td><td></td></tr><tr><td>  <em>Mycobacterium tuberculosis</em></td><td>21 (0.8)</td><td>5 (0.8)</td><td>&gt;.99</td></tr><tr><td>  NTM</td><td>2 (0.1)</td><td>5 (0.8)</td><td>.002</td></tr><tr><td>Fungi</td><td></td><td></td><td></td></tr><tr><td> <em>Aspergillus fumigatus</em></td><td>10 (0.4)</td><td>8 (1.3)</td><td>.01</td></tr><tr><td> <em>Actinomyces</em></td><td>2 (0.1)</td><td>0 (0.0)</td><td>&gt;.99</td></tr><tr><td> <em>Cryptococcus</em></td><td>3 (0.1)</td><td>0 (0.0)</td><td>.94</td></tr><tr><td> <em>Pneumocystis jirovecii</em></td><td>5 (0.2)</td><td>13 (2.2)</td><td>&lt;.001</td></tr><tr><td>Viruses</td><td></td><td></td><td></td></tr><tr><td> Adenovirus</td><td>5 (0.2)</td><td>0 (0.0)</td><td>.62</td></tr><tr><td> Coronavirus</td><td>3 (0.1)</td><td>3 (0.5)</td><td>.047</td></tr><tr><td> Metapneumovirus</td><td>3 (0.1)</td><td>2 (0.3)</td><td>.51</td></tr><tr><td> RSV</td><td>7 (0.3)</td><td>6 (1.0)</td><td>.03</td></tr><tr><td>MDR pathogens</td><td>231 (8.8)</td><td>54 (9.0)</td><td>.54</td></tr></tbody></table></div><div><div><span><p>Abbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant <em>Staphylococcus aureus</em>; MSSA, methicillin-sensitive <em>S. aureus</em>; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus.</p></span></div></div></div></div><p>Once adjusted for confounders, no risk factors of immunocompromise have been recognized for <em>P. aeruginosa</em> infection. Likewise, pathogens not covered by usual CAP therapy were found to be associated not with immunocompromise but with chronic obstructive pulmonary disease (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.07–2.99; <em>P</em> = .03), tracheostomy (2.91; 1.01–8.38; <em>P</em> = .048), and severe pneumonia (2.36; 1.42–3.93; <em>P</em> = .001) ().</p> \n<div><div><div><span>Table 3.</span><div><a href=\"\n                /view-large/134170127\">\n              Open in new tab\n            </a></div><div><p>Multivariable Logistic Regression Analysis</p></div> </div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>OR (CI 95%)<span>\n      . </span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span>\n      . </span></th><th>Non-CAP Bacteria<span>\n      . </span></th><th>Fungi<span>\n      . </span></th><th><em>Mycobacterium tuberculosis</em><span>\n      . </span></th><th>Virus Other Than Influenza<span>\n      . </span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36(1.42–3.93)</td><td>…</td><td>…</td><td>2.56(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65(1.85–11.69)</td><td>…</td><td>5.49(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>OR (CI 95%)<span>\n      . </span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span>\n      . </span></th><th>Non-CAP Bacteria<span>\n      . </span></th><th>Fungi<span>\n      . </span></th><th><em>Mycobacterium tuberculosis</em><span>\n      . </span></th><th>Virus Other Than Influenza<span>\n      . </span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36(1.42–3.93)</td><td>…</td><td>…</td><td>2.56(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65(1.85–11.69)</td><td>…</td><td>5.49(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div><div><span><p>Blank cells indicate no statistical significancy.</p></span></div><div><span><p>Abbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio.</p></span></div></div></div></div><div><div><div><span>Table 3.</span><div><a href=\"\n                /view-large/134170127\">\n              Open in new tab\n            </a></div><div><p>Multivariable Logistic Regression Analysis</p></div> </div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>OR (CI 95%)<span>\n      . </span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span>\n      . </span></th><th>Non-CAP Bacteria<span>\n      . </span></th><th>Fungi<span>\n      . </span></th><th><em>Mycobacterium tuberculosis</em><span>\n      . </span></th><th>Virus Other Than Influenza<span>\n      . </span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36(1.42–3.93)</td><td>…</td><td>…</td><td>2.56(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65(1.85–11.69)</td><td>…</td><td>5.49(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div><table><thead><tr><th>Variable<span>\n      . </span></th><th>OR (CI 95%)<span>\n      . </span></th></tr><tr><th><em>Pseudomonas aeruginosa</em><span>\n      . </span></th><th>Non-CAP Bacteria<span>\n      . </span></th><th>Fungi<span>\n      . </span></th><th><em>Mycobacterium tuberculosis</em><span>\n      . </span></th><th>Virus Other Than Influenza<span>\n      . </span></th></tr></thead><tbody><tr><td>Severe COPD</td><td>2.89 (1.34–6.22)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Tracheostomy</td><td>6.95 (2.87–16.85)</td><td>2.91(1.01–8.38)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>ICS use</td><td>1.76 (1.09–2.82)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Indwelling catheter</td><td>2.49 (1.02–6.06)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Prior <em>Pseudomonas</em></td><td>19.20(11.71–31.50)</td><td>…</td><td>…</td><td>…</td><td>…</td></tr><tr><td>COPD</td><td>…</td><td>1.78(1.07–2.99)</td><td>…</td><td>…</td><td>…</td></tr><tr><td>Severe CAP</td><td>…</td><td>2.36(1.42–3.93)</td><td>…</td><td>…</td><td>2.56(1.27–5.19)</td></tr><tr><td>AIDS</td><td>…</td><td>…</td><td>15.10(6.36–35.88)</td><td>…</td><td>…</td></tr><tr><td>Hematological cancer</td><td>…</td><td>…</td><td>4.65(1.85–11.69)</td><td>…</td><td>5.49(2.20–13.70)</td></tr><tr><td>Malnutrition</td><td>…</td><td>…</td><td>…</td><td>5.14 (2.21–11.93)</td><td>…</td></tr></tbody></table></div><div><div><span><p>Blank cells indicate no statistical significancy.</p></span></div><div><span><p>Abbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio.</p></span></div></div></div></div><p>Results showed that AIDS (OR, 15.10; 95% CI, 6.36–35.88; <em>P</em> ≤ .001) and hematological cancer (4.65; 91.85–11.69; <em>P</em> = .001) were independently associated with fungal infections; hematological cancer (5.49; 2.20–13.70; <em>P</em> &lt; .001) and severe pneumonia (2.56; 1.27–5.19; <em>P</em> = .009) with infection by viruses other than influenza; and AIDS (4.41; 1.53–12.73; <em>P</em> = .006) and malnutrition (4.50; 2.08–9.72; <em>P</em> &lt; .001) with mycobacterial infections. An additional analysis was conducted on mycobacteria, including <em>M. tuberculosis</em> and NTM. At multivariable analysis, <em>M. tuberculosis</em> was independently associated with malnutrition only (OR, 5.14; 95% CI, 2.21–11.93; <em>P</em> &lt; .001). At univariate analysis, patients with AIDS were at higher risk for NTM (23.06; 4.39–121.12; <em>P</em> &lt; .001).</p><p>A subanalysis was conducted among patients with chronic steroid use versus other risk factors for immunocompromise. Patients with chronic steroid use seemed to be more frequently affected by bacteria not covered by standard CAP therapy (10 [3.4%] vs 1 [0.3%] patients; <em>P</em> = .002), <em>Nocardia</em> spp. in particular (4 [0.4%] vs 0 [0.0%]; <em>P</em> = .03). No differences in the severity of the disease were found (see ).</p> <h2>DISCUSSION</h2>\n<p>The main findings of the present study are as follows: (1) 17.6% of patients admitted with pneumonia from the community have ≥1 risk factor for immunocompromise, with significant differences among continents and countries (ranging from 15.4% to 24.8% by continent and from 80.0% to 4.1% by country); (2) chronic steroid use is by far the most prevalent risk factor leading to immunocompromise, followed by hematological cancer and chemotherapy; (3) 1 of 2 immunocompromised patients has an overlap of ≥2 risk factors, which are also associated between one another in different ways; and (4) the 2 risk factors for immunocompromise independently associated with specific pathogens are AIDS (ie, fungal and mycobacterial infections) and hematological cancer (ie, fungal infection and viral infections other than influenza).</p><p>Almost 1 in 5 hospitalized patients with CAP are not immunocompetent. Therefore, it is mandatory to provide clinicians with recommendations or guidelines for the management of hospitalized patients with pneumonia coming from the community who have risk factors for immunocompromise. Currently, there are no guidelines for assessing pneumonia in immunocompromised patients coming from the community. Randomized controlled trials (RCTs) and observational prospective studies are missing owing to the fact that, generally, studies assessing management strategies for pneumonia exclude immunocompromised patients or take into account only a single specific risk factor []. This lack of information about immunocompromise could lead to both underestimation of the real prevalence with a higher rate of treatment failure and to overestimation and overuse of wide-spectrum antibiotics.</p><p>We found a 17.6% global prevalence of immunocompromise among patients coming from the community with pneumonia, with a significantly higher frequency in South and North America. This variability among continents and countries is probably attributable to different healthcare systems and rates of hospitalization of immunocompromised patients. Our analysis showed that the most frequent risk factor for immunocompromise is the chronic use of systemic steroids. Aging of the population and therapeutic advancements have favored the increased burden of chronic diseases and long-term therapies with immunosuppressive agents [, ]. In particular, steroids are the agents most frequently prescribed, for their wide spectrum of efficacy in several diseases [, , ]. Therefore, many patients presenting to the emergency room with pneumonia are receiving chronic steroid treatment. No data are available on this population group, and further studies are needed to characterize these patients and provide individualized management.</p><p>Hematological cancer and chemotherapy were other leading immunocompromised factors. These findings are consistent with those in previous studies; patients recruited in observational studies include patients with solid or hematological cancer and those who underwent chemotherapy with associated neutropenia [, ]. Dedicated guidelines and recommendations are available, especially on respiratory viruses, fungi, and <em>P. jirovecii</em> [].</p><p>Our network analysis showed that several risk factors for immunocompromise show associations, especially chemotherapy, associated with hematological cancer and solid tumor, and other immunocompromise, associated with chronic steroid use. Moreover, neutropenic patients are well represented and mainly affected also by hematological cancer or under treatment with chemotherapy. Our results suggest that patients may have &gt;1 risk factor characteristic and clinical assessment should be comprehensive, taking into consideration risk factors for immunocompromise and their associated biological mechanisms. In contrast, AIDS, lung transplantation, asplenia, and aplastic anemia seem to be less frequent at admission and to represent distinct clinical entities. Findings of previous studies seem to be in line with our results, with AIDS patients considered as a distinct patient population and with very few observational studies available on asplenia and aplastic anemia [, ]</p><p>In agreement with previous reports, <em>S. pneumoniae</em> is the leading microorganism in both immunocompromised and immunocompetent groups [, ]. Among pathogens covered by standard CAP therapy, only <em>P. aeruginosa</em> was more frequently isolated in immunocompromised compared with immunocompetent patients. These findings differ from microbiological results of previous studies. Gram-positive bacteria, especially <em>S. aureus</em>, were more frequently identified in patients with immunocompromise of different causes [, , ]. Only Li and coauthors [] found patients with immunological disorders, treated with systemic steroids and cytotoxic agents, to have a higher incidence of infections caused by gram-negative bacteria, mainly <em>P. aeruginosa</em>. This similarity with our findings could be explained by the prevalence of patients exposed to chronic steroids in our cohort.</p><p>Among pathogens not covered by standard CAP therapy, immunocompromised patients were more frequently infected by <em>Nocardia</em> spp., NTM, <em>P. jirovecii</em>, <em>A. fumigatus</em>, and viruses other than influenza. Infections by <em>P. jirovecii</em> and NTM are frequently identified in patients with AIDS []. <em>P. jirovecii</em> is also frequent in other types of immunocompromise, such as solid or hematological cancer in patients who underwent chemotherapy [, , ]. Fungal infections (eg, <em>Candida</em> spp. and <em>A. fumigatus</em>) are highly incident in neutropenic hematological cancer patients [, ]. Viral infections other than influenza, especially respiratory syncytial virus, are more frequent in patients who underwent hematopoietic stem cell or lung transplantation [, ]. Conversely, <em>Nocardia</em> spp. infections are mainly described in solid organ transplant recipients []. These results, consistent with previous findings, suggest the need for a more in-depth microbiological workup, including community-acquired pathogens and microorganisms not covered by standard therapy.</p><p>Surprisingly, we found that risk factors for immunocompromise were not independently associated with <em>P. aeruginosa</em> or non–community-acquired bacteria; in contrast, AIDS and hematological cancer are both associated with fungal, mycobacterial, and noninfluenza viral pneumonia, respectively. Empirical therapy should include <em>P. aeruginosa</em> coverage, which is highly prevalent in immunocompromised patients. On the contrary, particular attention should be given to fungal, mycobacterial, and viral causes should be for patients admitted with AIDS and hematological cancer [].</p><p>Finally, bacteremia rates did not differ between study groups. To our knowledge, there are no studies on bacteremia and immunocompromise in general. The majority of studies have focused on bacteremia in hematopoietic stem cell transplantation, with prevalences varying from 6% to 44% depending on the type of bacteria and host-related factors []. Few studies addressed this topic in kidney transplant recipients, reporting a prevalence of bacteremia ranging from 25% to 69% [, ]. Finally, few studies have addressed HIV and bacteremia, with prevalences ranging from 10% to 25%, depending on the pathogen and grade of immunosuppression [, ]. The prevalence of bacteremia in our study was 5T–6% in both immunocompetent and immunocompromised patients. Differences in the prevalence of bacteremia are due mainly to differences between the risk factors for immunocompromise in our study (chronic steroid use, hematological cancer, and chemotherapy) and those previously reported in the literature.</p><p>The current study has both limitations and strengths. First of all, to our knowledge, this is the first study showing a worldwide perspective on immunocompromise among patients coming from the community with pneumonia, with a large and diverse sample of patients enrolled across different countries in 6 continents. However, we were not able to involve many investigators from Asia and Africa, and most cases occurred in North America and Europe, thus limiting the generalizability of our findings. Another major limitation is the unfeasibility of grading the severity of immunocompromise and, therefore, stratifying patients and defining the physiopathological interaction between different risk factors, especially with regard to the use of biological drugs and chronic steroids. Furthermore, potentially important risk factors for an immunocompromised state, such as solid organ transplants other than lung, have not been specifically investigated. Finally, no outcome data have been collected, and this strongly limits our speculations as to the correct empiric antibiotic therapy for use in immunocompromised patients with CAP.</p><p>In conclusion, our study offers to the scientific community a perspective on immunocompromised patients coming from the community with pneumonia. Future prospective studies on patients with specific risk factors for immunocompromise could provide practical recommendations. In particular, it will be crucial to prepare guidelines on certain prevalent population groups, such as patients exposed to chronic steroids and those with hematological cancer.</p> <h2>Supplementary Data</h2>\n<p>Supplementary materials are available at <em>Clinical Infectious Diseases</em> online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.</p> <h2>Notes</h2>\n<p><strong><em>Author contributions.</em></strong> M. F. D. P., G. S., S. A., and M. I. R. participated in study design, analysis of data, and writing of the manuscript and take responsibility for the integrity of the work. A. G., D. R., S. T., L. F. R., J. R., J. G. d. C., and F. B. critically reviewed the final manuscript.</p><p><strong><em>Acknowledgments.</em></strong> We thank the Asociacion Latinoamericana de Torax, European Respiratory Society, World Federation of Societies of Intensive and Critical Care Medicine, and American College of Chest Physicians for their support of this project. We also thank the following study contributors for their valuable collaboration. <strong>Argentina:</strong> Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires), Silvia Attorri (Hospital Luis Lago Maggiore, Mendoza), Enrique Barimboim (Hospital Central de Mendoza), Juan Pablo Caeiro and María I. Garzón (Hospital Privado Universitario, Córdoba), Victor Hugo Cambursano, A. Cazaux (Servicio de Neumologia, Hospital Rawson, Córdoba), Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas), Julio Chertcoff, Florencia Lascar, and Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital), Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza), Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires) Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos Vicente Lopez y Planes from General Rodriguez, Buenos Aires), Sandra Lambert (Hospital El Cruce–Alta Complejidad en Red), Gustavo Lopardo (Hospital Bernardo Houssay, Vicente López), Carlos M. Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires), Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen), Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos), Antonio A. Cetrangolo (an individual who is being acknowledged for his contribution to the study), Claudia Pensotti (Infectious Diseases and Infection Control Department, Clinica Privada Monte Grande, Buenos Aires), Betiana Pereyra (Hospital San Roque, Córdoba), Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D. F. Santojanni), Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela); <strong>Australia:</strong> Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg); <strong>Austria:</strong> Felix Lötsch and Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna); <strong>Belgium:</strong> Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp), Camille A. Francois (Anesthesia and Critical Care Department, Erasme University Hospital, Brussels), Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital), Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels); <strong>Benin:</strong> Marcel Zannou Djimon, Jules Bashi and Roger Dodo (Centre Hospitalier Universitaire HKM of Cotonou); <strong>Brazil:</strong> Simone Aranha Nouér (Federal University of Rio de Janeiro); <strong>Bulgaria:</strong> Peter Chipev and Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofia), Darina Miteva, (UMHAT St Marina, Varna), Diana Petkova (University Hospital Varna); <strong>Cameroon:</strong> Adamou Dodo Balkissou (Yaounde Jamot Hospital, Yaounde), Eric Walter Pefura Yone (Département de Médecine Interne, University of Yaounde), Bertrand Hugo Mbatchou Ngahane (Douala General Hospital); <strong>China:</strong> Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing), Jin-fu Xu (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University); <strong>Colombia:</strong> Carlos Andres Bustamante Rico and Ricardo Buitrago (Clinica Shaio, Bogota), Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin); <strong>Congo:</strong> Jean-Marie Kayembe Ntumba (Cliniques Universitaires de Kinshasa); <strong>Croatia:</strong> Vesna Vladic Carevic (Interne Medicine, Dubrovnik), Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb), Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases), Zinka Matkovic (University Hospital Dubrava, Zagreb), Ivan Mitrecic (Karlovac General Hospital); <strong>Denmark:</strong> Marie-Laure Bouchy Jacobsson (Emergency Department, North Zealand’s Hospital–Hillerød), Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital), Uffe Christian Heitmann Bødtger (Department of Pulmonology, Naestved Hospital), Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde), Andreas Vestergaard Jensen, Gertrud Baunbæk-Knudsen, Pelle Trier Petersen, and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød); <strong>Egypt:</strong> Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University), Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University), Hanaa Shafiek (Chest Diseases Department, Faculty of Medicine, Alexandria University), Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo); <strong>Ethiopia:</strong> Kedir Abdella Abdulsemed (Department of Medical Laboratory Science and Pathology, College of Health Sciences, Mycobacteriology Research Centre, Institute of Biotechnology Research, Jimma University); <strong>France:</strong> Fabrice Bertrand (Critical Care Unit, Robert Ballanger Hospital, Aulnay sous Bois), Christian Brun-Buisson (University Hospital of Henri-Mondor, Créteil), Etienne de Montmollin (Intensive Care Unit, Hôpital Delafontaine, Centre Hospitalier de Saint-Denis), Muriel Fartoukh (Unité de Réanimation Médico-Chirurgicale, Pôle Thorax Voies Aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien), Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médico-chirurgicale, Hôpital Louis Mourier, Colombes, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité), Pierre Tattevin (Infectious Diseases and ICU, Pontchaillou University Hospital, Rennes), Abdo Khoury (Department of Emergency Medicine and Critical Care, University of Franche–Comté, Medical Center); <strong>Gambia:</strong> Bernard Ebruke (Medical Research Council Unit, Fajara, Gambia); <strong>Germany:</strong> Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen), Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden), Matthias Meisinger, Klinikum Niederlausitz, Klinik für Innere Medizin und Intensivmedizin, Senftenberg), Mathias W. Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital), Jan Rupp (Department of Infectious Diseases and Microbiology, University of Lübeck), Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg), Marc Spielmanns (Internal Medicine Department, Pulmonary Rehabilitation and Department of Health, School of Medicine, University Witten-Herdecke, St Remigius Hospital, Leverkusen) Petra Creutz and Norton Suttorp (Department of Infectious Disease and Respiratory Medicine, Charité–University Medicine, Berlin); <strong>Ghana</strong>: Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi); <strong>Greece</strong>: Katerina Dimakou (5th Respiratory Medicine Department, SOTIRIA Chest Hospital, Athens), Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens), Evdoxia Tsigou and Dimitrios Ampazis (Agioi Anargiroi Hospital, Kifissia, Athens), Evangelos Kaimakamis (Intensive Care Unit, G. Papanikolaou General Hospital of Thessaloniki); <strong>India</strong>: Mohit Bhatia (S. S. Hospital IMS BHU Varanasi), Raja Dhar (Fortis Hospitals, Kolkata), George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore), Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow), Parvaiz A. Koul (Department of Internal and Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar), P. A. Mahesh and B. S. Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore), Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala), Hirennappa B. Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka), Surya Kant (Department of Respiratory Medicine, King George’s Medical University, Chowk, Lucknow, Uttar Pradesh), Rajesh Swarnakar (Getwell Hospital and Research Institute, Dhantoli, Nagpur), Sneha Limaye and Sundeep Salvi (on behalf of the Respiratory Research Network of India from the Chest Research Foundation in Pune); <strong>Iran</strong>: Keihan Golshani (Isfahan University of Medical Sciences); <strong>Ireland</strong>: Vera M. Keatings (Letterkenny General Hospital, County Donegal), Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization, St James’s University Hospital, Trinity Centre for Health Sciences Dublin); <strong>Israel</strong>: Yasmin Maor (Infectious Disease Unit, affiliated with Tel Aviv University, Wolfson Medical Center, Holon), Jacob Strahilevitz (Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem); <strong>Italy</strong>: Salvatore Battaglia, University of Palermo, Pneumologia DiBiMIS, Palermo), Maria Carrabba (Internal Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca’ Granda Ospedale Maggiore Policlinico, Milano), Piero Ceriana (Pulmonary Rehabilitation, IRCCS Fondazione Maugeri, Pavia), Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste), Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan), Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples), Marino De Rosa (Unità Operativa Complessa [UOC] Pneumologia PO San Filippo Neri Azienda Sanitaria Locale Roma E Roma), Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena), Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria Azienda Ospedaliera Ospedali dei Colli PO Monaldi), Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, Sardegna), Francesco Menzella (Department of Cardiac-Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS–Arcispedale Santa Maria Nuova, Reggio Emilia), Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S. Anna Nuovo, Unità Operativa di Pneumologia, Como), Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital), Gerardo Palmiero (Respiratory Unit, Versilia Hospital, Lido di Camaiore, Lucca), Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli), Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero–Universitaria S. Maria della Misericordia, Udine), Claudio Sorino, Pulmonology Unit, A. O. Sant’Anna di Como), Gundi Steinhilber (Spedali Civili Brescia, U. O. Pneumologia e Fisiopatologia Respiratoria, Brescia), Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta), Fabio Franzetti, Manuela Carugati, Manuela Morosi, and Elisa Monge (Department of Biomedical and Clinical Sciences, Division of Infectious Diseases, Luigi Sacco Hospital, Università degli Studi di Milano), Mauro Carone, (Fondazione Salvatore Maugeri, IRCCS, Cassano Murge), Vincenzo Patella (Allergology and Clinical Immunology Unit, Department of Medical Sciences, Battipaglia Hospital, Battipaglia, Salerno), Simone Scarlata (Geriatrics, Unit of Respiratory Pathophysiology and Thoracic Endoscopy, Campus Bio Medico University and Teaching Hospital, Rome), Andrea Comel, UO Pneumologia, Ospedale Pederzoli, Peschiera del Garda); <strong>Japan</strong>: Kiyoyasu Kurahashi (Yokohama City University Medical Center); <strong>Lebanon</strong>: Zeina Aoun Bacha (Medicine School, St Joseph University, Beyrouth); <strong>Mexico</strong>: Daniel Barajas Ugalde (National Institute of Respiratory Diseases), Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California), José F. Villegas (Hospital Universitario Monterrey); <strong>Montenegro</strong>: Milic Medenica (Hospital for Lung Diseases–Brezovik, Niksic); <strong>Netherlands</strong>: E. M. W. van de Garde (Department of Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein); <strong>Nepal</strong>: Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences), Poojan Shrestha (Oxford University Clinical Research Unit, Patan Hospital); <strong>New Zealand</strong>: Elliott Ridgeon (Medical Research Institute of New Zealand); <strong>Nigeria</strong>: Babatunde Ishola Awokola (Department of Family Medicine and Primary Care, Lily Hospitals Limited, Warri), Ogonna N. O. Nwankwo (University of Calabar Teaching Hospital), Adefuye Bolanle Olufunlola (Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State), Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan), Kingsley N. Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State); <strong>Pakistan</strong>: Muhammad Irfan, Section of Pulmonary and Critical Care Medicine (Department of Medicine, Aga Khan University, Karachi); <strong>Poland</strong>: Lukasz Minarowski (Department of Lung Diseases and Tuberculosis, Medical University of Bialystok), Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec); <strong>Portugal</strong>: Felipe Froes (Hospital Pulido Valente–CHLN, Lisboa), Pedro Leuschner, (Centro Hospitalar do Porto), Mariana Meireles, Cláudia Ferrão, Pedro Leuschner, and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo Prof Abel Salazar, Porto), Sofia B. Ravara (Faculty of Health Sciences, University of Beira Interior, Cova da Beira Hospital Center, Covilhã); <strong>Republic of Moldova</strong>: Victoria Brocovschii (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu), Chesov Ion (Clinic of Anesthesia and Intensive Care Valeriu Ghrerg, Institute of Emergency Medicine, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau), Doina Rusu (SMFU N. Testemitanu, Chisinau), Cristina Toma (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau); <strong>Romania</strong>: Daniela Chirita (Hospital Sfantul Stefan, Bucharest), Carmen Mihaela Dorobat (Universitatea de Medicină şi Farmacie Gr T. Popa I a ş i Facultatea de Medicină Stomatologică, Spitalul Clinic de Boli Infecţioase Sfânta Parascheva I a ş i Iaşi); <strong>Russia</strong>: Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S. I. Georgievsky), Anna Kaluzhenina (Volgograd State Medical University); <strong>Saudi Arabia</strong>: Abdullah Almotairi (King Fahad Medical City, Riyadh), Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina), Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh), Amal Fathy (Pulmonary and Respiratory Critical Care Medicine, Mansoura University Egypt, Affiliate at Taibah University), Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh), Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa), Abdelhaleem Bella (Dammam University–Saudi Arabia and King Fahad Hospital); <strong>Serbia</strong>: Nada Bogdanović (Pulmonary Department of KHC, Dragiša Mišović, Belgrade), Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade), Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade); <strong>Spain</strong>: Luis Borderìas (Respiratory and Sleep Unit, Hospital San Jorge, Huesca), Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at Sant Joan Despí), Hugo Cabello Alarcón (Sant Hospital Seu de Urgell, Catalonia), Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona), Vicens Diaz-Brito and Xavier Casas (Infectious Diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona), Alicia Encabo González (Hospital Complex of Pontevedra), Maria Luisa Fernández-Almira (Medicina Interna, Hospital Universitario Central de Asturias), Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, and CIBER de Enfermedades Respiratorias, CIBERES, Bunyola), Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga), Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid), Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante), Elena Laserna Martínez (Hospital Mollet, Barcelona), Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid), Pedro J. Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña, INIBIC, Sergas, Universidade de A Coruña), Rosario Menéndez (Pneumology Service, University and Polytechnic Hospital La Fe, Valencia), Ana Pando-Sandoval (Hospital Universitario Central de Asturias, Area de Gestion Clinica de Pulmon, Servicio de Neumologia, Oviedo), Cristina Prat Aymerich, Alicia Lacoma de la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, and Universitat Autònoma de Barcelona, CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III), Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d’Hebron, Barcelona), Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia), Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona), Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria), Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo), Job F. M. van Boven (Hospital Universitari Son Espases, Palma de Mallorca), Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró); <strong>South Africa</strong>: Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand); <strong>South Korea</strong>: Ho Kee Yum (Inje University Seoul Paik Hospital); <strong>Togo</strong>: Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University Hospital of Sylvanus Olympio, Lomé); <strong>Tunisia</strong>: Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security, Marsa, Tunis); <strong>Turkey</strong>: Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir), Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul), Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir); <strong>Ukraine</strong>: Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa Regional Antituberculosis Hospital, Vinnitsa); <strong>United Arab Emirates</strong>: Naheed Elahi (Dubai Hospital); <strong>United Kingdom</strong>: Devesh J. Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife), Andrew Feneley, Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann, University Hospitals of Leicester NHS Trust and University of Leicester), Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool), Adam T. Hill (Royal Infirmary and University of Edinburgh), Banu Rudran (The Royal London Hospital, Barts Health Trust, London), Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, East Kilbride), Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds), Alexander Youzguin (Southport and Ormskirk Hospitals NHS Trust), Anika Singanayagam (Imperial College Healthcare NHS Trust, London); <strong>United States</strong>: Karen S. Allen (University of Oklahoma Health Sciences Center, Oklahoma City), Veronica Brito (Texas A&amp;M Health Science Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Baylor Scott &amp; White Health, Temple); Jessica Dietz (Fargo VA Health Care System, Fargo, North Dakota), Claire E. Dysart and Susan M. Kellie (Clement J. Zablocki VA Medical Center, Milwaukee, Wisconsin; Division of Infectious Diseases, University of New Mexico School of Medicine; and Raymond G. Murphy VA Medical Center, Albuquerque, New Mexico), Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, Illinois), Mina Gaga (7th Respiratory Medical Department and Asthma Center, Athens Chest Hospital), Thomas L. Holland and Stephen P. Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, Durham), Fayez Kheir (Department of Pulmonary Diseases, Critical Care and Environmental Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana), Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, Illinois), Manuel Lois (John Peter Smith Hospital, Fort Worth, Texas), Girish B. Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook, and Winthrop University Hospital, Mineola, New York), Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, Denver), Katherine Reyes (Henry Ford Hospital, Detroit, Illinois), William Rodriguez-Cintron, (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, San Juan Puerto Rico), Shigeki Saito (Tulane University, New Orleans), Nilam J. Soni, Julio Noda, Cecilia I. Hinojosa, Stephanie M. Levine, Luis F. Angel, and Antonio Anzueto (Divisions of Hospital Medicine and Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio), K. Scott Whitlow, John Hipskind, Kunal Sukhija, and Vicken Totten (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, California), Richard G. Wunderink and Ray D. Shah (Northwestern University Feinberg School of Medicine, Chicago, Illinois); <strong>Zambia</strong>: Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka). <strong>Other investigators</strong>: Lorena Noriega, Ezequiel Alvarado, Mohamed Aman, and Lucía Labra.</p><p><strong><em>Disclaimer.</em></strong> The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute, the National Institutes of Health, or the Department of Veterans Affairs.</p><p><strong><em>Financial support.</em></strong> This project was not funded and relied solely on voluntary site and investigator participation. M. I. R.’s time is partially protected by the National Heart, Lung, and Blood Institute (award K23HL096054).</p><p><strong><em>Potential conflicts of interest.</em></strong> F. B. reports personal fees from AstraZeneca, GlaxoSmithKline, Guidotti, Grifols, Menarini, and Novartis, and grants and personal fees from Bayer, Chiesi, Insmed, Pfizer, Teva, and Zambon, outside the submitted work. All other authors report no potential conflicts.</p> <h2>References</h2>\n<div><div><div><div><span>1.</span><div><div>Aliberti</div> <div>S</div>, <span><div>Di Pasquale</div> <div>M</div></span>, <span><div>Zanaboni</div> <div>AM</div></span>, et al. <div>Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia</div>. <div>Clin Infect Dis</div><div>2012</div>; <div>54</div>:<div>470</div>–<div>8</div>.</div></div></div></div><div><div><div><span>2.</span><div><div>Aliberti</div> <div>S</div>, <span><div>Cilloniz</div> <div>C</div></span>, <span><div>Chalmers</div> <div>JD</div></span>, et al. <div>Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective</div>. <div>Thorax</div><div>2013</div>; <div>68</div>:<div>997</div>–<div>9</div>.</div></div></div></div><div><div><div><span>3.</span><div><div>Shindo</div> <div>Y</div>, <span><div>Ito</div> <div>R</div></span>, <span><div>Kobayashi</div> <div>D</div></span>, et al. <div>Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia</div>. <div>Am J Respir Crit Care Med</div><div>2013</div>; <div>188</div>:<div>985</div>–<div>95</div>.</div></div></div></div><div><div><div><span>4.</span><div><div>Musher</div> <div>DM</div>, <span><div>Thorner</div> <div>AR</div></span>. <div>Community-acquired pneumonia</div>. <div>N Engl J Med</div><div>2014</div>; <div>371</div>:<div>1619</div>–<div>28</div>.</div></div></div></div><div><div><div><span>5.</span><div><div>Mandell</div> <div>LA</div>, <span><div>Wunderink</div> <div>RG</div></span>, <span><div>Anzueto</div> <div>A</div></span>, et al. ; <span><div>Infectious Diseases Society of America; American Thoracic Society</div></span>. <div>Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults</div>. <div>Clin Infect Dis</div><div>2007</div>; <div>44</div>(<div>suppl 2</div>):<div>S27</div>–<div>72</div>.</div></div></div></div><div><div><div><span>6.</span><div><div>Lim</div> <div>WS</div>, <span><div>Baudouin</div> <div>SV</div></span>, <span><div>George</div> <div>RC</div></span>, et al. <div>BTS guidelines for the management of community acquired pneumonia in adults</div>. <div>Thorax</div><div>2009</div>; <div>64</div>(<div>suppl III</div>):<div>iii1</div>–<div>55</div>.</div></div></div></div><div><div><div><span>7.</span><div><div>Woodhead</div> <div>M</div>, <span><div>Blasi</div> <div>F</div></span>, <span><div>Ewig</div> <div>S</div></span>, et al. ; <span><div>Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases</div></span>. <div>Guidelines for the management of adult lower respiratory tract infections—full version</div>. <div>Clin Microbiol Infect</div><div>2011</div>; <div>17(suppl 6)</div>:<div>E1</div>–<div>59</div>.</div></div></div></div><div><div><div><span>8.</span><div><div>Furman</div> <div>CD</div>, <span><div>Rayner</div> <div>AV</div></span>, <span><div>Tobin</div> <div>EP</div></span>. <div>Pneumonia in older residents of long-term care facilities</div>. <div>Am Fam Physician</div><div>2004</div>; <div>70</div>:<div>1495</div>–<div>500</div>.</div></div></div></div><div><div><div><span>9.</span><div><div>Cillóniz</div> <div>C</div>, <span><div>Polverino</div> <div>E</div></span>, <span><div>Ewig</div> <div>S</div></span>, et al. <div>Impact of age and comorbidity on cause and outcome in community-acquired pneumonia</div>. <div>Chest</div><div>2013</div>; <div>144</div>:<div>999</div>–<div>1007</div>.</div></div></div></div><div><div><div><span>10.</span><div><div>Aliberti</div> <div>S</div>, <span><div>Reyes</div> <div>LF</div></span>, <span><div>Faverio</div> <div>P</div></span>, et al. ; <span><div>GLIMP investigators</div></span>. <div>Global Initiative for Meticillin-Resistant <em>Staphylococcus aureus</em> Pneumonia (GLIMP): an international, observational cohort study</div>. <div>Lancet Infect Dis</div><div>2016</div>; <div>16</div>:<div>1364</div>–<div>76</div>.</div></div></div></div><div><div><div><span>11.</span><div><div>Magiorakos</div> <div>AP</div>, <span><div>Srinivasan</div> <div>A</div></span>, <span><div>Carey</div> <div>RB</div></span>, et al. <div>Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance</div>. <div>Clin Microbiol Infect</div><div>2012</div>; <div>18</div>:<div>268</div>–<div>81</div>.</div></div></div></div><div><div><div><span>12.</span><div><div>Wan</div> <div>QJ</div>, <span><div>Hu</div> <div>HF</div></span>, <span><div>He</div> <div>YC</div></span>, et al. <div>Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy</div>. <div>Kaohsiung J Med Sci</div><div>2015</div>; <div>31</div>:<div>42</div>–<div>6</div>.</div></div></div></div><div><div><div><span>13.</span><div><div>Li</div> <div>F</div>, <span><div>Jin</div> <div>HZ</div></span>, <span><div>Su</div> <div>F</div></span>, <span><div>Jia</div> <div>L</div></span>, <span><div>Sun</div> <div>QN</div></span>. <div>Pneumocystis pneumonia in patients with immunobullous dermatoses</div>. <div>Int J Dermatol</div><div>2011</div>; <div>50</div>:<div>1144</div>–<div>9</div>.</div></div></div></div><div><div><div><span>14.</span><div><div>Gruson</div> <div>D</div>, <span><div>Vargas</div> <div>F</div></span>, <span><div>Hilbert</div> <div>G</div></span>, et al. <div>Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia</div>. <div>Intensive Care Med</div><div>2004</div>; <div>30</div>:<div>965</div>–<div>71</div>.</div></div></div></div><div><div><div><span>15.</span><div><div>Garcia</div> <div>JB</div>, <span><div>Lei</div> <div>X</div></span>, <span><div>Wierda</div> <div>W</div></span>, et al. <div>Pneumonia during remission induction chemotherapy in patients with acute leukemia</div>. <div>Ann Am Thorac Soc</div><div>2013</div>; <div>10</div>:<div>432</div>–<div>40</div>.</div></div></div></div><div><div><div><span>16.</span><div><div>Lee</div> <div>JO</div>, <span><div>Kim</div> <div>DY</div></span>, <span><div>Lim</div> <div>JH</div></span>, et al. <div>Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients</div>. <div>Lung Cancer</div><div>2008</div>; <div>62</div>:<div>381</div>–<div>4</div>.</div></div></div></div><div><div><div><span>17.</span><div><div>Lim</div> <div>KH</div>, <span><div>Yoon</div> <div>HI</div></span>, <span><div>Kang</div> <div>YA</div></span>, et al. <div>Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab</div>. <div>Korean J Intern Med</div><div>2010</div>; <div>25</div>:<div>86</div>–<div>92</div>.</div></div></div></div><div><div><div><span>18.</span><div><div>Waks</div> <div>AG</div>, <span><div>Tolaney</div> <div>SM</div></span>, <span><div>Galar</div> <div>A</div></span>, et al. <div><em>Pneumocystis jiroveci</em> pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors</div>. <div>Breast Cancer Res Treat</div><div>2015</div>; <div>154</div>:<div>359</div>–<div>67</div>.</div></div></div></div><div><div><div><span>19.</span><div><div>Kim</div> <div>T</div>, <span><div>Choi</div> <div>SH</div></span>, <span><div>Kim</div> <div>SH</div></span>, et al. <div>Point prevalence of <em>Pneumocystis</em> pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy</div>. <div>Ann Hematol</div><div>2013</div>; <div>92</div>:<div>231</div>–<div>8</div>.</div></div></div></div><div><div><div><span>20.</span><div><div>Aliberti</div> <div>S</div>, <span><div>Myers</div> <div>JA</div></span>, <span><div>Peyrani</div> <div>P</div></span>, et al. <div>The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia</div>. <div>Eur Respir J</div><div>2009</div>; <div>33</div>:<div>142</div>–<div>7</div>.</div></div></div></div><div><div><div><span>21.</span><div><div>Sogaard</div> <div>OS</div>, <span><div>Lohse</div> <div>N</div></span>, <span><div>Gerstoft</div> <div>J</div></span>, et al. <div>Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study</div>. <div>Clin Infect Dis</div><div>2008</div>; <div>47</div>:<div>1345</div>–<div>53</div>.</div></div></div></div><div><div><div><span>22.</span><div><div>Kuehnhardt</div> <div>D</div>, <span><div>Hannemann</div> <div>M</div></span>, <span><div>Schmidt</div> <div>B</div></span>, <span><div>Heider</div> <div>U</div></span>, <span><div>Possinger</div> <div>K</div></span>, <span><div>Eucker</div> <div>J</div></span>. <div>Therapeutic implication of BAL in patients with neutropenia</div>. <div>Ann Hematol</div><div>2009</div>; <div>88</div>:<div>1249</div>–<div>56</div>.</div></div></div></div><div><div><div><span>23.</span><div><div>Maschmeyer</div> <div>G</div>, <span><div>Beinert</div> <div>T</div></span>, <span><div>Buchheidt</div> <div>D</div></span>, et al. <div>Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the Infectious Diseases Working Party of the German Society of Haematology and Oncology</div>. <div>Eur J Cancer</div><div>2009</div>; <div>45</div>:<div>2462</div>–<div>72</div>.</div></div></div></div><div><div><div><span>24.</span><div><div>Alanio</div> <div>A</div>, <span><div>Hauser</div> <div>PM</div></span>, <span><div>Lagrou</div> <div>K</div></span>, et al. ; <span><div>5th European Conference on Infections in Leukemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN)</div></span>. <div>ECIL guidelines for the diagnosis of <em>Pneumocystis jirovecii</em> pneumonia in patients with haematological malignancies and stem cell transplant recipients</div>. <div>J Antimicrob Chemother</div><div>2016</div>; <div>71</div>:<div>2386</div>–<div>96</div>.</div></div></div></div><div><div><div><span>25.</span><div><div>Freifeld</div> <div>AG</div>, <span><div>Bow</div> <div>EJ</div></span>, <span><div>Sepkowitz</div> <div>KA</div></span>, et al. ; <span><div>Infectious Diseases Society of America</div></span>. <div>Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America</div>. <div>Clin Infect Dis</div><div>2011</div>; <div>52</div>:<div>e56</div>–<div>93</div>.</div></div></div></div><div><div><div><span>26.</span><div><div>Chemaly</div> <div>RF</div>, <span><div>Shah</div> <div>DP</div></span>, <span><div>Boeckh</div> <div>MJ</div></span>. <div>Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies</div>. <div>Clin Infect Dis</div><div>2014</div>; <div>59</div>(<div>suppl 5</div>):<div>S344</div>–<div>51</div>.</div></div></div></div><div><div><div><span>27.</span><div><div>Buchacz</div> <div>K</div>, <span><div>Lau</div> <div>B</div></span>, <span><div>Jing</div> <div>Y</div></span>, et al. ; <span><div>North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA</div></span>. <div>Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010</div>. <div>J Infect Dis</div><div>2016</div>; <div>214</div>:<div>862</div>–<div>72</div>.</div></div></div></div><div><div><div><span>28.</span><div><div>Madeddu</div> <div>G</div>, <span><div>Porqueddu</div> <div>EM</div></span>, <span><div>Cambosu</div> <div>F</div></span>, et al. <div>Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era</div>. <div>Infection</div><div>2008</div>; <div>36</div>:<div>231</div>–<div>6</div>.</div></div></div></div><div><div><div><span>29.</span><div><div>Park</div> <div>DR</div>, <span><div>Sherbin</div> <div>VL</div></span>, <span><div>Goodman</div> <div>MS</div></span>, et al. ; <span><div>Harborview CAP Study Group</div></span>. <div>The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness</div>. <div>J Infect Dis</div><div>2001</div>; <div>184</div>:<div>268</div>–<div>77</div>.</div></div></div></div><div><div><div><span>30.</span><div><div>Torres</div> <div>HA</div>, <span><div>Bodey</div> <div>GP</div></span>, <span><div>Rolston</div> <div>KV</div></span>, <span><div>Kantarjian</div> <div>HM</div></span>, <span><div>Raad</div> <div>II</div></span>, <span><div>Kontoyiannis</div> <div>DP</div></span>. <div>Infections in patients with aplastic anemia: experience at a tertiary care cancer center</div>. <div>Cancer</div><div>2003</div>; <div>98</div>:<div>86</div>–<div>93</div>.</div></div></div></div><div><div><div><span>31.</span><div><div>Gil-Prieto</div> <div>R</div>, <span><div>Pascual-Garcia</div> <div>R</div></span>, <span><div>Walter</div> <div>S</div></span>, <span><div>Álvaro-Meca</div> <div>A</div></span>, <span><div>Gil-De-Miguel</div> <div>Á</div></span>. <div>Risk of hospitalization due to pneumococcal disease in adults in Spain: the CORIENNE study</div>. <div>Hum Vaccin Immunother</div><div>2016</div>; <div>12</div>:<div>1900</div>–<div>5</div>.</div></div></div></div><div><div><div><span>32.</span><div><div>Putot</div> <div>A</div>, <span><div>Tetu</div> <div>J</div></span>, <span><div>Perrin</div> <div>S</div></span>, et al. <div>Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients</div>. <div>Eur J Clin Microbiol Infect Dis</div><div>2016</div>; <div>35</div>:<div>489</div>–<div>95</div>.</div></div></div></div><div><div><div><span>33.</span><div><div>Polverino</div> <div>E</div>, <span><div>Dambrava</div> <div>P</div></span>, <span><div>Cillóniz</div> <div>C</div></span>, et al. <div>Nursing home-acquired pneumonia: a 10 year single-centre experience</div>. <div>Thorax</div><div>2010</div>; <div>65</div>:<div>354</div>–<div>9</div>.</div></div></div></div><div><div><div><span>34.</span><div><div>Kohli</div> <div>R</div>, <span><div>Lo</div> <div>Y</div></span>, <span><div>Homel</div> <div>P</div></span>, et al. ; <span><div>HER Study Group</div></span>. <div>Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study</div>. <div>Clin Infect Dis</div><div>2006</div>; <div>43</div>:<div>90</div>–<div>8</div>.</div></div></div></div><div><div><div><span>35.</span><div><div>Benito</div> <div>N</div>, <span><div>Rañó</div> <div>A</div></span>, <span><div>Moreno</div> <div>A</div></span>, et al. <div>Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain</div>. <div>J Acquir Immune Defic Syndr</div><div>2001</div>; <div>27</div>:<div>35</div>–<div>43</div>.</div></div></div></div><div><div><div><span>36.</span><div><div>Mori</div> <div>H</div>, <span><div>Ohno</div> <div>Y</div></span>, <span><div>Ito</div> <div>F</div></span>, et al. <div>Polymerase chain reaction positivity of <em>Pneumocystis jirovecii</em> during primary lung cancer treatment</div>. <div>Jpn J Clin Oncol</div><div>2010</div>; <div>40</div>:<div>658</div>–<div>62</div>.</div></div></div></div><div><div><div><span>37.</span><div><div>Boersma</div> <div>WG</div>, <span><div>Erjavec</div> <div>Z</div></span>, <span><div>van der Werf</div> <div>TS</div></span>, <span><div>de Vries-Hosper</div> <div>HG</div></span>, <span><div>Gouw</div> <div>AS</div></span>, <span><div>Manson</div> <div>WL</div></span>. <div>Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL</div>. <div>Respir Med</div><div>2007</div>; <div>101</div>:<div>317</div>–<div>25</div>.</div></div></div></div><div><div><div><span>38.</span><div><div>Mikulska</div> <div>M</div>, <span><div>Del Bono</div> <div>V</div></span>, <span><div>Gandolfo</div> <div>N</div></span>, et al. <div>Epidemiology of viral respiratory tract infections in an outpatient haematology facility</div>. <div>Ann Hematol</div><div>2014</div>; <div>93</div>:<div>669</div>–<div>76</div>.</div></div></div></div><div><div><div><span>39.</span><div><div>Beaird</div> <div>OE</div>, <span><div>Freifeld</div> <div>A</div></span>, <span><div>Ison</div> <div>MG</div></span>, et al. <div>Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative</div>. <div>Transpl Infect Dis</div><div>2016</div>; <div>18</div>:<div>210</div>–<div>5</div>.</div></div></div></div><div><div><div><span>40.</span><div><div>Poonyagariyagorn</div> <div>HK</div>, <span><div>Gershman</div> <div>A</div></span>, <span><div>Avery</div> <div>R</div></span>, et al. <div>Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients</div>. <div>Transpl Infect Dis</div><div>2008</div>; <div>10</div>:<div>403</div>–<div>8</div>.</div></div></div></div><div><div><div><span>41.</span><div><div>Tavadze</div> <div>M</div>, <span><div>Rybicki</div> <div>L</div></span>, <span><div>Mossad</div> <div>S</div></span>, et al. <div>Risk factors for vancomycin-resistant <em>Enterococcus</em> bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation</div>. <div>Bone Marrow Transplant</div><div>2014</div>; <div>49</div>:<div>1310</div>–<div>6</div>.</div></div></div></div><div><div><div><span>42.</span><div><div>Bock</div> <div>AM</div>, <span><div>Cao</div> <div>Q</div></span>, <span><div>Ferrieri</div> <div>P</div></span>, <span><div>Young</div> <div>JA</div></span>, <span><div>Weisdorf</div> <div>DJ</div></span>. <div>Bacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance</div>. <div>Biol Blood Marrow Transplant</div><div>2013</div>; <div>19</div>:<div>102</div>–<div>8</div>.</div></div></div></div><div><div><div><span>43.</span><div><div>Herbers</div> <div>AH</div>, <span><div>de Haan</div> <div>AF</div></span>, <span><div>van der Velden</div> <div>WJ</div></span>, <span><div>Donnelly</div> <div>JP</div></span>, <span><div>Blijlevens</div> <div>NM</div></span>. <div>Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients</div>. <div>Transpl Infect Dis</div><div>2014</div>; <div>16</div>:<div>279</div>–<div>85</div>.</div></div></div></div><div><div><div><span>44.</span><div><div>Wu</div> <div>SW</div>, <span><div>Liu</div> <div>KS</div></span>, <span><div>Lin</div> <div>CK</div></span>, et al. <div>Community-acquired urinary tract infection in kidney transplantation: risk factors for bacteremia and recurrent infection</div>. <div>J Formos Med Assoc</div><div>2013</div>; <div>112</div>:<div>138</div>–<div>43</div>.</div></div></div></div><div><div><div><span>45.</span><div><div>Daskalaki</div> <div>E</div>, <span><div>Koukoulaki</div> <div>M</div></span>, <span><div>Bakalis</div> <div>A</div></span>, et al. <div>Blood stream infections in renal transplant recipients: a single-center study</div>. <div>Transplant Proc</div><div>2014</div>; <div>46</div>:<div>3191</div>–<div>3</div>.</div></div></div></div><div><div><div><span>46.</span><div><div>Huson</div> <div>MA</div>, <span><div>Stolp</div> <div>SM</div></span>, <span><div>van der Poll</div> <div>T</div></span>, <span><div>Grobusch</div> <div>MP</div></span>. <div>Community-acquired bacterial bloodstream infections in HIV-infected patients: a systematic review</div>. <div>Clin Infect Dis</div><div>2014</div>; <div>58</div>:<div>79</div>–<div>92</div>.</div></div></div></div><div><div><div><span>47.</span><div><div>Taramasso</div> <div>L</div>, <span><div>Tatarelli</div> <div>P</div></span>, <span><div>Di Biagio</div> <div>A</div></span>. <div>Bloodstream infections in HIV-infected patients</div>. <div>Virulence</div><div>2016</div>; <div>7</div>:<div>320</div>–<div>8</div>.</div></div></div></div></div> \n\n<div>© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.</div><div><div>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<a href=\"https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model\">https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model</a>)</div></div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>Topic:</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>Issue Section:</div>\n<a href=\"/cid/search-results?f_TocHeadingTitleList=Articles+and+Commentaries\">Articles and Commentaries</a>\n</div>\n</div>\n</div>\n\n<div>\n<a href=\"/DownloadFile/DownloadImage.aspx?image=&amp;PPTtype=SlideSet&amp;ar=5078600&amp;xsltPath=~/UI/app/XSLT&amp;siteId=5269\">Download all slides</a>\n</div>\n<div>\n<h2>Supplementary data</h2>\n<div> - docx file</div>\n</div>\n\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<div>Advertisement</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<h3>Citations</h3>\n</div>\n<div>\n<h3>Views</h3>\n<div>\n<div>18,086</div>\n</div>\n</div>\n<div>\n<h3>Altmetric</h3>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<h3>Metrics</h3>\n<div>\n<div>\n<div>\n<span>Total Views</span>\n<span>18,086</span>\n</div>\n<div>\n<div>\n<span>11,927</span>\n<span>Pageviews</span>\n</div>\n<div>\n<span>6,159</span>\n<span>PDF Downloads</span>\n</div>\n</div>\n</div>\n<div>Since 8/1/2018</div>\n</div>\n<div>\n<div>\n<table>\n<thead>\n<tr>\n<th>Month:</th>\n<th>Total Views:</th>\n</tr>\n</thead>\n<tbody>\n<tr>\n<td>August 2018</td>\n<td>66</td>\n</tr>\n<tr>\n<td>September 2018</td>\n<td>28</td>\n</tr>\n<tr>\n<td>October 2018</td>\n<td>23</td>\n</tr>\n<tr>\n<td>November 2018</td>\n<td>70</td>\n</tr>\n<tr>\n<td>December 2018</td>\n<td>46</td>\n</tr>\n<tr>\n<td>January 2019</td>\n<td>53</td>\n</tr>\n<tr>\n<td>February 2019</td>\n<td>62</td>\n</tr>\n<tr>\n<td>March 2019</td>\n<td>31</td>\n</tr>\n<tr>\n<td>April 2019</td>\n<td>408</td>\n</tr>\n<tr>\n<td>May 2019</td>\n<td>355</td>\n</tr>\n<tr>\n<td>June 2019</td>\n<td>182</td>\n</tr>\n<tr>\n<td>July 2019</td>\n<td>176</td>\n</tr>\n<tr>\n<td>August 2019</td>\n<td>159</td>\n</tr>\n<tr>\n<td>September 2019</td>\n<td>111</td>\n</tr>\n<tr>\n<td>October 2019</td>\n<td>90</td>\n</tr>\n<tr>\n<td>November 2019</td>\n<td>66</td>\n</tr>\n<tr>\n<td>December 2019</td>\n<td>44</td>\n</tr>\n<tr>\n<td>January 2020</td>\n<td>69</td>\n</tr>\n<tr>\n<td>February 2020</td>\n<td>36</td>\n</tr>\n<tr>\n<td>March 2020</td>\n<td>223</td>\n</tr>\n<tr>\n<td>April 2020</td>\n<td>208</td>\n</tr>\n<tr>\n<td>May 2020</td>\n<td>140</td>\n</tr>\n<tr>\n<td>June 2020</td>\n<td>179</td>\n</tr>\n<tr>\n<td>July 2020</td>\n<td>162</td>\n</tr>\n<tr>\n<td>August 2020</td>\n<td>154</td>\n</tr>\n<tr>\n<td>September 2020</td>\n<td>217</td>\n</tr>\n<tr>\n<td>October 2020</td>\n<td>238</td>\n</tr>\n<tr>\n<td>November 2020</td>\n<td>237</td>\n</tr>\n<tr>\n<td>December 2020</td>\n<td>165</td>\n</tr>\n<tr>\n<td>January 2021</td>\n<td>140</td>\n</tr>\n<tr>\n<td>February 2021</td>\n<td>137</td>\n</tr>\n<tr>\n<td>March 2021</td>\n<td>236</td>\n</tr>\n<tr>\n<td>April 2021</td>\n<td>239</td>\n</tr>\n<tr>\n<td>May 2021</td>\n<td>239</td>\n</tr>\n<tr>\n<td>June 2021</td>\n<td>172</td>\n</tr>\n<tr>\n<td>July 2021</td>\n<td>131</td>\n</tr>\n<tr>\n<td>August 2021</td>\n<td>160</td>\n</tr>\n<tr>\n<td>September 2021</td>\n<td>205</td>\n</tr>\n<tr>\n<td>October 2021</td>\n<td>250</td>\n</tr>\n<tr>\n<td>November 2021</td>\n<td>227</td>\n</tr>\n<tr>\n<td>December 2021</td>\n<td>183</td>\n</tr>\n<tr>\n<td>January 2022</td>\n<td>202</td>\n</tr>\n<tr>\n<td>February 2022</td>\n<td>247</td>\n</tr>\n<tr>\n<td>March 2022</td>\n<td>301</td>\n</tr>\n<tr>\n<td>April 2022</td>\n<td>242</td>\n</tr>\n<tr>\n<td>May 2022</td>\n<td>240</td>\n</tr>\n<tr>\n<td>June 2022</td>\n<td>161</td>\n</tr>\n<tr>\n<td>July 2022</td>\n<td>159</td>\n</tr>\n<tr>\n<td>August 2022</td>\n<td>292</td>\n</tr>\n<tr>\n<td>September 2022</td>\n<td>404</td>\n</tr>\n<tr>\n<td>October 2022</td>\n<td>533</td>\n</tr>\n<tr>\n<td>November 2022</td>\n<td>300</td>\n</tr>\n<tr>\n<td>December 2022</td>\n<td>477</td>\n</tr>\n<tr>\n<td>January 2023</td>\n<td>287</td>\n</tr>\n<tr>\n<td>February 2023</td>\n<td>191</td>\n</tr>\n<tr>\n<td>March 2023</td>\n<td>310</td>\n</tr>\n<tr>\n<td>April 2023</td>\n<td>395</td>\n</tr>\n<tr>\n<td>May 2023</td>\n<td>248</td>\n</tr>\n<tr>\n<td>June 2023</td>\n<td>198</td>\n</tr>\n<tr>\n<td>July 2023</td>\n<td>185</td>\n</tr>\n<tr>\n<td>August 2023</td>\n<td>213</td>\n</tr>\n<tr>\n<td>September 2023</td>\n<td>248</td>\n</tr>\n<tr>\n<td>October 2023</td>\n<td>340</td>\n</tr>\n<tr>\n<td>November 2023</td>\n<td>311</td>\n</tr>\n<tr>\n<td>December 2023</td>\n<td>269</td>\n</tr>\n<tr>\n<td>January 2024</td>\n<td>301</td>\n</tr>\n<tr>\n<td>February 2024</td>\n<td>353</td>\n</tr>\n<tr>\n<td>March 2024</td>\n<td>372</td>\n</tr>\n<tr>\n<td>April 2024</td>\n<td>323</td>\n</tr>\n<tr>\n<td>May 2024</td>\n<td>341</td>\n</tr>\n<tr>\n<td>June 2024</td>\n<td>275</td>\n</tr>\n<tr>\n<td>July 2024</td>\n<td>268</td>\n</tr>\n<tr>\n<td>August 2024</td>\n<td>218</td>\n</tr>\n<tr>\n<td>September 2024</td>\n<td>253</td>\n</tr>\n<tr>\n<td>October 2024</td>\n<td>274</td>\n</tr>\n<tr>\n<td>November 2024</td>\n<td>312</td>\n</tr>\n<tr>\n<td>December 2024</td>\n<td>242</td>\n</tr>\n<tr>\n<td>January 2025</td>\n<td>250</td>\n</tr>\n<tr>\n<td>February 2025</td>\n<td>296</td>\n</tr>\n<tr>\n<td>March 2025</td>\n<td>396</td>\n</tr>\n<tr>\n<td>April 2025</td>\n<td>228</td>\n</tr>\n<tr>\n<td>May 2025</td>\n<td>228</td>\n</tr>\n<tr>\n<td>June 2025</td>\n<td>86</td>\n</tr>\n</tbody>\n</table>\n</div>\n</div>\n<div>\n<div>\n<div>Citations</div>\n<div>\n<span>Powered by Dimensions</span>\n</div>\n<div>\n<span>Web of Science</span>\n</div>\n</div>\n<div>\n<div>Altmetrics</div>\n<div>\n<div>\n<div><div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<b>346</b> readers on Mendeley\n     </div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div></div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<h3>Email alerts</h3>\n<div>\n<a href=\"/cid/new-journals-alert\">\n              New journal issues\n            </a>\n</div>\n<div>\n<a href=\"/cid/new-journal-articles-alert\">\n              New journal articles\n            </a>\n</div>\n<div>\n<button>\n              Activity related to this article\n            </button>\n</div>\n<div>\n<a href=\"/my-account/communication-preferences\">Sign up for marketing</a>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<h2>New journal issues alert</h2>\n</div>\n<div>\n<div>\n<div>\n<div><p>To set up an email alert, please to your personal account, or <a href=\"https://academic.oup.com/my-account/register?siteId=5269&amp;returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\">register</a></p></div>\n<div>\n<div>\n<div>\n<div>\n<h2>Sign in</h2>\n</div>\n</div>\n<div>\n<div>\n<h3>Personal account</h3>\n<ul>\n<li>Sign in with email/username &amp; password</li>\n<li>Get email alerts</li>\n<li>Save searches</li>\n<li>Purchase content</li>\n<li>Activate your purchase/trial code</li>\n<li>Add your ORCID iD</li>\n</ul>\n<div>\n<a href=\"/my-account/register?siteId=5269&amp;returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\">Register</a>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<h2>Journal article activity alert</h2>\n</div>\n<div>\n<div>\n<div>\n<div><p>To set up an email alert, please to your personal account, or <a href=\"https://academic.oup.com/my-account/register?siteId=5269&amp;returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\">register</a></p></div>\n<div>\n<div>\n<div>\n<div>\n<h2>Sign in</h2>\n</div>\n</div>\n<div>\n<div>\n<h3>Personal account</h3>\n<ul>\n<li>Sign in with email/username &amp; password</li>\n<li>Get email alerts</li>\n<li>Save searches</li>\n<li>Purchase content</li>\n<li>Activate your purchase/trial code</li>\n<li>Add your ORCID iD</li>\n</ul>\n<div>\n<a href=\"/my-account/register?siteId=5269&amp;returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\">Register</a>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n<button><span>Close Modal</span></button>\n</div>\n</div>\n<div>\n<h3>More on this topic</h3>\n<div>\n<div><a href=\"/cid/article/50/2/202/328880\">Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods</a></div>\n<div><a href=\"/cid/article/12/Supplement_8/S915/296667\">Microbial Agents Associated with Pneumonia in Children from Uruguay</a></div>\n<div><a href=\"/cid/article/59/9/iii/419445\">In the Literature</a></div>\n<div><a href=\"/cid/advance-article/7985365\">Comparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study</a></div>\n</div>\n</div>\n<div>\n<h3>Related articles in PubMed</h3>\n\n</div>\n<div>\n<div>\n<h3>Citing articles via</h3>\n</div>\n</div>\n<div>\n<section>\n<div>\n<div>\n<div>\n<div>\n<div>\n<a href=\"/cid/advance-article/doi/10.1093/cid/ciaf302/8159933?searchresult=1\">\n<div>\nEffectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial Study  </div>\n</a>\n</div>\n<div>\n<a href=\"/cid/advance-article/doi/10.1093/cid/ciaf311/8159932?searchresult=1\">\n<div>\nCharacteristics Associated with Disseminated Gonococcal Infections vs Uncomplicated Gonorrhea: A California Case-Control Study, 2021-2022  </div>\n</a>\n</div>\n<div>\n<a href=\"/cid/advance-article/doi/10.1093/cid/ciaf304/8157607?searchresult=1\">\n<div>\nNon-Operative versus Neurosurgical Treatment of Brain Abscess: An Emulated Trial Nested within a Nationwide, Population-Based Cohort  </div>\n</a>\n</div>\n<div>\n<a href=\"/cid/advance-article/doi/10.1093/cid/ciaf300/8157063?searchresult=1\">\n<div>\nIncidence of AIDS-defining Conditions among Adults with Perinatally Acquired HIV after Transition to Adult HIV Care in the United States and Canada, 2000-2022  </div>\n</a>\n</div>\n<div>\n<a href=\"/cid/article/80/5/e65/8156727?searchresult=1\">\n<div>\nState-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists  </div>\n</a>\n</div>\n</div>\n</div>\n</div></div>\n</section>\n\n</div>\n<div>\n<div>\n<div>More from Oxford Academic</div>\n<div>\n<a href=\"/search-results?tax=AcademicSubjects/MED00160\">Clinical Medicine</a>\n</div>\n<div>\n<a href=\"/search-results?tax=AcademicSubjects/MED00290\">Infectious Diseases</a>\n</div>\n<div>\n<a href=\"/search-results?tax=AcademicSubjects/MED00010\">Medicine and Health</a>\n</div>\n<div>\n<a href=\"/books\">Books</a>\n</div>\n<div>\n<a href=\"/journals\">Journals</a>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n      Having trouble contacting the network. Please try again in a moment or two.\n    </div>\n<div>\n<div><a href=\"http://global.oup.com/\"><img alt=\"Oxford University Press\" src=\"https://oup.silverchair-cdn.com/data/Multimedia/oup-logo.svg\"/></a></div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div> <div>\n<div>\n<div>\n<div>Advertisement</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n\n</div>\n</section>\n</div>\n<section>\n<div>\n<div>\n<div>\n<div>\n<div>Advertisement</div>\n<button>\n<span>close advertisement</span>\n</button>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<div>\n<div>\n<div>Advertisement</div>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n<ul>\n<li>\n<a href=\"/cid/pages/About\">About Clinical Infectious Diseases</a>\n</li> <li>\n<a href=\"/cid/pages/Editorial_Board\">Editorial Board</a>\n</li> <li>\n<a href=\"/cid/pages/General_Instructions\">Author Guidelines</a>\n</li>  </ul><ul> <li>\n<a href=\"/cid/subscribe\">Purchase</a>\n</li> <li>\n<a href=\"https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit\">Advertising and Corporate Services</a>\n</li> \n</ul>\n</div>\n<div>\n<a href=\"https://academic.oup.com/cid\">\n<img alt=\"Clinical Infectious Diseases\" class=\"journal-footer-affiliations-logo\" id=\"footer-logo-ClinicalInfectiousDiseases\" src=\"//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_f1483155260.svg\"/>\n</a> </div>\n<div>\n<ul>\n<li>Online ISSN 1537-6591</li> <li>Print ISSN 1058-4838</li> <li>Copyright © 2025 Infectious Diseases Society of America</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n<div>\n<div>\n<div>\n\n<div>\n<div>\n<ul>\n<li><a href=\"/pages/about-oxford-academic\">About Oxford Academic</a></li>\n<li><a href=\"/pages/about-oxford-academic/publish-journals-with-us\">Publish journals with us</a></li>\n<li><a href=\"/pages/about-oxford-academic/our-university-press-partners\">University press partners</a></li>\n<li><a href=\"/pages/what-we-publish\">What we publish</a></li>\n<li><a href=\"/pages/new-features\">New features</a> </li>\n</ul>\n</div>\n<div>\n<ul>\n<li><a href=\"/pages/for-authors\">For authors</a></li>\n<li><a href=\"/pages/open-research/open-access\">Open access</a></li>\n<li><a href=\"/pages/purchasing\">Purchasing</a></li>\n<li><a href=\"/pages/institutional-account-management\">Institutional account management</a></li>\n<li><a href=\"https://academic.oup.com/pages/purchasing/rights-and-permissions\">Rights and permissions</a></li>\n</ul>\n</div>\n<div>\n<ul>\n<li><a href=\"/pages/get-help-with-access\">Get help with access</a></li>\n<li><a href=\"/pages/about-oxford-academic/accessibility\">Accessibility</a></li>\n<li><a href=\"/pages/contact-us\">Contact us</a></li>\n<li><a href=\"/pages/advertising\">Advertising</a></li>\n<li><a href=\"/pages/media-enquiries\">Media enquiries</a></li>\n</ul>\n</div>\n<div>\n<ul>\n<li><a href=\"https://global.oup.com/\">Oxford University Press</a></li>\n<li><a href=\"https://corp.oup.com/press-office\">News</a></li>\n<li><a href=\"https://languages.oup.com/\">Oxford Languages</a></li>\n</ul>\n</div>\n<div>\n<p>Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide</p>\n<img alt=\"Oxford University Press\" class=\"journal-footer-logo\" height=\"69\" src=\"//oup.silverchair-cdn.com/UI/app/svg/umbrella/oup-logo.svg\" width=\"300\"/>\n</div>\n</div>\n<div>\n<div>\n<ul>\n<li>Copyright © 2025 Oxford University Press</li>\n<li><button>Cookie settings</button></li>\n<li><a href=\"https://global.oup.com/cookiepolicy\">Cookie policy</a></li>\n<li><a href=\"https://global.oup.com/privacy\">Privacy policy</a></li>\n<li><a href=\"https://academic.oup.com/pages/legal-notice\">Legal notice</a></li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</div>\n</section>\n</div>\n<div>\n\n<div>\n<div>\n<h5>This Feature Is Available To Subscribers Only</h5>\n<p><a href=\"/sign-in\">Sign In</a> or <a href=\"/my-account/register?siteId=5269&amp;returnUrl=%2fcid%2farticle%2f68%2f9%2f1482%2f5078600\">Create an Account</a></p>\n</div>\n</div>\n<div>\n<p>This PDF is available to Subscribers Only</p>\n<a><span>View Article Abstract &amp; Purchase Options</span></a>\n<div>\n<p>For full access to this pdf, sign in to an existing account, or purchase an annual subscription.</p>\n</div>\n</div>\n</div>\n\n\n\n\n\n\n\n<div>\n<div>\n<span>Manage Cookies</span>\n</div>\n<div>\n<div>\n<p>\n        When you visit web sites, they may store or retrieve data in your web browser. This storage is often necessary for basic functionality of the web site or the storage may be used for the purposes of marketing, analytics, and personalization of the web site such as storing your preferences.\n     </p>\n</div>\n<p>\n     Powered by \n</p>\n</div>\n<div>\n<button>\n     Save\n    </button>\n</div>\n</div><div>\n<div>\n<p>\n      Oxford University Press uses cookies to enhance your experience on our website. By selecting ‘accept all’ you are agreeing to our use of cookies. You can change your cookie settings at any time. More information can be found in our <a href=\"https://global.oup.com/cookiepolicy/?cc=gb\">Cookie Policy</a>.\n      \n     </p>\n<div>\n<button>\n       Reject and manage\n      </button>\n<button>\n       Deny all\n      </button>\n<button>\n       Accept all\n      </button>\n</div>\n</div>\n</div>",
        "markdown": {
          "raw_markdown": "[Skip to Main Content](https://academic.oup.com/cid/article/68/9/1482/5078600#skipNav)\nAdvertisement\n[ ![Oxford Academic](https://oup.silverchair-cdn.com/UI/app/svg/umbrella/oxford-academic-logo.svg) ](https://academic.oup.com/)\n[Journals](https://academic.oup.com/journals)\n[Books](https://academic.oup.com/books)\n  * [ ![Information](https://oup.silverchair-cdn.com/UI/app/svg/i.svg) ](https://academic.oup.com/pages/information)\n  * [ ![Information](https://oup.silverchair-cdn.com/UI/app/svg/i.svg) ](https://academic.oup.com/pages/information)\n\n\nNavbar Search Filter  Clinical Infectious DiseasesThis issueIDSA Journals Infectious DiseasesBooksJournalsOxford Academic Mobile Enter search term \n  * [ Issues ](https://academic.oup.com/cid/issue)\n  *     * [ Advance articles ](https://academic.oup.com/cid/advance-articles)\n    * [ Editor's Choice ](https://academic.oup.com/cid/search-results?page=1&f_OUPSeries=Editor%27s+Choice)\n    * [ Supplement Archive ](https://academic.oup.com/cid/supplements)\n    * [ Cover Archive ](https://academic.oup.com/cid/issue-covers/)\n    * [ IDSA Guidelines ](https://academic.oup.com/cid/pages/clinical-practice-guidelines)\n    * [ IDSA Journals ](https://academic.oup.com/idsa)\n    * [ The Journal of Infectious Diseases ](https://academic.oup.com/jid)\n    * [ Open Forum Infectious Diseases ](https://academic.oup.com/ofid)\n    * [ Clinical Dilemmas in ID ](https://academic.oup.com/cid/pages/clinical-dilemmas)\n    * [ Photo Quizzes ](https://academic.oup.com/cid/pages/photo-quizzes)\n    * [ State-of-the-Art Reviews ](https://academic.oup.com/cid/pages/state-of-the-art-reviews)\n    * [ Voices of ID ](https://academic.oup.com/cid/pages/voices-of-id)\n    * [ IDSA Content Collections ](https://academic.oup.com/idsa/pages/content-collections)\n  *     * [ Author Guidelines ](https://academic.oup.com/cid/pages/General_Instructions)\n    * [ Open Access ](https://academic.oup.com/cid/pages/General_Instructions)\n    * [ Why Publish ](https://academic.oup.com/cid/pages/why-publish)\n    * [ IDSA Journals Calls for Papers ](https://academic.oup.com/idsa/pages/calls-for-papers)\n  * [ Purchase ](https://academic.oup.com/cid/subscribe)\n  *     * [ Advertising and Corporate Services ](https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit)\n    * [ Advertising ](https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising)\n    * [ Mediakit ](https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit)\n    * [ Reprints and ePrints ](https://academic.oup.com/advertising-and-corporate-services/pages/reprints)\n    * [ Sponsored Supplements ](https://academic.oup.com/advertising-and-corporate-services/pages/supplements)\n    * [ Branded Books ](https://academic.oup.com/advertising-and-corporate-services/pages/branded-books)\n  *     * [ About Clinical Infectious Diseases ](https://academic.oup.com/cid/pages/About)\n    * [ IDSA COI Policy ](https://academic.oup.com/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf)\n    * [ Editorial Board ](https://academic.oup.com/cid/pages/Editorial_Board)\n    * [ Alerts ](https://academic.oup.com/my-account/email-alerts)\n    * [ Self-Archiving Policy ](https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b)\n    * [ For Reviewers ](https://academic.oup.com/cid/pages/For_Reviewers)\n    * [ For Press Offices ](https://academic.oup.com/idsa/pages/for_press_offices)\n  * [Journals on Oxford Academic](https://academic.oup.com/journals)\n  * [Books on Oxford Academic](https://academic.oup.com/books)\n\n\n[IDSA Journals](https://academic.oup.com/idsa)\n[ ![Clinical Infectious Diseases](https://oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_title-1229789578.svg) ](https://academic.oup.com/cid)\n  * [ Issues ](https://academic.oup.com/cid/issue)\n  *     * [ Advance articles ](https://academic.oup.com/cid/advance-articles)\n    * [ Editor's Choice ](https://academic.oup.com/cid/search-results?page=1&f_OUPSeries=Editor%27s+Choice)\n    * [ Supplement Archive ](https://academic.oup.com/cid/supplements)\n    * [ Cover Archive ](https://academic.oup.com/cid/issue-covers/)\n    * [ IDSA Guidelines ](https://academic.oup.com/cid/pages/clinical-practice-guidelines)\n    * [ IDSA Journals ](https://academic.oup.com/idsa)\n    * [ The Journal of Infectious Diseases ](https://academic.oup.com/jid)\n    * [ Open Forum Infectious Diseases ](https://academic.oup.com/ofid)\n    * [ Clinical Dilemmas in ID ](https://academic.oup.com/cid/pages/clinical-dilemmas)\n    * [ Photo Quizzes ](https://academic.oup.com/cid/pages/photo-quizzes)\n    * [ State-of-the-Art Reviews ](https://academic.oup.com/cid/pages/state-of-the-art-reviews)\n    * [ Voices of ID ](https://academic.oup.com/cid/pages/voices-of-id)\n    * [ IDSA Content Collections ](https://academic.oup.com/idsa/pages/content-collections)\n  *     * [ Author Guidelines ](https://academic.oup.com/cid/pages/General_Instructions)\n    * [ Open Access ](https://academic.oup.com/cid/pages/General_Instructions)\n    * [ Why Publish ](https://academic.oup.com/cid/pages/why-publish)\n    * [ IDSA Journals Calls for Papers ](https://academic.oup.com/idsa/pages/calls-for-papers)\n  * [ Purchase ](https://academic.oup.com/cid/subscribe)\n  *     * [ Advertising and Corporate Services ](https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit)\n    * [ Advertising ](https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising)\n    * [ Mediakit ](https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit)\n    * [ Reprints and ePrints ](https://academic.oup.com/advertising-and-corporate-services/pages/reprints)\n    * [ Sponsored Supplements ](https://academic.oup.com/advertising-and-corporate-services/pages/supplements)\n    * [ Branded Books ](https://academic.oup.com/advertising-and-corporate-services/pages/branded-books)\n  *     * [ About Clinical Infectious Diseases ](https://academic.oup.com/cid/pages/About)\n    * [ IDSA COI Policy ](https://academic.oup.com/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf)\n    * [ Editorial Board ](https://academic.oup.com/cid/pages/Editorial_Board)\n    * [ Alerts ](https://academic.oup.com/my-account/email-alerts)\n    * [ Self-Archiving Policy ](https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b)\n    * [ For Reviewers ](https://academic.oup.com/cid/pages/For_Reviewers)\n    * [ For Press Offices ](https://academic.oup.com/idsa/pages/for_press_offices)\n\n\nNavbar Search Filter  Clinical Infectious DiseasesThis issueIDSA Journals Infectious DiseasesBooksJournalsOxford Academic Enter search term \n[Advanced Search](https://academic.oup.com/cid/advanced-search?page=1&fl_SiteID=5269&SearchSourceType=1)\nArticle Navigation\nClose mobile search navigation\nArticle Navigation\n[ ![Clinical Infectious Diseases Cover Image for Volume 68, Issue 9](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/Issue/68/9/5/m_cover.jpeg?Expires=1752631924&Signature=VzkJpzpYIXCozHbdsaIS60qWT14TRuSLuGC1eukUyrcYSb6veXmlbdxxi4bsCqv56PfMH7dlbqN9LPLYakKnZ6uSxmWg0YAZOHfQIA39tvpONvJ71boTMCgDn8RhjNDckqV16RNIXTme4fSXo-Pb1NEzqABs9EzPZHe9bQMD6FT68PV8Vap~eeaNsVp85gS3jKjGejPEgn2-XCGy4vrE3MaPHJYIAkNxsVP0hL~5pIyLW4I1ZSyrhJhH-eg8MKmfcqb5InNKbRmJkLh~-95lJfZl5LOkCkFEzHqU5URne1xaCnWjdQWfdfTDCJXggdBa~HkCJsQ92f~1fLxypv7dIQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA) Volume 68 Issue 9 1 May 2019  ](https://academic.oup.com/cid/issue/68/9)\n### Article Contents\n  * [Abstract](https://academic.oup.com/cid/article/68/9/1482/5078600#134170092)\n  * [MATERIALS AND METHODS](https://academic.oup.com/cid/article/68/9/1482/5078600#134170097)\n  * [RESULTS](https://academic.oup.com/cid/article/68/9/1482/5078600#134170111)\n  * [DISCUSSION](https://academic.oup.com/cid/article/68/9/1482/5078600#134170130)\n  * [Supplementary Data](https://academic.oup.com/cid/article/68/9/1482/5078600#134170142)\n  * [Notes](https://academic.oup.com/cid/article/68/9/1482/5078600#134170144)\n  * [References](https://academic.oup.com/cid/article/68/9/1482/5078600#134170150)\n  * [Supplementary data](https://academic.oup.com/cid/article/68/9/1482/5078600#supplementary-data)\n\n\n  * [< Previous](https://academic.oup.com/cid/article/68/9/1472/5089945)\n  * [Next >](https://academic.oup.com/cid/article/68/9/1494/5087661)\n\n\nArticle Navigation \nArticle Navigation \nJournal Article\n#  Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients _Free_\n, \nMarta Francesca Di Pasquale \nDepartment of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Marta+Francesca+Di+Pasquale)\n, \nGiovanni Sotgiu \nClinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Giovanni+Sotgiu)\n, \nAndrea Gramegna \nDepartment of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Andrea+Gramegna)\n, \nDejan Radovanovic \nDepartment of Biomedical and Clinical Sciences (DIBIC), University of Milan, Pulmonary Unit, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Dejan+Radovanovic)\n, \nSilvia Terraneo \nRespiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Italy\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Silvia+Terraneo)\n, \nLuis F Reyes \nMicrobiology Department, Universidad de La Sabana, Chia, Colombia\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Luis+F+Reyes)\n, \nJan Rupp \nDepartment of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Jan+Rupp)\n, \nJuan González del Castillo \nEmergency Department, Hospital Clínico San Carlos, Universidad Complutense\nInstituto de Investigación Sanitaria del Hospital Clínico San Carlos, IdISSC, Madrid, Spain\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Juan+Gonz%c3%a1lez+del+Castillo)\n, \nFrancesco Blasi \nDepartment of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Francesco+Blasi)\n, \nStefano Aliberti \nDepartment of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\nCorrespondence: S. Aliberti, Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy ().\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Stefano+Aliberti)\n[ ... Show more ](https://academic.oup.com/cid/article/68/9/1482/5078600)\nMarcos I Restrepo \nDivision of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Marcos+I+Restrepo)\n_Clinical Infectious Diseases_ , Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, \nPublished:\n23 August 2018\nReceived:\n24 May 2018\nAccepted:\n20 August 2018\nPublished:\n23 August 2018\n  * [ ![pdf](https://oup.silverchair-cdn.com/UI/app/svg/pdf.svg)PDF ](https://academic.oup.com/cid/article-pdf/68/9/1482/28520951/ciy723.pdf)\n  * [ Cite ](https://academic.oup.com/cid/article/68/9/1482/5078600)\n### Cite\nMarta Francesca Di Pasquale, Giovanni Sotgiu, Andrea Gramegna, Dejan Radovanovic, Silvia Terraneo, Luis F Reyes, Jan Rupp, Juan González del Castillo, Francesco Blasi, Stefano Aliberti, Marcos I Restrepo, Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients, _Clinical Infectious Diseases_ , Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, \nSelect Format Select format .ris (Mendeley, Papers, Zotero) .enw (EndNote) .bibtex (BibTex) .txt (Medlars, RefWorks) Download citation\n\n\nNavbar Search Filter  Clinical Infectious DiseasesThis issueIDSA Journals Infectious DiseasesBooksJournalsOxford Academic Mobile Enter search term \nNavbar Search Filter  Clinical Infectious DiseasesThis issueIDSA Journals Infectious DiseasesBooksJournalsOxford Academic Enter search term \n[Advanced Search](https://academic.oup.com/cid/advanced-search?page=1&fl_SiteID=5269&SearchSourceType=1)\n## Abstract\nBackground\nThe correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia.\nMethods\nWe conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor.\nResults\nAt least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors significantly differed across continents and countries, with chronic steroid use (45%), hematological cancer (25%), and chemotherapy (22%) the most common. Among immunocompromised patients, community-acquired pneumonia (CAP) pathogens were the most frequently identified, and prevalences did not differ from those in immunocompetent patients. Risk factors for immunocompromise were independently associated with neither _Pseudomonas aeruginosa_ nor non–community-acquired bacteria. Specific risk factors were independently associated with fungal infections (odds ratio for AIDS and hematological cancer, 15.10 and 4.65, respectively; both _P_ = .001), mycobacterial infections (AIDS; _P_ = .006), and viral infections other than influenza (hematological cancer, 5.49; _P_ < .001).\nConclusions\nOur findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses.\n, , , , \nDuring initial evaluation of a patient coming from the community with pneumonia, the identification of possible risk factors for multidrug-resistant organisms or unusual pathogens is crucial []. Because a microbiological identification is found in about 30% of hospitalized patients with pneumonia coming from the community, and usually requires 24–48 hours to be available, most of patients are treated empirically []. Delay in initiation of appropriate empiric antibiotic therapy is a known risk factor for worse clinical outcomes []; therefore, it is relevant to promptly recognize patients at risk for specific pathogens, specially multidrug-resistant or atypical microbes [].\nThe aging of the population and advancements in therapeutic protocols have led to an increase prevalence of chronic diseases as well as long-term treatments with immunosuppressive agents [, ]. Thus, among patients with pneumonia coming from the community and admitted to the hospital, the number who might not be fully immunocompetent is constantly increasing [, ]. Nevertheless, the real prevalence of immunocompromise among patients with pneumonia coming from the community is still unknown. Moreover, guidelines for community-acquired and hospital-acquired pneumonia did not address this topic—what is more, they specifically excluded patients with clinical characteristics determining immunocompromise [], and current evidence in literature is also scarce.\nTo our knowledge, there are no studies addressing the clinical evaluation and initial empirical antibiotic coverage of patients coming from the community with pneumonia and immunocompromise. Moreover, specific risk factors to assess the causative microbiology and help clinicians choose more appropriate management for these patients have not been clearly identified. Thus, the aim of the current study was to identify the prevalence, type, microbiology, and intercorrelations between different risk factors for immunocompromise in hospitalized patients with pneumonia coming from the community.\n## MATERIALS AND METHODS\n### Study Design and Population\nThis is a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) database []. The GLIMP study was an international, multicenter, observational, point-prevalence study of adult patients hospitalized for community-onset pneumonia in 54 countries worldwide. Patients were enrolled on a single day during the months of March, April, May, and June 2015. The methods of the GLIMP study have been published elsewhere []. The coordinating center (University of Texas Health Science Center, San Antonio) received approval from its institutional review board (No. HSC20150184E).\nAll adult patients (aged >18 years old) coming from the community and hospitalized with pneumonia during study period were included. Pneumonia was defined as the presence of a new pulmonary infiltrate on chest radiograph at the time of hospitalization, associated with ≥1 of the following criteria: (1) new or increased cough with/without sputum production and/or purulent respiratory secretions, (2) fever or hypothermia, and (3) evidence of systemic inflammation (ie, abnormal white blood cell count or increased C-reactive protein or procalcitonin level). Hospitalized patients with a diagnosis of hospital-acquired or ventilator-associated pneumonia were excluded.\n### Data Collection\nData were collected from medical records at the time of hospital admission. Data gathered included demographics; respiratory and cardiovascular comorbid conditions; immunocompromised status and other chronic medical conditions; severity of pneumonia (defined as either intensive care unit admission, use of invasive or noninvasive mechanical ventilation, or use of vasopressors/inotropes during the first 24 hours after hospital admission); and specific risk factors for resistant pathogens infection, including chronic aspiration, being bedridden, malnutrition, presence of enteric tube feeding and indwelling catheters (including central venous and urinary catheters), previous infections, chronic microbial colonization, and previous healthcare exposures. The number and type of microbiological samples obtained within 24 hours after hospital admission were also collected. Culture-positive tests, kind of sample, and antibiotic resistance patterns were also gathered, along with empiric antibiotic treatment, given within 24 hours after hospital admission.\n### Microbiological Workup\nDiagnostic testing was performed according to local standard operating procedures and included collection of respiratory and blood cultures and testing for urinary antigens. Microbiological examinations and susceptibility testing were performed according to local standard protocols within the first 24 hours after hospital admission []. Multivariable logistic regression models were performed for patients who had a positive culture, to identify specific risk factors for single pathogens.\nCausative pathogens were stratified according to the coverage of standard therapy for community-acquired pneumonia (CAP) []. Those not covered by standard CAP therapy included the following: non–community-acquired bacteria (_Acinetobacter baumanii_ , _Enterococcus_ vancomycin-resistant, _Nocardia_ spp.), mycobacteria, fungi (_Aspergillus fumigatus, Coccidioides, Criptococcus_ , _Pneumocystis jirovecii_), and viruses other than influenza []. Those covered by standard CAP therapy included _Pseudomonas aeruginosa,_ methicillin-resistant _Staphylococcus aureus_ , methicillin-sensitive _S. aureus_ , _Enterobacter_ spp., _Enterococcus_ spp., _Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae_ , _Moraxella catarrhalis, Proteus mirabilis, Serratia marcescens, Streptococcus pneumoniae, Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella pneumophilia,_ anaerobes bacteria, and influenza viruses. Atypical pathogens included _C. pneumoniae, M. pneumoniae,_ and _L. pneumophilia._ CAP therapy was defined as β-lactams (ceftriaxone, ampicillin-sulbactam, amoxicillin-clavulanate, cefepime, ceftazidime, piperacillin-tazobactam) plus macrolide, or fluoroquinolones alone, and, eventually, in association with vancomycin, linezolid, or oseltamivir [].\n### Definition of Immunocompromised and Study Groups\nImmunocompromise was defined as the presence of ≥1 of the following risk factors: (1) AIDS, defined either as human immunodeficiency virus infection with CD4+ lymphocyte count <200/µL or by the occurrence of AIDS-defining conditions; (2) aplastic anemia; (3) asplenia; (4) hematological cancer, defined as lymphoma, acute or chronic leukemia, or multiple myeloma; (5) chemotherapy during the last 3 months; (6) neutropenia, defined as a neutrophil count <500/dL at complete blood cell count; (7) biological drug use (including trastuzumab and therapies for autoimmune diseases, eg, anti–tumor necrosis factor α, prescribed during ≥6 months before hospital admission); (8) lung transplantation; (9) chronic steroid use (>10 mg/d of prednisone or equivalent ≥3 months before hospital admission); (10) lung cancer with either neutropenia or chemotherapy; (11) other solid tumor with either neutropenia or chemotherapy; (12) other immunocompromise (any immunocompromised state, including congenital/genetic immunocompromise and immunosuppressive therapy due to hematological cancer/solid organ transplantation other than lung). Two study groups were identified: those with versus those without 1 risk factor for immunocompromise.\n### Statistical Analysis\nCategorical variables, expressed as counts (percentages), were compared using the χ2 test. Continuous variables were compared using the unpaired Student _t_ test or the Mann-Whitney test, when appropriate. Statistical significance was defined as _P_ < .05. A network analysis was conducted to represent the frequencies of all immunocompromise variables and their relationships. The size of the circles (the circles visible in Figure 4 [network analysis], each representing a single risk factor for immunocompromise) represents both prevalence of the risk factor and strength of association with other variables.\nThe predictive value of each variable was categorized by quartiles and analyzed using a univariate regression logistic analysis. A multivariable model was obtained using a Cox regression analysis to identify independent predictors of specific pathogens, using an entry level of P value ≤0.05 and a removal level of P value ≥0.10. Hazard ratios and adjusted analyses were obtained. All statistical analyses were performed with IBM SPSS software (version 22, Statistics for Mac; version 22.0, IBM Crop), and Stata 13 software (StataCorp).\n## RESULTS\n### Prevalence of Risk Factors for Immunocompromise\nAmong 3702 patients enrolled in the GLIMP database, ≥1 risk factor for immunocompromise was identified in 652 (17.6%). The prevalences of patients with pneumonia coming from the community and with ≥1 risk factor for immunocompromise differed among continents and countries, as depicted in and . The prevalence of immunocompromise was significantly higher in both North and South America than in the rest of the world (24.0% vs 16.5 [_P_ < .001] and 24.8% vs 17.2 [_P_ = .006], respectively) ().\n![Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases.](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1752554620&Signature=LKXAyrV74Aa9owXe0o-cQ75pOeSoID0-pehgygNtPZSFXNZMuhHSvh2bH2dv7qW8hH1yagXom1UIMLOtWgjAeeVu2LBuha-~CcDB2tnoDsCwd0W--ENWiqmCFTxq3yC2TQ0Umx7W~VJXwN6SRKyfDOflOkKvPGRNUobFX0ugYVCV63UYBnlhdsPfvI-fsKpp2D2I1PP6zBaXvsJbvI-0aIPK7XN9D-bkImy~2jyh7YxMl-ml056-m9M~e1NXIC1G-eMlJ-D0ihNbxsU~I2x~~h2BWrtr8AE9Sfu1WTqiFahp57mH4~iFGY9EkQkC4xJpjMyNKtQFhxpXjvQtYLzecQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\nFigure 1.\nDistribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases.\n[Open in new tab](https://academic.oup.com/view-large/figure/134170114/ciy72301.jpg)[Download slide](https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72301.jpeg?Expires=1752554620&Signature=NHcEJwNnhhuu~V7litr8igr9GFWfZ0zM0SxlfYOwAgN3ag3nsCMd9zXKoM9GZWcSFeGB~KznckX3sjRs7eZI6UovzOYWd5ChB8QCKT6DbvXvsAyPCY~~tvyw1nLgnCRXHxsEp9~pCDA4jyfmGwdzBmIxjxK32DKPE3r03H1NwaFfFuqtTjvCIQz2eID2dBiK~4lTbznS4INQ66i-Fh9DwTzI-HwYqclm24aYv1pSYlAiswZHOwaE-fO6wkuUxDcfD3pvVFQ~xscKfiFVbOt91lXVNkOd7p4CKoSAgaQv6yr5WZ9-7z1VyiIThnhC9G~HPkbIlB2Do4fo0jz7V2xwPA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170114&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269)\nThe prevalence of each risk factor for immunocompromise is depicted in , with chronic steroid use (45.0%), hematological cancer (25.0%), and chemotherapy (22.0%) being the most frequent ones. A total of 312 patients (8.4%) had >1 risk factor for immunocompromise ().\n![Prevalence of each single risk factor for immunocompromise.](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72302.jpeg?Expires=1752554620&Signature=tN-5VXAN-IRDKK8axKZA8P~Y5z--s9j8Erc8SOjWl6DrKKH4QL5os9eZxhVeV6eWVN~f~VDG9tfzyHUF6i7OVsMNB2vsk6C~94Qv-2aRHoy5JP-aM-LrL8khDyqEa4Lg2BfInF3Q0qGwXrmt25GlH1qSBKirMgS~VlVo9FK3dUDe2-XgCIv-DixycDR1NbxEUad1obLBQi7T-cMZnDc0-hSXzSelH07q4yY8dbVGxrERuy5IWOvusZ1u83w1jCK4dSvt3hPFFdMZMOmGLi~Fj-dVSs0cAjfbIHoEDmqErTby4pVDEijEs5muQVm-Ux~YEjgN-VhvWj8YtpZKL4eSXA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\nFigure 2.\nPrevalence of each single risk factor for immunocompromise.\n[Open in new tab](https://academic.oup.com/view-large/figure/134170116/ciy72302.jpg)[Download slide](https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72302.jpeg?Expires=1752554620&Signature=urCgidlWbN7Br1gKnVthRjYFEVioagJuBFmiXPuQQBoD2qmTrm4Heidc21Yt1dgPswbIwC7DPhnYrlHrjxMxL-tPDfinKG-olgkospAEDA-ocZW5BuK9lYsha0rJ0NF76fxfhqDzGVUbNAug3anPLTq4c4Wm9hmTgaDN4Qc2ECcT8hDYAnEm3od96dWn52Zy09JsZa4zT41kMG~qQJEZG62~24b5nEIG7eSCncOceqVPqOOaaIMniBLrAQuB7Hvqr~6AtHN5IBjBuLUjU1xYJcFJXX6WtIhnqkXKN21GOO7O7AU0AC7FLWQuEd1zCcVocKQxVv4RndCQeZ3XzZvegA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170116&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269)\n![Prevalence of the number of risk factors present simultaneously in a single patient.](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72303.jpeg?Expires=1752554620&Signature=Xts16a6pXvQbNfwKtUeejfXsqF17z~2gviy7VcLQhhckWHmCw0zRSSEtsyrG9SkI2LRw39TbhqnqYNb1VTXQKD-ybyHkb~R3s-eIxJ~94DOxaaXBbUvpzbvwY1vDACc5LpVzJJ8dZMntZ7nekvhgMs6NtlpySVWDDC~7ybF0bySgW6i55FBFevIdcUxB3ipChEHL9XiTlmDkdiHssMser494UBvbDyg4DUKM-Cpd988M8qpSwp-eg-3Yhkr9q2~L66QQUhwgYNILWRRA1azwsTAJvrWUq52Dpikbj4mzbXXstnhvc7GNMw5xxz6nFPKuHVKJlcE-HQsiIvj5ZOVUxg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\nFigure 3.\nPrevalence of the number of risk factors present simultaneously in a single patient.\n[Open in new tab](https://academic.oup.com/view-large/figure/134170117/ciy72303.jpg)[Download slide](https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72303.jpeg?Expires=1752554620&Signature=aODZPs-HRl9QmymSK-5bkx~xp6iLrndvYFKxy1ge9DczmeUzsNnr5McNlvqrMcXHLvgMkhfK7yT7VuvVZQyJiTDmkR2j-SEc5zFcORnQPNUjDvGORdypfvcWI0ap8MKwHNe5lyBn4KtJz~tW8Oy3Gx54ukE8wke7~kZBzMvO8MTOkttiu8JkRKLQBqO6IcM2MoQBEcRSt-iQJjHBC9eSqzTw9hfjbhfc1npEBjHchP6v69RipZnUipM4HSTXcHzcLlv5ZrElufmBjKlaCOuMXehhls70RLfvTvOnOA3AyEmOSecyKEGpTAKKWMZCZcKwFjPqwgrO2KIMNHBcdECFyg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170117&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269)\n### Network Analysis Among Risk Factors for Immunocompromise\nThe results of the network analysis of all risk factors for immunocompromise are depicted in . Relationships were identified between chemotherapy and solid tumor other than lung cancer, hematological cancer, and chronic steroid use, and between other immunocompromise and chronic steroid use.\n![Network analysis between risk factors for immunocompromise.](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72304.jpeg?Expires=1752554620&Signature=GuJUcrEhLaMR89vfrhqqYuGyB4HuDlfLUgnHqNu6Ksi5VkLMWjSpH0hVJWv0i4hnesvCDRYbQ~uAyBQyQ0AiLXq2xGVhq3CJd~~Uo~xFEO2RNWWcv5izwBv2Xd~h9Hdfe0hTA-AXnTA7hKM-ThAaURdGnReCFddtKpqnLFFI8QBpZfiXaSjcJTGzuOJpCX41BN9EmgqXfVfeCV2WjdANqIm2R0p4fJbe8r3T6ykoQ1g-IoQnAttT~9TBNl6irCxSuhZHs693bn8ZNDwodNBEKnNGVKaV3sMa8zH8GthYrKb1ARcjtit4vlO4Amlu5qUEW4FRAzxNeE5ch2OPPqoZ6g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\nFigure 4.\nNetwork analysis between risk factors for immunocompromise.\n[Open in new tab](https://academic.oup.com/view-large/figure/134170120/ciy72304.jpg)[Download slide](https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72304.jpeg?Expires=1752554620&Signature=YZzJ1wJWugBQStvfJV4l4KYj3Wo9NRpieCO~yvNqxtUBWQdjFeAYbw2G-Y6DLCVNq9Va5VeID5cdns-ikSqf31HJSxkU6nJ2ORJtfKpX9YRK1R4udPlHilZw7ywCq-EzR6AMwb3sY-BfsBS4sDesTOwvKTu1-DzRuTpqruza-~yCWEOuDxUkBBBhGOjezpmaPE1pK9FuWVCTdWQjhWi0Q1hWTQx8Y41~JVb3kGWNigqT8AD4v9JX1c4I3Lv7PwLI68bVFaY9GUswC-yS1tvJbrugsyrYyCUrS~h7Si20MQ14RfW5c61orGDtUvAkaoknOVddjBXj5tv5wBq7Hieh4A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170120&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269)\n### Clinical and Microbiological Characteristics of Patients With Immunocompromise\nClinical features and disease severity of immunocompetent versus immunocompromised patients are shown in and . Immunocompromised patients were significantly younger and malnourished, had a higher frequency of comorbid conditions, previous infections, and colonization by resistant pathogens, and had more frequent contacts with the healthcare system. The prevalences of severe pneumonia did not differ among the 2 study groups.\nTable 1.\n[ Open in new tab ](https://academic.oup.com/view-large/134170123)\nClinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised)\nVariable . | Patients, No. (%)a . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 3050) . | Immunocompromised(n = 652) .   \nAge, median (IQR)| 69 (54–81)| 65 (52–74)| <.001  \nUnderweight| 125 (6.5)| 41 (10.5)| .004  \nMalnutrition| 243 (8.0)| 80 (12.3)| <.001  \nBedridden| 355 (11.6)| 60 (9.2)| .04  \nChronic aspiration| 224 (7.3)| 33 (5.1)| .02  \nBronchiectasis| 136 (4.5)| 42 (6.4)| .03  \nSevere COPD| 72 (2.4)| 28 (4.3)| .006  \nInterstitial lung disease| 60 (2.0)| 35 (5.4)| <.001  \nLung transplantation| 0 (0.0)| 7 (1.1)| <.001  \nTracheostomy| 37 (1.2)| 16 (2.5)| .02  \nHypertension| 1401 (45.9)| 254 (39.0)| .001  \nLiver disease| 103 (3.4)| 37 (5.7)| .005  \nCirrhosis| 50 (1.6)| 20 (3.1)| .02  \nDementia| 372 (12.2)| 36 (5.5)| <.001  \nEnteral tube feeding| 36 (1.2)| 16 (2.5)| .01  \nChronic renal failure| 315 (10.3)| 85 (13.0)| .04  \nHemodialysis| 34 (1.1)| 18 (2.8)| .001  \nICS use| 462 (15.2)| 128 (19.6)| .005  \nPPI use| 777 (25.5)| 251 (38.5)| <.001  \nIndwelling catheter| 52 (1.7)| 27 (4.1)| <.001  \nPrior mycobacteria diseases| 70 (2.3)| 26 (4.0)| .01  \nPrior ESBL| 39 (1.3)| 16 (2.5)| .02  \nPrior _Pseudomonas_|  68 (2.2)| 33 (5.1)| <.001  \nSevere CAP| 840 (27.5)| 190 (29.1)| .41  \nVariable . | Patients, No. (%)a . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 3050) . | Immunocompromised(n = 652) .   \nAge, median (IQR)| 69 (54–81)| 65 (52–74)| <.001  \nUnderweight| 125 (6.5)| 41 (10.5)| .004  \nMalnutrition| 243 (8.0)| 80 (12.3)| <.001  \nBedridden| 355 (11.6)| 60 (9.2)| .04  \nChronic aspiration| 224 (7.3)| 33 (5.1)| .02  \nBronchiectasis| 136 (4.5)| 42 (6.4)| .03  \nSevere COPD| 72 (2.4)| 28 (4.3)| .006  \nInterstitial lung disease| 60 (2.0)| 35 (5.4)| <.001  \nLung transplantation| 0 (0.0)| 7 (1.1)| <.001  \nTracheostomy| 37 (1.2)| 16 (2.5)| .02  \nHypertension| 1401 (45.9)| 254 (39.0)| .001  \nLiver disease| 103 (3.4)| 37 (5.7)| .005  \nCirrhosis| 50 (1.6)| 20 (3.1)| .02  \nDementia| 372 (12.2)| 36 (5.5)| <.001  \nEnteral tube feeding| 36 (1.2)| 16 (2.5)| .01  \nChronic renal failure| 315 (10.3)| 85 (13.0)| .04  \nHemodialysis| 34 (1.1)| 18 (2.8)| .001  \nICS use| 462 (15.2)| 128 (19.6)| .005  \nPPI use| 777 (25.5)| 251 (38.5)| <.001  \nIndwelling catheter| 52 (1.7)| 27 (4.1)| <.001  \nPrior mycobacteria diseases| 70 (2.3)| 26 (4.0)| .01  \nPrior ESBL| 39 (1.3)| 16 (2.5)| .02  \nPrior _Pseudomonas_|  68 (2.2)| 33 (5.1)| <.001  \nSevere CAP| 840 (27.5)| 190 (29.1)| .41  \nAbbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors.\naData represent No. (%) unless otherwise specified.\nTable 1.\n[ Open in new tab ](https://academic.oup.com/view-large/134170123)\nClinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised)\nVariable . | Patients, No. (%)a . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 3050) . | Immunocompromised(n = 652) .   \nAge, median (IQR)| 69 (54–81)| 65 (52–74)| <.001  \nUnderweight| 125 (6.5)| 41 (10.5)| .004  \nMalnutrition| 243 (8.0)| 80 (12.3)| <.001  \nBedridden| 355 (11.6)| 60 (9.2)| .04  \nChronic aspiration| 224 (7.3)| 33 (5.1)| .02  \nBronchiectasis| 136 (4.5)| 42 (6.4)| .03  \nSevere COPD| 72 (2.4)| 28 (4.3)| .006  \nInterstitial lung disease| 60 (2.0)| 35 (5.4)| <.001  \nLung transplantation| 0 (0.0)| 7 (1.1)| <.001  \nTracheostomy| 37 (1.2)| 16 (2.5)| .02  \nHypertension| 1401 (45.9)| 254 (39.0)| .001  \nLiver disease| 103 (3.4)| 37 (5.7)| .005  \nCirrhosis| 50 (1.6)| 20 (3.1)| .02  \nDementia| 372 (12.2)| 36 (5.5)| <.001  \nEnteral tube feeding| 36 (1.2)| 16 (2.5)| .01  \nChronic renal failure| 315 (10.3)| 85 (13.0)| .04  \nHemodialysis| 34 (1.1)| 18 (2.8)| .001  \nICS use| 462 (15.2)| 128 (19.6)| .005  \nPPI use| 777 (25.5)| 251 (38.5)| <.001  \nIndwelling catheter| 52 (1.7)| 27 (4.1)| <.001  \nPrior mycobacteria diseases| 70 (2.3)| 26 (4.0)| .01  \nPrior ESBL| 39 (1.3)| 16 (2.5)| .02  \nPrior _Pseudomonas_|  68 (2.2)| 33 (5.1)| <.001  \nSevere CAP| 840 (27.5)| 190 (29.1)| .41  \nVariable . | Patients, No. (%)a . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 3050) . | Immunocompromised(n = 652) .   \nAge, median (IQR)| 69 (54–81)| 65 (52–74)| <.001  \nUnderweight| 125 (6.5)| 41 (10.5)| .004  \nMalnutrition| 243 (8.0)| 80 (12.3)| <.001  \nBedridden| 355 (11.6)| 60 (9.2)| .04  \nChronic aspiration| 224 (7.3)| 33 (5.1)| .02  \nBronchiectasis| 136 (4.5)| 42 (6.4)| .03  \nSevere COPD| 72 (2.4)| 28 (4.3)| .006  \nInterstitial lung disease| 60 (2.0)| 35 (5.4)| <.001  \nLung transplantation| 0 (0.0)| 7 (1.1)| <.001  \nTracheostomy| 37 (1.2)| 16 (2.5)| .02  \nHypertension| 1401 (45.9)| 254 (39.0)| .001  \nLiver disease| 103 (3.4)| 37 (5.7)| .005  \nCirrhosis| 50 (1.6)| 20 (3.1)| .02  \nDementia| 372 (12.2)| 36 (5.5)| <.001  \nEnteral tube feeding| 36 (1.2)| 16 (2.5)| .01  \nChronic renal failure| 315 (10.3)| 85 (13.0)| .04  \nHemodialysis| 34 (1.1)| 18 (2.8)| .001  \nICS use| 462 (15.2)| 128 (19.6)| .005  \nPPI use| 777 (25.5)| 251 (38.5)| <.001  \nIndwelling catheter| 52 (1.7)| 27 (4.1)| <.001  \nPrior mycobacteria diseases| 70 (2.3)| 26 (4.0)| .01  \nPrior ESBL| 39 (1.3)| 16 (2.5)| .02  \nPrior _Pseudomonas_|  68 (2.2)| 33 (5.1)| <.001  \nSevere CAP| 840 (27.5)| 190 (29.1)| .41  \nAbbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors.\naData represent No. (%) unless otherwise specified.\nMicrobiological testing was performed in 91.0% (596 of 652) of immunocompromised and 86.0% (2626 of 3050) of immunocompetent patients (_P_ < .001). Bacteremia was found in 6.0% (36 of 596) of immunocompromised and 5.5% (145 of 2626; _P_ = .62) of immunocompetent patients. At least 1 positive culture was obtained in 40.0% (238 of 596) immunocompromised and 36.0% (935 of 2626) immunocompetent patients (_P_ = .047). Microbiological findings are provided in and . Among pathogens covered by standard therapy, _P. aeruginosa_ was more prevalent in immunocompromised patients (35 [5.9%] vs 98 [3.7%] patients; _P_ < .02). Among pathogens not usually covered by standard therapy, immunocompromised patients were more likely to be infected by _Nocardia_ spp. (4 [0.7%] vs 0 [0%] patients; _P_ < .001), nontuberculous mycobacteria (NTM) (5 [0.8%] vs 2 [0.1%]; _P_ < .002), _A. fumigatus_ (8 [1.3%] vs 10 [0.4%]; _P_ < .01), _P. jirovecii_ (12 [2.0%] vs 5 [0.2%]; _P_ < .02), and viruses, such as coronavirus (3 [0.5%] vs 3 [0.1%]; _P_ < .047), and respiratory syncytial virus (6 [1.0%] vs 7 [0.3%]; _P_ < .03).\nTable 2.\n[ Open in new tab ](https://academic.oup.com/view-large/134170125)\nPathogens in the 2 Study Groups\nPathogen . | Patients, No. (%) . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 2626) . | Immunocompromised (n = 596) .   \nPathogens covered by CAP therapy| | |   \n _Streptococcus pneumoniae_|  218 (8.3)| 50 (8.4)| >.99  \nAtypical| 50 (1.9)| 13 (2.2)| .78  \n _Legionella_|  21 (0.8)| 10 (1.7)| .08  \nMRSA| 83 (3.2)| 12 (2.0)| .17  \nMSSA| 73 (2.8)| 20 (3.4)| .53  \n _Pseudomonas aeruginosa_|  98 (3.7)| 35 (5.9)| .02  \n _Haemophilus influenzae_|  65 (2.5)| 10 (1.7)| .31  \n _Klebsiella pneumoniae_|  89 (3.4)| 22 (3.7)| .81  \nInfluenza virus| 126 (4.8)| 28 (4.7)| >.99  \nPathogens not covered by CAP therapy| | |   \nNon-CAP bacteria| | |   \n _Acinetobacter baumanii_|  33 (1.3)| 7 (1.2)| >.99  \n _Nocardia_ spp.| 0 (0.0)| 4 (0.7)| <.001  \nMycobacteria| | |   \n _Mycobacterium tuberculosis_|  21 (0.8)| 5 (0.8)| >.99  \nNTM| 2 (0.1)| 5 (0.8)| .002  \nFungi| | |   \n _Aspergillus fumigatus_|  10 (0.4)| 8 (1.3)| .01  \n _Actinomyces_|  2 (0.1)| 0 (0.0)| >.99  \n _Cryptococcus_|  3 (0.1)| 0 (0.0)| .94  \n _Pneumocystis jirovecii_|  5 (0.2)| 13 (2.2)| <.001  \nViruses| | |   \nAdenovirus| 5 (0.2)| 0 (0.0)| .62  \nCoronavirus| 3 (0.1)| 3 (0.5)| .047  \nMetapneumovirus| 3 (0.1)| 2 (0.3)| .51  \nRSV| 7 (0.3)| 6 (1.0)| .03  \nMDR pathogens| 231 (8.8)| 54 (9.0)| .54  \nPathogen . | Patients, No. (%) . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 2626) . | Immunocompromised (n = 596) .   \nPathogens covered by CAP therapy| | |   \n _Streptococcus pneumoniae_|  218 (8.3)| 50 (8.4)| >.99  \nAtypical| 50 (1.9)| 13 (2.2)| .78  \n _Legionella_|  21 (0.8)| 10 (1.7)| .08  \nMRSA| 83 (3.2)| 12 (2.0)| .17  \nMSSA| 73 (2.8)| 20 (3.4)| .53  \n _Pseudomonas aeruginosa_|  98 (3.7)| 35 (5.9)| .02  \n _Haemophilus influenzae_|  65 (2.5)| 10 (1.7)| .31  \n _Klebsiella pneumoniae_|  89 (3.4)| 22 (3.7)| .81  \nInfluenza virus| 126 (4.8)| 28 (4.7)| >.99  \nPathogens not covered by CAP therapy| | |   \nNon-CAP bacteria| | |   \n _Acinetobacter baumanii_|  33 (1.3)| 7 (1.2)| >.99  \n _Nocardia_ spp.| 0 (0.0)| 4 (0.7)| <.001  \nMycobacteria| | |   \n _Mycobacterium tuberculosis_|  21 (0.8)| 5 (0.8)| >.99  \nNTM| 2 (0.1)| 5 (0.8)| .002  \nFungi| | |   \n _Aspergillus fumigatus_|  10 (0.4)| 8 (1.3)| .01  \n _Actinomyces_|  2 (0.1)| 0 (0.0)| >.99  \n _Cryptococcus_|  3 (0.1)| 0 (0.0)| .94  \n _Pneumocystis jirovecii_|  5 (0.2)| 13 (2.2)| <.001  \nViruses| | |   \nAdenovirus| 5 (0.2)| 0 (0.0)| .62  \nCoronavirus| 3 (0.1)| 3 (0.5)| .047  \nMetapneumovirus| 3 (0.1)| 2 (0.3)| .51  \nRSV| 7 (0.3)| 6 (1.0)| .03  \nMDR pathogens| 231 (8.8)| 54 (9.0)| .54  \nAbbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant _Staphylococcus aureus_ ; MSSA, methicillin-sensitive _S. aureus_ ; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus.\nTable 2.\n[ Open in new tab ](https://academic.oup.com/view-large/134170125)\nPathogens in the 2 Study Groups\nPathogen . | Patients, No. (%) . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 2626) . | Immunocompromised (n = 596) .   \nPathogens covered by CAP therapy| | |   \n _Streptococcus pneumoniae_|  218 (8.3)| 50 (8.4)| >.99  \nAtypical| 50 (1.9)| 13 (2.2)| .78  \n _Legionella_|  21 (0.8)| 10 (1.7)| .08  \nMRSA| 83 (3.2)| 12 (2.0)| .17  \nMSSA| 73 (2.8)| 20 (3.4)| .53  \n _Pseudomonas aeruginosa_|  98 (3.7)| 35 (5.9)| .02  \n _Haemophilus influenzae_|  65 (2.5)| 10 (1.7)| .31  \n _Klebsiella pneumoniae_|  89 (3.4)| 22 (3.7)| .81  \nInfluenza virus| 126 (4.8)| 28 (4.7)| >.99  \nPathogens not covered by CAP therapy| | |   \nNon-CAP bacteria| | |   \n _Acinetobacter baumanii_|  33 (1.3)| 7 (1.2)| >.99  \n _Nocardia_ spp.| 0 (0.0)| 4 (0.7)| <.001  \nMycobacteria| | |   \n _Mycobacterium tuberculosis_|  21 (0.8)| 5 (0.8)| >.99  \nNTM| 2 (0.1)| 5 (0.8)| .002  \nFungi| | |   \n _Aspergillus fumigatus_|  10 (0.4)| 8 (1.3)| .01  \n _Actinomyces_|  2 (0.1)| 0 (0.0)| >.99  \n _Cryptococcus_|  3 (0.1)| 0 (0.0)| .94  \n _Pneumocystis jirovecii_|  5 (0.2)| 13 (2.2)| <.001  \nViruses| | |   \nAdenovirus| 5 (0.2)| 0 (0.0)| .62  \nCoronavirus| 3 (0.1)| 3 (0.5)| .047  \nMetapneumovirus| 3 (0.1)| 2 (0.3)| .51  \nRSV| 7 (0.3)| 6 (1.0)| .03  \nMDR pathogens| 231 (8.8)| 54 (9.0)| .54  \nPathogen . | Patients, No. (%) . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 2626) . | Immunocompromised (n = 596) .   \nPathogens covered by CAP therapy| | |   \n _Streptococcus pneumoniae_|  218 (8.3)| 50 (8.4)| >.99  \nAtypical| 50 (1.9)| 13 (2.2)| .78  \n _Legionella_|  21 (0.8)| 10 (1.7)| .08  \nMRSA| 83 (3.2)| 12 (2.0)| .17  \nMSSA| 73 (2.8)| 20 (3.4)| .53  \n _Pseudomonas aeruginosa_|  98 (3.7)| 35 (5.9)| .02  \n _Haemophilus influenzae_|  65 (2.5)| 10 (1.7)| .31  \n _Klebsiella pneumoniae_|  89 (3.4)| 22 (3.7)| .81  \nInfluenza virus| 126 (4.8)| 28 (4.7)| >.99  \nPathogens not covered by CAP therapy| | |   \nNon-CAP bacteria| | |   \n _Acinetobacter baumanii_|  33 (1.3)| 7 (1.2)| >.99  \n _Nocardia_ spp.| 0 (0.0)| 4 (0.7)| <.001  \nMycobacteria| | |   \n _Mycobacterium tuberculosis_|  21 (0.8)| 5 (0.8)| >.99  \nNTM| 2 (0.1)| 5 (0.8)| .002  \nFungi| | |   \n _Aspergillus fumigatus_|  10 (0.4)| 8 (1.3)| .01  \n _Actinomyces_|  2 (0.1)| 0 (0.0)| >.99  \n _Cryptococcus_|  3 (0.1)| 0 (0.0)| .94  \n _Pneumocystis jirovecii_|  5 (0.2)| 13 (2.2)| <.001  \nViruses| | |   \nAdenovirus| 5 (0.2)| 0 (0.0)| .62  \nCoronavirus| 3 (0.1)| 3 (0.5)| .047  \nMetapneumovirus| 3 (0.1)| 2 (0.3)| .51  \nRSV| 7 (0.3)| 6 (1.0)| .03  \nMDR pathogens| 231 (8.8)| 54 (9.0)| .54  \nAbbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant _Staphylococcus aureus_ ; MSSA, methicillin-sensitive _S. aureus_ ; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus.\nOnce adjusted for confounders, no risk factors of immunocompromise have been recognized for _P. aeruginosa_ infection. Likewise, pathogens not covered by usual CAP therapy were found to be associated not with immunocompromise but with chronic obstructive pulmonary disease (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.07–2.99; _P_ = .03), tracheostomy (2.91; 1.01–8.38; _P_ = .048), and severe pneumonia (2.36; 1.42–3.93; _P_ = .001) ().\nTable 3.\n[ Open in new tab ](https://academic.oup.com/view-large/134170127)\nMultivariable Logistic Regression Analysis\nVariable . | OR (CI 95%) .   \n---|---  \n _Pseudomonas aeruginosa_ . | Non-CAP Bacteria . | Fungi . |  _Mycobacterium tuberculosis_ . | Virus Other Than Influenza .   \nSevere COPD| 2.89 (1.34–6.22)| …| …| …| …  \nTracheostomy| 6.95 (2.87–16.85)| 2.91(1.01–8.38)| …| …| …  \nICS use| 1.76 (1.09–2.82)| …| …| …| …  \nIndwelling catheter| 2.49 (1.02–6.06)| …| …| …| …  \nPrior _Pseudomonas_|  19.20(11.71–31.50)| …| …| …| …  \nCOPD| …| 1.78(1.07–2.99)| …| …| …  \nSevere CAP| …| 2.36(1.42–3.93)| …| …| 2.56(1.27–5.19)  \nAIDS| …| …| 15.10(6.36–35.88)| …| …  \nHematological cancer| …| …| 4.65(1.85–11.69)| …| 5.49(2.20–13.70)  \nMalnutrition| …| …| …| 5.14 (2.21–11.93)| …  \nVariable . | OR (CI 95%) .   \n---|---  \n _Pseudomonas aeruginosa_ . | Non-CAP Bacteria . | Fungi . |  _Mycobacterium tuberculosis_ . | Virus Other Than Influenza .   \nSevere COPD| 2.89 (1.34–6.22)| …| …| …| …  \nTracheostomy| 6.95 (2.87–16.85)| 2.91(1.01–8.38)| …| …| …  \nICS use| 1.76 (1.09–2.82)| …| …| …| …  \nIndwelling catheter| 2.49 (1.02–6.06)| …| …| …| …  \nPrior _Pseudomonas_|  19.20(11.71–31.50)| …| …| …| …  \nCOPD| …| 1.78(1.07–2.99)| …| …| …  \nSevere CAP| …| 2.36(1.42–3.93)| …| …| 2.56(1.27–5.19)  \nAIDS| …| …| 15.10(6.36–35.88)| …| …  \nHematological cancer| …| …| 4.65(1.85–11.69)| …| 5.49(2.20–13.70)  \nMalnutrition| …| …| …| 5.14 (2.21–11.93)| …  \nBlank cells indicate no statistical significancy.\nAbbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio.\nTable 3.\n[ Open in new tab ](https://academic.oup.com/view-large/134170127)\nMultivariable Logistic Regression Analysis\nVariable . | OR (CI 95%) .   \n---|---  \n _Pseudomonas aeruginosa_ . | Non-CAP Bacteria . | Fungi . |  _Mycobacterium tuberculosis_ . | Virus Other Than Influenza .   \nSevere COPD| 2.89 (1.34–6.22)| …| …| …| …  \nTracheostomy| 6.95 (2.87–16.85)| 2.91(1.01–8.38)| …| …| …  \nICS use| 1.76 (1.09–2.82)| …| …| …| …  \nIndwelling catheter| 2.49 (1.02–6.06)| …| …| …| …  \nPrior _Pseudomonas_|  19.20(11.71–31.50)| …| …| …| …  \nCOPD| …| 1.78(1.07–2.99)| …| …| …  \nSevere CAP| …| 2.36(1.42–3.93)| …| …| 2.56(1.27–5.19)  \nAIDS| …| …| 15.10(6.36–35.88)| …| …  \nHematological cancer| …| …| 4.65(1.85–11.69)| …| 5.49(2.20–13.70)  \nMalnutrition| …| …| …| 5.14 (2.21–11.93)| …  \nVariable . | OR (CI 95%) .   \n---|---  \n _Pseudomonas aeruginosa_ . | Non-CAP Bacteria . | Fungi . |  _Mycobacterium tuberculosis_ . | Virus Other Than Influenza .   \nSevere COPD| 2.89 (1.34–6.22)| …| …| …| …  \nTracheostomy| 6.95 (2.87–16.85)| 2.91(1.01–8.38)| …| …| …  \nICS use| 1.76 (1.09–2.82)| …| …| …| …  \nIndwelling catheter| 2.49 (1.02–6.06)| …| …| …| …  \nPrior _Pseudomonas_|  19.20(11.71–31.50)| …| …| …| …  \nCOPD| …| 1.78(1.07–2.99)| …| …| …  \nSevere CAP| …| 2.36(1.42–3.93)| …| …| 2.56(1.27–5.19)  \nAIDS| …| …| 15.10(6.36–35.88)| …| …  \nHematological cancer| …| …| 4.65(1.85–11.69)| …| 5.49(2.20–13.70)  \nMalnutrition| …| …| …| 5.14 (2.21–11.93)| …  \nBlank cells indicate no statistical significancy.\nAbbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio.\nResults showed that AIDS (OR, 15.10; 95% CI, 6.36–35.88; _P_ ≤ .001) and hematological cancer (4.65; 91.85–11.69; _P_ = .001) were independently associated with fungal infections; hematological cancer (5.49; 2.20–13.70; _P_ < .001) and severe pneumonia (2.56; 1.27–5.19; _P_ = .009) with infection by viruses other than influenza; and AIDS (4.41; 1.53–12.73; _P_ = .006) and malnutrition (4.50; 2.08–9.72; _P_ < .001) with mycobacterial infections. An additional analysis was conducted on mycobacteria, including _M. tuberculosis_ and NTM. At multivariable analysis, _M. tuberculosis_ was independently associated with malnutrition only (OR, 5.14; 95% CI, 2.21–11.93; _P_ < .001). At univariate analysis, patients with AIDS were at higher risk for NTM (23.06; 4.39–121.12; _P_ < .001).\nA subanalysis was conducted among patients with chronic steroid use versus other risk factors for immunocompromise. Patients with chronic steroid use seemed to be more frequently affected by bacteria not covered by standard CAP therapy (10 [3.4%] vs 1 [0.3%] patients; _P_ = .002), _Nocardia_ spp. in particular (4 [0.4%] vs 0 [0.0%]; _P_ = .03). No differences in the severity of the disease were found (see ).\n## DISCUSSION\nThe main findings of the present study are as follows: (1) 17.6% of patients admitted with pneumonia from the community have ≥1 risk factor for immunocompromise, with significant differences among continents and countries (ranging from 15.4% to 24.8% by continent and from 80.0% to 4.1% by country); (2) chronic steroid use is by far the most prevalent risk factor leading to immunocompromise, followed by hematological cancer and chemotherapy; (3) 1 of 2 immunocompromised patients has an overlap of ≥2 risk factors, which are also associated between one another in different ways; and (4) the 2 risk factors for immunocompromise independently associated with specific pathogens are AIDS (ie, fungal and mycobacterial infections) and hematological cancer (ie, fungal infection and viral infections other than influenza).\nAlmost 1 in 5 hospitalized patients with CAP are not immunocompetent. Therefore, it is mandatory to provide clinicians with recommendations or guidelines for the management of hospitalized patients with pneumonia coming from the community who have risk factors for immunocompromise. Currently, there are no guidelines for assessing pneumonia in immunocompromised patients coming from the community. Randomized controlled trials (RCTs) and observational prospective studies are missing owing to the fact that, generally, studies assessing management strategies for pneumonia exclude immunocompromised patients or take into account only a single specific risk factor []. This lack of information about immunocompromise could lead to both underestimation of the real prevalence with a higher rate of treatment failure and to overestimation and overuse of wide-spectrum antibiotics.\nWe found a 17.6% global prevalence of immunocompromise among patients coming from the community with pneumonia, with a significantly higher frequency in South and North America. This variability among continents and countries is probably attributable to different healthcare systems and rates of hospitalization of immunocompromised patients. Our analysis showed that the most frequent risk factor for immunocompromise is the chronic use of systemic steroids. Aging of the population and therapeutic advancements have favored the increased burden of chronic diseases and long-term therapies with immunosuppressive agents [, ]. In particular, steroids are the agents most frequently prescribed, for their wide spectrum of efficacy in several diseases [, , ]. Therefore, many patients presenting to the emergency room with pneumonia are receiving chronic steroid treatment. No data are available on this population group, and further studies are needed to characterize these patients and provide individualized management.\nHematological cancer and chemotherapy were other leading immunocompromised factors. These findings are consistent with those in previous studies; patients recruited in observational studies include patients with solid or hematological cancer and those who underwent chemotherapy with associated neutropenia [, ]. Dedicated guidelines and recommendations are available, especially on respiratory viruses, fungi, and _P. jirovecii_ [].\nOur network analysis showed that several risk factors for immunocompromise show associations, especially chemotherapy, associated with hematological cancer and solid tumor, and other immunocompromise, associated with chronic steroid use. Moreover, neutropenic patients are well represented and mainly affected also by hematological cancer or under treatment with chemotherapy. Our results suggest that patients may have >1 risk factor characteristic and clinical assessment should be comprehensive, taking into consideration risk factors for immunocompromise and their associated biological mechanisms. In contrast, AIDS, lung transplantation, asplenia, and aplastic anemia seem to be less frequent at admission and to represent distinct clinical entities. Findings of previous studies seem to be in line with our results, with AIDS patients considered as a distinct patient population and with very few observational studies available on asplenia and aplastic anemia [, ]\nIn agreement with previous reports, _S. pneumoniae_ is the leading microorganism in both immunocompromised and immunocompetent groups [, ]. Among pathogens covered by standard CAP therapy, only _P. aeruginosa_ was more frequently isolated in immunocompromised compared with immunocompetent patients. These findings differ from microbiological results of previous studies. Gram-positive bacteria, especially _S. aureus_ , were more frequently identified in patients with immunocompromise of different causes [, , ]. Only Li and coauthors [] found patients with immunological disorders, treated with systemic steroids and cytotoxic agents, to have a higher incidence of infections caused by gram-negative bacteria, mainly _P. aeruginosa_. This similarity with our findings could be explained by the prevalence of patients exposed to chronic steroids in our cohort.\nAmong pathogens not covered by standard CAP therapy, immunocompromised patients were more frequently infected by _Nocardia_ spp., NTM, _P. jirovecii_ , _A. fumigatus_ , and viruses other than influenza. Infections by _P. jirovecii_ and NTM are frequently identified in patients with AIDS []. _P. jirovecii_ is also frequent in other types of immunocompromise, such as solid or hematological cancer in patients who underwent chemotherapy [, , ]. Fungal infections (eg, _Candida_ spp. and _A. fumigatus_) are highly incident in neutropenic hematological cancer patients [, ]. Viral infections other than influenza, especially respiratory syncytial virus, are more frequent in patients who underwent hematopoietic stem cell or lung transplantation [, ]. Conversely, _Nocardia_ spp. infections are mainly described in solid organ transplant recipients []. These results, consistent with previous findings, suggest the need for a more in-depth microbiological workup, including community-acquired pathogens and microorganisms not covered by standard therapy.\nSurprisingly, we found that risk factors for immunocompromise were not independently associated with _P. aeruginosa_ or non–community-acquired bacteria; in contrast, AIDS and hematological cancer are both associated with fungal, mycobacterial, and noninfluenza viral pneumonia, respectively. Empirical therapy should include _P. aeruginosa_ coverage, which is highly prevalent in immunocompromised patients. On the contrary, particular attention should be given to fungal, mycobacterial, and viral causes should be for patients admitted with AIDS and hematological cancer [].\nFinally, bacteremia rates did not differ between study groups. To our knowledge, there are no studies on bacteremia and immunocompromise in general. The majority of studies have focused on bacteremia in hematopoietic stem cell transplantation, with prevalences varying from 6% to 44% depending on the type of bacteria and host-related factors []. Few studies addressed this topic in kidney transplant recipients, reporting a prevalence of bacteremia ranging from 25% to 69% [, ]. Finally, few studies have addressed HIV and bacteremia, with prevalences ranging from 10% to 25%, depending on the pathogen and grade of immunosuppression [, ]. The prevalence of bacteremia in our study was 5T–6% in both immunocompetent and immunocompromised patients. Differences in the prevalence of bacteremia are due mainly to differences between the risk factors for immunocompromise in our study (chronic steroid use, hematological cancer, and chemotherapy) and those previously reported in the literature.\nThe current study has both limitations and strengths. First of all, to our knowledge, this is the first study showing a worldwide perspective on immunocompromise among patients coming from the community with pneumonia, with a large and diverse sample of patients enrolled across different countries in 6 continents. However, we were not able to involve many investigators from Asia and Africa, and most cases occurred in North America and Europe, thus limiting the generalizability of our findings. Another major limitation is the unfeasibility of grading the severity of immunocompromise and, therefore, stratifying patients and defining the physiopathological interaction between different risk factors, especially with regard to the use of biological drugs and chronic steroids. Furthermore, potentially important risk factors for an immunocompromised state, such as solid organ transplants other than lung, have not been specifically investigated. Finally, no outcome data have been collected, and this strongly limits our speculations as to the correct empiric antibiotic therapy for use in immunocompromised patients with CAP.\nIn conclusion, our study offers to the scientific community a perspective on immunocompromised patients coming from the community with pneumonia. Future prospective studies on patients with specific risk factors for immunocompromise could provide practical recommendations. In particular, it will be crucial to prepare guidelines on certain prevalent population groups, such as patients exposed to chronic steroids and those with hematological cancer.\n## Supplementary Data\nSupplementary materials are available at _Clinical Infectious Diseases_ online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.\n## Notes\n**_Author contributions._** M. F. D. P., G. S., S. A., and M. I. R. participated in study design, analysis of data, and writing of the manuscript and take responsibility for the integrity of the work. A. G., D. R., S. T., L. F. R., J. R., J. G. d. C., and F. B. critically reviewed the final manuscript.\n**_Acknowledgments._** We thank the Asociacion Latinoamericana de Torax, European Respiratory Society, World Federation of Societies of Intensive and Critical Care Medicine, and American College of Chest Physicians for their support of this project. We also thank the following study contributors for their valuable collaboration. **Argentina:** Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires), Silvia Attorri (Hospital Luis Lago Maggiore, Mendoza), Enrique Barimboim (Hospital Central de Mendoza), Juan Pablo Caeiro and María I. Garzón (Hospital Privado Universitario, Córdoba), Victor Hugo Cambursano, A. Cazaux (Servicio de Neumologia, Hospital Rawson, Córdoba), Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas), Julio Chertcoff, Florencia Lascar, and Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital), Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza), Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires) Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos Vicente Lopez y Planes from General Rodriguez, Buenos Aires), Sandra Lambert (Hospital El Cruce–Alta Complejidad en Red), Gustavo Lopardo (Hospital Bernardo Houssay, Vicente López), Carlos M. Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires), Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen), Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos), Antonio A. Cetrangolo (an individual who is being acknowledged for his contribution to the study), Claudia Pensotti (Infectious Diseases and Infection Control Department, Clinica Privada Monte Grande, Buenos Aires), Betiana Pereyra (Hospital San Roque, Córdoba), Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D. F. Santojanni), Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela); **Australia:** Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg); **Austria:** Felix Lötsch and Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna); **Belgium:** Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp), Camille A. Francois (Anesthesia and Critical Care Department, Erasme University Hospital, Brussels), Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital), Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels); **Benin:** Marcel Zannou Djimon, Jules Bashi and Roger Dodo (Centre Hospitalier Universitaire HKM of Cotonou); **Brazil:** Simone Aranha Nouér (Federal University of Rio de Janeiro); **Bulgaria:** Peter Chipev and Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofia), Darina Miteva, (UMHAT St Marina, Varna), Diana Petkova (University Hospital Varna); **Cameroon:** Adamou Dodo Balkissou (Yaounde Jamot Hospital, Yaounde), Eric Walter Pefura Yone (Département de Médecine Interne, University of Yaounde), Bertrand Hugo Mbatchou Ngahane (Douala General Hospital); **China:** Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing), Jin-fu Xu (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University); **Colombia:** Carlos Andres Bustamante Rico and Ricardo Buitrago (Clinica Shaio, Bogota), Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin); **Congo:** Jean-Marie Kayembe Ntumba (Cliniques Universitaires de Kinshasa); **Croatia:** Vesna Vladic Carevic (Interne Medicine, Dubrovnik), Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb), Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases), Zinka Matkovic (University Hospital Dubrava, Zagreb), Ivan Mitrecic (Karlovac General Hospital); **Denmark:** Marie-Laure Bouchy Jacobsson (Emergency Department, North Zealand’s Hospital–Hillerød), Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital), Uffe Christian Heitmann Bødtger (Department of Pulmonology, Naestved Hospital), Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde), Andreas Vestergaard Jensen, Gertrud Baunbæk-Knudsen, Pelle Trier Petersen, and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød); **Egypt:** Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University), Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University), Hanaa Shafiek (Chest Diseases Department, Faculty of Medicine, Alexandria University), Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo); **Ethiopia:** Kedir Abdella Abdulsemed (Department of Medical Laboratory Science and Pathology, College of Health Sciences, Mycobacteriology Research Centre, Institute of Biotechnology Research, Jimma University); **France:** Fabrice Bertrand (Critical Care Unit, Robert Ballanger Hospital, Aulnay sous Bois), Christian Brun-Buisson (University Hospital of Henri-Mondor, Créteil), Etienne de Montmollin (Intensive Care Unit, Hôpital Delafontaine, Centre Hospitalier de Saint-Denis), Muriel Fartoukh (Unité de Réanimation Médico-Chirurgicale, Pôle Thorax Voies Aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien), Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médico-chirurgicale, Hôpital Louis Mourier, Colombes, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité), Pierre Tattevin (Infectious Diseases and ICU, Pontchaillou University Hospital, Rennes), Abdo Khoury (Department of Emergency Medicine and Critical Care, University of Franche–Comté, Medical Center); **Gambia:** Bernard Ebruke (Medical Research Council Unit, Fajara, Gambia); **Germany:** Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen), Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden), Matthias Meisinger, Klinikum Niederlausitz, Klinik für Innere Medizin und Intensivmedizin, Senftenberg), Mathias W. Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital), Jan Rupp (Department of Infectious Diseases and Microbiology, University of Lübeck), Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg), Marc Spielmanns (Internal Medicine Department, Pulmonary Rehabilitation and Department of Health, School of Medicine, University Witten-Herdecke, St Remigius Hospital, Leverkusen) Petra Creutz and Norton Suttorp (Department of Infectious Disease and Respiratory Medicine, Charité–University Medicine, Berlin); **Ghana** : Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi); **Greece** : Katerina Dimakou (5th Respiratory Medicine Department, SOTIRIA Chest Hospital, Athens), Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens), Evdoxia Tsigou and Dimitrios Ampazis (Agioi Anargiroi Hospital, Kifissia, Athens), Evangelos Kaimakamis (Intensive Care Unit, G. Papanikolaou General Hospital of Thessaloniki); **India** : Mohit Bhatia (S. S. Hospital IMS BHU Varanasi), Raja Dhar (Fortis Hospitals, Kolkata), George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore), Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow), Parvaiz A. Koul (Department of Internal and Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar), P. A. Mahesh and B. S. Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore), Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala), Hirennappa B. Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka), Surya Kant (Department of Respiratory Medicine, King George’s Medical University, Chowk, Lucknow, Uttar Pradesh), Rajesh Swarnakar (Getwell Hospital and Research Institute, Dhantoli, Nagpur), Sneha Limaye and Sundeep Salvi (on behalf of the Respiratory Research Network of India from the Chest Research Foundation in Pune); **Iran** : Keihan Golshani (Isfahan University of Medical Sciences); **Ireland** : Vera M. Keatings (Letterkenny General Hospital, County Donegal), Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization, St James’s University Hospital, Trinity Centre for Health Sciences Dublin); **Israel** : Yasmin Maor (Infectious Disease Unit, affiliated with Tel Aviv University, Wolfson Medical Center, Holon), Jacob Strahilevitz (Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem); **Italy** : Salvatore Battaglia, University of Palermo, Pneumologia DiBiMIS, Palermo), Maria Carrabba (Internal Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca’ Granda Ospedale Maggiore Policlinico, Milano), Piero Ceriana (Pulmonary Rehabilitation, IRCCS Fondazione Maugeri, Pavia), Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste), Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan), Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples), Marino De Rosa (Unità Operativa Complessa [UOC] Pneumologia PO San Filippo Neri Azienda Sanitaria Locale Roma E Roma), Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena), Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria Azienda Ospedaliera Ospedali dei Colli PO Monaldi), Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, Sardegna), Francesco Menzella (Department of Cardiac-Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS–Arcispedale Santa Maria Nuova, Reggio Emilia), Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S. Anna Nuovo, Unità Operativa di Pneumologia, Como), Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital), Gerardo Palmiero (Respiratory Unit, Versilia Hospital, Lido di Camaiore, Lucca), Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli), Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero–Universitaria S. Maria della Misericordia, Udine), Claudio Sorino, Pulmonology Unit, A. O. Sant’Anna di Como), Gundi Steinhilber (Spedali Civili Brescia, U. O. Pneumologia e Fisiopatologia Respiratoria, Brescia), Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta), Fabio Franzetti, Manuela Carugati, Manuela Morosi, and Elisa Monge (Department of Biomedical and Clinical Sciences, Division of Infectious Diseases, Luigi Sacco Hospital, Università degli Studi di Milano), Mauro Carone, (Fondazione Salvatore Maugeri, IRCCS, Cassano Murge), Vincenzo Patella (Allergology and Clinical Immunology Unit, Department of Medical Sciences, Battipaglia Hospital, Battipaglia, Salerno), Simone Scarlata (Geriatrics, Unit of Respiratory Pathophysiology and Thoracic Endoscopy, Campus Bio Medico University and Teaching Hospital, Rome), Andrea Comel, UO Pneumologia, Ospedale Pederzoli, Peschiera del Garda); **Japan** : Kiyoyasu Kurahashi (Yokohama City University Medical Center); **Lebanon** : Zeina Aoun Bacha (Medicine School, St Joseph University, Beyrouth); **Mexico** : Daniel Barajas Ugalde (National Institute of Respiratory Diseases), Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California), José F. Villegas (Hospital Universitario Monterrey); **Montenegro** : Milic Medenica (Hospital for Lung Diseases–Brezovik, Niksic); **Netherlands** : E. M. W. van de Garde (Department of Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein); **Nepal** : Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences), Poojan Shrestha (Oxford University Clinical Research Unit, Patan Hospital); **New Zealand** : Elliott Ridgeon (Medical Research Institute of New Zealand); **Nigeria** : Babatunde Ishola Awokola (Department of Family Medicine and Primary Care, Lily Hospitals Limited, Warri), Ogonna N. O. Nwankwo (University of Calabar Teaching Hospital), Adefuye Bolanle Olufunlola (Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State), Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan), Kingsley N. Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State); **Pakistan** : Muhammad Irfan, Section of Pulmonary and Critical Care Medicine (Department of Medicine, Aga Khan University, Karachi); **Poland** : Lukasz Minarowski (Department of Lung Diseases and Tuberculosis, Medical University of Bialystok), Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec); **Portugal** : Felipe Froes (Hospital Pulido Valente–CHLN, Lisboa), Pedro Leuschner, (Centro Hospitalar do Porto), Mariana Meireles, Cláudia Ferrão, Pedro Leuschner, and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo Prof Abel Salazar, Porto), Sofia B. Ravara (Faculty of Health Sciences, University of Beira Interior, Cova da Beira Hospital Center, Covilhã); **Republic of Moldova** : Victoria Brocovschii (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu), Chesov Ion (Clinic of Anesthesia and Intensive Care Valeriu Ghrerg, Institute of Emergency Medicine, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau), Doina Rusu (SMFU N. Testemitanu, Chisinau), Cristina Toma (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau); **Romania** : Daniela Chirita (Hospital Sfantul Stefan, Bucharest), Carmen Mihaela Dorobat (Universitatea de Medicină şi Farmacie Gr T. Popa I a ş i Facultatea de Medicină Stomatologică, Spitalul Clinic de Boli Infecţioase Sfânta Parascheva I a ş i Iaşi); **Russia** : Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S. I. Georgievsky), Anna Kaluzhenina (Volgograd State Medical University); **Saudi Arabia** : Abdullah Almotairi (King Fahad Medical City, Riyadh), Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina), Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh), Amal Fathy (Pulmonary and Respiratory Critical Care Medicine, Mansoura University Egypt, Affiliate at Taibah University), Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh), Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa), Abdelhaleem Bella (Dammam University–Saudi Arabia and King Fahad Hospital); **Serbia** : Nada Bogdanović (Pulmonary Department of KHC, Dragiša Mišović, Belgrade), Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade), Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade); **Spain** : Luis Borderìas (Respiratory and Sleep Unit, Hospital San Jorge, Huesca), Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at Sant Joan Despí), Hugo Cabello Alarcón (Sant Hospital Seu de Urgell, Catalonia), Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona), Vicens Diaz-Brito and Xavier Casas (Infectious Diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona), Alicia Encabo González (Hospital Complex of Pontevedra), Maria Luisa Fernández-Almira (Medicina Interna, Hospital Universitario Central de Asturias), Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, and CIBER de Enfermedades Respiratorias, CIBERES, Bunyola), Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga), Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid), Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante), Elena Laserna Martínez (Hospital Mollet, Barcelona), Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid), Pedro J. Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña, INIBIC, Sergas, Universidade de A Coruña), Rosario Menéndez (Pneumology Service, University and Polytechnic Hospital La Fe, Valencia), Ana Pando-Sandoval (Hospital Universitario Central de Asturias, Area de Gestion Clinica de Pulmon, Servicio de Neumologia, Oviedo), Cristina Prat Aymerich, Alicia Lacoma de la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, and Universitat Autònoma de Barcelona, CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III), Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d’Hebron, Barcelona), Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia), Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona), Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria), Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo), Job F. M. van Boven (Hospital Universitari Son Espases, Palma de Mallorca), Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró); **South Africa** : Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand); **South Korea** : Ho Kee Yum (Inje University Seoul Paik Hospital); **Togo** : Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University Hospital of Sylvanus Olympio, Lomé); **Tunisia** : Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security, Marsa, Tunis); **Turkey** : Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir), Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul), Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir); **Ukraine** : Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa Regional Antituberculosis Hospital, Vinnitsa); **United Arab Emirates** : Naheed Elahi (Dubai Hospital); **United Kingdom** : Devesh J. Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife), Andrew Feneley, Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann, University Hospitals of Leicester NHS Trust and University of Leicester), Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool), Adam T. Hill (Royal Infirmary and University of Edinburgh), Banu Rudran (The Royal London Hospital, Barts Health Trust, London), Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, East Kilbride), Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds), Alexander Youzguin (Southport and Ormskirk Hospitals NHS Trust), Anika Singanayagam (Imperial College Healthcare NHS Trust, London); **United States** : Karen S. Allen (University of Oklahoma Health Sciences Center, Oklahoma City), Veronica Brito (Texas A&M Health Science Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Baylor Scott & White Health, Temple); Jessica Dietz (Fargo VA Health Care System, Fargo, North Dakota), Claire E. Dysart and Susan M. Kellie (Clement J. Zablocki VA Medical Center, Milwaukee, Wisconsin; Division of Infectious Diseases, University of New Mexico School of Medicine; and Raymond G. Murphy VA Medical Center, Albuquerque, New Mexico), Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, Illinois), Mina Gaga (7th Respiratory Medical Department and Asthma Center, Athens Chest Hospital), Thomas L. Holland and Stephen P. Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, Durham), Fayez Kheir (Department of Pulmonary Diseases, Critical Care and Environmental Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana), Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, Illinois), Manuel Lois (John Peter Smith Hospital, Fort Worth, Texas), Girish B. Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook, and Winthrop University Hospital, Mineola, New York), Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, Denver), Katherine Reyes (Henry Ford Hospital, Detroit, Illinois), William Rodriguez-Cintron, (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, San Juan Puerto Rico), Shigeki Saito (Tulane University, New Orleans), Nilam J. Soni, Julio Noda, Cecilia I. Hinojosa, Stephanie M. Levine, Luis F. Angel, and Antonio Anzueto (Divisions of Hospital Medicine and Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio), K. Scott Whitlow, John Hipskind, Kunal Sukhija, and Vicken Totten (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, California), Richard G. Wunderink and Ray D. Shah (Northwestern University Feinberg School of Medicine, Chicago, Illinois); **Zambia** : Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka). **Other investigators** : Lorena Noriega, Ezequiel Alvarado, Mohamed Aman, and Lucía Labra.\n**_Disclaimer._** The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute, the National Institutes of Health, or the Department of Veterans Affairs.\n**_Financial support._** This project was not funded and relied solely on voluntary site and investigator participation. M. I. R.’s time is partially protected by the National Heart, Lung, and Blood Institute (award K23HL096054).\n**_Potential conflicts of interest._** F. B. reports personal fees from AstraZeneca, GlaxoSmithKline, Guidotti, Grifols, Menarini, and Novartis, and grants and personal fees from Bayer, Chiesi, Insmed, Pfizer, Teva, and Zambon, outside the submitted work. All other authors report no potential conflicts.\n## References\n1.\nAliberti\nS\n, \nDi Pasquale\nM\n, \nZanaboni\nAM\n, et al. \nStratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia\n. \nClin Infect Dis\n2012\n; \n54\n:\n470\n–\n8\n.\n2.\nAliberti\nS\n, \nCilloniz\nC\n, \nChalmers\nJD\n, et al. \nMultidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective\n. \nThorax\n2013\n; \n68\n:\n997\n–\n9\n.\n3.\nShindo\nY\n, \nIto\nR\n, \nKobayashi\nD\n, et al. \nRisk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia\n. \nAm J Respir Crit Care Med\n2013\n; \n188\n:\n985\n–\n95\n.\n4.\nMusher\nDM\n, \nThorner\nAR\n. \nCommunity-acquired pneumonia\n. \nN Engl J Med\n2014\n; \n371\n:\n1619\n–\n28\n.\n5.\nMandell\nLA\n, \nWunderink\nRG\n, \nAnzueto\nA\n, et al. ; \nInfectious Diseases Society of America; American Thoracic Society\n. \nInfectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults\n. \nClin Infect Dis\n2007\n; \n44\n(\nsuppl 2\n):\nS27\n–\n72\n.\n6.\nLim\nWS\n, \nBaudouin\nSV\n, \nGeorge\nRC\n, et al. \nBTS guidelines for the management of community acquired pneumonia in adults\n. \nThorax\n2009\n; \n64\n(\nsuppl III\n):\niii1\n–\n55\n.\n7.\nWoodhead\nM\n, \nBlasi\nF\n, \nEwig\nS\n, et al. ; \nJoint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases\n. \nGuidelines for the management of adult lower respiratory tract infections—full version\n. \nClin Microbiol Infect\n2011\n; \n17(suppl 6)\n:\nE1\n–\n59\n.\n8.\nFurman\nCD\n, \nRayner\nAV\n, \nTobin\nEP\n. \nPneumonia in older residents of long-term care facilities\n. \nAm Fam Physician\n2004\n; \n70\n:\n1495\n–\n500\n.\n9.\nCillóniz\nC\n, \nPolverino\nE\n, \nEwig\nS\n, et al. \nImpact of age and comorbidity on cause and outcome in community-acquired pneumonia\n. \nChest\n2013\n; \n144\n:\n999\n–\n1007\n.\n10.\nAliberti\nS\n, \nReyes\nLF\n, \nFaverio\nP\n, et al. ; \nGLIMP investigators\n. \nGlobal Initiative for Meticillin-Resistant _Staphylococcus aureus_ Pneumonia (GLIMP): an international, observational cohort study\n. \nLancet Infect Dis\n2016\n; \n16\n:\n1364\n–\n76\n.\n11.\nMagiorakos\nAP\n, \nSrinivasan\nA\n, \nCarey\nRB\n, et al. \nMultidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance\n. \nClin Microbiol Infect\n2012\n; \n18\n:\n268\n–\n81\n.\n12.\nWan\nQJ\n, \nHu\nHF\n, \nHe\nYC\n, et al. \nSevere pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy\n. \nKaohsiung J Med Sci\n2015\n; \n31\n:\n42\n–\n6\n.\n13.\nLi\nF\n, \nJin\nHZ\n, \nSu\nF\n, \nJia\nL\n, \nSun\nQN\n. \nPneumocystis pneumonia in patients with immunobullous dermatoses\n. \nInt J Dermatol\n2011\n; \n50\n:\n1144\n–\n9\n.\n14.\nGruson\nD\n, \nVargas\nF\n, \nHilbert\nG\n, et al. \nPredictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia\n. \nIntensive Care Med\n2004\n; \n30\n:\n965\n–\n71\n.\n15.\nGarcia\nJB\n, \nLei\nX\n, \nWierda\nW\n, et al. \nPneumonia during remission induction chemotherapy in patients with acute leukemia\n. \nAnn Am Thorac Soc\n2013\n; \n10\n:\n432\n–\n40\n.\n16.\nLee\nJO\n, \nKim\nDY\n, \nLim\nJH\n, et al. \nRisk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients\n. \nLung Cancer\n2008\n; \n62\n:\n381\n–\n4\n.\n17.\nLim\nKH\n, \nYoon\nHI\n, \nKang\nYA\n, et al. \nSevere pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab\n. \nKorean J Intern Med\n2010\n; \n25\n:\n86\n–\n92\n.\n18.\nWaks\nAG\n, \nTolaney\nSM\n, \nGalar\nA\n, et al. \n_Pneumocystis jiroveci_ pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors\n. \nBreast Cancer Res Treat\n2015\n; \n154\n:\n359\n–\n67\n.\n19.\nKim\nT\n, \nChoi\nSH\n, \nKim\nSH\n, et al. \nPoint prevalence of _Pneumocystis_ pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy\n. \nAnn Hematol\n2013\n; \n92\n:\n231\n–\n8\n.\n20.\nAliberti\nS\n, \nMyers\nJA\n, \nPeyrani\nP\n, et al. \nThe role of neutropenia on outcomes of cancer patients with community-acquired pneumonia\n. \nEur Respir J\n2009\n; \n33\n:\n142\n–\n7\n.\n21.\nSogaard\nOS\n, \nLohse\nN\n, \nGerstoft\nJ\n, et al. \nHospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study\n. \nClin Infect Dis\n2008\n; \n47\n:\n1345\n–\n53\n.\n22.\nKuehnhardt\nD\n, \nHannemann\nM\n, \nSchmidt\nB\n, \nHeider\nU\n, \nPossinger\nK\n, \nEucker\nJ\n. \nTherapeutic implication of BAL in patients with neutropenia\n. \nAnn Hematol\n2009\n; \n88\n:\n1249\n–\n56\n.\n23.\nMaschmeyer\nG\n, \nBeinert\nT\n, \nBuchheidt\nD\n, et al. \nDiagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the Infectious Diseases Working Party of the German Society of Haematology and Oncology\n. \nEur J Cancer\n2009\n; \n45\n:\n2462\n–\n72\n.\n24.\nAlanio\nA\n, \nHauser\nPM\n, \nLagrou\nK\n, et al. ; \n5th European Conference on Infections in Leukemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN)\n. \nECIL guidelines for the diagnosis of _Pneumocystis jirovecii_ pneumonia in patients with haematological malignancies and stem cell transplant recipients\n. \nJ Antimicrob Chemother\n2016\n; \n71\n:\n2386\n–\n96\n.\n25.\nFreifeld\nAG\n, \nBow\nEJ\n, \nSepkowitz\nKA\n, et al. ; \nInfectious Diseases Society of America\n. \nClinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America\n. \nClin Infect Dis\n2011\n; \n52\n:\ne56\n–\n93\n.\n26.\nChemaly\nRF\n, \nShah\nDP\n, \nBoeckh\nMJ\n. \nManagement of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies\n. \nClin Infect Dis\n2014\n; \n59\n(\nsuppl 5\n):\nS344\n–\n51\n.\n27.\nBuchacz\nK\n, \nLau\nB\n, \nJing\nY\n, et al. ; \nNorth American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA\n. \nIncidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010\n. \nJ Infect Dis\n2016\n; \n214\n:\n862\n–\n72\n.\n28.\nMadeddu\nG\n, \nPorqueddu\nEM\n, \nCambosu\nF\n, et al. \nBacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era\n. \nInfection\n2008\n; \n36\n:\n231\n–\n6\n.\n29.\nPark\nDR\n, \nSherbin\nVL\n, \nGoodman\nMS\n, et al. ; \nHarborview CAP Study Group\n. \nThe etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness\n. \nJ Infect Dis\n2001\n; \n184\n:\n268\n–\n77\n.\n30.\nTorres\nHA\n, \nBodey\nGP\n, \nRolston\nKV\n, \nKantarjian\nHM\n, \nRaad\nII\n, \nKontoyiannis\nDP\n. \nInfections in patients with aplastic anemia: experience at a tertiary care cancer center\n. \nCancer\n2003\n; \n98\n:\n86\n–\n93\n.\n31.\nGil-Prieto\nR\n, \nPascual-Garcia\nR\n, \nWalter\nS\n, \nÁlvaro-Meca\nA\n, \nGil-De-Miguel\nÁ\n. \nRisk of hospitalization due to pneumococcal disease in adults in Spain: the CORIENNE study\n. \nHum Vaccin Immunother\n2016\n; \n12\n:\n1900\n–\n5\n.\n32.\nPutot\nA\n, \nTetu\nJ\n, \nPerrin\nS\n, et al. \nImpact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients\n. \nEur J Clin Microbiol Infect Dis\n2016\n; \n35\n:\n489\n–\n95\n.\n33.\nPolverino\nE\n, \nDambrava\nP\n, \nCillóniz\nC\n, et al. \nNursing home-acquired pneumonia: a 10 year single-centre experience\n. \nThorax\n2010\n; \n65\n:\n354\n–\n9\n.\n34.\nKohli\nR\n, \nLo\nY\n, \nHomel\nP\n, et al. ; \nHER Study Group\n. \nBacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study\n. \nClin Infect Dis\n2006\n; \n43\n:\n90\n–\n8\n.\n35.\nBenito\nN\n, \nRañó\nA\n, \nMoreno\nA\n, et al. \nPulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain\n. \nJ Acquir Immune Defic Syndr\n2001\n; \n27\n:\n35\n–\n43\n.\n36.\nMori\nH\n, \nOhno\nY\n, \nIto\nF\n, et al. \nPolymerase chain reaction positivity of _Pneumocystis jirovecii_ during primary lung cancer treatment\n. \nJpn J Clin Oncol\n2010\n; \n40\n:\n658\n–\n62\n.\n37.\nBoersma\nWG\n, \nErjavec\nZ\n, \nvan der Werf\nTS\n, \nde Vries-Hosper\nHG\n, \nGouw\nAS\n, \nManson\nWL\n. \nBronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL\n. \nRespir Med\n2007\n; \n101\n:\n317\n–\n25\n.\n38.\nMikulska\nM\n, \nDel Bono\nV\n, \nGandolfo\nN\n, et al. \nEpidemiology of viral respiratory tract infections in an outpatient haematology facility\n. \nAnn Hematol\n2014\n; \n93\n:\n669\n–\n76\n.\n39.\nBeaird\nOE\n, \nFreifeld\nA\n, \nIson\nMG\n, et al. \nCurrent practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative\n. \nTranspl Infect Dis\n2016\n; \n18\n:\n210\n–\n5\n.\n40.\nPoonyagariyagorn\nHK\n, \nGershman\nA\n, \nAvery\nR\n, et al. \nChallenges in the diagnosis and management of Nocardia infections in lung transplant recipients\n. \nTranspl Infect Dis\n2008\n; \n10\n:\n403\n–\n8\n.\n41.\nTavadze\nM\n, \nRybicki\nL\n, \nMossad\nS\n, et al. \nRisk factors for vancomycin-resistant _Enterococcus_ bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation\n. \nBone Marrow Transplant\n2014\n; \n49\n:\n1310\n–\n6\n.\n42.\nBock\nAM\n, \nCao\nQ\n, \nFerrieri\nP\n, \nYoung\nJA\n, \nWeisdorf\nDJ\n. \nBacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance\n. \nBiol Blood Marrow Transplant\n2013\n; \n19\n:\n102\n–\n8\n.\n43.\nHerbers\nAH\n, \nde Haan\nAF\n, \nvan der Velden\nWJ\n, \nDonnelly\nJP\n, \nBlijlevens\nNM\n. \nMucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients\n. \nTranspl Infect Dis\n2014\n; \n16\n:\n279\n–\n85\n.\n44.\nWu\nSW\n, \nLiu\nKS\n, \nLin\nCK\n, et al. \nCommunity-acquired urinary tract infection in kidney transplantation: risk factors for bacteremia and recurrent infection\n. \nJ Formos Med Assoc\n2013\n; \n112\n:\n138\n–\n43\n.\n45.\nDaskalaki\nE\n, \nKoukoulaki\nM\n, \nBakalis\nA\n, et al. \nBlood stream infections in renal transplant recipients: a single-center study\n. \nTransplant Proc\n2014\n; \n46\n:\n3191\n–\n3\n.\n46.\nHuson\nMA\n, \nStolp\nSM\n, \nvan der Poll\nT\n, \nGrobusch\nMP\n. \nCommunity-acquired bacterial bloodstream infections in HIV-infected patients: a systematic review\n. \nClin Infect Dis\n2014\n; \n58\n:\n79\n–\n92\n.\n47.\nTaramasso\nL\n, \nTatarelli\nP\n, \nDi Biagio\nA\n. \nBloodstream infections in HIV-infected patients\n. \nVirulence\n2016\n; \n7\n:\n320\n–\n8\n.\n© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.\nThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model>)\nTopic:\nIssue Section:\n[Articles and Commentaries](https://academic.oup.com/cid/search-results?f_TocHeadingTitleList=Articles+and+Commentaries)\n[Download all slides](https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=&PPTtype=SlideSet&ar=5078600&xsltPath=~/UI/app/XSLT&siteId=5269)\n## Supplementary data\n- docx file\nAdvertisement\n### Citations\n### Views\n18,086\n### Altmetric\n### Metrics\nTotal Views 18,086\n11,927 Pageviews\n6,159 PDF Downloads\nSince 8/1/2018\nMonth: | Total Views:  \n---|---  \nAugust 2018 | 66  \nSeptember 2018 | 28  \nOctober 2018 | 23  \nNovember 2018 | 70  \nDecember 2018 | 46  \nJanuary 2019 | 53  \nFebruary 2019 | 62  \nMarch 2019 | 31  \nApril 2019 | 408  \nMay 2019 | 355  \nJune 2019 | 182  \nJuly 2019 | 176  \nAugust 2019 | 159  \nSeptember 2019 | 111  \nOctober 2019 | 90  \nNovember 2019 | 66  \nDecember 2019 | 44  \nJanuary 2020 | 69  \nFebruary 2020 | 36  \nMarch 2020 | 223  \nApril 2020 | 208  \nMay 2020 | 140  \nJune 2020 | 179  \nJuly 2020 | 162  \nAugust 2020 | 154  \nSeptember 2020 | 217  \nOctober 2020 | 238  \nNovember 2020 | 237  \nDecember 2020 | 165  \nJanuary 2021 | 140  \nFebruary 2021 | 137  \nMarch 2021 | 236  \nApril 2021 | 239  \nMay 2021 | 239  \nJune 2021 | 172  \nJuly 2021 | 131  \nAugust 2021 | 160  \nSeptember 2021 | 205  \nOctober 2021 | 250  \nNovember 2021 | 227  \nDecember 2021 | 183  \nJanuary 2022 | 202  \nFebruary 2022 | 247  \nMarch 2022 | 301  \nApril 2022 | 242  \nMay 2022 | 240  \nJune 2022 | 161  \nJuly 2022 | 159  \nAugust 2022 | 292  \nSeptember 2022 | 404  \nOctober 2022 | 533  \nNovember 2022 | 300  \nDecember 2022 | 477  \nJanuary 2023 | 287  \nFebruary 2023 | 191  \nMarch 2023 | 310  \nApril 2023 | 395  \nMay 2023 | 248  \nJune 2023 | 198  \nJuly 2023 | 185  \nAugust 2023 | 213  \nSeptember 2023 | 248  \nOctober 2023 | 340  \nNovember 2023 | 311  \nDecember 2023 | 269  \nJanuary 2024 | 301  \nFebruary 2024 | 353  \nMarch 2024 | 372  \nApril 2024 | 323  \nMay 2024 | 341  \nJune 2024 | 275  \nJuly 2024 | 268  \nAugust 2024 | 218  \nSeptember 2024 | 253  \nOctober 2024 | 274  \nNovember 2024 | 312  \nDecember 2024 | 242  \nJanuary 2025 | 250  \nFebruary 2025 | 296  \nMarch 2025 | 396  \nApril 2025 | 228  \nMay 2025 | 228  \nJune 2025 | 86  \nCitations\nPowered by Dimensions\nWeb of Science\nAltmetrics\n**346** readers on Mendeley \n### Email alerts\n[ New journal issues ](https://academic.oup.com/cid/new-journals-alert)\n[ New journal articles ](https://academic.oup.com/cid/new-journal-articles-alert)\nActivity related to this article \n[Sign up for marketing](https://academic.oup.com/my-account/communication-preferences)\n## New journal issues alert\nTo set up an email alert, please to your personal account, or [register](https://academic.oup.com/my-account/register?siteId=5269&returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600)\n## Sign in\n### Personal account\n  * Sign in with email/username & password\n  * Get email alerts\n  * Save searches\n  * Purchase content\n  * Activate your purchase/trial code\n  * Add your ORCID iD\n\n\n[Register](https://academic.oup.com/my-account/register?siteId=5269&returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600)\n## Journal article activity alert\nTo set up an email alert, please to your personal account, or [register](https://academic.oup.com/my-account/register?siteId=5269&returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600)\n## Sign in\n### Personal account\n  * Sign in with email/username & password\n  * Get email alerts\n  * Save searches\n  * Purchase content\n  * Activate your purchase/trial code\n  * Add your ORCID iD\n\n\n[Register](https://academic.oup.com/my-account/register?siteId=5269&returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600)\nClose Modal\n### More on this topic\n[Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods](https://academic.oup.com/cid/article/50/2/202/328880)\n[Microbial Agents Associated with Pneumonia in Children from Uruguay](https://academic.oup.com/cid/article/12/Supplement_8/S915/296667)\n[In the Literature](https://academic.oup.com/cid/article/59/9/iii/419445)\n[Comparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study](https://academic.oup.com/cid/advance-article/7985365)\n### Related articles in PubMed\n### Citing articles via\n[ Effectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial Study  ](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf302/8159933?searchresult=1)\n[ Characteristics Associated with Disseminated Gonococcal Infections vs Uncomplicated Gonorrhea: A California Case-Control Study, 2021-2022  ](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf311/8159932?searchresult=1)\n[ Non-Operative versus Neurosurgical Treatment of Brain Abscess: An Emulated Trial Nested within a Nationwide, Population-Based Cohort  ](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf304/8157607?searchresult=1)\n[ Incidence of AIDS-defining Conditions among Adults with Perinatally Acquired HIV after Transition to Adult HIV Care in the United States and Canada, 2000-2022  ](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf300/8157063?searchresult=1)\n[ State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists  ](https://academic.oup.com/cid/article/80/5/e65/8156727?searchresult=1)\nMore from Oxford Academic\n[Clinical Medicine](https://academic.oup.com/search-results?tax=AcademicSubjects/MED00160)\n[Infectious Diseases](https://academic.oup.com/search-results?tax=AcademicSubjects/MED00290)\n[Medicine and Health](https://academic.oup.com/search-results?tax=AcademicSubjects/MED00010)\n[Books](https://academic.oup.com/books)\n[Journals](https://academic.oup.com/journals)\nHaving trouble contacting the network. Please try again in a moment or two. \n[![Oxford University Press](https://oup.silverchair-cdn.com/data/Multimedia/oup-logo.svg)](http://global.oup.com/)\nAdvertisement\nAdvertisement\nclose advertisement\nAdvertisement\n  * [About Clinical Infectious Diseases](https://academic.oup.com/cid/pages/About)\n  * [Editorial Board](https://academic.oup.com/cid/pages/Editorial_Board)\n  * [Author Guidelines](https://academic.oup.com/cid/pages/General_Instructions)\n\n\n  * [Purchase](https://academic.oup.com/cid/subscribe)\n  * [Advertising and Corporate Services](https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit)\n\n\n[ ![Clinical Infectious Diseases](https://oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_f1483155260.svg) ](https://academic.oup.com/cid)\n  * Online ISSN 1537-6591\n  * Print ISSN 1058-4838\n  * Copyright © 2025 Infectious Diseases Society of America\n\n\n  * [About Oxford Academic](https://academic.oup.com/pages/about-oxford-academic)\n  * [Publish journals with us](https://academic.oup.com/pages/about-oxford-academic/publish-journals-with-us)\n  * [University press partners](https://academic.oup.com/pages/about-oxford-academic/our-university-press-partners)\n  * [What we publish](https://academic.oup.com/pages/what-we-publish)\n  * [New features](https://academic.oup.com/pages/new-features)\n\n\n  * [For authors](https://academic.oup.com/pages/for-authors)\n  * [Open access](https://academic.oup.com/pages/open-research/open-access)\n  * [Purchasing](https://academic.oup.com/pages/purchasing)\n  * [Institutional account management](https://academic.oup.com/pages/institutional-account-management)\n  * [Rights and permissions](https://academic.oup.com/pages/purchasing/rights-and-permissions)\n\n\n  * [Get help with access](https://academic.oup.com/pages/get-help-with-access)\n  * [Accessibility](https://academic.oup.com/pages/about-oxford-academic/accessibility)\n  * [Contact us](https://academic.oup.com/pages/contact-us)\n  * [Advertising](https://academic.oup.com/pages/advertising)\n  * [Media enquiries](https://academic.oup.com/pages/media-enquiries)\n\n\n  * [Oxford University Press](https://global.oup.com/)\n  * [News](https://corp.oup.com/press-office)\n  * [Oxford Languages](https://languages.oup.com/)\n\n\nOxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide\n![Oxford University Press](https://oup.silverchair-cdn.com/UI/app/svg/umbrella/oup-logo.svg)\n  * Copyright © 2025 Oxford University Press\n  * Cookie settings\n  * [Cookie policy](https://global.oup.com/cookiepolicy)\n  * [Privacy policy](https://global.oup.com/privacy)\n  * [Legal notice](https://academic.oup.com/pages/legal-notice)\n\n\n##### This Feature Is Available To Subscribers Only\n[Sign In](https://academic.oup.com/sign-in) or [Create an Account](https://academic.oup.com/my-account/register?siteId=5269&returnUrl=%2fcid%2farticle%2f68%2f9%2f1482%2f5078600)\nThis PDF is available to Subscribers Only\nView Article Abstract & Purchase Options\nFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.\nManage Cookies\nWhen you visit web sites, they may store or retrieve data in your web browser. This storage is often necessary for basic functionality of the web site or the storage may be used for the purposes of marketing, analytics, and personalization of the web site such as storing your preferences. \nPowered by \nSave \nOxford University Press uses cookies to enhance your experience on our website. By selecting ‘accept all’ you are agreeing to our use of cookies. You can change your cookie settings at any time. More information can be found in our [Cookie Policy](https://global.oup.com/cookiepolicy/?cc=gb). \nReject and manage  Deny all  Accept all \n",
          "fit_markdown": "",
          "fit_html": "",
          "primary_content": "[Skip to Main Content](https://academic.oup.com/cid/article/68/9/1482/5078600#skipNav)\nAdvertisement\n[ ![Oxford Academic](https://oup.silverchair-cdn.com/UI/app/svg/umbrella/oxford-academic-logo.svg) ](https://academic.oup.com/)\n[Journals](https://academic.oup.com/journals)\n[Books](https://academic.oup.com/books)\n  * [ ![Information](https://oup.silverchair-cdn.com/UI/app/svg/i.svg) ](https://academic.oup.com/pages/information)\n  * [ ![Information](https://oup.silverchair-cdn.com/UI/app/svg/i.svg) ](https://academic.oup.com/pages/information)\n\n\nNavbar Search Filter  Clinical Infectious DiseasesThis issueIDSA Journals Infectious DiseasesBooksJournalsOxford Academic Mobile Enter search term \n  * [ Issues ](https://academic.oup.com/cid/issue)\n  *     * [ Advance articles ](https://academic.oup.com/cid/advance-articles)\n    * [ Editor's Choice ](https://academic.oup.com/cid/search-results?page=1&f_OUPSeries=Editor%27s+Choice)\n    * [ Supplement Archive ](https://academic.oup.com/cid/supplements)\n    * [ Cover Archive ](https://academic.oup.com/cid/issue-covers/)\n    * [ IDSA Guidelines ](https://academic.oup.com/cid/pages/clinical-practice-guidelines)\n    * [ IDSA Journals ](https://academic.oup.com/idsa)\n    * [ The Journal of Infectious Diseases ](https://academic.oup.com/jid)\n    * [ Open Forum Infectious Diseases ](https://academic.oup.com/ofid)\n    * [ Clinical Dilemmas in ID ](https://academic.oup.com/cid/pages/clinical-dilemmas)\n    * [ Photo Quizzes ](https://academic.oup.com/cid/pages/photo-quizzes)\n    * [ State-of-the-Art Reviews ](https://academic.oup.com/cid/pages/state-of-the-art-reviews)\n    * [ Voices of ID ](https://academic.oup.com/cid/pages/voices-of-id)\n    * [ IDSA Content Collections ](https://academic.oup.com/idsa/pages/content-collections)\n  *     * [ Author Guidelines ](https://academic.oup.com/cid/pages/General_Instructions)\n    * [ Open Access ](https://academic.oup.com/cid/pages/General_Instructions)\n    * [ Why Publish ](https://academic.oup.com/cid/pages/why-publish)\n    * [ IDSA Journals Calls for Papers ](https://academic.oup.com/idsa/pages/calls-for-papers)\n  * [ Purchase ](https://academic.oup.com/cid/subscribe)\n  *     * [ Advertising and Corporate Services ](https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit)\n    * [ Advertising ](https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising)\n    * [ Mediakit ](https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit)\n    * [ Reprints and ePrints ](https://academic.oup.com/advertising-and-corporate-services/pages/reprints)\n    * [ Sponsored Supplements ](https://academic.oup.com/advertising-and-corporate-services/pages/supplements)\n    * [ Branded Books ](https://academic.oup.com/advertising-and-corporate-services/pages/branded-books)\n  *     * [ About Clinical Infectious Diseases ](https://academic.oup.com/cid/pages/About)\n    * [ IDSA COI Policy ](https://academic.oup.com/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf)\n    * [ Editorial Board ](https://academic.oup.com/cid/pages/Editorial_Board)\n    * [ Alerts ](https://academic.oup.com/my-account/email-alerts)\n    * [ Self-Archiving Policy ](https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b)\n    * [ For Reviewers ](https://academic.oup.com/cid/pages/For_Reviewers)\n    * [ For Press Offices ](https://academic.oup.com/idsa/pages/for_press_offices)\n  * [Journals on Oxford Academic](https://academic.oup.com/journals)\n  * [Books on Oxford Academic](https://academic.oup.com/books)\n\n\n[IDSA Journals](https://academic.oup.com/idsa)\n[ ![Clinical Infectious Diseases](https://oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_title-1229789578.svg) ](https://academic.oup.com/cid)\n  * [ Issues ](https://academic.oup.com/cid/issue)\n  *     * [ Advance articles ](https://academic.oup.com/cid/advance-articles)\n    * [ Editor's Choice ](https://academic.oup.com/cid/search-results?page=1&f_OUPSeries=Editor%27s+Choice)\n    * [ Supplement Archive ](https://academic.oup.com/cid/supplements)\n    * [ Cover Archive ](https://academic.oup.com/cid/issue-covers/)\n    * [ IDSA Guidelines ](https://academic.oup.com/cid/pages/clinical-practice-guidelines)\n    * [ IDSA Journals ](https://academic.oup.com/idsa)\n    * [ The Journal of Infectious Diseases ](https://academic.oup.com/jid)\n    * [ Open Forum Infectious Diseases ](https://academic.oup.com/ofid)\n    * [ Clinical Dilemmas in ID ](https://academic.oup.com/cid/pages/clinical-dilemmas)\n    * [ Photo Quizzes ](https://academic.oup.com/cid/pages/photo-quizzes)\n    * [ State-of-the-Art Reviews ](https://academic.oup.com/cid/pages/state-of-the-art-reviews)\n    * [ Voices of ID ](https://academic.oup.com/cid/pages/voices-of-id)\n    * [ IDSA Content Collections ](https://academic.oup.com/idsa/pages/content-collections)\n  *     * [ Author Guidelines ](https://academic.oup.com/cid/pages/General_Instructions)\n    * [ Open Access ](https://academic.oup.com/cid/pages/General_Instructions)\n    * [ Why Publish ](https://academic.oup.com/cid/pages/why-publish)\n    * [ IDSA Journals Calls for Papers ](https://academic.oup.com/idsa/pages/calls-for-papers)\n  * [ Purchase ](https://academic.oup.com/cid/subscribe)\n  *     * [ Advertising and Corporate Services ](https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit)\n    * [ Advertising ](https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising)\n    * [ Mediakit ](https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit)\n    * [ Reprints and ePrints ](https://academic.oup.com/advertising-and-corporate-services/pages/reprints)\n    * [ Sponsored Supplements ](https://academic.oup.com/advertising-and-corporate-services/pages/supplements)\n    * [ Branded Books ](https://academic.oup.com/advertising-and-corporate-services/pages/branded-books)\n  *     * [ About Clinical Infectious Diseases ](https://academic.oup.com/cid/pages/About)\n    * [ IDSA COI Policy ](https://academic.oup.com/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf)\n    * [ Editorial Board ](https://academic.oup.com/cid/pages/Editorial_Board)\n    * [ Alerts ](https://academic.oup.com/my-account/email-alerts)\n    * [ Self-Archiving Policy ](https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b)\n    * [ For Reviewers ](https://academic.oup.com/cid/pages/For_Reviewers)\n    * [ For Press Offices ](https://academic.oup.com/idsa/pages/for_press_offices)\n\n\nNavbar Search Filter  Clinical Infectious DiseasesThis issueIDSA Journals Infectious DiseasesBooksJournalsOxford Academic Enter search term \n[Advanced Search](https://academic.oup.com/cid/advanced-search?page=1&fl_SiteID=5269&SearchSourceType=1)\nArticle Navigation\nClose mobile search navigation\nArticle Navigation\n[ ![Clinical Infectious Diseases Cover Image for Volume 68, Issue 9](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/Issue/68/9/5/m_cover.jpeg?Expires=1752631924&Signature=VzkJpzpYIXCozHbdsaIS60qWT14TRuSLuGC1eukUyrcYSb6veXmlbdxxi4bsCqv56PfMH7dlbqN9LPLYakKnZ6uSxmWg0YAZOHfQIA39tvpONvJ71boTMCgDn8RhjNDckqV16RNIXTme4fSXo-Pb1NEzqABs9EzPZHe9bQMD6FT68PV8Vap~eeaNsVp85gS3jKjGejPEgn2-XCGy4vrE3MaPHJYIAkNxsVP0hL~5pIyLW4I1ZSyrhJhH-eg8MKmfcqb5InNKbRmJkLh~-95lJfZl5LOkCkFEzHqU5URne1xaCnWjdQWfdfTDCJXggdBa~HkCJsQ92f~1fLxypv7dIQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA) Volume 68 Issue 9 1 May 2019  ](https://academic.oup.com/cid/issue/68/9)\n### Article Contents\n  * [Abstract](https://academic.oup.com/cid/article/68/9/1482/5078600#134170092)\n  * [MATERIALS AND METHODS](https://academic.oup.com/cid/article/68/9/1482/5078600#134170097)\n  * [RESULTS](https://academic.oup.com/cid/article/68/9/1482/5078600#134170111)\n  * [DISCUSSION](https://academic.oup.com/cid/article/68/9/1482/5078600#134170130)\n  * [Supplementary Data](https://academic.oup.com/cid/article/68/9/1482/5078600#134170142)\n  * [Notes](https://academic.oup.com/cid/article/68/9/1482/5078600#134170144)\n  * [References](https://academic.oup.com/cid/article/68/9/1482/5078600#134170150)\n  * [Supplementary data](https://academic.oup.com/cid/article/68/9/1482/5078600#supplementary-data)\n\n\n  * [< Previous](https://academic.oup.com/cid/article/68/9/1472/5089945)\n  * [Next >](https://academic.oup.com/cid/article/68/9/1494/5087661)\n\n\nArticle Navigation \nArticle Navigation \nJournal Article\n#  Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients _Free_\n, \nMarta Francesca Di Pasquale \nDepartment of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Marta+Francesca+Di+Pasquale)\n, \nGiovanni Sotgiu \nClinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Giovanni+Sotgiu)\n, \nAndrea Gramegna \nDepartment of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Andrea+Gramegna)\n, \nDejan Radovanovic \nDepartment of Biomedical and Clinical Sciences (DIBIC), University of Milan, Pulmonary Unit, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Dejan+Radovanovic)\n, \nSilvia Terraneo \nRespiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Italy\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Silvia+Terraneo)\n, \nLuis F Reyes \nMicrobiology Department, Universidad de La Sabana, Chia, Colombia\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Luis+F+Reyes)\n, \nJan Rupp \nDepartment of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Jan+Rupp)\n, \nJuan González del Castillo \nEmergency Department, Hospital Clínico San Carlos, Universidad Complutense\nInstituto de Investigación Sanitaria del Hospital Clínico San Carlos, IdISSC, Madrid, Spain\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Juan+Gonz%c3%a1lez+del+Castillo)\n, \nFrancesco Blasi \nDepartment of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Francesco+Blasi)\n, \nStefano Aliberti \nDepartment of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan\nCorrespondence: S. Aliberti, Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy ().\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Stefano+Aliberti)\n[ ... Show more ](https://academic.oup.com/cid/article/68/9/1482/5078600)\nMarcos I Restrepo \nDivision of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio\nSearch for other works by this author on: \n[Oxford Academic](https://academic.oup.com/cid/search-results?f_Authors=Marcos+I+Restrepo)\n_Clinical Infectious Diseases_ , Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, \nPublished:\n23 August 2018\nReceived:\n24 May 2018\nAccepted:\n20 August 2018\nPublished:\n23 August 2018\n  * [ ![pdf](https://oup.silverchair-cdn.com/UI/app/svg/pdf.svg)PDF ](https://academic.oup.com/cid/article-pdf/68/9/1482/28520951/ciy723.pdf)\n  * [ Cite ](https://academic.oup.com/cid/article/68/9/1482/5078600)\n### Cite\nMarta Francesca Di Pasquale, Giovanni Sotgiu, Andrea Gramegna, Dejan Radovanovic, Silvia Terraneo, Luis F Reyes, Jan Rupp, Juan González del Castillo, Francesco Blasi, Stefano Aliberti, Marcos I Restrepo, Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients, _Clinical Infectious Diseases_ , Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, \nSelect Format Select format .ris (Mendeley, Papers, Zotero) .enw (EndNote) .bibtex (BibTex) .txt (Medlars, RefWorks) Download citation\n\n\nNavbar Search Filter  Clinical Infectious DiseasesThis issueIDSA Journals Infectious DiseasesBooksJournalsOxford Academic Mobile Enter search term \nNavbar Search Filter  Clinical Infectious DiseasesThis issueIDSA Journals Infectious DiseasesBooksJournalsOxford Academic Enter search term \n[Advanced Search](https://academic.oup.com/cid/advanced-search?page=1&fl_SiteID=5269&SearchSourceType=1)\n## Abstract\nBackground\nThe correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia.\nMethods\nWe conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor.\nResults\nAt least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors significantly differed across continents and countries, with chronic steroid use (45%), hematological cancer (25%), and chemotherapy (22%) the most common. Among immunocompromised patients, community-acquired pneumonia (CAP) pathogens were the most frequently identified, and prevalences did not differ from those in immunocompetent patients. Risk factors for immunocompromise were independently associated with neither _Pseudomonas aeruginosa_ nor non–community-acquired bacteria. Specific risk factors were independently associated with fungal infections (odds ratio for AIDS and hematological cancer, 15.10 and 4.65, respectively; both _P_ = .001), mycobacterial infections (AIDS; _P_ = .006), and viral infections other than influenza (hematological cancer, 5.49; _P_ < .001).\nConclusions\nOur findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses.\n, , , , \nDuring initial evaluation of a patient coming from the community with pneumonia, the identification of possible risk factors for multidrug-resistant organisms or unusual pathogens is crucial []. Because a microbiological identification is found in about 30% of hospitalized patients with pneumonia coming from the community, and usually requires 24–48 hours to be available, most of patients are treated empirically []. Delay in initiation of appropriate empiric antibiotic therapy is a known risk factor for worse clinical outcomes []; therefore, it is relevant to promptly recognize patients at risk for specific pathogens, specially multidrug-resistant or atypical microbes [].\nThe aging of the population and advancements in therapeutic protocols have led to an increase prevalence of chronic diseases as well as long-term treatments with immunosuppressive agents [, ]. Thus, among patients with pneumonia coming from the community and admitted to the hospital, the number who might not be fully immunocompetent is constantly increasing [, ]. Nevertheless, the real prevalence of immunocompromise among patients with pneumonia coming from the community is still unknown. Moreover, guidelines for community-acquired and hospital-acquired pneumonia did not address this topic—what is more, they specifically excluded patients with clinical characteristics determining immunocompromise [], and current evidence in literature is also scarce.\nTo our knowledge, there are no studies addressing the clinical evaluation and initial empirical antibiotic coverage of patients coming from the community with pneumonia and immunocompromise. Moreover, specific risk factors to assess the causative microbiology and help clinicians choose more appropriate management for these patients have not been clearly identified. Thus, the aim of the current study was to identify the prevalence, type, microbiology, and intercorrelations between different risk factors for immunocompromise in hospitalized patients with pneumonia coming from the community.\n## MATERIALS AND METHODS\n### Study Design and Population\nThis is a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) database []. The GLIMP study was an international, multicenter, observational, point-prevalence study of adult patients hospitalized for community-onset pneumonia in 54 countries worldwide. Patients were enrolled on a single day during the months of March, April, May, and June 2015. The methods of the GLIMP study have been published elsewhere []. The coordinating center (University of Texas Health Science Center, San Antonio) received approval from its institutional review board (No. HSC20150184E).\nAll adult patients (aged >18 years old) coming from the community and hospitalized with pneumonia during study period were included. Pneumonia was defined as the presence of a new pulmonary infiltrate on chest radiograph at the time of hospitalization, associated with ≥1 of the following criteria: (1) new or increased cough with/without sputum production and/or purulent respiratory secretions, (2) fever or hypothermia, and (3) evidence of systemic inflammation (ie, abnormal white blood cell count or increased C-reactive protein or procalcitonin level). Hospitalized patients with a diagnosis of hospital-acquired or ventilator-associated pneumonia were excluded.\n### Data Collection\nData were collected from medical records at the time of hospital admission. Data gathered included demographics; respiratory and cardiovascular comorbid conditions; immunocompromised status and other chronic medical conditions; severity of pneumonia (defined as either intensive care unit admission, use of invasive or noninvasive mechanical ventilation, or use of vasopressors/inotropes during the first 24 hours after hospital admission); and specific risk factors for resistant pathogens infection, including chronic aspiration, being bedridden, malnutrition, presence of enteric tube feeding and indwelling catheters (including central venous and urinary catheters), previous infections, chronic microbial colonization, and previous healthcare exposures. The number and type of microbiological samples obtained within 24 hours after hospital admission were also collected. Culture-positive tests, kind of sample, and antibiotic resistance patterns were also gathered, along with empiric antibiotic treatment, given within 24 hours after hospital admission.\n### Microbiological Workup\nDiagnostic testing was performed according to local standard operating procedures and included collection of respiratory and blood cultures and testing for urinary antigens. Microbiological examinations and susceptibility testing were performed according to local standard protocols within the first 24 hours after hospital admission []. Multivariable logistic regression models were performed for patients who had a positive culture, to identify specific risk factors for single pathogens.\nCausative pathogens were stratified according to the coverage of standard therapy for community-acquired pneumonia (CAP) []. Those not covered by standard CAP therapy included the following: non–community-acquired bacteria (_Acinetobacter baumanii_ , _Enterococcus_ vancomycin-resistant, _Nocardia_ spp.), mycobacteria, fungi (_Aspergillus fumigatus, Coccidioides, Criptococcus_ , _Pneumocystis jirovecii_), and viruses other than influenza []. Those covered by standard CAP therapy included _Pseudomonas aeruginosa,_ methicillin-resistant _Staphylococcus aureus_ , methicillin-sensitive _S. aureus_ , _Enterobacter_ spp., _Enterococcus_ spp., _Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae_ , _Moraxella catarrhalis, Proteus mirabilis, Serratia marcescens, Streptococcus pneumoniae, Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella pneumophilia,_ anaerobes bacteria, and influenza viruses. Atypical pathogens included _C. pneumoniae, M. pneumoniae,_ and _L. pneumophilia._ CAP therapy was defined as β-lactams (ceftriaxone, ampicillin-sulbactam, amoxicillin-clavulanate, cefepime, ceftazidime, piperacillin-tazobactam) plus macrolide, or fluoroquinolones alone, and, eventually, in association with vancomycin, linezolid, or oseltamivir [].\n### Definition of Immunocompromised and Study Groups\nImmunocompromise was defined as the presence of ≥1 of the following risk factors: (1) AIDS, defined either as human immunodeficiency virus infection with CD4+ lymphocyte count <200/µL or by the occurrence of AIDS-defining conditions; (2) aplastic anemia; (3) asplenia; (4) hematological cancer, defined as lymphoma, acute or chronic leukemia, or multiple myeloma; (5) chemotherapy during the last 3 months; (6) neutropenia, defined as a neutrophil count <500/dL at complete blood cell count; (7) biological drug use (including trastuzumab and therapies for autoimmune diseases, eg, anti–tumor necrosis factor α, prescribed during ≥6 months before hospital admission); (8) lung transplantation; (9) chronic steroid use (>10 mg/d of prednisone or equivalent ≥3 months before hospital admission); (10) lung cancer with either neutropenia or chemotherapy; (11) other solid tumor with either neutropenia or chemotherapy; (12) other immunocompromise (any immunocompromised state, including congenital/genetic immunocompromise and immunosuppressive therapy due to hematological cancer/solid organ transplantation other than lung). Two study groups were identified: those with versus those without 1 risk factor for immunocompromise.\n### Statistical Analysis\nCategorical variables, expressed as counts (percentages), were compared using the χ2 test. Continuous variables were compared using the unpaired Student _t_ test or the Mann-Whitney test, when appropriate. Statistical significance was defined as _P_ < .05. A network analysis was conducted to represent the frequencies of all immunocompromise variables and their relationships. The size of the circles (the circles visible in Figure 4 [network analysis], each representing a single risk factor for immunocompromise) represents both prevalence of the risk factor and strength of association with other variables.\nThe predictive value of each variable was categorized by quartiles and analyzed using a univariate regression logistic analysis. A multivariable model was obtained using a Cox regression analysis to identify independent predictors of specific pathogens, using an entry level of P value ≤0.05 and a removal level of P value ≥0.10. Hazard ratios and adjusted analyses were obtained. All statistical analyses were performed with IBM SPSS software (version 22, Statistics for Mac; version 22.0, IBM Crop), and Stata 13 software (StataCorp).\n## RESULTS\n### Prevalence of Risk Factors for Immunocompromise\nAmong 3702 patients enrolled in the GLIMP database, ≥1 risk factor for immunocompromise was identified in 652 (17.6%). The prevalences of patients with pneumonia coming from the community and with ≥1 risk factor for immunocompromise differed among continents and countries, as depicted in and . The prevalence of immunocompromise was significantly higher in both North and South America than in the rest of the world (24.0% vs 16.5 [_P_ < .001] and 24.8% vs 17.2 [_P_ = .006], respectively) ().\n![Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases.](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1752554620&Signature=LKXAyrV74Aa9owXe0o-cQ75pOeSoID0-pehgygNtPZSFXNZMuhHSvh2bH2dv7qW8hH1yagXom1UIMLOtWgjAeeVu2LBuha-~CcDB2tnoDsCwd0W--ENWiqmCFTxq3yC2TQ0Umx7W~VJXwN6SRKyfDOflOkKvPGRNUobFX0ugYVCV63UYBnlhdsPfvI-fsKpp2D2I1PP6zBaXvsJbvI-0aIPK7XN9D-bkImy~2jyh7YxMl-ml056-m9M~e1NXIC1G-eMlJ-D0ihNbxsU~I2x~~h2BWrtr8AE9Sfu1WTqiFahp57mH4~iFGY9EkQkC4xJpjMyNKtQFhxpXjvQtYLzecQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\nFigure 1.\nDistribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases.\n[Open in new tab](https://academic.oup.com/view-large/figure/134170114/ciy72301.jpg)[Download slide](https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72301.jpeg?Expires=1752554620&Signature=NHcEJwNnhhuu~V7litr8igr9GFWfZ0zM0SxlfYOwAgN3ag3nsCMd9zXKoM9GZWcSFeGB~KznckX3sjRs7eZI6UovzOYWd5ChB8QCKT6DbvXvsAyPCY~~tvyw1nLgnCRXHxsEp9~pCDA4jyfmGwdzBmIxjxK32DKPE3r03H1NwaFfFuqtTjvCIQz2eID2dBiK~4lTbznS4INQ66i-Fh9DwTzI-HwYqclm24aYv1pSYlAiswZHOwaE-fO6wkuUxDcfD3pvVFQ~xscKfiFVbOt91lXVNkOd7p4CKoSAgaQv6yr5WZ9-7z1VyiIThnhC9G~HPkbIlB2Do4fo0jz7V2xwPA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170114&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269)\nThe prevalence of each risk factor for immunocompromise is depicted in , with chronic steroid use (45.0%), hematological cancer (25.0%), and chemotherapy (22.0%) being the most frequent ones. A total of 312 patients (8.4%) had >1 risk factor for immunocompromise ().\n![Prevalence of each single risk factor for immunocompromise.](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72302.jpeg?Expires=1752554620&Signature=tN-5VXAN-IRDKK8axKZA8P~Y5z--s9j8Erc8SOjWl6DrKKH4QL5os9eZxhVeV6eWVN~f~VDG9tfzyHUF6i7OVsMNB2vsk6C~94Qv-2aRHoy5JP-aM-LrL8khDyqEa4Lg2BfInF3Q0qGwXrmt25GlH1qSBKirMgS~VlVo9FK3dUDe2-XgCIv-DixycDR1NbxEUad1obLBQi7T-cMZnDc0-hSXzSelH07q4yY8dbVGxrERuy5IWOvusZ1u83w1jCK4dSvt3hPFFdMZMOmGLi~Fj-dVSs0cAjfbIHoEDmqErTby4pVDEijEs5muQVm-Ux~YEjgN-VhvWj8YtpZKL4eSXA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\nFigure 2.\nPrevalence of each single risk factor for immunocompromise.\n[Open in new tab](https://academic.oup.com/view-large/figure/134170116/ciy72302.jpg)[Download slide](https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72302.jpeg?Expires=1752554620&Signature=urCgidlWbN7Br1gKnVthRjYFEVioagJuBFmiXPuQQBoD2qmTrm4Heidc21Yt1dgPswbIwC7DPhnYrlHrjxMxL-tPDfinKG-olgkospAEDA-ocZW5BuK9lYsha0rJ0NF76fxfhqDzGVUbNAug3anPLTq4c4Wm9hmTgaDN4Qc2ECcT8hDYAnEm3od96dWn52Zy09JsZa4zT41kMG~qQJEZG62~24b5nEIG7eSCncOceqVPqOOaaIMniBLrAQuB7Hvqr~6AtHN5IBjBuLUjU1xYJcFJXX6WtIhnqkXKN21GOO7O7AU0AC7FLWQuEd1zCcVocKQxVv4RndCQeZ3XzZvegA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170116&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269)\n![Prevalence of the number of risk factors present simultaneously in a single patient.](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72303.jpeg?Expires=1752554620&Signature=Xts16a6pXvQbNfwKtUeejfXsqF17z~2gviy7VcLQhhckWHmCw0zRSSEtsyrG9SkI2LRw39TbhqnqYNb1VTXQKD-ybyHkb~R3s-eIxJ~94DOxaaXBbUvpzbvwY1vDACc5LpVzJJ8dZMntZ7nekvhgMs6NtlpySVWDDC~7ybF0bySgW6i55FBFevIdcUxB3ipChEHL9XiTlmDkdiHssMser494UBvbDyg4DUKM-Cpd988M8qpSwp-eg-3Yhkr9q2~L66QQUhwgYNILWRRA1azwsTAJvrWUq52Dpikbj4mzbXXstnhvc7GNMw5xxz6nFPKuHVKJlcE-HQsiIvj5ZOVUxg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\nFigure 3.\nPrevalence of the number of risk factors present simultaneously in a single patient.\n[Open in new tab](https://academic.oup.com/view-large/figure/134170117/ciy72303.jpg)[Download slide](https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72303.jpeg?Expires=1752554620&Signature=aODZPs-HRl9QmymSK-5bkx~xp6iLrndvYFKxy1ge9DczmeUzsNnr5McNlvqrMcXHLvgMkhfK7yT7VuvVZQyJiTDmkR2j-SEc5zFcORnQPNUjDvGORdypfvcWI0ap8MKwHNe5lyBn4KtJz~tW8Oy3Gx54ukE8wke7~kZBzMvO8MTOkttiu8JkRKLQBqO6IcM2MoQBEcRSt-iQJjHBC9eSqzTw9hfjbhfc1npEBjHchP6v69RipZnUipM4HSTXcHzcLlv5ZrElufmBjKlaCOuMXehhls70RLfvTvOnOA3AyEmOSecyKEGpTAKKWMZCZcKwFjPqwgrO2KIMNHBcdECFyg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170117&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269)\n### Network Analysis Among Risk Factors for Immunocompromise\nThe results of the network analysis of all risk factors for immunocompromise are depicted in . Relationships were identified between chemotherapy and solid tumor other than lung cancer, hematological cancer, and chronic steroid use, and between other immunocompromise and chronic steroid use.\n![Network analysis between risk factors for immunocompromise.](https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72304.jpeg?Expires=1752554620&Signature=GuJUcrEhLaMR89vfrhqqYuGyB4HuDlfLUgnHqNu6Ksi5VkLMWjSpH0hVJWv0i4hnesvCDRYbQ~uAyBQyQ0AiLXq2xGVhq3CJd~~Uo~xFEO2RNWWcv5izwBv2Xd~h9Hdfe0hTA-AXnTA7hKM-ThAaURdGnReCFddtKpqnLFFI8QBpZfiXaSjcJTGzuOJpCX41BN9EmgqXfVfeCV2WjdANqIm2R0p4fJbe8r3T6ykoQ1g-IoQnAttT~9TBNl6irCxSuhZHs693bn8ZNDwodNBEKnNGVKaV3sMa8zH8GthYrKb1ARcjtit4vlO4Amlu5qUEW4FRAzxNeE5ch2OPPqoZ6g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)\nFigure 4.\nNetwork analysis between risk factors for immunocompromise.\n[Open in new tab](https://academic.oup.com/view-large/figure/134170120/ciy72304.jpg)[Download slide](https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72304.jpeg?Expires=1752554620&Signature=YZzJ1wJWugBQStvfJV4l4KYj3Wo9NRpieCO~yvNqxtUBWQdjFeAYbw2G-Y6DLCVNq9Va5VeID5cdns-ikSqf31HJSxkU6nJ2ORJtfKpX9YRK1R4udPlHilZw7ywCq-EzR6AMwb3sY-BfsBS4sDesTOwvKTu1-DzRuTpqruza-~yCWEOuDxUkBBBhGOjezpmaPE1pK9FuWVCTdWQjhWi0Q1hWTQx8Y41~JVb3kGWNigqT8AD4v9JX1c4I3Lv7PwLI68bVFaY9GUswC-yS1tvJbrugsyrYyCUrS~h7Si20MQ14RfW5c61orGDtUvAkaoknOVddjBXj5tv5wBq7Hieh4A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170120&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269)\n### Clinical and Microbiological Characteristics of Patients With Immunocompromise\nClinical features and disease severity of immunocompetent versus immunocompromised patients are shown in and . Immunocompromised patients were significantly younger and malnourished, had a higher frequency of comorbid conditions, previous infections, and colonization by resistant pathogens, and had more frequent contacts with the healthcare system. The prevalences of severe pneumonia did not differ among the 2 study groups.\nTable 1.\n[ Open in new tab ](https://academic.oup.com/view-large/134170123)\nClinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised)\nVariable . | Patients, No. (%)a . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 3050) . | Immunocompromised(n = 652) .   \nAge, median (IQR)| 69 (54–81)| 65 (52–74)| <.001  \nUnderweight| 125 (6.5)| 41 (10.5)| .004  \nMalnutrition| 243 (8.0)| 80 (12.3)| <.001  \nBedridden| 355 (11.6)| 60 (9.2)| .04  \nChronic aspiration| 224 (7.3)| 33 (5.1)| .02  \nBronchiectasis| 136 (4.5)| 42 (6.4)| .03  \nSevere COPD| 72 (2.4)| 28 (4.3)| .006  \nInterstitial lung disease| 60 (2.0)| 35 (5.4)| <.001  \nLung transplantation| 0 (0.0)| 7 (1.1)| <.001  \nTracheostomy| 37 (1.2)| 16 (2.5)| .02  \nHypertension| 1401 (45.9)| 254 (39.0)| .001  \nLiver disease| 103 (3.4)| 37 (5.7)| .005  \nCirrhosis| 50 (1.6)| 20 (3.1)| .02  \nDementia| 372 (12.2)| 36 (5.5)| <.001  \nEnteral tube feeding| 36 (1.2)| 16 (2.5)| .01  \nChronic renal failure| 315 (10.3)| 85 (13.0)| .04  \nHemodialysis| 34 (1.1)| 18 (2.8)| .001  \nICS use| 462 (15.2)| 128 (19.6)| .005  \nPPI use| 777 (25.5)| 251 (38.5)| <.001  \nIndwelling catheter| 52 (1.7)| 27 (4.1)| <.001  \nPrior mycobacteria diseases| 70 (2.3)| 26 (4.0)| .01  \nPrior ESBL| 39 (1.3)| 16 (2.5)| .02  \nPrior _Pseudomonas_|  68 (2.2)| 33 (5.1)| <.001  \nSevere CAP| 840 (27.5)| 190 (29.1)| .41  \nVariable . | Patients, No. (%)a . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 3050) . | Immunocompromised(n = 652) .   \nAge, median (IQR)| 69 (54–81)| 65 (52–74)| <.001  \nUnderweight| 125 (6.5)| 41 (10.5)| .004  \nMalnutrition| 243 (8.0)| 80 (12.3)| <.001  \nBedridden| 355 (11.6)| 60 (9.2)| .04  \nChronic aspiration| 224 (7.3)| 33 (5.1)| .02  \nBronchiectasis| 136 (4.5)| 42 (6.4)| .03  \nSevere COPD| 72 (2.4)| 28 (4.3)| .006  \nInterstitial lung disease| 60 (2.0)| 35 (5.4)| <.001  \nLung transplantation| 0 (0.0)| 7 (1.1)| <.001  \nTracheostomy| 37 (1.2)| 16 (2.5)| .02  \nHypertension| 1401 (45.9)| 254 (39.0)| .001  \nLiver disease| 103 (3.4)| 37 (5.7)| .005  \nCirrhosis| 50 (1.6)| 20 (3.1)| .02  \nDementia| 372 (12.2)| 36 (5.5)| <.001  \nEnteral tube feeding| 36 (1.2)| 16 (2.5)| .01  \nChronic renal failure| 315 (10.3)| 85 (13.0)| .04  \nHemodialysis| 34 (1.1)| 18 (2.8)| .001  \nICS use| 462 (15.2)| 128 (19.6)| .005  \nPPI use| 777 (25.5)| 251 (38.5)| <.001  \nIndwelling catheter| 52 (1.7)| 27 (4.1)| <.001  \nPrior mycobacteria diseases| 70 (2.3)| 26 (4.0)| .01  \nPrior ESBL| 39 (1.3)| 16 (2.5)| .02  \nPrior _Pseudomonas_|  68 (2.2)| 33 (5.1)| <.001  \nSevere CAP| 840 (27.5)| 190 (29.1)| .41  \nAbbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors.\naData represent No. (%) unless otherwise specified.\nTable 1.\n[ Open in new tab ](https://academic.oup.com/view-large/134170123)\nClinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised)\nVariable . | Patients, No. (%)a . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 3050) . | Immunocompromised(n = 652) .   \nAge, median (IQR)| 69 (54–81)| 65 (52–74)| <.001  \nUnderweight| 125 (6.5)| 41 (10.5)| .004  \nMalnutrition| 243 (8.0)| 80 (12.3)| <.001  \nBedridden| 355 (11.6)| 60 (9.2)| .04  \nChronic aspiration| 224 (7.3)| 33 (5.1)| .02  \nBronchiectasis| 136 (4.5)| 42 (6.4)| .03  \nSevere COPD| 72 (2.4)| 28 (4.3)| .006  \nInterstitial lung disease| 60 (2.0)| 35 (5.4)| <.001  \nLung transplantation| 0 (0.0)| 7 (1.1)| <.001  \nTracheostomy| 37 (1.2)| 16 (2.5)| .02  \nHypertension| 1401 (45.9)| 254 (39.0)| .001  \nLiver disease| 103 (3.4)| 37 (5.7)| .005  \nCirrhosis| 50 (1.6)| 20 (3.1)| .02  \nDementia| 372 (12.2)| 36 (5.5)| <.001  \nEnteral tube feeding| 36 (1.2)| 16 (2.5)| .01  \nChronic renal failure| 315 (10.3)| 85 (13.0)| .04  \nHemodialysis| 34 (1.1)| 18 (2.8)| .001  \nICS use| 462 (15.2)| 128 (19.6)| .005  \nPPI use| 777 (25.5)| 251 (38.5)| <.001  \nIndwelling catheter| 52 (1.7)| 27 (4.1)| <.001  \nPrior mycobacteria diseases| 70 (2.3)| 26 (4.0)| .01  \nPrior ESBL| 39 (1.3)| 16 (2.5)| .02  \nPrior _Pseudomonas_|  68 (2.2)| 33 (5.1)| <.001  \nSevere CAP| 840 (27.5)| 190 (29.1)| .41  \nVariable . | Patients, No. (%)a . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 3050) . | Immunocompromised(n = 652) .   \nAge, median (IQR)| 69 (54–81)| 65 (52–74)| <.001  \nUnderweight| 125 (6.5)| 41 (10.5)| .004  \nMalnutrition| 243 (8.0)| 80 (12.3)| <.001  \nBedridden| 355 (11.6)| 60 (9.2)| .04  \nChronic aspiration| 224 (7.3)| 33 (5.1)| .02  \nBronchiectasis| 136 (4.5)| 42 (6.4)| .03  \nSevere COPD| 72 (2.4)| 28 (4.3)| .006  \nInterstitial lung disease| 60 (2.0)| 35 (5.4)| <.001  \nLung transplantation| 0 (0.0)| 7 (1.1)| <.001  \nTracheostomy| 37 (1.2)| 16 (2.5)| .02  \nHypertension| 1401 (45.9)| 254 (39.0)| .001  \nLiver disease| 103 (3.4)| 37 (5.7)| .005  \nCirrhosis| 50 (1.6)| 20 (3.1)| .02  \nDementia| 372 (12.2)| 36 (5.5)| <.001  \nEnteral tube feeding| 36 (1.2)| 16 (2.5)| .01  \nChronic renal failure| 315 (10.3)| 85 (13.0)| .04  \nHemodialysis| 34 (1.1)| 18 (2.8)| .001  \nICS use| 462 (15.2)| 128 (19.6)| .005  \nPPI use| 777 (25.5)| 251 (38.5)| <.001  \nIndwelling catheter| 52 (1.7)| 27 (4.1)| <.001  \nPrior mycobacteria diseases| 70 (2.3)| 26 (4.0)| .01  \nPrior ESBL| 39 (1.3)| 16 (2.5)| .02  \nPrior _Pseudomonas_|  68 (2.2)| 33 (5.1)| <.001  \nSevere CAP| 840 (27.5)| 190 (29.1)| .41  \nAbbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors.\naData represent No. (%) unless otherwise specified.\nMicrobiological testing was performed in 91.0% (596 of 652) of immunocompromised and 86.0% (2626 of 3050) of immunocompetent patients (_P_ < .001). Bacteremia was found in 6.0% (36 of 596) of immunocompromised and 5.5% (145 of 2626; _P_ = .62) of immunocompetent patients. At least 1 positive culture was obtained in 40.0% (238 of 596) immunocompromised and 36.0% (935 of 2626) immunocompetent patients (_P_ = .047). Microbiological findings are provided in and . Among pathogens covered by standard therapy, _P. aeruginosa_ was more prevalent in immunocompromised patients (35 [5.9%] vs 98 [3.7%] patients; _P_ < .02). Among pathogens not usually covered by standard therapy, immunocompromised patients were more likely to be infected by _Nocardia_ spp. (4 [0.7%] vs 0 [0%] patients; _P_ < .001), nontuberculous mycobacteria (NTM) (5 [0.8%] vs 2 [0.1%]; _P_ < .002), _A. fumigatus_ (8 [1.3%] vs 10 [0.4%]; _P_ < .01), _P. jirovecii_ (12 [2.0%] vs 5 [0.2%]; _P_ < .02), and viruses, such as coronavirus (3 [0.5%] vs 3 [0.1%]; _P_ < .047), and respiratory syncytial virus (6 [1.0%] vs 7 [0.3%]; _P_ < .03).\nTable 2.\n[ Open in new tab ](https://academic.oup.com/view-large/134170125)\nPathogens in the 2 Study Groups\nPathogen . | Patients, No. (%) . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 2626) . | Immunocompromised (n = 596) .   \nPathogens covered by CAP therapy| | |   \n _Streptococcus pneumoniae_|  218 (8.3)| 50 (8.4)| >.99  \nAtypical| 50 (1.9)| 13 (2.2)| .78  \n _Legionella_|  21 (0.8)| 10 (1.7)| .08  \nMRSA| 83 (3.2)| 12 (2.0)| .17  \nMSSA| 73 (2.8)| 20 (3.4)| .53  \n _Pseudomonas aeruginosa_|  98 (3.7)| 35 (5.9)| .02  \n _Haemophilus influenzae_|  65 (2.5)| 10 (1.7)| .31  \n _Klebsiella pneumoniae_|  89 (3.4)| 22 (3.7)| .81  \nInfluenza virus| 126 (4.8)| 28 (4.7)| >.99  \nPathogens not covered by CAP therapy| | |   \nNon-CAP bacteria| | |   \n _Acinetobacter baumanii_|  33 (1.3)| 7 (1.2)| >.99  \n _Nocardia_ spp.| 0 (0.0)| 4 (0.7)| <.001  \nMycobacteria| | |   \n _Mycobacterium tuberculosis_|  21 (0.8)| 5 (0.8)| >.99  \nNTM| 2 (0.1)| 5 (0.8)| .002  \nFungi| | |   \n _Aspergillus fumigatus_|  10 (0.4)| 8 (1.3)| .01  \n _Actinomyces_|  2 (0.1)| 0 (0.0)| >.99  \n _Cryptococcus_|  3 (0.1)| 0 (0.0)| .94  \n _Pneumocystis jirovecii_|  5 (0.2)| 13 (2.2)| <.001  \nViruses| | |   \nAdenovirus| 5 (0.2)| 0 (0.0)| .62  \nCoronavirus| 3 (0.1)| 3 (0.5)| .047  \nMetapneumovirus| 3 (0.1)| 2 (0.3)| .51  \nRSV| 7 (0.3)| 6 (1.0)| .03  \nMDR pathogens| 231 (8.8)| 54 (9.0)| .54  \nPathogen . | Patients, No. (%) . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 2626) . | Immunocompromised (n = 596) .   \nPathogens covered by CAP therapy| | |   \n _Streptococcus pneumoniae_|  218 (8.3)| 50 (8.4)| >.99  \nAtypical| 50 (1.9)| 13 (2.2)| .78  \n _Legionella_|  21 (0.8)| 10 (1.7)| .08  \nMRSA| 83 (3.2)| 12 (2.0)| .17  \nMSSA| 73 (2.8)| 20 (3.4)| .53  \n _Pseudomonas aeruginosa_|  98 (3.7)| 35 (5.9)| .02  \n _Haemophilus influenzae_|  65 (2.5)| 10 (1.7)| .31  \n _Klebsiella pneumoniae_|  89 (3.4)| 22 (3.7)| .81  \nInfluenza virus| 126 (4.8)| 28 (4.7)| >.99  \nPathogens not covered by CAP therapy| | |   \nNon-CAP bacteria| | |   \n _Acinetobacter baumanii_|  33 (1.3)| 7 (1.2)| >.99  \n _Nocardia_ spp.| 0 (0.0)| 4 (0.7)| <.001  \nMycobacteria| | |   \n _Mycobacterium tuberculosis_|  21 (0.8)| 5 (0.8)| >.99  \nNTM| 2 (0.1)| 5 (0.8)| .002  \nFungi| | |   \n _Aspergillus fumigatus_|  10 (0.4)| 8 (1.3)| .01  \n _Actinomyces_|  2 (0.1)| 0 (0.0)| >.99  \n _Cryptococcus_|  3 (0.1)| 0 (0.0)| .94  \n _Pneumocystis jirovecii_|  5 (0.2)| 13 (2.2)| <.001  \nViruses| | |   \nAdenovirus| 5 (0.2)| 0 (0.0)| .62  \nCoronavirus| 3 (0.1)| 3 (0.5)| .047  \nMetapneumovirus| 3 (0.1)| 2 (0.3)| .51  \nRSV| 7 (0.3)| 6 (1.0)| .03  \nMDR pathogens| 231 (8.8)| 54 (9.0)| .54  \nAbbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant _Staphylococcus aureus_ ; MSSA, methicillin-sensitive _S. aureus_ ; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus.\nTable 2.\n[ Open in new tab ](https://academic.oup.com/view-large/134170125)\nPathogens in the 2 Study Groups\nPathogen . | Patients, No. (%) . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 2626) . | Immunocompromised (n = 596) .   \nPathogens covered by CAP therapy| | |   \n _Streptococcus pneumoniae_|  218 (8.3)| 50 (8.4)| >.99  \nAtypical| 50 (1.9)| 13 (2.2)| .78  \n _Legionella_|  21 (0.8)| 10 (1.7)| .08  \nMRSA| 83 (3.2)| 12 (2.0)| .17  \nMSSA| 73 (2.8)| 20 (3.4)| .53  \n _Pseudomonas aeruginosa_|  98 (3.7)| 35 (5.9)| .02  \n _Haemophilus influenzae_|  65 (2.5)| 10 (1.7)| .31  \n _Klebsiella pneumoniae_|  89 (3.4)| 22 (3.7)| .81  \nInfluenza virus| 126 (4.8)| 28 (4.7)| >.99  \nPathogens not covered by CAP therapy| | |   \nNon-CAP bacteria| | |   \n _Acinetobacter baumanii_|  33 (1.3)| 7 (1.2)| >.99  \n _Nocardia_ spp.| 0 (0.0)| 4 (0.7)| <.001  \nMycobacteria| | |   \n _Mycobacterium tuberculosis_|  21 (0.8)| 5 (0.8)| >.99  \nNTM| 2 (0.1)| 5 (0.8)| .002  \nFungi| | |   \n _Aspergillus fumigatus_|  10 (0.4)| 8 (1.3)| .01  \n _Actinomyces_|  2 (0.1)| 0 (0.0)| >.99  \n _Cryptococcus_|  3 (0.1)| 0 (0.0)| .94  \n _Pneumocystis jirovecii_|  5 (0.2)| 13 (2.2)| <.001  \nViruses| | |   \nAdenovirus| 5 (0.2)| 0 (0.0)| .62  \nCoronavirus| 3 (0.1)| 3 (0.5)| .047  \nMetapneumovirus| 3 (0.1)| 2 (0.3)| .51  \nRSV| 7 (0.3)| 6 (1.0)| .03  \nMDR pathogens| 231 (8.8)| 54 (9.0)| .54  \nPathogen . | Patients, No. (%) . |  _P_ Value .   \n---|---|---  \nImmunocompetent (n = 2626) . | Immunocompromised (n = 596) .   \nPathogens covered by CAP therapy| | |   \n _Streptococcus pneumoniae_|  218 (8.3)| 50 (8.4)| >.99  \nAtypical| 50 (1.9)| 13 (2.2)| .78  \n _Legionella_|  21 (0.8)| 10 (1.7)| .08  \nMRSA| 83 (3.2)| 12 (2.0)| .17  \nMSSA| 73 (2.8)| 20 (3.4)| .53  \n _Pseudomonas aeruginosa_|  98 (3.7)| 35 (5.9)| .02  \n _Haemophilus influenzae_|  65 (2.5)| 10 (1.7)| .31  \n _Klebsiella pneumoniae_|  89 (3.4)| 22 (3.7)| .81  \nInfluenza virus| 126 (4.8)| 28 (4.7)| >.99  \nPathogens not covered by CAP therapy| | |   \nNon-CAP bacteria| | |   \n _Acinetobacter baumanii_|  33 (1.3)| 7 (1.2)| >.99  \n _Nocardia_ spp.| 0 (0.0)| 4 (0.7)| <.001  \nMycobacteria| | |   \n _Mycobacterium tuberculosis_|  21 (0.8)| 5 (0.8)| >.99  \nNTM| 2 (0.1)| 5 (0.8)| .002  \nFungi| | |   \n _Aspergillus fumigatus_|  10 (0.4)| 8 (1.3)| .01  \n _Actinomyces_|  2 (0.1)| 0 (0.0)| >.99  \n _Cryptococcus_|  3 (0.1)| 0 (0.0)| .94  \n _Pneumocystis jirovecii_|  5 (0.2)| 13 (2.2)| <.001  \nViruses| | |   \nAdenovirus| 5 (0.2)| 0 (0.0)| .62  \nCoronavirus| 3 (0.1)| 3 (0.5)| .047  \nMetapneumovirus| 3 (0.1)| 2 (0.3)| .51  \nRSV| 7 (0.3)| 6 (1.0)| .03  \nMDR pathogens| 231 (8.8)| 54 (9.0)| .54  \nAbbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant _Staphylococcus aureus_ ; MSSA, methicillin-sensitive _S. aureus_ ; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus.\nOnce adjusted for confounders, no risk factors of immunocompromise have been recognized for _P. aeruginosa_ infection. Likewise, pathogens not covered by usual CAP therapy were found to be associated not with immunocompromise but with chronic obstructive pulmonary disease (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.07–2.99; _P_ = .03), tracheostomy (2.91; 1.01–8.38; _P_ = .048), and severe pneumonia (2.36; 1.42–3.93; _P_ = .001) ().\nTable 3.\n[ Open in new tab ](https://academic.oup.com/view-large/134170127)\nMultivariable Logistic Regression Analysis\nVariable . | OR (CI 95%) .   \n---|---  \n _Pseudomonas aeruginosa_ . | Non-CAP Bacteria . | Fungi . |  _Mycobacterium tuberculosis_ . | Virus Other Than Influenza .   \nSevere COPD| 2.89 (1.34–6.22)| …| …| …| …  \nTracheostomy| 6.95 (2.87–16.85)| 2.91(1.01–8.38)| …| …| …  \nICS use| 1.76 (1.09–2.82)| …| …| …| …  \nIndwelling catheter| 2.49 (1.02–6.06)| …| …| …| …  \nPrior _Pseudomonas_|  19.20(11.71–31.50)| …| …| …| …  \nCOPD| …| 1.78(1.07–2.99)| …| …| …  \nSevere CAP| …| 2.36(1.42–3.93)| …| …| 2.56(1.27–5.19)  \nAIDS| …| …| 15.10(6.36–35.88)| …| …  \nHematological cancer| …| …| 4.65(1.85–11.69)| …| 5.49(2.20–13.70)  \nMalnutrition| …| …| …| 5.14 (2.21–11.93)| …  \nVariable . | OR (CI 95%) .   \n---|---  \n _Pseudomonas aeruginosa_ . | Non-CAP Bacteria . | Fungi . |  _Mycobacterium tuberculosis_ . | Virus Other Than Influenza .   \nSevere COPD| 2.89 (1.34–6.22)| …| …| …| …  \nTracheostomy| 6.95 (2.87–16.85)| 2.91(1.01–8.38)| …| …| …  \nICS use| 1.76 (1.09–2.82)| …| …| …| …  \nIndwelling catheter| 2.49 (1.02–6.06)| …| …| …| …  \nPrior _Pseudomonas_|  19.20(11.71–31.50)| …| …| …| …  \nCOPD| …| 1.78(1.07–2.99)| …| …| …  \nSevere CAP| …| 2.36(1.42–3.93)| …| …| 2.56(1.27–5.19)  \nAIDS| …| …| 15.10(6.36–35.88)| …| …  \nHematological cancer| …| …| 4.65(1.85–11.69)| …| 5.49(2.20–13.70)  \nMalnutrition| …| …| …| 5.14 (2.21–11.93)| …  \nBlank cells indicate no statistical significancy.\nAbbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio.\nTable 3.\n[ Open in new tab ](https://academic.oup.com/view-large/134170127)\nMultivariable Logistic Regression Analysis\nVariable . | OR (CI 95%) .   \n---|---  \n _Pseudomonas aeruginosa_ . | Non-CAP Bacteria . | Fungi . |  _Mycobacterium tuberculosis_ . | Virus Other Than Influenza .   \nSevere COPD| 2.89 (1.34–6.22)| …| …| …| …  \nTracheostomy| 6.95 (2.87–16.85)| 2.91(1.01–8.38)| …| …| …  \nICS use| 1.76 (1.09–2.82)| …| …| …| …  \nIndwelling catheter| 2.49 (1.02–6.06)| …| …| …| …  \nPrior _Pseudomonas_|  19.20(11.71–31.50)| …| …| …| …  \nCOPD| …| 1.78(1.07–2.99)| …| …| …  \nSevere CAP| …| 2.36(1.42–3.93)| …| …| 2.56(1.27–5.19)  \nAIDS| …| …| 15.10(6.36–35.88)| …| …  \nHematological cancer| …| …| 4.65(1.85–11.69)| …| 5.49(2.20–13.70)  \nMalnutrition| …| …| …| 5.14 (2.21–11.93)| …  \nVariable . | OR (CI 95%) .   \n---|---  \n _Pseudomonas aeruginosa_ . | Non-CAP Bacteria . | Fungi . |  _Mycobacterium tuberculosis_ . | Virus Other Than Influenza .   \nSevere COPD| 2.89 (1.34–6.22)| …| …| …| …  \nTracheostomy| 6.95 (2.87–16.85)| 2.91(1.01–8.38)| …| …| …  \nICS use| 1.76 (1.09–2.82)| …| …| …| …  \nIndwelling catheter| 2.49 (1.02–6.06)| …| …| …| …  \nPrior _Pseudomonas_|  19.20(11.71–31.50)| …| …| …| …  \nCOPD| …| 1.78(1.07–2.99)| …| …| …  \nSevere CAP| …| 2.36(1.42–3.93)| …| …| 2.56(1.27–5.19)  \nAIDS| …| …| 15.10(6.36–35.88)| …| …  \nHematological cancer| …| …| 4.65(1.85–11.69)| …| 5.49(2.20–13.70)  \nMalnutrition| …| …| …| 5.14 (2.21–11.93)| …  \nBlank cells indicate no statistical significancy.\nAbbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio.\nResults showed that AIDS (OR, 15.10; 95% CI, 6.36–35.88; _P_ ≤ .001) and hematological cancer (4.65; 91.85–11.69; _P_ = .001) were independently associated with fungal infections; hematological cancer (5.49; 2.20–13.70; _P_ < .001) and severe pneumonia (2.56; 1.27–5.19; _P_ = .009) with infection by viruses other than influenza; and AIDS (4.41; 1.53–12.73; _P_ = .006) and malnutrition (4.50; 2.08–9.72; _P_ < .001) with mycobacterial infections. An additional analysis was conducted on mycobacteria, including _M. tuberculosis_ and NTM. At multivariable analysis, _M. tuberculosis_ was independently associated with malnutrition only (OR, 5.14; 95% CI, 2.21–11.93; _P_ < .001). At univariate analysis, patients with AIDS were at higher risk for NTM (23.06; 4.39–121.12; _P_ < .001).\nA subanalysis was conducted among patients with chronic steroid use versus other risk factors for immunocompromise. Patients with chronic steroid use seemed to be more frequently affected by bacteria not covered by standard CAP therapy (10 [3.4%] vs 1 [0.3%] patients; _P_ = .002), _Nocardia_ spp. in particular (4 [0.4%] vs 0 [0.0%]; _P_ = .03). No differences in the severity of the disease were found (see ).\n## DISCUSSION\nThe main findings of the present study are as follows: (1) 17.6% of patients admitted with pneumonia from the community have ≥1 risk factor for immunocompromise, with significant differences among continents and countries (ranging from 15.4% to 24.8% by continent and from 80.0% to 4.1% by country); (2) chronic steroid use is by far the most prevalent risk factor leading to immunocompromise, followed by hematological cancer and chemotherapy; (3) 1 of 2 immunocompromised patients has an overlap of ≥2 risk factors, which are also associated between one another in different ways; and (4) the 2 risk factors for immunocompromise independently associated with specific pathogens are AIDS (ie, fungal and mycobacterial infections) and hematological cancer (ie, fungal infection and viral infections other than influenza).\nAlmost 1 in 5 hospitalized patients with CAP are not immunocompetent. Therefore, it is mandatory to provide clinicians with recommendations or guidelines for the management of hospitalized patients with pneumonia coming from the community who have risk factors for immunocompromise. Currently, there are no guidelines for assessing pneumonia in immunocompromised patients coming from the community. Randomized controlled trials (RCTs) and observational prospective studies are missing owing to the fact that, generally, studies assessing management strategies for pneumonia exclude immunocompromised patients or take into account only a single specific risk factor []. This lack of information about immunocompromise could lead to both underestimation of the real prevalence with a higher rate of treatment failure and to overestimation and overuse of wide-spectrum antibiotics.\nWe found a 17.6% global prevalence of immunocompromise among patients coming from the community with pneumonia, with a significantly higher frequency in South and North America. This variability among continents and countries is probably attributable to different healthcare systems and rates of hospitalization of immunocompromised patients. Our analysis showed that the most frequent risk factor for immunocompromise is the chronic use of systemic steroids. Aging of the population and therapeutic advancements have favored the increased burden of chronic diseases and long-term therapies with immunosuppressive agents [, ]. In particular, steroids are the agents most frequently prescribed, for their wide spectrum of efficacy in several diseases [, , ]. Therefore, many patients presenting to the emergency room with pneumonia are receiving chronic steroid treatment. No data are available on this population group, and further studies are needed to characterize these patients and provide individualized management.\nHematological cancer and chemotherapy were other leading immunocompromised factors. These findings are consistent with those in previous studies; patients recruited in observational studies include patients with solid or hematological cancer and those who underwent chemotherapy with associated neutropenia [, ]. Dedicated guidelines and recommendations are available, especially on respiratory viruses, fungi, and _P. jirovecii_ [].\nOur network analysis showed that several risk factors for immunocompromise show associations, especially chemotherapy, associated with hematological cancer and solid tumor, and other immunocompromise, associated with chronic steroid use. Moreover, neutropenic patients are well represented and mainly affected also by hematological cancer or under treatment with chemotherapy. Our results suggest that patients may have >1 risk factor characteristic and clinical assessment should be comprehensive, taking into consideration risk factors for immunocompromise and their associated biological mechanisms. In contrast, AIDS, lung transplantation, asplenia, and aplastic anemia seem to be less frequent at admission and to represent distinct clinical entities. Findings of previous studies seem to be in line with our results, with AIDS patients considered as a distinct patient population and with very few observational studies available on asplenia and aplastic anemia [, ]\nIn agreement with previous reports, _S. pneumoniae_ is the leading microorganism in both immunocompromised and immunocompetent groups [, ]. Among pathogens covered by standard CAP therapy, only _P. aeruginosa_ was more frequently isolated in immunocompromised compared with immunocompetent patients. These findings differ from microbiological results of previous studies. Gram-positive bacteria, especially _S. aureus_ , were more frequently identified in patients with immunocompromise of different causes [, , ]. Only Li and coauthors [] found patients with immunological disorders, treated with systemic steroids and cytotoxic agents, to have a higher incidence of infections caused by gram-negative bacteria, mainly _P. aeruginosa_. This similarity with our findings could be explained by the prevalence of patients exposed to chronic steroids in our cohort.\nAmong pathogens not covered by standard CAP therapy, immunocompromised patients were more frequently infected by _Nocardia_ spp., NTM, _P. jirovecii_ , _A. fumigatus_ , and viruses other than influenza. Infections by _P. jirovecii_ and NTM are frequently identified in patients with AIDS []. _P. jirovecii_ is also frequent in other types of immunocompromise, such as solid or hematological cancer in patients who underwent chemotherapy [, , ]. Fungal infections (eg, _Candida_ spp. and _A. fumigatus_) are highly incident in neutropenic hematological cancer patients [, ]. Viral infections other than influenza, especially respiratory syncytial virus, are more frequent in patients who underwent hematopoietic stem cell or lung transplantation [, ]. Conversely, _Nocardia_ spp. infections are mainly described in solid organ transplant recipients []. These results, consistent with previous findings, suggest the need for a more in-depth microbiological workup, including community-acquired pathogens and microorganisms not covered by standard therapy.\nSurprisingly, we found that risk factors for immunocompromise were not independently associated with _P. aeruginosa_ or non–community-acquired bacteria; in contrast, AIDS and hematological cancer are both associated with fungal, mycobacterial, and noninfluenza viral pneumonia, respectively. Empirical therapy should include _P. aeruginosa_ coverage, which is highly prevalent in immunocompromised patients. On the contrary, particular attention should be given to fungal, mycobacterial, and viral causes should be for patients admitted with AIDS and hematological cancer [].\nFinally, bacteremia rates did not differ between study groups. To our knowledge, there are no studies on bacteremia and immunocompromise in general. The majority of studies have focused on bacteremia in hematopoietic stem cell transplantation, with prevalences varying from 6% to 44% depending on the type of bacteria and host-related factors []. Few studies addressed this topic in kidney transplant recipients, reporting a prevalence of bacteremia ranging from 25% to 69% [, ]. Finally, few studies have addressed HIV and bacteremia, with prevalences ranging from 10% to 25%, depending on the pathogen and grade of immunosuppression [, ]. The prevalence of bacteremia in our study was 5T–6% in both immunocompetent and immunocompromised patients. Differences in the prevalence of bacteremia are due mainly to differences between the risk factors for immunocompromise in our study (chronic steroid use, hematological cancer, and chemotherapy) and those previously reported in the literature.\nThe current study has both limitations and strengths. First of all, to our knowledge, this is the first study showing a worldwide perspective on immunocompromise among patients coming from the community with pneumonia, with a large and diverse sample of patients enrolled across different countries in 6 continents. However, we were not able to involve many investigators from Asia and Africa, and most cases occurred in North America and Europe, thus limiting the generalizability of our findings. Another major limitation is the unfeasibility of grading the severity of immunocompromise and, therefore, stratifying patients and defining the physiopathological interaction between different risk factors, especially with regard to the use of biological drugs and chronic steroids. Furthermore, potentially important risk factors for an immunocompromised state, such as solid organ transplants other than lung, have not been specifically investigated. Finally, no outcome data have been collected, and this strongly limits our speculations as to the correct empiric antibiotic therapy for use in immunocompromised patients with CAP.\nIn conclusion, our study offers to the scientific community a perspective on immunocompromised patients coming from the community with pneumonia. Future prospective studies on patients with specific risk factors for immunocompromise could provide practical recommendations. In particular, it will be crucial to prepare guidelines on certain prevalent population groups, such as patients exposed to chronic steroids and those with hematological cancer.\n## Supplementary Data\nSupplementary materials are available at _Clinical Infectious Diseases_ online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author.\n## Notes\n**_Author contributions._** M. F. D. P., G. S., S. A., and M. I. R. participated in study design, analysis of data, and writing of the manuscript and take responsibility for the integrity of the work. A. G., D. R., S. T., L. F. R., J. R., J. G. d. C., and F. B. critically reviewed the final manuscript.\n**_Acknowledgments._** We thank the Asociacion Latinoamericana de Torax, European Respiratory Society, World Federation of Societies of Intensive and Critical Care Medicine, and American College of Chest Physicians for their support of this project. We also thank the following study contributors for their valuable collaboration. **Argentina:** Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires), Silvia Attorri (Hospital Luis Lago Maggiore, Mendoza), Enrique Barimboim (Hospital Central de Mendoza), Juan Pablo Caeiro and María I. Garzón (Hospital Privado Universitario, Córdoba), Victor Hugo Cambursano, A. Cazaux (Servicio de Neumologia, Hospital Rawson, Córdoba), Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas), Julio Chertcoff, Florencia Lascar, and Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital), Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza), Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires) Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos Vicente Lopez y Planes from General Rodriguez, Buenos Aires), Sandra Lambert (Hospital El Cruce–Alta Complejidad en Red), Gustavo Lopardo (Hospital Bernardo Houssay, Vicente López), Carlos M. Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires), Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen), Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos), Antonio A. Cetrangolo (an individual who is being acknowledged for his contribution to the study), Claudia Pensotti (Infectious Diseases and Infection Control Department, Clinica Privada Monte Grande, Buenos Aires), Betiana Pereyra (Hospital San Roque, Córdoba), Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D. F. Santojanni), Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela); **Australia:** Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg); **Austria:** Felix Lötsch and Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna); **Belgium:** Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp), Camille A. Francois (Anesthesia and Critical Care Department, Erasme University Hospital, Brussels), Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital), Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels); **Benin:** Marcel Zannou Djimon, Jules Bashi and Roger Dodo (Centre Hospitalier Universitaire HKM of Cotonou); **Brazil:** Simone Aranha Nouér (Federal University of Rio de Janeiro); **Bulgaria:** Peter Chipev and Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofia), Darina Miteva, (UMHAT St Marina, Varna), Diana Petkova (University Hospital Varna); **Cameroon:** Adamou Dodo Balkissou (Yaounde Jamot Hospital, Yaounde), Eric Walter Pefura Yone (Département de Médecine Interne, University of Yaounde), Bertrand Hugo Mbatchou Ngahane (Douala General Hospital); **China:** Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing), Jin-fu Xu (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University); **Colombia:** Carlos Andres Bustamante Rico and Ricardo Buitrago (Clinica Shaio, Bogota), Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin); **Congo:** Jean-Marie Kayembe Ntumba (Cliniques Universitaires de Kinshasa); **Croatia:** Vesna Vladic Carevic (Interne Medicine, Dubrovnik), Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb), Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases), Zinka Matkovic (University Hospital Dubrava, Zagreb), Ivan Mitrecic (Karlovac General Hospital); **Denmark:** Marie-Laure Bouchy Jacobsson (Emergency Department, North Zealand’s Hospital–Hillerød), Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital), Uffe Christian Heitmann Bødtger (Department of Pulmonology, Naestved Hospital), Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde), Andreas Vestergaard Jensen, Gertrud Baunbæk-Knudsen, Pelle Trier Petersen, and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød); **Egypt:** Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University), Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University), Hanaa Shafiek (Chest Diseases Department, Faculty of Medicine, Alexandria University), Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo); **Ethiopia:** Kedir Abdella Abdulsemed (Department of Medical Laboratory Science and Pathology, College of Health Sciences, Mycobacteriology Research Centre, Institute of Biotechnology Research, Jimma University); **France:** Fabrice Bertrand (Critical Care Unit, Robert Ballanger Hospital, Aulnay sous Bois), Christian Brun-Buisson (University Hospital of Henri-Mondor, Créteil), Etienne de Montmollin (Intensive Care Unit, Hôpital Delafontaine, Centre Hospitalier de Saint-Denis), Muriel Fartoukh (Unité de Réanimation Médico-Chirurgicale, Pôle Thorax Voies Aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien), Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médico-chirurgicale, Hôpital Louis Mourier, Colombes, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité), Pierre Tattevin (Infectious Diseases and ICU, Pontchaillou University Hospital, Rennes), Abdo Khoury (Department of Emergency Medicine and Critical Care, University of Franche–Comté, Medical Center); **Gambia:** Bernard Ebruke (Medical Research Council Unit, Fajara, Gambia); **Germany:** Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen), Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden), Matthias Meisinger, Klinikum Niederlausitz, Klinik für Innere Medizin und Intensivmedizin, Senftenberg), Mathias W. Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital), Jan Rupp (Department of Infectious Diseases and Microbiology, University of Lübeck), Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg), Marc Spielmanns (Internal Medicine Department, Pulmonary Rehabilitation and Department of Health, School of Medicine, University Witten-Herdecke, St Remigius Hospital, Leverkusen) Petra Creutz and Norton Suttorp (Department of Infectious Disease and Respiratory Medicine, Charité–University Medicine, Berlin); **Ghana** : Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi); **Greece** : Katerina Dimakou (5th Respiratory Medicine Department, SOTIRIA Chest Hospital, Athens), Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens), Evdoxia Tsigou and Dimitrios Ampazis (Agioi Anargiroi Hospital, Kifissia, Athens), Evangelos Kaimakamis (Intensive Care Unit, G. Papanikolaou General Hospital of Thessaloniki); **India** : Mohit Bhatia (S. S. Hospital IMS BHU Varanasi), Raja Dhar (Fortis Hospitals, Kolkata), George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore), Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow), Parvaiz A. Koul (Department of Internal and Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar), P. A. Mahesh and B. S. Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore), Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala), Hirennappa B. Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka), Surya Kant (Department of Respiratory Medicine, King George’s Medical University, Chowk, Lucknow, Uttar Pradesh), Rajesh Swarnakar (Getwell Hospital and Research Institute, Dhantoli, Nagpur), Sneha Limaye and Sundeep Salvi (on behalf of the Respiratory Research Network of India from the Chest Research Foundation in Pune); **Iran** : Keihan Golshani (Isfahan University of Medical Sciences); **Ireland** : Vera M. Keatings (Letterkenny General Hospital, County Donegal), Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization, St James’s University Hospital, Trinity Centre for Health Sciences Dublin); **Israel** : Yasmin Maor (Infectious Disease Unit, affiliated with Tel Aviv University, Wolfson Medical Center, Holon), Jacob Strahilevitz (Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem); **Italy** : Salvatore Battaglia, University of Palermo, Pneumologia DiBiMIS, Palermo), Maria Carrabba (Internal Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca’ Granda Ospedale Maggiore Policlinico, Milano), Piero Ceriana (Pulmonary Rehabilitation, IRCCS Fondazione Maugeri, Pavia), Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste), Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan), Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples), Marino De Rosa (Unità Operativa Complessa [UOC] Pneumologia PO San Filippo Neri Azienda Sanitaria Locale Roma E Roma), Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena), Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria Azienda Ospedaliera Ospedali dei Colli PO Monaldi), Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, Sardegna), Francesco Menzella (Department of Cardiac-Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS–Arcispedale Santa Maria Nuova, Reggio Emilia), Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S. Anna Nuovo, Unità Operativa di Pneumologia, Como), Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital), Gerardo Palmiero (Respiratory Unit, Versilia Hospital, Lido di Camaiore, Lucca), Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli), Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero–Universitaria S. Maria della Misericordia, Udine), Claudio Sorino, Pulmonology Unit, A. O. Sant’Anna di Como), Gundi Steinhilber (Spedali Civili Brescia, U. O. Pneumologia e Fisiopatologia Respiratoria, Brescia), Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta), Fabio Franzetti, Manuela Carugati, Manuela Morosi, and Elisa Monge (Department of Biomedical and Clinical Sciences, Division of Infectious Diseases, Luigi Sacco Hospital, Università degli Studi di Milano), Mauro Carone, (Fondazione Salvatore Maugeri, IRCCS, Cassano Murge), Vincenzo Patella (Allergology and Clinical Immunology Unit, Department of Medical Sciences, Battipaglia Hospital, Battipaglia, Salerno), Simone Scarlata (Geriatrics, Unit of Respiratory Pathophysiology and Thoracic Endoscopy, Campus Bio Medico University and Teaching Hospital, Rome), Andrea Comel, UO Pneumologia, Ospedale Pederzoli, Peschiera del Garda); **Japan** : Kiyoyasu Kurahashi (Yokohama City University Medical Center); **Lebanon** : Zeina Aoun Bacha (Medicine School, St Joseph University, Beyrouth); **Mexico** : Daniel Barajas Ugalde (National Institute of Respiratory Diseases), Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California), José F. Villegas (Hospital Universitario Monterrey); **Montenegro** : Milic Medenica (Hospital for Lung Diseases–Brezovik, Niksic); **Netherlands** : E. M. W. van de Garde (Department of Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein); **Nepal** : Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences), Poojan Shrestha (Oxford University Clinical Research Unit, Patan Hospital); **New Zealand** : Elliott Ridgeon (Medical Research Institute of New Zealand); **Nigeria** : Babatunde Ishola Awokola (Department of Family Medicine and Primary Care, Lily Hospitals Limited, Warri), Ogonna N. O. Nwankwo (University of Calabar Teaching Hospital), Adefuye Bolanle Olufunlola (Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State), Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan), Kingsley N. Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State); **Pakistan** : Muhammad Irfan, Section of Pulmonary and Critical Care Medicine (Department of Medicine, Aga Khan University, Karachi); **Poland** : Lukasz Minarowski (Department of Lung Diseases and Tuberculosis, Medical University of Bialystok), Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec); **Portugal** : Felipe Froes (Hospital Pulido Valente–CHLN, Lisboa), Pedro Leuschner, (Centro Hospitalar do Porto), Mariana Meireles, Cláudia Ferrão, Pedro Leuschner, and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo Prof Abel Salazar, Porto), Sofia B. Ravara (Faculty of Health Sciences, University of Beira Interior, Cova da Beira Hospital Center, Covilhã); **Republic of Moldova** : Victoria Brocovschii (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu), Chesov Ion (Clinic of Anesthesia and Intensive Care Valeriu Ghrerg, Institute of Emergency Medicine, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau), Doina Rusu (SMFU N. Testemitanu, Chisinau), Cristina Toma (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau); **Romania** : Daniela Chirita (Hospital Sfantul Stefan, Bucharest), Carmen Mihaela Dorobat (Universitatea de Medicină şi Farmacie Gr T. Popa I a ş i Facultatea de Medicină Stomatologică, Spitalul Clinic de Boli Infecţioase Sfânta Parascheva I a ş i Iaşi); **Russia** : Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S. I. Georgievsky), Anna Kaluzhenina (Volgograd State Medical University); **Saudi Arabia** : Abdullah Almotairi (King Fahad Medical City, Riyadh), Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina), Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh), Amal Fathy (Pulmonary and Respiratory Critical Care Medicine, Mansoura University Egypt, Affiliate at Taibah University), Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh), Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa), Abdelhaleem Bella (Dammam University–Saudi Arabia and King Fahad Hospital); **Serbia** : Nada Bogdanović (Pulmonary Department of KHC, Dragiša Mišović, Belgrade), Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade), Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade); **Spain** : Luis Borderìas (Respiratory and Sleep Unit, Hospital San Jorge, Huesca), Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at Sant Joan Despí), Hugo Cabello Alarcón (Sant Hospital Seu de Urgell, Catalonia), Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona), Vicens Diaz-Brito and Xavier Casas (Infectious Diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona), Alicia Encabo González (Hospital Complex of Pontevedra), Maria Luisa Fernández-Almira (Medicina Interna, Hospital Universitario Central de Asturias), Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, and CIBER de Enfermedades Respiratorias, CIBERES, Bunyola), Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga), Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid), Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante), Elena Laserna Martínez (Hospital Mollet, Barcelona), Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid), Pedro J. Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña, INIBIC, Sergas, Universidade de A Coruña), Rosario Menéndez (Pneumology Service, University and Polytechnic Hospital La Fe, Valencia), Ana Pando-Sandoval (Hospital Universitario Central de Asturias, Area de Gestion Clinica de Pulmon, Servicio de Neumologia, Oviedo), Cristina Prat Aymerich, Alicia Lacoma de la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, and Universitat Autònoma de Barcelona, CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III), Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d’Hebron, Barcelona), Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia), Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona), Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria), Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo), Job F. M. van Boven (Hospital Universitari Son Espases, Palma de Mallorca), Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró); **South Africa** : Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand); **South Korea** : Ho Kee Yum (Inje University Seoul Paik Hospital); **Togo** : Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University Hospital of Sylvanus Olympio, Lomé); **Tunisia** : Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security, Marsa, Tunis); **Turkey** : Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir), Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul), Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir); **Ukraine** : Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa Regional Antituberculosis Hospital, Vinnitsa); **United Arab Emirates** : Naheed Elahi (Dubai Hospital); **United Kingdom** : Devesh J. Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife), Andrew Feneley, Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann, University Hospitals of Leicester NHS Trust and University of Leicester), Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool), Adam T. Hill (Royal Infirmary and University of Edinburgh), Banu Rudran (The Royal London Hospital, Barts Health Trust, London), Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, East Kilbride), Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds), Alexander Youzguin (Southport and Ormskirk Hospitals NHS Trust), Anika Singanayagam (Imperial College Healthcare NHS Trust, London); **United States** : Karen S. Allen (University of Oklahoma Health Sciences Center, Oklahoma City), Veronica Brito (Texas A&M Health Science Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Baylor Scott & White Health, Temple); Jessica Dietz (Fargo VA Health Care System, Fargo, North Dakota), Claire E. Dysart and Susan M. Kellie (Clement J. Zablocki VA Medical Center, Milwaukee, Wisconsin; Division of Infectious Diseases, University of New Mexico School of Medicine; and Raymond G. Murphy VA Medical Center, Albuquerque, New Mexico), Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, Illinois), Mina Gaga (7th Respiratory Medical Department and Asthma Center, Athens Chest Hospital), Thomas L. Holland and Stephen P. Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, Durham), Fayez Kheir (Department of Pulmonary Diseases, Critical Care and Environmental Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana), Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, Illinois), Manuel Lois (John Peter Smith Hospital, Fort Worth, Texas), Girish B. Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook, and Winthrop University Hospital, Mineola, New York), Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, Denver), Katherine Reyes (Henry Ford Hospital, Detroit, Illinois), William Rodriguez-Cintron, (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, San Juan Puerto Rico), Shigeki Saito (Tulane University, New Orleans), Nilam J. Soni, Julio Noda, Cecilia I. Hinojosa, Stephanie M. Levine, Luis F. Angel, and Antonio Anzueto (Divisions of Hospital Medicine and Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio), K. Scott Whitlow, John Hipskind, Kunal Sukhija, and Vicken Totten (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, California), Richard G. Wunderink and Ray D. Shah (Northwestern University Feinberg School of Medicine, Chicago, Illinois); **Zambia** : Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka). **Other investigators** : Lorena Noriega, Ezequiel Alvarado, Mohamed Aman, and Lucía Labra.\n**_Disclaimer._** The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute, the National Institutes of Health, or the Department of Veterans Affairs.\n**_Financial support._** This project was not funded and relied solely on voluntary site and investigator participation. M. I. R.’s time is partially protected by the National Heart, Lung, and Blood Institute (award K23HL096054).\n**_Potential conflicts of interest._** F. B. reports personal fees from AstraZeneca, GlaxoSmithKline, Guidotti, Grifols, Menarini, and Novartis, and grants and personal fees from Bayer, Chiesi, Insmed, Pfizer, Teva, and Zambon, outside the submitted work. All other authors report no potential conflicts.\n## References\n1.\nAliberti\nS\n, \nDi Pasquale\nM\n, \nZanaboni\nAM\n, et al. \nStratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia\n. \nClin Infect Dis\n2012\n; \n54\n:\n470\n–\n8\n.\n2.\nAliberti\nS\n, \nCilloniz\nC\n, \nChalmers\nJD\n, et al. \nMultidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective\n. \nThorax\n2013\n; \n68\n:\n997\n–\n9\n.\n3.\nShindo\nY\n, \nIto\nR\n, \nKobayashi\nD\n, et al. \nRisk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia\n. \nAm J Respir Crit Care Med\n2013\n; \n188\n:\n985\n–\n95\n.\n4.\nMusher\nDM\n, \nThorner\nAR\n. \nCommunity-acquired pneumonia\n. \nN Engl J Med\n2014\n; \n371\n:\n1619\n–\n28\n.\n5.\nMandell\nLA\n, \nWunderink\nRG\n, \nAnzueto\nA\n, et al. ; \nInfectious Diseases Society of America; American Thoracic Society\n. \nInfectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults\n. \nClin Infect Dis\n2007\n; \n44\n(\nsuppl 2\n):\nS27\n–\n72\n.\n6.\nLim\nWS\n, \nBaudouin\nSV\n, \nGeorge\nRC\n, et al. \nBTS guidelines for the management of community acquired pneumonia in adults\n. \nThorax\n2009\n; \n64\n(\nsuppl III\n):\niii1\n–\n55\n.\n7.\nWoodhead\nM\n, \nBlasi\nF\n, \nEwig\nS\n, et al. ; \nJoint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases\n. \nGuidelines for the management of adult lower respiratory tract infections—full version\n. \nClin Microbiol Infect\n2011\n; \n17(suppl 6)\n:\nE1\n–\n59\n.\n8.\nFurman\nCD\n, \nRayner\nAV\n, \nTobin\nEP\n. \nPneumonia in older residents of long-term care facilities\n. \nAm Fam Physician\n2004\n; \n70\n:\n1495\n–\n500\n.\n9.\nCillóniz\nC\n, \nPolverino\nE\n, \nEwig\nS\n, et al. \nImpact of age and comorbidity on cause and outcome in community-acquired pneumonia\n. \nChest\n2013\n; \n144\n:\n999\n–\n1007\n.\n10.\nAliberti\nS\n, \nReyes\nLF\n, \nFaverio\nP\n, et al. ; \nGLIMP investigators\n. \nGlobal Initiative for Meticillin-Resistant _Staphylococcus aureus_ Pneumonia (GLIMP): an international, observational cohort study\n. \nLancet Infect Dis\n2016\n; \n16\n:\n1364\n–\n76\n.\n11.\nMagiorakos\nAP\n, \nSrinivasan\nA\n, \nCarey\nRB\n, et al. \nMultidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance\n. \nClin Microbiol Infect\n2012\n; \n18\n:\n268\n–\n81\n.\n12.\nWan\nQJ\n, \nHu\nHF\n, \nHe\nYC\n, et al. \nSevere pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy\n. \nKaohsiung J Med Sci\n2015\n; \n31\n:\n42\n–\n6\n.\n13.\nLi\nF\n, \nJin\nHZ\n, \nSu\nF\n, \nJia\nL\n, \nSun\nQN\n. \nPneumocystis pneumonia in patients with immunobullous dermatoses\n. \nInt J Dermatol\n2011\n; \n50\n:\n1144\n–\n9\n.\n14.\nGruson\nD\n, \nVargas\nF\n, \nHilbert\nG\n, et al. \nPredictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia\n. \nIntensive Care Med\n2004\n; \n30\n:\n965\n–\n71\n.\n15.\nGarcia\nJB\n, \nLei\nX\n, \nWierda\nW\n, et al. \nPneumonia during remission induction chemotherapy in patients with acute leukemia\n. \nAnn Am Thorac Soc\n2013\n; \n10\n:\n432\n–\n40\n.\n16.\nLee\nJO\n, \nKim\nDY\n, \nLim\nJH\n, et al. \nRisk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients\n. \nLung Cancer\n2008\n; \n62\n:\n381\n–\n4\n.\n17.\nLim\nKH\n, \nYoon\nHI\n, \nKang\nYA\n, et al. \nSevere pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab\n. \nKorean J Intern Med\n2010\n; \n25\n:\n86\n–\n92\n.\n18.\nWaks\nAG\n, \nTolaney\nSM\n, \nGalar\nA\n, et al. \n_Pneumocystis jiroveci_ pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors\n. \nBreast Cancer Res Treat\n2015\n; \n154\n:\n359\n–\n67\n.\n19.\nKim\nT\n, \nChoi\nSH\n, \nKim\nSH\n, et al. \nPoint prevalence of _Pneumocystis_ pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy\n. \nAnn Hematol\n2013\n; \n92\n:\n231\n–\n8\n.\n20.\nAliberti\nS\n, \nMyers\nJA\n, \nPeyrani\nP\n, et al. \nThe role of neutropenia on outcomes of cancer patients with community-acquired pneumonia\n. \nEur Respir J\n2009\n; \n33\n:\n142\n–\n7\n.\n21.\nSogaard\nOS\n, \nLohse\nN\n, \nGerstoft\nJ\n, et al. \nHospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study\n. \nClin Infect Dis\n2008\n; \n47\n:\n1345\n–\n53\n.\n22.\nKuehnhardt\nD\n, \nHannemann\nM\n, \nSchmidt\nB\n, \nHeider\nU\n, \nPossinger\nK\n, \nEucker\nJ\n. \nTherapeutic implication of BAL in patients with neutropenia\n. \nAnn Hematol\n2009\n; \n88\n:\n1249\n–\n56\n.\n23.\nMaschmeyer\nG\n, \nBeinert\nT\n, \nBuchheidt\nD\n, et al. \nDiagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the Infectious Diseases Working Party of the German Society of Haematology and Oncology\n. \nEur J Cancer\n2009\n; \n45\n:\n2462\n–\n72\n.\n24.\nAlanio\nA\n, \nHauser\nPM\n, \nLagrou\nK\n, et al. ; \n5th European Conference on Infections in Leukemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN)\n. \nECIL guidelines for the diagnosis of _Pneumocystis jirovecii_ pneumonia in patients with haematological malignancies and stem cell transplant recipients\n. \nJ Antimicrob Chemother\n2016\n; \n71\n:\n2386\n–\n96\n.\n25.\nFreifeld\nAG\n, \nBow\nEJ\n, \nSepkowitz\nKA\n, et al. ; \nInfectious Diseases Society of America\n. \nClinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America\n. \nClin Infect Dis\n2011\n; \n52\n:\ne56\n–\n93\n.\n26.\nChemaly\nRF\n, \nShah\nDP\n, \nBoeckh\nMJ\n. \nManagement of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies\n. \nClin Infect Dis\n2014\n; \n59\n(\nsuppl 5\n):\nS344\n–\n51\n.\n27.\nBuchacz\nK\n, \nLau\nB\n, \nJing\nY\n, et al. ; \nNorth American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA\n. \nIncidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010\n. \nJ Infect Dis\n2016\n; \n214\n:\n862\n–\n72\n.\n28.\nMadeddu\nG\n, \nPorqueddu\nEM\n, \nCambosu\nF\n, et al. \nBacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era\n. \nInfection\n2008\n; \n36\n:\n231\n–\n6\n.\n29.\nPark\nDR\n, \nSherbin\nVL\n, \nGoodman\nMS\n, et al. ; \nHarborview CAP Study Group\n. \nThe etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness\n. \nJ Infect Dis\n2001\n; \n184\n:\n268\n–\n77\n.\n30.\nTorres\nHA\n, \nBodey\nGP\n, \nRolston\nKV\n, \nKantarjian\nHM\n, \nRaad\nII\n, \nKontoyiannis\nDP\n. \nInfections in patients with aplastic anemia: experience at a tertiary care cancer center\n. \nCancer\n2003\n; \n98\n:\n86\n–\n93\n.\n31.\nGil-Prieto\nR\n, \nPascual-Garcia\nR\n, \nWalter\nS\n, \nÁlvaro-Meca\nA\n, \nGil-De-Miguel\nÁ\n. \nRisk of hospitalization due to pneumococcal disease in adults in Spain: the CORIENNE study\n. \nHum Vaccin Immunother\n2016\n; \n12\n:\n1900\n–\n5\n.\n32.\nPutot\nA\n, \nTetu\nJ\n, \nPerrin\nS\n, et al. \nImpact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients\n. \nEur J Clin Microbiol Infect Dis\n2016\n; \n35\n:\n489\n–\n95\n.\n33.\nPolverino\nE\n, \nDambrava\nP\n, \nCillóniz\nC\n, et al. \nNursing home-acquired pneumonia: a 10 year single-centre experience\n. \nThorax\n2010\n; \n65\n:\n354\n–\n9\n.\n34.\nKohli\nR\n, \nLo\nY\n, \nHomel\nP\n, et al. ; \nHER Study Group\n. \nBacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study\n. \nClin Infect Dis\n2006\n; \n43\n:\n90\n–\n8\n.\n35.\nBenito\nN\n, \nRañó\nA\n, \nMoreno\nA\n, et al. \nPulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain\n. \nJ Acquir Immune Defic Syndr\n2001\n; \n27\n:\n35\n–\n43\n.\n36.\nMori\nH\n, \nOhno\nY\n, \nIto\nF\n, et al. \nPolymerase chain reaction positivity of _Pneumocystis jirovecii_ during primary lung cancer treatment\n. \nJpn J Clin Oncol\n2010\n; \n40\n:\n658\n–\n62\n.\n37.\nBoersma\nWG\n, \nErjavec\nZ\n, \nvan der Werf\nTS\n, \nde Vries-Hosper\nHG\n, \nGouw\nAS\n, \nManson\nWL\n. \nBronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL\n. \nRespir Med\n2007\n; \n101\n:\n317\n–\n25\n.\n38.\nMikulska\nM\n, \nDel Bono\nV\n, \nGandolfo\nN\n, et al. \nEpidemiology of viral respiratory tract infections in an outpatient haematology facility\n. \nAnn Hematol\n2014\n; \n93\n:\n669\n–\n76\n.\n39.\nBeaird\nOE\n, \nFreifeld\nA\n, \nIson\nMG\n, et al. \nCurrent practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative\n. \nTranspl Infect Dis\n2016\n; \n18\n:\n210\n–\n5\n.\n40.\nPoonyagariyagorn\nHK\n, \nGershman\nA\n, \nAvery\nR\n, et al. \nChallenges in the diagnosis and management of Nocardia infections in lung transplant recipients\n. \nTranspl Infect Dis\n2008\n; \n10\n:\n403\n–\n8\n.\n41.\nTavadze\nM\n, \nRybicki\nL\n, \nMossad\nS\n, et al. \nRisk factors for vancomycin-resistant _Enterococcus_ bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation\n. \nBone Marrow Transplant\n2014\n; \n49\n:\n1310\n–\n6\n.\n42.\nBock\nAM\n, \nCao\nQ\n, \nFerrieri\nP\n, \nYoung\nJA\n, \nWeisdorf\nDJ\n. \nBacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance\n. \nBiol Blood Marrow Transplant\n2013\n; \n19\n:\n102\n–\n8\n.\n43.\nHerbers\nAH\n, \nde Haan\nAF\n, \nvan der Velden\nWJ\n, \nDonnelly\nJP\n, \nBlijlevens\nNM\n. \nMucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients\n. \nTranspl Infect Dis\n2014\n; \n16\n:\n279\n–\n85\n.\n44.\nWu\nSW\n, \nLiu\nKS\n, \nLin\nCK\n, et al. \nCommunity-acquired urinary tract infection in kidney transplantation: risk factors for bacteremia and recurrent infection\n. \nJ Formos Med Assoc\n2013\n; \n112\n:\n138\n–\n43\n.\n45.\nDaskalaki\nE\n, \nKoukoulaki\nM\n, \nBakalis\nA\n, et al. \nBlood stream infections in renal transplant recipients: a single-center study\n. \nTransplant Proc\n2014\n; \n46\n:\n3191\n–\n3\n.\n46.\nHuson\nMA\n, \nStolp\nSM\n, \nvan der Poll\nT\n, \nGrobusch\nMP\n. \nCommunity-acquired bacterial bloodstream infections in HIV-infected patients: a systematic review\n. \nClin Infect Dis\n2014\n; \n58\n:\n79\n–\n92\n.\n47.\nTaramasso\nL\n, \nTatarelli\nP\n, \nDi Biagio\nA\n. \nBloodstream infections in HIV-infected patients\n. \nVirulence\n2016\n; \n7\n:\n320\n–\n8\n.\n© The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.\nThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model>)\nTopic:\nIssue Section:\n[Articles and Commentaries](https://academic.oup.com/cid/search-results?f_TocHeadingTitleList=Articles+and+Commentaries)\n[Download all slides](https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=&PPTtype=SlideSet&ar=5078600&xsltPath=~/UI/app/XSLT&siteId=5269)\n## Supplementary data\n- docx file\nAdvertisement\n### Citations\n### Views\n18,086\n### Altmetric\n### Metrics\nTotal Views 18,086\n11,927 Pageviews\n6,159 PDF Downloads\nSince 8/1/2018\nMonth: | Total Views:  \n---|---  \nAugust 2018 | 66  \nSeptember 2018 | 28  \nOctober 2018 | 23  \nNovember 2018 | 70  \nDecember 2018 | 46  \nJanuary 2019 | 53  \nFebruary 2019 | 62  \nMarch 2019 | 31  \nApril 2019 | 408  \nMay 2019 | 355  \nJune 2019 | 182  \nJuly 2019 | 176  \nAugust 2019 | 159  \nSeptember 2019 | 111  \nOctober 2019 | 90  \nNovember 2019 | 66  \nDecember 2019 | 44  \nJanuary 2020 | 69  \nFebruary 2020 | 36  \nMarch 2020 | 223  \nApril 2020 | 208  \nMay 2020 | 140  \nJune 2020 | 179  \nJuly 2020 | 162  \nAugust 2020 | 154  \nSeptember 2020 | 217  \nOctober 2020 | 238  \nNovember 2020 | 237  \nDecember 2020 | 165  \nJanuary 2021 | 140  \nFebruary 2021 | 137  \nMarch 2021 | 236  \nApril 2021 | 239  \nMay 2021 | 239  \nJune 2021 | 172  \nJuly 2021 | 131  \nAugust 2021 | 160  \nSeptember 2021 | 205  \nOctober 2021 | 250  \nNovember 2021 | 227  \nDecember 2021 | 183  \nJanuary 2022 | 202  \nFebruary 2022 | 247  \nMarch 2022 | 301  \nApril 2022 | 242  \nMay 2022 | 240  \nJune 2022 | 161  \nJuly 2022 | 159  \nAugust 2022 | 292  \nSeptember 2022 | 404  \nOctober 2022 | 533  \nNovember 2022 | 300  \nDecember 2022 | 477  \nJanuary 2023 | 287  \nFebruary 2023 | 191  \nMarch 2023 | 310  \nApril 2023 | 395  \nMay 2023 | 248  \nJune 2023 | 198  \nJuly 2023 | 185  \nAugust 2023 | 213  \nSeptember 2023 | 248  \nOctober 2023 | 340  \nNovember 2023 | 311  \nDecember 2023 | 269  \nJanuary 2024 | 301  \nFebruary 2024 | 353  \nMarch 2024 | 372  \nApril 2024 | 323  \nMay 2024 | 341  \nJune 2024 | 275  \nJuly 2024 | 268  \nAugust 2024 | 218  \nSeptember 2024 | 253  \nOctober 2024 | 274  \nNovember 2024 | 312  \nDecember 2024 | 242  \nJanuary 2025 | 250  \nFebruary 2025 | 296  \nMarch 2025 | 396  \nApril 2025 | 228  \nMay 2025 | 228  \nJune 2025 | 86  \nCitations\nPowered by Dimensions\nWeb of Science\nAltmetrics\n**346** readers on Mendeley \n### Email alerts\n[ New journal issues ](https://academic.oup.com/cid/new-journals-alert)\n[ New journal articles ](https://academic.oup.com/cid/new-journal-articles-alert)\nActivity related to this article \n[Sign up for marketing](https://academic.oup.com/my-account/communication-preferences)\n## New journal issues alert\nTo set up an email alert, please to your personal account, or [register](https://academic.oup.com/my-account/register?siteId=5269&returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600)\n## Sign in\n### Personal account\n  * Sign in with email/username & password\n  * Get email alerts\n  * Save searches\n  * Purchase content\n  * Activate your purchase/trial code\n  * Add your ORCID iD\n\n\n[Register](https://academic.oup.com/my-account/register?siteId=5269&returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600)\n## Journal article activity alert\nTo set up an email alert, please to your personal account, or [register](https://academic.oup.com/my-account/register?siteId=5269&returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600)\n## Sign in\n### Personal account\n  * Sign in with email/username & password\n  * Get email alerts\n  * Save searches\n  * Purchase content\n  * Activate your purchase/trial code\n  * Add your ORCID iD\n\n\n[Register](https://academic.oup.com/my-account/register?siteId=5269&returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600)\nClose Modal\n### More on this topic\n[Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods](https://academic.oup.com/cid/article/50/2/202/328880)\n[Microbial Agents Associated with Pneumonia in Children from Uruguay](https://academic.oup.com/cid/article/12/Supplement_8/S915/296667)\n[In the Literature](https://academic.oup.com/cid/article/59/9/iii/419445)\n[Comparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study](https://academic.oup.com/cid/advance-article/7985365)\n### Related articles in PubMed\n### Citing articles via\n[ Effectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial Study  ](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf302/8159933?searchresult=1)\n[ Characteristics Associated with Disseminated Gonococcal Infections vs Uncomplicated Gonorrhea: A California Case-Control Study, 2021-2022  ](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf311/8159932?searchresult=1)\n[ Non-Operative versus Neurosurgical Treatment of Brain Abscess: An Emulated Trial Nested within a Nationwide, Population-Based Cohort  ](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf304/8157607?searchresult=1)\n[ Incidence of AIDS-defining Conditions among Adults with Perinatally Acquired HIV after Transition to Adult HIV Care in the United States and Canada, 2000-2022  ](https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf300/8157063?searchresult=1)\n[ State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists  ](https://academic.oup.com/cid/article/80/5/e65/8156727?searchresult=1)\nMore from Oxford Academic\n[Clinical Medicine](https://academic.oup.com/search-results?tax=AcademicSubjects/MED00160)\n[Infectious Diseases](https://academic.oup.com/search-results?tax=AcademicSubjects/MED00290)\n[Medicine and Health](https://academic.oup.com/search-results?tax=AcademicSubjects/MED00010)\n[Books](https://academic.oup.com/books)\n[Journals](https://academic.oup.com/journals)\nHaving trouble contacting the network. Please try again in a moment or two. \n[![Oxford University Press](https://oup.silverchair-cdn.com/data/Multimedia/oup-logo.svg)](http://global.oup.com/)\nAdvertisement\nAdvertisement\nclose advertisement\nAdvertisement\n  * [About Clinical Infectious Diseases](https://academic.oup.com/cid/pages/About)\n  * [Editorial Board](https://academic.oup.com/cid/pages/Editorial_Board)\n  * [Author Guidelines](https://academic.oup.com/cid/pages/General_Instructions)\n\n\n  * [Purchase](https://academic.oup.com/cid/subscribe)\n  * [Advertising and Corporate Services](https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit)\n\n\n[ ![Clinical Infectious Diseases](https://oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_f1483155260.svg) ](https://academic.oup.com/cid)\n  * Online ISSN 1537-6591\n  * Print ISSN 1058-4838\n  * Copyright © 2025 Infectious Diseases Society of America\n\n\n  * [About Oxford Academic](https://academic.oup.com/pages/about-oxford-academic)\n  * [Publish journals with us](https://academic.oup.com/pages/about-oxford-academic/publish-journals-with-us)\n  * [University press partners](https://academic.oup.com/pages/about-oxford-academic/our-university-press-partners)\n  * [What we publish](https://academic.oup.com/pages/what-we-publish)\n  * [New features](https://academic.oup.com/pages/new-features)\n\n\n  * [For authors](https://academic.oup.com/pages/for-authors)\n  * [Open access](https://academic.oup.com/pages/open-research/open-access)\n  * [Purchasing](https://academic.oup.com/pages/purchasing)\n  * [Institutional account management](https://academic.oup.com/pages/institutional-account-management)\n  * [Rights and permissions](https://academic.oup.com/pages/purchasing/rights-and-permissions)\n\n\n  * [Get help with access](https://academic.oup.com/pages/get-help-with-access)\n  * [Accessibility](https://academic.oup.com/pages/about-oxford-academic/accessibility)\n  * [Contact us](https://academic.oup.com/pages/contact-us)\n  * [Advertising](https://academic.oup.com/pages/advertising)\n  * [Media enquiries](https://academic.oup.com/pages/media-enquiries)\n\n\n  * [Oxford University Press](https://global.oup.com/)\n  * [News](https://corp.oup.com/press-office)\n  * [Oxford Languages](https://languages.oup.com/)\n\n\nOxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide\n![Oxford University Press](https://oup.silverchair-cdn.com/UI/app/svg/umbrella/oup-logo.svg)\n  * Copyright © 2025 Oxford University Press\n  * Cookie settings\n  * [Cookie policy](https://global.oup.com/cookiepolicy)\n  * [Privacy policy](https://global.oup.com/privacy)\n  * [Legal notice](https://academic.oup.com/pages/legal-notice)\n\n\n##### This Feature Is Available To Subscribers Only\n[Sign In](https://academic.oup.com/sign-in) or [Create an Account](https://academic.oup.com/my-account/register?siteId=5269&returnUrl=%2fcid%2farticle%2f68%2f9%2f1482%2f5078600)\nThis PDF is available to Subscribers Only\nView Article Abstract & Purchase Options\nFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.\nManage Cookies\nWhen you visit web sites, they may store or retrieve data in your web browser. This storage is often necessary for basic functionality of the web site or the storage may be used for the purposes of marketing, analytics, and personalization of the web site such as storing your preferences. \nPowered by \nSave \nOxford University Press uses cookies to enhance your experience on our website. By selecting ‘accept all’ you are agreeing to our use of cookies. You can change your cookie settings at any time. More information can be found in our [Cookie Policy](https://global.oup.com/cookiepolicy/?cc=gb). \nReject and manage  Deny all  Accept all \n"
        },
        "text_content": "Skip to Main Content Advertisement Journals Books Navbar Search Filter Clinical Infectious Diseases This issue IDSA Journals Infectious Diseases Books Journals Oxford Academic Mobile Enter search term Issues Advance articles Editor's Choice Supplement Archive Cover Archive IDSA Guidelines IDSA Journals The Journal of Infectious Diseases Open Forum Infectious Diseases Clinical Dilemmas in ID Photo Quizzes State-of-the-Art Reviews Voices of ID IDSA Content Collections Author Guidelines Open Access Why Publish IDSA Journals Calls for Papers Purchase Advertising and Corporate Services Advertising Mediakit Reprints and ePrints Sponsored Supplements Branded Books About Clinical Infectious Diseases IDSA COI Policy Editorial Board Alerts Self-Archiving Policy For Reviewers For Press Offices Journals on Oxford Academic Books on Oxford Academic IDSA Journals Issues Advance articles Editor's Choice Supplement Archive Cover Archive IDSA Guidelines IDSA Journals The Journal of Infectious Diseases Open Forum Infectious Diseases Clinical Dilemmas in ID Photo Quizzes State-of-the-Art Reviews Voices of ID IDSA Content Collections Author Guidelines Open Access Why Publish IDSA Journals Calls for Papers Purchase Advertising and Corporate Services Advertising Mediakit Reprints and ePrints Sponsored Supplements Branded Books About Clinical Infectious Diseases IDSA COI Policy Editorial Board Alerts Self-Archiving Policy For Reviewers For Press Offices Navbar Search Filter Clinical Infectious Diseases This issue IDSA Journals Infectious Diseases Books Journals Oxford Academic Enter search term Advanced Search Article Navigation Close mobile search navigation Article Navigation Volume 68 Issue 9 1 May 2019 Article Contents Abstract MATERIALS AND METHODS RESULTS DISCUSSION Supplementary Data Notes References Supplementary data &lt; Previous Next &gt; Article Navigation Article Navigation Journal Article Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients Free , Marta Francesca Di Pasquale Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan Search for other works by this author on: Oxford Academic , Giovanni Sotgiu Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari Search for other works by this author on: Oxford Academic , Andrea Gramegna Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan Search for other works by this author on: Oxford Academic , Dejan Radovanovic Department of Biomedical and Clinical Sciences (DIBIC), University of Milan, Pulmonary Unit, Ospedale L. Sacco, ASST Fatebenfratelli-Sacco Search for other works by this author on: Oxford Academic , Silvia Terraneo Respiratory Unit, San Paolo Hospital, Department of Medical Sciences, University of Milan, Italy Search for other works by this author on: Oxford Academic , Luis F Reyes Microbiology Department, Universidad de La Sabana, Chia, Colombia Search for other works by this author on: Oxford Academic , Jan Rupp Department of Infectious Diseases and Microbiology, University Hospital Schleswig-Holstein/Campus Lübeck, Germany Search for other works by this author on: Oxford Academic , Juan González del Castillo Emergency Department, Hospital Clínico San Carlos, Universidad Complutense Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, IdISSC, Madrid, Spain Search for other works by this author on: Oxford Academic , Francesco Blasi Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan Search for other works by this author on: Oxford Academic , Stefano Aliberti Department of Pathophysiology and Transplantation, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Internal Medicine Department, Respiratory Unit and Adult Cystic Fibrosis Center, University of Milan Correspondence: S. Aliberti, Department of Pathophysiology and Transplantation, University of Milan, Internal Medicine Department, Respiratory Unit and Cystic Fibrosis Adult Center, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Via Francesco Sforza 35, 20122 Milan, Italy (). Search for other works by this author on: Oxford Academic ... Show more Marcos I Restrepo Division of Pulmonary Diseases and Critical Care Medicine, The University of Texas Health Science Center at San Antonio Search for other works by this author on: Oxford Academic Clinical Infectious Diseases , Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, Published: 23 August 2018 Received: 24 May 2018 Accepted: 20 August 2018 Published: 23 August 2018 PDF Cite Cite Marta Francesca Di Pasquale, Giovanni Sotgiu, Andrea Gramegna, Dejan Radovanovic, Silvia Terraneo, Luis F Reyes, Jan Rupp, Juan González del Castillo, Francesco Blasi, Stefano Aliberti, Marcos I Restrepo, Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients, Clinical Infectious Diseases , Volume 68, Issue 9, 1 May 2019, Pages 1482–1493, Select Format Select format .ris (Mendeley, Papers, Zotero) .enw (EndNote) .bibtex (BibTex) .txt (Medlars, RefWorks) Download citation Navbar Search Filter Clinical Infectious Diseases This issue IDSA Journals Infectious Diseases Books Journals Oxford Academic Mobile Enter search term Navbar Search Filter Clinical Infectious Diseases This issue IDSA Journals Infectious Diseases Books Journals Oxford Academic Enter search term Advanced Search Abstract Background The correct management of immunocompromised patients with pneumonia is debated. We evaluated the prevalence, risk factors, and characteristics of immunocompromised patients coming from the community with pneumonia. Methods We conducted a secondary analysis of an international, multicenter study enrolling adult patients coming from the community with pneumonia and hospitalized in 222 hospitals in 54 countries worldwide. Risk factors for immunocompromise included AIDS, aplastic anemia, asplenia, hematological cancer, chemotherapy, neutropenia, biological drug use, lung transplantation, chronic steroid use, and solid tumor. Results At least 1 risk factor for immunocompromise was recorded in 18% of the 3702 patients enrolled. The prevalences of risk factors significantly differed across continents and countries, with chronic steroid use (45%), hematological cancer (25%), and chemotherapy (22%) the most common. Among immunocompromised patients, community-acquired pneumonia (CAP) pathogens were the most frequently identified, and prevalences did not differ from those in immunocompetent patients. Risk factors for immunocompromise were independently associated with neither Pseudomonas aeruginosa nor non–community-acquired bacteria. Specific risk factors were independently associated with fungal infections (odds ratio for AIDS and hematological cancer, 15.10 and 4.65, respectively; both P = .001), mycobacterial infections (AIDS; P = .006), and viral infections other than influenza (hematological cancer, 5.49; P &lt; .001). Conclusions Our findings could be considered by clinicians in prescribing empiric antibiotic therapy for CAP in immunocompromised patients. Patients with AIDS and hematological cancer admitted with CAP may have higher prevalences of fungi, mycobacteria, and noninfluenza viruses. , , , , During initial evaluation of a patient coming from the community with pneumonia, the identification of possible risk factors for multidrug-resistant organisms or unusual pathogens is crucial []. Because a microbiological identification is found in about 30% of hospitalized patients with pneumonia coming from the community, and usually requires 24–48 hours to be available, most of patients are treated empirically []. Delay in initiation of appropriate empiric antibiotic therapy is a known risk factor for worse clinical outcomes []; therefore, it is relevant to promptly recognize patients at risk for specific pathogens, specially multidrug-resistant or atypical microbes []. The aging of the population and advancements in therapeutic protocols have led to an increase prevalence of chronic diseases as well as long-term treatments with immunosuppressive agents [, ]. Thus, among patients with pneumonia coming from the community and admitted to the hospital, the number who might not be fully immunocompetent is constantly increasing [, ]. Nevertheless, the real prevalence of immunocompromise among patients with pneumonia coming from the community is still unknown. Moreover, guidelines for community-acquired and hospital-acquired pneumonia did not address this topic—what is more, they specifically excluded patients with clinical characteristics determining immunocompromise [], and current evidence in literature is also scarce. To our knowledge, there are no studies addressing the clinical evaluation and initial empirical antibiotic coverage of patients coming from the community with pneumonia and immunocompromise. Moreover, specific risk factors to assess the causative microbiology and help clinicians choose more appropriate management for these patients have not been clearly identified. Thus, the aim of the current study was to identify the prevalence, type, microbiology, and intercorrelations between different risk factors for immunocompromise in hospitalized patients with pneumonia coming from the community. MATERIALS AND METHODS Study Design and Population This is a secondary analysis of the Global Initiative for MRSA Pneumonia (GLIMP) database []. The GLIMP study was an international, multicenter, observational, point-prevalence study of adult patients hospitalized for community-onset pneumonia in 54 countries worldwide. Patients were enrolled on a single day during the months of March, April, May, and June 2015. The methods of the GLIMP study have been published elsewhere []. The coordinating center (University of Texas Health Science Center, San Antonio) received approval from its institutional review board (No. HSC20150184E). All adult patients (aged &gt;18 years old) coming from the community and hospitalized with pneumonia during study period were included. Pneumonia was defined as the presence of a new pulmonary infiltrate on chest radiograph at the time of hospitalization, associated with ≥1 of the following criteria: (1) new or increased cough with/without sputum production and/or purulent respiratory secretions, (2) fever or hypothermia, and (3) evidence of systemic inflammation (ie, abnormal white blood cell count or increased C-reactive protein or procalcitonin level). Hospitalized patients with a diagnosis of hospital-acquired or ventilator-associated pneumonia were excluded. Data Collection Data were collected from medical records at the time of hospital admission. Data gathered included demographics; respiratory and cardiovascular comorbid conditions; immunocompromised status and other chronic medical conditions; severity of pneumonia (defined as either intensive care unit admission, use of invasive or noninvasive mechanical ventilation, or use of vasopressors/inotropes during the first 24 hours after hospital admission); and specific risk factors for resistant pathogens infection, including chronic aspiration, being bedridden, malnutrition, presence of enteric tube feeding and indwelling catheters (including central venous and urinary catheters), previous infections, chronic microbial colonization, and previous healthcare exposures. The number and type of microbiological samples obtained within 24 hours after hospital admission were also collected. Culture-positive tests, kind of sample, and antibiotic resistance patterns were also gathered, along with empiric antibiotic treatment, given within 24 hours after hospital admission. Microbiological Workup Diagnostic testing was performed according to local standard operating procedures and included collection of respiratory and blood cultures and testing for urinary antigens. Microbiological examinations and susceptibility testing were performed according to local standard protocols within the first 24 hours after hospital admission []. Multivariable logistic regression models were performed for patients who had a positive culture, to identify specific risk factors for single pathogens. Causative pathogens were stratified according to the coverage of standard therapy for community-acquired pneumonia (CAP) []. Those not covered by standard CAP therapy included the following: non–community-acquired bacteria ( Acinetobacter baumanii , Enterococcus vancomycin-resistant, Nocardia spp.), mycobacteria, fungi ( Aspergillus fumigatus, Coccidioides, Criptococcus , Pneumocystis jirovecii ), and viruses other than influenza []. Those covered by standard CAP therapy included Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus , methicillin-sensitive S. aureus , Enterobacter spp., Enterococcus spp., Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae , Moraxella catarrhalis, Proteus mirabilis, Serratia marcescens, Streptococcus pneumoniae, Chlamydia pneumoniae, Mycoplasma pneumoniae, Legionella pneumophilia, anaerobes bacteria, and influenza viruses. Atypical pathogens included C. pneumoniae, M. pneumoniae, and L. pneumophilia. CAP therapy was defined as β-lactams (ceftriaxone, ampicillin-sulbactam, amoxicillin-clavulanate, cefepime, ceftazidime, piperacillin-tazobactam) plus macrolide, or fluoroquinolones alone, and, eventually, in association with vancomycin, linezolid, or oseltamivir []. Definition of Immunocompromised and Study Groups Immunocompromise was defined as the presence of ≥1 of the following risk factors: (1) AIDS, defined either as human immunodeficiency virus infection with CD4 + lymphocyte count &lt;200/µL or by the occurrence of AIDS-defining conditions; (2) aplastic anemia; (3) asplenia; (4) hematological cancer, defined as lymphoma, acute or chronic leukemia, or multiple myeloma; (5) chemotherapy during the last 3 months; (6) neutropenia, defined as a neutrophil count &lt;500/dL at complete blood cell count; (7) biological drug use (including trastuzumab and therapies for autoimmune diseases, eg, anti–tumor necrosis factor α, prescribed during ≥6 months before hospital admission); (8) lung transplantation; (9) chronic steroid use (&gt;10 mg/d of prednisone or equivalent ≥3 months before hospital admission); (10) lung cancer with either neutropenia or chemotherapy; (11) other solid tumor with either neutropenia or chemotherapy; (12) other immunocompromise (any immunocompromised state, including congenital/genetic immunocompromise and immunosuppressive therapy due to hematological cancer/solid organ transplantation other than lung). Two study groups were identified: those with versus those without 1 risk factor for immunocompromise. Statistical Analysis Categorical variables, expressed as counts (percentages), were compared using the χ 2 test. Continuous variables were compared using the unpaired Student t test or the Mann-Whitney test, when appropriate. Statistical significance was defined as P &lt; .05. A network analysis was conducted to represent the frequencies of all immunocompromise variables and their relationships. The size of the circles (the circles visible in Figure 4 [network analysis], each representing a single risk factor for immunocompromise) represents both prevalence of the risk factor and strength of association with other variables. The predictive value of each variable was categorized by quartiles and analyzed using a univariate regression logistic analysis. A multivariable model was obtained using a Cox regression analysis to identify independent predictors of specific pathogens, using an entry level of P value ≤0.05 and a removal level of P value ≥0.10. Hazard ratios and adjusted analyses were obtained. All statistical analyses were performed with IBM SPSS software (version 22, Statistics for Mac; version 22.0, IBM Crop), and Stata 13 software (StataCorp). RESULTS Prevalence of Risk Factors for Immunocompromise Among 3702 patients enrolled in the GLIMP database, ≥1 risk factor for immunocompromise was identified in 652 (17.6%). The prevalences of patients with pneumonia coming from the community and with ≥1 risk factor for immunocompromise differed among continents and countries, as depicted in and . The prevalence of immunocompromise was significantly higher in both North and South America than in the rest of the world (24.0% vs 16.5 [ P &lt; .001] and 24.8% vs 17.2 [ P = .006], respectively) (). Figure 1. Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, &lt;5%, 5%–10%, 11%–20%, 21%–30%, or &gt;30% of total cases. Open in new tab Download slide The prevalence of each risk factor for immunocompromise is depicted in , with chronic steroid use (45.0%), hematological cancer (25.0%), and chemotherapy (22.0%) being the most frequent ones. A total of 312 patients (8.4%) had &gt;1 risk factor for immunocompromise (). Figure 2. Prevalence of each single risk factor for immunocompromise. Open in new tab Download slide Figure 3. Prevalence of the number of risk factors present simultaneously in a single patient. Open in new tab Download slide Network Analysis Among Risk Factors for Immunocompromise The results of the network analysis of all risk factors for immunocompromise are depicted in . Relationships were identified between chemotherapy and solid tumor other than lung cancer, hematological cancer, and chronic steroid use, and between other immunocompromise and chronic steroid use. Figure 4. Network analysis between risk factors for immunocompromise. Open in new tab Download slide Clinical and Microbiological Characteristics of Patients With Immunocompromise Clinical features and disease severity of immunocompetent versus immunocompromised patients are shown in and . Immunocompromised patients were significantly younger and malnourished, had a higher frequency of comorbid conditions, previous infections, and colonization by resistant pathogens, and had more frequent contacts with the healthcare system. The prevalences of severe pneumonia did not differ among the 2 study groups. Table 1. Open in new tab Clinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised) Variable . Patients, No. (%) a . P Value . Immunocompetent (n = 3050) . Immunocompromised(n = 652) . Age, median (IQR) 69 (54–81) 65 (52–74) &lt;.001 Underweight 125 (6.5) 41 (10.5) .004 Malnutrition 243 (8.0) 80 (12.3) &lt;.001 Bedridden 355 (11.6) 60 (9.2) .04 Chronic aspiration 224 (7.3) 33 (5.1) .02 Bronchiectasis 136 (4.5) 42 (6.4) .03 Severe COPD 72 (2.4) 28 (4.3) .006 Interstitial lung disease 60 (2.0) 35 (5.4) &lt;.001 Lung transplantation 0 (0.0) 7 (1.1) &lt;.001 Tracheostomy 37 (1.2) 16 (2.5) .02 Hypertension 1401 (45.9) 254 (39.0) .001 Liver disease 103 (3.4) 37 (5.7) .005 Cirrhosis 50 (1.6) 20 (3.1) .02 Dementia 372 (12.2) 36 (5.5) &lt;.001 Enteral tube feeding 36 (1.2) 16 (2.5) .01 Chronic renal failure 315 (10.3) 85 (13.0) .04 Hemodialysis 34 (1.1) 18 (2.8) .001 ICS use 462 (15.2) 128 (19.6) .005 PPI use 777 (25.5) 251 (38.5) &lt;.001 Indwelling catheter 52 (1.7) 27 (4.1) &lt;.001 Prior mycobacteria diseases 70 (2.3) 26 (4.0) .01 Prior ESBL 39 (1.3) 16 (2.5) .02 Prior Pseudomonas 68 (2.2) 33 (5.1) &lt;.001 Severe CAP 840 (27.5) 190 (29.1) .41 Variable . Patients, No. (%) a . P Value . Immunocompetent (n = 3050) . Immunocompromised(n = 652) . Age, median (IQR) 69 (54–81) 65 (52–74) &lt;.001 Underweight 125 (6.5) 41 (10.5) .004 Malnutrition 243 (8.0) 80 (12.3) &lt;.001 Bedridden 355 (11.6) 60 (9.2) .04 Chronic aspiration 224 (7.3) 33 (5.1) .02 Bronchiectasis 136 (4.5) 42 (6.4) .03 Severe COPD 72 (2.4) 28 (4.3) .006 Interstitial lung disease 60 (2.0) 35 (5.4) &lt;.001 Lung transplantation 0 (0.0) 7 (1.1) &lt;.001 Tracheostomy 37 (1.2) 16 (2.5) .02 Hypertension 1401 (45.9) 254 (39.0) .001 Liver disease 103 (3.4) 37 (5.7) .005 Cirrhosis 50 (1.6) 20 (3.1) .02 Dementia 372 (12.2) 36 (5.5) &lt;.001 Enteral tube feeding 36 (1.2) 16 (2.5) .01 Chronic renal failure 315 (10.3) 85 (13.0) .04 Hemodialysis 34 (1.1) 18 (2.8) .001 ICS use 462 (15.2) 128 (19.6) .005 PPI use 777 (25.5) 251 (38.5) &lt;.001 Indwelling catheter 52 (1.7) 27 (4.1) &lt;.001 Prior mycobacteria diseases 70 (2.3) 26 (4.0) .01 Prior ESBL 39 (1.3) 16 (2.5) .02 Prior Pseudomonas 68 (2.2) 33 (5.1) &lt;.001 Severe CAP 840 (27.5) 190 (29.1) .41 Abbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors. a Data represent No. (%) unless otherwise specified. Table 1. Open in new tab Clinical and Severity Characteristics of the 2 Study Groups (Immunocompetent vs Immunocompromised) Variable . Patients, No. (%) a . P Value . Immunocompetent (n = 3050) . Immunocompromised(n = 652) . Age, median (IQR) 69 (54–81) 65 (52–74) &lt;.001 Underweight 125 (6.5) 41 (10.5) .004 Malnutrition 243 (8.0) 80 (12.3) &lt;.001 Bedridden 355 (11.6) 60 (9.2) .04 Chronic aspiration 224 (7.3) 33 (5.1) .02 Bronchiectasis 136 (4.5) 42 (6.4) .03 Severe COPD 72 (2.4) 28 (4.3) .006 Interstitial lung disease 60 (2.0) 35 (5.4) &lt;.001 Lung transplantation 0 (0.0) 7 (1.1) &lt;.001 Tracheostomy 37 (1.2) 16 (2.5) .02 Hypertension 1401 (45.9) 254 (39.0) .001 Liver disease 103 (3.4) 37 (5.7) .005 Cirrhosis 50 (1.6) 20 (3.1) .02 Dementia 372 (12.2) 36 (5.5) &lt;.001 Enteral tube feeding 36 (1.2) 16 (2.5) .01 Chronic renal failure 315 (10.3) 85 (13.0) .04 Hemodialysis 34 (1.1) 18 (2.8) .001 ICS use 462 (15.2) 128 (19.6) .005 PPI use 777 (25.5) 251 (38.5) &lt;.001 Indwelling catheter 52 (1.7) 27 (4.1) &lt;.001 Prior mycobacteria diseases 70 (2.3) 26 (4.0) .01 Prior ESBL 39 (1.3) 16 (2.5) .02 Prior Pseudomonas 68 (2.2) 33 (5.1) &lt;.001 Severe CAP 840 (27.5) 190 (29.1) .41 Variable . Patients, No. (%) a . P Value . Immunocompetent (n = 3050) . Immunocompromised(n = 652) . Age, median (IQR) 69 (54–81) 65 (52–74) &lt;.001 Underweight 125 (6.5) 41 (10.5) .004 Malnutrition 243 (8.0) 80 (12.3) &lt;.001 Bedridden 355 (11.6) 60 (9.2) .04 Chronic aspiration 224 (7.3) 33 (5.1) .02 Bronchiectasis 136 (4.5) 42 (6.4) .03 Severe COPD 72 (2.4) 28 (4.3) .006 Interstitial lung disease 60 (2.0) 35 (5.4) &lt;.001 Lung transplantation 0 (0.0) 7 (1.1) &lt;.001 Tracheostomy 37 (1.2) 16 (2.5) .02 Hypertension 1401 (45.9) 254 (39.0) .001 Liver disease 103 (3.4) 37 (5.7) .005 Cirrhosis 50 (1.6) 20 (3.1) .02 Dementia 372 (12.2) 36 (5.5) &lt;.001 Enteral tube feeding 36 (1.2) 16 (2.5) .01 Chronic renal failure 315 (10.3) 85 (13.0) .04 Hemodialysis 34 (1.1) 18 (2.8) .001 ICS use 462 (15.2) 128 (19.6) .005 PPI use 777 (25.5) 251 (38.5) &lt;.001 Indwelling catheter 52 (1.7) 27 (4.1) &lt;.001 Prior mycobacteria diseases 70 (2.3) 26 (4.0) .01 Prior ESBL 39 (1.3) 16 (2.5) .02 Prior Pseudomonas 68 (2.2) 33 (5.1) &lt;.001 Severe CAP 840 (27.5) 190 (29.1) .41 Abbreviations: CAP, community-acquired pneumonia; COPD, chronic obstructive pulmonary disease; ESBL, extended-spectrum β-lactamase; ICS, inhaled corticosteroids; IQR, interquartile range; PPI, proton pump inhibitors. a Data represent No. (%) unless otherwise specified. Microbiological testing was performed in 91.0% (596 of 652) of immunocompromised and 86.0% (2626 of 3050) of immunocompetent patients ( P &lt; .001). Bacteremia was found in 6.0% (36 of 596) of immunocompromised and 5.5% (145 of 2626; P = .62) of immunocompetent patients. At least 1 positive culture was obtained in 40.0% (238 of 596) immunocompromised and 36.0% (935 of 2626) immunocompetent patients ( P = .047). Microbiological findings are provided in and . Among pathogens covered by standard therapy, P. aeruginosa was more prevalent in immunocompromised patients (35 [5.9%] vs 98 [3.7%] patients; P &lt; .02). Among pathogens not usually covered by standard therapy, immunocompromised patients were more likely to be infected by Nocardia spp. (4 [0.7%] vs 0 [0%] patients; P &lt; .001), nontuberculous mycobacteria (NTM) (5 [0.8%] vs 2 [0.1%]; P &lt; .002), A. fumigatus (8 [1.3%] vs 10 [0.4%]; P &lt; .01), P. jirovecii (12 [2.0%] vs 5 [0.2%]; P &lt; .02), and viruses, such as coronavirus (3 [0.5%] vs 3 [0.1%]; P &lt; .047), and respiratory syncytial virus (6 [1.0%] vs 7 [0.3%]; P &lt; .03). Table 2. Open in new tab Pathogens in the 2 Study Groups Pathogen . Patients, No. (%) . P Value . Immunocompetent (n = 2626) . Immunocompromised (n = 596) . Pathogens covered by CAP therapy Streptococcus pneumoniae 218 (8.3) 50 (8.4) &gt;.99 Atypical 50 (1.9) 13 (2.2) .78 Legionella 21 (0.8) 10 (1.7) .08 MRSA 83 (3.2) 12 (2.0) .17 MSSA 73 (2.8) 20 (3.4) .53 Pseudomonas aeruginosa 98 (3.7) 35 (5.9) .02 Haemophilus influenzae 65 (2.5) 10 (1.7) .31 Klebsiella pneumoniae 89 (3.4) 22 (3.7) .81 Influenza virus 126 (4.8) 28 (4.7) &gt;.99 Pathogens not covered by CAP therapy Non-CAP bacteria Acinetobacter baumanii 33 (1.3) 7 (1.2) &gt;.99 Nocardia spp. 0 (0.0) 4 (0.7) &lt;.001 Mycobacteria Mycobacterium tuberculosis 21 (0.8) 5 (0.8) &gt;.99 NTM 2 (0.1) 5 (0.8) .002 Fungi Aspergillus fumigatus 10 (0.4) 8 (1.3) .01 Actinomyces 2 (0.1) 0 (0.0) &gt;.99 Cryptococcus 3 (0.1) 0 (0.0) .94 Pneumocystis jirovecii 5 (0.2) 13 (2.2) &lt;.001 Viruses Adenovirus 5 (0.2) 0 (0.0) .62 Coronavirus 3 (0.1) 3 (0.5) .047 Metapneumovirus 3 (0.1) 2 (0.3) .51 RSV 7 (0.3) 6 (1.0) .03 MDR pathogens 231 (8.8) 54 (9.0) .54 Pathogen . Patients, No. (%) . P Value . Immunocompetent (n = 2626) . Immunocompromised (n = 596) . Pathogens covered by CAP therapy Streptococcus pneumoniae 218 (8.3) 50 (8.4) &gt;.99 Atypical 50 (1.9) 13 (2.2) .78 Legionella 21 (0.8) 10 (1.7) .08 MRSA 83 (3.2) 12 (2.0) .17 MSSA 73 (2.8) 20 (3.4) .53 Pseudomonas aeruginosa 98 (3.7) 35 (5.9) .02 Haemophilus influenzae 65 (2.5) 10 (1.7) .31 Klebsiella pneumoniae 89 (3.4) 22 (3.7) .81 Influenza virus 126 (4.8) 28 (4.7) &gt;.99 Pathogens not covered by CAP therapy Non-CAP bacteria Acinetobacter baumanii 33 (1.3) 7 (1.2) &gt;.99 Nocardia spp. 0 (0.0) 4 (0.7) &lt;.001 Mycobacteria Mycobacterium tuberculosis 21 (0.8) 5 (0.8) &gt;.99 NTM 2 (0.1) 5 (0.8) .002 Fungi Aspergillus fumigatus 10 (0.4) 8 (1.3) .01 Actinomyces 2 (0.1) 0 (0.0) &gt;.99 Cryptococcus 3 (0.1) 0 (0.0) .94 Pneumocystis jirovecii 5 (0.2) 13 (2.2) &lt;.001 Viruses Adenovirus 5 (0.2) 0 (0.0) .62 Coronavirus 3 (0.1) 3 (0.5) .047 Metapneumovirus 3 (0.1) 2 (0.3) .51 RSV 7 (0.3) 6 (1.0) .03 MDR pathogens 231 (8.8) 54 (9.0) .54 Abbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant Staphylococcus aureus ; MSSA, methicillin-sensitive S. aureus ; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus. Table 2. Open in new tab Pathogens in the 2 Study Groups Pathogen . Patients, No. (%) . P Value . Immunocompetent (n = 2626) . Immunocompromised (n = 596) . Pathogens covered by CAP therapy Streptococcus pneumoniae 218 (8.3) 50 (8.4) &gt;.99 Atypical 50 (1.9) 13 (2.2) .78 Legionella 21 (0.8) 10 (1.7) .08 MRSA 83 (3.2) 12 (2.0) .17 MSSA 73 (2.8) 20 (3.4) .53 Pseudomonas aeruginosa 98 (3.7) 35 (5.9) .02 Haemophilus influenzae 65 (2.5) 10 (1.7) .31 Klebsiella pneumoniae 89 (3.4) 22 (3.7) .81 Influenza virus 126 (4.8) 28 (4.7) &gt;.99 Pathogens not covered by CAP therapy Non-CAP bacteria Acinetobacter baumanii 33 (1.3) 7 (1.2) &gt;.99 Nocardia spp. 0 (0.0) 4 (0.7) &lt;.001 Mycobacteria Mycobacterium tuberculosis 21 (0.8) 5 (0.8) &gt;.99 NTM 2 (0.1) 5 (0.8) .002 Fungi Aspergillus fumigatus 10 (0.4) 8 (1.3) .01 Actinomyces 2 (0.1) 0 (0.0) &gt;.99 Cryptococcus 3 (0.1) 0 (0.0) .94 Pneumocystis jirovecii 5 (0.2) 13 (2.2) &lt;.001 Viruses Adenovirus 5 (0.2) 0 (0.0) .62 Coronavirus 3 (0.1) 3 (0.5) .047 Metapneumovirus 3 (0.1) 2 (0.3) .51 RSV 7 (0.3) 6 (1.0) .03 MDR pathogens 231 (8.8) 54 (9.0) .54 Pathogen . Patients, No. (%) . P Value . Immunocompetent (n = 2626) . Immunocompromised (n = 596) . Pathogens covered by CAP therapy Streptococcus pneumoniae 218 (8.3) 50 (8.4) &gt;.99 Atypical 50 (1.9) 13 (2.2) .78 Legionella 21 (0.8) 10 (1.7) .08 MRSA 83 (3.2) 12 (2.0) .17 MSSA 73 (2.8) 20 (3.4) .53 Pseudomonas aeruginosa 98 (3.7) 35 (5.9) .02 Haemophilus influenzae 65 (2.5) 10 (1.7) .31 Klebsiella pneumoniae 89 (3.4) 22 (3.7) .81 Influenza virus 126 (4.8) 28 (4.7) &gt;.99 Pathogens not covered by CAP therapy Non-CAP bacteria Acinetobacter baumanii 33 (1.3) 7 (1.2) &gt;.99 Nocardia spp. 0 (0.0) 4 (0.7) &lt;.001 Mycobacteria Mycobacterium tuberculosis 21 (0.8) 5 (0.8) &gt;.99 NTM 2 (0.1) 5 (0.8) .002 Fungi Aspergillus fumigatus 10 (0.4) 8 (1.3) .01 Actinomyces 2 (0.1) 0 (0.0) &gt;.99 Cryptococcus 3 (0.1) 0 (0.0) .94 Pneumocystis jirovecii 5 (0.2) 13 (2.2) &lt;.001 Viruses Adenovirus 5 (0.2) 0 (0.0) .62 Coronavirus 3 (0.1) 3 (0.5) .047 Metapneumovirus 3 (0.1) 2 (0.3) .51 RSV 7 (0.3) 6 (1.0) .03 MDR pathogens 231 (8.8) 54 (9.0) .54 Abbreviations: CAP, community-acquired pneumonia; MDR multidrug-resistant; MRSA methicillin-resistant Staphylococcus aureus ; MSSA, methicillin-sensitive S. aureus ; NTM, nontuberculous mycobacteria; RSV, respiratory syncitial virus. Once adjusted for confounders, no risk factors of immunocompromise have been recognized for P. aeruginosa infection. Likewise, pathogens not covered by usual CAP therapy were found to be associated not with immunocompromise but with chronic obstructive pulmonary disease (odds ratio [OR], 1.78; 95% confidence interval [CI], 1.07–2.99; P = .03), tracheostomy (2.91; 1.01–8.38; P = .048), and severe pneumonia (2.36; 1.42–3.93; P = .001) (). Table 3. Open in new tab Multivariable Logistic Regression Analysis Variable . OR (CI 95%) . Pseudomonas aeruginosa . Non-CAP Bacteria . Fungi . Mycobacterium tuberculosis . Virus Other Than Influenza . Severe COPD 2.89 (1.34–6.22) … … … … Tracheostomy 6.95 (2.87–16.85) 2.91(1.01–8.38) … … … ICS use 1.76 (1.09–2.82) … … … … Indwelling catheter 2.49 (1.02–6.06) … … … … Prior Pseudomonas 19.20(11.71–31.50) … … … … COPD … 1.78(1.07–2.99) … … … Severe CAP … 2.36(1.42–3.93) … … 2.56(1.27–5.19) AIDS … … 15.10(6.36–35.88) … … Hematological cancer … … 4.65(1.85–11.69) … 5.49(2.20–13.70) Malnutrition … … … 5.14 (2.21–11.93) … Variable . OR (CI 95%) . Pseudomonas aeruginosa . Non-CAP Bacteria . Fungi . Mycobacterium tuberculosis . Virus Other Than Influenza . Severe COPD 2.89 (1.34–6.22) … … … … Tracheostomy 6.95 (2.87–16.85) 2.91(1.01–8.38) … … … ICS use 1.76 (1.09–2.82) … … … … Indwelling catheter 2.49 (1.02–6.06) … … … … Prior Pseudomonas 19.20(11.71–31.50) … … … … COPD … 1.78(1.07–2.99) … … … Severe CAP … 2.36(1.42–3.93) … … 2.56(1.27–5.19) AIDS … … 15.10(6.36–35.88) … … Hematological cancer … … 4.65(1.85–11.69) … 5.49(2.20–13.70) Malnutrition … … … 5.14 (2.21–11.93) … Blank cells indicate no statistical significancy. Abbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio. Table 3. Open in new tab Multivariable Logistic Regression Analysis Variable . OR (CI 95%) . Pseudomonas aeruginosa . Non-CAP Bacteria . Fungi . Mycobacterium tuberculosis . Virus Other Than Influenza . Severe COPD 2.89 (1.34–6.22) … … … … Tracheostomy 6.95 (2.87–16.85) 2.91(1.01–8.38) … … … ICS use 1.76 (1.09–2.82) … … … … Indwelling catheter 2.49 (1.02–6.06) … … … … Prior Pseudomonas 19.20(11.71–31.50) … … … … COPD … 1.78(1.07–2.99) … … … Severe CAP … 2.36(1.42–3.93) … … 2.56(1.27–5.19) AIDS … … 15.10(6.36–35.88) … … Hematological cancer … … 4.65(1.85–11.69) … 5.49(2.20–13.70) Malnutrition … … … 5.14 (2.21–11.93) … Variable . OR (CI 95%) . Pseudomonas aeruginosa . Non-CAP Bacteria . Fungi . Mycobacterium tuberculosis . Virus Other Than Influenza . Severe COPD 2.89 (1.34–6.22) … … … … Tracheostomy 6.95 (2.87–16.85) 2.91(1.01–8.38) … … … ICS use 1.76 (1.09–2.82) … … … … Indwelling catheter 2.49 (1.02–6.06) … … … … Prior Pseudomonas 19.20(11.71–31.50) … … … … COPD … 1.78(1.07–2.99) … … … Severe CAP … 2.36(1.42–3.93) … … 2.56(1.27–5.19) AIDS … … 15.10(6.36–35.88) … … Hematological cancer … … 4.65(1.85–11.69) … 5.49(2.20–13.70) Malnutrition … … … 5.14 (2.21–11.93) … Blank cells indicate no statistical significancy. Abbreviations: CAP community-acquired pneumonia; CI, confidence interval; COPD, chronic obstructive pulmonary disease; ICS, inhaled corticosteroids; OR, odds ratio. Results showed that AIDS (OR, 15.10; 95% CI, 6.36–35.88; P ≤ .001) and hematological cancer (4.65; 91.85–11.69; P = .001) were independently associated with fungal infections; hematological cancer (5.49; 2.20–13.70; P &lt; .001) and severe pneumonia (2.56; 1.27–5.19; P = .009) with infection by viruses other than influenza; and AIDS (4.41; 1.53–12.73; P = .006) and malnutrition (4.50; 2.08–9.72; P &lt; .001) with mycobacterial infections. An additional analysis was conducted on mycobacteria, including M. tuberculosis and NTM. At multivariable analysis, M. tuberculosis was independently associated with malnutrition only (OR, 5.14; 95% CI, 2.21–11.93; P &lt; .001). At univariate analysis, patients with AIDS were at higher risk for NTM (23.06; 4.39–121.12; P &lt; .001). A subanalysis was conducted among patients with chronic steroid use versus other risk factors for immunocompromise. Patients with chronic steroid use seemed to be more frequently affected by bacteria not covered by standard CAP therapy (10 [3.4%] vs 1 [0.3%] patients; P = .002), Nocardia spp. in particular (4 [0.4%] vs 0 [0.0%]; P = .03). No differences in the severity of the disease were found (see ). DISCUSSION The main findings of the present study are as follows: (1) 17.6% of patients admitted with pneumonia from the community have ≥1 risk factor for immunocompromise, with significant differences among continents and countries (ranging from 15.4% to 24.8% by continent and from 80.0% to 4.1% by country); (2) chronic steroid use is by far the most prevalent risk factor leading to immunocompromise, followed by hematological cancer and chemotherapy; (3) 1 of 2 immunocompromised patients has an overlap of ≥2 risk factors, which are also associated between one another in different ways; and (4) the 2 risk factors for immunocompromise independently associated with specific pathogens are AIDS (ie, fungal and mycobacterial infections) and hematological cancer (ie, fungal infection and viral infections other than influenza). Almost 1 in 5 hospitalized patients with CAP are not immunocompetent. Therefore, it is mandatory to provide clinicians with recommendations or guidelines for the management of hospitalized patients with pneumonia coming from the community who have risk factors for immunocompromise. Currently, there are no guidelines for assessing pneumonia in immunocompromised patients coming from the community. Randomized controlled trials (RCTs) and observational prospective studies are missing owing to the fact that, generally, studies assessing management strategies for pneumonia exclude immunocompromised patients or take into account only a single specific risk factor []. This lack of information about immunocompromise could lead to both underestimation of the real prevalence with a higher rate of treatment failure and to overestimation and overuse of wide-spectrum antibiotics. We found a 17.6% global prevalence of immunocompromise among patients coming from the community with pneumonia, with a significantly higher frequency in South and North America. This variability among continents and countries is probably attributable to different healthcare systems and rates of hospitalization of immunocompromised patients. Our analysis showed that the most frequent risk factor for immunocompromise is the chronic use of systemic steroids. Aging of the population and therapeutic advancements have favored the increased burden of chronic diseases and long-term therapies with immunosuppressive agents [, ]. In particular, steroids are the agents most frequently prescribed, for their wide spectrum of efficacy in several diseases [, , ]. Therefore, many patients presenting to the emergency room with pneumonia are receiving chronic steroid treatment. No data are available on this population group, and further studies are needed to characterize these patients and provide individualized management. Hematological cancer and chemotherapy were other leading immunocompromised factors. These findings are consistent with those in previous studies; patients recruited in observational studies include patients with solid or hematological cancer and those who underwent chemotherapy with associated neutropenia [, ]. Dedicated guidelines and recommendations are available, especially on respiratory viruses, fungi, and P. jirovecii []. Our network analysis showed that several risk factors for immunocompromise show associations, especially chemotherapy, associated with hematological cancer and solid tumor, and other immunocompromise, associated with chronic steroid use. Moreover, neutropenic patients are well represented and mainly affected also by hematological cancer or under treatment with chemotherapy. Our results suggest that patients may have &gt;1 risk factor characteristic and clinical assessment should be comprehensive, taking into consideration risk factors for immunocompromise and their associated biological mechanisms. In contrast, AIDS, lung transplantation, asplenia, and aplastic anemia seem to be less frequent at admission and to represent distinct clinical entities. Findings of previous studies seem to be in line with our results, with AIDS patients considered as a distinct patient population and with very few observational studies available on asplenia and aplastic anemia [, ] In agreement with previous reports, S. pneumoniae is the leading microorganism in both immunocompromised and immunocompetent groups [, ]. Among pathogens covered by standard CAP therapy, only P. aeruginosa was more frequently isolated in immunocompromised compared with immunocompetent patients. These findings differ from microbiological results of previous studies. Gram-positive bacteria, especially S. aureus , were more frequently identified in patients with immunocompromise of different causes [, , ]. Only Li and coauthors [] found patients with immunological disorders, treated with systemic steroids and cytotoxic agents, to have a higher incidence of infections caused by gram-negative bacteria, mainly P. aeruginosa . This similarity with our findings could be explained by the prevalence of patients exposed to chronic steroids in our cohort. Among pathogens not covered by standard CAP therapy, immunocompromised patients were more frequently infected by Nocardia spp., NTM, P. jirovecii , A. fumigatus , and viruses other than influenza. Infections by P. jirovecii and NTM are frequently identified in patients with AIDS []. P. jirovecii is also frequent in other types of immunocompromise, such as solid or hematological cancer in patients who underwent chemotherapy [, , ]. Fungal infections (eg, Candida spp. and A. fumigatus ) are highly incident in neutropenic hematological cancer patients [, ]. Viral infections other than influenza, especially respiratory syncytial virus, are more frequent in patients who underwent hematopoietic stem cell or lung transplantation [, ]. Conversely, Nocardia spp. infections are mainly described in solid organ transplant recipients []. These results, consistent with previous findings, suggest the need for a more in-depth microbiological workup, including community-acquired pathogens and microorganisms not covered by standard therapy. Surprisingly, we found that risk factors for immunocompromise were not independently associated with P. aeruginosa or non–community-acquired bacteria; in contrast, AIDS and hematological cancer are both associated with fungal, mycobacterial, and noninfluenza viral pneumonia, respectively. Empirical therapy should include P. aeruginosa coverage, which is highly prevalent in immunocompromised patients. On the contrary, particular attention should be given to fungal, mycobacterial, and viral causes should be for patients admitted with AIDS and hematological cancer []. Finally, bacteremia rates did not differ between study groups. To our knowledge, there are no studies on bacteremia and immunocompromise in general. The majority of studies have focused on bacteremia in hematopoietic stem cell transplantation, with prevalences varying from 6% to 44% depending on the type of bacteria and host-related factors []. Few studies addressed this topic in kidney transplant recipients, reporting a prevalence of bacteremia ranging from 25% to 69% [, ]. Finally, few studies have addressed HIV and bacteremia, with prevalences ranging from 10% to 25%, depending on the pathogen and grade of immunosuppression [, ]. The prevalence of bacteremia in our study was 5T–6% in both immunocompetent and immunocompromised patients. Differences in the prevalence of bacteremia are due mainly to differences between the risk factors for immunocompromise in our study (chronic steroid use, hematological cancer, and chemotherapy) and those previously reported in the literature. The current study has both limitations and strengths. First of all, to our knowledge, this is the first study showing a worldwide perspective on immunocompromise among patients coming from the community with pneumonia, with a large and diverse sample of patients enrolled across different countries in 6 continents. However, we were not able to involve many investigators from Asia and Africa, and most cases occurred in North America and Europe, thus limiting the generalizability of our findings. Another major limitation is the unfeasibility of grading the severity of immunocompromise and, therefore, stratifying patients and defining the physiopathological interaction between different risk factors, especially with regard to the use of biological drugs and chronic steroids. Furthermore, potentially important risk factors for an immunocompromised state, such as solid organ transplants other than lung, have not been specifically investigated. Finally, no outcome data have been collected, and this strongly limits our speculations as to the correct empiric antibiotic therapy for use in immunocompromised patients with CAP. In conclusion, our study offers to the scientific community a perspective on immunocompromised patients coming from the community with pneumonia. Future prospective studies on patients with specific risk factors for immunocompromise could provide practical recommendations. In particular, it will be crucial to prepare guidelines on certain prevalent population groups, such as patients exposed to chronic steroids and those with hematological cancer. Supplementary Data Supplementary materials are available at Clinical Infectious Diseases online. Consisting of data provided by the authors to benefit the reader, the posted materials are not copyedited and are the sole responsibility of the authors, so questions or comments should be addressed to the corresponding author. Notes Author contributions. M. F. D. P., G. S., S. A., and M. I. R. participated in study design, analysis of data, and writing of the manuscript and take responsibility for the integrity of the work. A. G., D. R., S. T., L. F. R., J. R., J. G. d. C., and F. B. critically reviewed the final manuscript. Acknowledgments. We thank the Asociacion Latinoamericana de Torax, European Respiratory Society, World Federation of Societies of Intensive and Critical Care Medicine, and American College of Chest Physicians for their support of this project. We also thank the following study contributors for their valuable collaboration. Argentina: Patricia Karina Aruj (Department of Internal Medicine, University Hospital Alfredo Lanari, Buenos Aires), Silvia Attorri (Hospital Luis Lago Maggiore, Mendoza), Enrique Barimboim (Hospital Central de Mendoza), Juan Pablo Caeiro and María I. Garzón (Hospital Privado Universitario, Córdoba), Victor Hugo Cambursano, A. Cazaux (Servicio de Neumologia, Hospital Rawson, Córdoba), Adrian Ceccato (Hospital Nacional Prof Alejandro Posadas), Julio Chertcoff, Florencia Lascar, and Fernando Di Tulio (Critical Care Unit and Respiratory Medicine, Buenos Aires British Hospital), Ariel Cordon Díaz (Hospital General Alvear, Ciudad, Mendoza), Lautaro de Vedia (Respiratory Intensive Care Unit, Hospital Muñiz, Buenos Aires) Maria Cristina Ganaha (Infectious Diseases Ward, Hospital Interzonal General de Agudos Vicente Lopez y Planes from General Rodriguez, Buenos Aires), Sandra Lambert (Hospital El Cruce–Alta Complejidad en Red), Gustavo Lopardo (Hospital Bernardo Houssay, Vicente López), Carlos M. Luna (Pulmonary Medicine Division, Department of Medicine, Hospital de Clínicas, Universidad de Buenos Aires), Alessio Gerardo Malberti (Hospital Nuestra Señora del Carmen), Nora Morcillo and Silvina Tartara (Hospital Zonal Especializado de Agudos y Crónicos), Antonio A. Cetrangolo (an individual who is being acknowledged for his contribution to the study), Claudia Pensotti (Infectious Diseases and Infection Control Department, Clinica Privada Monte Grande, Buenos Aires), Betiana Pereyra (Hospital San Roque, Córdoba), Pablo Gustavo Scapellato (Infectious Diseases Department, Hospital D. F. Santojanni), Juan Pablo Stagnaro (HZGA Mi Pueblo, Florencio Varela); Australia: Sonali Shah (Department of General Medicine, Austin Hospital, Heidelberg); Austria: Felix Lötsch and Florian Thalhammer (Division of Infectious Diseases and Tropical Medicine, Department of Medicine I, Medical University of Vienna); Belgium: Kurt Anseeuw (ZNA Campus Stuivenberg, Antwerp), Camille A. Francois (Anesthesia and Critical Care Department, Erasme University Hospital, Brussels), Eva Van Braeckel (Department of Respiratory Medicine, Ghent University Hospital), Jean Louis Vincent (Department of Intensive Care, Erasme University Hospital, Université Libre de Bruxelles, Brussels); Benin: Marcel Zannou Djimon, Jules Bashi and Roger Dodo (Centre Hospitalier Universitaire HKM of Cotonou); Brazil: Simone Aranha Nouér (Federal University of Rio de Janeiro); Bulgaria: Peter Chipev and Milena Encheva (Clinic of Pulmonary Diseases, Military Medical Academy, Sofia), Darina Miteva, (UMHAT St Marina, Varna), Diana Petkova (University Hospital Varna); Cameroon: Adamou Dodo Balkissou (Yaounde Jamot Hospital, Yaounde), Eric Walter Pefura Yone (Département de Médecine Interne, University of Yaounde), Bertrand Hugo Mbatchou Ngahane (Douala General Hospital); China: Ning Shen (Respiratory Medicine, Peking University Third Hospital, Beijing), Jin-fu Xu (Department of Respiratory Medicine, Shanghai Pulmonary Hospital, Tongji University); Colombia: Carlos Andres Bustamante Rico and Ricardo Buitrago (Clinica Shaio, Bogota), Fernando Jose Pereira Paternina (Las Americas Clinic, Medellin); Congo: Jean-Marie Kayembe Ntumba (Cliniques Universitaires de Kinshasa); Croatia: Vesna Vladic Carevic (Interne Medicine, Dubrovnik), Marko Jakopovic (Medical School, University of Zagreb, Department for Respiratory Diseases Jordanovac, University Hospital Centre Zagreb), Mateja Jankovic (University Hospital Center Zagreb, Department for Respiratory Diseases), Zinka Matkovic (University Hospital Dubrava, Zagreb), Ivan Mitrecic (Karlovac General Hospital); Denmark: Marie-Laure Bouchy Jacobsson (Emergency Department, North Zealand’s Hospital–Hillerød), Anette Bro Christensen (Department of Anaethesiology, Viborg Region Hospital), Uffe Christian Heitmann Bødtger (Department of Pulmonology, Naestved Hospital), Christian Niels Meyer (Department of Internal Medicine, Roskilde Hospital, Copenhagen University Hospital, Roskilde), Andreas Vestergaard Jensen, Gertrud Baunbæk-Knudsen, Pelle Trier Petersen, and Stine Andersen (Department of Lung and Infectious Diseases, Nordsjællands Hospital-Hillerød); Egypt: Ibrahim El-Said Abd El-Wahhab (Thoracic Medicine, Faculty of Medicine, Mansoura University), Nesreen Elsayed Morsy (Pulmonary, Critical Care and Sleep Medicine, Faculty of Medicine, Mansoura University), Hanaa Shafiek (Chest Diseases Department, Faculty of Medicine, Alexandria University), Eman Sobh (Chest Diseases Department, Al-Azhar University, Cairo); Ethiopia: Kedir Abdella Abdulsemed (Department of Medical Laboratory Science and Pathology, College of Health Sciences, Mycobacteriology Research Centre, Institute of Biotechnology Research, Jimma University); France: Fabrice Bertrand (Critical Care Unit, Robert Ballanger Hospital, Aulnay sous Bois), Christian Brun-Buisson (University Hospital of Henri-Mondor, Créteil), Etienne de Montmollin (Intensive Care Unit, Hôpital Delafontaine, Centre Hospitalier de Saint-Denis), Muriel Fartoukh (Unité de Réanimation Médico-Chirurgicale, Pôle Thorax Voies Aériennes, Hôpital Tenon, Groupe Hospitalier Est Parisien), Jonathan Messika (Publique-Hôpital de Paris, Service de Réanimation Médico-chirurgicale, Hôpital Louis Mourier, Colombes, and Université Paris Diderot, IAME, UMR 1137, Sorbonne Paris Cité), Pierre Tattevin (Infectious Diseases and ICU, Pontchaillou University Hospital, Rennes), Abdo Khoury (Department of Emergency Medicine and Critical Care, University of Franche–Comté, Medical Center); Gambia: Bernard Ebruke (Medical Research Council Unit, Fajara, Gambia); Germany: Michael Dreher (Department of Cardiology, Pneumology, Vascular Medicine and Intensive Care Medicine, University Hospital Aachen), Martin Kolditz (Division of Pulmonology, Medical Department I, University Hospital Carl Gustav Carus, Technische Universität Dresden), Matthias Meisinger, Klinikum Niederlausitz, Klinik für Innere Medizin und Intensivmedizin, Senftenberg), Mathias W. Pletz and Stefan Hagel (Center for Infectious Diseases and Infection Control, Jena University Hospital), Jan Rupp (Department of Infectious Diseases and Microbiology, University of Lübeck), Tom Schaberg (Zentrum für Pneumologie, Agaplesion Diakonieklinikum Rotenburg), Marc Spielmanns (Internal Medicine Department, Pulmonary Rehabilitation and Department of Health, School of Medicine, University Witten-Herdecke, St Remigius Hospital, Leverkusen) Petra Creutz and Norton Suttorp (Department of Infectious Disease and Respiratory Medicine, Charité–University Medicine, Berlin); Ghana : Beatrice Siaw-Lartey (Komfo-Anokye Teaching Hospital, Kumasi); Greece : Katerina Dimakou (5th Respiratory Medicine Department, SOTIRIA Chest Hospital, Athens), Dimosthenis Papapetrou (Medical Group of Athens, Paleo Faliro Clinic, Athens), Evdoxia Tsigou and Dimitrios Ampazis (Agioi Anargiroi Hospital, Kifissia, Athens), Evangelos Kaimakamis (Intensive Care Unit, G. Papanikolaou General Hospital of Thessaloniki); India : Mohit Bhatia (S. S. Hospital IMS BHU Varanasi), Raja Dhar (Fortis Hospitals, Kolkata), George D’Souza (Department of Pulmonary Medicine, St John’s Medical College Hospital, Bangalore), Rajiv Garg (Department of Respiratory Medicine, King George’s Medical University UP, Lucknow), Parvaiz A. Koul (Department of Internal and Pulmonary Medicine, SheriKashmir Institute of Medical Sciences, Srinagar), P. A. Mahesh and B. S. Jayaraj (Department of Pulmonary Medicine, JSS Medical College, JSS University, Mysore), Kiran Vishnu Narayan (Pulmonary Medicine, Government Medical College Kozhikode, Kerala), Hirennappa B. Udnur and Shashi Bhaskara Krishnamurthy (Columbia Asia Hospital, Hebbal, Bengaluru, Karnataka), Surya Kant (Department of Respiratory Medicine, King George’s Medical University, Chowk, Lucknow, Uttar Pradesh), Rajesh Swarnakar (Getwell Hospital and Research Institute, Dhantoli, Nagpur), Sneha Limaye and Sundeep Salvi (on behalf of the Respiratory Research Network of India from the Chest Research Foundation in Pune); Iran : Keihan Golshani (Isfahan University of Medical Sciences); Ireland : Vera M. Keatings (Letterkenny General Hospital, County Donegal), Ignacio Martin-Loeches (Multidisciplinary Intensive Care Research Organization, St James’s University Hospital, Trinity Centre for Health Sciences Dublin); Israel : Yasmin Maor (Infectious Disease Unit, affiliated with Tel Aviv University, Wolfson Medical Center, Holon), Jacob Strahilevitz (Department of Clinical Microbiology and Infectious Diseases, Hadassah-Hebrew University, Jerusalem); Italy : Salvatore Battaglia, University of Palermo, Pneumologia DiBiMIS, Palermo), Maria Carrabba (Internal Medicine Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Ca’ Granda Ospedale Maggiore Policlinico, Milano), Piero Ceriana (Pulmonary Rehabilitation, IRCCS Fondazione Maugeri, Pavia), Marco Confalonieri (Department of Pulmunology, University Hospital, Trieste), Antonella d’Arminio Monforte (Department of Health Sciences, Clinic of Infectious Disease, San Paolo Hospital, University of Milan), Bruno Del Prato (Interventional Pneumology, Hospital Antonio Cardarelli, Naples), Marino De Rosa (Unità Operativa Complessa [UOC] Pneumologia PO San Filippo Neri Azienda Sanitaria Locale Roma E Roma), Riccardo Fantini (Respiratory Diseases Clinic, Policlinico di Modena, Modena), Giuseppe Fiorentino (UOC Fisiopatologia e Riabilitazione Respiratoria Azienda Ospedaliera Ospedali dei Colli PO Monaldi), Maria Antonia Gammino (Pulmonary Medicine Unit, San Martino Hospital, Sardegna), Francesco Menzella (Department of Cardiac-Thoracic-Vascular and Intensive Care Medicine, Pneumology Unit, IRCCS–Arcispedale Santa Maria Nuova, Reggio Emilia), Giuseppe Milani (Azienda Ospedaliera Sant Anna di Como, Presidio Ospedale S. Anna Nuovo, Unità Operativa di Pneumologia, Como), Stefano Nava (Alma Mater University of Bologna, DIMES, Respiratory and Critical Care Unit Sant’Orsola Malpighi Hospital), Gerardo Palmiero (Respiratory Unit, Versilia Hospital, Lido di Camaiore, Lucca), Roberta Petrino and Barbra Gabrielli (Emergency Medicine Unit, S. Andrea Hospital, Vercelli), Paolo Rossi (Internal Medicine Department, Azienda Ospedaliero–Universitaria S. Maria della Misericordia, Udine), Claudio Sorino, Pulmonology Unit, A. O. Sant’Anna di Como), Gundi Steinhilber (Spedali Civili Brescia, U. O. Pneumologia e Fisiopatologia Respiratoria, Brescia), Alessandro Zanforlin (ULSS 18 Rovigo, Ospedale San Luca, Trecenta), Fabio Franzetti, Manuela Carugati, Manuela Morosi, and Elisa Monge (Department of Biomedical and Clinical Sciences, Division of Infectious Diseases, Luigi Sacco Hospital, Università degli Studi di Milano), Mauro Carone, (Fondazione Salvatore Maugeri, IRCCS, Cassano Murge), Vincenzo Patella (Allergology and Clinical Immunology Unit, Department of Medical Sciences, Battipaglia Hospital, Battipaglia, Salerno), Simone Scarlata (Geriatrics, Unit of Respiratory Pathophysiology and Thoracic Endoscopy, Campus Bio Medico University and Teaching Hospital, Rome), Andrea Comel, UO Pneumologia, Ospedale Pederzoli, Peschiera del Garda); Japan : Kiyoyasu Kurahashi (Yokohama City University Medical Center); Lebanon : Zeina Aoun Bacha (Medicine School, St Joseph University, Beyrouth); Mexico : Daniel Barajas Ugalde (National Institute of Respiratory Diseases), Omar Ceballos Zuñiga (Hospital General de Mexicali, Mexicali, Baja California), José F. Villegas (Hospital Universitario Monterrey); Montenegro : Milic Medenica (Hospital for Lung Diseases–Brezovik, Niksic); Netherlands : E. M. W. van de Garde (Department of Clinical Pharmacy, St Antonius Hospital, Utrecht/Nieuwegein); Nepal : Deebya Raj Mihsra (Internal Medicine, BP Koirala Institute of Health Sciences), Poojan Shrestha (Oxford University Clinical Research Unit, Patan Hospital); New Zealand : Elliott Ridgeon (Medical Research Institute of New Zealand); Nigeria : Babatunde Ishola Awokola (Department of Family Medicine and Primary Care, Lily Hospitals Limited, Warri), Ogonna N. O. Nwankwo (University of Calabar Teaching Hospital), Adefuye Bolanle Olufunlola (Olabisi Onabanjo University Teaching Hospital, Sagamu, Ogun State), Segaolu Olumide (Department of Medicine, Pulmonary Unit, University College Hospital, Ibadan), Kingsley N. Ukwaja (Department of Medicine, Federal Teaching Hospital Abakaliki, Ebonyi State); Pakistan : Muhammad Irfan, Section of Pulmonary and Critical Care Medicine (Department of Medicine, Aga Khan University, Karachi); Poland : Lukasz Minarowski (Department of Lung Diseases and Tuberculosis, Medical University of Bialystok), Skoczyński Szymon (Department of Pneumology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Institute of Occupational Medicine and Environmental Health, Sosnowiec); Portugal : Felipe Froes (Hospital Pulido Valente–CHLN, Lisboa), Pedro Leuschner, (Centro Hospitalar do Porto), Mariana Meireles, Cláudia Ferrão, Pedro Leuschner, and João Neves (Serviço de Medicina, Centro Hospitalar do Porto, Largo Prof Abel Salazar, Porto), Sofia B. Ravara (Faculty of Health Sciences, University of Beira Interior, Cova da Beira Hospital Center, Covilhã); Republic of Moldova : Victoria Brocovschii (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu), Chesov Ion (Clinic of Anesthesia and Intensive Care Valeriu Ghrerg, Institute of Emergency Medicine, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau), Doina Rusu (SMFU N. Testemitanu, Chisinau), Cristina Toma (Department of Pneumology and Allergology, State University of Medicine and Pharmacy Nicolae Testemitanu, Chisinau); Romania : Daniela Chirita (Hospital Sfantul Stefan, Bucharest), Carmen Mihaela Dorobat (Universitatea de Medicină şi Farmacie Gr T. Popa I a ş i Facultatea de Medicină Stomatologică, Spitalul Clinic de Boli Infecţioase Sfânta Parascheva I a ş i Iaşi); Russia : Alexei Birkun (Department of Anesthesiology, Critical Care and Emergency Medicine, Medical Academy named after S. I. Georgievsky), Anna Kaluzhenina (Volgograd State Medical University); Saudi Arabia : Abdullah Almotairi (King Fahad Medical City, Riyadh), Zakeya Abdulbaqi Ali Bukhary (College of Medicine, Taibah University, Medina), Jameela Edathodu (Al Faisal University, King Faisal Specialist Hospital, Riyadh), Amal Fathy (Pulmonary and Respiratory Critical Care Medicine, Mansoura University Egypt, Affiliate at Taibah University), Abdullah Mushira Abdulaziz Enani and Nazik Eltayeb Mohamed (Infectious Diseases Section, Medical Specialties Department, King Fahad Medical City, Riyadh), Jawed Ulhadi Memon (Pulmonology Division, Department of Internal Medicine, King Fahad Hospital, Hofuf, Al Ahasa), Abdelhaleem Bella (Dammam University–Saudi Arabia and King Fahad Hospital); Serbia : Nada Bogdanović (Pulmonary Department of KHC, Dragiša Mišović, Belgrade), Branislava Milenkovic (Clinic for Pulmonary Diseases, Clinical Centre of Serbia, Faculty of Medicine, University of Belgrade), Dragica Pesut (University of Belgrade School of Medicine, Teaching Hospital of Pulmonology, Clinical Centre of Serbia, Belgrade); Spain : Luis Borderìas (Respiratory and Sleep Unit, Hospital San Jorge, Huesca), Noel Manuel Bordon Garcia (Barcelona Policlínic and Moises Broggi Hospital at Sant Joan Despí), Hugo Cabello Alarcón (Sant Hospital Seu de Urgell, Catalonia), Catia Cilloniz and Antoni Torres (Department of Pneumology, Institut Clinic del Tórax, Hospital Clinic of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer, University of Barcelona), Vicens Diaz-Brito and Xavier Casas (Infectious Diseases Unit and Pneumology Service, Parc Sanitari Sant Joan de Deu, Sant Boi, Barcelona), Alicia Encabo González (Hospital Complex of Pontevedra), Maria Luisa Fernández-Almira (Medicina Interna, Hospital Universitario Central de Asturias), Miguel Gallego (Department of Respiratory Medicine, Hospital de Sabadell, Institut Universitari Parc Taulí-UAB, Sabadell, and CIBER de Enfermedades Respiratorias, CIBERES, Bunyola), Inmaculada Gaspar-GarcÍa (Department of Respiratory Medicine, Hospital Costa del Sol, Marbella, Málaga), Juan González del Castillo (Emergency Department, Hospital Universitario Clínico San Carlos, Madrid), Patricia Javaloyes Victoria (Hospital General Universitario de Alicante, Alicante), Elena Laserna Martínez (Hospital Mollet, Barcelona), Rosa Malo de Molina (University Hospital Puerta de Hierro Majadahonda, Madrid), Pedro J. Marcos (Servicio de Neumología, Complejo Hospitalario Universitario de A Coruña, INIBIC, Sergas, Universidade de A Coruña), Rosario Menéndez (Pneumology Service, University and Polytechnic Hospital La Fe, Valencia), Ana Pando-Sandoval (Hospital Universitario Central de Asturias, Area de Gestion Clinica de Pulmon, Servicio de Neumologia, Oviedo), Cristina Prat Aymerich, Alicia Lacoma de la Torre, and Ignasi García-Olivé (Microbiology Department and Pneumology Department, Hospital Universitari Germans Trias i Pujol, Institut d’Investigació Germans Trias i Pujol, Badalona, and Universitat Autònoma de Barcelona, CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III), Jordi Rello and Silvia Moyano (Critical Care Department, Hospital Vall d’Hebron, Barcelona), Francisco Sanz (Servicio de Neumología, Consorci Hospital General Universitari de Valencia, Valencia), Oriol Sibila and Ana Rodrigo-Troyano (Servei de Pneumologia, Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, Barcelona), Jordi Solé-Violán (Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria), Ane Uranga (Pulmology Department, Hospital of Galdakao-Usansolo), Job F. M. van Boven (Hospital Universitari Son Espases, Palma de Mallorca), Ester Vendrell Torra and Jordi Almirall Pujol (Intensive Care Medicine, Hospital de Mataró); South Africa : Charles Feldman (Division of Pulmonology, Department of Internal Medicine, Charlotte Maxeke Johannesburg Academic Hospital, Faculty of Health Sciences, University of the Witwatersrand); South Korea : Ho Kee Yum (Inje University Seoul Paik Hospital); Togo : Arnauld Attannon Fiogbe (Pulmonology and Infectious Diseases Service/University Hospital of Sylvanus Olympio, Lomé); Tunisia : Ferdaous Yangui (Department of Pneumology, Hospital of Internal Forces Security, Marsa, Tunis); Turkey : Semra Bilaceroglu (Izmir Dr Suat Seren Training and Research Hospital for Thoracic Medicine and Surgery, Izmir), Levent Dalar (Pulmonary Medicine, Istanbul Bilim University, Istanbul), Ufuk Yilmaz (Suat Seren Chest Disease and Surgery Training and Research Hospital, İzmir); Ukraine : Artemii Bogomolov (Vinnitsa National Pirogov Memorial Medical University, Vinnitsa Regional Antituberculosis Hospital, Vinnitsa); United Arab Emirates : Naheed Elahi (Dubai Hospital); United Kingdom : Devesh J. Dhasmana (Victoria Hospital, Kirkcaldy, NHS Fife), Andrew Feneley, Rhiannon Ions, Julie Skeemer, and Gerrit Woltmann, University Hospitals of Leicester NHS Trust and University of Leicester), Carole Hancock (Royal Respiratory Research Team, Royal Liverpool University Hospital, Liverpool), Adam T. Hill (Royal Infirmary and University of Edinburgh), Banu Rudran (The Royal London Hospital, Barts Health Trust, London), Silvia Ruiz-Buitrago and Marion Campbell (Hairmyres Hospital, East Kilbride), Paul Whitaker (Department of Respiratory Medicine, St James’s Hospital, Leeds), Alexander Youzguin (Southport and Ormskirk Hospitals NHS Trust), Anika Singanayagam (Imperial College Healthcare NHS Trust, London); United States : Karen S. Allen (University of Oklahoma Health Sciences Center, Oklahoma City), Veronica Brito (Texas A&amp;M Health Science Center, Division of Pulmonary, Critical Care, and Sleep Medicine, Baylor Scott &amp; White Health, Temple); Jessica Dietz (Fargo VA Health Care System, Fargo, North Dakota), Claire E. Dysart and Susan M. Kellie (Clement J. Zablocki VA Medical Center, Milwaukee, Wisconsin; Division of Infectious Diseases, University of New Mexico School of Medicine; and Raymond G. Murphy VA Medical Center, Albuquerque, New Mexico), Ricardo A Franco-Sadud and Garnet Meier (Division of Hospital Medicine, Cook County Hospital, Chicago, Illinois), Mina Gaga (7th Respiratory Medical Department and Asthma Center, Athens Chest Hospital), Thomas L. Holland and Stephen P. Bergin (Department of Medicine, Duke University Medical Center and School of Medicine, Duke Clinical Research Institute, Durham), Fayez Kheir (Department of Pulmonary Diseases, Critical Care and Environmental Medicine, Tulane University Health Sciences Center, New Orleans, Louisiana), Mark Landmeier (Division of Pulmonary and Critical Care Medicine, Northwestern Memorial Hospital, Chicago, Illinois), Manuel Lois (John Peter Smith Hospital, Fort Worth, Texas), Girish B. Nair (Interstitial Lung Disease Program and Pulmonary Rehabilitation, SUNY Stony Brook, and Winthrop University Hospital, Mineola, New York), Hemali Patel (Department of Medicine, Division of General Internal Medicine, Hospital Medicine Group, University of Colorado, Denver), Katherine Reyes (Henry Ford Hospital, Detroit, Illinois), William Rodriguez-Cintron, (Pulmonary/Critical Care Medicine VA Caribbean Healthcare System, San Juan Puerto Rico), Shigeki Saito (Tulane University, New Orleans), Nilam J. Soni, Julio Noda, Cecilia I. Hinojosa, Stephanie M. Levine, Luis F. Angel, and Antonio Anzueto (Divisions of Hospital Medicine and Pulmonary/Critical Care Medicine, South Texas Veterans Health Care System, University of Texas Health Science Center San Antonio, San Antonio), K. Scott Whitlow, John Hipskind, Kunal Sukhija, and Vicken Totten (Kaweah Delta Health Care District, Department of Emergency Medicine, Visalia, California), Richard G. Wunderink and Ray D. Shah (Northwestern University Feinberg School of Medicine, Chicago, Illinois); Zambia : Kondwelani John Mateyo (Department of Internal Medicine, University Teaching Hospital, Lusaka). Other investigators : Lorena Noriega, Ezequiel Alvarado, Mohamed Aman, and Lucía Labra. Disclaimer. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute, the National Institutes of Health, or the Department of Veterans Affairs. Financial support. This project was not funded and relied solely on voluntary site and investigator participation. M. I. R.’s time is partially protected by the National Heart, Lung, and Blood Institute (award K23HL096054). Potential conflicts of interest. F. B. reports personal fees from AstraZeneca, GlaxoSmithKline, Guidotti, Grifols, Menarini, and Novartis, and grants and personal fees from Bayer, Chiesi, Insmed, Pfizer, Teva, and Zambon, outside the submitted work. All other authors report no potential conflicts. References 1. Aliberti S , Di Pasquale M , Zanaboni AM , et al. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia . Clin Infect Dis 2012 ; 54 : 470 – 8 . 2. Aliberti S , Cilloniz C , Chalmers JD , et al. Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective . Thorax 2013 ; 68 : 997 – 9 . 3. Shindo Y , Ito R , Kobayashi D , et al. Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia . Am J Respir Crit Care Med 2013 ; 188 : 985 – 95 . 4. Musher DM , Thorner AR . Community-acquired pneumonia . N Engl J Med 2014 ; 371 : 1619 – 28 . 5. Mandell LA , Wunderink RG , Anzueto A , et al. ; Infectious Diseases Society of America; American Thoracic Society . Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults . Clin Infect Dis 2007 ; 44 ( suppl 2 ): S27 – 72 . 6. Lim WS , Baudouin SV , George RC , et al. BTS guidelines for the management of community acquired pneumonia in adults . Thorax 2009 ; 64 ( suppl III ): iii1 – 55 . 7. Woodhead M , Blasi F , Ewig S , et al. ; Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases . Guidelines for the management of adult lower respiratory tract infections—full version . Clin Microbiol Infect 2011 ; 17(suppl 6) : E1 – 59 . 8. Furman CD , Rayner AV , Tobin EP . Pneumonia in older residents of long-term care facilities . Am Fam Physician 2004 ; 70 : 1495 – 500 . 9. Cillóniz C , Polverino E , Ewig S , et al. Impact of age and comorbidity on cause and outcome in community-acquired pneumonia . Chest 2013 ; 144 : 999 – 1007 . 10. Aliberti S , Reyes LF , Faverio P , et al. ; GLIMP investigators . Global Initiative for Meticillin-Resistant Staphylococcus aureus Pneumonia (GLIMP): an international, observational cohort study . Lancet Infect Dis 2016 ; 16 : 1364 – 76 . 11. Magiorakos AP , Srinivasan A , Carey RB , et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance . Clin Microbiol Infect 2012 ; 18 : 268 – 81 . 12. Wan QJ , Hu HF , He YC , et al. Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy . Kaohsiung J Med Sci 2015 ; 31 : 42 – 6 . 13. Li F , Jin HZ , Su F , Jia L , Sun QN . Pneumocystis pneumonia in patients with immunobullous dermatoses . Int J Dermatol 2011 ; 50 : 1144 – 9 . 14. Gruson D , Vargas F , Hilbert G , et al. Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia . Intensive Care Med 2004 ; 30 : 965 – 71 . 15. Garcia JB , Lei X , Wierda W , et al. Pneumonia during remission induction chemotherapy in patients with acute leukemia . Ann Am Thorac Soc 2013 ; 10 : 432 – 40 . 16. Lee JO , Kim DY , Lim JH , et al. Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients . Lung Cancer 2008 ; 62 : 381 – 4 . 17. Lim KH , Yoon HI , Kang YA , et al. Severe pulmonary adverse effects in lymphoma patients treated with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus rituximab . Korean J Intern Med 2010 ; 25 : 86 – 92 . 18. Waks AG , Tolaney SM , Galar A , et al. Pneumocystis jiroveci pneumonia (PCP) in patients receiving neoadjuvant and adjuvant anthracycline-based chemotherapy for breast cancer: incidence and risk factors . Breast Cancer Res Treat 2015 ; 154 : 359 – 67 . 19. Kim T , Choi SH , Kim SH , et al. Point prevalence of Pneumocystis pneumonia in patients with non-Hodgkin lymphoma according to the number of cycles of R-CHOP chemotherapy . Ann Hematol 2013 ; 92 : 231 – 8 . 20. Aliberti S , Myers JA , Peyrani P , et al. The role of neutropenia on outcomes of cancer patients with community-acquired pneumonia . Eur Respir J 2009 ; 33 : 142 – 7 . 21. Sogaard OS , Lohse N , Gerstoft J , et al. Hospitalization for pneumonia among individuals with and without HIV infection, 1995-2007: a Danish population-based, nationwide cohort study . Clin Infect Dis 2008 ; 47 : 1345 – 53 . 22. Kuehnhardt D , Hannemann M , Schmidt B , Heider U , Possinger K , Eucker J . Therapeutic implication of BAL in patients with neutropenia . Ann Hematol 2009 ; 88 : 1249 – 56 . 23. Maschmeyer G , Beinert T , Buchheidt D , et al. Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients: guidelines of the Infectious Diseases Working Party of the German Society of Haematology and Oncology . Eur J Cancer 2009 ; 45 : 2462 – 72 . 24. Alanio A , Hauser PM , Lagrou K , et al. ; 5th European Conference on Infections in Leukemia (ECIL-5), a joint venture of the European Group for Blood and Marrow Transplantation (EBMT), the European Organization for Research and Treatment of Cancer (EORTC), the Immunocompromised Host Society (ICHS) and the European LeukemiaNet (ELN) . ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients . J Antimicrob Chemother 2016 ; 71 : 2386 – 96 . 25. Freifeld AG , Bow EJ , Sepkowitz KA , et al. ; Infectious Diseases Society of America . Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America . Clin Infect Dis 2011 ; 52 : e56 – 93 . 26. Chemaly RF , Shah DP , Boeckh MJ . Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies . Clin Infect Dis 2014 ; 59 ( suppl 5 ): S344 – 51 . 27. Buchacz K , Lau B , Jing Y , et al. ; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA . Incidence of AIDS-defining opportunistic infections in a multicohort analysis of HIV-infected persons in the United States and Canada, 2000-2010 . J Infect Dis 2016 ; 214 : 862 – 72 . 28. Madeddu G , Porqueddu EM , Cambosu F , et al. Bacterial community acquired pneumonia in HIV-infected inpatients in the highly active antiretroviral therapy era . Infection 2008 ; 36 : 231 – 6 . 29. Park DR , Sherbin VL , Goodman MS , et al. ; Harborview CAP Study Group . The etiology of community-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness . J Infect Dis 2001 ; 184 : 268 – 77 . 30. Torres HA , Bodey GP , Rolston KV , Kantarjian HM , Raad II , Kontoyiannis DP . Infections in patients with aplastic anemia: experience at a tertiary care cancer center . Cancer 2003 ; 98 : 86 – 93 . 31. Gil-Prieto R , Pascual-Garcia R , Walter S , Álvaro-Meca A , Gil-De-Miguel Á . Risk of hospitalization due to pneumococcal disease in adults in Spain: the CORIENNE study . Hum Vaccin Immunother 2016 ; 12 : 1900 – 5 . 32. Putot A , Tetu J , Perrin S , et al. Impact of microbiological samples in the hospital management of community-acquired, nursing home-acquired and hospital-acquired pneumonia in older patients . Eur J Clin Microbiol Infect Dis 2016 ; 35 : 489 – 95 . 33. Polverino E , Dambrava P , Cillóniz C , et al. Nursing home-acquired pneumonia: a 10 year single-centre experience . Thorax 2010 ; 65 : 354 – 9 . 34. Kohli R , Lo Y , Homel P , et al. ; HER Study Group . Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study . Clin Infect Dis 2006 ; 43 : 90 – 8 . 35. Benito N , Rañó A , Moreno A , et al. Pulmonary infiltrates in HIV-infected patients in the highly active antiretroviral therapy era in Spain . J Acquir Immune Defic Syndr 2001 ; 27 : 35 – 43 . 36. Mori H , Ohno Y , Ito F , et al. Polymerase chain reaction positivity of Pneumocystis jirovecii during primary lung cancer treatment . Jpn J Clin Oncol 2010 ; 40 : 658 – 62 . 37. Boersma WG , Erjavec Z , van der Werf TS , de Vries-Hosper HG , Gouw AS , Manson WL . Bronchoscopic diagnosis of pulmonary infiltrates in granulocytopenic patients with hematologic malignancies: BAL versus PSB and PBAL . Respir Med 2007 ; 101 : 317 – 25 . 38. Mikulska M , Del Bono V , Gandolfo N , et al. Epidemiology of viral respiratory tract infections in an outpatient haematology facility . Ann Hematol 2014 ; 93 : 669 – 76 . 39. Beaird OE , Freifeld A , Ison MG , et al. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative . Transpl Infect Dis 2016 ; 18 : 210 – 5 . 40. Poonyagariyagorn HK , Gershman A , Avery R , et al. Challenges in the diagnosis and management of Nocardia infections in lung transplant recipients . Transpl Infect Dis 2008 ; 10 : 403 – 8 . 41. Tavadze M , Rybicki L , Mossad S , et al. Risk factors for vancomycin-resistant Enterococcus bacteremia and its influence on survival after allogeneic hematopoietic cell transplantation . Bone Marrow Transplant 2014 ; 49 : 1310 – 6 . 42. Bock AM , Cao Q , Ferrieri P , Young JA , Weisdorf DJ . Bacteremia in blood or marrow transplantation patients: clinical risk factors for infection and emerging antibiotic resistance . Biol Blood Marrow Transplant 2013 ; 19 : 102 – 8 . 43. Herbers AH , de Haan AF , van der Velden WJ , Donnelly JP , Blijlevens NM . Mucositis not neutropenia determines bacteremia among hematopoietic stem cell transplant recipients . Transpl Infect Dis 2014 ; 16 : 279 – 85 . 44. Wu SW , Liu KS , Lin CK , et al. Community-acquired urinary tract infection in kidney transplantation: risk factors for bacteremia and recurrent infection . J Formos Med Assoc 2013 ; 112 : 138 – 43 . 45. Daskalaki E , Koukoulaki M , Bakalis A , et al. Blood stream infections in renal transplant recipients: a single-center study . Transplant Proc 2014 ; 46 : 3191 – 3 . 46. Huson MA , Stolp SM , van der Poll T , Grobusch MP . Community-acquired bacterial bloodstream infections in HIV-infected patients: a systematic review . Clin Infect Dis 2014 ; 58 : 79 – 92 . 47. Taramasso L , Tatarelli P , Di Biagio A . Bloodstream infections in HIV-infected patients . Virulence 2016 ; 7 : 320 – 8 . © The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model ) Topic: Issue Section: Articles and Commentaries Download all slides Supplementary data - docx file Advertisement Citations Views 18,086 Altmetric Metrics Total Views 18,086 11,927 Pageviews 6,159 PDF Downloads Since 8/1/2018 Month: Total Views: August 2018 66 September 2018 28 October 2018 23 November 2018 70 December 2018 46 January 2019 53 February 2019 62 March 2019 31 April 2019 408 May 2019 355 June 2019 182 July 2019 176 August 2019 159 September 2019 111 October 2019 90 November 2019 66 December 2019 44 January 2020 69 February 2020 36 March 2020 223 April 2020 208 May 2020 140 June 2020 179 July 2020 162 August 2020 154 September 2020 217 October 2020 238 November 2020 237 December 2020 165 January 2021 140 February 2021 137 March 2021 236 April 2021 239 May 2021 239 June 2021 172 July 2021 131 August 2021 160 September 2021 205 October 2021 250 November 2021 227 December 2021 183 January 2022 202 February 2022 247 March 2022 301 April 2022 242 May 2022 240 June 2022 161 July 2022 159 August 2022 292 September 2022 404 October 2022 533 November 2022 300 December 2022 477 January 2023 287 February 2023 191 March 2023 310 April 2023 395 May 2023 248 June 2023 198 July 2023 185 August 2023 213 September 2023 248 October 2023 340 November 2023 311 December 2023 269 January 2024 301 February 2024 353 March 2024 372 April 2024 323 May 2024 341 June 2024 275 July 2024 268 August 2024 218 September 2024 253 October 2024 274 November 2024 312 December 2024 242 January 2025 250 February 2025 296 March 2025 396 April 2025 228 May 2025 228 June 2025 86 Citations Powered by Dimensions Web of Science Altmetrics 346 readers on Mendeley Email alerts New journal issues New journal articles Activity related to this article Sign up for marketing New journal issues alert To set up an email alert, please to your personal account, or register Sign in Personal account Sign in with email/username &amp; password Get email alerts Save searches Purchase content Activate your purchase/trial code Add your ORCID iD Register Journal article activity alert To set up an email alert, please to your personal account, or register Sign in Personal account Sign in with email/username &amp; password Get email alerts Save searches Purchase content Activate your purchase/trial code Add your ORCID iD Register Close Modal More on this topic Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods Microbial Agents Associated with Pneumonia in Children from Uruguay In the Literature Comparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study Related articles in PubMed Citing articles via Effectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial Study Characteristics Associated with Disseminated Gonococcal Infections vs Uncomplicated Gonorrhea: A California Case-Control Study, 2021-2022 Non-Operative versus Neurosurgical Treatment of Brain Abscess: An Emulated Trial Nested within a Nationwide, Population-Based Cohort Incidence of AIDS-defining Conditions among Adults with Perinatally Acquired HIV after Transition to Adult HIV Care in the United States and Canada, 2000-2022 State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists More from Oxford Academic Clinical Medicine Infectious Diseases Medicine and Health Books Journals Having trouble contacting the network. Please try again in a moment or two. Advertisement Advertisement close advertisement Advertisement About Clinical Infectious Diseases Editorial Board Author Guidelines Purchase Advertising and Corporate Services Online ISSN 1537-6591 Print ISSN 1058-4838 Copyright © 2025 Infectious Diseases Society of America About Oxford Academic Publish journals with us University press partners What we publish New features For authors Open access Purchasing Institutional account management Rights and permissions Get help with access Accessibility Contact us Advertising Media enquiries Oxford University Press News Oxford Languages Oxford University Press is a department of the University of Oxford. It furthers the University's objective of excellence in research, scholarship, and education by publishing worldwide Copyright © 2025 Oxford University Press Cookie settings Cookie policy Privacy policy Legal notice This Feature Is Available To Subscribers Only Sign In or Create an Account This PDF is available to Subscribers Only View Article Abstract &amp; Purchase Options For full access to this pdf, sign in to an existing account, or purchase an annual subscription. Manage Cookies When you visit web sites, they may store or retrieve data in your web browser. This storage is often necessary for basic functionality of the web site or the storage may be used for the purposes of marketing, analytics, and personalization of the web site such as storing your preferences. Powered by Save Oxford University Press uses cookies to enhance your experience on our website. By selecting ‘accept all’ you are agreeing to our use of cookies. You can change your cookie settings at any time. More information can be found in our Cookie Policy . Reject and manage Deny all Accept all"
      },
      "media": {
        "images": [
          {
            "src": "//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_title-1229789578.svg",
            "data": "",
            "alt": "Clinical Infectious Diseases",
            "desc": "IDSA Journals",
            "score": 3,
            "type": "image",
            "group_id": 3,
            "format": null,
            "width": null
          },
          {
            "src": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/Issue/68/9/5/m_cover.jpeg?Expires=1752631924&Signature=VzkJpzpYIXCozHbdsaIS60qWT14TRuSLuGC1eukUyrcYSb6veXmlbdxxi4bsCqv56PfMH7dlbqN9LPLYakKnZ6uSxmWg0YAZOHfQIA39tvpONvJ71boTMCgDn8RhjNDckqV16RNIXTme4fSXo-Pb1NEzqABs9EzPZHe9bQMD6FT68PV8Vap~eeaNsVp85gS3jKjGejPEgn2-XCGy4vrE3MaPHJYIAkNxsVP0hL~5pIyLW4I1ZSyrhJhH-eg8MKmfcqb5InNKbRmJkLh~-95lJfZl5LOkCkFEzHqU5URne1xaCnWjdQWfdfTDCJXggdBa~HkCJsQ92f~1fLxypv7dIQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
            "data": "",
            "alt": "Clinical Infectious Diseases Cover Image for Volume 68, Issue 9",
            "desc": "Volume 68 Issue 9 1 May 2019",
            "score": 5,
            "type": "image",
            "group_id": 4,
            "format": "jpeg",
            "width": null
          },
          {
            "src": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1752554620&Signature=LKXAyrV74Aa9owXe0o-cQ75pOeSoID0-pehgygNtPZSFXNZMuhHSvh2bH2dv7qW8hH1yagXom1UIMLOtWgjAeeVu2LBuha-~CcDB2tnoDsCwd0W--ENWiqmCFTxq3yC2TQ0Umx7W~VJXwN6SRKyfDOflOkKvPGRNUobFX0ugYVCV63UYBnlhdsPfvI-fsKpp2D2I1PP6zBaXvsJbvI-0aIPK7XN9D-bkImy~2jyh7YxMl-ml056-m9M~e1NXIC1G-eMlJ-D0ihNbxsU~I2x~~h2BWrtr8AE9Sfu1WTqiFahp57mH4~iFGY9EkQkC4xJpjMyNKtQFhxpXjvQtYLzecQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
            "data": "",
            "alt": "Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases.",
            "desc": "Figure 1. Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases. Open in new tab Download slide",
            "score": 5,
            "type": "image",
            "group_id": 6,
            "format": "jpeg",
            "width": null
          },
          {
            "src": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72302.jpeg?Expires=1752554620&Signature=tN-5VXAN-IRDKK8axKZA8P~Y5z--s9j8Erc8SOjWl6DrKKH4QL5os9eZxhVeV6eWVN~f~VDG9tfzyHUF6i7OVsMNB2vsk6C~94Qv-2aRHoy5JP-aM-LrL8khDyqEa4Lg2BfInF3Q0qGwXrmt25GlH1qSBKirMgS~VlVo9FK3dUDe2-XgCIv-DixycDR1NbxEUad1obLBQi7T-cMZnDc0-hSXzSelH07q4yY8dbVGxrERuy5IWOvusZ1u83w1jCK4dSvt3hPFFdMZMOmGLi~Fj-dVSs0cAjfbIHoEDmqErTby4pVDEijEs5muQVm-Ux~YEjgN-VhvWj8YtpZKL4eSXA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
            "data": "",
            "alt": "Prevalence of each single risk factor for immunocompromise.",
            "desc": "Figure 2. Prevalence of each single risk factor for immunocompromise. Open in new tab Download slide",
            "score": 4,
            "type": "image",
            "group_id": 7,
            "format": "jpeg",
            "width": null
          },
          {
            "src": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72303.jpeg?Expires=1752554620&Signature=Xts16a6pXvQbNfwKtUeejfXsqF17z~2gviy7VcLQhhckWHmCw0zRSSEtsyrG9SkI2LRw39TbhqnqYNb1VTXQKD-ybyHkb~R3s-eIxJ~94DOxaaXBbUvpzbvwY1vDACc5LpVzJJ8dZMntZ7nekvhgMs6NtlpySVWDDC~7ybF0bySgW6i55FBFevIdcUxB3ipChEHL9XiTlmDkdiHssMser494UBvbDyg4DUKM-Cpd988M8qpSwp-eg-3Yhkr9q2~L66QQUhwgYNILWRRA1azwsTAJvrWUq52Dpikbj4mzbXXstnhvc7GNMw5xxz6nFPKuHVKJlcE-HQsiIvj5ZOVUxg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
            "data": "",
            "alt": "Prevalence of the number of risk factors present simultaneously in a single patient.",
            "desc": "Figure 3. Prevalence of the number of risk factors present simultaneously in a single patient. Open in new tab Download slide",
            "score": 4,
            "type": "image",
            "group_id": 8,
            "format": "jpeg",
            "width": null
          }
        ],
        "videos": [],
        "audio": [],
        "all_media": {
          "images": [
            {
              "src": "//oup.silverchair-cdn.com/data/SiteBuilderAssets/Live/Images/cid/cid_title-1229789578.svg",
              "data": "",
              "alt": "Clinical Infectious Diseases",
              "desc": "IDSA Journals",
              "score": 3,
              "type": "image",
              "group_id": 3,
              "format": null,
              "width": null
            },
            {
              "src": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/Issue/68/9/5/m_cover.jpeg?Expires=1752631924&Signature=VzkJpzpYIXCozHbdsaIS60qWT14TRuSLuGC1eukUyrcYSb6veXmlbdxxi4bsCqv56PfMH7dlbqN9LPLYakKnZ6uSxmWg0YAZOHfQIA39tvpONvJ71boTMCgDn8RhjNDckqV16RNIXTme4fSXo-Pb1NEzqABs9EzPZHe9bQMD6FT68PV8Vap~eeaNsVp85gS3jKjGejPEgn2-XCGy4vrE3MaPHJYIAkNxsVP0hL~5pIyLW4I1ZSyrhJhH-eg8MKmfcqb5InNKbRmJkLh~-95lJfZl5LOkCkFEzHqU5URne1xaCnWjdQWfdfTDCJXggdBa~HkCJsQ92f~1fLxypv7dIQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
              "data": "",
              "alt": "Clinical Infectious Diseases Cover Image for Volume 68, Issue 9",
              "desc": "Volume 68 Issue 9 1 May 2019",
              "score": 5,
              "type": "image",
              "group_id": 4,
              "format": "jpeg",
              "width": null
            },
            {
              "src": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1752554620&Signature=LKXAyrV74Aa9owXe0o-cQ75pOeSoID0-pehgygNtPZSFXNZMuhHSvh2bH2dv7qW8hH1yagXom1UIMLOtWgjAeeVu2LBuha-~CcDB2tnoDsCwd0W--ENWiqmCFTxq3yC2TQ0Umx7W~VJXwN6SRKyfDOflOkKvPGRNUobFX0ugYVCV63UYBnlhdsPfvI-fsKpp2D2I1PP6zBaXvsJbvI-0aIPK7XN9D-bkImy~2jyh7YxMl-ml056-m9M~e1NXIC1G-eMlJ-D0ihNbxsU~I2x~~h2BWrtr8AE9Sfu1WTqiFahp57mH4~iFGY9EkQkC4xJpjMyNKtQFhxpXjvQtYLzecQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
              "data": "",
              "alt": "Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases.",
              "desc": "Figure 1. Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases. Open in new tab Download slide",
              "score": 5,
              "type": "image",
              "group_id": 6,
              "format": "jpeg",
              "width": null
            },
            {
              "src": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72302.jpeg?Expires=1752554620&Signature=tN-5VXAN-IRDKK8axKZA8P~Y5z--s9j8Erc8SOjWl6DrKKH4QL5os9eZxhVeV6eWVN~f~VDG9tfzyHUF6i7OVsMNB2vsk6C~94Qv-2aRHoy5JP-aM-LrL8khDyqEa4Lg2BfInF3Q0qGwXrmt25GlH1qSBKirMgS~VlVo9FK3dUDe2-XgCIv-DixycDR1NbxEUad1obLBQi7T-cMZnDc0-hSXzSelH07q4yY8dbVGxrERuy5IWOvusZ1u83w1jCK4dSvt3hPFFdMZMOmGLi~Fj-dVSs0cAjfbIHoEDmqErTby4pVDEijEs5muQVm-Ux~YEjgN-VhvWj8YtpZKL4eSXA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
              "data": "",
              "alt": "Prevalence of each single risk factor for immunocompromise.",
              "desc": "Figure 2. Prevalence of each single risk factor for immunocompromise. Open in new tab Download slide",
              "score": 4,
              "type": "image",
              "group_id": 7,
              "format": "jpeg",
              "width": null
            },
            {
              "src": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72303.jpeg?Expires=1752554620&Signature=Xts16a6pXvQbNfwKtUeejfXsqF17z~2gviy7VcLQhhckWHmCw0zRSSEtsyrG9SkI2LRw39TbhqnqYNb1VTXQKD-ybyHkb~R3s-eIxJ~94DOxaaXBbUvpzbvwY1vDACc5LpVzJJ8dZMntZ7nekvhgMs6NtlpySVWDDC~7ybF0bySgW6i55FBFevIdcUxB3ipChEHL9XiTlmDkdiHssMser494UBvbDyg4DUKM-Cpd988M8qpSwp-eg-3Yhkr9q2~L66QQUhwgYNILWRRA1azwsTAJvrWUq52Dpikbj4mzbXXstnhvc7GNMw5xxz6nFPKuHVKJlcE-HQsiIvj5ZOVUxg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
              "data": "",
              "alt": "Prevalence of the number of risk factors present simultaneously in a single patient.",
              "desc": "Figure 3. Prevalence of the number of risk factors present simultaneously in a single patient. Open in new tab Download slide",
              "score": 4,
              "type": "image",
              "group_id": 8,
              "format": "jpeg",
              "width": null
            }
          ],
          "videos": [],
          "audios": []
        }
      },
      "links": {
        "internal": [
          {
            "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#skipNav",
            "text": "Skip to Main Content",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/",
            "text": "",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/journals",
            "text": "Journals",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/books",
            "text": "Books",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/information",
            "text": "",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/issue",
            "text": "Issues",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/advance-articles",
            "text": "Advance articles",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/search-results?page=1&f_OUPSeries=Editor%27s+Choice",
            "text": "Editor's Choice",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/supplements",
            "text": "Supplement Archive",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/issue-covers/",
            "text": "Cover Archive",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/pages/clinical-practice-guidelines",
            "text": "IDSA Guidelines",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/idsa",
            "text": "IDSA Journals",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/jid",
            "text": "The Journal of Infectious Diseases",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/ofid",
            "text": "Open Forum Infectious Diseases",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/pages/clinical-dilemmas",
            "text": "Clinical Dilemmas in ID",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/pages/photo-quizzes",
            "text": "Photo Quizzes",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/pages/state-of-the-art-reviews",
            "text": "State-of-the-Art Reviews",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/pages/voices-of-id",
            "text": "Voices of ID",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/idsa/pages/content-collections",
            "text": "IDSA Content Collections",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/pages/General_Instructions",
            "text": "Author Guidelines",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/pages/why-publish",
            "text": "Why Publish",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/idsa/pages/calls-for-papers",
            "text": "IDSA Journals Calls for Papers",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/subscribe",
            "text": "Purchase",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit",
            "text": "Advertising and Corporate Services",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising",
            "text": "Advertising",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/advertising-and-corporate-services/pages/reprints",
            "text": "Reprints and ePrints",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/advertising-and-corporate-services/pages/supplements",
            "text": "Sponsored Supplements",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/advertising-and-corporate-services/pages/branded-books",
            "text": "Branded Books",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/pages/About",
            "text": "About Clinical Infectious Diseases",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf",
            "text": "IDSA COI Policy",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/pages/Editorial_Board",
            "text": "Editorial Board",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/my-account/email-alerts",
            "text": "Alerts",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b",
            "text": "Self-Archiving Policy",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/pages/For_Reviewers",
            "text": "For Reviewers",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/idsa/pages/for_press_offices",
            "text": "For Press Offices",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid",
            "text": "",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/advanced-search?page=1&fl_SiteID=5269&SearchSourceType=1",
            "text": "Advanced Search",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/issue/68/9",
            "text": "Volume 68\nIssue 9\n\n\n1 May 2019",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#134170092",
            "text": "Abstract",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#134170097",
            "text": "MATERIALS AND METHODS",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#134170111",
            "text": "RESULTS",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#134170130",
            "text": "DISCUSSION",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#134170142",
            "text": "Supplementary Data",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#134170144",
            "text": "Notes",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#134170150",
            "text": "References",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#supplementary-data",
            "text": "Supplementary data",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article/68/9/1472/5089945",
            "text": "< Previous",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article/68/9/1494/5087661",
            "text": "Next >",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/search-results?f_Authors=Marta+Francesca+Di+Pasquale",
            "text": "Oxford Academic",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/search-results?f_Authors=Giovanni+Sotgiu",
            "text": "Oxford Academic",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/search-results?f_Authors=Andrea+Gramegna",
            "text": "Oxford Academic",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/search-results?f_Authors=Dejan+Radovanovic",
            "text": "Oxford Academic",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/search-results?f_Authors=Silvia+Terraneo",
            "text": "Oxford Academic",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/search-results?f_Authors=Luis+F+Reyes",
            "text": "Oxford Academic",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/search-results?f_Authors=Jan+Rupp",
            "text": "Oxford Academic",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/search-results?f_Authors=Juan+Gonz%c3%a1lez+del+Castillo",
            "text": "Oxford Academic",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/search-results?f_Authors=Francesco+Blasi",
            "text": "Oxford Academic",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/search-results?f_Authors=Stefano+Aliberti",
            "text": "Oxford Academic",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/",
            "text": "... Show more",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/search-results?f_Authors=Marcos+I+Restrepo",
            "text": "Oxford Academic",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article-pdf/68/9/1482/28520951/ciy723.pdf",
            "text": "PDF",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/view-large/figure/134170114/ciy72301.jpg",
            "text": "Open in new tab",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72301.jpeg?Expires=1752554620&Signature=NHcEJwNnhhuu~V7litr8igr9GFWfZ0zM0SxlfYOwAgN3ag3nsCMd9zXKoM9GZWcSFeGB~KznckX3sjRs7eZI6UovzOYWd5ChB8QCKT6DbvXvsAyPCY~~tvyw1nLgnCRXHxsEp9~pCDA4jyfmGwdzBmIxjxK32DKPE3r03H1NwaFfFuqtTjvCIQz2eID2dBiK~4lTbznS4INQ66i-Fh9DwTzI-HwYqclm24aYv1pSYlAiswZHOwaE-fO6wkuUxDcfD3pvVFQ~xscKfiFVbOt91lXVNkOd7p4CKoSAgaQv6yr5WZ9-7z1VyiIThnhC9G~HPkbIlB2Do4fo0jz7V2xwPA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170114&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269",
            "text": "Download slide",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/view-large/figure/134170116/ciy72302.jpg",
            "text": "Open in new tab",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72302.jpeg?Expires=1752554620&Signature=urCgidlWbN7Br1gKnVthRjYFEVioagJuBFmiXPuQQBoD2qmTrm4Heidc21Yt1dgPswbIwC7DPhnYrlHrjxMxL-tPDfinKG-olgkospAEDA-ocZW5BuK9lYsha0rJ0NF76fxfhqDzGVUbNAug3anPLTq4c4Wm9hmTgaDN4Qc2ECcT8hDYAnEm3od96dWn52Zy09JsZa4zT41kMG~qQJEZG62~24b5nEIG7eSCncOceqVPqOOaaIMniBLrAQuB7Hvqr~6AtHN5IBjBuLUjU1xYJcFJXX6WtIhnqkXKN21GOO7O7AU0AC7FLWQuEd1zCcVocKQxVv4RndCQeZ3XzZvegA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170116&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269",
            "text": "Download slide",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/view-large/figure/134170117/ciy72303.jpg",
            "text": "Open in new tab",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72303.jpeg?Expires=1752554620&Signature=aODZPs-HRl9QmymSK-5bkx~xp6iLrndvYFKxy1ge9DczmeUzsNnr5McNlvqrMcXHLvgMkhfK7yT7VuvVZQyJiTDmkR2j-SEc5zFcORnQPNUjDvGORdypfvcWI0ap8MKwHNe5lyBn4KtJz~tW8Oy3Gx54ukE8wke7~kZBzMvO8MTOkttiu8JkRKLQBqO6IcM2MoQBEcRSt-iQJjHBC9eSqzTw9hfjbhfc1npEBjHchP6v69RipZnUipM4HSTXcHzcLlv5ZrElufmBjKlaCOuMXehhls70RLfvTvOnOA3AyEmOSecyKEGpTAKKWMZCZcKwFjPqwgrO2KIMNHBcdECFyg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170117&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269",
            "text": "Download slide",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/view-large/figure/134170120/ciy72304.jpg",
            "text": "Open in new tab",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72304.jpeg?Expires=1752554620&Signature=YZzJ1wJWugBQStvfJV4l4KYj3Wo9NRpieCO~yvNqxtUBWQdjFeAYbw2G-Y6DLCVNq9Va5VeID5cdns-ikSqf31HJSxkU6nJ2ORJtfKpX9YRK1R4udPlHilZw7ywCq-EzR6AMwb3sY-BfsBS4sDesTOwvKTu1-DzRuTpqruza-~yCWEOuDxUkBBBhGOjezpmaPE1pK9FuWVCTdWQjhWi0Q1hWTQx8Y41~JVb3kGWNigqT8AD4v9JX1c4I3Lv7PwLI68bVFaY9GUswC-yS1tvJbrugsyrYyCUrS~h7Si20MQ14RfW5c61orGDtUvAkaoknOVddjBXj5tv5wBq7Hieh4A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170120&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269",
            "text": "Download slide",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/view-large/134170123",
            "text": "Open in new tab",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/view-large/134170125",
            "text": "Open in new tab",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/view-large/134170127",
            "text": "Open in new tab",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model",
            "text": "https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/search-results?f_TocHeadingTitleList=Articles+and+Commentaries",
            "text": "Articles and Commentaries",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=&PPTtype=SlideSet&ar=5078600&xsltPath=~/UI/app/XSLT&siteId=5269",
            "text": "Download all slides",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/new-journals-alert",
            "text": "New journal issues",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/new-journal-articles-alert",
            "text": "New journal articles",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/my-account/communication-preferences",
            "text": "Sign up for marketing",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/my-account/register?siteId=5269&returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600",
            "text": "register",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/my-account/register?siteId=5269&returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600",
            "text": "Register",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article/50/2/202/328880",
            "text": "Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article/12/Supplement_8/S915/296667",
            "text": "Microbial Agents Associated with Pneumonia in Children from Uruguay",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article/59/9/iii/419445",
            "text": "In the Literature",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/advance-article/7985365",
            "text": "Comparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf302/8159933?searchresult=1",
            "text": "Effectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial Study",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf311/8159932?searchresult=1",
            "text": "Characteristics Associated with Disseminated Gonococcal Infections vs Uncomplicated Gonorrhea: A California Case-Control Study, 2021-2022",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf304/8157607?searchresult=1",
            "text": "Non-Operative versus Neurosurgical Treatment of Brain Abscess: An Emulated Trial Nested within a Nationwide, Population-Based Cohort",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf300/8157063?searchresult=1",
            "text": "Incidence of AIDS-defining Conditions among Adults with Perinatally Acquired HIV after Transition to Adult HIV Care in the United States and Canada, 2000-2022",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/cid/article/80/5/e65/8156727?searchresult=1",
            "text": "State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/search-results?tax=AcademicSubjects/MED00160",
            "text": "Clinical Medicine",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/search-results?tax=AcademicSubjects/MED00290",
            "text": "Infectious Diseases",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/search-results?tax=AcademicSubjects/MED00010",
            "text": "Medicine and Health",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "http://global.oup.com/",
            "text": "",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/about-oxford-academic",
            "text": "About Oxford Academic",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/about-oxford-academic/publish-journals-with-us",
            "text": "Publish journals with us",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/about-oxford-academic/our-university-press-partners",
            "text": "University press partners",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/what-we-publish",
            "text": "What we publish",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/new-features",
            "text": "New features",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/for-authors",
            "text": "For authors",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/open-research/open-access",
            "text": "Open access",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/purchasing",
            "text": "Purchasing",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/institutional-account-management",
            "text": "Institutional account management",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/purchasing/rights-and-permissions",
            "text": "Rights and permissions",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/get-help-with-access",
            "text": "Get help with access",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/about-oxford-academic/accessibility",
            "text": "Accessibility",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/contact-us",
            "text": "Contact us",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/advertising",
            "text": "Advertising",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/media-enquiries",
            "text": "Media enquiries",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://global.oup.com/",
            "text": "Oxford University Press",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://corp.oup.com/press-office",
            "text": "News",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://languages.oup.com/",
            "text": "Oxford Languages",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://global.oup.com/cookiepolicy",
            "text": "Cookie policy",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://global.oup.com/privacy",
            "text": "Privacy policy",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/pages/legal-notice",
            "text": "Legal notice",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/sign-in",
            "text": "Sign In",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://academic.oup.com/my-account/register?siteId=5269&returnUrl=%2fcid%2farticle%2f68%2f9%2f1482%2f5078600",
            "text": "Create an Account",
            "title": "",
            "base_domain": "oup.com"
          },
          {
            "href": "https://global.oup.com/cookiepolicy/?cc=gb",
            "text": "Cookie Policy",
            "title": "",
            "base_domain": "oup.com"
          }
        ],
        "external": [],
        "all_links": {
          "internal": [
            {
              "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#skipNav",
              "text": "Skip to Main Content",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/",
              "text": "",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/journals",
              "text": "Journals",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/books",
              "text": "Books",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/information",
              "text": "",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/issue",
              "text": "Issues",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/advance-articles",
              "text": "Advance articles",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/search-results?page=1&f_OUPSeries=Editor%27s+Choice",
              "text": "Editor's Choice",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/supplements",
              "text": "Supplement Archive",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/issue-covers/",
              "text": "Cover Archive",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/pages/clinical-practice-guidelines",
              "text": "IDSA Guidelines",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/idsa",
              "text": "IDSA Journals",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/jid",
              "text": "The Journal of Infectious Diseases",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/ofid",
              "text": "Open Forum Infectious Diseases",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/pages/clinical-dilemmas",
              "text": "Clinical Dilemmas in ID",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/pages/photo-quizzes",
              "text": "Photo Quizzes",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/pages/state-of-the-art-reviews",
              "text": "State-of-the-Art Reviews",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/pages/voices-of-id",
              "text": "Voices of ID",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/idsa/pages/content-collections",
              "text": "IDSA Content Collections",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/pages/General_Instructions",
              "text": "Author Guidelines",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/pages/why-publish",
              "text": "Why Publish",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/idsa/pages/calls-for-papers",
              "text": "IDSA Journals Calls for Papers",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/subscribe",
              "text": "Purchase",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/advertising-and-corporate-services/pages/cid-media-kit",
              "text": "Advertising and Corporate Services",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/advertising-and-corporate-services/pages/digital-advertising",
              "text": "Advertising",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/advertising-and-corporate-services/pages/reprints",
              "text": "Reprints and ePrints",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/advertising-and-corporate-services/pages/supplements",
              "text": "Sponsored Supplements",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/advertising-and-corporate-services/pages/branded-books",
              "text": "Branded Books",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/pages/About",
              "text": "About Clinical Infectious Diseases",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/DocumentLibrary/CID/idsa_coi_policies_november_2013.pdf",
              "text": "IDSA COI Policy",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/pages/Editorial_Board",
              "text": "Editorial Board",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/my-account/email-alerts",
              "text": "Alerts",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/journals/pages/access_purchase/rights_and_permissions/self_archiving_policy_b",
              "text": "Self-Archiving Policy",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/pages/For_Reviewers",
              "text": "For Reviewers",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/idsa/pages/for_press_offices",
              "text": "For Press Offices",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid",
              "text": "",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/advanced-search?page=1&fl_SiteID=5269&SearchSourceType=1",
              "text": "Advanced Search",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/issue/68/9",
              "text": "Volume 68\nIssue 9\n\n\n1 May 2019",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#134170092",
              "text": "Abstract",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#134170097",
              "text": "MATERIALS AND METHODS",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#134170111",
              "text": "RESULTS",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#134170130",
              "text": "DISCUSSION",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#134170142",
              "text": "Supplementary Data",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#134170144",
              "text": "Notes",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#134170150",
              "text": "References",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/#supplementary-data",
              "text": "Supplementary data",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article/68/9/1472/5089945",
              "text": "< Previous",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article/68/9/1494/5087661",
              "text": "Next >",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/search-results?f_Authors=Marta+Francesca+Di+Pasquale",
              "text": "Oxford Academic",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/search-results?f_Authors=Giovanni+Sotgiu",
              "text": "Oxford Academic",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/search-results?f_Authors=Andrea+Gramegna",
              "text": "Oxford Academic",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/search-results?f_Authors=Dejan+Radovanovic",
              "text": "Oxford Academic",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/search-results?f_Authors=Silvia+Terraneo",
              "text": "Oxford Academic",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/search-results?f_Authors=Luis+F+Reyes",
              "text": "Oxford Academic",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/search-results?f_Authors=Jan+Rupp",
              "text": "Oxford Academic",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/search-results?f_Authors=Juan+Gonz%c3%a1lez+del+Castillo",
              "text": "Oxford Academic",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/search-results?f_Authors=Francesco+Blasi",
              "text": "Oxford Academic",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/search-results?f_Authors=Stefano+Aliberti",
              "text": "Oxford Academic",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article/68/9/1482/5078600/",
              "text": "... Show more",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/search-results?f_Authors=Marcos+I+Restrepo",
              "text": "Oxford Academic",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article-pdf/68/9/1482/28520951/ciy723.pdf",
              "text": "PDF",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/view-large/figure/134170114/ciy72301.jpg",
              "text": "Open in new tab",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72301.jpeg?Expires=1752554620&Signature=NHcEJwNnhhuu~V7litr8igr9GFWfZ0zM0SxlfYOwAgN3ag3nsCMd9zXKoM9GZWcSFeGB~KznckX3sjRs7eZI6UovzOYWd5ChB8QCKT6DbvXvsAyPCY~~tvyw1nLgnCRXHxsEp9~pCDA4jyfmGwdzBmIxjxK32DKPE3r03H1NwaFfFuqtTjvCIQz2eID2dBiK~4lTbznS4INQ66i-Fh9DwTzI-HwYqclm24aYv1pSYlAiswZHOwaE-fO6wkuUxDcfD3pvVFQ~xscKfiFVbOt91lXVNkOd7p4CKoSAgaQv6yr5WZ9-7z1VyiIThnhC9G~HPkbIlB2Do4fo0jz7V2xwPA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170114&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269",
              "text": "Download slide",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/view-large/figure/134170116/ciy72302.jpg",
              "text": "Open in new tab",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72302.jpeg?Expires=1752554620&Signature=urCgidlWbN7Br1gKnVthRjYFEVioagJuBFmiXPuQQBoD2qmTrm4Heidc21Yt1dgPswbIwC7DPhnYrlHrjxMxL-tPDfinKG-olgkospAEDA-ocZW5BuK9lYsha0rJ0NF76fxfhqDzGVUbNAug3anPLTq4c4Wm9hmTgaDN4Qc2ECcT8hDYAnEm3od96dWn52Zy09JsZa4zT41kMG~qQJEZG62~24b5nEIG7eSCncOceqVPqOOaaIMniBLrAQuB7Hvqr~6AtHN5IBjBuLUjU1xYJcFJXX6WtIhnqkXKN21GOO7O7AU0AC7FLWQuEd1zCcVocKQxVv4RndCQeZ3XzZvegA__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170116&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269",
              "text": "Download slide",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/view-large/figure/134170117/ciy72303.jpg",
              "text": "Open in new tab",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72303.jpeg?Expires=1752554620&Signature=aODZPs-HRl9QmymSK-5bkx~xp6iLrndvYFKxy1ge9DczmeUzsNnr5McNlvqrMcXHLvgMkhfK7yT7VuvVZQyJiTDmkR2j-SEc5zFcORnQPNUjDvGORdypfvcWI0ap8MKwHNe5lyBn4KtJz~tW8Oy3Gx54ukE8wke7~kZBzMvO8MTOkttiu8JkRKLQBqO6IcM2MoQBEcRSt-iQJjHBC9eSqzTw9hfjbhfc1npEBjHchP6v69RipZnUipM4HSTXcHzcLlv5ZrElufmBjKlaCOuMXehhls70RLfvTvOnOA3AyEmOSecyKEGpTAKKWMZCZcKwFjPqwgrO2KIMNHBcdECFyg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170117&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269",
              "text": "Download slide",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/view-large/figure/134170120/ciy72304.jpg",
              "text": "Open in new tab",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/ciy72304.jpeg?Expires=1752554620&Signature=YZzJ1wJWugBQStvfJV4l4KYj3Wo9NRpieCO~yvNqxtUBWQdjFeAYbw2G-Y6DLCVNq9Va5VeID5cdns-ikSqf31HJSxkU6nJ2ORJtfKpX9YRK1R4udPlHilZw7ywCq-EzR6AMwb3sY-BfsBS4sDesTOwvKTu1-DzRuTpqruza-~yCWEOuDxUkBBBhGOjezpmaPE1pK9FuWVCTdWQjhWi0Q1hWTQx8Y41~JVb3kGWNigqT8AD4v9JX1c4I3Lv7PwLI68bVFaY9GUswC-yS1tvJbrugsyrYyCUrS~h7Si20MQ14RfW5c61orGDtUvAkaoknOVddjBXj5tv5wBq7Hieh4A__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA&sec=134170120&ar=5078600&xsltPath=~/UI/app/XSLT&imagename=&siteId=5269",
              "text": "Download slide",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/view-large/134170123",
              "text": "Open in new tab",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/view-large/134170125",
              "text": "Open in new tab",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/view-large/134170127",
              "text": "Open in new tab",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model",
              "text": "https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/search-results?f_TocHeadingTitleList=Articles+and+Commentaries",
              "text": "Articles and Commentaries",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/DownloadFile/DownloadImage.aspx?image=&PPTtype=SlideSet&ar=5078600&xsltPath=~/UI/app/XSLT&siteId=5269",
              "text": "Download all slides",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/new-journals-alert",
              "text": "New journal issues",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/new-journal-articles-alert",
              "text": "New journal articles",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/my-account/communication-preferences",
              "text": "Sign up for marketing",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/my-account/register?siteId=5269&returnUrl=https://academic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600",
              "text": "register",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/my-account/register?siteId=5269&returnUrl=http%3a%2f%2facademic.oup.com%2fcid%2farticle%2f68%2f9%2f1482%2f5078600",
              "text": "Register",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article/50/2/202/328880",
              "text": "Etiology of Community-Acquired Pneumonia: Increased Microbiological Yield with New Diagnostic Methods",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article/12/Supplement_8/S915/296667",
              "text": "Microbial Agents Associated with Pneumonia in Children from Uruguay",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article/59/9/iii/419445",
              "text": "In the Literature",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/advance-article/7985365",
              "text": "Comparative Outcomes of Babesiosis in Immunocompromised and Nonimmunocompromised Hosts: A Multicenter Cohort Study",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf302/8159933?searchresult=1",
              "text": "Effectiveness and safety of Autologous Virus-Specific T Cell Therapy for Persistent COVID-19 in People with Immunocompromise: A Clinical Trial Study",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf311/8159932?searchresult=1",
              "text": "Characteristics Associated with Disseminated Gonococcal Infections vs Uncomplicated Gonorrhea: A California Case-Control Study, 2021-2022",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf304/8157607?searchresult=1",
              "text": "Non-Operative versus Neurosurgical Treatment of Brain Abscess: An Emulated Trial Nested within a Nationwide, Population-Based Cohort",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaf300/8157063?searchresult=1",
              "text": "Incidence of AIDS-defining Conditions among Adults with Perinatally Acquired HIV after Transition to Adult HIV Care in the United States and Canada, 2000-2022",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/cid/article/80/5/e65/8156727?searchresult=1",
              "text": "State-of-the-Art Review: Transformative Changes in the Care of People With Cystic Fibrosis: Implications for Infectious Diseases Specialists",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/search-results?tax=AcademicSubjects/MED00160",
              "text": "Clinical Medicine",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/search-results?tax=AcademicSubjects/MED00290",
              "text": "Infectious Diseases",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/search-results?tax=AcademicSubjects/MED00010",
              "text": "Medicine and Health",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "http://global.oup.com/",
              "text": "",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/about-oxford-academic",
              "text": "About Oxford Academic",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/about-oxford-academic/publish-journals-with-us",
              "text": "Publish journals with us",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/about-oxford-academic/our-university-press-partners",
              "text": "University press partners",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/what-we-publish",
              "text": "What we publish",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/new-features",
              "text": "New features",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/for-authors",
              "text": "For authors",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/open-research/open-access",
              "text": "Open access",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/purchasing",
              "text": "Purchasing",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/institutional-account-management",
              "text": "Institutional account management",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/purchasing/rights-and-permissions",
              "text": "Rights and permissions",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/get-help-with-access",
              "text": "Get help with access",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/about-oxford-academic/accessibility",
              "text": "Accessibility",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/contact-us",
              "text": "Contact us",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/advertising",
              "text": "Advertising",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/media-enquiries",
              "text": "Media enquiries",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://global.oup.com/",
              "text": "Oxford University Press",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://corp.oup.com/press-office",
              "text": "News",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://languages.oup.com/",
              "text": "Oxford Languages",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://global.oup.com/cookiepolicy",
              "text": "Cookie policy",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://global.oup.com/privacy",
              "text": "Privacy policy",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/pages/legal-notice",
              "text": "Legal notice",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/sign-in",
              "text": "Sign In",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://academic.oup.com/my-account/register?siteId=5269&returnUrl=%2fcid%2farticle%2f68%2f9%2f1482%2f5078600",
              "text": "Create an Account",
              "title": "",
              "base_domain": "oup.com"
            },
            {
              "href": "https://global.oup.com/cookiepolicy/?cc=gb",
              "text": "Cookie Policy",
              "title": "",
              "base_domain": "oup.com"
            }
          ],
          "external": []
        }
      },
      "structured_data": {},
      "json_ld": [],
      "microdata": {},
      "rdfa": {},
      "screenshot": null,
      "meta_tags": {},
      "page_title": "",
      "headers": {},
      "cookies": [],
      "performance_metrics": {},
      "content_analysis": {
        "sizes": {
          "raw_html_size": 491157,
          "cleaned_html_size": 140935,
          "markdown_size": 103498,
          "text_length": 83129
        },
        "counts": {
          "images_count": 5,
          "videos_count": 0,
          "internal_links_count": 117,
          "external_links_count": 0,
          "total_links_count": 117
        },
        "quality_indicators": {
          "has_title": true,
          "has_description": true,
          "has_images": true,
          "has_structured_data": false,
          "content_richness_score": 65
        }
      },
      "logos": [],
      "institution_hints": {
        "institution_type": "hospital",
        "detected_keywords": [
          "hospital",
          "medical",
          "health",
          "patient",
          "care",
          "treatment",
          "clinic",
          "emergency",
          "surgery"
        ],
        "contact_indicators": [
          "phone",
          "email"
        ],
        "social_media_present": false
      }
    },
    "content_quality_score": 65,
    "metadata": {
      "title": "Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients | Clinical Infectious Diseases | Oxford Academic",
      "description": "Of patients with pneumonia coming from the community, 18% are immunocompromised. Specific immunocompromised states are associated with specific microbiolog",
      "keywords": null,
      "author": null,
      "og:site_name": "OUP Academic",
      "og:title": "Prevalence and Etiology of Community-acquired Pneumonia in Immunocompromised Patients",
      "og:description": "Of patients with pneumonia coming from the community, 18% are immunocompromised. Specific immunocompromised states are associated with specific microbiolog",
      "og:type": "article",
      "og:url": "https://dx.doi.org/10.1093/cid/ciy723",
      "og:image": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
      "og:image:url": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
      "og:image:secure_url": "https://oup.silverchair-cdn.com/oup/backfile/Content_public/Journal/cid/68/9/10.1093_cid_ciy723/1/m_ciy72301.jpeg?Expires=1812602620&Signature=OBrpDZdf0BCGtQi4CB0RkBCBD-GDK5taIMieHwZkHJQlhtCMOnAkwJ8FQrt9YP~ojuR9SvtlEVictqQZWVnhHbYIbaO5-oq4wDSk5mNLvU8wECisAUXJonLR59JmtTS5hb5hlu4P~c8QSRwoJMdMVkYYssfsl8A1Ci5BxXvkLy-RN8wZgmpzC57ZbM82t-ujOseMV7k5ohEA~G1H4abgZidZKvpBvhtXEJqzdBqi8KWj1N63zxSE02YSwhmHzv25AqICK8Kmr6k4QEWkL7cOmsNrsaje45GSzCKzX5auEBx1SW42I16oOeKIegZt-UmqkApnBDlySmJrziujRiUdDg__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA",
      "og:image:alt": "Distribution of prevalence of immunocompromise among the different countries participating in the study, categorized as no data, <5%, 5%–10%, 11%–20%, 21%–30%, or >30% of total cases.",
      "twitter:card": "summary_large_image"
    },
    "word_count": 12125,
    "size_bytes": 491157
  }
}